data_1k3n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k3n _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.884 0.374 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -35.68 74.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.81 -42.38 79.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -32.46 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 20' ' ' ILE . 2.3 mt -73.16 -35.39 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.808 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -57.26 -39.18 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 110.434 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -67.09 -24.05 65.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.233 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.794 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.427 -1.601 0 CA-C-O 121.866 0.841 . . . . 0.0 111.077 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' H ' ' HA ' ' A' ' 49' ' ' SER . 2.4 t -58.02 -66.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.193 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.1 m -152.23 165.13 35.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.836 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -125.86 138.03 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.072 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.414 ' HB ' ' CE1' ' A' ' 76' ' ' TYR . 21.7 t -102.57 123.81 56.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.408 HD12 ' CD2' ' A' ' 146' ' ' PHE . 11.4 mt -123.14 124.94 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.1 t -81.71 123.04 28.39 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 t -86.72 -28.92 22.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 142' ' ' SER . 36.8 p -79.91 -2.13 42.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.688 0.28 . . . . 0.0 111.552 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.75 77.0 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -145.36 -43.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -111.35 140.85 23.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.3 Cg_endo -72.52 131.43 17.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.127 1.884 . . . . 0.0 111.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.6 mt -51.84 131.56 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.659 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.87 164.21 19.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.251 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.404 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -117.84 120.1 36.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 111.536 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.557 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -97.64 134.87 40.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.426 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.794 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.79 157.25 43.63 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.74 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 120.73 0.3 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.5 t -124.87 139.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 111.983 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.557 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.7 m-90 -100.9 139.23 36.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.435 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.417 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.92 128.45 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -117.25 145.52 43.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.624 -177.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.76 -169.61 40.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.722 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.4 mtp-105 -83.25 -1.62 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.76 136.22 39.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 111.602 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.1 Cg_exo -67.44 -10.57 29.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.843 2.362 . . . . 0.0 111.979 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.55 -44.47 15.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.84 0.829 . . . . 0.0 109.02 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.78 139.31 2.33 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.42 -18.21 10.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.955 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -129.18 118.67 22.77 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.897 0.379 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.7 m -54.79 -34.94 63.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.067 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -26.63 67.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.406 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 33.1 mt -91.63 152.18 20.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -93.64 167.25 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -42.95 -54.12 4.39 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.374 0.607 . . . . 0.0 109.77 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.65 82.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.2 -46.25 88.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.836 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.5 p90 -143.57 159.84 41.71 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.13 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.516 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.7 tt0 -135.77 143.05 45.05 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.385 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 49.6 mt -118.69 127.86 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.973 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.426 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -114.11 141.81 47.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 111.956 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.407 ' CD1' ' HG ' ' A' ' 99' ' ' LEU . 7.5 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.229 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.9 0.381 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.31 145.41 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.316 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.77 121.37 44.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.888 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.6 t30 -116.81 115.66 25.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.789 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.7 p30 -78.96 136.62 37.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.751 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.8 pt -144.26 39.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.551 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.65 152.63 19.85 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.157 0.504 . . . . 0.0 111.956 -179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.0 m -68.79 -31.57 70.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.809 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.07 -19.97 17.64 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.541 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.53 157.04 10.58 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.695 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.38 137.71 52.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.04 148.56 40.06 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.556 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.39 43.64 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.96 -13.16 61.93 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.435 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.26 118.53 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.467 . . . . 0.0 110.465 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.66 129.26 38.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.52 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -97.84 163.45 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.91 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.71 125.34 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.487 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.1 tttt -52.25 161.27 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.755 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.19 34.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.21 145.03 40.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.145 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -85.69 129.13 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -129.09 146.23 51.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.548 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.75 111.97 8.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.246 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.0 tp -50.66 157.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.397 0.618 . . . . 0.0 111.646 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.45 153.13 42.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.6 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.73 124.75 25.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.83 20.91 50.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t70 -55.79 174.96 0.1 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.6 mt-10 -145.04 135.7 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.316 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.422 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 5.6 mt -111.59 126.99 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.493 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.65 137.23 42.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.944 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.518 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.47 158.32 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.29 22.81 42.87 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.324 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.512 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.4 t -62.62 140.33 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.663 0.744 . . . . 0.0 112.388 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -43.98 0.57 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.211 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 44.7 t -126.47 138.32 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -38.42 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.71 0.291 . . . . 0.0 111.584 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 t -93.55 6.2 49.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 133' ' ' GLY . 3.2 m-20 -116.31 22.52 12.8 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.2 mt -107.06 139.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.22 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 tt -124.48 134.27 53.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 40' ' ' THR . 46.9 t -111.28 150.54 29.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.716 0.769 . . . . 0.0 112.211 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 66.8 mt -135.38 156.57 48.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.67 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.413 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 20.9 t -125.68 137.54 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mt -106.48 120.96 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -106.01 122.39 46.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.407 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.4 mp -112.91 134.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.482 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -93.52 135.46 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -74.02 -21.34 60.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -58.22 -44.23 88.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.1 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.753 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.824 0.345 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -42.58 99.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -38.62 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.555 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.8 tp -58.1 -31.94 67.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.49 -35.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.726 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.67 -36.18 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.309 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.217 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.621 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm . . . . . 0 N--CA 1.426 -1.635 0 CA-C-O 121.763 0.792 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.43 -50.48 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.974 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.11 146.17 10.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.204 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -113.88 131.45 56.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.286 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.431 ' HB ' ' CZ ' ' A' ' 76' ' ' TYR . 28.7 t -97.8 122.79 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.3 mt -123.34 119.56 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.269 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.5 t -80.48 121.05 25.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.23 -27.72 18.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.422 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 142' ' ' SER . 69.2 p -80.31 -2.96 47.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.686 0.279 . . . . 0.0 111.556 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.86 80.74 0.2 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.375 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 15.2 mt-30 -149.62 -45.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.862 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.02 141.16 26.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.68 139.81 28.52 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.169 1.913 . . . . 0.0 112.125 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mt -55.23 135.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.725 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -134.37 164.02 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.209 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.2 119.72 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.7 mt -90.6 137.49 32.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.621 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.44 157.37 45.24 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.937 0 CA-C-N 113.3 -1.773 . . . . 0.0 110.497 178.379 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.4 t -129.95 139.61 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.293 0.568 . . . . 0.0 111.809 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.554 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.3 m-90 -100.24 139.68 35.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.146 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.539 HG22 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.23 131.94 54.59 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 0.0 111.624 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.74 -174.43 41.44 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.554 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.6 mtm105 -81.52 -0.78 43.54 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.77 135.66 40.02 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.666 0.269 . . . . 0.0 111.273 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.52 -7.53 20.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.728 2.285 . . . . 0.0 111.876 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.42 15.63 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.977 0.894 . . . . 0.0 108.936 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.73 137.33 5.46 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.646 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.45 -18.81 12.52 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.853 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.3 t80 -129.86 117.25 19.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.887 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.496 179.624 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.5 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.951 0.405 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -43.17 73.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.343 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -44.15 97.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 HD21 ' CE1' ' A' ' 88' ' ' HIS . 46.5 mt -72.77 152.18 41.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.188 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.5 p -95.49 165.5 12.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.741 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.671 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.39 -53.01 5.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.344 0.593 . . . . 0.0 109.627 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' HD11 ' A' ' 104' ' ' ILE . 17.1 mttt -119.69 84.57 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -63.99 -45.27 89.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.095 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.407 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.6 p90 -150.99 162.39 40.92 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.155 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.539 ' HG2' HG22 ' A' ' 67' ' ' THR . 11.6 mt-30 -135.49 158.27 44.8 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.378 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 64.2 mt -127.45 132.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.957 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -113.72 144.46 42.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.731 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.521 179.713 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.464 ' CG ' HD23 ' A' ' 124' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.95 0.405 . . . . 0.0 111.047 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.447 ' HB2' ' CG ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.55 149.44 50.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.506 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.52 131.59 54.92 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 90' ' ' GLN . 46.9 t30 -113.28 115.92 28.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.661 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.1 p30 -76.65 143.06 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.45 HG12 ' HG3' ' A' ' 90' ' ' GLN . 10.0 pt -150.75 37.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.582 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.06 158.82 15.25 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.047 0.451 . . . . 0.0 111.807 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.9 m -68.92 -35.31 76.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.587 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -20.04 17.3 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.33 163.36 11.96 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.488 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 20.8 m -117.53 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.811 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -114.36 148.4 37.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.17 113.43 18.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.281 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 43.72 43.4 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.48 -12.43 66.84 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.482 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -104.96 118.53 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.067 0.461 . . . . 0.0 110.642 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.811 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.19 134.9 45.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.501 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -105.01 164.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.4 tp10 -69.95 125.07 25.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.661 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.6 tttt -51.82 160.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.422 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 35.89 33.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.54 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.57 145.09 40.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 179.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -86.81 129.79 34.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.789 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.6 mm-40 -127.53 147.74 50.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.409 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.58 120.95 18.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.539 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 125' ' ' SER . 5.9 tp -58.89 155.94 12.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.486 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.553 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.3 t -124.25 153.43 41.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.342 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 6.5 tp60 -71.41 123.99 23.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.28 22.17 42.99 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.276 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.7 t70 -58.14 174.56 0.27 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -145.2 135.46 24.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.146 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 16.0 mt -111.59 128.39 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.261 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.487 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.08 138.85 40.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 30.3 m -140.15 158.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.89 22.37 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.85 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.32 140.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 121.598 0.713 . . . . 0.0 112.442 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.37 -39.87 0.7 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 52.0 t -126.59 128.62 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.48 -34.68 25.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 87.4 p -93.54 6.3 48.69 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 7.5 t0 -124.18 24.85 8.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.543 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.9 mt -104.78 139.61 25.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.823 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.403 ' HG ' ' CD2' ' A' ' 143' ' ' LEU . 25.3 tp -117.54 134.75 54.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.956 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.582 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.8 OUTLIER -111.54 135.47 52.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.547 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.403 ' CD2' ' HG ' ' A' ' 141' ' ' LEU . 1.9 mm? -131.04 138.48 49.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.84 138.7 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.339 . . . . 0.0 110.927 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 6.6 mt -106.26 139.01 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.9 119.88 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 3.4 mt -85.62 134.17 27.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.553 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.55 107.48 13.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -58.21 -32.18 68.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -60.25 -45.92 91.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 . . . . . 0 N--CA 1.452 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.074 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.797 0.332 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -42.62 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.65 -38.08 74.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -31.81 70.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.19 -35.54 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.49 -39.96 77.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -67.1 -23.87 65.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.4 mm . . . . . 0 N--CA 1.429 -1.511 0 CA-C-O 121.566 0.698 . . . . 0.0 112.575 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -93.53 -59.46 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.643 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 m -152.81 150.48 29.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.383 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -115.18 131.71 56.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.777 0.322 . . . . 0.0 111.248 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.407 ' HB ' ' CE1' ' A' ' 76' ' ' TYR . 43.8 t -96.18 122.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.053 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.5 mt -124.01 121.38 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.661 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.5 t -82.04 121.65 26.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.459 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.414 ' CG2' HG21 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -94.58 -25.1 16.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.501 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 5.9 p -80.04 -2.38 44.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.663 0.268 . . . . 0.0 111.386 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.09 78.98 0.21 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.851 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 15.5 mt-30 -149.38 -40.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 9.2 mt -124.2 141.68 37.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.97 146.13 41.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.193 1.928 . . . . 0.0 112.12 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.8 mt -60.3 146.32 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.647 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -140.31 163.23 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.07 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.29 119.8 36.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 111.843 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.557 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.6 mt -93.25 137.42 32.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.273 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.39 157.32 43.76 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.854 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 49' ' ' SER . 8.6 ttpt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.887 0.375 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.9 p -110.44 140.23 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.557 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 13.5 m-90 -100.22 139.22 36.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.852 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.85 128.74 56.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -116.61 145.63 43.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.353 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.37 -170.0 39.38 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.788 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.9 mtp-105 -81.22 1.17 33.38 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 140.32 37.92 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.661 0.267 . . . . 0.0 110.903 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.27 -11.69 22.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.511 2.141 . . . . 0.0 111.354 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.7 18.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.12 138.31 3.01 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.317 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.36 -18.53 11.21 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.874 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.498 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 3.7 t80 -129.54 127.97 41.82 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.713 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.751 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.427 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 41.1 mt . . . . . 0 N--CA 1.458 -0.027 0 CA-C-O 120.799 0.333 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.55 -35.63 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.279 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.03 -45.65 93.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.834 0.349 . . . . 0.0 110.699 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 16.1 mt -75.32 148.29 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -93.7 167.13 11.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.601 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.54 -53.62 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.393 0.616 . . . . 0.0 109.834 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.38 82.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.4 t60 -58.8 -46.26 88.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.772 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.7 p90 -144.7 162.19 37.32 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.099 -0.641 . . . . 0.0 112.121 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 2.8 tt0 -135.59 146.79 48.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.09 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 64.8 mt -123.14 130.42 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.506 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.99 141.03 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.222 0.534 . . . . 0.0 112.188 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.778 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.887 0.375 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.8 mp -121.4 142.46 49.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.31 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.71 124.13 51.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.2 t30 -116.05 115.51 26.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.493 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.686 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 19.5 p30 -79.16 137.7 37.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -146.61 40.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.567 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.85 160.18 14.51 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.971 0.415 . . . . 0.0 111.681 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.3 m -68.94 -36.44 77.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.46 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.94 17.26 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.485 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.52 163.94 12.29 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.581 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.51 137.89 52.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.799 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.94 148.46 36.8 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 113.43 18.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.039 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 45.09 42.39 6.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.265 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.78 -7.98 79.29 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.499 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.05 118.47 36.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.174 0.487 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.799 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.14 129.76 38.77 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.297 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.0 m -101.8 166.71 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.272 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.8 tp10 -70.02 126.17 28.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.3 tttt -52.78 162.65 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.227 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.91 36.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.066 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.0 p -111.84 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.547 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -91.93 129.51 37.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.888 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.02 149.84 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.91 123.46 23.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.456 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.67 155.72 9.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.59 152.92 42.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.459 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 125.52 27.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.05 22.88 44.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.193 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.2 t0 -56.34 173.4 0.17 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 0.9 OUTLIER -145.02 135.46 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.073 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.414 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 4.0 mt -114.16 127.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-O 120.893 0.377 . . . . 0.0 110.377 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.45 136.53 43.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.825 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.4 m -140.3 158.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 24.57 41.65 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.28 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.53 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.2 t -63.25 140.4 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.72 0.771 . . . . 0.0 112.462 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.67 -44.17 0.54 Allowed Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.353 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.5 t -126.37 137.87 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -50.75 -38.13 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.59 6.31 48.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 74.0 m-20 -117.25 22.97 12.14 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.2 mt -107.11 139.63 28.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.175 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.53 134.49 55.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.674 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.528 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.29 131.6 56.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.584 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.4 HD21 ' CD1' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -127.01 142.79 51.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.892 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.429 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 11.3 t -111.0 140.32 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.5 mt -105.85 120.88 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.069 0.461 . . . . 0.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.98 122.68 45.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.682 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.51 121.28 48.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.982 0.42 . . . . 0.0 111.376 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.463 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 10.5 p30 -82.92 135.79 34.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.1 -20.2 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.183 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -57.47 -43.74 84.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.623 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.678 179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.792 0.329 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -60.0 -40.35 88.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -36.02 82.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -41.39 93.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -69.23 -35.08 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.26 -36.81 71.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.24 -23.78 65.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.738 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.69 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm . . . . . 0 N--CA 1.43 -1.475 0 CA-C-O 121.626 0.727 . . . . 0.0 112.336 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -92.3 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.667 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.12 157.4 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.904 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.869 0.366 . . . . 0.0 111.472 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.18 122.64 57.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.627 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.5 mt -129.49 118.34 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 t -81.81 119.57 24.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.281 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.41 -25.59 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.893 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 142' ' ' SER . 30.8 p -79.99 -2.21 43.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.559 0.218 . . . . 0.0 111.508 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.15 73.25 0.64 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.825 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -141.58 -47.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.76 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mp -114.0 140.68 25.16 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.85 139.91 31.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.182 1.921 . . . . 0.0 112.24 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mt -54.2 139.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.555 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -129.33 164.1 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.492 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.36 119.87 35.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.112 0.482 . . . . 0.0 111.372 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.8 mt -97.9 128.89 44.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.69 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.84 158.32 43.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.4 ttpt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.765 0.317 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.461 HG11 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -132.16 139.36 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.376 0.607 . . . . 0.0 112.255 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.526 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.8 m-90 -101.68 139.26 37.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.935 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.66 128.68 56.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.859 0.361 . . . . 0.0 110.027 177.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -120.49 145.23 47.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.61 -166.72 34.98 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.47 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' ASN . 4.9 mtp85 -79.01 2.05 21.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.71 130.83 51.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 0.0 111.197 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.67 -15.91 51.26 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.515 2.144 . . . . 0.0 111.495 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -41.61 18.96 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.76 139.11 1.73 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.537 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.25 -18.63 11.04 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.109 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.535 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -129.82 125.09 34.89 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 179.461 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 81' ' ' ILE . 30.7 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.883 0.373 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -42.58 71.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -60.85 -18.69 57.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.332 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -103.3 151.19 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.62 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.1 p -97.8 163.99 12.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.728 0.299 . . . . 0.0 111.667 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.577 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -43.22 -52.93 5.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.401 0.62 . . . . 0.0 109.912 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -117.67 80.73 1.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.4 t60 -60.34 -45.53 93.13 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.652 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 35.0 p90 -147.11 159.5 43.53 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.237 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.461 ' HG2' HG11 ' A' ' 65' ' ' VAL . 4.7 tt0 -136.14 142.88 44.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.114 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 62.7 mt -117.64 129.25 74.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.662 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.42 ' HB3' HG13 ' A' ' 65' ' ' VAL . 1.6 pt? -115.95 148.04 40.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.113 0.482 . . . . 0.0 111.855 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.2 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.058 179.23 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.791 0.329 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.4 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 1.4 mp -128.26 143.29 51.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.313 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tp -112.79 121.6 45.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.159 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 90' ' ' GLN . 56.5 t30 -115.38 115.72 27.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.543 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.666 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 p30 -79.77 137.97 37.14 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.42 29.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.563 0.22 . . . . 0.0 111.268 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.559 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 12.9 t -90.32 160.2 16.25 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.253 0.549 . . . . 0.0 112.369 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.5 m -69.54 -52.47 26.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.598 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -19.23 27.69 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.93 157.76 9.38 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.606 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -116.94 137.73 52.02 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.372 0.669 . . . . 0.0 109.252 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.874 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -112.27 149.15 32.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.24 113.5 18.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.319 176.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 44.54 43.39 6.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.649 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.29 -13.49 63.45 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.725 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.07 118.6 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.106 0.453 . . . . 0.0 110.639 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.874 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.9 tptm -73.28 125.1 27.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.307 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.67 163.4 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.032 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.3 tt0 -69.96 128.87 37.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.549 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 1.8 tttt -54.08 156.84 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.092 0.473 . . . . 0.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.601 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.5 p30 37.46 34.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.065 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.9 144.89 40.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.865 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -88.59 129.0 35.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -129.25 147.79 51.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.299 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.1 tp -72.77 119.02 16.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.361 . . . . 0.0 110.192 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.7 tp -53.6 157.24 2.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.346 0.593 . . . . 0.0 111.643 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.47 153.28 42.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.422 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -71.57 122.71 20.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.192 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.95 19.29 56.25 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.152 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.3 t70 -52.15 171.79 0.05 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.767 0.318 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.1 mt-10 -145.24 135.51 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.5 mt -110.91 126.48 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.009 0.433 . . . . 0.0 110.476 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.485 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.28 140.78 37.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.571 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.58 158.36 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.84 35.57 21.5 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.164 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.9 t -74.33 140.24 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.612 0.72 . . . . 0.0 112.24 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -40.91 0.83 Allowed Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.247 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -126.52 127.91 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.282 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -50.49 -31.49 15.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.217 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.8 m -93.67 6.16 49.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -124.35 21.65 8.65 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.5 mt -103.63 139.0 25.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 tt -124.53 134.43 53.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.454 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.9 t -109.57 150.18 28.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.664 0.745 . . . . 0.0 112.359 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.7 mt -135.84 153.01 51.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.484 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.5 t -121.53 139.18 49.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.294 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.9 mt -106.47 128.53 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.977 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.7 114.11 25.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 147' ' ' ILE . 4.1 mt -84.76 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.3 113.38 17.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -37.38 83.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -60.09 -46.02 90.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.966 0.412 . . . . 0.0 110.855 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.6 t80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.107 -179.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.726 0.298 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -47.51 67.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.818 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -35.83 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -31.77 72.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.773 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mt -71.86 -35.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.71 -46.17 84.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.441 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.25 -23.76 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.393 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.427 -1.591 0 CA-C-O 121.469 0.652 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -91.46 -60.23 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.998 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.5 p -146.53 162.11 39.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.434 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -131.68 128.47 39.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.281 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 22.7 t -97.8 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.925 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.9 115.5 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.21 99.81 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 110.343 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -80.25 -19.89 45.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.739 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.543 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.8 p -80.04 -2.59 44.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.574 0.226 . . . . 0.0 111.378 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.79 75.48 0.57 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.964 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -147.84 -41.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.068 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.0 mt -127.43 141.29 40.45 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.8 Cg_endo -72.52 145.38 42.18 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.012 1.808 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.7 mt -54.36 142.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.225 0.536 . . . . 0.0 111.908 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 33.8 mtt-85 -140.84 164.28 30.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.79 120.43 26.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 9.3 mp -86.38 137.08 32.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.188 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.662 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -142.61 156.01 45.03 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.427 1.108 . . . . 0.0 113.664 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.65 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.761 0.315 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.492 HG11 ' HG2' ' A' ' 90' ' ' GLN . 16.3 t -128.64 139.31 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.256 0.551 . . . . 0.0 111.959 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.536 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.6 m-90 -105.82 139.07 40.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.03 128.09 55.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.563 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -111.65 145.93 38.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.926 -178.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.72 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.08 -175.98 41.51 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -79.57 -2.52 42.79 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.85 134.63 41.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.644 0.259 . . . . 0.0 111.01 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.34 -7.09 19.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.658 2.238 . . . . 0.0 111.708 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.7 16.55 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.956 0.884 . . . . 0.0 108.932 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.08 137.69 4.17 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.477 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -56.43 -18.89 12.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.834 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.7 t80 -129.89 120.34 24.74 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.723 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.8 mm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.09 -44.07 74.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -24.19 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.452 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 57.5 mt -93.24 152.26 19.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.8 0.333 . . . . 0.0 111.181 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.43 167.11 11.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.794 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.72 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.86 -53.9 5.7 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.65 82.97 1.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.541 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.2 t60 -60.44 -47.4 86.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.483 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.62 159.85 42.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.62 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.492 ' HG2' HG11 ' A' ' 65' ' ' VAL . 5.3 tt0 -135.78 139.59 43.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 68' ' ' PHE . 57.6 mt -114.72 131.38 67.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.096 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.53 147.87 42.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.096 0.474 . . . . 0.0 111.758 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.2 tp . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.912 178.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.739 0.304 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.4 mp -132.46 143.46 49.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.415 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.81 126.04 55.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.223 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.4 t30 -119.02 115.54 24.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 111.564 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.693 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.9 p30 -78.27 141.21 38.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.665 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.8 pt -149.08 37.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.541 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.65 153.69 18.05 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.9 m -68.87 -31.7 70.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.005 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.4 -20.02 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.36 157.53 10.56 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.738 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.8 m -117.53 137.83 52.31 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.111 0.564 . . . . 0.0 109.573 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.818 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.67 148.49 38.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.04 113.41 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.392 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 44.3 42.86 5.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.08 76.02 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.51 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.64 118.68 37.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.9 tptp -73.27 121.71 20.8 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.203 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 m -93.69 165.52 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.267 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 120' ' ' SER . 26.1 mt-10 -69.8 126.33 29.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.6 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.9 tttm -54.55 162.76 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.655 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.26 34.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.015 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.04 40.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.136 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -91.69 130.75 37.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.889 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.2 mm-40 -129.26 150.07 50.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.651 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.67 115.41 11.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.1 tp -52.74 157.18 1.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.413 0.625 . . . . 0.0 111.571 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.39 153.0 42.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.524 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -71.8 124.26 24.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.93 20.57 53.66 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.136 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.1 t0 -55.06 172.83 0.11 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.0 111.07 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -145.04 135.4 24.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.204 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 17.1 mt -114.76 127.95 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.509 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.42 139.27 39.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.991 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.25 158.27 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.01 27.69 33.34 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.106 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.5 t -67.33 140.24 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.582 0.706 . . . . 0.0 112.332 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.61 -41.75 0.73 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.283 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.0 t -126.39 133.28 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.61 -35.82 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.796 0.331 . . . . 0.0 111.485 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -93.59 6.3 48.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -119.89 21.88 11.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 134' ' ' VAL . 7.4 mt -104.88 139.59 25.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.155 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 tt -121.81 134.36 54.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.606 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.543 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -111.5 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.111 0.482 . . . . 0.0 111.801 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.5 mt -124.12 138.41 54.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.71 136.61 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.401 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.2 mt -106.28 130.56 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.58 118.15 31.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.705 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.93 134.11 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.684 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.96 117.55 23.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.721 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.28 -29.89 65.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -60.29 -46.01 91.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.6 t80 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.151 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.767 0.318 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -61.1 -36.15 78.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.34 -39.88 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.3 tp -58.9 -31.96 69.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.01 -35.52 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.5 -38.44 74.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.25 -23.86 65.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.645 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.428 -1.534 0 CA-C-O 121.463 0.649 . . . . 0.0 112.398 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -93.7 -60.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.191 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.2 m -147.01 156.42 43.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.754 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 138.15 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.095 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.425 HG21 ' CE1' ' A' ' 76' ' ' TYR . 2.8 m -108.27 122.62 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.795 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.8 mt -128.27 122.63 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.542 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.1 t -80.27 109.98 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 0.0 110.248 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.71 -26.26 57.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.924 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 142' ' ' SER . 47.3 p -79.82 -2.23 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.54 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 77.65 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.863 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -147.09 -43.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.915 0.388 . . . . 0.0 110.865 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.564 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.8 mt -115.16 141.43 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.783 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.9 Cg_endo -71.12 145.96 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.138 1.892 . . . . 0.0 112.248 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.0 mt -56.94 141.57 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.38 164.07 28.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.991 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.63 119.91 26.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.423 . . . . 0.0 111.973 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.504 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.0 mp -89.64 129.35 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.347 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.645 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.34 157.04 47.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.998 0.904 . . . . 0.0 113.341 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.024 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.291 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 49' ' ' SER . 33.6 ttpt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.713 0.292 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 HG11 ' HG2' ' A' ' 90' ' ' GLN . 3.6 t -121.14 138.84 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 111.664 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.618 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.0 m-90 -102.96 139.3 38.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.244 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.75 127.21 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -111.32 145.63 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.397 -178.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.84 -174.59 40.02 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -78.59 -2.22 37.9 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.86 135.05 40.47 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.9 Cg_exo -69.05 -7.86 22.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.779 2.32 . . . . 0.0 111.827 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.79 -43.77 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.949 0.88 . . . . 0.0 108.669 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.0 137.96 2.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -18.94 12.1 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.119 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 60.0 t80 -129.9 128.15 41.6 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.694 0.283 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 p -54.86 -35.18 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.89 -45.94 87.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.054 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.8 152.09 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.125 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p -95.17 168.27 10.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -44.63 -53.6 7.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.373 0.606 . . . . 0.0 109.636 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -119.43 83.1 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -60.49 -46.24 90.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.691 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.8 p90 -146.21 161.2 40.76 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.814 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -135.78 142.34 44.9 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.44 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 27.1 mt -115.87 132.37 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.185 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.479 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.09 145.21 34.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.024 0.44 . . . . 0.0 111.807 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 2.6 tm? . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.409 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.823 0.344 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB3' ' OD1' ' A' ' 121' ' ' ASN . 11.3 mt -132.97 146.95 52.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.57 124.48 48.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.9 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.479 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 47.9 t30 -114.38 115.5 27.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 111.531 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.708 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 17.6 p30 -79.47 138.63 37.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.2 pt -147.15 39.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.4 159.33 14.98 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.039 0.447 . . . . 0.0 111.497 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.88 -35.56 77.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.299 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -19.86 17.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.512 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 164.22 12.64 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.442 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.3 m -117.48 137.7 52.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.12 148.28 35.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.19 113.41 18.28 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.298 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 44.11 42.93 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.41 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.6 -11.46 68.32 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.583 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -103.98 118.35 36.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.045 0.422 . . . . 0.0 110.777 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -74.0 127.89 34.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.3 m -98.11 165.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.19 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 mm-40 -69.83 126.57 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.708 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.9 tttt -53.65 162.66 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.61 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.063 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.13 40.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.377 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 8.9 m-80 -91.64 125.92 36.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.409 ' N ' HD23 ' A' ' 100' ' ' LEU . 43.1 mm-40 -127.44 147.54 50.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.429 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.8 tp -72.63 117.11 13.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.17 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.73 166.98 0.61 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.782 0.801 . . . . 0.0 111.952 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.37 153.28 43.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.398 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.26 118.18 13.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.67 24.01 69.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.8 t70 -55.83 175.21 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.8 tt0 -145.06 135.54 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 17.9 mt -115.34 126.66 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.55 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.51 138.34 41.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 27.4 m -140.39 158.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.42 28.98 28.61 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.159 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.535 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.5 t -68.56 140.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.535 0.684 . . . . 0.0 112.409 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.08 -43.45 0.6 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.261 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.8 t -126.43 136.36 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -50.7 -37.7 42.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.64 6.39 48.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.93 21.15 13.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.1 mt -106.58 139.17 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.239 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.38 134.37 53.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.229 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 40' ' ' THR . 47.2 t -109.83 150.23 28.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.7 0.762 . . . . 0.0 112.589 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 72.8 mt -135.88 151.15 49.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.725 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 36.7 t -122.03 135.88 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 145' ' ' ILE . 46.2 mt -106.12 125.66 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.77 114.73 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -84.92 130.12 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.33 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -83.63 119.05 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -27.54 69.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.04 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -42.53 81.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 110.613 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.5 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -71.01 -42.84 69.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -36.89 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.43 -31.93 70.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.86 -35.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.4 -41.11 79.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.502 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -67.19 -23.87 65.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.64 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.224 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 121.532 0.682 . . . . 0.0 112.653 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -91.8 -60.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.735 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 p -147.82 153.62 39.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.095 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.77 138.13 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.541 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -103.04 122.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.591 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 146' ' ' PHE . 18.9 mt -130.41 119.24 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.729 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.4 t -79.86 118.31 21.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.233 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.76 -25.12 28.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.979 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 142' ' ' SER . 52.5 p -79.82 -2.11 41.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.02 76.55 0.28 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.718 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -146.51 -44.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.08 141.45 27.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.792 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.6 Cg_endo -73.2 141.49 32.49 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 0.0 112.265 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.3 mt -56.98 143.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.14 164.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.38 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 119.85 35.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.189 0.518 . . . . 0.0 111.69 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.6 mt -98.64 134.54 41.42 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.683 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.96 158.95 43.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -178.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.883 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.878 0.371 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.455 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 6.8 t -125.49 137.58 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.548 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.9 m-90 -101.98 139.27 37.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.184 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.38 130.51 56.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -119.18 145.3 46.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.274 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.28 -170.74 36.38 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -78.86 3.72 16.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.66 132.03 47.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.574 0.226 . . . . 0.0 111.102 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.69 -13.74 41.1 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.476 2.117 . . . . 0.0 111.761 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -42.72 17.76 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.949 0.88 . . . . 0.0 108.937 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.5 139.51 1.09 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.015 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 m-20 -56.49 -18.75 12.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.015 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.459 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 16.7 t80 -129.55 123.01 30.35 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.117 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 179.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.45 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.0 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.803 0.335 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.2 p -56.49 -37.47 70.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.567 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.449 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.66 -22.1 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.19 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.45 HD23 ' HB ' ' A' ' 81' ' ' ILE . 2.1 mm? -107.54 152.64 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.905 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -96.93 163.77 12.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.45 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.619 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.84 -52.9 4.88 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.497 0.665 . . . . 0.0 109.663 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -120.84 82.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -61.4 -45.93 92.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.672 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.6 p90 -143.86 159.06 43.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.795 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.451 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.09 140.56 43.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.316 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.455 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 58.1 mt -114.0 132.28 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.791 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.444 ' HB3' HG12 ' A' ' 65' ' ' VAL . 2.0 pt? -120.59 133.59 55.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.03 0.443 . . . . 0.0 111.967 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.4 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 2.6 tm? . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.064 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.679 0.276 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mp -125.85 143.29 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.484 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 2.4 mm? -112.8 122.82 48.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.897 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' GLN . 49.9 t30 -115.28 115.47 26.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.654 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.671 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.3 p30 -78.17 138.43 38.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.9 pt -145.12 40.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.69 156.45 16.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 111.362 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.79 -36.52 78.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.361 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.75 -19.7 17.32 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.524 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.14 159.18 10.44 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.005 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -117.55 137.93 52.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.991 -0.604 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.74 148.72 34.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.45 18.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.455 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 42.8 44.0 3.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.75 62.41 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -103.34 118.52 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.614 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.4 tptp -72.92 128.16 34.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.425 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.9 m -98.79 163.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.193 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 tp10 -69.92 126.89 31.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.536 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -53.16 160.74 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.81 35.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.311 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.13 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.136 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -85.13 127.92 34.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.93 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.29 146.93 51.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.532 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tp -72.77 134.2 44.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.287 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.425 ' CD2' HG12 ' A' ' 147' ' ' ILE . 65.2 tp -69.33 155.88 39.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.458 0.647 . . . . 0.0 111.485 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.58 153.02 42.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.256 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 121.3 18.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.886 0.374 . . . . 0.0 110.287 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.44 58.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.131 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.0 t70 -54.43 173.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.739 0.304 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.2 mt-10 -145.07 135.72 24.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.318 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 12.9 mt -114.41 127.16 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.61 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.42 140.06 38.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.884 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.517 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.5 m -140.4 158.33 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 0.0 112.346 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.91 36.03 16.85 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.079 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.8 t -75.14 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.641 0.734 . . . . 0.0 112.505 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.21 -42.89 0.57 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.62 129.11 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 -31.18 14.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.795 0.331 . . . . 0.0 111.183 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -93.53 6.42 48.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -125.69 23.2 7.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.9 mt -105.35 139.33 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.011 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -124.23 134.43 53.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.577 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.492 ' HB3' HG21 ' A' ' 40' ' ' THR . 48.3 t -109.4 150.57 27.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 112.25 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 74.0 mt -135.53 156.0 49.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.5 t -124.57 136.84 59.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.3 mm -106.33 126.37 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.923 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 37' ' ' ILE . 1.5 m-85 -112.53 116.33 30.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.738 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.7 mt -84.8 134.26 27.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.542 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -75.97 118.48 18.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.588 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -37.49 78.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -60.6 -45.73 92.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.402 ' CE2' HG11 ' A' ' 33' ' ' VAL . 19.5 t80 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.187 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -46.06 88.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -57.04 -36.14 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -31.86 71.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.46 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.15 -35.53 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.86 -37.91 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.352 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.2 -23.64 65.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.996 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.564 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.6 mm . . . . . 0 N--CA 1.425 -1.69 0 CA-C-O 121.782 0.801 . . . . 0.0 112.361 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.407 HG11 ' CH2' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -105.78 -51.35 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.05 -178.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -155.17 165.37 36.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.635 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 138.0 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.425 HG12 ' CZ ' ' A' ' 76' ' ' TYR . 16.4 t -106.23 122.84 60.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.211 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 mt -127.28 115.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.342 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.3 t -80.81 123.39 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.3 -26.88 22.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 142' ' ' SER . 53.2 p -79.95 -2.3 43.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.632 0.253 . . . . 0.0 111.559 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.59 76.29 0.29 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.007 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -147.18 -44.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.5 mt -108.78 140.46 21.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.502 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.36 146.03 34.93 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.203 1.936 . . . . 0.0 112.257 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.5 mt -59.98 130.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.629 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 164.21 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.194 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.89 119.47 34.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.972 0.415 . . . . 0.0 111.779 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.551 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.3 mp -86.09 133.54 33.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.576 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -139.9 156.49 46.66 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.38 1.086 . . . . 0.0 113.694 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.403 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.051 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.805 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.801 0.334 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 16.9 t -132.75 139.19 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.289 0.566 . . . . 0.0 111.858 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.576 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.9 m-90 -100.9 140.29 35.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.374 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.444 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -109.15 124.74 51.3 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.589 ' CE2' ' CG ' ' A' ' 76' ' ' TYR . 2.9 m-85 -112.46 145.68 39.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.045 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.76 -169.61 38.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.933 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.7 mtp180 -84.87 10.18 12.32 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 10.0 t-20 -93.86 134.82 25.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.547 0.213 . . . . 0.0 111.135 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.3 Cg_exo -67.21 -11.01 30.62 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.516 2.144 . . . . 0.0 111.651 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.04 -42.7 17.17 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.874 0.845 . . . . 0.0 109.004 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.6 137.8 2.06 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.831 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.46 -18.59 11.86 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.927 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CG ' ' CE2' ' A' ' 68' ' ' PHE . 7.7 t80 -129.35 120.38 25.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.964 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.615 179.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.442 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 26.7 mm . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.848 0.356 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -31.77 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -73.98 -21.49 59.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.15 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.412 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 21.1 mt -99.13 152.33 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 111.007 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.67 165.27 12.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.91 -53.26 4.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 109.839 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.43 82.5 1.86 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.8 t60 -61.81 -45.0 95.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.919 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 22.1 p90 -146.74 164.15 33.69 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.298 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 7.6 mt-30 -135.7 140.78 44.7 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.39 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 2.7 mp -116.37 132.47 65.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.356 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.462 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -117.7 147.44 42.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 111.696 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.437 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.756 0.312 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 8.5 mt -133.25 143.14 48.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.213 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -112.81 129.1 56.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.491 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.1 t30 -119.76 115.54 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.679 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.3 p30 -79.68 141.71 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 87' ' ' LYS . 9.2 pt -148.3 39.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.68 151.06 21.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.058 0.456 . . . . 0.0 111.869 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.7 m -68.78 -31.7 70.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.901 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.42 -19.69 17.56 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.567 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.1 155.66 9.87 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.632 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.48 137.73 52.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.812 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.2 148.47 39.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.43 18.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.056 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.94 43.3 7.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -7.86 77.74 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.48 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -105.63 118.48 36.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.143 0.472 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.812 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 m -95.94 165.47 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.405 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 120' ' ' SER . 3.7 tt0 -69.93 129.55 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.9 tttt -54.33 163.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.193 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.6 m-80 33.92 36.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.827 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.72 145.22 39.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.843 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -93.0 127.75 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 65.3 mm-40 -128.98 151.24 49.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.43 117.38 14.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.955 0.407 . . . . 0.0 110.553 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.5 tp -57.89 157.8 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.37 153.2 42.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.438 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.58 124.42 24.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.49 20.16 55.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.954 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.37 173.25 0.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.04 135.58 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.41 ' CD1' ' CD2' ' A' ' 101' ' ' LEU . 7.2 mt -113.36 128.66 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.496 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 86.7 m -103.92 138.87 39.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.106 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.2 m -140.16 158.15 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.71 40.59 14.55 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.814 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -79.87 140.39 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.654 0.74 . . . . 0.0 112.537 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.13 0.56 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.289 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 43.5 t -126.42 134.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.67 -39.55 51.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.745 0.307 . . . . 0.0 111.702 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -93.5 6.43 48.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.4 t0 -118.06 23.05 11.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.2 mt -106.12 139.49 27.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.302 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tp -120.51 134.34 55.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.232 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 40' ' ' THR . 43.8 t -113.46 150.32 32.99 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 112.672 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -136.23 146.05 46.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.572 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.72 132.82 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 111.097 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 6.3 mt -106.25 128.33 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.84 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.97 120.63 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.0 mt -84.82 134.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.278 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -79.16 127.75 32.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -74.06 -32.3 63.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -45.3 91.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.0 t80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -64.02 -39.52 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.63 -35.09 78.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.22 -39.99 84.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.6 mm -71.25 -35.14 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.27 -34.17 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.401 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -67.34 -23.81 65.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm . . . . . 0 N--CA 1.428 -1.534 0 CA-C-O 121.611 0.719 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.0 -60.51 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 m -143.47 162.43 35.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.355 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 123.59 32.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.142 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.16 122.77 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.041 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -126.89 123.13 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.407 ' HA ' HD23 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -92.14 100.11 12.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.592 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.524 HG22 ' CB ' ' A' ' 142' ' ' SER . 6.5 p -79.92 -2.63 44.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 111.341 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.81 73.28 0.66 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.065 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -144.9 -38.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.9 mt -127.54 141.32 40.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.846 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.76 137.97 28.14 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.112 1.874 . . . . 0.0 112.15 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mt -55.26 144.03 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.785 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.37 164.32 30.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.263 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.85 119.84 34.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 112.008 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.5 mt -94.67 137.43 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.25 158.09 43.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.424 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.649 0.261 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 4.4 t -120.44 138.52 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.199 0.523 . . . . 0.0 112.031 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.526 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -100.74 139.69 36.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.403 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.4 129.7 55.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -120.43 145.66 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.628 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.64 -169.56 36.39 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.73 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.7 mtm105 -82.54 5.17 21.68 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -84.9 132.62 45.43 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.523 0.201 . . . . 0.0 110.773 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.39 -13.97 42.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.446 2.097 . . . . 0.0 111.685 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.1 16.01 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.842 0.829 . . . . 0.0 108.835 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.25 137.84 3.33 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.871 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.49 -18.6 12.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.726 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -129.54 124.29 33.51 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.771 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.2 mt . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.905 0.383 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -54.81 -44.9 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.455 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -45.55 89.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD23 ' CE1' ' A' ' 88' ' ' HIS . 28.6 mt -72.79 152.27 41.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.695 0.283 . . . . 0.0 111.318 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -97.18 163.5 12.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.017 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.621 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.76 -51.62 5.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.442 0.639 . . . . 0.0 109.846 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 16.3 ptmt -120.32 82.24 1.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -64.78 -45.39 86.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.455 -176.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.435 ' HA ' HG12 ' A' ' 104' ' ' ILE . 47.5 p90 -150.21 163.38 38.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.234 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.534 ' HG2' HG23 ' A' ' 67' ' ' THR . 10.3 mt-30 -135.71 158.41 44.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.468 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 68.2 mt -125.8 131.15 72.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.138 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -114.12 145.57 41.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.1 0.476 . . . . 0.0 111.711 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.2 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.192 179.28 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.898 0.38 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.423 ' HB3' HD13 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -133.15 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.233 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.5 OUTLIER -114.17 128.8 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.217 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 90' ' ' GLN . 42.0 t30 -115.42 115.48 26.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.458 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.0 p30 -79.53 143.05 35.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 15.2 pt -150.93 37.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.32 158.31 15.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.003 0.43 . . . . 0.0 111.613 -178.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -68.87 -34.93 76.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.436 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.88 17.29 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.09 161.7 11.62 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.647 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.7 m -117.52 137.87 52.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.813 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.65 148.32 36.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.3 18.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.174 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 44.17 43.39 5.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.285 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 -5.82 84.46 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.454 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.14 118.51 36.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.094 0.474 . . . . 0.0 110.828 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.813 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.2 tptp -74.89 120.59 20.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.363 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.5 m -95.17 163.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.4 tp10 -69.84 127.3 32.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.0 tttm -52.18 161.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.753 0.311 . . . . 0.0 110.577 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.48 34.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.215 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.09 40.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.901 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.48 128.42 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.032 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.403 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 35.1 mm-40 -129.69 149.13 51.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.605 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.7 126.08 29.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.394 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.408 ' HG ' ' N ' ' A' ' 125' ' ' SER . 65.9 tp -64.69 158.43 24.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.301 0.572 . . . . 0.0 111.424 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.14 153.32 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.242 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.405 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.13 122.71 20.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 0.0 110.478 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.18 20.76 55.17 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.162 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.6 t70 -56.2 174.12 0.14 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.7 tt0 -145.12 135.59 24.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.104 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.415 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 12.7 mt -109.05 127.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.371 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.0 m -104.47 137.84 41.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.513 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.32 158.42 25.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.88 24.57 44.74 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.266 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.1 t -64.78 140.43 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.58 0.705 . . . . 0.0 112.237 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.36 -42.31 0.85 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.369 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 44.7 t -126.39 131.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.52 -33.08 20.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.56 6.25 48.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.1 m-20 -120.7 20.2 11.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.486 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 13.9 mt -102.95 139.52 23.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.07 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 tt -124.32 134.41 53.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.267 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.524 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -113.3 127.8 56.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.105 0.478 . . . . 0.0 111.742 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.2 mt -121.2 139.82 52.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.8 139.68 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.147 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.491 HG22 HD12 ' A' ' 145' ' ' ILE . 41.4 mt -106.04 130.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.65 114.0 25.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.36 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.92 132.98 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.544 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -76.97 110.9 11.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.733 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -60.81 -39.35 88.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.995 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -46.05 92.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.3 t80 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.961 -179.878 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.746 0.308 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.88 -45.29 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.63 -32.39 70.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.2 -35.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -36.04 71.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -67.15 -31.11 71.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.311 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.8 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.455 0.645 . . . . 0.0 111.112 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 121.384 0.611 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -93.99 -60.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.168 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 p -145.09 164.53 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.485 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.17 126.86 44.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -93.96 122.83 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -126.8 122.56 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.512 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.27 106.64 18.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 110.372 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -77.31 -20.37 55.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.064 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 142' ' ' SER . 81.1 p -79.9 -2.46 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 74.25 0.48 Allowed Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.808 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -147.3 -44.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 0.0 110.805 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.515 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.2 mt -112.3 140.39 23.6 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.38 132.83 16.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.262 1.974 . . . . 0.0 112.036 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mt -53.22 135.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.57 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.72 164.24 25.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.524 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.26 119.89 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 0.0 111.425 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 15.0 mt -93.85 137.08 33.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.812 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.86 157.63 44.09 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.503 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.967 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.023 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.6 ttmt . . . . . 0 CA--C 1.519 -0.217 0 CA-C-O 120.818 0.342 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.9 t -130.61 138.97 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.434 0.635 . . . . 0.0 112.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.548 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 13.0 m-90 -105.09 140.02 38.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.17 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.488 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.29 126.08 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -117.51 145.44 44.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.811 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.287 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -78.03 -1.28 31.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -84.89 131.88 47.7 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.621 0.248 . . . . 0.0 111.093 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 14.1 Cg_exo -68.02 -10.57 29.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.469 2.112 . . . . 0.0 111.626 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.87 16.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.897 0.856 . . . . 0.0 108.988 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -38.93 141.14 0.31 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.74 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.17 -19.07 11.98 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.908 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.4 t80 -129.92 130.43 45.12 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.993 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.789 0.328 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -35.1 63.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.415 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -61.19 -18.66 59.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 mt -104.81 147.35 27.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.66 160.58 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.546 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.619 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -40.87 -51.32 3.18 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.606 0.717 . . . . 0.0 109.741 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 104' ' ' ILE . 18.0 mttt -120.82 82.6 1.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.555 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 17.1 t60 -63.16 -46.06 88.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.968 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.8 p90 -146.25 161.87 39.32 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.282 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.35 137.26 42.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.38 -178.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 45.2 mt -115.22 132.09 65.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -121.39 145.86 47.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.139 0.495 . . . . 0.0 111.876 -179.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.194 179.368 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.832 0.349 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.9 OUTLIER -128.37 138.37 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 pp -113.04 120.72 42.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.077 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' GLN . 56.0 t30 -114.57 116.03 28.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.668 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.8 p30 -77.45 140.51 39.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.063 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 87' ' ' LYS . 12.1 pt -143.89 28.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.448 0.166 . . . . 0.0 111.407 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 9.3 t -89.56 159.67 17.07 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.519 0.676 . . . . 0.0 112.677 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -69.72 -50.42 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.417 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.25 2.92 54.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.266 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.33 159.36 28.11 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.898 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.0 m -117.74 138.05 52.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.347 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.12 148.82 31.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.86 113.3 18.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.228 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 44.77 42.9 6.4 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.57 -14.21 60.39 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.548 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.2 118.38 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.075 0.438 . . . . 0.0 110.482 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.92 123.9 23.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.407 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.7 m -95.39 165.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.029 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 mp0 -69.85 126.81 30.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.685 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 62.9 tttt -54.84 162.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.991 0.424 . . . . 0.0 110.579 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.59 33.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.147 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.54 144.55 41.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.89 179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -93.22 133.32 36.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.946 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 53.8 mm-40 -129.24 151.25 50.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.61 113.56 9.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.29 156.55 0.57 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.629 . . . . 0.0 111.739 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.48 153.48 41.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.641 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.2 121.93 19.27 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.57 19.68 65.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.734 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -49.26 165.35 0.06 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.857 0.361 . . . . 0.0 111.172 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.5 tt0 -143.2 135.48 27.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.973 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.5 mt -115.12 127.77 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.646 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.5 m -104.64 139.13 39.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.9 m -140.57 158.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.08 23.48 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.148 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.5 t -71.75 140.34 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 121.536 0.684 . . . . 0.0 112.391 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.88 -42.18 0.67 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.314 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 44.7 t -126.34 131.76 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 -34.8 25.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 111.414 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.9 m -93.53 6.37 48.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.415 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 59.2 m-20 -121.16 21.82 11.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.1 mt -103.93 139.28 25.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.99 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 tt -124.36 134.53 53.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.217 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.498 ' HB3' HG22 ' A' ' 40' ' ' THR . 46.6 t -110.59 150.21 29.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.716 0.769 . . . . 0.0 112.368 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 70.1 mt -135.68 145.74 47.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.831 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.51 139.97 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.349 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.6 mt -106.14 126.22 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.18 118.9 36.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.601 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.3 mt -84.64 133.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -84.3 115.42 22.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.809 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -58.87 -29.05 66.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.019 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.9 t80 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.898 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.798 0.332 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -63.34 -36.16 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -40.43 93.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.01 -44.82 95.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.6 mm -67.7 -35.16 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -57.18 -35.8 70.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.358 . . . . 0.0 110.43 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -23.86 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.807 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.179 0 CA-C-O 121.067 0.461 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.429 -1.503 0 CA-C-O 121.521 0.677 . . . . 0.0 112.48 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.71 -61.01 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.035 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 p -147.16 151.4 36.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.394 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.45 138.14 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 24.7 t -105.55 122.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.412 HD11 ' CD1' ' A' ' 146' ' ' PHE . 17.0 mt -125.81 117.06 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.407 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.8 t -79.75 124.67 28.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.52 -24.56 17.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.387 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 142' ' ' SER . 67.6 p -79.86 -2.36 43.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.397 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 73.84 0.54 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.894 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.77 -43.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.7 mt -115.15 140.53 25.78 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.24 138.47 25.09 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.2 1.933 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.3 mt -56.11 129.48 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.629 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -126.23 164.14 21.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 119.71 35.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.994 0.426 . . . . 0.0 111.797 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.0 mt -92.42 137.27 32.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.55 158.8 43.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.75 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.5 ttpt . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 3.7 t -111.87 139.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.264 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.596 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.2 m-90 -100.42 139.29 36.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.899 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.46 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.39 133.69 53.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -116.01 145.57 42.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.313 -178.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.775 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 170.57 -175.46 44.4 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.455 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -82.19 -4.39 56.92 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.4 p30 -87.71 139.34 31.31 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.861 0.362 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.7 Cg_exo -69.49 -4.27 13.5 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.889 2.393 . . . . 0.0 111.88 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -46.8 12.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.869 0.842 . . . . 0.0 109.081 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 139.01 3.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.724 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -19.09 12.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.552 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.9 t80 -129.75 120.76 25.6 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.848 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.681 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.0 mt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.922 0.391 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -58.62 -33.89 70.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.484 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 5.1 tpt180 -60.71 -47.69 85.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.661 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 4.2 mp -72.63 153.61 41.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' ASN . 46.3 p -94.61 166.55 11.97 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.933 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.775 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m120 -40.54 -74.69 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' HD11 ' A' ' 104' ' ' ILE . 15.0 mttt -97.95 85.59 3.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.581 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -63.32 -44.86 93.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.957 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 104' ' ' ILE . 31.7 p90 -153.49 162.4 41.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 10.6 mt-30 -135.92 160.0 39.94 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 58.3 mt -123.78 131.96 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.081 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.66 139.58 39.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.071 0.463 . . . . 0.0 111.685 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.8 tm? . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 179.328 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.913 0.387 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mt -133.42 147.25 51.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.66 130.33 56.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.413 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 49.6 t30 -115.05 115.63 27.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.642 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.696 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 19.6 p-10 -81.18 141.27 34.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.137 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 89' ' ' PHE . 13.6 pt -149.82 37.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.581 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.39 156.42 16.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.11 0.481 . . . . 0.0 111.84 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.2 m -68.55 -32.79 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.103 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -98.63 -19.9 17.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.112 -179.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.541 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.91 164.3 13.45 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.215 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.9 m -117.4 137.68 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.797 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -115.74 148.42 39.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.41 113.36 18.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.544 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 45.76 37.4 3.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.013 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.58 -1.86 76.39 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.556 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -107.97 118.65 37.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.02 0.438 . . . . 0.0 110.919 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.797 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -75.63 129.72 37.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.348 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.49 165.11 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.358 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.85 131.77 44.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.209 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 6.1 tttt -55.45 168.78 0.35 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER 31.85 37.19 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.302 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.0 p -111.96 145.08 40.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.342 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -93.58 122.44 36.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.626 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -128.59 146.73 50.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.23 115.48 12.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.148 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.03 169.66 2.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.804 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.454 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.4 153.72 41.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.116 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.07 120.55 16.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.035 0.445 . . . . 0.0 110.136 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.58 20.84 64.2 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.139 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.454 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 5.0 t70 -61.63 179.6 0.24 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.852 0.358 . . . . 0.0 110.796 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.1 mt-10 -145.17 135.66 24.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.307 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.35 128.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.286 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.463 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.27 137.91 41.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.533 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 13.9 m -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.88 30.12 29.94 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.171 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.5 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.3 t -69.0 140.24 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.661 0.743 . . . . 0.0 112.332 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.8 -43.49 0.67 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.266 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 42.4 t -126.48 135.21 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.48 -37.15 37.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.666 0.269 . . . . 0.0 111.679 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 95.0 p -93.58 6.33 48.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.31 19.88 14.56 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.2 mt -106.04 138.96 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.238 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tt -124.57 134.49 52.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.142 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.494 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.8 t -111.56 150.32 30.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.8 . . . . 0.0 112.732 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.9 mm? -135.81 149.54 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.159 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.416 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 16.2 t -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.178 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 145' ' ' ILE . 10.8 mt -106.4 120.88 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.412 ' CD1' HD11 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -110.04 107.69 17.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.274 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 mt -84.77 128.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.71 119.46 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.91 -32.0 72.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.7 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.949 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.87 0.367 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.99 -43.64 81.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.81 -31.92 72.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.13 -35.35 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -57.44 -43.6 84.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.476 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -67.21 -23.7 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.546 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.229 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 121.618 0.723 . . . . 0.0 112.551 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -91.97 -59.59 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.938 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 157.78 43.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.468 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 124.85 43.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.43 122.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.992 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.03 125.44 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.431 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.4 t -89.91 107.87 19.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -79.99 -26.2 40.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.767 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 58.7 p -79.83 -2.59 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.525 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.57 80.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.067 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -147.73 -39.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.015 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.8 mt -127.43 141.99 42.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.8 Cg_endo -71.92 141.62 37.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.11 1.873 . . . . 0.0 112.127 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.2 mt -55.86 149.11 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.847 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.29 162.85 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -121.21 122.67 40.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.08 0.467 . . . . 0.0 111.907 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -101.03 137.26 39.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.193 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.67 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -143.12 158.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.12 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' A' ' 49' ' ' SER . 28.1 ttpt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 92' ' ' LEU . 9.3 t -124.79 138.66 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.223 0.535 . . . . 0.0 111.702 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.598 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.9 m-90 -100.75 139.86 35.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.145 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -110.84 130.58 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -120.09 145.1 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.034 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.58 -172.78 39.58 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.109 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 30.5 mtp180 -75.74 1.64 14.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.67 141.93 39.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.339 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 61.7 Cg_endo -73.76 -14.37 24.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.6 2.2 . . . . 0.0 111.271 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.28 17.21 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.881 0.848 . . . . 0.0 108.735 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 140.83 1.2 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.898 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.26 -18.58 10.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.094 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.58 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.0 t80 -129.18 122.68 30.29 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.723 0.296 . . . . 0.0 110.842 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.441 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.151 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 28.8 mt . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.861 0.363 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -35.68 64.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.019 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -29.42 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.15 152.35 21.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.55 166.11 12.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.599 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.51 -53.64 5.39 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.475 0.655 . . . . 0.0 109.507 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HB3' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.74 84.42 2.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -62.04 -44.93 95.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.982 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -146.31 162.85 37.23 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.399 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 11.2 mt-30 -135.57 148.01 48.93 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.414 HG13 ' CE1' ' A' ' 68' ' ' PHE . 64.5 mt -125.07 132.4 71.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.677 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -126.04 135.22 51.51 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.034 0.445 . . . . 0.0 112.146 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.43 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 1.8 tm? . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.161 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 124' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.73 0.3 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 5.7 mp -129.79 142.93 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.08 125.14 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.132 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.541 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.2 t30 -116.57 116.33 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.68 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.5 p30 -76.63 139.49 40.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.831 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 87' ' ' LYS . 8.2 pt -145.32 38.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.542 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.31 152.65 19.69 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.076 0.465 . . . . 0.0 111.829 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.0 m -68.9 -31.41 70.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.994 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -97.99 -19.92 17.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.01 157.37 10.8 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.841 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.46 137.81 52.28 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.48 148.35 37.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.47 18.35 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.329 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 44.17 43.5 5.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.87 68.25 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.517 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -104.06 118.46 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.08 0.44 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 18.4 tptt -74.08 123.15 23.85 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.247 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.5 m -94.35 165.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.5 tp10 -69.94 127.24 32.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 69.2 tttt -55.07 162.53 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 110.354 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 36.83 32.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.115 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 144.99 41.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.818 179.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -94.8 133.44 38.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.042 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.5 mm-40 -129.22 152.28 48.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.376 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.34 125.81 28.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.948 0.404 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.488 HD23 HG12 ' A' ' 147' ' ' ILE . 30.7 tp -56.36 154.68 7.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 0.0 111.814 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.453 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.88 152.93 43.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.601 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -72.11 124.25 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.779 0.323 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.04 22.56 42.95 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.15 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.5 t70 -52.81 171.81 0.06 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.96 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.5 mt-10 -143.91 135.5 26.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.094 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.5 mt -114.94 126.01 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.436 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.496 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.29 138.44 40.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.24 158.26 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 84.97 27.09 35.16 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.105 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.0 t -66.28 140.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.618 0.723 . . . . 0.0 112.496 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.51 -41.58 0.62 Allowed Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.289 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.44 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.1 t -126.46 136.49 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -39.88 52.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.7 0.286 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.45 6.33 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 23.1 t0 -116.62 23.28 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.0 mt -107.03 139.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.317 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.25 134.39 55.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.563 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.562 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 1.5 m -109.01 141.98 40.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 111.654 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 73.8 mt -135.13 141.97 46.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.787 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 17.3 t -114.08 140.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.798 0.332 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 145' ' ' ILE . 50.3 mt -106.16 129.64 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.83 115.29 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.488 HG12 HD23 ' A' ' 124' ' ' LEU . 1.8 mt -84.77 134.03 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -83.46 103.96 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -29.47 64.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -45.02 91.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.0 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.882 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -61.26 -36.8 81.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.825 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -65.71 -38.27 88.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.24 -43.18 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.8 mm -68.23 -35.12 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.21 -34.73 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.378 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -67.23 -23.9 65.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.814 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm . . . . . 0 N--CA 1.427 -1.606 0 CA-C-O 121.79 0.805 . . . . 0.0 112.477 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.421 HG11 ' CH2' ' A' ' 66' ' ' TRP . 0.9 OUTLIER -109.94 -49.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.785 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -152.72 158.7 42.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.422 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -130.83 136.88 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.749 0.309 . . . . 0.0 111.476 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -108.54 122.62 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.964 0.411 . . . . 0.0 110.647 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mt -126.76 115.21 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.463 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.6 t -81.4 101.87 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 110.409 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -24.09 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.755 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.503 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 13.7 p -79.82 -2.42 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.417 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.6 78.81 0.26 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.133 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -147.64 -40.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.007 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.0 mt -124.64 141.85 39.05 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -71.57 137.64 30.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.252 1.968 . . . . 0.0 111.925 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -54.62 137.54 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.914 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 163.33 27.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.976 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.5 m-20 -118.65 119.75 35.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.892 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.4 mt -92.24 137.37 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.5 158.59 44.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.228 1.013 . . . . 0.0 113.665 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.344 178.273 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.8 ttpt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.824 0.345 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' A' ' 92' ' ' LEU . 15.2 t -129.98 138.91 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.003 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.527 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.6 m-90 -102.13 139.6 37.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.107 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.87 126.78 55.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.115 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -117.47 145.58 44.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.317 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.31 -173.12 40.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.892 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 mtp-105 -77.48 -1.29 29.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.81 133.58 43.38 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.691 0.281 . . . . 0.0 111.216 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.66 -9.5 26.31 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.797 2.331 . . . . 0.0 112.065 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 -43.02 17.18 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.842 0.83 . . . . 0.0 108.921 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.28 139.56 0.72 Allowed 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.939 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.26 -18.77 11.5 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.977 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 55.6 t80 -129.55 123.68 32.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.832 0.349 . . . . 0.0 110.769 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.414 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.7 mm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.77 0.319 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -42.3 75.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -26.52 67.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.16 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 39.7 mt -90.96 152.33 20.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -99.88 167.44 10.52 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.96 -53.83 5.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.308 0.575 . . . . 0.0 109.808 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -117.19 82.3 1.79 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 14.0 t60 -58.65 -45.34 89.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.772 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -147.23 160.88 41.96 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.979 -0.688 . . . . 0.0 112.399 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.33 130.39 34.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 51.3 mt -110.78 130.82 63.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.924 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -124.21 141.45 52.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.956 0.408 . . . . 0.0 111.607 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.3 tt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 179.362 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.724 0.297 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.0 mp -132.17 141.45 49.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.944 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.74 124.16 51.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.518 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.409 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 65.9 t30 -117.29 132.66 56.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.105 0.478 . . . . 0.0 112.057 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.8 p30 -93.26 134.46 35.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.613 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 89' ' ' PHE . 4.2 pt -136.1 26.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.531 0.205 . . . . 0.0 111.504 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.2 t -91.38 156.47 17.73 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.538 0.685 . . . . 0.0 112.539 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -69.68 -52.21 27.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.873 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -81.49 -1.02 44.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.389 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.77 158.97 30.58 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.417 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.54 137.72 52.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -111.95 148.54 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 113.32 18.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.4 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 43.9 43.64 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.37 66.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.35 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.97 118.58 37.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.467 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.7 tptm -73.93 121.17 20.55 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.551 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.8 m -92.37 163.7 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -69.91 128.44 36.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.4 tttt -53.91 161.59 1.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.314 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.3 p30 36.83 32.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.42 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 144.73 41.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.818 179.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -93.9 130.54 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.972 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -129.98 152.15 49.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.34 111.68 10.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.18 168.43 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.806 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 t -124.35 153.48 41.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.236 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.28 115.64 10.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.025 0.441 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.85 18.55 78.98 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.188 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.14 179.45 0.1 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.669 0.271 . . . . 0.0 110.588 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 11.0 mt-10 -145.23 135.7 24.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.66 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 6.2 mt -112.0 128.26 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.497 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 140.51 37.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.595 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.45 158.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.23 31.33 28.52 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.179 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.512 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.3 t -70.21 140.37 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.688 0.756 . . . . 0.0 112.503 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.84 -43.44 0.61 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.138 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.43 131.38 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.47 -33.04 19.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.824 0.345 . . . . 0.0 111.275 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 88.1 p -93.64 6.19 49.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.58 22.63 9.84 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.7 mt -104.6 139.6 25.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.058 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 tt -119.64 134.55 55.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.454 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.503 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -110.19 136.7 49.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.678 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 57.9 mt -131.0 144.52 51.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.593 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.402 HG13 ' HG3' ' A' ' 129' ' ' GLU . 17.7 t -110.95 135.12 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.402 . . . . 0.0 111.381 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 145' ' ' ILE . 2.0 mp -106.06 123.14 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.316 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.25 106.75 15.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.504 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -84.79 133.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -75.96 118.72 19.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.003 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -74.01 -30.67 62.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.41 91.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.627 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.854 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.732 0.301 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -71.1 -38.05 72.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.897 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -41.22 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -31.95 70.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.27 -35.24 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.47 -41.1 79.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.52 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -23.99 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.648 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.703 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.5 mm . . . . . 0 N--CA 1.427 -1.577 0 CA-C-O 121.566 0.698 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.78 -60.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.617 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.38 165.02 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.986 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 124.15 33.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 111.343 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.43 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 24.8 t -93.22 122.8 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.085 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -127.34 118.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.205 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 t -80.04 109.81 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.428 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -80.46 -27.25 37.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.61 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.498 HG22 ' OG ' ' A' ' 142' ' ' SER . 6.2 p -79.94 -2.61 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.669 0.271 . . . . 0.0 111.351 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.46 79.97 0.19 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.926 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -148.04 -39.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.886 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.5 mt -123.44 141.72 36.99 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.79 138.89 29.7 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.132 1.888 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.7 mt -54.9 132.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.956 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 1.5 ttt180 -126.13 164.21 21.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.051 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -117.63 119.71 35.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 111.976 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.8 mp -91.49 125.81 36.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.703 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -139.46 156.52 46.9 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 113.299 -1.773 . . . . 0.0 110.531 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.8 ttpt . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.711 0.291 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.8 t -125.86 139.31 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.248 0.546 . . . . 0.0 112.111 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.53 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.4 m-90 -102.32 139.14 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.054 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.4 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.53 126.78 55.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -110.47 145.66 37.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.646 -178.336 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.7 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -176.25 39.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.708 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -77.64 -0.93 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.84 134.04 42.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.259 . . . . 0.0 111.029 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.64 -8.09 22.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.749 2.299 . . . . 0.0 111.763 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.56 16.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.009 0.909 . . . . 0.0 108.796 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 137.32 2.99 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.507 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.53 -18.68 12.46 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.904 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.47 125.36 36.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.747 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.795 0.331 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.96 -40.7 70.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.012 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -60.94 -15.88 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.227 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.9 mt -105.97 149.59 26.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.2 p -93.97 165.21 12.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.863 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.7 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -41.66 -52.51 3.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.375 0.607 . . . . 0.0 109.818 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.06 82.16 1.88 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.0 t60 -60.62 -45.85 92.48 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.023 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 19.0 p90 -146.34 159.09 43.82 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.719 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.4 tt0 -135.53 141.66 45.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.285 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.7 mt -117.54 127.12 75.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.073 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -110.05 148.52 31.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.025 0.44 . . . . 0.0 111.748 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.446 179.435 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.411 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.774 0.321 . . . . 0.0 110.868 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 7.3 mt -132.03 144.01 50.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.346 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.5 mt -112.69 124.18 51.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.299 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.6 t30 -118.11 115.79 25.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 111.729 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.5 p30 -77.5 139.2 39.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.83 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 16.7 pt -146.83 39.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.567 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -95.72 158.51 15.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.039 0.447 . . . . 0.0 111.571 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -68.91 -38.19 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.581 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.71 -19.73 17.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.169 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.495 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.99 158.64 10.09 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.929 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.58 138.01 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.943 -0.628 . . . . 0.0 109.517 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.26 148.57 35.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.03 113.46 18.43 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.366 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.87 43.64 5.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.415 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.75 -10.2 70.98 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.421 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -105.08 118.6 36.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.158 0.504 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 5.4 tptt -72.25 119.19 16.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.25 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.1 m -89.95 163.87 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.165 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.0 mm-40 -69.86 125.88 28.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.0 tttp -53.35 161.34 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.832 0.348 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.12 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.1 40.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.976 179.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -89.51 131.81 35.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.9 mm-40 -129.25 148.95 51.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.517 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.77 135.91 45.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.52 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 125' ' ' SER . 35.5 tp -59.87 152.85 22.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.55 0.69 . . . . 0.0 111.515 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.444 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.41 152.83 44.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.552 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.3 120.56 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.266 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 145' ' ' ILE . . . 58.98 23.9 57.52 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.27 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.444 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.2 t70 -52.23 167.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.006 0.432 . . . . 0.0 111.314 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -145.22 135.62 24.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.151 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.411 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 11.0 mt -113.55 128.14 70.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.51 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.63 138.98 40.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.993 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.3 m -140.45 158.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.13 26.85 29.9 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.318 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.1 t -66.86 140.26 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.533 0.682 . . . . 0.0 112.204 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.51 -41.54 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 43.8 t -126.33 134.84 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.65 -34.69 27.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.712 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -93.5 -6.74 46.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.1 m-20 -102.42 19.7 18.37 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.51 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 7.8 mt -105.73 139.33 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.353 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.4 tt -124.22 134.45 53.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.342 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 40' ' ' THR . 0.6 OUTLIER -110.58 128.93 55.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.151 0.5 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.2 mt -122.37 134.2 54.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.847 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.92 137.57 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.4 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 33.6 mt -106.14 137.61 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -118.78 121.96 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.503 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.412 ' CD1' HD21 ' A' ' 124' ' ' LEU . 4.5 mt -85.47 134.12 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -86.11 113.16 21.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.3 -29.15 70.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -57.4 -42.88 83.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.98 0.419 . . . . 0.0 110.574 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.923 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.851 0.357 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -35.94 82.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.69 -40.2 91.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.28 -41.09 92.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.6 mm -69.34 -35.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.28 -35.36 69.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.421 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -67.32 -23.78 65.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.868 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm . . . . . 0 N--CA 1.428 -1.533 0 CA-C-O 121.52 0.676 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.62 -60.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.758 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -150.08 165.23 33.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.25 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -129.18 138.1 51.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.88 0.372 . . . . 0.0 111.404 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -105.16 122.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.8 mt -121.83 124.57 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.321 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.0 t -87.08 102.72 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.577 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -76.09 -21.18 56.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.666 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 142' ' ' SER . 82.3 p -79.94 -2.34 43.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.821 0.343 . . . . 0.0 111.599 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.91 74.76 0.39 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.818 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -147.49 -41.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.081 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -120.32 141.67 32.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.6 Cg_endo -72.05 140.03 33.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.135 1.89 . . . . 0.0 112.187 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.9 mt -56.41 144.89 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 111.797 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 164.08 30.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.916 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -122.73 119.81 31.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.443 . . . . 0.0 112.029 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 4.2 mp -85.1 129.56 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.641 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.03 155.85 49.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.231 1.015 . . . . 0.0 113.324 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.892 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.651 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.8 ttpt . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 120.808 0.337 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.462 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.7 t -133.59 139.28 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.22 0.533 . . . . 0.0 111.905 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.546 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.4 m-90 -103.21 139.21 38.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.524 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.422 HG23 HD12 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -109.95 130.79 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -120.01 145.44 46.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.02 -168.44 37.81 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 mtp-105 -81.76 1.84 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.4 t-20 -84.82 134.42 41.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.676 0.274 . . . . 0.0 111.553 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.4 Cg_exo -66.65 -13.53 40.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.747 2.298 . . . . 0.0 111.756 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -43.85 16.38 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.952 0.882 . . . . 0.0 109.05 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.56 140.17 1.34 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.593 . . . . 0.0 111.176 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 m-20 -56.35 -18.52 11.15 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.076 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.6 t80 -129.36 115.29 17.33 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 120.761 0.315 . . . . 0.0 110.697 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 81' ' ' ILE . 26.1 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.854 0.359 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -38.19 67.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.86 -23.43 65.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.01 151.97 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.127 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 m -95.72 165.02 12.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.598 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.85 -52.78 4.95 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 109.782 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 15.0 ptmt -119.33 81.77 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -60.21 -46.9 88.15 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.656 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.9 p90 -144.42 160.77 40.51 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.894 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.462 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.3 tt0 -136.07 142.58 44.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.24 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' CD1' ' CZ ' ' A' ' 68' ' ' PHE . 63.6 mt -116.27 127.72 73.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.87 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -113.2 148.57 35.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.139 0.495 . . . . 0.0 111.645 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.371 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.811 0.339 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 3.2 mt -133.09 146.89 52.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.998 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.69 124.97 53.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.481 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 90' ' ' GLN . 45.4 t30 -115.06 115.56 27.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.679 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.9 p30 -79.53 136.78 36.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.072 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -145.98 39.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.6 152.85 19.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -68.92 -31.7 70.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.886 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.4 -19.87 17.47 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.37 157.35 10.3 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.812 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.98 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.786 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.48 148.68 40.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.22 113.64 18.56 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.983 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 46.95 35.82 3.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.212 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.42 -8.84 74.8 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.502 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -106.45 118.53 36.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.111 0.456 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.786 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.35 137.49 48.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.212 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -111.24 168.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.506 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.7 tt0 -70.18 125.91 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.615 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 41.8 tttt -53.31 162.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.998 0.428 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.88 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.14 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.41 145.12 40.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.916 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -86.68 133.86 33.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.994 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 38.2 mm-40 -129.26 148.25 51.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 tp -72.66 119.78 17.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.6 OUTLIER -57.49 153.67 12.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.537 0.685 . . . . 0.0 111.474 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.438 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.2 t -124.31 153.53 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.59 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.456 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 12.7 tp60 -71.54 124.16 24.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.414 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.48 21.54 49.28 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.086 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.7 t70 -56.64 172.21 0.26 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.177 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -145.25 135.58 24.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.377 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.85 128.39 67.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.341 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.476 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.0 m -104.16 137.89 41.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.968 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.527 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.7 m -140.15 158.33 25.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.71 29.88 31.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.909 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -68.52 140.3 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.753 0.787 . . . . 0.0 112.487 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.54 -44.13 0.5 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.454 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 32.3 t -126.27 140.75 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.86 -42.03 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 6.27 48.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.467 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 4.4 m-20 -112.69 21.37 15.64 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.7 mt -107.27 139.43 29.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.4 tt -123.41 134.35 53.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.206 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.46 ' HB3' HG23 ' A' ' 40' ' ' THR . 37.4 t -112.69 150.64 31.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.607 0.718 . . . . 0.0 112.932 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -135.46 139.14 43.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.321 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.1 t -110.66 140.4 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.216 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.452 HG23 HD12 ' A' ' 145' ' ' ILE . 38.8 mt -105.91 127.06 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.071 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 117.65 32.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.708 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.8 mt -84.89 134.18 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.11 108.36 17.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.53 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.03 -30.5 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -59.66 -45.89 90.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.666 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.2 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.811 0.339 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -64.46 -45.35 87.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -60.77 -35.06 75.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.34 -44.1 92.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -67.24 -35.02 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.23 -40.04 76.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -24.37 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.956 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.679 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm . . . . . 0 N--CA 1.429 -1.514 0 CA-C-O 121.579 0.704 . . . . 0.0 112.627 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -92.08 -60.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.832 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.4 148.92 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.123 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 131.38 56.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.511 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -97.94 122.69 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.844 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -125.29 129.02 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.34 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.9 t -95.54 101.05 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.732 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -78.11 -19.08 54.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.518 HG22 ' OG ' ' A' ' 142' ' ' SER . 29.1 p -79.93 -2.88 45.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.777 0.322 . . . . 0.0 111.429 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.21 69.82 1.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.237 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -144.54 -35.11 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.413 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mt -127.52 141.0 39.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.732 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.2 Cg_endo -72.49 137.49 28.03 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.166 1.911 . . . . 0.0 112.286 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.5 mt -55.83 141.11 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.755 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.06 164.18 27.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.12 119.89 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.8 mt -95.39 135.74 36.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.679 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.0 158.52 43.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.511 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.687 0.279 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.0 t -126.48 139.15 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.273 0.559 . . . . 0.0 112.091 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.562 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.2 m-90 -101.09 139.38 36.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.7 130.16 55.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -119.31 145.28 46.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.72 -166.49 35.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.264 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.58 2.35 29.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -84.81 132.04 47.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.54 0.21 . . . . 0.0 111.279 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -65.46 -15.37 49.39 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.497 2.132 . . . . 0.0 111.44 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.57 -42.65 18.04 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.946 0.879 . . . . 0.0 108.833 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 139.3 1.96 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.836 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 m-20 -56.17 -18.8 11.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.922 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.66 124.95 34.9 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.65 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.941 0.4 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -39.24 68.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.517 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -21.47 63.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.357 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.422 HD21 ' CE1' ' A' ' 88' ' ' HIS . 32.8 mt -103.09 152.07 21.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 111.07 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 166.96 11.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.745 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.567 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.19 -53.48 6.5 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.416 0.626 . . . . 0.0 109.634 179.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -118.97 82.61 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.87 -46.41 89.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.634 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.8 p90 -145.75 161.41 39.97 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.091 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.3 tt0 -135.85 143.43 45.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 77.8 mt -117.62 124.2 72.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.237 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -102.41 147.99 26.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.533 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.9 tp . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.604 179.61 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.403 ' N ' HD13 ' A' ' 99' ' ' LEU . 6.2 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.822 0.344 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.7 mp -112.81 121.51 44.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.008 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' GLN . 49.7 t30 -116.61 115.52 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.772 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.0 p30 -78.6 139.66 38.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.001 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.6 pt -147.82 38.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.55 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.51 152.6 19.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.102 0.477 . . . . 0.0 111.834 -178.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.96 -31.52 70.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.925 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.15 -19.84 17.66 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.55 156.59 10.23 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.771 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.75 148.62 39.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.36 18.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.358 177.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 44.4 43.19 5.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -11.15 68.42 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.486 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.13 118.64 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.082 0.441 . . . . 0.0 110.667 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -72.76 129.74 38.9 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.47 166.73 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.453 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 120' ' ' SER . 27.9 mt-10 -69.93 126.48 29.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.667 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.5 tttt -53.57 163.91 0.59 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.619 0.247 . . . . 0.0 110.365 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.2 m-80 33.35 37.19 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.887 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.1 p -111.71 144.97 40.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -91.38 129.4 37.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.737 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 61.5 mm-40 -128.47 149.9 50.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.437 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.65 136.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.534 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 147' ' ' ILE . 42.6 tp -61.66 153.27 28.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.456 0.646 . . . . 0.0 111.621 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.403 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -125.32 152.66 44.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.561 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 121.73 19.58 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.54 25.6 55.54 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.02 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -51.09 168.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 111.427 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.16 135.29 23.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.865 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.7 mt -117.37 127.9 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.494 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.1 m -104.31 139.36 39.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.122 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.483 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.46 33.45 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.093 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.2 140.33 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.604 0.716 . . . . 0.0 112.266 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.04 -40.17 0.85 Allowed Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.246 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -126.5 131.13 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.62 -35.57 31.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.328 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.3 p -93.59 6.38 48.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -120.87 22.28 11.14 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.494 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 8.9 mt -103.69 139.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.926 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.79 134.42 54.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.64 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.518 ' OG ' HG22 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.11 132.0 55.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.065 0.459 . . . . 0.0 111.616 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.39 136.81 53.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.543 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 19.6 t -110.93 139.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.343 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.18 132.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.166 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 117.9 31.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.345 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.416 ' CD1' HD22 ' A' ' 124' ' ' LEU . 5.3 mt -84.77 134.11 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -83.72 109.45 17.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.52 -31.03 67.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -60.49 -46.0 91.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.766 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.03 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.753 0.311 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -60.24 -39.06 85.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.8 -41.72 87.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.45 -31.86 69.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.39 -35.41 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.822 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.8 82.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.71 65.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.429 -1.5 0 CA-C-O 121.435 0.636 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -93.83 -61.48 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.02 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -145.19 161.74 38.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.261 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.41 138.13 54.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.776 0.322 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.22 122.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.867 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mt -126.19 120.89 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.91 106.81 17.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.428 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.9 -22.83 58.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.89 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.469 HG21 ' HB3' ' A' ' 142' ' ' SER . 61.9 p -79.9 -2.36 43.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.614 0.245 . . . . 0.0 111.544 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.38 72.99 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.975 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -143.39 -44.74 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 110.869 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -111.78 140.93 23.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.7 Cg_endo -73.59 132.02 16.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.117 1.878 . . . . 0.0 112.051 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.4 mt -54.08 130.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.579 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 164.13 20.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.42 119.78 38.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.567 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 8.1 mt -91.5 136.29 33.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.355 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.26 158.37 43.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.716 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.599 0.238 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.0 t -125.57 139.12 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.149 0.5 . . . . 0.0 112.252 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.536 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 14.6 m-90 -100.72 139.26 36.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.969 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.11 128.91 56.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -120.25 145.4 47.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.137 -178.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.83 -169.95 36.61 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.556 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.51 1.02 15.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.57 126.27 69.32 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.365 0.126 . . . . 0.0 111.005 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 23.6 Cg_exo -64.19 -14.01 41.28 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.395 2.063 . . . . 0.0 111.417 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.87 17.63 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.73 140.98 0.62 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.422 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.12 -18.78 10.82 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.736 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.514 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -129.45 131.64 46.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.543 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.428 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 19.3 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.857 0.361 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -34.8 65.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -61.88 -25.99 67.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.03 150.4 20.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.944 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 m -93.81 166.2 12.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.399 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.552 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.54 -54.82 4.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.422 0.629 . . . . 0.0 109.675 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 16.1 ptpt -119.22 82.6 1.89 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.7 t60 -58.96 -46.02 89.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.877 -176.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.0 p90 -145.19 160.32 41.63 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.358 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.7 tt0 -135.65 144.06 45.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.954 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.1 mt -118.76 125.44 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.104 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -101.58 149.39 24.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.985 0.421 . . . . 0.0 111.499 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.409 ' CD2' ' CB ' ' A' ' 50' ' ' ALA . 48.7 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 8.5 mp -133.1 143.18 49.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.756 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.83 121.37 44.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.864 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' GLN . 49.2 t30 -116.51 115.55 26.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.676 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.0 p30 -78.18 139.91 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.776 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -146.23 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.534 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.85 152.13 20.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.984 0.421 . . . . 0.0 111.822 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.85 -31.51 70.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -97.67 -19.82 18.02 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.64 157.12 10.58 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.748 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.2 m -117.45 137.79 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.86 148.56 36.47 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.02 113.38 18.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.369 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 43.75 43.75 5.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.528 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.91 -13.58 62.61 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.532 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -103.97 118.48 36.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.964 0.411 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.2 tptm -72.25 127.4 32.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.76 164.59 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 120' ' ' SER . 27.1 tt0 -69.89 124.55 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.584 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.4 tttt -52.82 162.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 34.51 34.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.155 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.13 40.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.138 179.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -88.29 129.84 35.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.8 mm-40 -129.51 148.26 51.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.9 125.57 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.149 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.0 tp -58.08 156.41 9.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.371 0.605 . . . . 0.0 111.683 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -124.66 153.47 42.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.691 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.426 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.8 tp60 -71.24 122.63 20.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.31 21.67 54.31 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.764 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 31.8 t70 -49.7 168.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.993 0.425 . . . . 0.0 111.24 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 tt0 -145.03 135.45 24.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.839 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.421 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.8 mt -115.49 127.21 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.661 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.476 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.69 138.2 41.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.876 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.478 ' CG1' ' CD2' ' A' ' 88' ' ' HIS . 32.7 m -140.12 158.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.8 25.77 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.954 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -70.95 140.38 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.64 0.733 . . . . 0.0 112.314 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.88 -40.08 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.312 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 47.5 t -126.4 136.18 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -50.61 -41.62 55.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -93.42 6.29 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.814 . . . . 0.0 113.196 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.429 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 9.0 t0 -117.5 24.76 10.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.6 mt -105.93 139.57 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.91 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.2 tt -122.03 134.41 54.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.705 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.469 ' HB3' HG21 ' A' ' 40' ' ' THR . 40.0 t -110.61 150.38 29.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.695 0.76 . . . . 0.0 112.548 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 76.0 mt -135.9 146.76 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.681 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.42 140.31 43.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.742 0.306 . . . . 0.0 111.065 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.2 mt -105.98 126.1 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.347 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.55 109.75 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.318 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.4 mp -84.89 134.14 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.021 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.45 106.78 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.35 -26.42 63.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.353 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -60.18 -46.04 91.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.152 -179.818 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.767 0.318 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -71.19 -35.82 71.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.488 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -56.88 -43.17 81.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.18 -31.85 69.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.205 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 13.7 mt -68.74 -47.99 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.58 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -33.61 73.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.441 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -57.47 -47.11 82.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.952 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 20' ' ' ILE . 5.1 p90 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.838 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.426 -1.665 0 CA-C-O 121.842 0.829 . . . . 0.0 110.807 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' H ' ' HA ' ' A' ' 49' ' ' SER . 2.3 t -50.55 -67.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.937 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.9 p -146.79 165.32 30.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.397 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.43 124.2 37.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -88.94 122.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 111.192 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 mt -129.6 119.56 48.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 t -80.82 113.5 19.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.399 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 p -86.55 -23.03 25.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.798 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.649 HG21 ' OG ' ' A' ' 142' ' ' SER . 81.7 p -79.91 -2.65 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.714 0.292 . . . . 0.0 111.487 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.84 75.42 0.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.551 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -145.29 -40.49 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 111.09 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.589 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.4 mt -125.1 142.74 42.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 39.1 Cg_endo -69.19 145.27 59.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.203 1.935 . . . . 0.0 112.266 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.3 mt -58.9 150.88 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.738 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -142.27 164.35 30.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.301 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -122.8 119.76 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 0.0 111.756 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.561 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.2 mt -100.02 133.17 44.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.139 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.838 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.71 156.82 43.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.441 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.828 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.575 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 10.2 ttpt . . . . . 0 N--CA 1.463 0.21 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 9.7 p -110.61 139.34 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.561 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.94 139.51 36.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.437 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.71 129.48 56.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -118.11 145.27 45.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.881 0.372 . . . . 0.0 111.669 -178.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.54 -172.28 40.25 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.774 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -78.96 0.15 28.65 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.7 135.32 40.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 111.478 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.7 Cg_exo -66.37 -12.95 37.78 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.789 2.326 . . . . 0.0 111.84 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.5 -44.92 15.36 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.874 0.845 . . . . 0.0 108.965 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.15 141.87 1.12 Allowed 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.818 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.0 m-20 -56.22 -18.77 11.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.149 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.503 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.8 t80 -129.36 127.03 40.22 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-O 120.762 0.315 . . . . 0.0 110.693 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.433 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.278 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.442 HD12 HG23 ' A' ' 81' ' ' ILE . 25.0 mt . . . . . 0 N--CA 1.46 0.052 0 CA-C-O 120.92 0.39 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -54.76 -35.8 64.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -63.6 -42.11 98.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 53.3 mt -72.91 152.13 41.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -94.39 167.33 11.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.718 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.608 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -42.95 -54.82 4.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.413 0.625 . . . . 0.0 109.769 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.02 82.95 1.95 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -58.52 -46.53 86.56 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.411 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -142.41 160.26 40.62 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.794 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 102' ' ' ASN . 4.3 tt0 -135.95 142.7 44.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.919 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 62.1 mt -118.83 129.36 75.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.601 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.444 ' HB3' HG21 ' A' ' 65' ' ' VAL . 1.9 pt? -118.65 140.61 49.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.842 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.972 179.082 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.76 0.314 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 mp -129.43 142.62 50.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.138 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.63 122.39 47.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.2 t30 -113.23 115.49 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.39 . . . . 0.0 111.402 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.694 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 18.0 p30 -79.96 134.37 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.875 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.1 pt -142.34 40.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.54 158.08 15.99 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.082 0.468 . . . . 0.0 111.435 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.83 -35.71 77.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.443 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.6 -19.8 17.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.62 161.31 11.41 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.41 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.52 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.24 148.36 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 113.39 18.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.086 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 44.99 43.02 6.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -7.05 81.28 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.569 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.61 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.704 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 22.1 tptt -75.1 125.44 28.94 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.18 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.2 m -99.65 165.95 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 120' ' ' SER . 21.9 tt0 -69.88 128.75 37.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.372 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -54.03 163.75 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.93 37.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.5 p -111.64 145.06 39.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -91.43 124.35 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.789 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -129.25 147.13 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.867 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp -72.97 113.47 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 167.39 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.643 0.735 . . . . 0.0 111.823 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.27 153.22 43.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.476 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 121.48 18.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.09 22.4 62.71 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.073 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.44 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 6.8 t70 -60.5 177.16 0.3 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.838 0.352 . . . . 0.0 110.919 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.0 tt0 -145.16 135.66 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.421 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.5 mt -108.72 127.04 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.105 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.513 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.34 136.44 43.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.109 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.516 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.2 m -140.28 158.51 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.46 29.35 30.33 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.072 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.8 t -68.12 140.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.605 0.717 . . . . 0.0 112.406 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.42 -41.46 0.75 Allowed Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 47.8 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -50.55 -35.1 28.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.868 0.366 . . . . 0.0 111.331 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.5 t -93.57 6.33 48.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.425 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.4 t0 -120.2 21.9 11.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.513 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.6 mt -105.09 139.71 25.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.95 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 tt -122.34 134.4 54.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.929 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.649 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.73 133.58 53.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.086 0.47 . . . . 0.0 111.571 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 34.6 mt -126.1 133.23 51.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.78 140.03 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 111.485 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.2 mt -106.31 139.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.932 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.24 103.91 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.7 mt -88.31 118.4 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.094 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -75.88 127.66 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.02 -21.71 64.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -44.15 85.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.016 0.436 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.0 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.732 179.832 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.762 0.315 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -40.5 85.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -38.4 90.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -40.78 96.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 43.0 mm -67.62 -48.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -33.65 72.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.35 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -47.14 85.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.017 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 20' ' ' ILE . 4.6 p90 . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.146 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm . . . . . 0 N--CA 1.429 -1.495 0 CA-C-O 121.493 0.663 . . . . 0.0 112.601 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -92.65 -59.67 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.35 147.41 29.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.328 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.97 136.59 52.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.23 122.52 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.804 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.2 mt -126.59 127.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.358 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.0 t -93.31 115.67 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.596 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.4 t -88.88 -22.64 23.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.428 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.556 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.4 p -79.82 -2.69 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.3 . . . . 0.0 111.48 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.54 71.82 0.83 Allowed Glycine 0 N--CA 1.454 -0.106 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.947 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -142.9 -40.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.525 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 11.7 mt -122.88 140.77 33.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.66 141.79 28.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.165 1.91 . . . . 0.0 112.076 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mt -53.53 149.85 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.696 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -143.32 164.18 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.316 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -122.13 119.85 32.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.068 0.461 . . . . 0.0 111.962 -179.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.2 mt -98.51 136.69 38.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.2 158.79 44.07 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.796 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.712 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.79 0.328 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 7.3 t -127.89 138.19 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.175 0.512 . . . . 0.0 111.739 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.511 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.1 m-90 -100.85 139.12 36.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.207 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.12 125.94 54.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -112.96 145.68 40.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.475 -178.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.67 -169.1 38.54 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.711 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.9 mtp-105 -82.56 0.73 41.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 30.5 t-20 -84.96 132.63 45.21 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.057 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.6 Cg_exo -67.67 -10.26 28.16 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 111.656 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.54 16.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.898 0.856 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.46 139.09 1.15 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.342 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.15 -18.79 11.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.794 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.491 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.8 131.99 46.36 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.127 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.572 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 28.6 mm . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.871 0.367 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 m -54.87 -43.43 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.482 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.402 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.5 mmp_? -60.78 -18.19 53.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.411 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.6 mt -103.48 147.08 27.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.882 0.372 . . . . 0.0 110.722 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m -93.56 164.74 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.765 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.82 -52.47 5.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -120.45 82.4 1.9 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -60.46 -45.91 91.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.714 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.1 p90 -145.07 158.95 43.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.648 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.5 tt0 -135.64 140.94 44.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.431 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 62.0 mt -117.31 132.04 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.098 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -109.98 147.11 34.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.073 0.463 . . . . 0.0 111.652 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 tp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 179.721 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.759 0.314 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.5 mp -132.98 141.96 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mp -112.56 127.35 56.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.155 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' GLN . 43.5 t30 -115.89 115.58 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 111.702 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.687 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 19.0 p30 -77.37 135.33 38.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.676 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.0 pt -143.94 41.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.87 161.13 13.8 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.096 0.474 . . . . 0.0 111.503 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.91 -38.8 79.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.698 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.63 -19.7 17.4 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.99 161.81 11.24 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.088 -1.053 . . . . 0.0 114.01 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 17.4 m -117.6 137.87 52.32 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.224 0.61 . . . . 0.0 109.565 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.822 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.11 148.43 37.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -124.65 113.52 18.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 47.05 42.26 12.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.0 -10.15 71.76 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.863 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.413 ' CB ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -105.52 118.7 37.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.245 0.523 . . . . 0.0 110.765 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -73.13 134.43 44.46 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.349 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -107.01 166.58 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.334 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 mm-40 -69.88 123.96 22.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.553 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 75.7 tttt -52.95 163.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.513 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 36.09 33.19 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.032 -179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.35 145.08 40.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.105 179.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.78 131.94 36.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.955 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 62.0 mm-40 -129.37 151.79 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.644 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt -72.83 133.33 44.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.238 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.437 HD23 HG12 ' A' ' 147' ' ' ILE . 66.9 tp -65.15 154.85 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.512 0.672 . . . . 0.0 111.668 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.92 153.09 43.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.75 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 123.69 23.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.358 . . . . 0.0 110.106 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.43 47.4 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.173 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -51.11 172.21 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.834 0.35 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -144.87 135.56 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.028 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 5.5 mt -118.51 124.84 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.32 140.47 37.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.896 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.29 158.26 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.61 30.23 24.77 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.873 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.545 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.7 t -71.17 140.44 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.645 0.736 . . . . 0.0 112.385 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.06 -38.52 0.69 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.341 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 50.4 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.59 -37.03 37.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.793 0.33 . . . . 0.0 111.479 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 m -93.53 6.52 47.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -124.34 26.51 7.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.5 mt -105.93 139.68 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.634 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt -120.93 134.16 55.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.069 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.556 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 3.0 m -108.56 143.71 37.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -135.48 144.18 46.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.534 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.3 t -114.13 136.53 50.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.037 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.57 126.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -112.95 121.78 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.665 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 124' ' ' LEU . 3.5 mt -85.05 134.14 27.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.395 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.85 109.0 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -62.15 -42.44 99.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -46.02 90.8 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.3 t80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.835 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.77 0.319 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -62.84 -35.99 81.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.5 -38.65 91.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 tp -63.05 -45.05 94.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.1 mm -66.98 -34.99 73.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -40.22 76.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.987 0.422 . . . . 0.0 110.445 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -67.26 -23.84 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.53 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.198 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm . . . . . 0 N--CA 1.428 -1.561 0 CA-C-O 121.527 0.679 . . . . 0.0 112.561 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.8 t -89.92 -61.02 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.28 148.42 28.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.308 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -115.92 127.7 55.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.27 122.75 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.3 mt -120.62 128.45 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.347 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.87 121.51 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.475 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.5 t -88.15 -27.12 22.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.634 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 142' ' ' SER . 35.4 p -79.94 -2.17 42.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.545 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 77.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.84 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -146.86 -44.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.564 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -113.54 141.51 26.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.91 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.6 Cg_endo -71.14 145.81 50.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.017 1.811 . . . . 0.0 112.037 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.0 mt -56.69 143.91 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.916 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.03 163.3 33.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.813 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.67 120.53 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 112.178 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.8 mp -84.7 128.3 34.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -133.48 155.92 48.69 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.904 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.304 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.2 ttpt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.72 0.295 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 90' ' ' GLN . 9.6 t -131.1 139.21 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.525 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.2 m-90 -103.38 139.51 38.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.057 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.93 127.19 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.154 0.502 . . . . 0.0 110.223 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.583 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -113.6 146.26 40.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 169.61 -174.87 43.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.487 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -87.06 45.65 1.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.495 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -141.11 139.07 18.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.975 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 12.5 Cg_exo -68.27 -6.48 17.49 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.875 2.383 . . . . 0.0 111.904 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.33 11.14 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.88 0.848 . . . . 0.0 109.279 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.95 141.81 1.05 Allowed 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.96 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.41 -19.27 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.966 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 44.8 t80 -129.89 122.68 29.11 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.797 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.424 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.793 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.827 0.346 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.5 p -55.21 -34.65 64.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.86 -23.26 65.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.206 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 mt -97.49 147.73 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 111.084 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.17 164.75 12.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.998 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.631 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.44 -52.05 4.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.447 0.641 . . . . 0.0 109.847 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.51 79.92 1.55 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.5 t60 -60.87 -47.23 87.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.538 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 17.5 p90 -146.48 159.07 43.89 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.552 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.495 ' HG2' HG11 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.84 141.2 44.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.656 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 37.2 mt -115.48 130.51 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.075 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.461 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -122.39 139.21 54.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.047 0.451 . . . . 0.0 111.839 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.425 ' CD1' ' HG ' ' A' ' 99' ' ' LEU . 4.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.967 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HG ' ' CD1' ' A' ' 93' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.876 0.37 . . . . 0.0 110.777 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -123.18 139.38 54.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.8 120.06 40.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.981 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.7 t30 -116.82 119.97 37.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.402 . . . . 0.0 112.057 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.652 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.3 p30 -79.87 141.0 36.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.982 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.9 pt -147.06 36.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.428 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.53 149.81 21.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.128 0.489 . . . . 0.0 112.043 -178.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.0 m -68.62 -31.55 70.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.682 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -97.18 -19.75 18.41 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.652 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.569 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.12 156.15 10.42 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.604 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.9 m -117.45 137.81 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.31 148.62 37.24 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.35 18.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.452 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 43.43 43.74 4.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.499 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.3 -13.71 62.9 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.418 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -103.38 118.54 36.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.027 0.442 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.6 tptm -72.66 127.6 33.05 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 m -97.89 162.95 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.6 tt0 -69.99 126.9 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.489 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.652 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttm -52.09 160.79 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.462 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 35.75 33.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.41 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 118.04 34.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.106 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.406 ' ND2' ' CD1' ' A' ' 92' ' ' LEU . 14.3 m120 -66.01 135.16 54.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 33.1 mm-40 -129.48 151.14 50.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.77 132.71 43.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.27 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.401 HD21 ' CD1' ' A' ' 147' ' ' ILE . 44.0 tp -58.1 152.56 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.713 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.42 152.63 44.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.645 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -72.51 123.35 22.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.253 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.31 23.42 41.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.085 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.7 t70 -49.12 167.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.015 0.436 . . . . 0.0 111.429 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 mt-10 -144.8 135.44 24.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -117.35 127.81 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.748 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.67 138.12 41.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.933 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.31 158.06 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 30.93 25.2 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.811 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -70.83 140.41 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 112.452 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.48 -41.0 0.47 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.2 t -126.47 134.74 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 115.1 -0.55 . . . . 0.0 109.519 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -38.67 48.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.781 0.325 . . . . 0.0 111.467 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.9 m -93.42 6.32 48.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 6.9 t0 -121.36 26.95 8.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.7 mt -107.1 139.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.948 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 134.43 55.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.461 ' HB3' HG22 ' A' ' 40' ' ' THR . 47.3 t -112.11 150.78 30.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.518 0.675 . . . . 0.0 112.282 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.2 mm? -135.62 155.53 50.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.403 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 19.2 t -125.6 140.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.825 0.345 . . . . 0.0 111.431 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.4 HG13 HD13 ' A' ' 130' ' ' ILE . 34.0 mt -106.46 123.08 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.165 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.98 116.83 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.401 ' CD1' HD21 ' A' ' 124' ' ' LEU . 4.4 mt -86.27 134.21 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.608 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.78 122.91 27.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.649 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.28 -36.82 77.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -59.12 -45.37 91.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 110.719 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.9 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.904 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.8 0.333 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.4 36.92 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.811 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.95 -43.89 94.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.617 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -35.68 74.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.81 -42.38 79.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -32.46 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 20' ' ' ILE . 2.3 mt -73.16 -35.39 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.808 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -57.26 -39.18 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 110.434 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -67.09 -24.05 65.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.66 -47.47 79.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.233 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.4 p -66.9 -28.07 68.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 64.48 -174.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.83 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.93 127.78 32.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.51 120.12 25.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.816 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mm -83.12 138.34 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.679 0.752 . . . . 0.0 111.873 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . 115.63 25.35 3.73 Favored Glycine 0 C--N 1.314 -0.657 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.556 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.12 -23.64 22.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.69 0.281 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.87 -23.8 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.298 0.571 . . . . 0.0 110.977 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.794 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -70.05 101.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.077 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' H ' ' HA ' ' A' ' 49' ' ' SER . 2.4 t -58.02 -66.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.193 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.1 m -152.23 165.13 35.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.836 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -125.86 138.03 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.072 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.414 ' HB ' ' CE1' ' A' ' 76' ' ' TYR . 21.7 t -102.57 123.81 56.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.408 HD12 ' CD2' ' A' ' 146' ' ' PHE . 11.4 mt -123.14 124.94 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.1 t -81.71 123.04 28.39 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 t -86.72 -28.92 22.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 142' ' ' SER . 36.8 p -79.91 -2.13 42.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.688 0.28 . . . . 0.0 111.552 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.75 77.0 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -145.36 -43.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.0 mt -111.35 140.85 23.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.3 Cg_endo -72.52 131.43 17.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.127 1.884 . . . . 0.0 111.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.6 mt -51.84 131.56 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.659 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.87 164.21 19.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.251 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -117.84 120.1 36.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 111.536 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.557 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -97.64 134.87 40.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.426 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.794 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.79 157.25 43.63 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.03 142.11 31.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.74 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -74.98 133.3 41.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.154 0.502 . . . . 0.0 111.265 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.6 mt -64.58 -44.8 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.072 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.3 m -56.88 -39.39 74.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.35 0.595 . . . . 0.0 110.724 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.413 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 6.5 mm100 -68.55 -36.78 79.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.616 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.7 t -69.79 -43.77 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.066 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 tp -70.88 -32.11 68.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -30.95 65.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.996 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.17 116.85 27.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -114.95 31.71 6.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.712 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.1 mtm105 -168.0 148.35 4.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.734 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.27 -165.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.766 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.404 HG22 ' HB2' ' A' ' 92' ' ' LEU . 40.5 mm -91.21 156.29 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.15 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -90.41 -63.85 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -145.33 132.92 20.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.5 t -124.87 139.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 111.983 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.557 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.7 m-90 -100.9 139.23 36.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.435 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.417 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.92 128.45 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -117.25 145.52 43.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.624 -177.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.76 -169.61 40.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.722 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.4 mtp-105 -83.25 -1.62 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.76 136.22 39.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 111.602 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.1 Cg_exo -67.44 -10.57 29.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.843 2.362 . . . . 0.0 111.979 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.55 -44.47 15.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.84 0.829 . . . . 0.0 109.02 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.78 139.31 2.33 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.42 -18.21 10.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.955 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -129.18 118.67 22.77 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 -88.79 118.84 28.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.417 ' HG ' ' CD1' ' A' ' 43' ' ' ILE . 8.5 mp -89.99 -177.17 5.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.578 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.03 -82.55 0.38 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.275 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.4 p30 176.32 68.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 110.702 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.49 112.9 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.413 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.7 m -54.79 -34.94 63.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.067 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -26.63 67.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.406 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 33.1 mt -91.63 152.18 20.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -93.64 167.25 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -42.95 -54.12 4.39 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.374 0.607 . . . . 0.0 109.77 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -119.65 82.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.2 -46.25 88.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.836 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.5 p90 -143.57 159.84 41.71 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.13 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.516 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.7 tt0 -135.77 143.05 45.05 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.385 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 49.6 mt -118.69 127.86 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.973 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.426 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -114.11 141.81 47.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 111.956 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.407 ' CD1' ' HG ' ' A' ' 99' ' ' LEU . 7.5 tp -125.22 122.88 38.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.229 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.93 -129.42 1.79 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.59 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 62.7 -79.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.702 0.286 . . . . 0.0 110.852 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.26 -41.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.41 -33.85 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -63.73 -174.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -115.65 156.96 24.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.002 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.31 145.41 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.316 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.77 121.37 44.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.888 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.6 t30 -116.81 115.66 25.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.789 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.7 p30 -78.96 136.62 37.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.751 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.8 pt -144.26 39.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.551 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.65 152.63 19.85 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.157 0.504 . . . . 0.0 111.956 -179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.0 m -68.79 -31.57 70.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.809 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.07 -19.97 17.64 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.541 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.53 157.04 10.58 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.695 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.38 137.71 52.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.04 148.56 40.06 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.556 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.39 43.64 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.96 -13.16 61.93 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.435 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.26 118.53 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.467 . . . . 0.0 110.465 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.66 129.26 38.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.52 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.4 m -97.84 163.45 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.91 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.71 125.34 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.487 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.1 tttt -52.25 161.27 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.755 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.19 34.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.21 145.03 40.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.145 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -85.69 129.13 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -129.09 146.23 51.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.548 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.75 111.97 8.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.246 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.0 tp -50.66 157.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.397 0.618 . . . . 0.0 111.646 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.403 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.8 OUTLIER -124.45 153.13 42.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.6 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.73 124.75 25.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.83 20.91 50.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t70 -55.79 174.96 0.1 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.6 mt-10 -145.04 135.7 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.316 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.422 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 5.6 mt -111.59 126.99 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.493 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.65 137.23 42.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.944 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.518 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.47 158.32 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.29 22.81 42.87 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.324 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.512 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.4 t -62.62 140.33 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.663 0.744 . . . . 0.0 112.388 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -43.98 0.57 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.211 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 44.7 t -126.47 138.32 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -38.42 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.71 0.291 . . . . 0.0 111.584 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 t -93.55 6.2 49.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 133' ' ' GLY . 3.2 m-20 -116.31 22.52 12.8 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.2 mt -107.06 139.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.22 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 tt -124.48 134.27 53.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 40' ' ' THR . 46.9 t -111.28 150.54 29.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.716 0.769 . . . . 0.0 112.211 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 66.8 mt -135.38 156.57 48.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.67 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.413 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 20.9 t -125.68 137.54 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mt -106.48 120.96 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -106.01 122.39 46.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.407 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.4 mp -112.91 134.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.482 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.414 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 28.7 p30 -93.52 135.46 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -74.02 -21.34 60.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -58.22 -44.23 88.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -58.37 -44.02 88.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.753 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -33.95 76.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -60.5 -47.0 88.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.4 t -59.79 -45.96 90.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.972 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.19 -46.01 91.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.755 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -67.74 -43.76 79.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.824 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -22.15 66.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.091 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -125.09 98.43 5.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.895 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -85.67 150.41 24.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.2 m -73.19 132.74 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.156 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.03 159.38 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.72 77.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 pp -81.61 136.65 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.972 179.909 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 14.3 mttt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.872 0.368 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 113.01 3.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.82 176.6 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 1.3 m -92.57 148.55 21.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -65.71 163.17 17.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -101.95 -60.65 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.69 90.47 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.43 2.087 . . . . 0.0 112.286 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 38.5 m -81.06 123.15 28.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.11 126.92 85.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.47 106.99 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.303 2.002 . . . . 0.0 112.264 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 3.5 pp -173.42 -179.37 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.955 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.87 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.7 p -103.92 -53.16 2.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -67.79 -43.48 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -42.58 99.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -38.62 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.555 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.8 tp -58.1 -31.94 67.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.49 -35.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.726 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.67 -36.18 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.309 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.56 -47.45 79.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.217 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -30.78 71.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -74.02 154.75 39.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -101.02 158.04 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.84 137.96 34.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.65 138.57 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.547 0.689 . . . . 0.0 111.836 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.82 64.37 0.47 Allowed Glycine 0 C--N 1.315 -0.584 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.34 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -42.38 99.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.591 0.234 . . . . 0.0 111.401 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 179.68 39.75 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.621 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -71.47 142.42 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.284 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.43 -50.48 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.974 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.11 146.17 10.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.204 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -113.88 131.45 56.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.286 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' HB ' ' CZ ' ' A' ' 76' ' ' TYR . 28.7 t -97.8 122.79 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.3 mt -123.34 119.56 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.269 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.5 t -80.48 121.05 25.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.23 -27.72 18.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.422 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.582 HG22 ' HB2' ' A' ' 142' ' ' SER . 69.2 p -80.31 -2.96 47.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.686 0.279 . . . . 0.0 111.556 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.86 80.74 0.2 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.375 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 15.2 mt-30 -149.62 -45.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.862 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.02 141.16 26.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.68 139.81 28.52 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.169 1.913 . . . . 0.0 112.125 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mt -55.23 135.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.725 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -134.37 164.02 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.209 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.2 119.72 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.7 mt -90.6 137.49 32.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.621 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.44 157.37 45.24 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.98 141.91 23.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.3 -1.773 . . . . 0.0 110.497 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.486 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -81.09 133.17 35.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.264 0.554 . . . . 0.0 111.197 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.1 mt -64.86 -43.13 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.542 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.6 m -58.44 -42.73 87.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.623 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.486 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 3.7 pt20 -68.43 -36.87 79.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.563 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 47.7 t -68.05 -47.48 78.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.29 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -29.56 69.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.156 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -44.39 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.007 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.96 131.56 49.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.7 53.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.36 -174.86 2.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -59.64 -32.68 70.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 8.5 tp -152.55 159.69 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.161 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -102.1 -72.9 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -130.27 132.2 45.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.413 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.4 t -129.95 139.61 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.293 0.568 . . . . 0.0 111.809 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.554 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.3 m-90 -100.24 139.68 35.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.146 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.539 HG22 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.23 131.94 54.59 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 0.0 111.624 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.74 -174.43 41.44 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.554 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.6 mtm105 -81.52 -0.78 43.54 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.77 135.66 40.02 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.666 0.269 . . . . 0.0 111.273 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.52 -7.53 20.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.728 2.285 . . . . 0.0 111.876 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.42 15.63 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.977 0.894 . . . . 0.0 108.936 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.73 137.33 5.46 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.646 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.45 -18.81 12.52 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.853 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.3 t80 -129.86 117.25 19.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.887 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -90.66 107.73 19.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.496 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.7 mt -78.93 -71.63 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.164 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.38 -100.9 0.14 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.1 p30 -175.32 47.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 111.225 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.5 mt -80.77 126.14 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.916 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -43.17 73.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.343 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -44.15 97.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 HD21 ' CE1' ' A' ' 88' ' ' HIS . 46.5 mt -72.77 152.18 41.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.188 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.5 p -95.49 165.5 12.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.741 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.671 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.39 -53.01 5.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.344 0.593 . . . . 0.0 109.627 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.44 ' HB3' HD11 ' A' ' 104' ' ' ILE . 17.1 mttt -119.69 84.57 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -63.99 -45.27 89.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.095 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.407 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.6 p90 -150.99 162.39 40.92 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.155 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.539 ' HG2' HG22 ' A' ' 67' ' ' THR . 11.6 mt-30 -135.49 158.27 44.8 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.378 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 64.2 mt -127.45 132.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.957 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -113.72 144.46 42.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.731 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -119.71 123.14 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.521 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.55 -120.95 0.77 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.379 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 56.27 -176.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 111.078 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -47.95 58.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -156.56 55.95 0.39 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -177.24 -176.44 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.727 0.299 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.464 ' CG ' HD23 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -128.47 160.44 32.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.047 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.447 ' HB2' ' CG ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.55 149.44 50.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.506 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.52 131.59 54.92 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 90' ' ' GLN . 46.9 t30 -113.28 115.92 28.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.661 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.1 p30 -76.65 143.06 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.45 HG12 ' HG3' ' A' ' 90' ' ' GLN . 10.0 pt -150.75 37.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.582 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.06 158.82 15.25 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.047 0.451 . . . . 0.0 111.807 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.9 m -68.92 -35.31 76.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.587 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -20.04 17.3 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.33 163.36 11.96 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.488 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 20.8 m -117.53 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.811 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -114.36 148.4 37.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.17 113.43 18.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.281 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 43.72 43.4 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.48 -12.43 66.84 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.482 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -104.96 118.53 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.067 0.461 . . . . 0.0 110.642 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.811 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.19 134.9 45.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.501 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -105.01 164.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.4 tp10 -69.95 125.07 25.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.661 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.6 tttt -51.82 160.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.422 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 35.89 33.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.54 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.57 145.09 40.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 179.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -86.81 129.79 34.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.789 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.6 mm-40 -127.53 147.74 50.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.409 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.58 120.95 18.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.539 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 125' ' ' SER . 5.9 tp -58.89 155.94 12.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.486 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.553 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.3 t -124.25 153.43 41.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.342 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 6.5 tp60 -71.41 123.99 23.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.28 22.17 42.99 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.276 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.7 t70 -58.14 174.56 0.27 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -145.2 135.46 24.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.146 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 16.0 mt -111.59 128.39 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.261 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.487 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.08 138.85 40.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 30.3 m -140.15 158.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.89 22.37 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.85 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.32 140.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 121.598 0.713 . . . . 0.0 112.442 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.37 -39.87 0.7 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 52.0 t -126.59 128.62 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.48 -34.68 25.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 87.4 p -93.54 6.3 48.69 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 7.5 t0 -124.18 24.85 8.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.543 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.9 mt -104.78 139.61 25.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.823 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.403 ' HG ' ' CD2' ' A' ' 143' ' ' LEU . 25.3 tp -117.54 134.75 54.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.956 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.582 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.8 OUTLIER -111.54 135.47 52.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.547 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.403 ' CD2' ' HG ' ' A' ' 141' ' ' LEU . 1.9 mm? -131.04 138.48 49.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.84 138.7 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.339 . . . . 0.0 110.927 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 6.6 mt -106.26 139.01 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.9 119.88 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 3.4 mt -85.62 134.17 27.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.553 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.55 107.48 13.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -58.21 -32.18 68.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -60.25 -45.92 91.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -59.64 -44.09 93.63 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.074 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -35.13 79.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.023 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -40.73 92.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.125 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.62 -45.09 80.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -35.99 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.02 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.28 -39.37 93.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.018 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -86.72 -36.39 18.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.67 39.87 1.8 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.508 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.43 147.78 38.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.824 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.5 m -71.8 136.97 24.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -172.4 134.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.7 103.16 15.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.57 131.57 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 2.8 mttp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.787 0.327 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 13.3 mttm 62.11 150.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 5.1 mmt -147.29 -47.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 2.6 m 62.06 116.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 66.53 -68.93 0.13 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.916 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 64.43 48.85 2.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.982 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.75 125.6 14.66 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.583 2.189 . . . . 0.0 112.472 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 21.2 p -89.04 -55.13 3.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.992 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.8 108.36 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.57 154.24 71.99 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.424 2.083 . . . . 0.0 112.231 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mt 59.77 179.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.823 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.906 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.812 0.339 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.1 p -69.32 -50.07 49.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.45 -40.43 91.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -42.62 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.65 -38.08 74.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -31.81 70.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.19 -35.54 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.49 -39.96 77.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -67.1 -23.87 65.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.7 -47.49 79.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 p -67.04 -37.29 83.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.79 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.47 81.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.989 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -99.94 125.33 45.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.67 101.85 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 29' ' ' GLY . 18.1 mm -87.69 138.27 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-O 121.728 0.775 . . . . 0.0 111.737 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 28' ' ' ILE . . . 126.33 99.24 1.12 Allowed Glycine 0 C--N 1.315 -0.615 0 CA-C-N 114.458 -1.247 . . . . 0.0 112.526 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.16 -39.57 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.74 0.305 . . . . 0.0 110.995 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -171.4 34.03 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.4 mm -72.58 135.76 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.575 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -93.53 -59.46 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.643 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 m -152.81 150.48 29.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.383 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -115.18 131.71 56.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.777 0.322 . . . . 0.0 111.248 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.407 ' HB ' ' CE1' ' A' ' 76' ' ' TYR . 43.8 t -96.18 122.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.053 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.5 mt -124.01 121.38 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.661 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.5 t -82.04 121.65 26.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.459 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.414 ' CG2' HG21 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -94.58 -25.1 16.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.501 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 5.9 p -80.04 -2.38 44.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.663 0.268 . . . . 0.0 111.386 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.09 78.98 0.21 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.851 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 15.5 mt-30 -149.38 -40.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.555 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 9.2 mt -124.2 141.68 37.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.97 146.13 41.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.193 1.928 . . . . 0.0 112.12 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.8 mt -60.3 146.32 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.647 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -140.31 163.23 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.07 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.29 119.8 36.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 111.843 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.557 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.6 mt -93.25 137.42 32.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.273 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.39 157.32 43.76 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.29 141.89 27.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.854 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.483 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.1 m-20 -77.78 129.82 35.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.101 0.476 . . . . 0.0 111.023 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -64.39 -45.02 97.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.531 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -57.0 -42.1 79.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.398 0.618 . . . . 0.0 110.914 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 5.5 mt-30 -68.51 -37.07 79.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.977 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 44.7 t -68.79 -49.17 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.017 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -29.17 68.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -74.36 -39.37 62.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.91 135.84 40.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.0 31.25 6.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -101.84 -176.98 3.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.84 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -79.54 -24.01 42.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.405 HD13 ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -131.71 137.35 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -109.23 -61.77 1.58 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 49' ' ' SER . 8.6 ttpt -136.0 116.47 13.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.227 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.9 p -110.44 140.23 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.557 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 13.5 m-90 -100.22 139.22 36.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.852 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.85 128.74 56.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -116.61 145.63 43.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.353 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.37 -170.0 39.38 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.788 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.9 mtp-105 -81.22 1.17 33.38 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 140.32 37.92 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.661 0.267 . . . . 0.0 110.903 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.27 -11.69 22.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.511 2.141 . . . . 0.0 111.354 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.7 18.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.12 138.31 3.01 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.317 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.36 -18.53 11.21 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.874 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.498 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 3.7 t80 -129.54 127.97 41.82 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.713 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.55 107.98 19.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.751 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 ' HB3' HD11 ' A' ' 43' ' ' ILE . 27.4 mt -77.49 -72.64 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.362 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.02 -96.31 0.1 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.363 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -173.62 51.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.801 0.334 . . . . 0.0 111.345 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.427 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 41.1 mt -90.33 121.16 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.612 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.55 -35.63 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.279 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.03 -45.65 93.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.834 0.349 . . . . 0.0 110.699 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 16.1 mt -75.32 148.29 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -93.7 167.13 11.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.601 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.54 -53.62 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.393 0.616 . . . . 0.0 109.834 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.38 82.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.4 t60 -58.8 -46.26 88.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.772 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.7 p90 -144.7 162.19 37.32 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.099 -0.641 . . . . 0.0 112.121 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 2.8 tt0 -135.59 146.79 48.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.09 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 64.8 mt -123.14 130.42 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.506 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.99 141.03 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.222 0.534 . . . . 0.0 112.188 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.13 123.12 39.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.778 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.63 -140.28 4.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.074 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.47 -168.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 111.264 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t70 73.53 -62.29 0.47 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.002 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.8 -32.38 2.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.349 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.08 -176.51 5.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.754 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.19 154.74 20.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.8 mp -121.4 142.46 49.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.31 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.71 124.13 51.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.2 t30 -116.05 115.51 26.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.493 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.686 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 19.5 p30 -79.16 137.7 37.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -146.61 40.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.567 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.85 160.18 14.51 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.971 0.415 . . . . 0.0 111.681 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.3 m -68.94 -36.44 77.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.46 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.94 17.26 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.485 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.52 163.94 12.29 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.581 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.51 137.89 52.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.799 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.94 148.46 36.8 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 113.43 18.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.039 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 45.09 42.39 6.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.265 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.78 -7.98 79.29 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.499 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.05 118.47 36.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.174 0.487 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.799 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.14 129.76 38.77 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.297 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.0 m -101.8 166.71 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.272 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.8 tp10 -70.02 126.17 28.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.686 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.3 tttt -52.78 162.65 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.227 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.91 36.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.066 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.0 p -111.84 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.547 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -91.93 129.51 37.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.888 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.02 149.84 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -72.91 123.46 23.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.456 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.67 155.72 9.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.59 152.92 42.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.459 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 125.52 27.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.05 22.88 44.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.193 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.2 t0 -56.34 173.4 0.17 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 0.9 OUTLIER -145.02 135.46 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.073 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.414 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 4.0 mt -114.16 127.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-O 120.893 0.377 . . . . 0.0 110.377 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.45 136.53 43.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.825 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.4 m -140.3 158.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 24.57 41.65 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.28 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.53 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.2 t -63.25 140.4 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.72 0.771 . . . . 0.0 112.462 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.67 -44.17 0.54 Allowed Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.353 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.5 t -126.37 137.87 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -50.75 -38.13 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.59 6.31 48.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 74.0 m-20 -117.25 22.97 12.14 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.2 mt -107.11 139.63 28.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.175 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.53 134.49 55.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.674 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.528 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.29 131.6 56.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.584 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.4 HD21 ' CD1' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -127.01 142.79 51.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.892 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.429 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 11.3 t -111.0 140.32 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.5 mt -105.85 120.88 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.069 0.461 . . . . 0.0 111.001 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.98 122.68 45.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.682 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.51 121.28 48.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.982 0.42 . . . . 0.0 111.376 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.463 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 10.5 p30 -82.92 135.79 34.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.1 -20.2 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.183 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -57.47 -43.74 84.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.623 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -59.26 -43.97 92.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.678 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -65.13 -33.96 77.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.5 -45.09 95.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -67.22 -43.6 81.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.909 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -35.81 78.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -60.61 -43.4 97.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.755 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' LYS . 42.8 mt-30 -84.83 -30.04 24.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.52 -90.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.626 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 157' ' ' GLN . 6.9 tptt -100.43 134.99 42.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.4 p -96.8 132.06 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.082 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 60.61 93.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -155.86 73.27 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pt -105.05 114.25 44.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.171 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.837 0.351 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 62.16 149.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 9.6 mtm -68.22 173.69 4.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.964 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 9.4 t -152.51 159.43 43.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -110.2 118.32 36.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.14 -29.98 31.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.5 144.22 84.39 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.441 2.094 . . . . 0.0 112.197 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 3.6 t -117.49 42.13 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.946 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 4.4 t0 59.49 90.27 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.86 117.48 5.05 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.558 2.172 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.73 158.05 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.815 0.34 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 t -167.87 -43.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.952 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -60.39 -36.51 78.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -60.0 -40.35 88.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -36.02 82.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -41.39 93.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -69.23 -35.08 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.26 -36.81 71.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.24 -23.78 65.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.738 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.81 -47.52 80.05 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.84 -27.3 36.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.049 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 64.66 162.84 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.88 128.28 42.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.63 131.74 44.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.0 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.613 0.721 . . . . 0.0 111.698 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.28 102.87 0.92 Allowed Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.439 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.02 -31.29 56.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 0.0 110.957 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 176.9 38.73 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.69 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.58 135.78 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 113.631 -1.622 . . . . 0.0 112.336 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -92.3 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.667 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.12 157.4 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.904 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.869 0.366 . . . . 0.0 111.472 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.18 122.64 57.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.627 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.5 mt -129.49 118.34 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 t -81.81 119.57 24.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.281 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.41 -25.59 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.893 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 142' ' ' SER . 30.8 p -79.99 -2.21 43.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.559 0.218 . . . . 0.0 111.508 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.15 73.25 0.64 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.825 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -141.58 -47.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.76 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mp -114.0 140.68 25.16 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.85 139.91 31.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.182 1.921 . . . . 0.0 112.24 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mt -54.2 139.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.555 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -129.33 164.1 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.492 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.36 119.87 35.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.112 0.482 . . . . 0.0 111.372 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.8 mt -97.9 128.89 44.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.69 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.84 158.32 43.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.06 141.93 29.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.563 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -77.17 137.23 38.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 111.462 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.31 -45.23 94.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.337 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -58.51 -42.92 88.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.764 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.6 -36.77 79.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 0.0 110.46 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.33 -43.06 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -32.74 69.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.28 -44.01 59.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -89.99 109.59 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -97.26 -31.08 12.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.26 167.25 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.35 -173.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -88.73 149.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.011 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -83.43 -75.89 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.4 ttpt -144.49 137.69 27.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.165 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.461 HG11 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -132.16 139.36 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.376 0.607 . . . . 0.0 112.255 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.526 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.8 m-90 -101.68 139.26 37.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.935 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.66 128.68 56.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.859 0.361 . . . . 0.0 110.027 177.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -120.49 145.23 47.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.61 -166.72 34.98 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.47 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' ASN . 4.9 mtp85 -79.01 2.05 21.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.71 130.83 51.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 0.0 111.197 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.67 -15.91 51.26 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.515 2.144 . . . . 0.0 111.495 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.77 -41.61 18.96 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.76 139.11 1.73 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.537 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.25 -18.63 11.04 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.109 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.535 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -129.82 125.09 34.89 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.3 107.98 19.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' HA ' HG12 ' A' ' 43' ' ' ILE . 7.1 mt -75.4 -69.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.199 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.79 -88.47 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.584 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -170.79 57.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.764 0.316 . . . . 0.0 111.32 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 81' ' ' ILE . 30.7 mt -95.52 115.8 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.942 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -42.58 71.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -60.85 -18.69 57.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.332 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -103.3 151.19 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.62 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.1 p -97.8 163.99 12.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.728 0.299 . . . . 0.0 111.667 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.577 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -43.22 -52.93 5.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.401 0.62 . . . . 0.0 109.912 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -117.67 80.73 1.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.4 t60 -60.34 -45.53 93.13 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.652 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 35.0 p90 -147.11 159.5 43.53 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.237 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.461 ' HG2' HG11 ' A' ' 65' ' ' VAL . 4.7 tt0 -136.14 142.88 44.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.114 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 62.7 mt -117.64 129.25 74.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.662 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.42 ' HB3' HG13 ' A' ' 65' ' ' VAL . 1.6 pt? -115.95 148.04 40.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.113 0.482 . . . . 0.0 111.855 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 26.2 tp -125.02 134.75 52.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.058 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.39 -166.77 38.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.537 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 59.14 -176.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.699 0.285 . . . . 0.0 110.704 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.45 80.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.73 -158.84 49.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.433 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 61.38 163.21 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.985 0.422 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.77 160.04 24.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.689 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.4 ' HB3' ' CD2' ' A' ' 92' ' ' LEU . 1.4 mp -128.26 143.29 51.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.313 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tp -112.79 121.6 45.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.159 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 90' ' ' GLN . 56.5 t30 -115.38 115.72 27.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.543 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.666 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.5 p30 -79.77 137.97 37.14 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.42 29.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.563 0.22 . . . . 0.0 111.268 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.559 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 12.9 t -90.32 160.2 16.25 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.253 0.549 . . . . 0.0 112.369 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.5 m -69.54 -52.47 26.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.598 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -19.23 27.69 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.93 157.76 9.38 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.606 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -116.94 137.73 52.02 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.372 0.669 . . . . 0.0 109.252 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.874 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -112.27 149.15 32.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.24 113.5 18.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.319 176.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 44.54 43.39 6.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.649 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.29 -13.49 63.45 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.725 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.07 118.6 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.106 0.453 . . . . 0.0 110.639 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.874 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.9 tptm -73.28 125.1 27.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.307 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.67 163.4 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.032 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.3 tt0 -69.96 128.87 37.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.549 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 1.8 tttt -54.08 156.84 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.092 0.473 . . . . 0.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.601 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.5 p30 37.46 34.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.065 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.9 144.89 40.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.865 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -88.59 129.0 35.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 111.126 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -129.25 147.79 51.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.299 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.1 tp -72.77 119.02 16.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.361 . . . . 0.0 110.192 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.7 tp -53.6 157.24 2.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.346 0.593 . . . . 0.0 111.643 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.47 153.28 42.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.422 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -71.57 122.71 20.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.192 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.95 19.29 56.25 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.152 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.3 t70 -52.15 171.79 0.05 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.767 0.318 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.1 mt-10 -145.24 135.51 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.5 mt -110.91 126.48 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.009 0.433 . . . . 0.0 110.476 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.485 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.28 140.78 37.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.571 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.58 158.36 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.84 35.57 21.5 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.164 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.9 t -74.33 140.24 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.612 0.72 . . . . 0.0 112.24 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -40.91 0.83 Allowed Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.247 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -126.52 127.91 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.282 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -50.49 -31.49 15.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.217 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.8 m -93.67 6.16 49.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -124.35 21.65 8.65 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.5 mt -103.63 139.0 25.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 tt -124.53 134.43 53.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.454 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.9 t -109.57 150.18 28.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.664 0.745 . . . . 0.0 112.359 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 77.7 mt -135.84 153.01 51.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.484 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.5 t -121.53 139.18 49.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.294 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.9 mt -106.47 128.53 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.977 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.7 114.11 25.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 147' ' ' ILE . 4.1 mt -84.76 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.3 113.38 17.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -37.38 83.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -60.09 -46.02 90.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.966 0.412 . . . . 0.0 110.855 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -59.23 -44.13 92.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.107 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -40.06 91.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -59.09 -40.7 86.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.103 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.4 t -67.38 -46.06 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.999 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -66.62 -35.92 81.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.838 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.86 -42.34 98.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.851 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LYS . 2.6 tp60 -84.68 -31.71 23.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.818 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.77 -90.71 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.65 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 157' ' ' GLN . 7.6 tttt -74.82 139.99 43.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.65 125.78 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.04 125.18 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? 66.11 -72.47 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.111 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.22 139.99 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.15 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.881 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -158.93 -57.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.868 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.9 mmm -132.12 148.39 52.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 31.6 m -138.8 151.93 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.42 ' CE2' ' HG3' ' B' ' 172' ' ' PRO . 1.5 t80 -117.61 88.23 2.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.88 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 -67.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' B' ' 169' ' ' PHE . 73.1 Cg_exo -48.86 145.14 13.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.469 2.113 . . . . 0.0 112.406 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 12.4 p -124.62 139.97 53.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.995 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.56 83.22 41.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.813 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.92 178.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.587 2.191 . . . . 0.0 112.277 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.89 108.07 19.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.922 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.82 0.343 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -147.98 -44.63 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -59.88 -47.0 87.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -47.51 67.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.818 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -35.83 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -31.77 72.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.773 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 mt -71.86 -35.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.71 -46.17 84.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.441 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.25 -23.76 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -47.6 79.84 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.393 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.1 p -63.53 -32.27 73.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -79.43 -75.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -96.25 142.44 28.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.48 125.55 31.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -82.16 138.34 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.659 0.742 . . . . 0.0 111.818 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.78 73.8 0.16 Allowed Glycine 0 C--N 1.315 -0.629 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.474 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -88.95 -36.66 15.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.749 0.309 . . . . 0.0 110.969 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 179.05 38.92 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -77.18 135.24 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 113.75 -1.568 . . . . 0.0 112.3 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -91.46 -60.23 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.998 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.5 p -146.53 162.11 39.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.434 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -131.68 128.47 39.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.281 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 22.7 t -97.8 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.925 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.9 115.5 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.21 99.81 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 110.343 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -80.25 -19.89 45.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.739 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.543 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.8 p -80.04 -2.59 44.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.574 0.226 . . . . 0.0 111.378 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.79 75.48 0.57 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.964 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -147.84 -41.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.068 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.0 mt -127.43 141.29 40.45 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.8 Cg_endo -72.52 145.38 42.18 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.012 1.808 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.7 mt -54.36 142.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.225 0.536 . . . . 0.0 111.908 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 33.8 mtt-85 -140.84 164.28 30.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.79 120.43 26.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 9.3 mp -86.38 137.08 32.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.188 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.662 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -142.61 156.01 45.03 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.427 1.108 . . . . 0.0 113.664 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -135.11 141.86 46.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.65 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.506 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -78.08 137.58 38.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.042 0.449 . . . . 0.0 111.4 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 52' ' ' ILE . 81.4 mt -64.21 -41.64 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.224 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.4 m -56.32 -40.26 74.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.506 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.0 mt-30 -68.35 -36.85 79.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.207 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.3 t -61.58 -40.48 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.99 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.05 -39.43 72.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -58.96 -36.68 75.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.006 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -88.99 125.05 34.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.1 74.69 5.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.8 mtt-85 59.23 78.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 t -152.03 -65.25 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 tp -173.49 139.24 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.15 -71.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.767 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt -155.14 150.11 26.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.002 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.492 HG11 ' HG2' ' A' ' 90' ' ' GLN . 16.3 t -128.64 139.31 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.256 0.551 . . . . 0.0 111.959 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.536 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.6 m-90 -105.82 139.07 40.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.03 128.09 55.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.563 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -111.65 145.93 38.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.926 -178.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.72 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.08 -175.98 41.51 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -79.57 -2.52 42.79 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.85 134.63 41.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.644 0.259 . . . . 0.0 111.01 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.34 -7.09 19.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.658 2.238 . . . . 0.0 111.708 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.7 16.55 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.956 0.884 . . . . 0.0 108.932 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.08 137.69 4.17 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.477 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -56.43 -18.89 12.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.834 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.7 t80 -129.89 120.34 24.74 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.723 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.14 119.31 31.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.428 HD21 ' CD1' ' A' ' 76' ' ' TYR . 7.3 mt -111.49 -176.06 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 111.09 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.78 136.67 20.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.375 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -61.58 89.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.389 . . . . 0.0 111.278 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 37.8 mm -112.15 125.0 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.759 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.09 -44.07 74.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -24.19 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.452 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.459 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 57.5 mt -93.24 152.26 19.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.8 0.333 . . . . 0.0 111.181 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.43 167.11 11.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.794 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.72 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.86 -53.9 5.7 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.65 82.97 1.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.541 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.2 t60 -60.44 -47.4 86.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.483 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.62 159.85 42.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.62 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.492 ' HG2' HG11 ' A' ' 65' ' ' VAL . 5.3 tt0 -135.78 139.59 43.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 68' ' ' PHE . 57.6 mt -114.72 131.38 67.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.096 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.53 147.87 42.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.096 0.474 . . . . 0.0 111.758 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.2 tp -124.99 122.62 37.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.912 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.45 89.85 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.594 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -177.86 35.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.741 0.305 . . . . 0.0 110.975 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 t70 60.49 22.78 12.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.378 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.34 -54.78 0.56 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.094 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -55.83 149.56 14.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 111.208 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.78 160.0 17.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.791 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.4 mp -132.46 143.46 49.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.415 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.81 126.04 55.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.223 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.4 t30 -119.02 115.54 24.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 111.564 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.693 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.9 p30 -78.27 141.21 38.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.665 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.8 pt -149.08 37.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.541 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.65 153.69 18.05 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.9 m -68.87 -31.7 70.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.005 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.4 -20.02 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.36 157.53 10.56 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.738 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.8 m -117.53 137.83 52.31 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.111 0.564 . . . . 0.0 109.573 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.818 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.67 148.49 38.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.04 113.41 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.392 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 44.3 42.86 5.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.08 76.02 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.51 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.64 118.68 37.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.9 tptp -73.27 121.71 20.8 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.203 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 m -93.69 165.52 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.267 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 120' ' ' SER . 26.1 mt-10 -69.8 126.33 29.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.6 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.9 tttm -54.55 162.76 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.655 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.26 34.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.015 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.04 40.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.136 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -91.69 130.75 37.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.889 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.2 mm-40 -129.26 150.07 50.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.651 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.67 115.41 11.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.1 tp -52.74 157.18 1.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.413 0.625 . . . . 0.0 111.571 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.39 153.0 42.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.524 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -71.8 124.26 24.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.93 20.57 53.66 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.136 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.1 t0 -55.06 172.83 0.11 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.0 111.07 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -145.04 135.4 24.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.204 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 17.1 mt -114.76 127.95 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.509 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.42 139.27 39.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.991 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.25 158.27 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.01 27.69 33.34 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.106 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.5 t -67.33 140.24 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.582 0.706 . . . . 0.0 112.332 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.61 -41.75 0.73 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.283 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.0 t -126.39 133.28 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.61 -35.82 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.796 0.331 . . . . 0.0 111.485 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -93.59 6.3 48.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -119.89 21.88 11.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 134' ' ' VAL . 7.4 mt -104.88 139.59 25.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.155 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 tt -121.81 134.36 54.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.606 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.543 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -111.5 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.111 0.482 . . . . 0.0 111.801 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.5 mt -124.12 138.41 54.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.71 136.61 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.401 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.2 mt -106.28 130.56 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.58 118.15 31.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.705 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.93 134.11 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.684 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.96 117.55 23.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.721 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.28 -29.89 65.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -60.29 -46.01 91.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -58.68 -44.16 90.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.151 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -61.06 -33.84 73.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.834 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -47.05 86.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -64.55 -45.93 85.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.963 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -39.62 94.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.933 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.34 -40.71 87.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -85.24 -36.66 20.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.966 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.68 31.72 0.32 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.476 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 152.68 44.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 p -103.06 122.84 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.162 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -108.94 -31.73 7.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -129.41 176.35 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.61 122.23 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.876 0.369 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -75.88 157.03 33.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.07 -70.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 6.6 m -108.13 118.37 36.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' B' ' 172' ' ' PRO . 1.2 t80 -93.6 122.96 36.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -131.26 -46.27 1.0 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.042 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.416 ' HA ' ' CZ ' ' B' ' 169' ' ' PHE . 54.4 Cg_exo -52.57 102.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.505 2.136 . . . . 0.0 112.195 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 2.3 m -97.6 139.23 33.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.51 86.67 15.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.86 157.15 6.05 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.587 2.191 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.94 176.21 8.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.957 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.823 0.344 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -94.09 52.92 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -46.94 87.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -61.1 -36.15 78.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.34 -39.88 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.3 tp -58.9 -31.96 69.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.01 -35.52 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.5 -38.44 74.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.25 -23.86 65.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.71 -47.31 80.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.51 -31.15 37.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.721 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 159.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -62.98 135.96 57.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -73.15 112.09 8.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.943 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.94 138.39 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.63 0.729 . . . . 0.0 111.82 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.87 49.63 0.75 Allowed Glycine 0 C--N 1.315 -0.626 0 CA-C-N 114.491 -1.231 . . . . 0.0 112.478 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -87.67 -44.93 10.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.685 0.279 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 177.59 38.89 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.645 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -74.42 136.62 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.697 -1.592 . . . . 0.0 112.398 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -93.7 -60.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.191 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.2 m -147.01 156.42 43.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.754 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 138.15 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.095 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.425 HG21 ' CE1' ' A' ' 76' ' ' TYR . 2.8 m -108.27 122.62 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.795 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.8 mt -128.27 122.63 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.542 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.1 t -80.27 109.98 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 0.0 110.248 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.71 -26.26 57.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.924 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 142' ' ' SER . 47.3 p -79.82 -2.23 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.54 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 77.65 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.863 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -147.09 -43.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.915 0.388 . . . . 0.0 110.865 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.564 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.8 mt -115.16 141.43 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.783 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.9 Cg_endo -71.12 145.96 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.138 1.892 . . . . 0.0 112.248 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.0 mt -56.94 141.57 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.38 164.07 28.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.991 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.63 119.91 26.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.423 . . . . 0.0 111.973 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.504 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.0 mp -89.64 129.35 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.347 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.645 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.34 157.04 47.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.998 0.904 . . . . 0.0 113.341 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.53 150.36 43.61 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.291 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' CB ' ' CG ' ' A' ' 54' ' ' GLN . 3.0 m-20 -96.2 102.25 14.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.37 -45.24 96.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.092 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -59.63 -40.25 86.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.282 0.563 . . . . 0.0 110.643 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.439 ' CG ' ' CB ' ' A' ' 51' ' ' ASP . 38.6 mm-40 -68.57 -37.86 80.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.622 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.08 -40.29 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.971 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -30.74 67.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.733 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -73.9 -40.5 63.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.756 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -98.0 114.8 27.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -70.56 113.93 8.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.028 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.96 -177.68 6.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 m -98.93 -44.75 6.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.8 tp -109.24 146.72 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HB2' HD11 ' A' ' 93' ' ' LEU . 18.8 mttm -96.12 -71.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.984 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 49' ' ' SER . 33.6 ttpt -147.29 139.73 24.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 HG11 ' HG2' ' A' ' 90' ' ' GLN . 3.6 t -121.14 138.84 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 111.664 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.618 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.0 m-90 -102.96 139.3 38.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.244 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.75 127.21 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -111.32 145.63 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.397 -178.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.84 -174.59 40.02 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -78.59 -2.22 37.9 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.86 135.05 40.47 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.9 Cg_exo -69.05 -7.86 22.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.779 2.32 . . . . 0.0 111.827 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.79 -43.77 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.949 0.88 . . . . 0.0 108.669 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.0 137.96 2.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -18.94 12.1 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.119 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 60.0 t80 -129.9 128.15 41.6 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.52 120.91 41.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 pp -120.81 -178.27 3.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.087 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.91 146.99 41.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.525 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -78.9 76.87 5.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 111.195 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 36.0 mt -94.7 124.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.827 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 p -54.86 -35.18 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.89 -45.94 87.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.054 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.1 mt -72.8 152.09 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.125 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p -95.17 168.27 10.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -44.63 -53.6 7.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.373 0.606 . . . . 0.0 109.636 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -119.43 83.1 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -60.49 -46.24 90.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.691 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.8 p90 -146.21 161.2 40.76 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.814 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -135.78 142.34 44.9 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.44 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 27.1 mt -115.87 132.37 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.185 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.479 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.09 145.21 34.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.024 0.44 . . . . 0.0 111.807 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 2.6 tm? -125.33 122.64 37.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.409 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 139.83 -112.14 0.8 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.737 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 70.0 -65.76 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -165.37 -50.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.801 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.8 38.66 0.21 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.35 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -159.27 -174.23 4.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.84 153.58 24.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB3' ' OD1' ' A' ' 121' ' ' ASN . 11.3 mt -132.97 146.95 52.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.57 124.48 48.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.9 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.479 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 47.9 t30 -114.38 115.5 27.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 111.531 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.708 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 17.6 p30 -79.47 138.63 37.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.2 pt -147.15 39.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.4 159.33 14.98 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.039 0.447 . . . . 0.0 111.497 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.88 -35.56 77.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.299 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -19.86 17.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.512 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 164.22 12.64 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.442 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.3 m -117.48 137.7 52.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.12 148.28 35.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.19 113.41 18.28 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.298 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 44.11 42.93 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.41 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.6 -11.46 68.32 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.583 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -103.98 118.35 36.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.045 0.422 . . . . 0.0 110.777 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -74.0 127.89 34.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.3 m -98.11 165.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.19 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 mm-40 -69.83 126.57 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.708 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.9 tttt -53.65 162.66 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.61 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.063 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.13 40.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.377 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 100' ' ' LEU . 8.9 m-80 -91.64 125.92 36.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.409 ' N ' HD23 ' A' ' 100' ' ' LEU . 43.1 mm-40 -127.44 147.54 50.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.429 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.8 tp -72.63 117.11 13.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.17 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.73 166.98 0.61 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.782 0.801 . . . . 0.0 111.952 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.37 153.28 43.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.398 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.26 118.18 13.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.67 24.01 69.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.8 t70 -55.83 175.21 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.8 tt0 -145.06 135.54 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 17.9 mt -115.34 126.66 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.55 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.51 138.34 41.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 27.4 m -140.39 158.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.42 28.98 28.61 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.159 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.535 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.5 t -68.56 140.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.535 0.684 . . . . 0.0 112.409 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.08 -43.45 0.6 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.261 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.8 t -126.43 136.36 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -50.7 -37.7 42.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.64 6.39 48.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.93 21.15 13.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.1 mt -106.58 139.17 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.239 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.38 134.37 53.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.229 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 40' ' ' THR . 47.2 t -109.83 150.23 28.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.7 0.762 . . . . 0.0 112.589 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 72.8 mt -135.88 151.15 49.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.725 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 36.7 t -122.03 135.88 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 145' ' ' ILE . 46.2 mt -106.12 125.66 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.77 114.73 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -84.92 130.12 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.33 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -83.63 119.05 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -27.54 69.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.04 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -42.53 81.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 110.613 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 34.5 t80 -59.16 -43.74 92.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -34.08 70.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.827 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -41.51 95.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.5 t -67.08 -46.08 75.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.428 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -67.01 -35.95 81.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.948 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -62.19 -37.0 83.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.974 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -92.06 -33.45 14.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.3 p30 42.58 73.73 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 123.66 20.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.7 m -85.33 136.7 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.47 38.57 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.77 -38.39 6.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.03 126.93 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.971 179.937 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 9.2 pttp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.779 0.323 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.98 168.73 9.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -159.12 34.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 3.3 p -66.05 162.6 19.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.415 ' CE1' ' HD3' ' B' ' 172' ' ' PRO . 2.8 p90 -58.9 -178.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -99.22 -64.26 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . 0.425 ' HA ' ' O2P' ' B' ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.415 ' HD3' ' CE1' ' B' ' 169' ' ' PHE . 50.1 Cg_endo -68.87 142.3 51.55 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.351 2.034 . . . . 0.0 112.191 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 53.8 p -138.52 -179.06 5.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.021 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.13 102.82 10.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.25 153.82 73.61 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.384 2.056 . . . . 0.0 112.251 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.08 91.48 8.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.924 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.792 0.329 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.0 m -113.01 -72.28 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -37.45 83.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -71.01 -42.84 69.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -36.89 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.43 -31.93 70.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.86 -35.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.4 -41.11 79.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.502 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -67.19 -23.87 65.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.64 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.67 -47.41 79.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.224 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 p -81.07 -32.34 34.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.31 -75.99 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -85.68 156.42 20.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -82.39 122.48 28.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.812 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 HG13 ' CD1' ' A' ' 23' ' ' PHE . 20.2 mm -81.98 138.35 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.652 0.739 . . . . 0.0 111.828 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.39 66.61 0.5 Allowed Glycine 0 C--N 1.315 -0.637 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.453 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -80.8 -38.41 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.739 0.304 . . . . 0.0 110.969 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 176.33 39.09 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.683 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.09 135.27 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.653 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -91.8 -60.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.735 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 p -147.82 153.62 39.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.095 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.77 138.13 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.541 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -103.04 122.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.591 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 146' ' ' PHE . 18.9 mt -130.41 119.24 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.729 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.4 t -79.86 118.31 21.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.233 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.76 -25.12 28.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.979 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 142' ' ' SER . 52.5 p -79.82 -2.11 41.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.02 76.55 0.28 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.718 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -146.51 -44.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.08 141.45 27.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.792 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.6 Cg_endo -73.2 141.49 32.49 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 0.0 112.265 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.3 mt -56.98 143.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.14 164.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.38 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 119.85 35.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.189 0.518 . . . . 0.0 111.69 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.6 mt -98.64 134.54 41.42 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.683 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.96 158.95 43.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -178.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.74 142.17 25.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.883 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 6.1 m-20 -74.94 132.62 41.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.144 0.497 . . . . 0.0 111.454 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.2 mt -64.4 -44.28 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.24 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -56.52 -37.52 70.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.251 0.548 . . . . 0.0 110.688 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.423 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 6.4 mm-40 -68.63 -36.84 79.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.264 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 46.1 t -73.1 -42.57 58.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.113 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.05 -28.2 66.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.98 -49.83 64.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.966 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.63 136.94 39.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.52 -32.03 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.42 -169.44 2.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m 61.35 178.22 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 93' ' ' LEU . 10.4 tp -93.32 157.04 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -101.48 -81.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.259 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt -121.51 134.16 55.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.878 0.371 . . . . 0.0 111.216 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.455 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 6.8 t -125.49 137.58 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.548 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.9 m-90 -101.98 139.27 37.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.184 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.38 130.51 56.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -119.18 145.3 46.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.274 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.28 -170.74 36.38 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -78.86 3.72 16.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -84.66 132.03 47.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.574 0.226 . . . . 0.0 111.102 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.69 -13.74 41.1 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.476 2.117 . . . . 0.0 111.761 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -42.72 17.76 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.949 0.88 . . . . 0.0 108.937 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.5 139.51 1.09 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.015 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 m-20 -56.49 -18.75 12.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.015 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.459 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 16.7 t80 -129.55 123.01 30.35 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.117 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -99.87 107.96 20.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 pp -111.29 173.89 6.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.841 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.26 135.68 43.92 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.766 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.29 84.2 1.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.945 0.402 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.45 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.0 mt -111.25 135.49 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.921 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.2 p -56.49 -37.47 70.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.567 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.449 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -60.66 -22.1 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.19 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.45 HD23 ' HB ' ' A' ' 81' ' ' ILE . 2.1 mm? -107.54 152.64 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.905 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -96.93 163.77 12.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.45 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.619 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.84 -52.9 4.88 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.497 0.665 . . . . 0.0 109.663 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -120.84 82.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -61.4 -45.93 92.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.672 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.6 p90 -143.86 159.06 43.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.795 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.451 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.09 140.56 43.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.316 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.455 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 58.1 mt -114.0 132.28 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.791 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' HB3' HG12 ' A' ' 65' ' ' VAL . 2.0 pt? -120.59 133.59 55.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.03 0.443 . . . . 0.0 111.967 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.413 ' N ' HD13 ' A' ' 62' ' ' ILE . 2.6 tm? -125.2 122.69 37.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.064 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 135.91 94.98 0.44 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.467 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.64 -42.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.594 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.0 -173.11 4.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.711 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.11 60.5 3.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.524 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.4 p30 177.67 -178.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 110.982 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.61 160.14 16.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.76 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mp -125.85 143.29 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.484 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 2.4 mm? -112.8 122.82 48.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.897 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' GLN . 49.9 t30 -115.28 115.47 26.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.654 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.671 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.3 p30 -78.17 138.43 38.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.9 pt -145.12 40.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.69 156.45 16.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 111.362 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.79 -36.52 78.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.361 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.75 -19.7 17.32 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.524 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.14 159.18 10.44 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.005 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -117.55 137.93 52.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.991 -0.604 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.858 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.74 148.72 34.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.1 113.45 18.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.455 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 42.8 44.0 3.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.75 62.41 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -103.34 118.52 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.614 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.4 tptp -72.92 128.16 34.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.425 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.9 m -98.79 163.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.193 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 tp10 -69.92 126.89 31.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.536 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -53.16 160.74 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.81 35.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.311 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.13 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.136 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -85.13 127.92 34.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.93 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.29 146.93 51.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.532 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tp -72.77 134.2 44.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.287 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.425 ' CD2' HG12 ' A' ' 147' ' ' ILE . 65.2 tp -69.33 155.88 39.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.458 0.647 . . . . 0.0 111.485 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.58 153.02 42.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.256 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 121.3 18.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.886 0.374 . . . . 0.0 110.287 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.44 58.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.131 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.0 t70 -54.43 173.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.739 0.304 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.2 mt-10 -145.07 135.72 24.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.318 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 12.9 mt -114.41 127.16 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.61 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.42 140.06 38.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.884 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.517 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.5 m -140.4 158.33 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 0.0 112.346 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.91 36.03 16.85 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.079 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.8 t -75.14 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.641 0.734 . . . . 0.0 112.505 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.21 -42.89 0.57 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.62 129.11 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 -31.18 14.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.795 0.331 . . . . 0.0 111.183 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -93.53 6.42 48.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -125.69 23.2 7.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.9 mt -105.35 139.33 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.011 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -124.23 134.43 53.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.577 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.492 ' HB3' HG21 ' A' ' 40' ' ' THR . 48.3 t -109.4 150.57 27.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 112.25 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 74.0 mt -135.53 156.0 49.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.5 t -124.57 136.84 59.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.3 mm -106.33 126.37 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.923 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 37' ' ' ILE . 1.5 m-85 -112.53 116.33 30.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.738 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.425 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.7 mt -84.8 134.26 27.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.542 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -75.97 118.48 18.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.588 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -37.49 78.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -60.6 -45.73 92.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.432 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 19.5 t80 -63.45 -43.8 96.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.187 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -60.06 -50.06 75.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.388 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -60.24 -36.9 78.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.078 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.8 t -68.08 -45.87 72.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.978 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -69.0 -42.51 76.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.956 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.58 -45.21 92.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.029 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.74 -36.84 28.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.68 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.422 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -60.0 133.05 55.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.05 125.85 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -106.08 120.7 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 60.01 70.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.6 tt -86.04 139.92 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.105 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 1.6 tttp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.792 0.329 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -140.49 143.72 35.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -137.56 -173.88 3.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 78.4 p -79.59 97.15 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' B' ' 172' ' ' PRO . 29.1 t80 -91.36 51.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.683 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -73.74 114.9 12.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.162 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . 0.441 ' HA ' ' HD2' ' B' ' 172' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' B' ' 171' ' ' TPO . 9.4 Cg_endo -52.57 163.39 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.679 2.253 . . . . 0.0 112.293 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 82.7 p -135.87 128.46 30.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.85 104.81 14.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.74 100.69 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.427 2.084 . . . . 0.0 112.389 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.49 151.55 39.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.974 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.834 0.349 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.3 p -148.26 -47.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.96 -47.12 72.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -46.06 88.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -57.04 -36.14 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -31.86 71.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.46 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.15 -35.53 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.86 -37.91 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.352 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.2 -23.64 65.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.996 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.69 -47.48 79.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.13 -30.01 58.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.968 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.23 -179.93 7.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.65 159.02 26.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.93 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -90.53 104.41 17.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.06 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.38 138.53 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.534 0.683 . . . . 0.0 111.823 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.02 64.02 0.51 Allowed Glycine 0 C--N 1.314 -0.645 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.239 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -40.18 84.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.647 0.261 . . . . 0.0 111.275 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 178.8 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.564 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.6 mm -71.49 142.64 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.361 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.407 HG11 ' CH2' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -105.78 -51.35 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.05 -178.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -155.17 165.37 36.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.635 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 138.0 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.425 HG12 ' CZ ' ' A' ' 76' ' ' TYR . 16.4 t -106.23 122.84 60.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.211 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 mt -127.28 115.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.342 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.3 t -80.81 123.39 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.3 -26.88 22.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.474 HG23 ' HB3' ' A' ' 142' ' ' SER . 53.2 p -79.95 -2.3 43.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.632 0.253 . . . . 0.0 111.559 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.59 76.29 0.29 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.007 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -147.18 -44.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.5 mt -108.78 140.46 21.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.502 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.36 146.03 34.93 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.203 1.936 . . . . 0.0 112.257 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.5 mt -59.98 130.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.629 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 164.21 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.194 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.89 119.47 34.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.972 0.415 . . . . 0.0 111.779 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.551 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.3 mp -86.09 133.54 33.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.576 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -139.9 156.49 46.66 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.38 1.086 . . . . 0.0 113.694 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.403 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.44 141.75 27.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.805 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.513 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 12.7 m-20 -79.2 122.06 25.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.157 0.503 . . . . 0.0 110.891 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.2 mt -64.47 -39.7 86.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.784 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -56.97 -42.46 80.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.102 0.477 . . . . 0.0 111.14 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.513 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.4 mt-30 -68.98 -38.18 79.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.903 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.75 -45.06 99.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.273 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 tt -71.03 -36.23 72.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -42.06 45.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.056 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -87.4 112.56 22.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.1 31.2 5.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.766 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -174.83 3.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 62' ' ' ILE . 1.2 m -59.48 113.14 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.946 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 61' ' ' SER . 6.7 tp 52.0 161.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.963 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.99 -75.58 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.439 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -127.98 138.17 52.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.637 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 16.9 t -132.75 139.19 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.289 0.566 . . . . 0.0 111.858 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.576 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.9 m-90 -100.9 140.29 35.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.374 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.444 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -109.15 124.74 51.3 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.589 ' CE2' ' CG ' ' A' ' 76' ' ' TYR . 2.9 m-85 -112.46 145.68 39.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.045 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.76 -169.61 38.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.933 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.7 mtp180 -84.87 10.18 12.32 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 10.0 t-20 -93.86 134.82 25.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.547 0.213 . . . . 0.0 111.135 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.3 Cg_exo -67.21 -11.01 30.62 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.516 2.144 . . . . 0.0 111.651 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.04 -42.7 17.17 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.874 0.845 . . . . 0.0 109.004 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.6 137.8 2.06 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.831 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.46 -18.59 11.86 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.927 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.589 ' CG ' ' CE2' ' A' ' 68' ' ' PHE . 7.7 t80 -129.35 120.38 25.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.964 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -96.95 107.88 20.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 1.1 pp -113.37 174.97 5.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.152 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.16 146.56 23.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.735 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -81.77 96.99 7.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.442 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 26.7 mm -110.56 126.63 67.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -31.77 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -73.98 -21.49 59.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.15 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.412 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 21.1 mt -99.13 152.33 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 111.007 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.67 165.27 12.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.91 -53.26 4.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 109.839 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.43 82.5 1.86 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.8 t60 -61.81 -45.0 95.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.919 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 22.1 p90 -146.74 164.15 33.69 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.298 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 7.6 mt-30 -135.7 140.78 44.7 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.39 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 2.7 mp -116.37 132.47 65.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.356 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.462 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 1.0 OUTLIER -117.7 147.44 42.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 111.696 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.71 123.49 40.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.437 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.0 -130.53 1.37 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.398 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.7 -177.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.866 0.365 . . . . 0.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -61.96 -31.36 71.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.62 52.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.22 172.79 14.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.01 155.26 20.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 8.5 mt -133.25 143.14 48.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.213 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -112.81 129.1 56.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.491 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.1 t30 -119.76 115.54 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.679 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.3 p30 -79.68 141.71 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 87' ' ' LYS . 9.2 pt -148.3 39.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.68 151.06 21.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.058 0.456 . . . . 0.0 111.869 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.7 m -68.78 -31.7 70.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.901 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.42 -19.69 17.56 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.567 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.1 155.66 9.87 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.632 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.48 137.73 52.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.812 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.2 148.47 39.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.43 18.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.056 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.94 43.3 7.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -7.86 77.74 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.48 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -105.63 118.48 36.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.143 0.472 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.812 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.4 m -95.94 165.47 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.405 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 120' ' ' SER . 3.7 tt0 -69.93 129.55 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.9 tttt -54.33 163.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.193 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.6 m-80 33.92 36.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.827 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.72 145.22 39.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.843 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -93.0 127.75 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 65.3 mm-40 -128.98 151.24 49.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.43 117.38 14.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.955 0.407 . . . . 0.0 110.553 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.5 tp -57.89 157.8 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.37 153.2 42.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.438 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.58 124.42 24.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.49 20.16 55.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.954 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.37 173.25 0.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.04 135.58 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.41 ' CD1' ' CD2' ' A' ' 101' ' ' LEU . 7.2 mt -113.36 128.66 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.496 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 86.7 m -103.92 138.87 39.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.106 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.2 m -140.16 158.15 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.71 40.59 14.55 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.814 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -79.87 140.39 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.654 0.74 . . . . 0.0 112.537 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.13 0.56 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.289 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 43.5 t -126.42 134.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.67 -39.55 51.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.745 0.307 . . . . 0.0 111.702 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -93.5 6.43 48.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.4 t0 -118.06 23.05 11.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.2 mt -106.12 139.49 27.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.302 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 tp -120.51 134.34 55.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.232 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 40' ' ' THR . 43.8 t -113.46 150.32 32.99 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 112.672 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -136.23 146.05 46.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.572 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.72 132.82 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 111.097 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 6.3 mt -106.25 128.33 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.84 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.97 120.63 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.0 mt -84.82 134.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.278 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -79.16 127.75 32.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -74.06 -32.3 63.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -45.3 91.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -58.25 -44.04 88.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -34.11 76.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -60.35 -45.01 94.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.36 -43.68 76.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.064 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -50.19 50.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.322 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -33.71 70.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.98 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -77.74 -30.32 51.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.753 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -123.66 75.96 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.935 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.0 149.99 30.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.85 131.6 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.175 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -178.61 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -144.28 157.2 44.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 23.9 mm -92.13 116.12 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.865 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.916 0.389 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? 66.85 -74.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 5.5 ttp -65.44 152.37 44.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 -47.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -111.69 136.23 51.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -103.72 -56.52 2.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.41 122.49 7.79 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.602 2.201 . . . . 0.0 112.431 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 59.6 p -72.06 -59.26 2.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.027 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -165.89 92.31 0.84 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.08 118.92 5.98 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.522 2.148 . . . . 0.0 112.26 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.52 147.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 m -101.46 -58.77 1.82 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -65.32 -41.0 94.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -64.02 -39.52 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.63 -35.09 78.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.22 -39.99 84.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.6 mm -71.25 -35.14 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.27 -34.17 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.401 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -67.34 -23.81 65.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.78 -47.6 79.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.2 m -68.99 -26.88 65.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.024 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 62.66 162.89 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.934 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.65 125.36 24.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -110.97 118.82 37.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.07 138.26 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.608 0.718 . . . . 0.0 111.779 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.46 52.5 0.48 Allowed Glycine 0 C--N 1.314 -0.671 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.515 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.95 -43.81 10.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 177.69 38.8 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -75.07 134.62 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.76 -1.563 . . . . 0.0 112.583 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.0 -60.51 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 m -143.47 162.43 35.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.355 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 123.59 32.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.142 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.16 122.77 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.041 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -126.89 123.13 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.407 ' HA ' HD23 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -92.14 100.11 12.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.592 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.524 HG22 ' CB ' ' A' ' 142' ' ' SER . 6.5 p -79.92 -2.63 44.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 111.341 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.81 73.28 0.66 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.065 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -144.9 -38.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.9 mt -127.54 141.32 40.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.846 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.76 137.97 28.14 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.112 1.874 . . . . 0.0 112.15 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mt -55.26 144.03 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.785 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.37 164.32 30.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.263 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.85 119.84 34.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 112.008 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.5 mt -94.67 137.43 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.25 158.09 43.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.82 141.98 31.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.424 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.6 OUTLIER -78.33 134.9 37.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 111.424 -179.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.46 -45.0 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.819 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.5 m -60.11 -39.11 85.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.305 0.574 . . . . 0.0 110.601 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.8 mm100 -68.49 -36.79 79.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.481 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.4 -49.92 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.019 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.83 -30.75 69.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.927 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -35.32 64.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -80.45 115.66 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -99.08 31.78 2.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.61 -178.46 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 t -80.41 -30.76 37.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.8 tp -112.73 147.19 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.96 -65.21 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.862 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt -150.22 126.5 10.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 4.4 t -120.44 138.52 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.199 0.523 . . . . 0.0 112.031 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.526 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -100.74 139.69 36.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.403 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.4 129.7 55.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -120.43 145.66 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.628 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.64 -169.56 36.39 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.73 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.7 mtm105 -82.54 5.17 21.68 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -84.9 132.62 45.43 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.523 0.201 . . . . 0.0 110.773 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.39 -13.97 42.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.446 2.097 . . . . 0.0 111.685 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.1 16.01 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.842 0.829 . . . . 0.0 108.835 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.25 137.84 3.33 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.871 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.49 -18.6 12.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.726 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -129.54 124.29 33.51 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.17 108.05 20.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.771 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mp -72.63 -172.96 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.153 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.99 38.96 3.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.82 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.89 64.38 0.99 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 111.886 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.2 mt -94.08 133.73 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.741 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -54.81 -44.9 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.455 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -45.55 89.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD23 ' CE1' ' A' ' 88' ' ' HIS . 28.6 mt -72.79 152.27 41.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.695 0.283 . . . . 0.0 111.318 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -97.18 163.5 12.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.017 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.621 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.76 -51.62 5.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.442 0.639 . . . . 0.0 109.846 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 16.3 ptmt -120.32 82.24 1.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -64.78 -45.39 86.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.455 -176.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.435 ' HA ' HG12 ' A' ' 104' ' ' ILE . 47.5 p90 -150.21 163.38 38.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.234 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.534 ' HG2' HG23 ' A' ' 67' ' ' THR . 10.3 mt-30 -135.71 158.41 44.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.468 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 68.2 mt -125.8 131.15 72.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.138 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -114.12 145.57 41.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.1 0.476 . . . . 0.0 111.711 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.2 tp -125.18 126.96 46.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.192 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.8 -179.4 17.81 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.674 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.78 -166.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 110.975 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.15 -64.29 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.968 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.35 -17.25 1.69 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.782 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -69.43 173.75 5.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.858 0.361 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -124.73 155.35 39.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.423 ' HB3' HD13 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -133.15 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.233 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.5 OUTLIER -114.17 128.8 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.217 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 90' ' ' GLN . 42.0 t30 -115.42 115.48 26.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.458 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.678 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 15.0 p30 -79.53 143.05 35.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 15.2 pt -150.93 37.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.32 158.31 15.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.003 0.43 . . . . 0.0 111.613 -178.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -68.87 -34.93 76.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.436 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.88 17.29 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.478 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.09 161.7 11.62 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.647 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.7 m -117.52 137.87 52.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.813 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.65 148.32 36.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.08 113.3 18.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.174 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 44.17 43.39 5.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.285 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 -5.82 84.46 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.454 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.14 118.51 36.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.094 0.474 . . . . 0.0 110.828 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.813 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.2 tptp -74.89 120.59 20.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.363 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.5 m -95.17 163.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.4 tp10 -69.84 127.3 32.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.0 tttm -52.18 161.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.753 0.311 . . . . 0.0 110.577 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.48 34.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.215 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.09 40.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.901 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -88.48 128.42 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.032 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.403 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 35.1 mm-40 -129.69 149.13 51.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.605 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.7 126.08 29.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.394 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.408 ' HG ' ' N ' ' A' ' 125' ' ' SER . 65.9 tp -64.69 158.43 24.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.301 0.572 . . . . 0.0 111.424 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.14 153.32 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.242 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.405 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.13 122.71 20.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 0.0 110.478 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.18 20.76 55.17 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.162 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.6 t70 -56.2 174.12 0.14 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.7 tt0 -145.12 135.59 24.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.104 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.415 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 12.7 mt -109.05 127.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.371 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.0 m -104.47 137.84 41.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.513 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.32 158.42 25.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.88 24.57 44.74 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.266 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.1 t -64.78 140.43 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.58 0.705 . . . . 0.0 112.237 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.36 -42.31 0.85 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.369 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 44.7 t -126.39 131.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.52 -33.08 20.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.56 6.25 48.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.1 m-20 -120.7 20.2 11.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.486 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 13.9 mt -102.95 139.52 23.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.07 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 tt -124.32 134.41 53.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.267 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.524 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -113.3 127.8 56.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.105 0.478 . . . . 0.0 111.742 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 19.2 mt -121.2 139.82 52.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.8 139.68 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.147 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.491 HG22 HD12 ' A' ' 145' ' ' ILE . 41.4 mt -106.04 130.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.65 114.0 25.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.36 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.92 132.98 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.544 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -76.97 110.9 11.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.733 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -60.81 -39.35 88.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.995 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -46.05 92.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.2 -44.19 97.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -64.92 -33.88 77.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.061 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -58.89 -45.97 88.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.042 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.95 -45.94 72.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.978 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -38.14 84.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.966 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.99 -43.49 95.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -85.58 -35.36 21.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.4 p30 42.47 84.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.456 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.22 150.93 20.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.1 p -82.57 117.07 27.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.165 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -125.03 32.0 5.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.95 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.72 -169.48 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.2 mt -93.35 116.15 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.217 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.324 -0.845 . . . . 0.0 110.925 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.827 0.346 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.24 149.9 17.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.787 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 60.37 110.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 8.7 t -127.32 138.16 52.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.41 ' CE1' ' HG3' ' B' ' 172' ' ' PRO . 1.0 OUTLIER -58.23 179.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -134.32 126.96 30.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.41 ' HG3' ' CE1' ' B' ' 169' ' ' PHE . 33.5 Cg_exo -59.85 97.38 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.755 2.303 . . . . 0.0 112.222 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 70.9 p -65.66 175.13 1.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -110.43 86.6 5.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.21 132.85 23.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.58 2.187 . . . . 0.0 112.361 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.86 177.42 1.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 t -154.99 -51.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -72.03 -46.97 55.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.88 -45.29 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.63 -32.39 70.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.736 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.2 -35.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -36.04 71.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -67.15 -31.11 71.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.311 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.8 m-85 -56.91 -48.2 78.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.455 0.645 . . . . 0.0 111.112 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.66 -27.34 37.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.062 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 64.38 121.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.9 158.2 33.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -78.45 135.45 37.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.814 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.68 136.62 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 C-N-CA 123.037 0.535 . . . . 0.0 110.623 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.55 67.1 0.52 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.427 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.5 -38.37 26.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.979 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 175.93 39.08 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.648 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -71.88 135.63 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.357 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -93.99 -60.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.168 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 p -145.09 164.53 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.485 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.17 126.86 44.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -93.96 122.83 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -126.8 122.56 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.512 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.27 106.64 18.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 110.372 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -77.31 -20.37 55.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.064 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 142' ' ' SER . 81.1 p -79.9 -2.46 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 74.25 0.48 Allowed Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.808 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -147.3 -44.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 0.0 110.805 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.515 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.2 mt -112.3 140.39 23.6 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.38 132.83 16.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.262 1.974 . . . . 0.0 112.036 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mt -53.22 135.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.57 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.72 164.24 25.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.524 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.26 119.89 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 0.0 111.425 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 15.0 mt -93.85 137.08 33.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.812 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.86 157.63 44.09 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.503 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -130.86 150.63 51.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.023 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -93.66 96.89 10.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.955 0.407 . . . . 0.0 110.439 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.35 -45.16 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 m -61.37 -41.53 97.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.234 0.54 . . . . 0.0 110.743 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.427 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 3.3 mm-40 -68.41 -41.21 80.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.9 t -70.98 -37.85 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.999 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -33.29 71.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.734 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -68.32 -51.28 46.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.51 137.05 54.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -73.56 -7.29 51.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.468 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.56 166.95 0.11 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.829 0.347 . . . . 0.0 111.083 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.71 41.21 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.16 138.27 7.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 93' ' ' LEU . 2.5 mptt -84.86 -81.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.6 ttmt -155.37 156.53 35.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.9 t -130.61 138.97 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.434 0.635 . . . . 0.0 112.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.548 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 13.0 m-90 -105.09 140.02 38.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.17 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.488 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.29 126.08 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -117.51 145.44 44.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.811 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.287 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -78.03 -1.28 31.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -84.89 131.88 47.7 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.621 0.248 . . . . 0.0 111.093 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 14.1 Cg_exo -68.02 -10.57 29.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.469 2.112 . . . . 0.0 111.626 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.87 16.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.897 0.856 . . . . 0.0 108.988 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -38.93 141.14 0.31 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.74 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.17 -19.07 11.98 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.908 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.4 t80 -129.92 130.43 45.12 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.993 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -103.12 107.85 18.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.24 -70.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.31 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.34 -109.1 0.29 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.656 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -153.77 63.14 0.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.774 0.321 . . . . 0.0 111.166 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mt -112.01 115.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.947 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -35.1 63.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.415 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -61.19 -18.66 59.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 mt -104.81 147.35 27.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.66 160.58 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.546 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.619 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -40.87 -51.32 3.18 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.606 0.717 . . . . 0.0 109.741 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 104' ' ' ILE . 18.0 mttt -120.82 82.6 1.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.555 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 17.1 t60 -63.16 -46.06 88.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.968 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.8 p90 -146.25 161.87 39.32 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.282 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.35 137.26 42.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.38 -178.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 45.2 mt -115.22 132.09 65.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -121.39 145.86 47.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.139 0.495 . . . . 0.0 111.876 -179.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 1.9 tm? -125.07 138.2 54.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.194 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -140.25 -147.55 5.02 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.631 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.88 177.69 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.862 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 60.66 157.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.93 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.8 59.84 4.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -142.3 171.47 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.972 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.28 158.33 38.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.771 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.9 OUTLIER -128.37 138.37 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 pp -113.04 120.72 42.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.077 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' GLN . 56.0 t30 -114.57 116.03 28.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.668 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.8 p30 -77.45 140.51 39.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.063 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 87' ' ' LYS . 12.1 pt -143.89 28.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.448 0.166 . . . . 0.0 111.407 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 9.3 t -89.56 159.67 17.07 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.519 0.676 . . . . 0.0 112.677 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -69.72 -50.42 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.417 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.25 2.92 54.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.266 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.33 159.36 28.11 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.898 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.0 m -117.74 138.05 52.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.347 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.12 148.82 31.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.86 113.3 18.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.228 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 44.77 42.9 6.4 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.57 -14.21 60.39 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.548 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.2 118.38 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.075 0.438 . . . . 0.0 110.482 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.92 123.9 23.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.407 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.7 m -95.39 165.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.029 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 mp0 -69.85 126.81 30.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.685 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 62.9 tttt -54.84 162.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.991 0.424 . . . . 0.0 110.579 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.59 33.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.147 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.54 144.55 41.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.89 179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -93.22 133.32 36.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.946 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 53.8 mm-40 -129.24 151.25 50.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.61 113.56 9.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.29 156.55 0.57 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.629 . . . . 0.0 111.739 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.48 153.48 41.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.641 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.2 121.93 19.27 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.57 19.68 65.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.734 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -49.26 165.35 0.06 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.857 0.361 . . . . 0.0 111.172 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.5 tt0 -143.2 135.48 27.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.973 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.5 mt -115.12 127.77 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.646 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.5 m -104.64 139.13 39.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.9 m -140.57 158.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.08 23.48 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.148 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.5 t -71.75 140.34 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 121.536 0.684 . . . . 0.0 112.391 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.88 -42.18 0.67 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.314 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 44.7 t -126.34 131.76 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 -34.8 25.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 111.414 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.9 m -93.53 6.37 48.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.415 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 59.2 m-20 -121.16 21.82 11.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.1 mt -103.93 139.28 25.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.99 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 tt -124.36 134.53 53.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.217 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.498 ' HB3' HG22 ' A' ' 40' ' ' THR . 46.6 t -110.59 150.21 29.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.716 0.769 . . . . 0.0 112.368 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 70.1 mt -135.68 145.74 47.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.831 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.51 139.97 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.349 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.6 mt -106.14 126.22 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.18 118.9 36.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.601 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.3 mt -84.64 133.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -84.3 115.42 22.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.809 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -58.87 -29.05 66.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.019 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -59.24 -44.04 92.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -33.86 73.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -67.31 -37.01 82.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -62.66 -46.02 90.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.97 -37.77 78.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.861 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -59.52 -39.78 84.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.974 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -35.93 14.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.956 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.7 p30 44.63 -171.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.554 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -59.32 156.28 12.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.859 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 t -66.92 136.44 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.101 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -156.69 165.36 36.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.96 168.0 9.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.5 pt -82.58 132.63 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.048 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.821 179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.956 0.407 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -168.88 -68.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -42.21 5.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.46 139.82 47.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' B' ' 172' ' ' PRO . 1.2 t80 -169.45 171.77 7.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.61 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.433 ' HA ' ' CE2' ' B' ' 169' ' ' PHE . 57.6 Cg_exo -51.84 126.48 20.03 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.561 2.174 . . . . 0.0 112.333 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 23.5 p -89.0 153.99 20.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -109.09 81.91 1.74 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.05 155.81 60.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.582 2.188 . . . . 0.0 112.239 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.44 106.41 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.979 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.215 -0.897 . . . . 0.0 110.813 -179.933 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.813 0.34 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.1 m -144.72 -55.63 0.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.72 -46.97 56.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -63.34 -36.16 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -40.43 93.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.01 -44.82 95.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.6 mm -67.7 -35.16 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -57.18 -35.8 70.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.358 . . . . 0.0 110.43 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -23.86 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.807 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.54 -47.54 79.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.067 0.461 . . . . 0.0 111.363 -179.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.5 -32.82 48.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.886 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.37 14.51 9.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.15 132.34 46.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.775 0.321 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.48 101.94 13.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.27 138.41 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.664 0.745 . . . . 0.0 111.775 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.79 51.97 0.27 Allowed Glycine 0 C--N 1.313 -0.704 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.431 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.34 -45.89 75.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 0.0 111.067 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -169.64 32.9 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.33 134.19 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.48 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.71 -61.01 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.035 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 p -147.16 151.4 36.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.394 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.45 138.14 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 24.7 t -105.55 122.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.412 HD11 ' CD1' ' A' ' 146' ' ' PHE . 17.0 mt -125.81 117.06 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.407 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.8 t -79.75 124.67 28.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 110.579 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.52 -24.56 17.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.387 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 142' ' ' SER . 67.6 p -79.86 -2.36 43.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.397 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 73.84 0.54 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.894 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.77 -43.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.7 mt -115.15 140.53 25.78 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.24 138.47 25.09 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.2 1.933 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.3 mt -56.11 129.48 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.629 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -126.23 164.14 21.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 119.71 35.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.994 0.426 . . . . 0.0 111.797 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.0 mt -92.42 137.27 32.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.55 158.8 43.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.89 142.68 30.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.75 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 2.7 m-20 -74.92 121.81 22.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.039 0.447 . . . . 0.0 111.109 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.3 mt -64.32 -44.84 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.038 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -60.38 -40.85 92.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.235 0.54 . . . . 0.0 110.658 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.444 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 5.7 mm100 -68.6 -36.77 79.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.826 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.26 -43.24 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.972 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -27.31 63.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.039 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -39.39 65.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.051 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.39 125.24 48.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.034 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.17 98.95 9.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -148.6 -167.2 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.2 t -76.27 -56.87 4.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.009 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.3 mm -125.97 153.57 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -72.42 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.734 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.5 ttpt -126.36 125.5 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 3.7 t -111.87 139.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.264 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.596 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.2 m-90 -100.42 139.29 36.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.899 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.46 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.39 133.69 53.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -116.01 145.57 42.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.313 -178.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.775 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 170.57 -175.46 44.4 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.455 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -82.19 -4.39 56.92 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.4 p30 -87.71 139.34 31.31 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.861 0.362 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.7 Cg_exo -69.49 -4.27 13.5 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.889 2.393 . . . . 0.0 111.88 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -46.8 12.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.869 0.842 . . . . 0.0 109.081 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 139.01 3.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.724 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -19.09 12.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.552 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.9 t80 -129.75 120.76 25.6 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.848 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.41 107.92 19.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.681 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.14 -83.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.306 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.95 -96.8 0.1 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -175.37 60.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.298 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.0 mt -103.13 122.12 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.783 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -58.62 -33.89 70.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.484 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 5.1 tpt180 -60.71 -47.69 85.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.661 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 4.2 mp -72.63 153.61 41.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' ASN . 46.3 p -94.61 166.55 11.97 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.933 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.775 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m120 -40.54 -74.69 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB2' HD11 ' A' ' 104' ' ' ILE . 15.0 mttt -97.95 85.59 3.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.581 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -63.32 -44.86 93.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.957 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 104' ' ' ILE . 31.7 p90 -153.49 162.4 41.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 10.6 mt-30 -135.92 160.0 39.94 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 58.3 mt -123.78 131.96 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.081 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.66 139.58 39.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.071 0.463 . . . . 0.0 111.685 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -125.41 122.93 38.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.13 -139.38 5.5 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.622 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.03 -178.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.348 . . . . 0.0 110.855 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.08 -60.73 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -157.76 68.91 0.27 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -168.18 173.11 8.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.955 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.0 156.23 31.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.743 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mt -133.42 147.25 51.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.66 130.33 56.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.413 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 49.6 t30 -115.05 115.63 27.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.642 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.696 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 19.6 p-10 -81.18 141.27 34.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.137 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 89' ' ' PHE . 13.6 pt -149.82 37.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.581 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -97.39 156.42 16.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.11 0.481 . . . . 0.0 111.84 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.2 m -68.55 -32.79 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.103 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -98.63 -19.9 17.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.112 -179.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.541 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.91 164.3 13.45 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.215 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.9 m -117.4 137.68 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.797 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -115.74 148.42 39.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.41 113.36 18.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.544 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 45.76 37.4 3.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.013 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.58 -1.86 76.39 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.556 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -107.97 118.65 37.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.02 0.438 . . . . 0.0 110.919 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.797 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -75.63 129.72 37.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.348 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.49 165.11 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.358 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.85 131.77 44.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.209 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 6.1 tttt -55.45 168.78 0.35 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER 31.85 37.19 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.302 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.0 p -111.96 145.08 40.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.342 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -93.58 122.44 36.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.626 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -128.59 146.73 50.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.23 115.48 12.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.148 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -62.03 169.66 2.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.804 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.454 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.4 153.72 41.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.116 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.07 120.55 16.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.035 0.445 . . . . 0.0 110.136 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.58 20.84 64.2 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.139 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.454 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 5.0 t70 -61.63 179.6 0.24 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.852 0.358 . . . . 0.0 110.796 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.1 mt-10 -145.17 135.66 24.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.307 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.35 128.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.286 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.463 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.27 137.91 41.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.533 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 13.9 m -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.88 30.12 29.94 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.171 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.5 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.3 t -69.0 140.24 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.661 0.743 . . . . 0.0 112.332 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.8 -43.49 0.67 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.266 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 42.4 t -126.48 135.21 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.48 -37.15 37.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.666 0.269 . . . . 0.0 111.679 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 95.0 p -93.58 6.33 48.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.31 19.88 14.56 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.2 mt -106.04 138.96 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.238 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tt -124.57 134.49 52.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.142 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.494 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.8 t -111.56 150.32 30.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.8 . . . . 0.0 112.732 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.9 mm? -135.81 149.54 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.159 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.416 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 16.2 t -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.178 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 145' ' ' ILE . 10.8 mt -106.4 120.88 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.412 ' CD1' HD11 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -110.04 107.69 17.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.274 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.6 mt -84.77 128.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.71 119.46 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.91 -32.0 72.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.83 -44.06 90.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -64.98 -42.04 94.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -59.47 -39.65 84.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.929 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.7 t -64.59 -46.09 84.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.89 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.98 -39.32 79.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.11 -35.68 75.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.16 -36.99 13.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 p30 44.1 -170.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.573 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 119.03 6.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.966 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 p -101.3 131.49 48.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -85.75 -176.89 6.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -108.04 147.84 30.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.91 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.9 tp -86.83 140.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.051 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.904 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.783 0.325 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 -171.47 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtt -125.42 116.74 22.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 3.3 t 43.35 74.58 0.11 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.467 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' ' 172' ' ' PRO . 0.2 OUTLIER -132.13 89.49 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -73.63 68.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.414 ' HB3' ' CE2' ' B' ' 169' ' ' PHE . 44.2 Cg_endo -68.16 88.62 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.468 2.112 . . . . 0.0 112.347 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t -64.89 -37.9 89.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.36 139.83 0.51 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.798 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.67 114.52 4.04 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.446 2.097 . . . . 0.0 112.268 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.52 166.99 22.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.786 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.0 p -112.33 -71.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -71.89 -42.56 66.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.99 -43.64 81.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.81 -31.92 72.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.13 -35.35 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -57.44 -43.6 84.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.476 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -67.21 -23.7 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.546 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.72 -47.46 79.95 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.229 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.9 -29.67 50.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.883 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 62.12 116.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.51 152.19 45.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.53 138.28 31.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.823 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.16 138.41 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.69 0.757 . . . . 0.0 111.707 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.89 64.32 0.39 Allowed Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.536 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -87.77 -36.47 17.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 110.985 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 t-20 175.42 39.71 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -71.73 136.22 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.551 -177.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -91.97 -59.59 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.938 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 157.78 43.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.468 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 124.85 43.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.43 122.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.992 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.03 125.44 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.431 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.4 t -89.91 107.87 19.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -79.99 -26.2 40.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.767 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 58.7 p -79.83 -2.59 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.525 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.57 80.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.067 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -147.73 -39.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.015 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 6.8 mt -127.43 141.99 42.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.8 Cg_endo -71.92 141.62 37.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.11 1.873 . . . . 0.0 112.127 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.2 mt -55.86 149.11 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.847 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.29 162.85 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -121.21 122.67 40.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.08 0.467 . . . . 0.0 111.907 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -101.03 137.26 39.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.193 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.67 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -143.12 158.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.89 148.56 31.93 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.12 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -78.75 122.27 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.0 111.233 -179.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 52' ' ' ILE . 49.9 mt -64.45 -42.47 95.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.142 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.1 t -59.68 -40.19 87.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.36 0.6 . . . . 0.0 110.61 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.42 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 6.1 mm100 -68.48 -36.83 79.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.517 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.35 -37.96 67.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.107 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -41.36 74.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.74 -44.97 91.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -99.59 119.42 38.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.972 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.65 -27.18 12.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -88.93 154.9 19.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 m 61.32 -178.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.067 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 63' ' ' LYS . 9.0 tp -92.5 152.79 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.022 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' N ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -84.51 -79.48 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' A' ' 49' ' ' SER . 28.1 ttpt -132.77 138.47 47.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 92' ' ' LEU . 9.3 t -124.79 138.66 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.223 0.535 . . . . 0.0 111.702 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.598 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.9 m-90 -100.75 139.86 35.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.145 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -110.84 130.58 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -120.09 145.1 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.034 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.58 -172.78 39.58 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.109 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 30.5 mtp180 -75.74 1.64 14.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.67 141.93 39.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.339 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 61.7 Cg_endo -73.76 -14.37 24.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.6 2.2 . . . . 0.0 111.271 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.28 17.21 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.881 0.848 . . . . 0.0 108.735 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 140.83 1.2 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.898 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.26 -18.58 10.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.094 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.58 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.0 t80 -129.18 122.68 30.29 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.723 0.296 . . . . 0.0 110.842 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.441 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 -97.0 110.99 23.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.151 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 43' ' ' ILE . 12.8 mt -92.59 170.75 9.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.658 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.43 -86.41 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.413 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.61 77.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.917 0.389 . . . . 0.0 110.665 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 28.8 mt -109.94 116.65 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -35.68 64.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.019 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -29.42 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.8 mt -90.15 152.35 21.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.55 166.11 12.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.599 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.51 -53.64 5.39 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.475 0.655 . . . . 0.0 109.507 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HB3' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.74 84.42 2.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -62.04 -44.93 95.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.982 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -146.31 162.85 37.23 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.399 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 11.2 mt-30 -135.57 148.01 48.93 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.414 HG13 ' CE1' ' A' ' 68' ' ' PHE . 64.5 mt -125.07 132.4 71.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.677 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -126.04 135.22 51.51 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.034 0.445 . . . . 0.0 112.146 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.43 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 1.8 tm? -125.41 131.38 52.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.161 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 154.05 -137.46 5.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.552 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 67.11 -74.26 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.824 0.345 . . . . 0.0 110.835 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -150.57 -60.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.26 172.2 30.83 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.468 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m120 60.99 175.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 124' ' ' LEU . 5.6 mp -112.61 160.25 18.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.848 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 5.7 mp -129.79 142.93 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.08 125.14 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.132 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.541 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.2 t30 -116.57 116.33 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.68 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.5 p30 -76.63 139.49 40.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.831 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 87' ' ' LYS . 8.2 pt -145.32 38.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.542 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.31 152.65 19.69 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.076 0.465 . . . . 0.0 111.829 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.0 m -68.9 -31.41 70.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.994 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -97.99 -19.92 17.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.01 157.37 10.8 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.841 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.46 137.81 52.28 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.48 148.35 37.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.47 18.35 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.329 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 44.17 43.5 5.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.87 68.25 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.517 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -104.06 118.46 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.08 0.44 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 18.4 tptt -74.08 123.15 23.85 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.247 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.5 m -94.35 165.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.5 tp10 -69.94 127.24 32.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 69.2 tttt -55.07 162.53 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 110.354 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 36.83 32.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.115 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 144.99 41.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.818 179.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -94.8 133.44 38.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.042 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.5 mm-40 -129.22 152.28 48.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.376 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.34 125.81 28.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.948 0.404 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.488 HD23 HG12 ' A' ' 147' ' ' ILE . 30.7 tp -56.36 154.68 7.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 0.0 111.814 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.453 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.88 152.93 43.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.601 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -72.11 124.25 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.779 0.323 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.04 22.56 42.95 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.15 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.5 t70 -52.81 171.81 0.06 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.96 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.5 mt-10 -143.91 135.5 26.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.094 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.5 mt -114.94 126.01 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.436 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.496 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.29 138.44 40.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.24 158.26 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 84.97 27.09 35.16 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.105 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.0 t -66.28 140.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.618 0.723 . . . . 0.0 112.496 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.51 -41.58 0.62 Allowed Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.289 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.44 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.1 t -126.46 136.49 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -39.88 52.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.7 0.286 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.45 6.33 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 23.1 t0 -116.62 23.28 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.0 mt -107.03 139.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.317 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.25 134.39 55.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.563 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.562 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 1.5 m -109.01 141.98 40.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 111.654 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 73.8 mt -135.13 141.97 46.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.787 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.402 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 17.3 t -114.08 140.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.798 0.332 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 145' ' ' ILE . 50.3 mt -106.16 129.64 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.83 115.29 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.488 HG12 HD23 ' A' ' 124' ' ' LEU . 1.8 mt -84.77 134.03 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -83.46 103.96 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -29.47 64.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -45.02 91.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -59.24 -44.3 92.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -40.47 94.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -59.12 -43.1 91.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.3 t -60.04 -45.98 91.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -36.02 81.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -64.79 -37.34 87.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -87.28 -36.43 17.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.783 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.56 35.78 0.71 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.488 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.68 139.68 52.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -65.02 116.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.8 105.81 16.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.4 ttp-105 -68.44 107.49 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.8 pt -91.09 130.29 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.189 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.4 ttp85 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.913 179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.799 0.333 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -74.15 -63.18 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -90.98 99.84 12.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 1.7 m -154.01 152.36 30.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.4 ' O ' ' CD1' ' B' ' 169' ' ' PHE . 36.4 p90 -98.79 118.76 36.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.09 80.75 3.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.7 150.09 17.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.585 2.19 . . . . 0.0 112.314 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 73.4 p -107.05 -67.04 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -155.53 72.73 5.46 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.2 -171.84 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.564 2.176 . . . . 0.0 112.244 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 2.5 mp -130.56 154.71 47.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.967 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.805 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.727 0.299 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 77.87 -56.55 0.49 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -39.34 84.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -61.26 -36.8 81.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.825 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -65.71 -38.27 88.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.24 -43.18 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.8 mm -68.23 -35.12 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.21 -34.73 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.378 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -67.23 -23.9 65.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.814 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.64 -47.63 79.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.87 -26.37 62.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.958 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 63.02 145.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.82 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.49 124.19 28.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.956 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -95.14 136.94 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.756 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.03 138.36 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.667 0.746 . . . . 0.0 111.785 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.47 30.96 0.47 Allowed Glycine 0 C--N 1.314 -0.678 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.56 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -41.62 85.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.722 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 49' ' ' SER . 3.0 m-20 179.78 38.09 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -71.39 143.77 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.477 -176.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 HG11 ' CH2' ' A' ' 66' ' ' TRP . 0.9 OUTLIER -109.94 -49.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.785 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -152.72 158.7 42.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.422 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -130.83 136.88 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.749 0.309 . . . . 0.0 111.476 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -108.54 122.62 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.964 0.411 . . . . 0.0 110.647 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mt -126.76 115.21 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.463 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.6 t -81.4 101.87 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 110.409 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -24.09 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.755 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.503 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 13.7 p -79.82 -2.42 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.417 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.6 78.81 0.26 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.133 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -147.64 -40.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.007 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.0 mt -124.64 141.85 39.05 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -71.57 137.64 30.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.252 1.968 . . . . 0.0 111.925 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -54.62 137.54 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.914 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 163.33 27.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.976 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.5 m-20 -118.65 119.75 35.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.892 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.4 mt -92.24 137.37 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.5 158.59 44.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.228 1.013 . . . . 0.0 113.665 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.09 141.72 38.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.344 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 1.2 m-20 -75.34 133.31 41.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.362 0.601 . . . . 0.0 111.424 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.6 mt -64.82 -39.82 86.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.072 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -60.33 -42.69 96.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.598 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 3.5 pt20 -68.3 -38.6 81.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.451 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.37 -49.97 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.899 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.12 -27.23 67.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -81.23 -32.91 33.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.056 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.91 118.96 17.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.77 99.2 9.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.63 -164.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.786 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 t 65.04 -168.16 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 0.0 110.841 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.4 tp -89.27 154.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -104.27 -67.9 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.204 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.8 ttpt -141.37 140.65 33.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.328 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' A' ' 92' ' ' LEU . 15.2 t -129.98 138.91 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.003 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.527 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.6 m-90 -102.13 139.6 37.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.107 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.87 126.78 55.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.115 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -117.47 145.58 44.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.317 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.31 -173.12 40.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.892 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 mtp-105 -77.48 -1.29 29.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.81 133.58 43.38 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.691 0.281 . . . . 0.0 111.216 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.66 -9.5 26.31 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.797 2.331 . . . . 0.0 112.065 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 -43.02 17.18 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.842 0.83 . . . . 0.0 108.921 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.28 139.56 0.72 Allowed 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.939 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.26 -18.77 11.5 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.977 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 55.6 t80 -129.55 123.68 32.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.832 0.349 . . . . 0.0 110.769 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 -98.77 117.71 33.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 pp -123.37 -177.08 3.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.774 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.34 163.18 7.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.596 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -97.28 68.22 2.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 0.0 110.934 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.414 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.7 mm -85.73 128.29 39.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -42.3 75.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.91 -26.52 67.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.16 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 39.7 mt -90.96 152.33 20.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -99.88 167.44 10.52 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.96 -53.83 5.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.308 0.575 . . . . 0.0 109.808 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -117.19 82.3 1.79 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 14.0 t60 -58.65 -45.34 89.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.772 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -147.23 160.88 41.96 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.979 -0.688 . . . . 0.0 112.399 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.33 130.39 34.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 51.3 mt -110.78 130.82 63.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.924 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -124.21 141.45 52.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.956 0.408 . . . . 0.0 111.607 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.3 tt -125.25 126.37 45.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.01 120.92 2.45 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.554 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -176.56 -46.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -158.07 -45.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.19 38.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.554 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -162.21 -174.72 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mp -112.68 160.17 18.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.0 mp -132.17 141.45 49.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.944 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.74 124.16 51.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.518 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.409 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 65.9 t30 -117.29 132.66 56.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.105 0.478 . . . . 0.0 112.057 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.8 p30 -93.26 134.46 35.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.613 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 89' ' ' PHE . 4.2 pt -136.1 26.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.531 0.205 . . . . 0.0 111.504 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.2 t -91.38 156.47 17.73 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.538 0.685 . . . . 0.0 112.539 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -69.68 -52.21 27.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.873 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -81.49 -1.02 44.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.389 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.77 158.97 30.58 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.417 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.0 m -117.54 137.72 52.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -111.95 148.54 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 113.32 18.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.4 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 43.9 43.64 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.37 66.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.35 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.97 118.58 37.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.467 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.7 tptm -73.93 121.17 20.55 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.551 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.8 m -92.37 163.7 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -69.91 128.44 36.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.4 tttt -53.91 161.59 1.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.314 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.3 p30 36.83 32.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.42 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 144.73 41.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.818 179.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -93.9 130.54 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.972 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -129.98 152.15 49.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.34 111.68 10.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.18 168.43 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.806 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 t -124.35 153.48 41.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.236 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.28 115.64 10.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.025 0.441 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.85 18.55 78.98 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.188 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.14 179.45 0.1 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.669 0.271 . . . . 0.0 110.588 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 11.0 mt-10 -145.23 135.7 24.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.66 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 6.2 mt -112.0 128.26 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.497 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 140.51 37.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.595 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.45 158.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.23 31.33 28.52 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.179 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.512 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.3 t -70.21 140.37 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.688 0.756 . . . . 0.0 112.503 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.84 -43.44 0.61 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.138 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.43 131.38 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.47 -33.04 19.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.824 0.345 . . . . 0.0 111.275 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 88.1 p -93.64 6.19 49.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.58 22.63 9.84 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.7 mt -104.6 139.6 25.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.058 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.8 tt -119.64 134.55 55.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.454 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.503 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -110.19 136.7 49.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.678 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 57.9 mt -131.0 144.52 51.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.593 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.402 HG13 ' HG3' ' A' ' 129' ' ' GLU . 17.7 t -110.95 135.12 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.402 . . . . 0.0 111.381 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 145' ' ' ILE . 2.0 mp -106.06 123.14 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.316 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.25 106.75 15.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.504 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -84.79 133.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -75.96 118.72 19.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.003 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -74.01 -30.67 62.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.41 91.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.627 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -58.15 -43.96 87.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.854 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -59.59 -41.09 89.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.43 -45.16 94.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.6 t -68.1 -42.15 80.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.66 -37.27 84.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.96 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.77 -39.65 93.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -86.28 -32.46 21.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 p30 42.47 85.49 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.441 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -104.25 116.51 32.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 p -84.06 136.89 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.079 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.15 31.55 2.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.99 143.86 29.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.3 pp -105.01 123.4 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.897 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.755 0.312 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -110.99 -31.84 7.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.963 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' MET . . . . . 0.417 ' HB3' ' CE2' ' B' ' 169' ' ' PHE . 0.0 OUTLIER -175.65 -39.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 4.8 p 58.44 107.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' B' ' 167' ' ' MET . 0.7 OUTLIER -163.41 -178.01 5.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.03 -70.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.956 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.19 151.23 68.61 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.477 2.118 . . . . 0.0 112.299 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 9.7 p -113.67 -25.84 8.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.189 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.73 68.59 0.75 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.762 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.43 109.39 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.639 2.226 . . . . 0.0 112.384 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.88 119.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.962 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.792 0.329 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -151.21 -48.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.7 -36.26 78.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -71.1 -38.05 72.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.897 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -41.22 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -31.95 70.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.27 -35.24 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.47 -41.1 79.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.52 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -23.99 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.648 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.75 -47.51 79.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.02 -38.34 27.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.921 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -81.49 105.47 12.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 120.95 32.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.705 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -107.1 108.68 20.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.024 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.0 138.43 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.606 0.717 . . . . 0.0 111.641 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.41 47.66 3.46 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.435 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -83.72 -31.08 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.702 0.287 . . . . 0.0 111.143 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.88 35.89 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.703 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.5 mm -77.85 135.09 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.457 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.78 -60.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.617 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.38 165.02 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.986 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 124.15 33.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 111.343 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.43 ' HB ' ' CE2' ' A' ' 76' ' ' TYR . 24.8 t -93.22 122.8 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.085 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -127.34 118.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.205 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 t -80.04 109.81 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.428 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -80.46 -27.25 37.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.61 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.498 HG22 ' OG ' ' A' ' 142' ' ' SER . 6.2 p -79.94 -2.61 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.669 0.271 . . . . 0.0 111.351 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.46 79.97 0.19 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.926 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -148.04 -39.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.886 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.5 mt -123.44 141.72 36.99 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.79 138.89 29.7 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.132 1.888 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.7 mt -54.9 132.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.956 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 1.5 ttt180 -126.13 164.21 21.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.051 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -117.63 119.71 35.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 111.976 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.8 mp -91.49 125.81 36.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.703 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -139.46 156.52 46.9 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.91 141.76 29.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.299 -1.773 . . . . 0.0 110.531 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.489 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -79.44 135.61 36.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.136 0.493 . . . . 0.0 111.039 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.418 HD13 ' CE1' ' A' ' 151' ' ' PHE . 22.7 mm -64.3 -42.41 95.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.221 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.96 -40.21 76.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.129 0.49 . . . . 0.0 110.948 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 9.3 mt-30 -68.43 -40.11 81.31 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.74 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.19 -37.93 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.04 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -40.61 78.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.149 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -76.9 -38.67 53.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.07 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.93 120.84 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.97 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.19 -18.9 18.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -53.62 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.858 0.361 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.6 p -81.28 -32.07 33.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.5 mm -119.23 157.22 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -119.42 -62.88 1.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.8 ttpt -139.78 130.24 25.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.941 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.8 t -125.86 139.31 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.248 0.546 . . . . 0.0 112.111 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.53 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.4 m-90 -102.32 139.14 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.054 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.4 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.53 126.78 55.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -110.47 145.66 37.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.646 -178.336 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.7 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -176.25 39.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.708 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -77.64 -0.93 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.84 134.04 42.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.259 . . . . 0.0 111.029 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.64 -8.09 22.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.749 2.299 . . . . 0.0 111.763 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.56 16.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.009 0.909 . . . . 0.0 108.796 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 137.32 2.99 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.507 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.53 -18.68 12.46 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.904 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.47 125.36 36.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.63 123.65 45.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.747 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 ' HB3' ' CD1' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -123.98 173.5 8.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.997 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.12 154.3 10.61 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.687 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 83.0 4.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.5 mm -104.16 119.55 53.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.96 -40.7 70.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.012 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -60.94 -15.88 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.227 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.9 mt -105.97 149.59 26.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.2 p -93.97 165.21 12.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.863 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.7 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -41.66 -52.51 3.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.375 0.607 . . . . 0.0 109.818 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.06 82.16 1.88 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.0 t60 -60.62 -45.85 92.48 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.023 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 19.0 p90 -146.34 159.09 43.82 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.719 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.4 tt0 -135.53 141.66 45.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.285 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 46.7 mt -117.54 127.12 75.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.073 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -110.05 148.52 31.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.025 0.44 . . . . 0.0 111.748 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -125.18 122.87 38.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.446 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.38 -129.77 1.61 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.663 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.26 -71.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.857 0.361 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -176.34 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.86 58.25 0.48 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.442 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -173.38 177.95 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.411 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -116.45 160.14 21.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 7.3 mt -132.03 144.01 50.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.346 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.5 mt -112.69 124.18 51.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.299 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.6 t30 -118.11 115.79 25.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 111.729 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.5 p30 -77.5 139.2 39.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.83 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 16.7 pt -146.83 39.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.567 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -95.72 158.51 15.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.039 0.447 . . . . 0.0 111.571 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -68.91 -38.19 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.581 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.71 -19.73 17.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.169 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.495 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.99 158.64 10.09 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.929 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.58 138.01 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.943 -0.628 . . . . 0.0 109.517 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.82 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.26 148.57 35.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.03 113.46 18.43 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.366 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.87 43.64 5.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.415 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.75 -10.2 70.98 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.421 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -105.08 118.6 36.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.158 0.504 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.82 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 5.4 tptt -72.25 119.19 16.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.25 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.1 m -89.95 163.87 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.165 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.0 mm-40 -69.86 125.88 28.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.0 tttp -53.35 161.34 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.832 0.348 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.12 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.1 40.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.976 179.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -89.51 131.81 35.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.9 mm-40 -129.25 148.95 51.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.517 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.77 135.91 45.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.52 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 125' ' ' SER . 35.5 tp -59.87 152.85 22.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.55 0.69 . . . . 0.0 111.515 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.444 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.41 152.83 44.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.552 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.3 120.56 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.266 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 145' ' ' ILE . . . 58.98 23.9 57.52 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.27 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.444 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.2 t70 -52.23 167.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.006 0.432 . . . . 0.0 111.314 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -145.22 135.62 24.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.151 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.411 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 11.0 mt -113.55 128.14 70.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.51 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.63 138.98 40.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.993 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.3 m -140.45 158.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.13 26.85 29.9 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.318 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.1 t -66.86 140.26 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.533 0.682 . . . . 0.0 112.204 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.51 -41.54 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 43.8 t -126.33 134.84 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.65 -34.69 27.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.712 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -93.5 -6.74 46.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 2.1 m-20 -102.42 19.7 18.37 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.51 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 7.8 mt -105.73 139.33 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.353 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.4 tt -124.22 134.45 53.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.342 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 40' ' ' THR . 0.6 OUTLIER -110.58 128.93 55.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.151 0.5 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.2 mt -122.37 134.2 54.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.847 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.92 137.57 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.4 ' O ' ' HA2' ' A' ' 127' ' ' GLY . 33.6 mt -106.14 137.61 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -118.78 121.96 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.503 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.412 ' CD1' HD21 ' A' ' 124' ' ' LEU . 4.5 mt -85.47 134.12 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -86.11 113.16 21.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.3 -29.15 70.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -57.4 -42.88 83.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.98 0.419 . . . . 0.0 110.574 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 52' ' ' ILE . 26.1 t80 -59.11 -44.0 91.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.923 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -60.94 -33.89 73.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.989 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.54 -45.7 92.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.75 -43.41 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.03 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -35.93 82.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.59 -48.06 83.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -82.55 -36.0 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.916 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.4 p30 42.78 43.83 3.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.468 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.66 158.72 20.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.46 129.0 49.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.142 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.18 87.27 6.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 ttt85 -113.88 152.31 30.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pt -76.99 124.28 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.985 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.792 0.329 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -74.51 134.51 42.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.857 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 70.6 mmm -96.55 100.61 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.15 119.29 26.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.432 ' CD2' ' HG3' ' B' ' 172' ' ' PRO . 0.1 OUTLIER -126.26 -49.99 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.03 -78.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.432 ' HG3' ' CD2' ' B' ' 169' ' ' PHE . 69.5 Cg_exo -51.42 112.69 0.87 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.522 2.148 . . . . 0.0 112.323 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -37.37 79.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.734 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 t70 60.01 81.73 0.24 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.83 140.8 43.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.542 2.161 . . . . 0.0 112.34 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 4.0 mt -123.72 130.95 53.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.836 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.93 -179.934 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.82 0.343 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 p -88.15 66.6 8.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -68.18 -41.88 80.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.813 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -35.94 82.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.69 -40.2 91.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.28 -41.09 92.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.6 mm -69.34 -35.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.28 -35.36 69.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.421 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -67.32 -23.78 65.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.868 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.63 -47.66 79.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -80.25 -31.12 38.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.794 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.58 71.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.969 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.68 121.06 31.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.738 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.14 103.12 14.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 HG23 ' N ' ' A' ' 29' ' ' GLY . 18.3 mm -81.88 138.14 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 121.595 0.712 . . . . 0.0 111.779 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -173.13 102.28 0.17 Allowed Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.572 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -80.47 -33.72 36.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.827 0.346 . . . . 0.0 110.813 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 177.47 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -76.28 135.06 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.538 -177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -91.62 -60.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.758 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -150.08 165.23 33.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.25 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -129.18 138.1 51.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.88 0.372 . . . . 0.0 111.404 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -105.16 122.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.8 mt -121.83 124.57 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.321 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.0 t -87.08 102.72 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.577 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -76.09 -21.18 56.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.666 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 142' ' ' SER . 82.3 p -79.94 -2.34 43.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.821 0.343 . . . . 0.0 111.599 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.91 74.76 0.39 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.818 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -147.49 -41.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.081 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -120.32 141.67 32.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.6 Cg_endo -72.05 140.03 33.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.135 1.89 . . . . 0.0 112.187 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.9 mt -56.41 144.89 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 111.797 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 164.08 30.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.916 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -122.73 119.81 31.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.443 . . . . 0.0 112.029 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 4.2 mp -85.1 129.56 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.641 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -137.03 155.85 49.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.231 1.015 . . . . 0.0 113.324 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.04 142.86 29.0 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.651 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.464 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -74.91 137.07 41.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.222 0.534 . . . . 0.0 111.058 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.14 -41.44 92.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.896 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 m -56.87 -40.72 76.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.94 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.4 OUTLIER -68.45 -36.86 79.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.734 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -70.83 -38.37 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.09 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.07 -33.52 70.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -50.42 15.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.79 119.39 24.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -135.65 25.47 3.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.989 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -137.87 -52.76 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -88.37 -166.22 1.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.609 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.413 HG12 ' CG2' ' A' ' 65' ' ' VAL . 7.6 tp -89.66 132.05 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.158 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -65.72 0.7 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.284 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.8 ttpt -153.23 141.22 20.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.464 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.462 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.7 t -133.59 139.28 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.22 0.533 . . . . 0.0 111.905 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.546 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.4 m-90 -103.21 139.21 38.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.524 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.422 HG23 HD12 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -109.95 130.79 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -120.01 145.44 46.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.02 -168.44 37.81 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 mtp-105 -81.76 1.84 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.4 t-20 -84.82 134.42 41.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.676 0.274 . . . . 0.0 111.553 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.4 Cg_exo -66.65 -13.53 40.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.747 2.298 . . . . 0.0 111.756 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -43.85 16.38 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.952 0.882 . . . . 0.0 109.05 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.56 140.17 1.34 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.593 . . . . 0.0 111.176 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 m-20 -56.35 -18.52 11.15 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.076 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.6 t80 -129.36 115.29 17.33 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 120.761 0.315 . . . . 0.0 110.697 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 -85.95 115.29 23.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.406 HD13 ' CD2' ' A' ' 76' ' ' TYR . 8.0 mp -91.75 166.05 12.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.66 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.65 -87.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.472 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 178.44 72.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.764 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 81' ' ' ILE . 26.1 mt -106.94 116.65 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.403 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -38.19 67.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.86 -23.43 65.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.01 151.97 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.127 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 m -95.72 165.02 12.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.598 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.629 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.85 -52.78 4.95 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 109.782 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 15.0 ptmt -119.33 81.77 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -60.21 -46.9 88.15 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.656 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.9 p90 -144.42 160.77 40.51 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.894 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.462 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.3 tt0 -136.07 142.58 44.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.24 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' CD1' ' CZ ' ' A' ' 68' ' ' PHE . 63.6 mt -116.27 127.72 73.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.87 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -113.2 148.57 35.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.139 0.495 . . . . 0.0 111.645 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.2 tp -125.1 123.46 39.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.66 -140.98 3.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.515 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 63.41 -79.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.845 0.355 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -159.46 -76.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -132.61 22.15 4.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.516 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -115.91 175.25 5.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.773 0.321 . . . . 0.0 110.777 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mp -120.92 158.16 28.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.025 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 3.2 mt -133.09 146.89 52.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.998 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.69 124.97 53.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.481 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 90' ' ' GLN . 45.4 t30 -115.06 115.56 27.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.679 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.9 p30 -79.53 136.78 36.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.072 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -145.98 39.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -100.6 152.85 19.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -68.92 -31.7 70.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.886 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.4 -19.87 17.47 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.37 157.35 10.3 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.812 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.98 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.786 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.48 148.68 40.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.22 113.64 18.56 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.983 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 46.95 35.82 3.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.212 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.42 -8.84 74.8 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.502 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -106.45 118.53 36.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.111 0.456 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.786 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.35 137.49 48.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.212 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -111.24 168.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.506 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.7 tt0 -70.18 125.91 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.615 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.679 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 41.8 tttt -53.31 162.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.998 0.428 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.88 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.14 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.41 145.12 40.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.916 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -86.68 133.86 33.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.994 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 38.2 mm-40 -129.26 148.25 51.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 tp -72.66 119.78 17.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.6 OUTLIER -57.49 153.67 12.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.537 0.685 . . . . 0.0 111.474 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.438 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.2 t -124.31 153.53 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.59 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.456 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 12.7 tp60 -71.54 124.16 24.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.414 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.48 21.54 49.28 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.086 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.7 t70 -56.64 172.21 0.26 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.177 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -145.25 135.58 24.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.377 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.85 128.39 67.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.341 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.476 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.0 m -104.16 137.89 41.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.968 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.527 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.7 m -140.15 158.33 25.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.71 29.88 31.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.909 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -68.52 140.3 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.753 0.787 . . . . 0.0 112.487 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.54 -44.13 0.5 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.454 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 32.3 t -126.27 140.75 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.86 -42.03 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 6.27 48.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.467 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 4.4 m-20 -112.69 21.37 15.64 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.7 mt -107.27 139.43 29.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.4 tt -123.41 134.35 53.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.206 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.46 ' HB3' HG23 ' A' ' 40' ' ' THR . 37.4 t -112.69 150.64 31.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.607 0.718 . . . . 0.0 112.932 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -135.46 139.14 43.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.321 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.1 t -110.66 140.4 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.216 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.452 HG23 HD12 ' A' ' 145' ' ' ILE . 38.8 mt -105.91 127.06 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.071 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 117.65 32.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.708 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.8 mt -84.89 134.18 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.11 108.36 17.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.53 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.03 -30.5 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -59.66 -45.89 90.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.666 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.54 -44.11 89.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -64.74 -33.97 77.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.023 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -59.26 -46.07 89.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.9 t -61.74 -46.02 91.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.092 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.04 -35.99 74.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.068 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -33.96 76.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.002 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -91.6 -35.24 14.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.026 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.58 90.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.463 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -99.46 114.9 28.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.97 128.16 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.91 113.58 27.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.26 -62.7 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.41 129.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.811 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.791 0.329 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -86.4 114.6 23.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.913 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 6.0 mtt -142.04 151.37 42.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 4.3 t -172.68 131.17 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 2.6 t80 61.47 82.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -30.9 14.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.01 135.63 60.31 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.6 2.2 . . . . 0.0 112.167 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 61.5 p -105.43 133.15 50.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -107.01 77.1 0.49 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.05 139.64 39.7 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.512 2.141 . . . . 0.0 112.332 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.62 155.13 28.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.906 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.748 0.308 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.1 p -120.95 77.39 1.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.959 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -63.21 -47.0 84.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -64.46 -45.35 87.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -60.77 -35.06 75.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.34 -44.1 92.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -67.24 -35.02 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.23 -40.04 76.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -24.37 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.9 -47.45 80.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.956 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -77.4 -24.57 50.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.87 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -81.01 58.54 3.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -99.11 147.03 25.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.633 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.77 101.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.707 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 29' ' ' GLY . 18.7 mm -82.91 138.05 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.642 0.734 . . . . 0.0 111.655 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 28' ' ' ILE . . . 70.22 112.48 0.03 OUTLIER Glycine 0 C--N 1.313 -0.741 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.368 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -87.67 -23.87 24.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.6 0.238 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 174.69 40.38 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.679 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -71.92 134.55 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.627 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -92.08 -60.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.832 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.4 148.92 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.123 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.98 131.38 56.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.511 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -97.94 122.69 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.844 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -125.29 129.02 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.34 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 5.9 t -95.54 101.05 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.732 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -78.11 -19.08 54.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.518 HG22 ' OG ' ' A' ' 142' ' ' SER . 29.1 p -79.93 -2.88 45.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.777 0.322 . . . . 0.0 111.429 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.21 69.82 1.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.237 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -144.54 -35.11 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.413 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.6 mt -127.52 141.0 39.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.732 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.2 Cg_endo -72.49 137.49 28.03 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.166 1.911 . . . . 0.0 112.286 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.5 mt -55.83 141.11 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.755 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.06 164.18 27.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.12 119.89 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.8 mt -95.39 135.74 36.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.679 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.0 158.52 43.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.56 141.79 30.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.511 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 2.7 m-20 -79.64 129.92 34.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.11 0.481 . . . . 0.0 111.099 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.9 mt -64.13 -38.67 83.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.858 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -41.02 76.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.938 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.49 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.37 -44.22 75.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.642 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.42 -45.88 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.112 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.01 -28.23 64.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.072 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.31 -46.88 13.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.14 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.26 114.39 9.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.958 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.83 30.45 4.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 169.38 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.505 ' O ' ' CG2' ' A' ' 62' ' ' ILE . 18.6 p -60.64 147.38 42.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.505 ' CG2' ' O ' ' A' ' 61' ' ' SER . 9.5 tp 51.69 158.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.973 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' N ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -129.14 -61.71 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.059 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -144.37 133.62 23.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.087 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 12.0 t -126.48 139.15 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.273 0.559 . . . . 0.0 112.091 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.562 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.2 m-90 -101.09 139.38 36.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.7 130.16 55.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -119.31 145.28 46.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.72 -166.49 35.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.264 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.58 2.35 29.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -84.81 132.04 47.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.54 0.21 . . . . 0.0 111.279 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -65.46 -15.37 49.39 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.497 2.132 . . . . 0.0 111.44 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.57 -42.65 18.04 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.946 0.879 . . . . 0.0 108.833 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 139.3 1.96 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.836 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 m-20 -56.17 -18.8 11.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.922 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.66 124.95 34.9 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.67 107.94 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.65 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.5 mt -71.14 -71.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.313 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.26 -78.53 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.44 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -176.35 48.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 111.254 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.94 111.96 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.941 0.4 . . . . 0.0 110.791 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -39.24 68.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.517 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -21.47 63.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.357 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.422 HD21 ' CE1' ' A' ' 88' ' ' HIS . 32.8 mt -103.09 152.07 21.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 111.07 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 166.96 11.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.745 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.567 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.19 -53.48 6.5 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.416 0.626 . . . . 0.0 109.634 179.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -118.97 82.61 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.87 -46.41 89.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.634 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.8 p90 -145.75 161.41 39.97 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.091 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.3 tt0 -135.85 143.43 45.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 77.8 mt -117.62 124.2 72.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.237 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.419 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -102.41 147.99 26.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.533 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.9 tp -125.12 122.99 38.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.604 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.55 -156.24 18.13 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.62 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.52 173.4 11.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.343 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.3 t0 58.99 177.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.23 58.59 4.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -141.42 147.3 37.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.394 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.403 ' N ' HD13 ' A' ' 99' ' ' LEU . 6.2 mp -124.29 160.1 28.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.813 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.7 mp -112.81 121.51 44.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.008 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' GLN . 49.7 t30 -116.61 115.52 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.772 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.0 p30 -78.6 139.66 38.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.001 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.6 pt -147.82 38.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.55 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.51 152.6 19.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.102 0.477 . . . . 0.0 111.834 -178.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.96 -31.52 70.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.925 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.15 -19.84 17.66 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.55 156.59 10.23 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.771 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.827 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.75 148.62 39.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.36 18.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.358 177.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 44.4 43.19 5.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -11.15 68.42 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.486 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.13 118.64 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.082 0.441 . . . . 0.0 110.667 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.827 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -72.76 129.74 38.9 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.47 166.73 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.453 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 120' ' ' SER . 27.9 mt-10 -69.93 126.48 29.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.667 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.5 tttt -53.57 163.91 0.59 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.619 0.247 . . . . 0.0 110.365 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.2 m-80 33.35 37.19 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.887 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.1 p -111.71 144.97 40.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -91.38 129.4 37.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.737 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 61.5 mm-40 -128.47 149.9 50.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.437 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.65 136.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.534 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 147' ' ' ILE . 42.6 tp -61.66 153.27 28.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.456 0.646 . . . . 0.0 111.621 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.403 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -125.32 152.66 44.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.561 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 121.73 19.58 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.54 25.6 55.54 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.02 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -51.09 168.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 111.427 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.16 135.29 23.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.865 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.7 mt -117.37 127.9 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.494 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.1 m -104.31 139.36 39.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.122 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.483 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.46 33.45 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.093 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.2 140.33 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.604 0.716 . . . . 0.0 112.266 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.04 -40.17 0.85 Allowed Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.246 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -126.5 131.13 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.62 -35.57 31.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.328 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.3 p -93.59 6.38 48.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -120.87 22.28 11.14 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.494 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 8.9 mt -103.69 139.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.926 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.79 134.42 54.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.64 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.518 ' OG ' HG22 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.11 132.0 55.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.065 0.459 . . . . 0.0 111.616 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.39 136.81 53.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.543 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 19.6 t -110.93 139.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.343 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.18 132.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.166 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 117.9 31.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.345 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.416 ' CD1' HD22 ' A' ' 124' ' ' LEU . 5.3 mt -84.77 134.11 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -83.72 109.45 17.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.52 -31.03 67.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -60.49 -46.0 91.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.766 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -59.95 -44.17 94.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.03 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -33.93 77.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.117 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -58.93 -47.14 86.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.18 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.1 t -64.35 -46.11 84.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.019 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.83 -35.91 82.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.793 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -59.72 -39.01 83.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' LYS . 33.1 mt-30 -90.0 -29.37 18.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.03 -90.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.607 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 157' ' ' GLN . 1.6 tmtm? -85.16 123.69 30.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.96 0.41 . . . . 0.0 110.777 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.32 134.9 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.055 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.64 -69.48 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -113.51 147.32 38.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.4 tp -82.25 134.4 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.063 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.856 0.36 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.73 121.4 28.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -151.34 33.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 21.8 p -95.9 74.32 3.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -109.76 -29.96 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.67 33.45 15.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.943 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.38 115.94 2.21 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.516 2.144 . . . . 0.0 112.383 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 p -69.19 -13.66 62.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.263 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 t0 66.95 70.09 0.49 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.765 0.316 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.95 -174.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.506 2.137 . . . . 0.0 112.356 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 6.8 mt -74.8 172.44 12.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.768 0.318 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 p -146.07 -59.45 0.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -46.76 75.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -60.24 -39.06 85.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.8 -41.72 87.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.45 -31.86 69.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.39 -35.41 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.822 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.8 82.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.71 65.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.78 -47.48 80.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.0 m -80.78 -31.63 35.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.857 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -45.66 90.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.25 128.97 36.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 109.0 20.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.95 138.35 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.66 0.743 . . . . 0.0 111.715 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.58 96.27 1.4 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.447 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -77.52 -42.1 36.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.776 0.322 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 179.92 37.61 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.43 136.0 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.665 -1.607 . . . . 0.0 112.647 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -93.83 -61.48 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.02 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -145.19 161.74 38.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.261 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.41 138.13 54.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.776 0.322 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.4 t -106.22 122.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.867 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mt -126.19 120.89 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.91 106.81 17.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.428 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.9 -22.83 58.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.89 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.469 HG21 ' HB3' ' A' ' 142' ' ' SER . 61.9 p -79.9 -2.36 43.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.614 0.245 . . . . 0.0 111.544 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.38 72.99 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.975 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -143.39 -44.74 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 110.869 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -111.78 140.93 23.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.7 Cg_endo -73.59 132.02 16.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.117 1.878 . . . . 0.0 112.051 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.4 mt -54.08 130.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.579 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 164.13 20.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.42 119.78 38.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.567 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 8.1 mt -91.5 136.29 33.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.355 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -146.26 158.37 43.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.79 143.54 29.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.716 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 5.0 m-20 -74.98 130.75 39.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.152 0.501 . . . . 0.0 111.236 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.39 -44.92 97.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.054 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -57.67 -40.35 79.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.29 0.567 . . . . 0.0 110.686 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.403 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 5.0 mm100 -68.44 -36.93 79.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.782 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.6 -40.87 63.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.974 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -35.13 71.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -71.24 -47.87 54.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.789 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.43 100.06 12.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -30.57 18.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -90.28 159.11 16.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.958 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.84 -168.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.1 tp -89.39 154.43 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -87.14 -67.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.943 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -149.18 134.08 17.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.0 t -125.57 139.12 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.149 0.5 . . . . 0.0 112.252 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.536 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 14.6 m-90 -100.72 139.26 36.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.969 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.428 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.11 128.91 56.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -120.25 145.4 47.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.137 -178.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.83 -169.95 36.61 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.556 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.51 1.02 15.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.57 126.27 69.32 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.365 0.126 . . . . 0.0 111.005 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 23.6 Cg_exo -64.19 -14.01 41.28 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.395 2.063 . . . . 0.0 111.417 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.87 17.63 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.73 140.98 0.62 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.422 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.12 -18.78 10.82 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.736 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.514 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -129.45 131.64 46.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.543 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.428 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -102.79 109.08 20.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 5.9 mp -94.23 166.92 11.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.09 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.34 159.84 40.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.34 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.52 73.33 0.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.359 . . . . 0.0 111.117 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 19.3 mt -107.86 114.29 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -34.8 65.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -61.88 -25.99 67.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.03 150.4 20.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.944 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 m -93.81 166.2 12.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.399 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.552 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.54 -54.82 4.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.422 0.629 . . . . 0.0 109.675 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 16.1 ptpt -119.22 82.6 1.89 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.7 t60 -58.96 -46.02 89.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.877 -176.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.0 p90 -145.19 160.32 41.63 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.358 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.7 tt0 -135.65 144.06 45.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.954 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 50.1 mt -118.76 125.44 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.104 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -101.58 149.39 24.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.985 0.421 . . . . 0.0 111.499 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.409 ' CD2' ' CB ' ' A' ' 50' ' ' ALA . 48.7 tp -125.13 122.89 38.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.46 -141.06 3.59 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.632 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 60.44 -179.38 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -83.42 58.66 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.25 38.54 5.05 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -136.55 170.52 15.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 0.0 110.985 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.12 159.77 27.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 8.5 mp -133.1 143.18 49.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.756 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.83 121.37 44.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.864 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' GLN . 49.2 t30 -116.51 115.55 26.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.676 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.0 p30 -78.18 139.91 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.776 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -146.23 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.534 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.85 152.13 20.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.984 0.421 . . . . 0.0 111.822 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.85 -31.51 70.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -97.67 -19.82 18.02 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.64 157.12 10.58 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.748 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.2 m -117.45 137.79 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.86 148.56 36.47 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.02 113.38 18.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.369 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 43.75 43.75 5.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.528 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.91 -13.58 62.61 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.532 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -103.97 118.48 36.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.964 0.411 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.2 tptm -72.25 127.4 32.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.76 164.59 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 120' ' ' SER . 27.1 tt0 -69.89 124.55 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.584 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.4 tttt -52.82 162.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.465 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 34.51 34.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.155 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.13 40.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.138 179.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -88.29 129.84 35.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.8 mm-40 -129.51 148.26 51.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.9 125.57 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.149 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.0 tp -58.08 156.41 9.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.371 0.605 . . . . 0.0 111.683 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -124.66 153.47 42.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.691 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.426 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.8 tp60 -71.24 122.63 20.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.31 21.67 54.31 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.764 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 31.8 t70 -49.7 168.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.993 0.425 . . . . 0.0 111.24 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 tt0 -145.03 135.45 24.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.839 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.421 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 2.8 mt -115.49 127.21 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.661 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.476 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.69 138.2 41.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.876 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.478 ' CG1' ' CD2' ' A' ' 88' ' ' HIS . 32.7 m -140.12 158.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.8 25.77 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.954 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -70.95 140.38 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.64 0.733 . . . . 0.0 112.314 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.88 -40.08 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.312 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 47.5 t -126.4 136.18 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -50.61 -41.62 55.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -93.42 6.29 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.814 . . . . 0.0 113.196 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.429 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 9.0 t0 -117.5 24.76 10.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.6 mt -105.93 139.57 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.91 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.2 tt -122.03 134.41 54.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.705 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.469 ' HB3' HG21 ' A' ' 40' ' ' THR . 40.0 t -110.61 150.38 29.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.695 0.76 . . . . 0.0 112.548 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 76.0 mt -135.9 146.76 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.681 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.42 140.31 43.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.742 0.306 . . . . 0.0 111.065 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.2 mt -105.98 126.1 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.347 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.55 109.75 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.318 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.4 mp -84.89 134.14 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.021 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.45 106.78 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.35 -26.42 63.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.353 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -60.18 -46.04 91.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -60.13 -44.28 95.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.152 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -65.16 -33.92 77.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.162 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -40.03 90.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.187 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.7 t -66.96 -43.71 82.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -36.0 75.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.101 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -43.96 97.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.156 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.22 -36.32 24.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.056 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p30 45.16 -173.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.574 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -99.35 125.01 44.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.972 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.4 m -91.85 135.74 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.05 121.55 44.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.94 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.69 120.62 32.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.25 138.13 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.872 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.852 0.358 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 -51.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 5.3 mmt -104.5 -64.19 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.31 156.59 16.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.795 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' B' ' 170' ' ' GLN . 31.9 p90 -177.08 -38.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.032 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . 0.448 ' N ' ' CD1' ' B' ' 169' ' ' PHE . 1.3 mt-30 70.18 -63.75 0.39 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.995 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.414 ' HG3' ' CE1' ' B' ' 169' ' ' PHE . 75.5 Cg_exo -49.55 174.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.563 2.175 . . . . 0.0 112.385 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 2.4 m -152.08 27.52 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.68 88.07 0.13 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.981 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.78 -174.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.55 2.167 . . . . 0.0 112.346 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.18 101.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.841 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.45 37.03 1.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.801 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -43.87 94.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -71.19 -35.82 71.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.488 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -56.88 -43.17 81.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.18 -31.85 69.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.205 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 13.7 mt -68.74 -47.99 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.58 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -33.61 73.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.441 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -57.47 -47.11 82.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.952 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 24' ' ' SER . 5.1 p90 -71.97 -47.22 53.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.561 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 83.9 p -56.38 -39.47 73.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.074 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.69 84.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -100.61 121.32 41.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -68.53 141.65 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.935 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 29' ' ' GLY . 18.3 mm -83.43 138.1 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.633 0.73 . . . . 0.0 111.897 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -172.85 31.3 0.11 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.592 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.16 -23.75 22.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.3 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -145.6 -2.29 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.838 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.62 100.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 121.842 0.829 . . . . 0.0 110.807 -179.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' H ' ' HA ' ' A' ' 49' ' ' SER . 2.3 t -50.55 -67.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.937 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.9 p -146.79 165.32 30.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.397 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.43 124.2 37.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -88.94 122.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 111.192 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 mt -129.6 119.56 48.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 t -80.82 113.5 19.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.399 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 p -86.55 -23.03 25.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.798 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.649 HG21 ' OG ' ' A' ' 142' ' ' SER . 81.7 p -79.91 -2.65 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.714 0.292 . . . . 0.0 111.487 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.84 75.42 0.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.551 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -145.29 -40.49 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 111.09 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.589 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.4 mt -125.1 142.74 42.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 39.1 Cg_endo -69.19 145.27 59.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.203 1.935 . . . . 0.0 112.266 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.3 mt -58.9 150.88 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.738 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -142.27 164.35 30.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.301 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -122.8 119.76 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 0.0 111.756 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.561 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.2 mt -100.02 133.17 44.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.139 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.838 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.71 156.82 43.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.78 146.71 34.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.575 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.473 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.6 m-20 -74.86 132.82 41.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.943 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.8 mt -63.94 -38.71 83.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.668 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.3 t -56.65 -41.35 77.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.883 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.473 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.4 OUTLIER -68.49 -38.15 80.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.553 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.6 t -70.29 -46.86 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.158 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -28.36 65.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -85.4 -57.03 3.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.25 129.36 39.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.4 29.8 0.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.29 -60.35 0.67 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 m -94.51 -173.2 2.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.491 HG21 HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -76.78 134.64 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.05 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' HD2' ' HA2' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -81.21 -65.37 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.083 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 10.2 ttpt -148.82 117.35 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 9.7 p -110.61 139.34 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.561 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.94 139.51 36.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.437 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.71 129.48 56.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 1.0 OUTLIER -118.11 145.27 45.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.881 0.372 . . . . 0.0 111.669 -178.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.54 -172.28 40.25 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.774 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -78.96 0.15 28.65 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.7 135.32 40.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 111.478 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.7 Cg_exo -66.37 -12.95 37.78 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.789 2.326 . . . . 0.0 111.84 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.5 -44.92 15.36 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.874 0.845 . . . . 0.0 108.965 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.15 141.87 1.12 Allowed 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.818 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.0 m-20 -56.22 -18.77 11.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.149 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.503 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.8 t80 -129.36 127.03 40.22 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-O 120.762 0.315 . . . . 0.0 110.693 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.433 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -97.92 108.75 21.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.278 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.456 HD23 ' CD2' ' A' ' 76' ' ' TYR . 17.1 mt -88.13 170.27 11.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.646 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.19 -86.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.391 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 175.64 69.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.942 0.401 . . . . 0.0 110.594 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.442 HD12 HG23 ' A' ' 81' ' ' ILE . 25.0 mt -97.48 116.23 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.304 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -54.76 -35.8 64.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -63.6 -42.11 98.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 53.3 mt -72.91 152.13 41.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -94.39 167.33 11.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.718 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.608 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -42.95 -54.82 4.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.413 0.625 . . . . 0.0 109.769 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.02 82.95 1.95 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -58.52 -46.53 86.56 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.411 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -142.41 160.26 40.62 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.794 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 102' ' ' ASN . 4.3 tt0 -135.95 142.7 44.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.919 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 62.1 mt -118.83 129.36 75.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.601 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' HB3' HG21 ' A' ' 65' ' ' VAL . 1.9 pt? -118.65 140.61 49.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.842 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.7 tp -116.53 122.9 46.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.972 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA2' ' HD2' ' A' ' 63' ' ' LYS . . . -176.07 -141.41 3.83 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.542 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 69.83 -65.76 0.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.746 0.308 . . . . 0.0 110.969 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -167.58 -44.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.29 -38.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.669 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -61.38 171.04 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.1 mt -107.45 156.28 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 mp -129.43 142.62 50.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.138 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 tt -112.63 122.39 47.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.2 t30 -113.23 115.49 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.39 . . . . 0.0 111.402 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.694 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 18.0 p30 -79.96 134.37 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.875 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.1 pt -142.34 40.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.54 158.08 15.99 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.082 0.468 . . . . 0.0 111.435 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.83 -35.71 77.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.443 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.6 -19.8 17.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.62 161.31 11.41 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.41 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.52 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.24 148.36 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 113.39 18.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.086 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 44.99 43.02 6.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -7.05 81.28 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.569 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.61 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.704 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 22.1 tptt -75.1 125.44 28.94 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.18 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.2 m -99.65 165.95 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 120' ' ' SER . 21.9 tt0 -69.88 128.75 37.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.372 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -54.03 163.75 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.93 37.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.5 p -111.64 145.06 39.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -91.43 124.35 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.789 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -129.25 147.13 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.867 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp -72.97 113.47 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 167.39 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.643 0.735 . . . . 0.0 111.823 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.27 153.22 43.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.476 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 121.48 18.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.09 22.4 62.71 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.073 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.44 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 6.8 t70 -60.5 177.16 0.3 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.838 0.352 . . . . 0.0 110.919 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.0 tt0 -145.16 135.66 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.421 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 1.5 mt -108.72 127.04 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.105 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.513 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.34 136.44 43.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.109 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.516 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.2 m -140.28 158.51 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.46 29.35 30.33 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.072 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.8 t -68.12 140.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.605 0.717 . . . . 0.0 112.406 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.42 -41.46 0.75 Allowed Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 47.8 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -50.55 -35.1 28.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.868 0.366 . . . . 0.0 111.331 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.5 t -93.57 6.33 48.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.425 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.4 t0 -120.2 21.9 11.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.513 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.6 mt -105.09 139.71 25.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.95 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 tt -122.34 134.4 54.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.929 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.649 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.73 133.58 53.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.086 0.47 . . . . 0.0 111.571 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 34.6 mt -126.1 133.23 51.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.78 140.03 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 111.485 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.2 mt -106.31 139.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.932 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.24 103.91 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.7 mt -88.31 118.4 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.094 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -75.88 127.66 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.02 -21.71 64.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -44.15 85.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.016 0.436 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -58.55 -44.02 89.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.732 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -65.2 -40.28 93.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.935 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -38.07 78.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.4 t -68.17 -40.1 82.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -50.03 51.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.45 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.11 -33.84 74.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.604 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -37.04 14.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.104 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.48 56.65 3.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.452 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.72 151.19 39.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.6 p -99.88 131.06 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 61.11 173.49 0.11 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.849 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.3 43.12 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.94 133.3 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.863 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.787 0.327 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.77 88.5 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 1.5 mtp -170.04 -44.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.88 87.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -65.82 83.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.7 -31.41 13.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.87 110.49 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.414 2.076 . . . . 0.0 112.248 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 34.4 p -73.34 165.75 24.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -135.38 63.57 55.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.7 93.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.596 2.197 . . . . 0.0 112.311 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 6.5 mt -86.47 154.1 21.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.923 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.85 0.357 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.9 p -141.86 -50.2 0.4 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -35.71 77.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -40.5 85.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -38.4 90.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -40.78 96.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 43.0 mm -67.62 -48.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -33.65 72.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.35 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -47.14 85.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.017 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.6 p90 -71.76 -47.43 53.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.146 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.551 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 20.5 p -63.18 -30.52 71.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 60.91 71.77 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -69.8 127.06 31.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.98 125.06 23.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.85 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.99 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.606 0.717 . . . . 0.0 111.699 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.47 74.56 0.06 OUTLIER Glycine 0 C--N 1.313 -0.738 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.54 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.77 -40.2 94.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 175.81 39.36 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm -72.02 135.2 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.594 -1.639 . . . . 0.0 112.601 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -92.65 -59.67 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.35 147.41 29.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.328 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.97 136.59 52.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.23 122.52 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.804 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.2 mt -126.59 127.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.358 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.0 t -93.31 115.67 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.596 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.4 t -88.88 -22.64 23.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.428 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.556 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.4 p -79.82 -2.69 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.3 . . . . 0.0 111.48 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.54 71.82 0.83 Allowed Glycine 0 N--CA 1.454 -0.106 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.947 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -142.9 -40.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.525 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 11.7 mt -122.88 140.77 33.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.66 141.79 28.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.165 1.91 . . . . 0.0 112.076 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mt -53.53 149.85 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.696 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -143.32 164.18 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.316 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -122.13 119.85 32.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.068 0.461 . . . . 0.0 111.962 -179.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.2 mt -98.51 136.69 38.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.2 158.79 44.07 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.8 141.84 29.49 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.712 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.487 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -75.04 133.26 41.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 110.966 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.08 -39.79 86.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.717 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 p -56.45 -38.99 72.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.754 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.487 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -68.52 -44.9 73.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.77 -46.27 96.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.136 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.0 -28.58 65.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.992 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -83.62 -35.01 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.076 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -79.27 136.79 37.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.07 30.77 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.826 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -91.11 -67.3 0.86 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -172.92 -41.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.106 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.8 tp -127.3 152.93 35.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.176 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -122.46 -64.87 1.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -141.49 132.05 25.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.258 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 7.3 t -127.89 138.19 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.175 0.512 . . . . 0.0 111.739 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.511 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.1 m-90 -100.85 139.12 36.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.207 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.12 125.94 54.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -112.96 145.68 40.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.475 -178.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.67 -169.1 38.54 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.711 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.9 mtp-105 -82.56 0.73 41.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 30.5 t-20 -84.96 132.63 45.21 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.057 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.6 Cg_exo -67.67 -10.26 28.16 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 111.656 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.54 16.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.898 0.856 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.46 139.09 1.15 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.342 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.15 -18.79 11.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.794 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.491 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.8 131.99 46.36 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.127 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.95 110.13 22.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.572 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.2 mt -85.31 -71.27 0.54 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.466 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.72 -109.61 0.25 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.587 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -163.14 61.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 111.273 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 28.6 mm -98.65 124.07 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 m -54.87 -43.43 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.482 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.402 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.5 mmp_? -60.78 -18.19 53.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.411 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.6 mt -103.48 147.08 27.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.882 0.372 . . . . 0.0 110.722 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m -93.56 164.74 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.765 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.82 -52.47 5.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -120.45 82.4 1.9 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -60.46 -45.91 91.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.714 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.1 p90 -145.07 158.95 43.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.648 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.5 tt0 -135.64 140.94 44.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.431 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 62.0 mt -117.31 132.04 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.098 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -109.98 147.11 34.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.073 0.463 . . . . 0.0 111.652 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.9 tp -125.13 122.96 38.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.58 -178.96 38.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.545 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.34 90.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.784 0.326 . . . . 0.0 110.983 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.23 -174.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.19 60.1 4.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.451 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -139.82 177.61 7.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.09 156.72 48.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.5 mp -132.98 141.96 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mp -112.56 127.35 56.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.155 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' GLN . 43.5 t30 -115.89 115.58 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 111.702 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.687 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 19.0 p30 -77.37 135.33 38.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.676 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.0 pt -143.94 41.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.87 161.13 13.8 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.096 0.474 . . . . 0.0 111.503 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.91 -38.8 79.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.698 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.63 -19.7 17.4 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.99 161.81 11.24 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.088 -1.053 . . . . 0.0 114.01 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 17.4 m -117.6 137.87 52.32 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.224 0.61 . . . . 0.0 109.565 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.822 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.11 148.43 37.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -124.65 113.52 18.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 47.05 42.26 12.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.0 -10.15 71.76 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.863 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.413 ' CB ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -105.52 118.7 37.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.245 0.523 . . . . 0.0 110.765 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -73.13 134.43 44.46 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.349 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -107.01 166.58 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.334 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 mm-40 -69.88 123.96 22.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.553 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 75.7 tttt -52.95 163.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.513 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 36.09 33.19 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.032 -179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.35 145.08 40.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.105 179.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.78 131.94 36.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.955 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 62.0 mm-40 -129.37 151.79 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.644 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt -72.83 133.33 44.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.238 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.437 HD23 HG12 ' A' ' 147' ' ' ILE . 66.9 tp -65.15 154.85 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.512 0.672 . . . . 0.0 111.668 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.92 153.09 43.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.75 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 123.69 23.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.358 . . . . 0.0 110.106 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.43 47.4 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.173 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -51.11 172.21 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.834 0.35 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -144.87 135.56 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.028 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 5.5 mt -118.51 124.84 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.32 140.47 37.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.896 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.29 158.26 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.61 30.23 24.77 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.873 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.545 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.7 t -71.17 140.44 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.645 0.736 . . . . 0.0 112.385 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.06 -38.52 0.69 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.341 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 50.4 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.59 -37.03 37.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.793 0.33 . . . . 0.0 111.479 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 m -93.53 6.52 47.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -124.34 26.51 7.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.5 mt -105.93 139.68 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.634 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt -120.93 134.16 55.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.069 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.556 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 3.0 m -108.56 143.71 37.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -135.48 144.18 46.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.534 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.3 t -114.13 136.53 50.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.037 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.57 126.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -112.95 121.78 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.665 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.437 HG12 HD23 ' A' ' 124' ' ' LEU . 3.5 mt -85.05 134.14 27.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.395 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.85 109.0 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -62.15 -42.44 99.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -46.02 90.8 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -59.3 -44.09 92.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -33.87 77.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.85 -41.91 88.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.0 t -67.79 -44.53 77.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.014 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -42.24 75.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.09 -48.07 59.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.471 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -37.15 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.186 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p30 42.43 31.4 0.27 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.486 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -125.12 162.05 25.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.011 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.63 132.99 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.03 127.99 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.004 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.07 148.2 34.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.16 110.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.882 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.787 0.327 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -107.52 105.26 15.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.03 124.18 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.851 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' B' ' 170' ' ' GLN . 11.6 p90 -112.09 -35.89 5.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.965 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . 0.423 ' N ' ' CD1' ' B' ' 169' ' ' PHE . 0.2 OUTLIER 67.92 -70.64 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.418 ' HG3' ' CD1' ' B' ' 169' ' ' PHE . 63.2 Cg_exo -51.62 139.33 48.02 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.653 2.235 . . . . 0.0 112.274 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.78 20.98 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.176 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.78 101.09 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.947 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.18 101.92 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.409 2.072 . . . . 0.0 112.273 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 mt -124.02 -171.43 2.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.807 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 120.936 0.398 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.99 79.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.702 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.8 -47.13 69.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.983 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -62.84 -35.99 81.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.5 -38.65 91.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 tp -63.05 -45.05 94.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.1 mm -66.98 -34.99 73.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -40.22 76.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.987 0.422 . . . . 0.0 110.445 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -67.26 -23.84 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.53 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.75 -47.36 80.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.198 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -60.24 -32.79 71.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -123.44 45.0 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -73.91 129.35 37.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.99 101.98 11.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.813 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 29' ' ' GLY . 18.2 mm -84.7 138.27 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.661 0.744 . . . . 0.0 111.747 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 28' ' ' ILE . . . 86.9 28.38 26.23 Favored Glycine 0 C--N 1.313 -0.703 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.483 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -75.78 -46.34 31.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.944 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -170.2 34.95 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.651 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -77.79 133.2 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 113.787 -1.552 . . . . 0.0 112.561 -177.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 2.8 t -89.92 -61.02 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.28 148.42 28.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.308 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -115.92 127.7 55.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.27 122.75 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.3 mt -120.62 128.45 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.347 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.87 121.51 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.475 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.5 t -88.15 -27.12 22.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.634 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 142' ' ' SER . 35.4 p -79.94 -2.17 42.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.545 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 77.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.84 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -146.86 -44.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.564 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -113.54 141.51 26.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.91 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.6 Cg_endo -71.14 145.81 50.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.017 1.811 . . . . 0.0 112.037 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.0 mt -56.69 143.91 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.916 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.03 163.3 33.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.813 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.67 120.53 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 112.178 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.8 mp -84.7 128.3 34.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.651 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -133.48 155.92 48.69 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -155.37 141.94 18.77 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.304 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.499 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -82.06 143.26 31.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.145 0.498 . . . . 0.0 111.33 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.27 -41.47 92.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.542 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -56.98 -38.66 73.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.43 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 2.5 mm-40 -68.48 -37.04 79.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.475 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 43.4 t -73.12 -42.53 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.158 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 tp -66.14 -33.89 76.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.887 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -53.82 16.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.94 110.62 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.96 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.08 -29.13 15.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.37 166.54 14.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.19 -178.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.1 tp -85.01 153.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 7.1 mptt -87.02 -74.3 0.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.023 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.2 ttpt -133.17 134.86 44.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 90' ' ' GLN . 9.6 t -131.1 139.21 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.525 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.2 m-90 -103.38 139.51 38.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.057 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.93 127.19 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.154 0.502 . . . . 0.0 110.223 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.583 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -113.6 146.26 40.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.631 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 169.61 -174.87 43.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.487 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -87.06 45.65 1.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.495 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -141.11 139.07 18.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.975 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 12.5 Cg_exo -68.27 -6.48 17.49 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.875 2.383 . . . . 0.0 111.904 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.33 11.14 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.88 0.848 . . . . 0.0 109.279 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.95 141.81 1.05 Allowed 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.96 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.41 -19.27 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.966 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 44.8 t80 -129.89 122.68 29.11 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.797 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.424 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -88.92 107.83 19.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.793 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 69' ' ' GLY . 1.7 mm? -68.63 -82.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.038 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.85 -96.3 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.535 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -167.05 60.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 111.199 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 mm -112.18 115.68 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.023 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.5 p -55.21 -34.65 64.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.86 -23.26 65.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.206 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 mt -97.49 147.73 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 111.084 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.17 164.75 12.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.998 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.631 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.44 -52.05 4.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.447 0.641 . . . . 0.0 109.847 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.51 79.92 1.55 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.5 t60 -60.87 -47.23 87.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.538 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 17.5 p90 -146.48 159.07 43.89 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.552 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.495 ' HG2' HG11 ' A' ' 65' ' ' VAL . 4.5 tt0 -135.84 141.2 44.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.656 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 37.2 mt -115.48 130.51 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.075 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.461 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -122.39 139.21 54.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.047 0.451 . . . . 0.0 111.839 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.425 ' CD1' ' HG ' ' A' ' 99' ' ' LEU . 4.4 tp -125.35 129.47 50.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.967 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.44 -30.27 0.86 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.714 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -53.76 -29.05 38.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.744 0.307 . . . . 0.0 111.26 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -171.26 -175.57 1.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.25 -21.39 39.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -94.32 -176.39 3.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.699 0.285 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HG ' ' CD1' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -106.92 159.6 16.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.777 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -123.18 139.38 54.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.8 120.06 40.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.981 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.7 t30 -116.82 119.97 37.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.402 . . . . 0.0 112.057 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.652 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.3 p30 -79.87 141.0 36.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.982 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.9 pt -147.06 36.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.428 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.53 149.81 21.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.128 0.489 . . . . 0.0 112.043 -178.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.0 m -68.62 -31.55 70.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.682 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -97.18 -19.75 18.41 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.652 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.569 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.12 156.15 10.42 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.604 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.9 m -117.45 137.81 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.31 148.62 37.24 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.35 18.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.452 177.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 43.43 43.74 4.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.499 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.3 -13.71 62.9 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.418 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -103.38 118.54 36.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.027 0.442 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.6 tptm -72.66 127.6 33.05 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 m -97.89 162.95 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.6 tt0 -69.99 126.9 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.489 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.652 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttm -52.09 160.79 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.462 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 35.75 33.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.41 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 118.04 34.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.106 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.406 ' ND2' ' CD1' ' A' ' 92' ' ' LEU . 14.3 m120 -66.01 135.16 54.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 33.1 mm-40 -129.48 151.14 50.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -72.77 132.71 43.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.27 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.401 HD21 ' CD1' ' A' ' 147' ' ' ILE . 44.0 tp -58.1 152.56 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.713 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.42 152.63 44.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.645 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -72.51 123.35 22.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.253 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.31 23.42 41.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.085 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.7 t70 -49.12 167.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.015 0.436 . . . . 0.0 111.429 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.4 mt-10 -144.8 135.44 24.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -117.35 127.81 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.748 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.67 138.12 41.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.933 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.8 m -140.31 158.06 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 30.93 25.2 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.811 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -70.83 140.41 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 112.452 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.48 -41.0 0.47 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.2 t -126.47 134.74 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 115.1 -0.55 . . . . 0.0 109.519 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -38.67 48.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.781 0.325 . . . . 0.0 111.467 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.9 m -93.42 6.32 48.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 6.9 t0 -121.36 26.95 8.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.7 mt -107.1 139.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.948 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 134.43 55.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.461 ' HB3' HG22 ' A' ' 40' ' ' THR . 47.3 t -112.11 150.78 30.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.518 0.675 . . . . 0.0 112.282 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.2 mm? -135.62 155.53 50.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.403 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 19.2 t -125.6 140.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.825 0.345 . . . . 0.0 111.431 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.4 HG13 HD13 ' A' ' 130' ' ' ILE . 34.0 mt -106.46 123.08 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.165 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.98 116.83 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 ' CD1' HD21 ' A' ' 124' ' ' LEU . 4.4 mt -86.27 134.21 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.608 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.78 122.91 27.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.649 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.28 -36.82 77.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -59.12 -45.37 91.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 110.719 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -57.81 -44.11 86.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -60.99 -34.01 74.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.218 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -60.38 -47.26 86.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.348 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.5 t -68.24 -42.44 79.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.45 -35.87 82.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.74 -45.26 93.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.929 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 159' ' ' LYS . 42.1 mm-40 -84.58 -31.02 24.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.966 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.05 -90.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.618 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 157' ' ' GLN . 3.8 mttm -125.0 148.68 48.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.812 0.339 . . . . 0.0 110.816 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.47 126.25 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.099 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.4 t70 60.49 97.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.75 131.93 12.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.806 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.3 mm -101.8 133.18 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.187 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.831 0.348 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -154.13 143.81 21.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.766 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 7.8 tpp -158.63 84.5 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 3.4 t -77.11 -38.55 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.817 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -101.78 152.1 21.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.85 38.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.5 140.65 44.03 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.621 2.214 . . . . 0.0 112.37 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 3.9 t -134.11 43.66 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 60.98 74.6 0.51 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.31 172.69 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.59 2.194 . . . . 0.0 112.31 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 17.0 mt -137.94 159.75 41.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.958 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.884 0.374 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -35.68 74.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.81 -42.38 79.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -32.46 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.16 -35.39 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.808 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -57.26 -39.18 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 110.434 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -67.09 -24.05 65.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.233 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.771 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.427 -1.601 0 CA-C-O 121.866 0.841 . . . . 0.0 111.077 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -58.02 -66.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.193 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.749 ' SG ' HG23 ' A' ' 147' ' ' ILE . 91.1 m -152.23 165.13 35.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.836 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -125.86 138.03 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.072 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.751 HG23 HD11 ' A' ' 48' ' ' LEU . 21.7 t -102.57 123.81 56.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.768 HG23 HG12 ' A' ' 45' ' ' ILE . 11.4 mt -123.14 124.94 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.483 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.1 t -81.71 123.04 28.39 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 t -86.72 -28.92 22.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 142' ' ' SER . 36.8 p -79.91 -2.13 42.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.688 0.28 . . . . 0.0 111.552 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.75 77.0 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -145.36 -43.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.885 HD12 HD21 ' A' ' 143' ' ' LEU . 3.0 mt -111.35 140.85 23.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.3 Cg_endo -72.52 131.43 17.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.127 1.884 . . . . 0.0 111.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.768 HG12 HG23 ' A' ' 37' ' ' ILE . 32.6 mt -51.84 131.56 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.659 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.87 164.21 19.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.251 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -117.84 120.1 36.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 111.536 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.751 HD11 HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -97.64 134.87 40.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.426 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.864 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.79 157.25 43.63 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.74 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.6 ttpt . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 120.73 0.3 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.659 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.5 t -124.87 139.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 111.983 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.574 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.7 m-90 -100.9 139.23 36.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.435 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.92 128.45 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.312 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.25 145.52 43.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.624 -177.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.76 -169.61 40.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.722 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 3.4 mtp-105 -83.25 -1.62 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.76 136.22 39.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 111.602 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.1 Cg_exo -67.44 -10.57 29.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.843 2.362 . . . . 0.0 111.979 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.55 -44.47 15.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.84 0.829 . . . . 0.0 109.02 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.78 139.31 2.33 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.42 -18.21 10.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.955 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -129.18 118.67 22.77 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.897 0.379 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.7 m -54.79 -34.94 63.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.067 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -26.63 67.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 81' ' ' ILE . 33.1 mt -91.63 152.18 20.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -93.64 167.25 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -42.95 -54.12 4.39 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.374 0.607 . . . . 0.0 109.77 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.65 82.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.2 -46.25 88.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.836 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.5 p90 -143.57 159.84 41.71 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.13 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.7 tt0 -135.77 143.05 45.05 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.385 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.586 ' C ' HG13 ' A' ' 65' ' ' VAL . 49.6 mt -118.69 127.86 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.973 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.641 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -114.11 141.81 47.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 111.956 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 33' ' ' VAL . 7.5 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.229 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.632 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.9 0.381 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.0 mm? -130.31 145.41 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.316 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.77 121.37 44.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.888 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.641 ' HB2' HD23 ' A' ' 92' ' ' LEU . 49.6 t30 -116.81 115.66 25.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.789 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.849 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.7 p30 -78.96 136.62 37.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.751 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.8 pt -144.26 39.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.65 152.63 19.85 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.157 0.504 . . . . 0.0 111.956 -179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.0 m -68.79 -31.57 70.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.809 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.07 -19.97 17.64 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.628 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.53 157.04 10.58 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.695 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.38 137.71 52.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.04 148.56 40.06 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.556 177.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m120 44.39 43.64 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.96 -13.16 61.93 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.435 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.26 118.53 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.467 . . . . 0.0 110.465 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.66 129.26 38.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.52 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.849 HG23 ' OD2' ' A' ' 103' ' ' ASP . 17.4 m -97.84 163.45 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.91 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.71 125.34 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.487 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.1 tttt -52.25 161.27 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.755 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.19 34.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.21 145.03 40.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.145 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.501 ' HB3' HD12 ' A' ' 100' ' ' LEU . 70.5 m-20 -85.69 129.13 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.758 ' O ' HD13 ' A' ' 100' ' ' LEU . 6.7 mm100 -129.09 146.23 51.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.548 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.6 tm? -72.75 111.97 8.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.246 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.712 HD11 HG21 ' A' ' 145' ' ' ILE . 66.0 tp -50.66 157.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.397 0.618 . . . . 0.0 111.646 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.4 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -124.45 153.13 42.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.6 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.668 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.73 124.75 25.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.83 20.91 50.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t70 -55.79 174.96 0.1 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.934 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.6 mt-10 -145.04 135.7 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.316 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 145' ' ' ILE . 5.6 mt -111.59 126.99 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.624 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.65 137.23 42.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.944 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.637 HG23 HD21 ' A' ' 84' ' ' LEU . 34.8 m -140.47 158.32 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.29 22.81 42.87 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.324 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.4 t -62.62 140.33 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.663 0.744 . . . . 0.0 112.388 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -43.98 0.57 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.211 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.47 138.32 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -38.42 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.71 0.291 . . . . 0.0 111.584 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.449 ' H ' HG12 ' A' ' 136' ' ' VAL . 7.9 t -93.55 6.2 49.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 133' ' ' GLY . 3.2 m-20 -116.31 22.52 12.8 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.06 139.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.22 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 142' ' ' SER . 9.2 tt -124.48 134.27 53.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.243 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.507 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.9 t -111.28 150.54 29.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.716 0.769 . . . . 0.0 112.211 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.885 HD21 HD12 ' A' ' 43' ' ' ILE . 66.8 mt -135.38 156.57 48.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.67 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.934 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.9 t -125.68 137.54 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 130' ' ' ILE . 36.5 mt -106.48 120.96 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.01 122.39 46.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.749 HG23 ' SG ' ' A' ' 34' ' ' CYS . 3.4 mp -112.91 134.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.482 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.405 ' ND2' HG22 ' A' ' 32' ' ' ILE . 28.7 p30 -93.52 135.46 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -74.02 -21.34 60.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -58.22 -44.23 88.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.1 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.753 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.824 0.345 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -42.58 99.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -38.62 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.555 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 19' ' ' LEU . 13.8 tp -58.1 -31.94 67.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.49 -35.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.726 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.67 -36.18 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.309 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.217 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm . . . . . 0 N--CA 1.426 -1.635 0 CA-C-O 121.763 0.792 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.685 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.43 -50.48 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.974 -178.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -163.11 146.17 10.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.204 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -113.88 131.45 56.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.286 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 ' HE2' ' A' ' 68' ' ' PHE . 28.7 t -97.8 122.79 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 25.3 mt -123.34 119.56 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.269 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.643 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.5 t -80.48 121.05 25.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.451 ' CG2' HG21 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -91.23 -27.72 18.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.422 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 142' ' ' SER . 69.2 p -80.31 -2.96 47.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.686 0.279 . . . . 0.0 111.556 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.86 80.74 0.2 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.375 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.777 ' OE1' HD13 ' A' ' 141' ' ' LEU . 15.2 mt-30 -149.62 -45.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.862 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.02 141.16 26.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.68 139.81 28.52 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.169 1.913 . . . . 0.0 112.125 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -55.23 135.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.725 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -134.37 164.02 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.209 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.2 119.72 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 36' ' ' VAL . 5.7 mt -90.6 137.49 32.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.618 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.44 157.37 45.24 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.685 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.937 0 CA-C-N 113.3 -1.773 . . . . 0.0 110.497 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.4 t -129.95 139.61 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.293 0.568 . . . . 0.0 111.809 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.559 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.3 m-90 -100.24 139.68 35.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.146 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.23 131.94 54.59 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 0.0 111.624 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.74 -174.43 41.44 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.554 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.6 mtm105 -81.52 -0.78 43.54 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.77 135.66 40.02 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.666 0.269 . . . . 0.0 111.273 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.52 -7.53 20.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.728 2.285 . . . . 0.0 111.876 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.42 15.63 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.977 0.894 . . . . 0.0 108.936 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.73 137.33 5.46 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.646 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.45 -18.81 12.52 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.853 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.3 t80 -129.86 117.25 19.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.887 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.496 179.624 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 84' ' ' LEU . 31.5 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.951 0.405 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -43.17 73.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.343 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -44.15 97.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.654 ' CD1' HD12 ' A' ' 81' ' ' ILE . 46.5 mt -72.77 152.18 41.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.188 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.5 p -95.49 165.5 12.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.741 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.39 -53.01 5.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.344 0.593 . . . . 0.0 109.627 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.6 ' HB3' HG22 ' A' ' 67' ' ' THR . 17.1 mttt -119.69 84.57 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -63.99 -45.27 89.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.095 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.6 p90 -150.99 162.39 40.92 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.155 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.691 ' CD ' HG23 ' A' ' 67' ' ' THR . 11.6 mt-30 -135.49 158.27 44.8 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.378 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.53 ' O ' HG13 ' A' ' 65' ' ' VAL . 64.2 mt -127.45 132.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.957 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.776 ' CD1' HD13 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -113.72 144.46 42.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.731 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.605 HD13 ' C ' ' A' ' 93' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.521 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.073 HD11 HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.95 0.405 . . . . 0.0 111.047 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.776 HD13 ' CD1' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.55 149.44 50.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.506 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.872 HD21 HD12 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -110.52 131.59 54.92 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' HD22 ' A' ' 92' ' ' LEU . 46.9 t30 -113.28 115.92 28.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.849 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.1 p30 -76.65 143.06 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 87' ' ' LYS . 10.0 pt -150.75 37.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.06 158.82 15.25 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.047 0.451 . . . . 0.0 111.807 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.9 m -68.92 -35.31 76.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.587 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -20.04 17.3 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.538 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.33 163.36 11.96 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.488 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 20.8 m -117.53 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.842 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -114.36 148.4 37.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.17 113.43 18.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.281 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 43.72 43.4 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.48 -12.43 66.84 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.482 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -104.96 118.53 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.067 0.461 . . . . 0.0 110.642 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.19 134.9 45.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.501 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.849 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -105.01 164.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.4 tp10 -69.95 125.07 25.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.6 tttt -51.82 160.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.6 p-10 35.89 33.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.54 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.57 145.09 40.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 179.227 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -86.81 129.79 34.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.789 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.6 mm-40 -127.53 147.74 50.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.409 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.58 120.95 18.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.539 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.073 HD22 HD11 ' A' ' 99' ' ' LEU . 5.9 tp -58.89 155.94 12.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.486 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.573 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.3 t -124.25 153.43 41.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.342 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 2.0 tp-100 -71.41 123.99 23.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.28 22.17 42.99 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.276 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.7 t70 -58.14 174.56 0.27 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -145.2 135.46 24.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.146 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.437 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.0 mt -111.59 128.39 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.261 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.663 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.08 138.85 40.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.543 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 30.3 m -140.15 158.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.89 22.37 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.85 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.579 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.32 140.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 121.598 0.713 . . . . 0.0 112.442 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.37 -39.87 0.7 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 138' ' ' SER . 52.0 t -126.59 128.62 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.48 -34.68 25.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 136' ' ' VAL . 87.4 p -93.54 6.3 48.69 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 7.5 t0 -124.18 24.85 8.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.663 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.9 mt -104.78 139.61 25.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.823 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.777 HD13 ' OE1' ' A' ' 42' ' ' GLN . 25.3 tp -117.54 134.75 54.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.956 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.663 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.8 OUTLIER -111.54 135.47 52.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.547 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.643 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.9 mm? -131.04 138.48 49.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 39' ' ' THR . 21.4 t -110.84 138.7 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.339 . . . . 0.0 110.927 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 124' ' ' LEU . 6.6 mt -106.26 139.01 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -119.9 119.88 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.762 HG12 HD21 ' A' ' 124' ' ' LEU . 3.4 mt -85.62 134.17 27.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.553 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.55 107.48 13.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -58.21 -32.18 68.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -60.25 -45.92 91.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 . . . . . 0 N--CA 1.452 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.074 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.797 0.332 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -42.62 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.65 -38.08 74.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -31.81 70.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.19 -35.54 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.49 -39.96 77.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -67.1 -23.87 65.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.4 mm . . . . . 0 N--CA 1.429 -1.511 0 CA-C-O 121.566 0.698 . . . . 0.0 112.575 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.006 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -93.53 -59.46 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.643 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.68 ' SG ' HD13 ' A' ' 99' ' ' LEU . 4.7 m -152.81 150.48 29.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.383 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -115.18 131.71 56.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.777 0.322 . . . . 0.0 111.248 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.746 HG21 ' HE2' ' A' ' 68' ' ' PHE . 43.8 t -96.18 122.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.053 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.839 HG23 HG12 ' A' ' 45' ' ' ILE . 16.5 mt -124.01 121.38 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.5 t -82.04 121.65 26.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.459 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.58 -25.1 16.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.501 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.599 HG21 ' OG ' ' A' ' 142' ' ' SER . 5.9 p -80.04 -2.38 44.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.663 0.268 . . . . 0.0 111.386 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.09 78.98 0.21 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.851 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 15.5 mt-30 -149.38 -40.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 9.2 mt -124.2 141.68 37.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.97 146.13 41.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.193 1.928 . . . . 0.0 112.12 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.839 HG12 HG23 ' A' ' 37' ' ' ILE . 33.8 mt -60.3 146.32 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.647 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 1.5 ttt180 -140.31 163.23 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.07 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.29 119.8 36.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 111.843 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.619 HD11 HG23 ' A' ' 36' ' ' VAL . 4.6 mt -93.25 137.42 32.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.273 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.006 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.39 157.32 43.76 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.854 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 49' ' ' SER . 8.6 ttpt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.887 0.375 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.749 HG22 ' HG2' ' A' ' 90' ' ' GLN . 13.9 p -110.44 140.23 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.568 ' HH2' HG21 ' A' ' 33' ' ' VAL . 13.5 m-90 -100.22 139.22 36.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.852 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.85 128.74 56.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.746 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -116.61 145.63 43.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.353 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.37 -170.0 39.38 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.788 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.9 mtp-105 -81.22 1.17 33.38 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 140.32 37.92 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.661 0.267 . . . . 0.0 110.903 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.27 -11.69 22.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.511 2.141 . . . . 0.0 111.354 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.7 18.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.12 138.31 3.01 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.317 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.36 -18.53 11.21 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.874 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.498 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 3.7 t80 -129.54 127.97 41.82 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.713 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.751 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.858 HD12 HD11 ' A' ' 84' ' ' LEU . 41.1 mt . . . . . 0 N--CA 1.458 -0.027 0 CA-C-O 120.799 0.333 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.55 -35.63 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.279 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.48 HH11 HG23 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -61.03 -45.65 93.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.834 0.349 . . . . 0.0 110.699 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.858 HD11 HD12 ' A' ' 81' ' ' ILE . 16.1 mt -75.32 148.29 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -93.7 167.13 11.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.54 -53.62 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.393 0.616 . . . . 0.0 109.834 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.38 82.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.4 t60 -58.8 -46.26 88.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.772 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.7 p90 -144.7 162.19 37.32 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.099 -0.641 . . . . 0.0 112.121 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 65' ' ' VAL . 2.8 tt0 -135.59 146.79 48.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.09 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 65' ' ' VAL . 64.8 mt -123.14 130.42 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.506 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.442 HD12 ' CB ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -124.99 141.03 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.222 0.534 . . . . 0.0 112.188 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.406 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.778 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.868 HD11 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.887 0.375 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.8 mp -121.4 142.46 49.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.31 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.561 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -112.71 124.13 51.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.478 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.2 t30 -116.05 115.51 26.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.493 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.5 p30 -79.16 137.7 37.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.0 pt -146.61 40.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.85 160.18 14.51 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.971 0.415 . . . . 0.0 111.681 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.3 m -68.94 -36.44 77.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.46 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.94 17.26 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.52 163.94 12.29 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.581 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.51 137.89 52.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.828 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.94 148.46 36.8 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.11 113.43 18.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.039 177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 45.09 42.39 6.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.265 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.78 -7.98 79.29 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.499 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.05 118.47 36.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.174 0.487 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.828 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.14 129.76 38.77 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.297 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -101.8 166.71 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.272 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.8 tp10 -70.02 126.17 28.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.3 tttt -52.78 162.65 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.227 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.91 36.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.066 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.0 p -111.84 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.547 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.503 ' HB3' HD23 ' A' ' 100' ' ' LEU . 60.9 m-20 -91.93 129.51 37.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.888 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.02 149.84 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.5 tm? -72.91 123.46 23.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.456 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.641 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.6 tt -57.67 155.72 9.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 152.92 42.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.459 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.618 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.1 mm-40 -71.85 125.52 27.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.05 22.88 44.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.193 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -56.34 173.4 0.17 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.93 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -145.02 135.46 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.073 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 145' ' ' ILE . 4.0 mt -114.16 127.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-O 120.893 0.377 . . . . 0.0 110.377 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.703 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.45 136.53 43.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.825 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.554 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.4 m -140.3 158.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 24.57 41.65 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.28 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.2 t -63.25 140.4 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.72 0.771 . . . . 0.0 112.462 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.67 -44.17 0.54 Allowed Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.353 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.48 HG23 HH11 ' A' ' 83' ' ' ARG . 45.5 t -126.37 137.87 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -50.75 -38.13 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.59 6.31 48.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 74.0 m-20 -117.25 22.97 12.14 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.703 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.11 139.63 28.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.175 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.546 ' CD2' HD13 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -119.53 134.49 55.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.674 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.599 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.29 131.6 56.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.584 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.546 HD13 ' CD2' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -127.01 142.79 51.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.892 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.93 HG22 ' CG ' ' A' ' 129' ' ' GLU . 11.3 t -111.0 140.32 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 130' ' ' ILE . 38.5 mt -105.85 120.88 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.069 0.461 . . . . 0.0 111.001 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.98 122.68 45.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.682 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -98.51 121.28 48.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.982 0.42 . . . . 0.0 111.376 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.461 ' ND2' ' HB2' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -82.92 135.79 34.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.997 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.1 -20.2 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.183 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -57.47 -43.74 84.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.623 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.461 ' HB2' ' ND2' ' A' ' 148' ' ' ASN . 31.7 t80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.678 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.792 0.329 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -60.0 -40.35 88.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -36.02 82.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -41.39 93.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -69.23 -35.08 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.26 -36.81 71.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.24 -23.78 65.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.738 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.71 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm . . . . . 0 N--CA 1.43 -1.475 0 CA-C-O 121.626 0.727 . . . . 0.0 112.336 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.981 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -92.3 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.667 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.8 p -145.12 157.4 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.904 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.869 0.366 . . . . 0.0 111.472 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.7 HG11 ' CE2' ' A' ' 68' ' ' PHE . 30.7 m -104.18 122.64 57.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.627 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.841 HG23 HG12 ' A' ' 45' ' ' ILE . 19.5 mt -129.49 118.34 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.548 ' SG ' HD21 ' A' ' 141' ' ' LEU . 24.6 t -81.81 119.57 24.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.281 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.41 -25.59 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.893 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' H ' ' A' ' 142' ' ' SER . 30.8 p -79.99 -2.21 43.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.559 0.218 . . . . 0.0 111.508 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.15 73.25 0.64 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.825 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' CB ' HD11 ' A' ' 141' ' ' LEU . 3.3 mt-30 -141.58 -47.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.76 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.72 HD13 HD21 ' A' ' 143' ' ' LEU . 3.1 mp -114.0 140.68 25.16 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.85 139.91 31.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.182 1.921 . . . . 0.0 112.24 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.841 HG12 HG23 ' A' ' 37' ' ' ILE . 37.2 mt -54.2 139.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.555 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -129.33 164.1 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.492 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -119.36 119.87 35.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.112 0.482 . . . . 0.0 111.372 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.8 mt -97.9 128.89 44.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.981 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.84 158.32 43.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.4 ttpt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.765 0.317 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.665 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -132.16 139.36 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.376 0.607 . . . . 0.0 112.255 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.8 m-90 -101.68 139.26 37.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.935 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.66 128.68 56.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.859 0.361 . . . . 0.0 110.027 177.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -120.49 145.23 47.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.61 -166.72 34.98 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.47 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 4.9 mtp85 -79.01 2.05 21.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.609 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.71 130.83 51.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 0.0 111.197 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.67 -15.91 51.26 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.515 2.144 . . . . 0.0 111.495 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.77 -41.61 18.96 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -42.76 139.11 1.73 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.537 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.25 -18.63 11.04 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.109 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.546 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -129.82 125.09 34.89 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 179.461 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.769 HD12 ' CD1' ' A' ' 84' ' ' LEU . 30.7 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.883 0.373 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -42.58 71.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HB3' ' HA2' ' A' ' 133' ' ' GLY . 3.8 mtp85 -60.85 -18.69 57.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.332 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.769 ' CD1' HD12 ' A' ' 81' ' ' ILE . 29.7 mt -103.3 151.19 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.62 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.1 p -97.8 163.99 12.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.728 0.299 . . . . 0.0 111.667 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.576 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.22 -52.93 5.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.401 0.62 . . . . 0.0 109.912 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.66 ' CB ' HD12 ' A' ' 104' ' ' ILE . 12.9 mttm -117.67 80.73 1.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.637 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 62.2 t-80 -60.34 -45.53 93.13 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.652 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 35.0 p90 -147.11 159.5 43.53 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.237 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.7 tt0 -136.14 142.88 44.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.114 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.595 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.7 mt -117.64 129.25 74.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.662 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.6 pt? -115.95 148.04 40.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.113 0.482 . . . . 0.0 111.855 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.73 HD22 HG11 ' A' ' 33' ' ' VAL . 26.2 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.058 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.542 HD11 ' CG1' ' A' ' 33' ' ' VAL . 4.2 mm? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.791 0.329 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.4 mp -128.26 143.29 51.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.313 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.434 HD12 HG12 ' A' ' 91' ' ' ILE . 2.0 tp -112.79 121.6 45.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.522 ' HB2' HD22 ' A' ' 92' ' ' LEU . 56.5 t30 -115.38 115.72 27.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.543 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -79.77 137.97 37.14 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.66 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.3 pt -139.42 29.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.563 0.22 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 12.9 t -90.32 160.2 16.25 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.253 0.549 . . . . 0.0 112.369 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.5 m -69.54 -52.47 26.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.598 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -19.23 27.69 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.93 157.76 9.38 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.606 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -116.94 137.73 52.02 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.372 0.669 . . . . 0.0 109.252 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.904 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -112.27 149.15 32.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.733 HD23 ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -124.24 113.5 18.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.319 176.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 44.54 43.39 6.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.649 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.29 -13.49 63.45 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.725 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.07 118.6 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.106 0.453 . . . . 0.0 110.639 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.904 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.9 tptm -73.28 125.1 27.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.307 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -98.67 163.4 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.032 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.3 tt0 -69.96 128.87 37.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.549 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 1.8 tttt -54.08 156.84 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.092 0.473 . . . . 0.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.613 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.5 p-10 37.46 34.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.065 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.9 144.89 40.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.865 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.402 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.0 m120 -88.59 129.0 35.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -129.25 147.79 51.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.299 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.1 tp -72.77 119.02 16.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.361 . . . . 0.0 110.192 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.942 HD11 HG21 ' A' ' 145' ' ' ILE . 66.7 tp -53.6 157.24 2.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.346 0.593 . . . . 0.0 111.643 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.416 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.47 153.28 42.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.422 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.406 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 7.9 tp60 -71.57 122.71 20.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.192 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.95 19.29 56.25 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.152 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.3 t70 -52.15 171.79 0.05 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.767 0.318 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.853 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.1 mt-10 -145.24 135.51 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.063 HD11 HD11 ' A' ' 145' ' ' ILE . 1.5 mt -110.91 126.48 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.009 0.433 . . . . 0.0 110.476 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.625 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.28 140.78 37.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.637 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.58 158.36 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 81.84 35.57 21.5 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.164 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.9 t -74.33 140.24 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.612 0.72 . . . . 0.0 112.24 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -40.91 0.83 Allowed Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.247 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 46.9 t -126.52 127.91 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.282 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -50.49 -31.49 15.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.217 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 66.8 m -93.67 6.16 49.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -124.35 21.65 8.65 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.625 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.5 mt -103.63 139.0 25.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 142' ' ' SER . 5.0 tt -124.53 134.43 53.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 141' ' ' LEU . 46.9 t -109.57 150.18 28.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.664 0.745 . . . . 0.0 112.359 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 43' ' ' ILE . 77.7 mt -135.84 153.01 51.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.484 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.853 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -121.53 139.18 49.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.294 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.063 HD11 HD11 ' A' ' 130' ' ' ILE . 33.9 mt -106.47 128.53 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.977 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.7 114.11 25.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.621 HG12 HD21 ' A' ' 124' ' ' LEU . 4.1 mt -84.76 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.3 113.38 17.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -37.38 83.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -60.09 -46.02 90.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.966 0.412 . . . . 0.0 110.855 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.6 t80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.107 -179.896 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.726 0.298 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -47.51 67.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.818 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -35.83 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -31.77 72.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.773 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -71.86 -35.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.71 -46.17 84.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.441 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.25 -23.76 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.393 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.427 -1.591 0 CA-C-O 121.469 0.652 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.983 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.46 -60.23 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.998 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' HD22 ' A' ' 48' ' ' LEU . 11.5 p -146.53 162.11 39.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.434 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -131.68 128.47 39.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.281 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.695 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.7 t -97.8 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.925 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.842 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -120.9 115.5 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -82.21 99.81 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 110.343 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -80.25 -19.89 45.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.739 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.657 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.8 p -80.04 -2.59 44.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.574 0.226 . . . . 0.0 111.378 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.79 75.48 0.57 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.964 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -147.84 -41.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.068 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.0 mt -127.43 141.29 40.45 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.8 Cg_endo -72.52 145.38 42.18 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.012 1.808 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.842 HG12 HG23 ' A' ' 37' ' ' ILE . 41.7 mt -54.36 142.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.225 0.536 . . . . 0.0 111.908 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 33.8 mtt-85 -140.84 164.28 30.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.79 120.43 26.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.802 HD23 ' CD2' ' A' ' 66' ' ' TRP . 9.3 mp -86.38 137.08 32.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.188 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.983 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.61 156.01 45.03 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.427 1.108 . . . . 0.0 113.664 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.65 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.761 0.315 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.625 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.3 t -128.64 139.31 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.256 0.551 . . . . 0.0 111.959 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.802 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.6 m-90 -105.82 139.07 40.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.538 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.03 128.09 55.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.179 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -111.65 145.93 38.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.926 -178.08 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.08 -175.98 41.51 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -79.57 -2.52 42.79 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.85 134.63 41.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.644 0.259 . . . . 0.0 111.01 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.34 -7.09 19.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.658 2.238 . . . . 0.0 111.708 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.7 16.55 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.956 0.884 . . . . 0.0 108.932 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.08 137.69 4.17 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.477 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -56.43 -18.89 12.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.834 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.7 t80 -129.89 120.34 24.74 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.723 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.8 mm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.09 -44.07 74.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH1' ' HA3' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -61.58 -24.19 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.452 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.537 HD22 ' CE1' ' A' ' 88' ' ' HIS . 57.5 mt -93.24 152.26 19.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.8 0.333 . . . . 0.0 111.181 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.43 167.11 11.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.794 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.736 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.86 -53.9 5.7 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -117.65 82.97 1.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.2 t60 -60.44 -47.4 86.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.483 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.62 159.85 42.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.62 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.625 ' HG2' HG12 ' A' ' 65' ' ' VAL . 29.1 tt0 -135.78 139.59 43.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.723 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 57.6 mt -114.72 131.38 67.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.096 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.504 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.53 147.87 42.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.096 0.474 . . . . 0.0 111.758 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.757 HD22 ' CG1' ' A' ' 33' ' ' VAL . 20.2 tp . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.912 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.739 0.304 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.4 mp -132.46 143.46 49.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.415 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.537 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.81 126.04 55.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.4 t30 -119.02 115.54 24.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 111.564 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.817 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -78.27 141.21 38.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.665 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 67' ' ' THR . 13.8 pt -149.08 37.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.65 153.69 18.05 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.9 m -68.87 -31.7 70.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.005 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.4 -20.02 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.36 157.53 10.56 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.738 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.8 m -117.53 137.83 52.31 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.111 0.564 . . . . 0.0 109.573 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.67 148.49 38.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.473 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.04 113.41 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.392 177.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 90.8 m-20 44.3 42.86 5.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.08 76.02 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.51 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.64 118.68 37.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.9 tptp -73.27 121.71 20.8 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.203 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.817 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.3 m -93.69 165.52 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.267 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 26.1 mt-10 -69.8 126.33 29.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.6 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.9 tttm -54.55 162.76 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.655 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.26 34.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.015 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.04 40.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.136 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.66 ' HB3' HD23 ' A' ' 100' ' ' LEU . 68.6 m-20 -91.69 130.75 37.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.889 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.2 mm-40 -129.26 150.07 50.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.651 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.67 115.41 11.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.561 HD21 HG12 ' A' ' 147' ' ' ILE . 66.1 tp -52.74 157.18 1.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.413 0.625 . . . . 0.0 111.571 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.39 153.0 42.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.524 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.419 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -71.8 124.26 24.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.93 20.57 53.66 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.136 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.1 t0 -55.06 172.83 0.11 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.0 111.07 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.5 tt0 -145.04 135.4 24.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.204 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.472 ' CG2' HG22 ' A' ' 109' ' ' THR . 17.1 mt -114.76 127.95 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.42 139.27 39.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.991 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.489 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.25 158.27 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.01 27.69 33.34 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.106 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.544 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.5 t -67.33 140.24 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.582 0.706 . . . . 0.0 112.332 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.409 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 151.61 -41.75 0.73 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.283 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 138' ' ' SER . 45.0 t -126.39 133.28 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.61 -35.82 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.796 0.331 . . . . 0.0 111.485 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.1 m -93.59 6.3 48.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -119.89 21.88 11.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.4 mt -104.88 139.59 25.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.155 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 142' ' ' SER . 7.0 tt -121.81 134.36 54.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.606 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.662 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -111.5 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.111 0.482 . . . . 0.0 111.801 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.53 HD22 HG12 ' A' ' 36' ' ' VAL . 20.5 mt -124.12 138.41 54.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.504 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.4 t -110.71 136.61 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.401 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 124' ' ' LEU . 8.2 mt -106.28 130.56 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.58 118.15 31.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.705 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.561 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.93 134.11 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.684 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.96 117.55 23.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.721 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.28 -29.89 65.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -60.29 -46.01 91.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.6 t80 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.151 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.767 0.318 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -61.1 -36.15 78.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.34 -39.88 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.3 tp -58.9 -31.96 69.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.01 -35.52 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.5 -38.44 74.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.25 -23.86 65.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.428 -1.534 0 CA-C-O 121.463 0.649 . . . . 0.0 112.398 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -93.7 -60.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.191 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.581 ' SG ' HD22 ' A' ' 99' ' ' LEU . 1.2 m -147.01 156.42 43.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.754 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 138.15 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.095 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.725 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.8 m -108.27 122.62 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.795 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.837 HG23 HG12 ' A' ' 45' ' ' ILE . 18.8 mt -128.27 122.63 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.542 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD23 ' A' ' 143' ' ' LEU . 54.1 t -80.27 109.98 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 0.0 110.248 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.464 HG23 HG21 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -75.71 -26.26 57.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.924 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 142' ' ' SER . 47.3 p -79.82 -2.23 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.54 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 77.65 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.863 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -147.09 -43.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.915 0.388 . . . . 0.0 110.865 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.8 mt -115.16 141.43 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.783 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.9 Cg_endo -71.12 145.96 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.138 1.892 . . . . 0.0 112.248 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.837 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -56.94 141.57 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.38 164.07 28.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.991 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.63 119.91 26.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.423 . . . . 0.0 111.973 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.0 mp -89.64 129.35 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.347 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -134.34 157.04 47.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.998 0.904 . . . . 0.0 113.341 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.024 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.291 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 49' ' ' SER . 33.6 ttpt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.713 0.292 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.611 HG12 ' HG2' ' A' ' 90' ' ' GLN . 3.6 t -121.14 138.84 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 111.664 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.766 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.0 m-90 -102.96 139.3 38.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.244 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.684 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.75 127.21 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -111.32 145.63 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.397 -178.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.84 -174.59 40.02 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -78.59 -2.22 37.9 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.86 135.05 40.47 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.9 Cg_exo -69.05 -7.86 22.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.779 2.32 . . . . 0.0 111.827 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.79 -43.77 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.949 0.88 . . . . 0.0 108.669 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.0 137.96 2.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -18.94 12.1 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.119 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.587 ' CE2' HG21 ' A' ' 43' ' ' ILE . 60.0 t80 -129.9 128.15 41.6 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 84' ' ' LEU . 36.0 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.694 0.283 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 p -54.86 -35.18 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -63.89 -45.94 87.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.054 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 81' ' ' ILE . 49.1 mt -72.8 152.09 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.125 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p -95.17 168.27 10.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -44.63 -53.6 7.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.373 0.606 . . . . 0.0 109.636 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HB2' HD12 ' A' ' 104' ' ' ILE . 33.8 mttm -119.43 83.1 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -60.49 -46.24 90.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.691 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.8 p90 -146.21 161.2 40.76 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.814 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.684 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -135.78 142.34 44.9 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 65' ' ' VAL . 27.1 mt -115.87 132.37 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.185 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.957 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.09 145.21 34.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.024 0.44 . . . . 0.0 111.807 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.624 ' HG ' HG11 ' A' ' 33' ' ' VAL . 2.6 tm? . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.409 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.604 ' HB3' HD13 ' A' ' 124' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.823 0.344 . . . . 0.0 110.956 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.722 HD13 ' OD1' ' A' ' 121' ' ' ASN . 11.3 mt -132.97 146.95 52.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.59 HD23 HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -117.57 124.48 48.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.9 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.957 ' HB2' HD11 ' A' ' 92' ' ' LEU . 47.9 t30 -114.38 115.5 27.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 111.531 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.782 ' OD2' HG23 ' A' ' 116' ' ' VAL . 17.6 p30 -79.47 138.63 37.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.2 pt -147.15 39.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -97.4 159.33 14.98 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.039 0.447 . . . . 0.0 111.497 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.88 -35.56 77.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.299 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -19.86 17.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 164.22 12.64 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.442 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.3 m -117.48 137.7 52.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.882 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.12 148.28 35.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.41 18.28 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.298 177.466 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.7 m120 44.11 42.93 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.41 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.6 -11.46 68.32 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.583 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -103.98 118.35 36.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.045 0.422 . . . . 0.0 110.777 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.882 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -74.0 127.89 34.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.782 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.3 m -98.11 165.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.19 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 mm-40 -69.83 126.57 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.707 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.9 tttt -53.65 162.66 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.61 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.063 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.13 40.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.377 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.722 ' OD1' HD13 ' A' ' 100' ' ' LEU . 8.9 m-80 -91.64 125.92 36.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.601 ' O ' HD23 ' A' ' 100' ' ' LEU . 43.1 mm-40 -127.44 147.54 50.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.429 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.8 tp -72.63 117.11 13.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.17 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.756 ' CD2' HG21 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -55.73 166.98 0.61 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.782 0.801 . . . . 0.0 111.952 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.37 153.28 43.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.398 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.558 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.26 118.18 13.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.67 24.01 69.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.8 t70 -55.83 175.21 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.8 tt0 -145.06 135.54 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 145' ' ' ILE . 17.9 mt -115.34 126.66 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.55 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.659 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.51 138.34 41.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.524 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 27.4 m -140.39 158.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.42 28.98 28.61 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.159 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.5 t -68.56 140.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.535 0.684 . . . . 0.0 112.409 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.08 -43.45 0.6 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.261 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 138' ' ' SER . 45.8 t -126.43 136.36 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -50.7 -37.7 42.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.469 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.64 6.39 48.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.93 21.15 13.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.659 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -106.58 139.17 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.239 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 142' ' ' SER . 7.6 tt -124.38 134.37 53.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.229 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.527 ' H ' HG21 ' A' ' 40' ' ' THR . 47.2 t -109.83 150.23 28.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.7 0.762 . . . . 0.0 112.589 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' CYS . 72.8 mt -135.88 151.15 49.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.725 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 HG23 ' A' ' 39' ' ' THR . 36.7 t -122.03 135.88 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 130' ' ' ILE . 46.2 mt -106.12 125.66 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.77 114.73 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.1 mt -84.92 130.12 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.33 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -83.63 119.05 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -27.54 69.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.04 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -42.53 81.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 110.613 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.5 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -71.01 -42.84 69.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -36.89 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.43 -31.93 70.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.86 -35.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.4 -41.11 79.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.502 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -67.19 -23.87 65.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.64 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.224 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 121.532 0.682 . . . . 0.0 112.653 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.8 -60.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.735 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.4 p -147.82 153.62 39.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.095 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.77 138.13 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.541 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 36' ' ' VAL . 11.7 p -103.04 122.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.591 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -130.41 119.24 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.729 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.625 ' HA ' HD23 ' A' ' 143' ' ' LEU . 44.4 t -79.86 118.31 21.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.233 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.76 -25.12 28.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.979 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.526 HG21 ' H ' ' A' ' 142' ' ' SER . 52.5 p -79.82 -2.11 41.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.02 76.55 0.28 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.718 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -146.51 -44.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.08 141.45 27.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.792 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.6 Cg_endo -73.2 141.49 32.49 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 0.0 112.265 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 37' ' ' ILE . 38.3 mt -56.98 143.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.14 164.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.38 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 119.85 35.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.189 0.518 . . . . 0.0 111.69 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.694 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.6 mt -98.64 134.54 41.42 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.96 158.95 43.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -178.632 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.883 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.878 0.371 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.8 t -125.49 137.58 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.694 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.9 m-90 -101.98 139.27 37.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.184 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.679 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.38 130.51 56.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -119.18 145.3 46.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.274 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.28 -170.74 36.38 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -78.86 3.72 16.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.617 HD21 ' HB3' ' A' ' 73' ' ' ALA . 30.5 t30 -84.66 132.03 47.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.574 0.226 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.3 Cg_exo -66.69 -13.74 41.1 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.476 2.117 . . . . 0.0 111.761 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 71' ' ' ASN . . . -82.68 -42.72 17.76 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.949 0.88 . . . . 0.0 108.937 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.5 139.51 1.09 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.015 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 m-20 -56.49 -18.75 12.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.015 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 16.7 t80 -129.55 123.01 30.35 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.117 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 179.755 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.863 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.0 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.803 0.335 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.2 p -56.49 -37.47 70.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.567 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.57 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.66 -22.1 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.19 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.863 HD23 ' HB ' ' A' ' 81' ' ' ILE . 2.1 mm? -107.54 152.64 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.905 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -96.93 163.77 12.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.45 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.622 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.84 -52.9 4.88 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.497 0.665 . . . . 0.0 109.663 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.1 mttm -120.84 82.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -61.4 -45.93 92.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.672 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.6 p90 -143.86 159.06 43.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.795 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.679 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.09 140.56 43.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.316 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.564 ' O ' HG13 ' A' ' 65' ' ' VAL . 58.1 mt -114.0 132.28 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.791 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.0 pt? -120.59 133.59 55.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.03 0.443 . . . . 0.0 111.967 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.676 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.6 tm? . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.064 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.676 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.679 0.276 . . . . 0.0 110.76 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.573 ' H ' HD23 ' A' ' 99' ' ' LEU . 3.2 mp -125.85 143.29 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.484 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 101' ' ' LEU . 2.4 mm? -112.8 122.82 48.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.897 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.627 ' HB2' HD22 ' A' ' 92' ' ' LEU . 49.9 t30 -115.28 115.47 26.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.654 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.83 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -78.17 138.43 38.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.9 pt -145.12 40.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.611 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.69 156.45 16.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 111.362 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.79 -36.52 78.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.361 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.75 -19.7 17.32 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.14 159.18 10.44 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.005 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -117.55 137.93 52.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.991 -0.604 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.891 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.74 148.72 34.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.45 18.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.455 177.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 42.8 44.0 3.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.75 62.41 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -103.34 118.52 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.614 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.891 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.4 tptp -72.92 128.16 34.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.425 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.83 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.9 m -98.79 163.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.193 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 tp10 -69.92 126.89 31.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.536 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -53.16 160.74 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.81 35.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.311 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.13 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.136 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.502 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.1 m120 -85.13 127.92 34.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.93 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.29 146.93 51.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.532 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tp -72.77 134.2 44.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.287 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.883 HD11 HG21 ' A' ' 145' ' ' ILE . 65.2 tp -69.33 155.88 39.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.458 0.647 . . . . 0.0 111.485 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.452 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.58 153.02 42.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.256 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 121.3 18.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.886 0.374 . . . . 0.0 110.287 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.44 58.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.131 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.0 t70 -54.43 173.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.739 0.304 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.2 mt-10 -145.07 135.72 24.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.318 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.46 ' CG2' HG22 ' A' ' 109' ' ' THR . 12.9 mt -114.41 127.16 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.61 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.566 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.42 140.06 38.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.884 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.74 HG23 HD11 ' A' ' 84' ' ' LEU . 35.5 m -140.4 158.33 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 0.0 112.346 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.91 36.03 16.85 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.079 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.577 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.8 t -75.14 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.641 0.734 . . . . 0.0 112.505 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.21 -42.89 0.57 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.62 129.11 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 -31.18 14.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.795 0.331 . . . . 0.0 111.183 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.598 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 m -93.53 6.42 48.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -125.69 23.2 7.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.9 mt -105.35 139.33 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.011 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -124.23 134.43 53.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.577 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.526 ' H ' HG21 ' A' ' 40' ' ' THR . 48.3 t -109.4 150.57 27.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 112.25 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.0 mt -135.53 156.0 49.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.5 t -124.57 136.84 59.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.032 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.883 HG21 HD11 ' A' ' 124' ' ' LEU . 2.3 mm -106.33 126.37 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.923 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 37' ' ' ILE . 1.5 m-85 -112.53 116.33 30.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.738 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.749 HG12 HD21 ' A' ' 124' ' ' LEU . 3.7 mt -84.8 134.26 27.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.542 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -75.97 118.48 18.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.588 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -37.49 78.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -60.6 -45.73 92.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 33' ' ' VAL . 19.5 t80 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.187 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -46.06 88.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -57.04 -36.14 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -31.86 71.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.46 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.15 -35.53 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.86 -37.91 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.352 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.2 -23.64 65.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.996 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.568 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.6 mm . . . . . 0 N--CA 1.425 -1.69 0 CA-C-O 121.782 0.801 . . . . 0.0 112.361 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.757 HG22 HD13 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -105.78 -51.35 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.05 -178.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.454 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -155.17 165.37 36.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.635 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 138.0 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 16.4 t -106.23 122.84 60.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.211 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 mt -127.28 115.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.342 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.547 ' HA ' HD13 ' A' ' 143' ' ' LEU . 53.3 t -80.81 123.39 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -88.3 -26.88 22.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.639 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 142' ' ' SER . 53.2 p -79.95 -2.3 43.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.632 0.253 . . . . 0.0 111.559 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.59 76.29 0.29 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.007 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -147.18 -44.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.961 HD12 HD11 ' A' ' 143' ' ' LEU . 1.5 mt -108.78 140.46 21.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.36 146.03 34.93 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.203 1.936 . . . . 0.0 112.257 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.5 mt -59.98 130.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.629 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 164.21 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.194 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.89 119.47 34.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.972 0.415 . . . . 0.0 111.779 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.3 mp -86.09 133.54 33.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.581 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -139.9 156.49 46.66 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.38 1.086 . . . . 0.0 113.694 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.051 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.805 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.801 0.334 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.572 HG22 ' CB ' ' A' ' 92' ' ' LEU . 16.9 t -132.75 139.19 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.289 0.566 . . . . 0.0 111.858 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.581 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.9 m-90 -100.9 140.29 35.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.374 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.816 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -109.15 124.74 51.3 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.721 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.9 m-85 -112.46 145.68 39.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.045 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.76 -169.61 38.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.933 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.7 mtp180 -84.87 10.18 12.32 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.845 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 53.2 t30 -93.86 134.82 25.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.547 0.213 . . . . 0.0 111.135 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.3 Cg_exo -67.21 -11.01 30.62 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.516 2.144 . . . . 0.0 111.651 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.845 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . . . -83.04 -42.7 17.17 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.874 0.845 . . . . 0.0 109.004 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.6 137.8 2.06 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.831 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.46 -18.59 11.86 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.927 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CE2' HG21 ' A' ' 43' ' ' ILE . 7.7 t80 -129.35 120.38 25.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.964 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.615 179.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.7 mm . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.848 0.356 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -31.77 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.542 ' H ' HG22 ' A' ' 81' ' ' ILE . 15.6 mtt-85 -73.98 -21.49 59.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 HD21 HG23 ' A' ' 132' ' ' VAL . 21.1 mt -99.13 152.33 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 111.007 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.67 165.27 12.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.668 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.91 -53.26 4.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 109.839 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.672 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.43 82.5 1.86 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.309 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.8 t60 -61.81 -45.0 95.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.919 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 22.1 p90 -146.74 164.15 33.69 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.298 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.816 ' CG ' HG23 ' A' ' 67' ' ' THR . 7.6 mt-30 -135.7 140.78 44.7 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.39 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 65' ' ' VAL . 2.7 mp -116.37 132.47 65.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.356 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.7 147.44 42.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 111.696 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.757 HD13 HG22 ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.437 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 93' ' ' LEU . 4.2 mm? . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.756 0.312 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.886 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -133.25 143.14 48.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.213 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.875 HD11 HD12 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -112.81 129.1 56.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.491 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB2' HD22 ' A' ' 92' ' ' LEU . 47.1 t30 -119.76 115.54 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.766 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -79.68 141.71 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.2 pt -148.3 39.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.655 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.68 151.06 21.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.058 0.456 . . . . 0.0 111.869 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.7 m -68.78 -31.7 70.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.901 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.42 -19.69 17.56 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.1 155.66 9.87 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.632 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.48 137.73 52.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.2 148.47 39.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.43 18.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.056 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m120 44.94 43.3 7.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -7.86 77.74 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.48 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -105.63 118.48 36.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.143 0.472 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.766 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.4 m -95.94 165.47 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.405 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 3.7 tt0 -69.93 129.55 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.9 tttt -54.33 163.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.193 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.6 m-80 33.92 36.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.827 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.72 145.22 39.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.843 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.725 ' HB3' HD22 ' A' ' 100' ' ' LEU . 29.9 m120 -93.0 127.75 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.813 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.886 ' O ' HD23 ' A' ' 100' ' ' LEU . 65.3 mm-40 -128.98 151.24 49.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.43 117.38 14.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.955 0.407 . . . . 0.0 110.553 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 101' ' ' LEU . 64.5 tp -57.89 157.8 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.408 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -124.37 153.2 42.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.438 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -71.58 124.42 24.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.49 20.16 55.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.954 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.37 173.25 0.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.04 135.58 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.822 ' CD1' HD21 ' A' ' 101' ' ' LEU . 7.2 mt -113.36 128.66 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.496 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 86.7 m -103.92 138.87 39.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.106 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.589 HG23 HD21 ' A' ' 84' ' ' LEU . 33.2 m -140.16 158.15 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.71 40.59 14.55 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.814 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -79.87 140.39 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.654 0.74 . . . . 0.0 112.537 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.13 0.56 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.289 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 43.5 t -126.42 134.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.67 -39.55 51.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.745 0.307 . . . . 0.0 111.702 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.428 ' H ' HG12 ' A' ' 136' ' ' VAL . 14.3 m -93.5 6.43 48.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.444 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.4 t0 -118.06 23.05 11.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.2 mt -106.12 139.49 27.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.302 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 43' ' ' ILE . 3.1 tp -120.51 134.34 55.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.232 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.555 ' C ' HD22 ' A' ' 143' ' ' LEU . 43.8 t -113.46 150.32 32.99 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 112.672 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 43' ' ' ILE . 2.5 mm? -136.23 146.05 46.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.572 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 39' ' ' THR . 23.9 t -116.72 132.82 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 111.097 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.875 HD12 HD11 ' A' ' 101' ' ' LEU . 6.3 mt -106.25 128.33 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.84 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.97 120.63 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.0 mt -84.82 134.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.278 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.16 127.75 32.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -74.06 -32.3 63.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -45.3 91.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.0 t80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -64.02 -39.52 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.63 -35.09 78.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.22 -39.99 84.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.6 mm -71.25 -35.14 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.27 -34.17 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.401 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -67.34 -23.81 65.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.696 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm . . . . . 0 N--CA 1.428 -1.534 0 CA-C-O 121.611 0.719 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.0 -60.51 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 m -143.47 162.43 35.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.355 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 123.59 32.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.142 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.71 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -91.16 122.77 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -126.89 123.13 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.628 ' SG ' HD21 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -92.14 100.11 12.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.592 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.749 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.5 p -79.92 -2.63 44.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 111.341 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.81 73.28 0.66 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.065 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -144.9 -38.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.9 mt -127.54 141.32 40.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.846 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.76 137.97 28.14 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.112 1.874 . . . . 0.0 112.15 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -55.26 144.03 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.785 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.37 164.32 30.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.263 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.85 119.84 34.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 112.008 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.5 mt -94.67 137.43 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.25 158.09 43.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.424 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.649 0.261 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.575 HG11 HD23 ' A' ' 92' ' ' LEU . 4.4 t -120.44 138.52 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.199 0.523 . . . . 0.0 112.031 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -100.74 139.69 36.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.403 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.722 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.4 129.7 55.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.711 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -120.43 145.66 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.628 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.64 -169.56 36.39 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.73 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.7 mtm105 -82.54 5.17 21.68 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.3 t-20 -84.9 132.62 45.43 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.523 0.201 . . . . 0.0 110.773 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.39 -13.97 42.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.446 2.097 . . . . 0.0 111.685 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -44.1 16.01 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.842 0.829 . . . . 0.0 108.835 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.25 137.84 3.33 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.871 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.49 -18.6 12.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.726 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -129.54 124.29 33.51 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.771 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 84' ' ' LEU . 39.2 mt . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.905 0.383 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -54.81 -44.9 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.455 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -45.55 89.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' CD1' HD12 ' A' ' 81' ' ' ILE . 28.6 mt -72.79 152.27 41.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.695 0.283 . . . . 0.0 111.318 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -97.18 163.5 12.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.017 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.76 -51.62 5.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.442 0.639 . . . . 0.0 109.846 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB2' HD11 ' A' ' 104' ' ' ILE . 16.3 ptmt -120.32 82.24 1.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -64.78 -45.39 86.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.455 -176.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.495 ' HA ' HG12 ' A' ' 104' ' ' ILE . 47.5 p90 -150.21 163.38 38.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.234 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.722 ' CD ' HG23 ' A' ' 67' ' ' THR . 10.3 mt-30 -135.71 158.41 44.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.468 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.711 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 68.2 mt -125.8 131.15 72.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.138 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.678 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -114.12 145.57 41.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.1 0.476 . . . . 0.0 111.711 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 33' ' ' VAL . 25.2 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.192 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.439 ' CD1' HD13 ' A' ' 93' ' ' LEU . 3.1 mm? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.898 0.38 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.605 ' HB3' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -133.15 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.233 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.17 128.8 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.678 ' HB2' HD11 ' A' ' 92' ' ' LEU . 42.0 t30 -115.42 115.48 26.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.458 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.0 p30 -79.53 143.05 35.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.602 HD13 ' CG ' ' A' ' 90' ' ' GLN . 15.2 pt -150.93 37.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.32 158.31 15.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.003 0.43 . . . . 0.0 111.613 -178.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -68.87 -34.93 76.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.436 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.88 17.29 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.09 161.7 11.62 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.647 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.7 m -117.52 137.87 52.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.65 148.32 36.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.08 113.3 18.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.174 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.0 m120 44.17 43.39 5.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.285 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 -5.82 84.46 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.454 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.14 118.51 36.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.094 0.474 . . . . 0.0 110.828 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.2 tptp -74.89 120.59 20.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.363 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -95.17 163.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.4 tp10 -69.84 127.3 32.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.0 tttm -52.18 161.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.753 0.311 . . . . 0.0 110.577 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 35.48 34.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.215 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.09 40.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.901 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.41 ' HB3' ' CD2' ' A' ' 100' ' ' LEU . 1.9 m-80 -88.48 128.42 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.032 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.1 mm-40 -129.69 149.13 51.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.605 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.7 126.08 29.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.394 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.549 HD21 HG12 ' A' ' 147' ' ' ILE . 65.9 tp -64.69 158.43 24.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.301 0.572 . . . . 0.0 111.424 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.425 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -124.14 153.32 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.242 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.501 ' HA ' HD12 ' A' ' 147' ' ' ILE . 2.9 mm-40 -71.13 122.71 20.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 0.0 110.478 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.18 20.76 55.17 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.162 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.6 t70 -56.2 174.12 0.14 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.7 tt0 -145.12 135.59 24.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.104 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.829 HD11 HD11 ' A' ' 145' ' ' ILE . 12.7 mt -109.05 127.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.371 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.0 m -104.47 137.84 41.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.32 158.42 25.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.88 24.57 44.74 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.266 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.1 t -64.78 140.43 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.58 0.705 . . . . 0.0 112.237 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.36 -42.31 0.85 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.369 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.39 131.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.52 -33.08 20.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.557 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.56 6.25 48.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.7 20.2 11.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 134' ' ' VAL . 13.9 mt -102.95 139.52 23.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.07 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 142' ' ' SER . 6.4 tt -124.32 134.41 53.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.749 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -113.3 127.8 56.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.105 0.478 . . . . 0.0 111.742 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.487 HD11 HD12 ' A' ' 43' ' ' ILE . 19.2 mt -121.2 139.82 52.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.8 139.68 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.147 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.829 HD11 HD11 ' A' ' 130' ' ' ILE . 41.4 mt -106.04 130.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.65 114.0 25.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.36 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.549 HG12 HD21 ' A' ' 124' ' ' LEU . 6.6 mt -84.92 132.98 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.544 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -76.97 110.9 11.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.733 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -60.81 -39.35 88.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.995 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -46.05 92.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.3 t80 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.961 -179.878 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.746 0.308 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.88 -45.29 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -59.63 -32.39 70.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.2 -35.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -36.04 71.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -67.15 -31.11 71.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.311 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.8 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.455 0.645 . . . . 0.0 111.112 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 121.384 0.611 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.967 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -93.99 -60.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.168 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -145.09 164.53 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.485 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.678 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -126.17 126.86 44.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.769 HG21 ' HE2' ' A' ' 68' ' ' PHE . 36.5 t -93.96 122.83 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.79 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -126.8 122.56 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.512 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.27 106.64 18.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 110.372 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -77.31 -20.37 55.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.064 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' H ' ' A' ' 142' ' ' SER . 81.1 p -79.9 -2.46 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 74.25 0.48 Allowed Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.808 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -147.3 -44.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 0.0 110.805 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.78 HD12 HD21 ' A' ' 143' ' ' LEU . 4.2 mt -112.3 140.39 23.6 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.38 132.83 16.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.262 1.974 . . . . 0.0 112.036 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -53.22 135.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.57 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -130.72 164.24 25.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.524 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 6.5 m-20 -114.26 119.89 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 0.0 111.425 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.885 HD22 ' CD1' ' A' ' 66' ' ' TRP . 15.0 mt -93.85 137.08 33.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.812 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.967 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.86 157.63 44.09 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.503 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.967 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.023 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.6 ttmt . . . . . 0 CA--C 1.519 -0.217 0 CA-C-O 120.818 0.342 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.9 t -130.61 138.97 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.434 0.635 . . . . 0.0 112.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.885 ' CD1' HD22 ' A' ' 48' ' ' LEU . 13.0 m-90 -105.09 140.02 38.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.17 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.91 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.29 126.08 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.769 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -117.51 145.44 44.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.811 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.287 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -78.03 -1.28 31.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 28.8 t-20 -84.89 131.88 47.7 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.621 0.248 . . . . 0.0 111.093 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.1 Cg_exo -68.02 -10.57 29.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.469 2.112 . . . . 0.0 111.626 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.87 16.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.897 0.856 . . . . 0.0 108.988 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -38.93 141.14 0.31 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.74 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.17 -19.07 11.98 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.908 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.4 t80 -129.92 130.43 45.12 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.993 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 84' ' ' LEU . 31.1 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.789 0.328 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -35.1 63.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -61.19 -18.66 59.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 81' ' ' ILE . 13.7 mt -104.81 147.35 27.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.66 160.58 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.546 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.62 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -40.87 -51.32 3.18 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.606 0.717 . . . . 0.0 109.741 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 67' ' ' THR . 18.0 mttt -120.82 82.6 1.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.664 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.6 t-80 -63.16 -46.06 88.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.968 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.8 p90 -146.25 161.87 39.32 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.282 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.91 ' CG ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.35 137.26 42.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.38 -178.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 65' ' ' VAL . 45.2 mt -115.22 132.09 65.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -121.39 145.86 47.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.139 0.495 . . . . 0.0 111.876 -179.266 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.561 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.9 tm? . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.194 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.807 ' CB ' HD13 ' A' ' 124' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.832 0.349 . . . . 0.0 110.771 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.9 OUTLIER -128.37 138.37 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.594 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.1 pp -113.04 120.72 42.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.077 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.0 t30 -114.57 116.03 28.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.668 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.8 p30 -77.45 140.51 39.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.063 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.1 pt -143.89 28.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.448 0.166 . . . . 0.0 111.407 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 9.3 t -89.56 159.67 17.07 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.519 0.676 . . . . 0.0 112.677 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -69.72 -50.42 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.417 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.25 2.92 54.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.266 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.33 159.36 28.11 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.898 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.543 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.0 m -117.74 138.05 52.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.347 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.855 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.12 148.82 31.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.86 113.3 18.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.228 177.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.423 ' N ' HD12 ' A' ' 111' ' ' LEU . 59.1 m-20 44.77 42.9 6.4 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.57 -14.21 60.39 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.548 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.2 118.38 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.075 0.438 . . . . 0.0 110.482 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.855 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.92 123.9 23.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.407 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.7 m -95.39 165.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.029 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 mp0 -69.85 126.81 30.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.685 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 62.9 tttt -54.84 162.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.991 0.424 . . . . 0.0 110.579 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.59 33.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.147 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.54 144.55 41.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.89 179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.4 ' HB3' HD23 ' A' ' 100' ' ' LEU . 24.2 m-80 -93.22 133.32 36.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.946 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 53.8 mm-40 -129.24 151.25 50.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.61 113.56 9.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.2 tt -49.29 156.55 0.57 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.629 . . . . 0.0 111.739 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.48 153.48 41.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.641 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 4.8 mm-40 -71.2 121.93 19.27 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.57 19.68 65.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.734 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -49.26 165.35 0.06 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.857 0.361 . . . . 0.0 111.172 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.5 tt0 -143.2 135.48 27.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.973 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.555 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -115.12 127.77 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.646 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.6 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.5 m -104.64 139.13 39.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.664 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.9 m -140.57 158.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.08 23.48 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.148 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.5 t -71.75 140.34 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 121.536 0.684 . . . . 0.0 112.391 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.405 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 152.88 -42.18 0.67 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.314 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.34 131.76 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 -34.8 25.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 111.414 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.9 m -93.53 6.37 48.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 59.2 m-20 -121.16 21.82 11.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.6 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -103.93 139.28 25.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.99 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 141' ' ' LEU . 7.9 tt -124.36 134.53 53.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.505 ' H ' HG21 ' A' ' 40' ' ' THR . 46.6 t -110.59 150.21 29.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.716 0.769 . . . . 0.0 112.368 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.78 HD21 HD12 ' A' ' 43' ' ' ILE . 70.1 mt -135.68 145.74 47.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.831 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.51 139.97 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.349 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.555 HD11 HD11 ' A' ' 130' ' ' ILE . 39.6 mt -106.14 126.22 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.18 118.9 36.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.601 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.507 HD11 HD21 ' A' ' 124' ' ' LEU . 6.3 mt -84.64 133.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -84.3 115.42 22.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.809 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -58.87 -29.05 66.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.019 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.9 t80 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.898 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.798 0.332 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -63.34 -36.16 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -40.43 93.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.01 -44.82 95.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.6 mm -67.7 -35.16 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -57.18 -35.8 70.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.358 . . . . 0.0 110.43 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -23.86 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.807 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.53 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.179 0 CA-C-O 121.067 0.461 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.429 -1.503 0 CA-C-O 121.521 0.677 . . . . 0.0 112.48 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.71 -61.01 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.035 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.7 p -147.16 151.4 36.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.394 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.45 138.14 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.711 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.7 t -105.55 122.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.761 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -125.81 117.06 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.407 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.8 t -79.75 124.67 28.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 110.579 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.429 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -94.52 -24.56 17.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.387 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.486 HG23 ' HB3' ' A' ' 142' ' ' SER . 67.6 p -79.86 -2.36 43.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.397 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 73.84 0.54 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.894 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.77 -43.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.7 mt -115.15 140.53 25.78 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.24 138.47 25.09 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.2 1.933 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.761 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -56.11 129.48 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.629 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -126.23 164.14 21.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 119.71 35.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.994 0.426 . . . . 0.0 111.797 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 66' ' ' TRP . 2.0 mt -92.42 137.27 32.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.55 158.8 43.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.75 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.5 ttpt . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 91' ' ' ILE . 3.7 t -111.87 139.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.264 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.601 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.2 m-90 -100.42 139.29 36.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.899 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.39 133.69 53.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.711 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -116.01 145.57 42.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.313 -178.578 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.797 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 170.57 -175.46 44.4 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.455 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -82.19 -4.39 56.92 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.4 p30 -87.71 139.34 31.31 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.861 0.362 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.7 Cg_exo -69.49 -4.27 13.5 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.889 2.393 . . . . 0.0 111.88 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -46.8 12.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.869 0.842 . . . . 0.0 109.081 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 139.01 3.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.724 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -19.09 12.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.552 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.9 t80 -129.75 120.76 25.6 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.848 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.681 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.756 HD11 HD12 ' A' ' 141' ' ' LEU . 41.0 mt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.922 0.391 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -58.62 -33.89 70.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.484 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 5.1 tpt180 -60.71 -47.69 85.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.661 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.2 mp -72.63 153.61 41.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' ASN . 46.3 p -94.61 166.55 11.97 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.933 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.797 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m120 -40.54 -74.69 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.586 ' HB3' HG22 ' A' ' 67' ' ' THR . 15.0 mttt -97.95 85.59 3.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -63.32 -44.86 93.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.957 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' HA ' HG12 ' A' ' 104' ' ' ILE . 31.7 p90 -153.49 162.4 41.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG23 ' A' ' 67' ' ' THR . 10.6 mt-30 -135.92 160.0 39.94 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.732 HG23 HD23 ' A' ' 101' ' ' LEU . 58.3 mt -123.78 131.96 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.081 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.66 139.58 39.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.071 0.463 . . . . 0.0 111.685 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.6 HD13 ' C ' ' A' ' 93' ' ' LEU . 1.8 tm? . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.787 HD11 HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.913 0.387 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.8 mt -133.42 147.25 51.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.732 HD23 HG23 ' A' ' 91' ' ' ILE . 14.2 mt -112.66 130.33 56.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.617 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.6 t30 -115.05 115.63 27.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.642 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.762 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.6 p-10 -81.18 141.27 34.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.137 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.56 HG21 ' OE1' ' A' ' 90' ' ' GLN . 13.6 pt -149.82 37.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.606 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -97.39 156.42 16.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.11 0.481 . . . . 0.0 111.84 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.2 m -68.55 -32.79 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.103 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -98.63 -19.9 17.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.112 -179.59 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.606 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.91 164.3 13.45 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.215 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.9 m -117.4 137.68 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -115.74 148.42 39.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.601 ' CD1' HG11 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -124.41 113.36 18.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.544 177.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 45.76 37.4 3.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.013 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.58 -1.86 76.39 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.556 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -107.97 118.65 37.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.02 0.438 . . . . 0.0 110.919 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -75.63 129.72 37.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.348 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.762 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.4 m -106.49 165.11 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.358 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.85 131.77 44.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.209 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 6.1 tttt -55.45 168.78 0.35 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER 31.85 37.19 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.302 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.0 p -111.96 145.08 40.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.342 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.58 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.8 m-80 -93.58 122.44 36.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.626 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -128.59 146.73 50.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.23 115.48 12.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.148 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 99' ' ' LEU . 1.7 pt? -62.03 169.66 2.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.804 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.4 153.72 41.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.116 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.479 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.07 120.55 16.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.035 0.445 . . . . 0.0 110.136 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.58 20.84 64.2 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.139 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD2' HD23 ' A' ' 111' ' ' LEU . 5.0 t70 -61.63 179.6 0.24 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.852 0.358 . . . . 0.0 110.796 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.902 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.1 mt-10 -145.17 135.66 24.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.307 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 145' ' ' ILE . 11.8 mt -108.35 128.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.286 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.27 137.91 41.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 13.9 m -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.88 30.12 29.94 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.171 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.532 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.3 t -69.0 140.24 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.661 0.743 . . . . 0.0 112.332 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.8 -43.49 0.67 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.266 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 138' ' ' SER . 42.4 t -126.48 135.21 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.48 -37.15 37.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.666 0.269 . . . . 0.0 111.679 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.448 ' H ' HG12 ' A' ' 136' ' ' VAL . 95.0 p -93.58 6.33 48.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.31 19.88 14.56 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.678 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -106.04 138.96 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.238 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.756 HD12 HD11 ' A' ' 81' ' ' ILE . 3.3 tt -124.57 134.49 52.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.681 ' N ' HD23 ' A' ' 141' ' ' LEU . 38.8 t -111.56 150.32 30.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.8 . . . . 0.0 112.732 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -135.81 149.54 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.159 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.2 t -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.178 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 130' ' ' ILE . 10.8 mt -106.4 120.88 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 107.69 17.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.274 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.77 128.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.71 119.46 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.91 -32.0 72.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.7 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.949 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.87 0.367 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.99 -43.64 81.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.81 -31.92 72.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.13 -35.35 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -57.44 -43.6 84.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.476 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -67.21 -23.7 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.546 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.229 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.694 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 121.618 0.723 . . . . 0.0 112.551 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.017 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -91.97 -59.59 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.938 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 157.78 43.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.468 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -123.56 124.85 43.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.679 HG21 ' HE2' ' A' ' 68' ' ' PHE . 46.4 t -92.43 122.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.992 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.856 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -129.03 125.44 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.431 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.4 t -89.91 107.87 19.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -79.99 -26.2 40.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.767 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 142' ' ' SER . 58.7 p -79.83 -2.59 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.525 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.57 80.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.067 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 141' ' ' LEU . 9.2 mt-30 -147.73 -39.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.015 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.809 HD12 HD21 ' A' ' 143' ' ' LEU . 6.8 mt -127.43 141.99 42.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.8 Cg_endo -71.92 141.62 37.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.11 1.873 . . . . 0.0 112.127 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.856 HG12 HG23 ' A' ' 37' ' ' ILE . 34.2 mt -55.86 149.11 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.847 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.29 162.85 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -121.21 122.67 40.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.08 0.467 . . . . 0.0 111.907 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -101.03 137.26 39.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.193 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.017 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.12 158.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.12 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' A' ' 49' ' ' SER . 28.1 ttpt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 92' ' ' LEU . 9.3 t -124.79 138.66 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.223 0.535 . . . . 0.0 111.702 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.601 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.9 m-90 -100.75 139.86 35.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.145 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.818 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.84 130.58 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.365 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.726 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -120.09 145.1 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.034 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.58 -172.78 39.58 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.109 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 30.5 mtp180 -75.74 1.64 14.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.481 HD22 ' HB3' ' A' ' 73' ' ' ALA . 1.9 t30 -84.67 141.93 39.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.339 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.76 -14.37 24.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.6 2.2 . . . . 0.0 111.271 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -43.28 17.21 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.881 0.848 . . . . 0.0 108.735 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 140.83 1.2 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.898 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.26 -18.58 10.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.094 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.59 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.0 t80 -129.18 122.68 30.29 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.723 0.296 . . . . 0.0 110.842 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.151 -179.846 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.745 HD11 HD12 ' A' ' 141' ' ' LEU . 28.8 mt . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.861 0.363 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -35.68 64.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.019 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -29.42 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.593 HD11 HD12 ' A' ' 81' ' ' ILE . 46.8 mt -90.15 152.35 21.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.55 166.11 12.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.51 -53.64 5.39 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.475 0.655 . . . . 0.0 109.507 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.729 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.74 84.42 2.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.15 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -62.04 -44.93 95.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.982 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -146.31 162.85 37.23 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.399 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.818 ' CG ' HG23 ' A' ' 67' ' ' THR . 11.2 mt-30 -135.57 148.01 48.93 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.726 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 64.5 mt -125.07 132.4 71.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.677 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.725 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -126.04 135.22 51.51 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.034 0.445 . . . . 0.0 112.146 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 93' ' ' LEU . 1.8 tm? . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.161 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.987 HD21 HG12 ' A' ' 33' ' ' VAL . 5.6 mp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.73 0.3 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.7 mp -129.79 142.93 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.08 125.14 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.132 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.567 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.2 t30 -116.57 116.33 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.792 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -76.63 139.49 40.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.831 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.2 pt -145.32 38.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.31 152.65 19.69 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.076 0.465 . . . . 0.0 111.829 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.0 m -68.9 -31.41 70.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.994 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -97.99 -19.92 17.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.01 157.37 10.8 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.841 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.46 137.81 52.28 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.48 148.35 37.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.2 113.47 18.35 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.329 177.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.408 ' N ' HD12 ' A' ' 111' ' ' LEU . 91.4 m-20 44.17 43.5 5.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.87 68.25 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.517 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -104.06 118.46 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.08 0.44 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 18.4 tptt -74.08 123.15 23.85 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.247 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.792 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -94.35 165.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.5 tp10 -69.94 127.24 32.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 69.2 tttt -55.07 162.53 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 110.354 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.411 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER 36.83 32.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.115 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 144.99 41.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.818 179.182 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.725 ' OD1' HD21 ' A' ' 92' ' ' LEU . 14.8 m-80 -94.8 133.44 38.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.042 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.5 mm-40 -129.22 152.28 48.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.376 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.34 125.81 28.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.948 0.404 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 145' ' ' ILE . 30.7 tp -56.36 154.68 7.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 0.0 111.814 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.467 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.88 152.93 43.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.601 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -72.11 124.25 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.779 0.323 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.04 22.56 42.95 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.15 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.5 t70 -52.81 171.81 0.06 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.96 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.927 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.5 mt-10 -143.91 135.5 26.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.094 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.854 HD11 HD11 ' A' ' 145' ' ' ILE . 15.5 mt -114.94 126.01 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.436 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.69 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.29 138.44 40.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 84' ' ' LEU . 35.7 m -140.24 158.26 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 84.97 27.09 35.16 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.105 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.0 t -66.28 140.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.618 0.723 . . . . 0.0 112.496 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.51 -41.58 0.62 Allowed Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.289 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.1 t -126.46 136.49 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -39.88 52.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.7 0.286 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.446 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.45 6.33 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 23.1 t0 -116.62 23.28 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.69 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.317 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 HD11 ' A' ' 81' ' ' ILE . 6.8 tt -119.25 134.39 55.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.591 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.5 m -109.01 141.98 40.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 111.654 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.809 HD21 HD12 ' A' ' 43' ' ' ILE . 73.8 mt -135.13 141.97 46.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.787 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.927 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.3 t -114.08 140.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.798 0.332 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.854 HD11 HD11 ' A' ' 130' ' ' ILE . 50.3 mt -106.16 129.64 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.83 115.29 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.446 HG12 HD21 ' A' ' 124' ' ' LEU . 1.8 mt -84.77 134.03 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -83.46 103.96 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -29.47 64.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -45.02 91.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.0 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.882 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -61.26 -36.8 81.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.825 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -65.71 -38.27 88.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.24 -43.18 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.8 mm -68.23 -35.12 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.21 -34.73 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.378 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -67.23 -23.9 65.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.814 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm . . . . . 0 N--CA 1.427 -1.606 0 CA-C-O 121.79 0.805 . . . . 0.0 112.477 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.86 HG22 HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -109.94 -49.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.785 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.621 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -152.72 158.7 42.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.422 179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -130.83 136.88 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.749 0.309 . . . . 0.0 111.476 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 68' ' ' PHE . 58.3 t -108.54 122.62 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.964 0.411 . . . . 0.0 110.647 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -126.76 115.21 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.463 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.563 ' HA ' HD23 ' A' ' 143' ' ' LEU . 17.6 t -81.4 101.87 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 110.409 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -24.09 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.755 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.639 HG21 ' H ' ' A' ' 142' ' ' SER . 13.7 p -79.82 -2.42 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.417 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.6 78.81 0.26 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.133 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -147.64 -40.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.007 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.0 mt -124.64 141.85 39.05 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -71.57 137.64 30.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.252 1.968 . . . . 0.0 111.925 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -54.62 137.54 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.914 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 163.33 27.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.976 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.5 m-20 -118.65 119.75 35.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.892 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 34' ' ' CYS . 3.4 mt -92.24 137.37 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.5 158.59 44.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.228 1.013 . . . . 0.0 113.665 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.344 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.8 ttpt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.824 0.345 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.543 HG22 ' CB ' ' A' ' 92' ' ' LEU . 15.2 t -129.98 138.91 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.003 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.599 ' CH2' HG11 ' A' ' 33' ' ' VAL . 15.6 m-90 -102.13 139.6 37.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.107 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.944 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.87 126.78 55.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.115 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -117.47 145.58 44.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.317 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.31 -173.12 40.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.892 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 5.7 mtp-105 -77.48 -1.29 29.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.474 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.81 133.58 43.38 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.691 0.281 . . . . 0.0 111.216 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.66 -9.5 26.31 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.797 2.331 . . . . 0.0 112.065 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.8 -43.02 17.18 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.842 0.83 . . . . 0.0 108.921 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.28 139.56 0.72 Allowed 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.939 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.26 -18.77 11.5 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.977 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 55.6 t80 -129.55 123.68 32.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.832 0.349 . . . . 0.0 110.769 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.928 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.7 mm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.77 0.319 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -42.3 75.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.402 ' HB3' ' HA2' ' A' ' 133' ' ' GLY . 1.0 OUTLIER -60.91 -26.52 67.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.16 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.708 HD21 HG23 ' A' ' 132' ' ' VAL . 39.7 mt -90.96 152.33 20.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -99.88 167.44 10.52 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.687 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.96 -53.83 5.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.308 0.575 . . . . 0.0 109.808 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' HG22 ' A' ' 67' ' ' THR . 9.7 mttt -117.19 82.3 1.79 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.653 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 60.5 t-80 -58.65 -45.34 89.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.772 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -147.23 160.88 41.96 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.979 -0.688 . . . . 0.0 112.399 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.944 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.33 130.39 34.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 65' ' ' VAL . 51.3 mt -110.78 130.82 63.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.924 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.728 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -124.21 141.45 52.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.956 0.408 . . . . 0.0 111.607 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 33' ' ' VAL . 8.3 tt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 93' ' ' LEU . 3.2 mp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.724 0.297 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 99' ' ' LEU . 10.0 mp -132.17 141.45 49.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.944 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.645 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.74 124.16 51.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.518 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.581 ' HB2' HD21 ' A' ' 92' ' ' LEU . 65.9 t30 -117.29 132.66 56.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.105 0.478 . . . . 0.0 112.057 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.765 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.8 p30 -93.26 134.46 35.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.613 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.52 HD13 ' HG3' ' A' ' 90' ' ' GLN . 4.2 pt -136.1 26.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.531 0.205 . . . . 0.0 111.504 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.553 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.2 t -91.38 156.47 17.73 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.538 0.685 . . . . 0.0 112.539 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -69.68 -52.21 27.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.873 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -81.49 -1.02 44.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.389 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.77 158.97 30.58 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.417 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.545 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.0 m -117.54 137.72 52.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.88 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -111.95 148.54 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.608 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.05 113.32 18.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.4 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 72.1 m-20 43.9 43.64 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.37 66.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.35 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.97 118.58 37.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.467 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.88 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.7 tptm -73.93 121.17 20.55 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.551 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.8 m -92.37 163.7 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -69.91 128.44 36.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.4 tttt -53.91 161.59 1.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.314 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 36.83 32.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.42 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 144.73 41.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.818 179.063 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.728 ' OD1' HD11 ' A' ' 92' ' ' LEU . 15.7 m-80 -93.9 130.54 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -129.98 152.15 49.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.34 111.68 10.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.706 HD21 ' CB ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.18 168.43 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.806 -178.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 t -124.35 153.48 41.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.236 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.28 115.64 10.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.025 0.441 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.85 18.55 78.98 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.188 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.608 ' OD2' HD13 ' A' ' 111' ' ' LEU . 10.3 t70 -59.14 179.45 0.1 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.669 0.271 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.872 ' CG ' HG22 ' A' ' 144' ' ' VAL . 11.0 mt-10 -145.23 135.7 24.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.66 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 101' ' ' LEU . 6.2 mt -112.0 128.26 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 140.51 37.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.595 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.708 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.45 158.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 83.23 31.33 28.52 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.179 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.3 t -70.21 140.37 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.688 0.756 . . . . 0.0 112.503 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.84 -43.44 0.61 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.138 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.551 HG12 ' H ' ' A' ' 138' ' ' SER . 43.7 t -126.43 131.38 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.47 -33.04 19.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.824 0.345 . . . . 0.0 111.275 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.551 ' H ' HG12 ' A' ' 136' ' ' VAL . 88.1 p -93.64 6.19 49.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.58 22.63 9.84 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.7 mt -104.6 139.6 25.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.058 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 142' ' ' SER . 4.8 tt -119.64 134.55 55.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.454 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.639 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -110.19 136.7 49.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.678 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 38' ' ' CYS . 57.9 mt -131.0 144.52 51.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.593 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.872 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.7 t -110.95 135.12 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.402 . . . . 0.0 111.381 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.795 ' N ' HD12 ' A' ' 145' ' ' ILE . 2.0 mp -106.06 123.14 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.316 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.25 106.75 15.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.504 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.645 HG12 HD22 ' A' ' 124' ' ' LEU . 6.3 mt -84.79 133.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -75.96 118.72 19.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.003 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -74.01 -30.67 62.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.41 91.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.627 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.854 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.732 0.301 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -71.1 -38.05 72.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.897 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -41.22 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -31.95 70.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.27 -35.24 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.47 -41.1 79.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.52 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -23.99 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.648 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.5 mm . . . . . 0 N--CA 1.427 -1.577 0 CA-C-O 121.566 0.698 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.043 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.78 -60.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.617 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.38 165.02 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.986 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 124.15 33.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 111.343 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.745 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.8 t -93.22 122.8 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.085 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.803 HG23 HG12 ' A' ' 45' ' ' ILE . 22.3 mt -127.34 118.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.205 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.434 ' HA ' HD23 ' A' ' 143' ' ' LEU . 12.2 t -80.04 109.81 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.428 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -80.46 -27.25 37.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.61 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.66 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.2 p -79.94 -2.61 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.669 0.271 . . . . 0.0 111.351 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.46 79.97 0.19 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.926 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.427 ' CB ' HD11 ' A' ' 141' ' ' LEU . 17.0 mt-30 -148.04 -39.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.886 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.597 HD12 HD21 ' A' ' 143' ' ' LEU . 7.5 mt -123.44 141.72 36.99 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.79 138.89 29.7 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.132 1.888 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.803 HG12 HG23 ' A' ' 37' ' ' ILE . 37.7 mt -54.9 132.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.956 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 1.5 ttt180 -126.13 164.21 21.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.051 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -117.63 119.71 35.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 111.976 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.759 HD23 ' CD2' ' A' ' 66' ' ' TRP . 5.8 mp -91.49 125.81 36.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.043 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.46 156.52 46.9 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 113.299 -1.773 . . . . 0.0 110.531 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.8 ttpt . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.711 0.291 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.718 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.8 t -125.86 139.31 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.248 0.546 . . . . 0.0 112.111 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.759 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.4 m-90 -102.32 139.14 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.054 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.679 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.53 126.78 55.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.745 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -110.47 145.66 37.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.646 -178.336 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -176.25 39.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.708 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 12.0 mtp180 -77.64 -0.93 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.7 t-20 -84.84 134.04 42.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.259 . . . . 0.0 111.029 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.6 Cg_exo -68.64 -8.09 22.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.749 2.299 . . . . 0.0 111.763 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.56 16.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.009 0.909 . . . . 0.0 108.796 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 137.32 2.99 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.507 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.53 -18.68 12.46 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.904 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.47 125.36 36.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.747 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.436 ' HB ' HD12 ' A' ' 84' ' ' LEU . 24.5 mm . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.795 0.331 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.96 -40.7 70.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.012 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -60.94 -15.88 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.227 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 132' ' ' VAL . 26.9 mt -105.97 149.59 26.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.2 p -93.97 165.21 12.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.863 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.707 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -41.66 -52.51 3.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.375 0.607 . . . . 0.0 109.818 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.06 82.16 1.88 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.0 t60 -60.62 -45.85 92.48 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.023 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 19.0 p90 -146.34 159.09 43.82 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.719 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.718 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.4 tt0 -135.53 141.66 45.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.285 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.782 HG12 HD23 ' A' ' 101' ' ' LEU . 46.7 mt -117.54 127.12 75.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.073 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.569 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -110.05 148.52 31.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.025 0.44 . . . . 0.0 111.748 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 33' ' ' VAL . 33.5 tp . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.446 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.643 HD21 ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.774 0.321 . . . . 0.0 110.868 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 122' ' ' GLN . 7.3 mt -132.03 144.01 50.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.346 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.782 HD23 HG12 ' A' ' 91' ' ' ILE . 13.5 mt -112.69 124.18 51.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.6 t30 -118.11 115.79 25.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 111.729 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.5 p30 -77.5 139.2 39.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.83 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 67' ' ' THR . 16.7 pt -146.83 39.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.72 158.51 15.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.039 0.447 . . . . 0.0 111.571 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -68.91 -38.19 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.581 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.71 -19.73 17.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.169 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.99 158.64 10.09 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.929 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.58 138.01 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.943 -0.628 . . . . 0.0 109.517 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.851 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.26 148.57 35.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.03 113.46 18.43 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.366 177.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.87 43.64 5.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.415 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.75 -10.2 70.98 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.421 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -105.08 118.6 36.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.158 0.504 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.851 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 5.4 tptt -72.25 119.19 16.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.25 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.1 m -89.95 163.87 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.0 mm-40 -69.86 125.88 28.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.0 tttp -53.35 161.34 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.832 0.348 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.8 p-10 35.12 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.1 40.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.976 179.378 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.757 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.6 m-80 -89.51 131.81 35.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.888 ' O ' HD23 ' A' ' 100' ' ' LEU . 49.9 mm-40 -129.25 148.95 51.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.517 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -72.77 135.91 45.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.52 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.883 HD21 HG12 ' A' ' 147' ' ' ILE . 35.5 tp -59.87 152.85 22.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.55 0.69 . . . . 0.0 111.515 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.41 152.83 44.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.552 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.403 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.3 120.56 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.266 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.98 23.9 57.52 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.27 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.446 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.2 t70 -52.23 167.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.006 0.432 . . . . 0.0 111.314 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 16.5 tt0 -145.22 135.62 24.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.151 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 101' ' ' LEU . 11.0 mt -113.55 128.14 70.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.562 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.63 138.98 40.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.993 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.612 HG23 HD21 ' A' ' 84' ' ' LEU . 35.3 m -140.45 158.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.13 26.85 29.9 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.318 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.1 t -66.86 140.26 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.533 0.682 . . . . 0.0 112.204 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.51 -41.54 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 138' ' ' SER . 43.8 t -126.33 134.84 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.65 -34.69 27.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.712 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.5 -6.74 46.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.1 m-20 -102.42 19.7 18.37 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.562 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.8 mt -105.73 139.33 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.353 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 142' ' ' SER . 7.4 tt -124.22 134.45 53.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.342 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.66 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -110.58 128.93 55.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.151 0.5 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.597 HD21 HD12 ' A' ' 43' ' ' ILE . 20.2 mt -122.37 134.2 54.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.847 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.92 137.57 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.443 ' CD1' HD21 ' A' ' 101' ' ' LEU . 33.6 mt -106.14 137.61 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.518 ' CD1' HD12 ' A' ' 37' ' ' ILE . 9.3 m-85 -118.78 121.96 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.503 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.883 HG12 HD21 ' A' ' 124' ' ' LEU . 4.5 mt -85.47 134.12 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -86.11 113.16 21.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.3 -29.15 70.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -57.4 -42.88 83.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.98 0.419 . . . . 0.0 110.574 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.923 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.851 0.357 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -35.94 82.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.69 -40.2 91.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.28 -41.09 92.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.6 mm -69.34 -35.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.28 -35.36 69.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.421 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -67.32 -23.78 65.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.868 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm . . . . . 0 N--CA 1.428 -1.533 0 CA-C-O 121.52 0.676 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.62 -60.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.758 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' HD22 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -150.08 165.23 33.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.25 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -129.18 138.1 51.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.88 0.372 . . . . 0.0 111.404 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.66 HG21 ' CE2' ' A' ' 68' ' ' PHE . 40.5 t -105.16 122.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.773 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -121.83 124.57 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.321 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.627 ' HA ' HD13 ' A' ' 143' ' ' LEU . 7.0 t -87.08 102.72 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.577 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -76.09 -21.18 56.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.666 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.493 HG21 ' H ' ' A' ' 142' ' ' SER . 82.3 p -79.94 -2.34 43.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.821 0.343 . . . . 0.0 111.599 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.91 74.76 0.39 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.818 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -147.49 -41.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.081 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -120.32 141.67 32.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.6 Cg_endo -72.05 140.03 33.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.135 1.89 . . . . 0.0 112.187 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.773 HG12 HG23 ' A' ' 37' ' ' ILE . 45.9 mt -56.41 144.89 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 111.797 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 164.08 30.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.916 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -122.73 119.81 31.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.443 . . . . 0.0 112.029 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 4.2 mp -85.1 129.56 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.98 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.03 155.85 49.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.231 1.015 . . . . 0.0 113.324 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.892 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.651 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.8 ttpt . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 120.808 0.337 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.691 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.7 t -133.59 139.28 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.22 0.533 . . . . 0.0 111.905 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.4 m-90 -103.21 139.21 38.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.524 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -109.95 130.79 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.668 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.822 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -120.01 145.44 46.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.02 -168.44 37.81 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 6.7 mtp-105 -81.76 1.84 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.4 t-20 -84.82 134.42 41.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.676 0.274 . . . . 0.0 111.553 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.4 Cg_exo -66.65 -13.53 40.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.747 2.298 . . . . 0.0 111.756 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -43.85 16.38 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.952 0.882 . . . . 0.0 109.05 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.56 140.17 1.34 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.593 . . . . 0.0 111.176 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 m-20 -56.35 -18.52 11.15 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.076 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.515 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.6 t80 -129.36 115.29 17.33 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 120.761 0.315 . . . . 0.0 110.697 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.474 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.788 HD12 HD11 ' A' ' 84' ' ' LEU . 26.1 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.854 0.359 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -38.19 67.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.86 -23.43 65.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 81' ' ' ILE . 30.3 mt -98.01 151.97 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.127 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 m -95.72 165.02 12.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.598 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.632 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.85 -52.78 4.95 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 109.782 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.468 ' HB2' HG22 ' A' ' 67' ' ' THR . 15.0 ptmt -119.33 81.77 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -60.21 -46.9 88.15 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.656 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.9 p90 -144.42 160.77 40.51 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.894 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.691 ' HG2' HG12 ' A' ' 65' ' ' VAL . 26.8 tt0 -136.07 142.58 44.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.24 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.784 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 63.6 mt -116.27 127.72 73.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.87 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -113.2 148.57 35.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.139 0.495 . . . . 0.0 111.645 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 33' ' ' VAL . 16.2 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.636 HD22 ' SG ' ' A' ' 34' ' ' CYS . 4.0 mp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.811 0.339 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.899 HD23 ' O ' ' A' ' 122' ' ' GLN . 3.2 mt -133.09 146.89 52.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.998 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.722 HD11 HD12 ' A' ' 145' ' ' ILE . 0.8 OUTLIER -112.69 124.97 53.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.481 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.4 t30 -115.06 115.56 27.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.781 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.9 p30 -79.53 136.78 36.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.072 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -145.98 39.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.634 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.6 152.85 19.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -68.92 -31.7 70.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.886 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.4 -19.87 17.47 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.634 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.37 157.35 10.3 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.812 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.98 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.48 148.68 40.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.868 HD12 HG11 ' A' ' 116' ' ' VAL . 1.1 mt -124.22 113.64 18.56 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.983 177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 46.95 35.82 3.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.212 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.42 -8.84 74.8 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.502 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -106.45 118.53 36.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.111 0.456 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.35 137.49 48.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.212 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.868 HG11 HD12 ' A' ' 111' ' ' LEU . 6.7 m -111.24 168.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.7 tt0 -70.18 125.91 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.615 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 41.8 tttt -53.31 162.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.998 0.428 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.88 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.14 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.41 145.12 40.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.916 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.879 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.0 m-80 -86.68 133.86 33.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.994 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.899 ' O ' HD23 ' A' ' 100' ' ' LEU . 38.2 mm-40 -129.26 148.25 51.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 tp -72.66 119.78 17.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.77 HD11 HG21 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -57.49 153.67 12.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.537 0.685 . . . . 0.0 111.474 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.459 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.2 t -124.31 153.53 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.59 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 3.4 tp-100 -71.54 124.16 24.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.414 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.48 21.54 49.28 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.086 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.516 ' OD2' HD23 ' A' ' 111' ' ' LEU . 11.7 t70 -56.64 172.21 0.26 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.177 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.652 ' HG3' HG22 ' A' ' 144' ' ' VAL . 17.4 tt0 -145.25 135.58 24.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.377 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.949 HD11 HD11 ' A' ' 145' ' ' ILE . 1.3 mp -110.85 128.39 67.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.341 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.727 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.0 m -104.16 137.89 41.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.968 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.7 m -140.15 158.33 25.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.71 29.88 31.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.909 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -68.52 140.3 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.753 0.787 . . . . 0.0 112.487 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.54 -44.13 0.5 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.454 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 32.3 t -126.27 140.75 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.86 -42.03 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 6.27 48.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.467 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 4.4 m-20 -112.69 21.37 15.64 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.727 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.27 139.43 29.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 142' ' ' SER . 5.4 tt -123.41 134.35 53.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.206 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.695 ' N ' HD23 ' A' ' 141' ' ' LEU . 37.4 t -112.69 150.64 31.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.607 0.718 . . . . 0.0 112.932 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.627 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.2 mm? -135.46 139.14 43.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.321 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.652 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.1 t -110.66 140.4 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.216 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.949 HD11 HD11 ' A' ' 130' ' ' ILE . 38.8 mt -105.91 127.06 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.071 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 117.65 32.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.708 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.623 HG12 HD21 ' A' ' 124' ' ' LEU . 5.8 mt -84.89 134.18 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.11 108.36 17.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.53 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.03 -30.5 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -59.66 -45.89 90.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.666 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.2 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.811 0.339 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -64.46 -45.35 87.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -60.77 -35.06 75.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.34 -44.1 92.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -67.24 -35.02 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.23 -40.04 76.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -24.37 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.956 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.706 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm . . . . . 0 N--CA 1.429 -1.514 0 CA-C-O 121.579 0.704 . . . . 0.0 112.627 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.072 HG12 HD21 ' A' ' 99' ' ' LEU . 3.0 t -92.08 -60.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.832 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.4 148.92 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.123 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.98 131.38 56.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.511 -179.213 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.595 HG13 HD11 ' A' ' 48' ' ' LEU . 3.6 m -97.94 122.69 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.844 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.796 HG23 HG12 ' A' ' 45' ' ' ILE . 22.3 mt -125.29 129.02 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.509 ' SG ' HD21 ' A' ' 141' ' ' LEU . 5.9 t -95.54 101.05 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.732 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -78.11 -19.08 54.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.617 HG21 ' OG ' ' A' ' 142' ' ' SER . 29.1 p -79.93 -2.88 45.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.777 0.322 . . . . 0.0 111.429 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.21 69.82 1.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.237 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB2' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -144.54 -35.11 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.413 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.592 HD12 HD21 ' A' ' 143' ' ' LEU . 3.6 mt -127.52 141.0 39.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.732 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.2 Cg_endo -72.49 137.49 28.03 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.166 1.911 . . . . 0.0 112.286 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.796 HG12 HG23 ' A' ' 37' ' ' ILE . 34.5 mt -55.83 141.11 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.755 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.06 164.18 27.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 m-20 -118.12 119.89 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD11 HG13 ' A' ' 36' ' ' VAL . 2.8 mt -95.39 135.74 36.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.014 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.0 158.52 43.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.511 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.9 ttpt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.687 0.279 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.707 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.0 t -126.48 139.15 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.273 0.559 . . . . 0.0 112.091 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.575 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.2 m-90 -101.09 139.38 36.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.7 130.16 55.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.467 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.806 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -119.31 145.28 46.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.72 -166.49 35.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.264 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.58 2.35 29.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.754 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.2 t-20 -84.81 132.04 47.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.54 0.21 . . . . 0.0 111.279 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.2 Cg_exo -65.46 -15.37 49.39 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.497 2.132 . . . . 0.0 111.44 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.57 -42.65 18.04 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.946 0.879 . . . . 0.0 108.833 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 139.3 1.96 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.836 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 m-20 -56.17 -18.8 11.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.922 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.552 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.66 124.95 34.9 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.65 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.941 0.4 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -39.24 68.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.517 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -21.47 63.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.357 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' CE1' ' A' ' 88' ' ' HIS . 32.8 mt -103.09 152.07 21.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 111.07 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 166.96 11.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.745 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.572 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -44.19 -53.48 6.5 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.416 0.626 . . . . 0.0 109.634 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HB2' HD12 ' A' ' 104' ' ' ILE . 1.9 mttt -118.97 82.61 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.87 -46.41 89.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.634 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.8 p90 -145.75 161.41 39.97 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.091 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.85 143.43 45.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.806 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 77.8 mt -117.62 124.2 72.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.237 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.41 147.99 26.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.533 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.949 HD22 HG11 ' A' ' 33' ' ' VAL . 27.9 tp . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.604 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.072 HD21 HG12 ' A' ' 33' ' ' VAL . 6.2 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.822 0.344 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.531 HD21 HD12 ' A' ' 145' ' ' ILE . 8.7 mp -112.81 121.51 44.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.008 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.7 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.7 t30 -116.61 115.52 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.772 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.818 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.0 p30 -78.6 139.66 38.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.001 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.6 pt -147.82 38.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.614 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.51 152.6 19.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.102 0.477 . . . . 0.0 111.834 -178.817 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.96 -31.52 70.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.925 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.15 -19.84 17.66 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.55 156.59 10.23 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.771 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.75 148.62 39.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.36 18.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.358 177.457 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 44.4 43.19 5.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -11.15 68.42 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.486 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.13 118.64 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.082 0.441 . . . . 0.0 110.667 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -72.76 129.74 38.9 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.818 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -101.47 166.73 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.453 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.93 126.48 29.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.667 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.5 tttt -53.57 163.91 0.59 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.619 0.247 . . . . 0.0 110.365 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.2 m-80 33.35 37.19 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.887 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -111.71 144.97 40.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.728 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.7 m-80 -91.38 129.4 37.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.737 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.859 ' O ' HD23 ' A' ' 100' ' ' LEU . 61.5 mm-40 -128.47 149.9 50.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.437 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 124' ' ' LEU . 4.0 tt -72.65 136.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.534 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.847 HD21 HG12 ' A' ' 147' ' ' ILE . 42.6 tp -61.66 153.27 28.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.456 0.646 . . . . 0.0 111.621 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.416 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -125.32 152.66 44.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.561 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 121.73 19.58 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.54 25.6 55.54 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.02 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -51.09 168.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 111.427 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.861 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.16 135.29 23.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.865 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.7 mt -117.37 127.9 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.1 m -104.31 139.36 39.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.122 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.49 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.46 33.45 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.093 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.2 140.33 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.604 0.716 . . . . 0.0 112.266 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.04 -40.17 0.85 Allowed Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.246 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 138' ' ' SER . 49.1 t -126.5 131.13 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.62 -35.57 31.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.328 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.54 ' H ' HG12 ' A' ' 136' ' ' VAL . 12.3 p -93.59 6.38 48.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.3 t0 -120.87 22.28 11.14 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.639 ' CG2' HG22 ' A' ' 131' ' ' THR . 8.9 mt -103.69 139.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.926 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.686 HD22 ' CD2' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -121.79 134.42 54.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.64 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.11 132.0 55.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.065 0.459 . . . . 0.0 111.616 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.686 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.6 mm? -125.39 136.81 53.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.543 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.861 HG22 ' CG ' ' A' ' 129' ' ' GLU . 19.6 t -110.93 139.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.343 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.531 HD12 HD21 ' A' ' 101' ' ' LEU . 49.6 mt -106.18 132.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.166 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 117.9 31.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.345 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.847 HG12 HD21 ' A' ' 124' ' ' LEU . 5.3 mt -84.77 134.11 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -83.72 109.45 17.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.52 -31.03 67.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -60.49 -46.0 91.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.766 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.03 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.753 0.311 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -60.24 -39.06 85.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.8 -41.72 87.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.45 -31.86 69.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.39 -35.41 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.822 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.8 82.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.71 65.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.693 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.429 -1.5 0 CA-C-O 121.435 0.636 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.996 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -93.83 -61.48 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.02 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.647 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -145.19 161.74 38.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.261 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.41 138.13 54.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.776 0.322 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.743 HG21 ' HE2' ' A' ' 68' ' ' PHE . 39.4 t -106.22 122.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.867 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.764 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -126.19 120.89 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.615 ' SG ' HD21 ' A' ' 141' ' ' LEU . 49.8 t -85.91 106.81 17.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.428 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.9 -22.83 58.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.89 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.525 HG21 ' H ' ' A' ' 142' ' ' SER . 61.9 p -79.9 -2.36 43.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.614 0.245 . . . . 0.0 111.544 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.38 72.99 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.975 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' CB ' HD11 ' A' ' 141' ' ' LEU . 6.1 mt-30 -143.39 -44.74 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.807 HD12 HD21 ' A' ' 143' ' ' LEU . 2.8 mt -111.78 140.93 23.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.7 Cg_endo -73.59 132.02 16.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.117 1.878 . . . . 0.0 112.051 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.764 HG12 HG23 ' A' ' 37' ' ' ILE . 35.4 mt -54.08 130.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.579 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 164.13 20.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.42 119.78 38.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.567 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 36' ' ' VAL . 8.1 mt -91.5 136.29 33.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.355 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.996 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.26 158.37 43.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.716 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.599 0.238 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.0 t -125.57 139.12 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.149 0.5 . . . . 0.0 112.252 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.617 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.6 m-90 -100.72 139.26 36.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.969 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.685 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.11 128.91 56.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.743 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -120.25 145.4 47.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.137 -178.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.83 -169.95 36.61 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.556 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.51 1.02 15.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.57 126.27 69.32 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.365 0.126 . . . . 0.0 111.005 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 23.6 Cg_exo -64.19 -14.01 41.28 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.395 2.063 . . . . 0.0 111.417 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.87 17.63 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.73 140.98 0.62 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.422 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.12 -18.78 10.82 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.736 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -129.45 131.64 46.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.543 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.641 HD12 HD11 ' A' ' 84' ' ' LEU . 19.3 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.857 0.361 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -34.8 65.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -61.88 -25.99 67.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.641 HD11 HD12 ' A' ' 81' ' ' ILE . 25.9 mt -96.03 150.4 20.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 m -93.81 166.2 12.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.399 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.555 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.9 m-20 -43.54 -54.82 4.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.422 0.629 . . . . 0.0 109.675 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HB2' HG22 ' A' ' 67' ' ' THR . 16.1 ptpt -119.22 82.6 1.89 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.7 t60 -58.96 -46.02 89.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.877 -176.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.0 p90 -145.19 160.32 41.63 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.358 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.7 tt0 -135.65 144.06 45.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.954 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.591 ' C ' HG13 ' A' ' 65' ' ' VAL . 50.1 mt -118.76 125.44 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.104 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -101.58 149.39 24.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.985 0.421 . . . . 0.0 111.499 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.79 HD22 HG11 ' A' ' 33' ' ' VAL . 48.7 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.762 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 99' ' ' LEU . 8.5 mp -133.1 143.18 49.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.756 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.699 HD21 HD11 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -112.83 121.37 44.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.864 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.685 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.2 t30 -116.51 115.55 26.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.844 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.0 p30 -78.18 139.91 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.776 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -146.23 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.62 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.85 152.13 20.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.984 0.421 . . . . 0.0 111.822 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.85 -31.51 70.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -97.67 -19.82 18.02 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.64 157.12 10.58 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.748 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.2 m -117.45 137.79 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.881 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.86 148.56 36.47 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.38 18.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.369 177.534 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.422 ' N ' HD12 ' A' ' 111' ' ' LEU . 21.9 m-20 43.75 43.75 5.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.528 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.91 -13.58 62.61 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.532 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -103.97 118.48 36.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.964 0.411 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.881 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.2 tptm -72.25 127.4 32.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.844 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.1 m -96.76 164.59 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' SER . 27.1 tt0 -69.89 124.55 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.584 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.4 tttt -52.82 162.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 34.51 34.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.155 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.13 40.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.138 179.45 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.732 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.2 m-80 -88.29 129.84 35.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.8 mm-40 -129.51 148.26 51.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.9 125.57 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.149 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 145' ' ' ILE . 65.0 tp -58.08 156.41 9.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.371 0.605 . . . . 0.0 111.683 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.573 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.66 153.47 42.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.691 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.656 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.8 tp60 -71.24 122.63 20.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.31 21.67 54.31 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.764 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 31.8 t70 -49.7 168.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.993 0.425 . . . . 0.0 111.24 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 tt0 -145.03 135.45 24.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.839 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 145' ' ' ILE . 2.8 mt -115.49 127.21 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.661 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.635 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.69 138.2 41.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.876 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.7 m -140.12 158.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.8 25.77 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.954 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -70.95 140.38 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.64 0.733 . . . . 0.0 112.314 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.88 -40.08 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.312 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 47.5 t -126.4 136.18 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -50.61 -41.62 55.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.406 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.3 m -93.42 6.29 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.814 . . . . 0.0 113.196 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 9.0 t0 -117.5 24.76 10.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.635 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -105.93 139.57 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.91 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.615 HD21 ' SG ' ' A' ' 38' ' ' CYS . 5.2 tt -122.03 134.41 54.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.705 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 141' ' ' LEU . 40.0 t -110.61 150.38 29.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.695 0.76 . . . . 0.0 112.548 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.807 HD21 HD12 ' A' ' 43' ' ' ILE . 76.0 mt -135.9 146.76 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.681 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.42 140.31 43.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.742 0.306 . . . . 0.0 111.065 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 130' ' ' ILE . 47.2 mt -105.98 126.1 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.347 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.55 109.75 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.318 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.4 mp -84.89 134.14 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.021 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.45 106.78 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.35 -26.42 63.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.353 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -60.18 -46.04 91.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.152 -179.818 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.767 0.318 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -71.19 -35.82 71.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.488 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -56.88 -43.17 81.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.18 -31.85 69.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.205 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.58 HG23 ' HE2' ' A' ' 23' ' ' PHE . 13.7 mt -68.74 -47.99 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.58 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -33.61 73.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.441 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -57.47 -47.11 82.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.952 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.58 ' HE2' HG23 ' A' ' 20' ' ' ILE . 5.1 p90 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.855 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.426 -1.665 0 CA-C-O 121.842 0.829 . . . . 0.0 110.807 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.738 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.3 t -50.55 -67.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.937 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.9 p -146.79 165.32 30.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.397 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.43 124.2 37.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG13 HD11 ' A' ' 48' ' ' LEU . 3.7 m -88.94 122.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 111.192 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.858 HG23 HG12 ' A' ' 45' ' ' ILE . 19.8 mt -129.6 119.56 48.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 t -80.82 113.5 19.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.399 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 p -86.55 -23.03 25.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.798 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.654 HG21 ' OG ' ' A' ' 142' ' ' SER . 81.7 p -79.91 -2.65 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.714 0.292 . . . . 0.0 111.487 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.84 75.42 0.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.551 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' CB ' HD11 ' A' ' 141' ' ' LEU . 9.6 mt-30 -145.29 -40.49 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 111.09 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.4 mt -125.1 142.74 42.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 43' ' ' ILE . 39.1 Cg_endo -69.19 145.27 59.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.203 1.935 . . . . 0.0 112.266 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.858 HG12 HG23 ' A' ' 37' ' ' ILE . 33.3 mt -58.9 150.88 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.738 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -142.27 164.35 30.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.301 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -122.8 119.76 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 0.0 111.756 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.773 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -100.02 133.17 44.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.139 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.855 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.71 156.82 43.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.828 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.575 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 10.2 ttpt . . . . . 0 N--CA 1.463 0.21 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 91' ' ' ILE . 9.7 p -110.61 139.34 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.94 139.51 36.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.437 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.683 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.71 129.48 56.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -118.11 145.27 45.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.881 0.372 . . . . 0.0 111.669 -178.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.54 -172.28 40.25 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.774 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -78.96 0.15 28.65 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.7 135.32 40.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 111.478 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.7 Cg_exo -66.37 -12.95 37.78 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.789 2.326 . . . . 0.0 111.84 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.5 -44.92 15.36 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.874 0.845 . . . . 0.0 108.965 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.15 141.87 1.12 Allowed 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.818 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.0 m-20 -56.22 -18.77 11.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.149 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.52 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.8 t80 -129.36 127.03 40.22 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-O 120.762 0.315 . . . . 0.0 110.693 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.278 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 84' ' ' LEU . 25.0 mt . . . . . 0 N--CA 1.46 0.052 0 CA-C-O 120.92 0.39 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -54.76 -35.8 64.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -63.6 -42.11 98.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 81' ' ' ILE . 53.3 mt -72.91 152.13 41.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -94.39 167.33 11.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.718 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -42.95 -54.82 4.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.413 0.625 . . . . 0.0 109.769 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.683 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -119.02 82.95 1.95 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 177.214 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -58.52 -46.53 86.56 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.411 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -142.41 160.26 40.62 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.794 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.662 ' HG2' HG22 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.95 142.7 44.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.919 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 65' ' ' VAL . 62.1 mt -118.83 129.36 75.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.601 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.9 pt? -118.65 140.61 49.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.842 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.493 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.7 tp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.972 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.714 ' HB3' HD13 ' A' ' 124' ' ' LEU . 2.1 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.76 0.314 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.6 mp -129.43 142.62 50.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.138 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.5 HD11 HG12 ' A' ' 130' ' ' ILE . 1.4 tt -112.63 122.39 47.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.629 ' HB2' HD22 ' A' ' 92' ' ' LEU . 50.2 t30 -113.23 115.49 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.39 . . . . 0.0 111.402 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.761 ' OD2' HG23 ' A' ' 116' ' ' VAL . 18.0 p30 -79.96 134.37 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.875 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.1 pt -142.34 40.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.581 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 158.08 15.99 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.082 0.468 . . . . 0.0 111.435 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.83 -35.71 77.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.443 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.6 -19.8 17.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.581 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.62 161.31 11.41 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.41 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.52 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.24 148.36 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.05 113.39 18.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.086 177.287 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 54.1 m-20 44.99 43.02 6.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -7.05 81.28 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.569 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.61 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.704 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 22.1 tptt -75.1 125.44 28.94 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.18 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.761 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.2 m -99.65 165.95 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 120' ' ' SER . 21.9 tt0 -69.88 128.75 37.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.372 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -54.03 163.75 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.93 37.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.5 p -111.64 145.06 39.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' HB3' HD23 ' A' ' 100' ' ' LEU . 6.9 m-80 -91.43 124.35 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -129.25 147.13 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.867 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp -72.97 113.47 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -55.35 167.39 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.643 0.735 . . . . 0.0 111.823 -179.145 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.27 153.22 43.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.476 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.59 121.48 18.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.09 22.4 62.71 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.073 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 144' ' ' VAL . 6.8 t70 -60.5 177.16 0.3 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.838 0.352 . . . . 0.0 110.919 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.0 tt0 -145.16 135.66 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.501 ' CG2' HG22 ' A' ' 109' ' ' THR . 1.5 mt -108.72 127.04 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.105 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.34 136.44 43.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.109 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.524 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.2 m -140.28 158.51 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.46 29.35 30.33 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.072 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.8 t -68.12 140.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.605 0.717 . . . . 0.0 112.406 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.42 -41.46 0.75 Allowed Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 138' ' ' SER . 47.8 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -50.55 -35.1 28.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.868 0.366 . . . . 0.0 111.331 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.54 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.5 t -93.57 6.33 48.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.466 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.4 t0 -120.2 21.9 11.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.678 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.6 mt -105.09 139.71 25.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.95 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.68 HD12 HD11 ' A' ' 81' ' ' ILE . 4.3 tt -122.34 134.4 54.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.654 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.73 133.58 53.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.086 0.47 . . . . 0.0 111.571 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 34.6 mt -126.1 133.23 51.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 128' ' ' ASP . 21.5 t -110.78 140.03 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 111.485 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 91' ' ' ILE . 9.2 mt -106.31 139.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.932 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.24 103.91 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 126' ' ' GLN . 8.7 mt -88.31 118.4 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.094 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -75.88 127.66 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.02 -21.71 64.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -44.15 85.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.016 0.436 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.0 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.732 179.832 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.762 0.315 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -40.5 85.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -38.4 90.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -40.78 96.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.627 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.0 mm -67.62 -48.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -33.65 72.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.35 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -47.14 85.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.017 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.627 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.6 p90 . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.146 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.697 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm . . . . . 0 N--CA 1.429 -1.495 0 CA-C-O 121.493 0.663 . . . . 0.0 112.601 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.007 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.65 -59.67 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.35 147.41 29.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.328 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.97 136.59 52.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.609 HG21 ' HE2' ' A' ' 68' ' ' PHE . 10.7 t -103.23 122.52 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.804 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.832 HG23 HG12 ' A' ' 45' ' ' ILE . 15.2 mt -126.59 127.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.358 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' HD21 ' A' ' 141' ' ' LEU . 8.0 t -93.31 115.67 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.596 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.4 t -88.88 -22.64 23.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.428 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.674 HG23 ' HB2' ' A' ' 142' ' ' SER . 67.4 p -79.82 -2.69 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.3 . . . . 0.0 111.48 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.54 71.82 0.83 Allowed Glycine 0 N--CA 1.454 -0.106 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.947 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.682 ' HB2' HD21 ' A' ' 141' ' ' LEU . 4.5 mt-30 -142.9 -40.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.545 HD12 HD21 ' A' ' 143' ' ' LEU . 11.7 mt -122.88 140.77 33.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.66 141.79 28.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.165 1.91 . . . . 0.0 112.076 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.832 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -53.53 149.85 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.696 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -143.32 164.18 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.316 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -122.13 119.85 32.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.068 0.461 . . . . 0.0 111.962 -179.476 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.2 mt -98.51 136.69 38.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.007 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.2 158.79 44.07 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.796 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.712 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.79 0.328 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.613 HG12 ' HG2' ' A' ' 90' ' ' GLN . 7.3 t -127.89 138.19 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.175 0.512 . . . . 0.0 111.739 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.523 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.1 m-90 -100.85 139.12 36.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.207 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.673 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.12 125.94 54.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -112.96 145.68 40.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.475 -178.602 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.67 -169.1 38.54 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.711 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.9 mtp-105 -82.56 0.73 41.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 30.5 t-20 -84.96 132.63 45.21 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.057 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.6 Cg_exo -67.67 -10.26 28.16 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 111.656 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.54 16.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.898 0.856 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.46 139.09 1.15 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.342 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.15 -18.79 11.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.794 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.491 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.8 131.99 46.36 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.127 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.572 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.443 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 28.6 mm . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.871 0.367 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 m -54.87 -43.43 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.482 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.402 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.5 mmp_? -60.78 -18.19 53.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.411 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD12 ' HB ' ' A' ' 81' ' ' ILE . 17.6 mt -103.48 147.08 27.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.882 0.372 . . . . 0.0 110.722 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m -93.56 164.74 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.765 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.82 -52.47 5.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.578 ' HB3' HG22 ' A' ' 67' ' ' THR . 8.4 mttp -120.45 82.4 1.9 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -60.46 -45.91 91.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.714 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.1 p90 -145.07 158.95 43.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.648 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.673 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.64 140.94 44.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.0 mt -117.31 132.04 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.098 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -109.98 147.11 34.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.073 0.463 . . . . 0.0 111.652 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.699 HD22 HG11 ' A' ' 33' ' ' VAL . 26.9 tp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.641 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.759 0.314 . . . . 0.0 110.962 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.641 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.5 mp -132.98 141.96 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.522 ' CD2' HD11 ' A' ' 130' ' ' ILE . 4.5 mp -112.56 127.35 56.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.155 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.5 t30 -115.89 115.58 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 111.702 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.0 p30 -77.37 135.33 38.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.676 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.0 pt -143.94 41.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.87 161.13 13.8 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.096 0.474 . . . . 0.0 111.503 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.91 -38.8 79.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.698 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.63 -19.7 17.4 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.99 161.81 11.24 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.088 -1.053 . . . . 0.0 114.01 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 17.4 m -117.6 137.87 52.32 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.224 0.61 . . . . 0.0 109.565 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.11 148.43 37.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.3 OUTLIER -124.65 113.52 18.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.606 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 47.05 42.26 12.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.0 -10.15 71.76 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.863 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.777 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -105.52 118.7 37.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.245 0.523 . . . . 0.0 110.765 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -73.13 134.43 44.46 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.349 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.825 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -107.01 166.58 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.334 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 mm-40 -69.88 123.96 22.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.553 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 75.7 tttt -52.95 163.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.513 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 36.09 33.19 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.032 -179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.35 145.08 40.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.105 179.381 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -91.78 131.94 36.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.955 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 62.0 mm-40 -129.37 151.79 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.644 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.7 tt -72.83 133.33 44.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.238 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.648 HD11 HG21 ' A' ' 145' ' ' ILE . 66.9 tp -65.15 154.85 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.512 0.672 . . . . 0.0 111.668 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.409 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.92 153.09 43.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -72.0 123.69 23.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.358 . . . . 0.0 110.106 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.43 47.4 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.173 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -51.11 172.21 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.834 0.35 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.844 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.8 mt-10 -144.87 135.56 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.028 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.522 HD11 ' CD2' ' A' ' 101' ' ' LEU . 5.5 mt -118.51 124.84 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.32 140.47 37.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.896 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.29 158.26 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.61 30.23 24.77 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.873 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.588 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.7 t -71.17 140.44 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.645 0.736 . . . . 0.0 112.385 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.4 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 154.06 -38.52 0.69 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.341 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 138' ' ' SER . 50.4 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.59 -37.03 37.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.793 0.33 . . . . 0.0 111.479 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.6 m -93.53 6.52 47.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -124.34 26.51 7.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.5 mt -105.93 139.68 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.634 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 42' ' ' GLN . 1.2 tt -120.93 134.16 55.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.069 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.674 ' HB2' HG23 ' A' ' 40' ' ' THR . 3.0 m -108.56 143.71 37.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.0 mm? -135.48 144.18 46.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.534 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.844 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.3 t -114.13 136.53 50.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.037 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.648 HG21 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -106.57 126.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.436 ' CD1' HD12 ' A' ' 37' ' ' ILE . 5.4 m-85 -112.95 121.78 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.665 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.532 HG12 HD21 ' A' ' 124' ' ' LEU . 3.5 mt -85.05 134.14 27.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.395 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.85 109.0 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -62.15 -42.44 99.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -46.02 90.8 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.3 t80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.835 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.77 0.319 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -62.84 -35.99 81.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.5 -38.65 91.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 tp -63.05 -45.05 94.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.1 mm -66.98 -34.99 73.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -40.22 76.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.987 0.422 . . . . 0.0 110.445 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -67.26 -23.84 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.53 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.198 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm . . . . . 0 N--CA 1.428 -1.561 0 CA-C-O 121.527 0.679 . . . . 0.0 112.561 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.015 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -89.92 -61.02 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.28 148.42 28.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.308 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -115.92 127.7 55.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 68' ' ' PHE . 43.5 t -97.27 122.75 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 111.02 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.908 HG23 HG12 ' A' ' 45' ' ' ILE . 12.3 mt -120.62 128.45 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.73 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.3 t -81.87 121.51 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.475 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.5 t -88.15 -27.12 22.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.634 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 142' ' ' SER . 35.4 p -79.94 -2.17 42.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.545 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 77.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.84 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -146.86 -44.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.574 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -113.54 141.51 26.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.91 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.574 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.6 Cg_endo -71.14 145.81 50.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.017 1.811 . . . . 0.0 112.037 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.908 HG12 HG23 ' A' ' 37' ' ' ILE . 39.0 mt -56.69 143.91 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.916 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.03 163.3 33.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.813 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.67 120.53 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 112.178 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.746 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.8 mp -84.7 128.3 34.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.015 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -133.48 155.92 48.69 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.904 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.304 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.2 ttpt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.72 0.295 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 90' ' ' GLN . 9.6 t -131.1 139.21 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.746 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.2 m-90 -103.38 139.51 38.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.057 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.697 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.93 127.19 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.154 0.502 . . . . 0.0 110.223 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.583 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -113.6 146.26 40.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 169.61 -174.87 43.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.487 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -87.06 45.65 1.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.495 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -141.11 139.07 18.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.27 -6.48 17.49 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.875 2.383 . . . . 0.0 111.904 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.33 11.14 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.88 0.848 . . . . 0.0 109.279 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.95 141.81 1.05 Allowed 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.96 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.41 -19.27 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.966 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 44.8 t80 -129.89 122.68 29.11 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.797 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.793 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.827 0.346 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.5 p -55.21 -34.65 64.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.86 -23.26 65.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.206 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 132' ' ' VAL . 14.5 mt -97.49 147.73 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 111.084 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.17 164.75 12.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.998 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.639 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.44 -52.05 4.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.447 0.641 . . . . 0.0 109.847 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -120.51 79.92 1.55 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.5 t60 -60.87 -47.23 87.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.538 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 17.5 p90 -146.48 159.07 43.89 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.552 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.84 141.2 44.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.656 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 65' ' ' VAL . 37.2 mt -115.48 130.51 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.075 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.954 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -122.39 139.21 54.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.047 0.451 . . . . 0.0 111.839 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.809 HD22 ' CG1' ' A' ' 33' ' ' VAL . 4.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.967 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.851 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.876 0.37 . . . . 0.0 110.777 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.659 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -123.18 139.38 54.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -112.8 120.06 40.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.981 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.954 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.7 t30 -116.82 119.97 37.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.402 . . . . 0.0 112.057 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.829 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.3 p30 -79.87 141.0 36.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.982 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -147.06 36.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.428 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.651 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.53 149.81 21.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.128 0.489 . . . . 0.0 112.043 -178.688 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.0 m -68.62 -31.55 70.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.682 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -97.18 -19.75 18.41 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.652 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.651 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.12 156.15 10.42 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.604 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.9 m -117.45 137.81 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.876 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.31 148.62 37.24 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.35 18.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.452 177.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.8 m120 43.43 43.74 4.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.499 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.3 -13.71 62.9 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.418 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -103.38 118.54 36.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.027 0.442 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.876 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.6 tptm -72.66 127.6 33.05 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.829 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.0 m -97.89 162.95 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.6 tt0 -69.99 126.9 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.489 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.655 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttm -52.09 160.79 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.7 p-10 35.75 33.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.41 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 118.04 34.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.106 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.769 ' OD1' HD11 ' A' ' 92' ' ' LEU . 18.9 m-80 -66.01 135.16 54.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 33.1 mm-40 -129.48 151.14 50.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.8 tm? -72.77 132.71 43.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' A' ' 99' ' ' LEU . 44.0 tp -58.1 152.56 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.713 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.42 152.63 44.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.645 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -72.51 123.35 22.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.253 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.31 23.42 41.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.085 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.7 t70 -49.12 167.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.015 0.436 . . . . 0.0 111.429 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.909 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.4 mt-10 -144.8 135.44 24.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.007 HD11 HD11 ' A' ' 145' ' ' ILE . 1.1 mp -117.35 127.81 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.748 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.624 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.67 138.12 41.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.933 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 84' ' ' LEU . 34.8 m -140.31 158.06 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 30.93 25.2 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.811 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -70.83 140.41 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 112.452 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.48 -41.0 0.47 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 138' ' ' SER . 49.2 t -126.47 134.74 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 115.1 -0.55 . . . . 0.0 109.519 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -38.67 48.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.781 0.325 . . . . 0.0 111.467 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.496 ' H ' HG12 ' A' ' 136' ' ' VAL . 57.9 m -93.42 6.32 48.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.9 t0 -121.36 26.95 8.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.1 139.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.948 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 134.43 55.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.611 ' C ' HD22 ' A' ' 143' ' ' LEU . 47.3 t -112.11 150.78 30.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.518 0.675 . . . . 0.0 112.282 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -135.62 155.53 50.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.909 HG22 ' CG ' ' A' ' 129' ' ' GLU . 19.2 t -125.6 140.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.825 0.345 . . . . 0.0 111.431 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.007 HD11 HD11 ' A' ' 130' ' ' ILE . 34.0 mt -106.46 123.08 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.165 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.524 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -109.98 116.83 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.763 HG12 HD21 ' A' ' 124' ' ' LEU . 4.4 mt -86.27 134.21 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.608 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.78 122.91 27.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.649 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.28 -36.82 77.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -59.12 -45.37 91.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 110.719 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.9 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.904 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.8 0.333 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.4 36.92 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.811 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.95 -43.89 94.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.617 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -35.68 74.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.81 -42.38 79.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -32.46 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.16 -35.39 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.808 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -57.26 -39.18 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 110.434 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -67.09 -24.05 65.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.66 -47.47 79.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.233 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.4 p -66.9 -28.07 68.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 64.48 -174.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.83 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.93 127.78 32.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.51 120.12 25.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.816 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mm -83.12 138.34 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.679 0.752 . . . . 0.0 111.873 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . 115.63 25.35 3.73 Favored Glycine 0 C--N 1.314 -0.657 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.556 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.12 -23.64 22.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.69 0.281 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.87 -23.8 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.298 0.571 . . . . 0.0 110.977 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.771 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -70.05 101.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.077 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -58.02 -66.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.193 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.749 ' SG ' HG23 ' A' ' 147' ' ' ILE . 91.1 m -152.23 165.13 35.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.836 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -125.86 138.03 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.072 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.751 HG23 HD11 ' A' ' 48' ' ' LEU . 21.7 t -102.57 123.81 56.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.768 HG23 HG12 ' A' ' 45' ' ' ILE . 11.4 mt -123.14 124.94 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.483 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.1 t -81.71 123.04 28.39 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 t -86.72 -28.92 22.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 142' ' ' SER . 36.8 p -79.91 -2.13 42.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.688 0.28 . . . . 0.0 111.552 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.75 77.0 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -145.36 -43.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.885 HD12 HD21 ' A' ' 143' ' ' LEU . 3.0 mt -111.35 140.85 23.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.3 Cg_endo -72.52 131.43 17.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.127 1.884 . . . . 0.0 111.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.768 HG12 HG23 ' A' ' 37' ' ' ILE . 32.6 mt -51.84 131.56 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.659 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.87 164.21 19.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.251 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -117.84 120.1 36.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 111.536 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.751 HD11 HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -97.64 134.87 40.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.426 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.864 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.79 157.25 43.63 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -143.03 142.11 31.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.74 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -74.98 133.3 41.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.154 0.502 . . . . 0.0 111.265 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.725 HD13 ' SG ' ' A' ' 154' ' ' CYS . 88.6 mt -64.58 -44.8 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.072 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.3 m -56.88 -39.39 74.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.35 0.595 . . . . 0.0 110.724 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.444 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 6.5 mm100 -68.55 -36.78 79.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.616 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.7 t -69.79 -43.77 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.066 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 tp -70.88 -32.11 68.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -30.95 65.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.996 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.17 116.85 27.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -114.95 31.71 6.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.712 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 60' ' ' ARG . 5.1 mtm105 -168.0 148.35 4.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.734 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.27 -165.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.766 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.535 HG21 HG22 ' A' ' 65' ' ' VAL . 40.5 mm -91.21 156.29 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.15 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' HG2' HG13 ' A' ' 55' ' ' VAL . 6.5 mptt -90.41 -63.85 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.6 ttpt -145.33 132.92 20.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.659 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.5 t -124.87 139.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 111.983 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.574 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.7 m-90 -100.9 139.23 36.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.435 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.92 128.45 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.312 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.25 145.52 43.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.624 -177.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.76 -169.61 40.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.722 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 3.4 mtp-105 -83.25 -1.62 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.76 136.22 39.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 111.602 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.1 Cg_exo -67.44 -10.57 29.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.843 2.362 . . . . 0.0 111.979 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.55 -44.47 15.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.84 0.829 . . . . 0.0 109.02 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.78 139.31 2.33 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.42 -18.21 10.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.955 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -129.18 118.67 22.77 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.79 118.84 28.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.586 HD13 ' CA ' ' A' ' 69' ' ' GLY . 8.5 mp -89.99 -177.17 5.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.578 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.03 -82.55 0.38 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.275 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.6 OUTLIER 176.32 68.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 110.702 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp -107.49 112.9 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.413 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.7 m -54.79 -34.94 63.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.067 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -26.63 67.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 81' ' ' ILE . 33.1 mt -91.63 152.18 20.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -93.64 167.25 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -42.95 -54.12 4.39 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.374 0.607 . . . . 0.0 109.77 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.65 82.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.2 -46.25 88.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.836 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.5 p90 -143.57 159.84 41.71 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.13 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.7 tt0 -135.77 143.05 45.05 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.385 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.586 ' C ' HG13 ' A' ' 65' ' ' VAL . 49.6 mt -118.69 127.86 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.973 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.641 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -114.11 141.81 47.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 111.956 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 33' ' ' VAL . 7.5 tp -125.22 122.88 38.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.229 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.93 -129.42 1.79 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.59 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 62.7 -79.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.702 0.286 . . . . 0.0 110.852 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.26 -41.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.41 -33.85 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -63.73 -174.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.632 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -115.65 156.96 24.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.002 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.0 mm? -130.31 145.41 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.316 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.77 121.37 44.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.888 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.641 ' HB2' HD23 ' A' ' 92' ' ' LEU . 49.6 t30 -116.81 115.66 25.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.789 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.849 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.7 p30 -78.96 136.62 37.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.751 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.8 pt -144.26 39.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.65 152.63 19.85 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.157 0.504 . . . . 0.0 111.956 -179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.0 m -68.79 -31.57 70.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.809 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.07 -19.97 17.64 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.628 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.53 157.04 10.58 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.695 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.38 137.71 52.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.04 148.56 40.06 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.556 177.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.5 m120 44.39 43.64 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.96 -13.16 61.93 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.435 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.26 118.53 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.467 . . . . 0.0 110.465 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.66 129.26 38.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.52 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.849 HG23 ' OD2' ' A' ' 103' ' ' ASP . 17.4 m -97.84 163.45 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.91 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.71 125.34 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.487 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.1 tttt -52.25 161.27 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.755 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.19 34.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.21 145.03 40.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.145 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.501 ' HB3' HD12 ' A' ' 100' ' ' LEU . 70.5 m-20 -85.69 129.13 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.758 ' O ' HD13 ' A' ' 100' ' ' LEU . 6.7 mm100 -129.09 146.23 51.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.548 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.6 tm? -72.75 111.97 8.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.246 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.712 HD11 HG21 ' A' ' 145' ' ' ILE . 66.0 tp -50.66 157.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.397 0.618 . . . . 0.0 111.646 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.4 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -124.45 153.13 42.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.6 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.668 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.73 124.75 25.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.83 20.91 50.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t70 -55.79 174.96 0.1 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.934 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.6 mt-10 -145.04 135.7 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.316 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 145' ' ' ILE . 5.6 mt -111.59 126.99 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.624 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.65 137.23 42.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.944 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.637 HG23 HD21 ' A' ' 84' ' ' LEU . 34.8 m -140.47 158.32 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.29 22.81 42.87 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.324 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.4 t -62.62 140.33 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.663 0.744 . . . . 0.0 112.388 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -43.98 0.57 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.211 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.47 138.32 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -38.42 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.71 0.291 . . . . 0.0 111.584 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.449 ' H ' HG12 ' A' ' 136' ' ' VAL . 7.9 t -93.55 6.2 49.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 133' ' ' GLY . 3.2 m-20 -116.31 22.52 12.8 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.06 139.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.22 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 142' ' ' SER . 9.2 tt -124.48 134.27 53.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.243 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.507 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.9 t -111.28 150.54 29.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.716 0.769 . . . . 0.0 112.211 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.885 HD21 HD12 ' A' ' 43' ' ' ILE . 66.8 mt -135.38 156.57 48.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.67 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.934 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.9 t -125.68 137.54 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 130' ' ' ILE . 36.5 mt -106.48 120.96 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.01 122.39 46.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.749 HG23 ' SG ' ' A' ' 34' ' ' CYS . 3.4 mp -112.91 134.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.482 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.434 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 28.7 p30 -93.52 135.46 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -74.02 -21.34 60.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -58.22 -44.23 88.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -58.37 -44.02 88.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.753 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -33.95 76.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -60.5 -47.0 88.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.725 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.4 t -59.79 -45.96 90.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.972 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -60.19 -46.01 91.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.755 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -67.74 -43.76 79.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.824 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -22.15 66.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.091 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -125.09 98.43 5.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.895 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -85.67 150.41 24.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 160' ' ' VAL . 10.2 m -73.19 132.74 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.156 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.03 159.38 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.72 77.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 pp -81.61 136.65 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.972 179.909 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 14.3 mttt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.872 0.368 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 113.01 3.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.82 176.6 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 1.3 m -92.57 148.55 21.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -65.71 163.17 17.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -101.95 -60.65 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.69 90.47 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.43 2.087 . . . . 0.0 112.286 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 38.5 m -81.06 123.15 28.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.11 126.92 85.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.47 106.99 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.303 2.002 . . . . 0.0 112.264 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 3.5 pp -173.42 -179.37 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.955 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.87 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.7 p -103.92 -53.16 2.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -67.79 -43.48 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -42.58 99.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -38.62 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.555 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 19' ' ' LEU . 13.8 tp -58.1 -31.94 67.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.49 -35.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.726 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.67 -36.18 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.309 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.56 -47.45 79.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.217 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -30.78 71.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -74.02 154.75 39.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -101.02 158.04 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.84 137.96 34.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.65 138.57 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.547 0.689 . . . . 0.0 111.836 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -68.82 64.37 0.47 Allowed Glycine 0 C--N 1.315 -0.584 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.34 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -42.38 99.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.591 0.234 . . . . 0.0 111.401 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.6 m-20 179.68 39.75 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -71.47 142.42 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.284 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.685 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.43 -50.48 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.974 -178.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -163.11 146.17 10.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.204 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -113.88 131.45 56.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.286 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 ' HE2' ' A' ' 68' ' ' PHE . 28.7 t -97.8 122.79 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 25.3 mt -123.34 119.56 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.269 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.643 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.5 t -80.48 121.05 25.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.451 ' CG2' HG21 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -91.23 -27.72 18.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.422 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 142' ' ' SER . 69.2 p -80.31 -2.96 47.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.686 0.279 . . . . 0.0 111.556 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.86 80.74 0.2 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.375 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.777 ' OE1' HD13 ' A' ' 141' ' ' LEU . 15.2 mt-30 -149.62 -45.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.862 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.882 HD13 HD22 ' A' ' 78' ' ' LEU . 3.8 mt -115.02 141.16 26.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.68 139.81 28.52 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.169 1.913 . . . . 0.0 112.125 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -55.23 135.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.725 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -134.37 164.02 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.209 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.2 119.72 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 36' ' ' VAL . 5.7 mt -90.6 137.49 32.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.618 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.44 157.37 45.24 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.685 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -149.98 141.91 23.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.3 -1.773 . . . . 0.0 110.497 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -81.09 133.17 35.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.264 0.554 . . . . 0.0 111.197 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.759 HD13 ' SG ' ' A' ' 154' ' ' CYS . 44.1 mt -64.86 -43.13 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.542 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.6 m -58.44 -42.73 87.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.623 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 3.7 pt20 -68.43 -36.87 79.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.563 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.7 t -68.05 -47.48 78.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.29 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -29.56 69.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.156 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -44.39 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.007 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.96 131.56 49.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.7 53.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.36 -174.86 2.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -59.64 -32.68 70.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.571 HD13 HD12 ' A' ' 92' ' ' LEU . 8.5 tp -152.55 159.69 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.161 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.758 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -102.1 -72.9 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -130.27 132.2 45.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.413 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.4 t -129.95 139.61 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.293 0.568 . . . . 0.0 111.809 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.559 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.3 m-90 -100.24 139.68 35.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.146 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.23 131.94 54.59 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 0.0 111.624 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.74 -174.43 41.44 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.554 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.6 mtm105 -81.52 -0.78 43.54 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.77 135.66 40.02 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.666 0.269 . . . . 0.0 111.273 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.52 -7.53 20.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.728 2.285 . . . . 0.0 111.876 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.42 15.63 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.977 0.894 . . . . 0.0 108.936 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.73 137.33 5.46 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.646 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.45 -18.81 12.52 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.853 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.3 t80 -129.86 117.25 19.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.887 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -90.66 107.73 19.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.496 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.882 HD22 HD13 ' A' ' 43' ' ' ILE . 51.7 mt -78.93 -71.63 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.164 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.38 -100.9 0.14 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.1 p30 -175.32 47.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 111.225 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 84' ' ' LEU . 31.5 mt -80.77 126.14 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.916 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -43.17 73.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.343 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -44.15 97.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.654 ' CD1' HD12 ' A' ' 81' ' ' ILE . 46.5 mt -72.77 152.18 41.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.188 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.5 p -95.49 165.5 12.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.741 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.39 -53.01 5.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.344 0.593 . . . . 0.0 109.627 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.6 ' HB3' HG22 ' A' ' 67' ' ' THR . 17.1 mttt -119.69 84.57 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -63.99 -45.27 89.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.095 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.6 p90 -150.99 162.39 40.92 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.155 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.691 ' CD ' HG23 ' A' ' 67' ' ' THR . 11.6 mt-30 -135.49 158.27 44.8 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.378 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.53 ' O ' HG13 ' A' ' 65' ' ' VAL . 64.2 mt -127.45 132.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.957 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.776 ' CD1' HD13 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -113.72 144.46 42.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.731 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.605 HD13 ' C ' ' A' ' 93' ' ' LEU . 3.2 tm? -119.71 123.14 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.521 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.55 -120.95 0.77 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.379 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 56.27 -176.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 111.078 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -47.95 58.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.483 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -156.56 55.95 0.39 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.509 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -177.24 -176.44 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.727 0.299 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.073 HD11 HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -128.47 160.44 32.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.047 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.776 HD13 ' CD1' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.55 149.44 50.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.506 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.872 HD21 HD12 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -110.52 131.59 54.92 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' HD22 ' A' ' 92' ' ' LEU . 46.9 t30 -113.28 115.92 28.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.849 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.1 p30 -76.65 143.06 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 87' ' ' LYS . 10.0 pt -150.75 37.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.06 158.82 15.25 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.047 0.451 . . . . 0.0 111.807 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.9 m -68.92 -35.31 76.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.587 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -20.04 17.3 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.538 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.33 163.36 11.96 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.488 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 20.8 m -117.53 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.842 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -114.36 148.4 37.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.17 113.43 18.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.281 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 43.72 43.4 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.48 -12.43 66.84 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.482 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -104.96 118.53 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.067 0.461 . . . . 0.0 110.642 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.19 134.9 45.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.501 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.849 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -105.01 164.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.4 tp10 -69.95 125.07 25.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.6 tttt -51.82 160.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.6 p-10 35.89 33.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.54 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.57 145.09 40.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 179.227 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -86.81 129.79 34.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.789 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.6 mm-40 -127.53 147.74 50.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.409 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.58 120.95 18.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.539 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.073 HD22 HD11 ' A' ' 99' ' ' LEU . 5.9 tp -58.89 155.94 12.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.486 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.573 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.3 t -124.25 153.43 41.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.342 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 2.0 tp-100 -71.41 123.99 23.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.28 22.17 42.99 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.276 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.7 t70 -58.14 174.56 0.27 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -145.2 135.46 24.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.146 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.437 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.0 mt -111.59 128.39 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.261 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.663 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.08 138.85 40.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.543 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 30.3 m -140.15 158.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.89 22.37 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.85 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.579 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.32 140.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 121.598 0.713 . . . . 0.0 112.442 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.37 -39.87 0.7 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 138' ' ' SER . 52.0 t -126.59 128.62 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.48 -34.68 25.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 136' ' ' VAL . 87.4 p -93.54 6.3 48.69 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 7.5 t0 -124.18 24.85 8.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.663 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.9 mt -104.78 139.61 25.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.823 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.777 HD13 ' OE1' ' A' ' 42' ' ' GLN . 25.3 tp -117.54 134.75 54.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.956 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.663 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.8 OUTLIER -111.54 135.47 52.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.547 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.643 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.9 mm? -131.04 138.48 49.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 39' ' ' THR . 21.4 t -110.84 138.7 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.339 . . . . 0.0 110.927 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 124' ' ' LEU . 6.6 mt -106.26 139.01 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -119.9 119.88 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.762 HG12 HD21 ' A' ' 124' ' ' LEU . 3.4 mt -85.62 134.17 27.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.553 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.55 107.48 13.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -58.21 -32.18 68.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -60.25 -45.92 91.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -59.64 -44.09 93.63 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.074 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -35.13 79.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.023 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -40.73 92.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.125 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.759 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.2 t -66.62 -45.09 80.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.951 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.483 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -65.75 -35.99 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.02 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.28 -39.37 93.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.018 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -86.72 -36.39 18.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.67 39.87 1.8 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.508 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.43 147.78 38.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.824 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.5 m -71.8 136.97 24.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -172.4 134.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.7 103.16 15.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.57 131.57 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 2.8 mttp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.787 0.327 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 13.3 mttm 62.11 150.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 5.1 mmt -147.29 -47.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' THR . . . . . 0.414 ' O ' ' N ' ' B' ' 170' ' ' GLN . 2.6 m 62.06 116.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 66.53 -68.93 0.13 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.916 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' B' ' 168' ' ' THR . 2.8 tt0 64.43 48.85 2.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.982 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.75 125.6 14.66 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.583 2.189 . . . . 0.0 112.472 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 21.2 p -89.04 -55.13 3.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.992 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.8 108.36 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.57 154.24 71.99 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.424 2.083 . . . . 0.0 112.231 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mt 59.77 179.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.823 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.906 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.622 ' HB1' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.812 0.339 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.1 p -69.32 -50.07 49.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.45 -40.43 91.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.622 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -68.61 -42.62 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.924 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.65 -38.08 74.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -31.81 70.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.19 -35.54 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.49 -39.96 77.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -67.1 -23.87 65.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.7 -47.49 79.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 p -67.04 -37.29 83.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.79 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.47 81.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.989 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -99.94 125.33 45.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.67 101.85 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.1 mm -87.69 138.27 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-O 121.728 0.775 . . . . 0.0 111.737 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 126.33 99.24 1.12 Allowed Glycine 0 C--N 1.315 -0.615 0 CA-C-N 114.458 -1.247 . . . . 0.0 112.526 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.16 -39.57 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.74 0.305 . . . . 0.0 110.995 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -171.4 34.03 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.4 mm -72.58 135.76 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.575 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.006 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -93.53 -59.46 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.643 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.68 ' SG ' HD13 ' A' ' 99' ' ' LEU . 4.7 m -152.81 150.48 29.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.383 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -115.18 131.71 56.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.777 0.322 . . . . 0.0 111.248 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.746 HG21 ' HE2' ' A' ' 68' ' ' PHE . 43.8 t -96.18 122.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.053 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.839 HG23 HG12 ' A' ' 45' ' ' ILE . 16.5 mt -124.01 121.38 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.5 t -82.04 121.65 26.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.459 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.58 -25.1 16.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.501 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.599 HG21 ' OG ' ' A' ' 142' ' ' SER . 5.9 p -80.04 -2.38 44.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.663 0.268 . . . . 0.0 111.386 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.09 78.98 0.21 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.851 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 15.5 mt-30 -149.38 -40.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.992 HD13 HD22 ' A' ' 78' ' ' LEU . 9.2 mt -124.2 141.68 37.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.97 146.13 41.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.193 1.928 . . . . 0.0 112.12 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.839 HG12 HG23 ' A' ' 37' ' ' ILE . 33.8 mt -60.3 146.32 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.647 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 1.5 ttt180 -140.31 163.23 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.07 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.29 119.8 36.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 111.843 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.619 HD11 HG23 ' A' ' 36' ' ' VAL . 4.6 mt -93.25 137.42 32.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.273 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.006 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.39 157.32 43.76 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.29 141.89 27.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.854 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.893 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 m-20 -77.78 129.82 35.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.101 0.476 . . . . 0.0 111.023 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 52' ' ' ILE . 3.8 mp -64.39 -45.02 97.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.531 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -57.0 -42.1 79.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.398 0.618 . . . . 0.0 110.914 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 22.1 mt-30 -68.51 -37.07 79.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.977 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.7 t -68.79 -49.17 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.017 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -29.17 68.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -74.36 -39.37 62.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.91 135.84 40.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.0 31.25 6.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -101.84 -176.98 3.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.84 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -79.54 -24.01 42.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.412 ' CG1' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.71 137.35 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.756 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -109.23 -61.77 1.58 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 49' ' ' SER . 8.6 ttpt -136.0 116.47 13.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.227 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.749 HG22 ' HG2' ' A' ' 90' ' ' GLN . 13.9 p -110.44 140.23 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.568 ' HH2' HG21 ' A' ' 33' ' ' VAL . 13.5 m-90 -100.22 139.22 36.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.852 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.85 128.74 56.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.746 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -116.61 145.63 43.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.353 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.37 -170.0 39.38 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.788 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.9 mtp-105 -81.22 1.17 33.38 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 140.32 37.92 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.661 0.267 . . . . 0.0 110.903 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.27 -11.69 22.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.511 2.141 . . . . 0.0 111.354 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.7 18.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.12 138.31 3.01 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.317 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.36 -18.53 11.21 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.874 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.498 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 3.7 t80 -129.54 127.97 41.82 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.713 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.55 107.98 19.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.751 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.992 HD22 HD13 ' A' ' 43' ' ' ILE . 27.4 mt -77.49 -72.64 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.362 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.02 -96.31 0.1 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.363 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -173.62 51.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.801 0.334 . . . . 0.0 111.345 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.858 HD12 HD11 ' A' ' 84' ' ' LEU . 41.1 mt -90.33 121.16 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.612 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.55 -35.63 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.279 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.48 HH11 HG23 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -61.03 -45.65 93.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.834 0.349 . . . . 0.0 110.699 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.858 HD11 HD12 ' A' ' 81' ' ' ILE . 16.1 mt -75.32 148.29 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -93.7 167.13 11.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.54 -53.62 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.393 0.616 . . . . 0.0 109.834 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.38 82.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.4 t60 -58.8 -46.26 88.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.772 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.7 p90 -144.7 162.19 37.32 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.099 -0.641 . . . . 0.0 112.121 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 65' ' ' VAL . 2.8 tt0 -135.59 146.79 48.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.09 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 65' ' ' VAL . 64.8 mt -123.14 130.42 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.506 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.442 HD12 ' CB ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -124.99 141.03 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.222 0.534 . . . . 0.0 112.188 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.406 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.13 123.12 39.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.778 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.63 -140.28 4.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.074 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.47 -168.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 111.264 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t70 73.53 -62.29 0.47 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.002 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.8 -32.38 2.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.349 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.08 -176.51 5.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.754 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.868 HD11 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -107.19 154.74 20.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.8 mp -121.4 142.46 49.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.31 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.561 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -112.71 124.13 51.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.478 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.2 t30 -116.05 115.51 26.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.493 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.5 p30 -79.16 137.7 37.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.0 pt -146.61 40.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.85 160.18 14.51 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.971 0.415 . . . . 0.0 111.681 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.452 HG22 ' HB ' ' B' ' 173' ' ' THR . 88.3 m -68.94 -36.44 77.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.46 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.94 17.26 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.52 163.94 12.29 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.581 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.51 137.89 52.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.828 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.94 148.46 36.8 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.11 113.43 18.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.039 177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 45.09 42.39 6.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.265 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.78 -7.98 79.29 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.499 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.05 118.47 36.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.174 0.487 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.828 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.14 129.76 38.77 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.297 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -101.8 166.71 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.272 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.8 tp10 -70.02 126.17 28.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.3 tttt -52.78 162.65 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.227 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.91 36.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.066 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.0 p -111.84 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.547 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.503 ' HB3' HD23 ' A' ' 100' ' ' LEU . 60.9 m-20 -91.93 129.51 37.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.888 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.02 149.84 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.5 tm? -72.91 123.46 23.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.456 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.641 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.6 tt -57.67 155.72 9.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 152.92 42.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.459 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.618 ' HA ' HD13 ' A' ' 147' ' ' ILE . 4.1 mm-40 -71.85 125.52 27.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.05 22.88 44.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.193 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -56.34 173.4 0.17 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.93 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -145.02 135.46 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.073 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 145' ' ' ILE . 4.0 mt -114.16 127.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-O 120.893 0.377 . . . . 0.0 110.377 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.703 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.45 136.53 43.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.825 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.554 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.4 m -140.3 158.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 24.57 41.65 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.28 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.2 t -63.25 140.4 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.72 0.771 . . . . 0.0 112.462 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.67 -44.17 0.54 Allowed Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.353 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.48 HG23 HH11 ' A' ' 83' ' ' ARG . 45.5 t -126.37 137.87 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -50.75 -38.13 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.59 6.31 48.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 74.0 m-20 -117.25 22.97 12.14 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.703 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.11 139.63 28.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.175 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.546 ' CD2' HD13 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -119.53 134.49 55.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.674 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.599 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.29 131.6 56.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.584 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.546 HD13 ' CD2' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -127.01 142.79 51.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.892 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.93 HG22 ' CG ' ' A' ' 129' ' ' GLU . 11.3 t -111.0 140.32 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 130' ' ' ILE . 38.5 mt -105.85 120.88 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.069 0.461 . . . . 0.0 111.001 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.98 122.68 45.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.682 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -98.51 121.28 48.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.982 0.42 . . . . 0.0 111.376 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.461 ' ND2' ' HB2' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -82.92 135.79 34.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.997 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.1 -20.2 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.183 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -57.47 -43.74 84.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.623 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.461 ' HB2' ' ND2' ' A' ' 148' ' ' ASN . 31.7 t80 -59.26 -43.97 92.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.678 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -65.13 -33.96 77.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.5 -45.09 95.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -67.22 -43.6 81.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.909 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -35.81 78.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -60.61 -43.4 97.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.755 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' LYS . 42.8 mt-30 -84.83 -30.04 24.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.52 -90.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.626 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 157' ' ' GLN . 6.9 tptt -100.43 134.99 42.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.4 p -96.8 132.06 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.082 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 60.61 93.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -155.86 73.27 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pt -105.05 114.25 44.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.171 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.837 0.351 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 62.16 149.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 9.6 mtm -68.22 173.69 4.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.964 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 9.4 t -152.51 159.43 43.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -110.2 118.32 36.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.14 -29.98 31.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' TPO . . . . . 0.404 ' HA ' ' HD2' ' B' ' 172' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' B' ' 171' ' ' TPO . 33.3 Cg_endo -64.5 144.22 84.39 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.441 2.094 . . . . 0.0 112.197 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.452 ' HB ' HG22 ' A' ' 106' ' ' THR . 3.6 t -117.49 42.13 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.946 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' ASP . . . . . 0.609 ' O ' HD12 ' B' ' 176' ' ' LEU . 4.4 t0 59.49 90.27 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.86 117.48 5.05 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.558 2.172 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' LEU . . . . . 0.609 HD12 ' O ' ' B' ' 174' ' ' ASP . 1.1 mp -143.73 158.05 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.815 0.34 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 t -167.87 -43.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.952 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -60.39 -36.51 78.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -60.0 -40.35 88.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -36.02 82.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -41.39 93.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -69.23 -35.08 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.26 -36.81 71.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.24 -23.78 65.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.738 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.81 -47.52 80.05 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.84 -27.3 36.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.049 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 64.66 162.84 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.88 128.28 42.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.63 131.74 44.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.0 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.613 0.721 . . . . 0.0 111.698 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.28 102.87 0.92 Allowed Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.439 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.02 -31.29 56.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 0.0 110.957 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 176.9 38.73 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.71 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.58 135.78 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 113.631 -1.622 . . . . 0.0 112.336 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.981 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -92.3 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.667 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.8 p -145.12 157.4 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.904 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.869 0.366 . . . . 0.0 111.472 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.7 HG11 ' CE2' ' A' ' 68' ' ' PHE . 30.7 m -104.18 122.64 57.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.627 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.841 HG23 HG12 ' A' ' 45' ' ' ILE . 19.5 mt -129.49 118.34 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.548 ' SG ' HD21 ' A' ' 141' ' ' LEU . 24.6 t -81.81 119.57 24.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.281 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.41 -25.59 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.893 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' H ' ' A' ' 142' ' ' SER . 30.8 p -79.99 -2.21 43.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.559 0.218 . . . . 0.0 111.508 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.15 73.25 0.64 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.825 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' CB ' HD11 ' A' ' 141' ' ' LEU . 3.3 mt-30 -141.58 -47.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.76 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.72 HD13 HD21 ' A' ' 143' ' ' LEU . 3.1 mp -114.0 140.68 25.16 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.85 139.91 31.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.182 1.921 . . . . 0.0 112.24 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.841 HG12 HG23 ' A' ' 37' ' ' ILE . 37.2 mt -54.2 139.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.555 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -129.33 164.1 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.492 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -119.36 119.87 35.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.112 0.482 . . . . 0.0 111.372 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.8 mt -97.9 128.89 44.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.981 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.84 158.32 43.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.06 141.93 29.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.848 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -77.17 137.23 38.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 111.462 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.627 HD13 ' SG ' ' A' ' 154' ' ' CYS . 61.9 mt -65.31 -45.23 94.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.337 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -58.51 -42.92 88.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.764 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.6 -36.77 79.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 0.0 110.46 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.1 t -70.33 -43.06 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -32.74 69.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.28 -44.01 59.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -89.99 109.59 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -97.26 -31.08 12.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.26 167.25 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.35 -173.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -88.73 149.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.011 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.596 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -83.43 -75.89 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.4 ttpt -144.49 137.69 27.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.165 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.665 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -132.16 139.36 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.376 0.607 . . . . 0.0 112.255 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.8 m-90 -101.68 139.26 37.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.935 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.66 128.68 56.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.859 0.361 . . . . 0.0 110.027 177.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -120.49 145.23 47.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.61 -166.72 34.98 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.47 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 4.9 mtp85 -79.01 2.05 21.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.609 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.71 130.83 51.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 0.0 111.197 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.67 -15.91 51.26 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.515 2.144 . . . . 0.0 111.495 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.77 -41.61 18.96 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -42.76 139.11 1.73 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.537 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.25 -18.63 11.04 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.109 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.546 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -129.82 125.09 34.89 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.3 107.98 19.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HA ' HG12 ' A' ' 43' ' ' ILE . 7.1 mt -75.4 -69.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.199 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.79 -88.47 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.584 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -170.79 57.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.764 0.316 . . . . 0.0 111.32 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.769 HD12 ' CD1' ' A' ' 84' ' ' LEU . 30.7 mt -95.52 115.8 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.942 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -42.58 71.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HB3' ' HA2' ' A' ' 133' ' ' GLY . 3.8 mtp85 -60.85 -18.69 57.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.332 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.769 ' CD1' HD12 ' A' ' 81' ' ' ILE . 29.7 mt -103.3 151.19 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.62 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.1 p -97.8 163.99 12.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.728 0.299 . . . . 0.0 111.667 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.576 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.22 -52.93 5.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.401 0.62 . . . . 0.0 109.912 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.66 ' CB ' HD12 ' A' ' 104' ' ' ILE . 12.9 mttm -117.67 80.73 1.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.637 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 62.2 t-80 -60.34 -45.53 93.13 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.652 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 35.0 p90 -147.11 159.5 43.53 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.237 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.7 tt0 -136.14 142.88 44.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.114 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.595 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.7 mt -117.64 129.25 74.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.662 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.6 pt? -115.95 148.04 40.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.113 0.482 . . . . 0.0 111.855 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.73 HD22 HG11 ' A' ' 33' ' ' VAL . 26.2 tp -125.02 134.75 52.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.058 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.39 -166.77 38.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.537 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 59.14 -176.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.699 0.285 . . . . 0.0 110.704 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.45 80.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.73 -158.84 49.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.433 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 61.38 163.21 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.985 0.422 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.542 HD11 ' CG1' ' A' ' 33' ' ' VAL . 4.2 mm? -120.77 160.04 24.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.689 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.4 mp -128.26 143.29 51.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.313 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.434 HD12 HG12 ' A' ' 91' ' ' ILE . 2.0 tp -112.79 121.6 45.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.522 ' HB2' HD22 ' A' ' 92' ' ' LEU . 56.5 t30 -115.38 115.72 27.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.543 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -79.77 137.97 37.14 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.66 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.3 pt -139.42 29.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.563 0.22 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 12.9 t -90.32 160.2 16.25 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.253 0.549 . . . . 0.0 112.369 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.588 HG22 HG22 ' B' ' 173' ' ' THR . 24.5 m -69.54 -52.47 26.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.598 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -19.23 27.69 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.93 157.76 9.38 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.606 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -116.94 137.73 52.02 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.372 0.669 . . . . 0.0 109.252 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.904 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -112.27 149.15 32.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.733 HD23 ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -124.24 113.5 18.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.319 176.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 44.54 43.39 6.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.649 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.29 -13.49 63.45 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.725 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.07 118.6 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.106 0.453 . . . . 0.0 110.639 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.904 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.9 tptm -73.28 125.1 27.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.307 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -98.67 163.4 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.032 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.3 tt0 -69.96 128.87 37.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.549 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 1.8 tttt -54.08 156.84 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.092 0.473 . . . . 0.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.613 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.5 p-10 37.46 34.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.065 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.9 144.89 40.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.865 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.402 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.0 m120 -88.59 129.0 35.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -129.25 147.79 51.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.299 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.1 tp -72.77 119.02 16.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.361 . . . . 0.0 110.192 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.942 HD11 HG21 ' A' ' 145' ' ' ILE . 66.7 tp -53.6 157.24 2.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.346 0.593 . . . . 0.0 111.643 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.416 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.47 153.28 42.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.422 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.406 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 7.9 tp60 -71.57 122.71 20.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.192 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.95 19.29 56.25 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.152 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.3 t70 -52.15 171.79 0.05 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.767 0.318 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.853 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.1 mt-10 -145.24 135.51 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.063 HD11 HD11 ' A' ' 145' ' ' ILE . 1.5 mt -110.91 126.48 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.009 0.433 . . . . 0.0 110.476 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.625 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.28 140.78 37.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.637 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.58 158.36 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 81.84 35.57 21.5 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.164 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.9 t -74.33 140.24 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.612 0.72 . . . . 0.0 112.24 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -40.91 0.83 Allowed Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.247 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 46.9 t -126.52 127.91 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.282 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -50.49 -31.49 15.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.217 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 66.8 m -93.67 6.16 49.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -124.35 21.65 8.65 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.625 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.5 mt -103.63 139.0 25.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 142' ' ' SER . 5.0 tt -124.53 134.43 53.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 141' ' ' LEU . 46.9 t -109.57 150.18 28.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.664 0.745 . . . . 0.0 112.359 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 43' ' ' ILE . 77.7 mt -135.84 153.01 51.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.484 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.853 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -121.53 139.18 49.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.294 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.063 HD11 HD11 ' A' ' 130' ' ' ILE . 33.9 mt -106.47 128.53 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.977 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.7 114.11 25.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.621 HG12 HD21 ' A' ' 124' ' ' LEU . 4.1 mt -84.76 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.3 113.38 17.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -37.38 83.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -60.09 -46.02 90.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.966 0.412 . . . . 0.0 110.855 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -59.23 -44.13 92.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.107 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.593 ' HE3' HG21 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -60.83 -40.06 91.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -59.09 -40.7 86.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.103 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.627 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.4 t -67.38 -46.06 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.999 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -66.62 -35.92 81.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.838 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.86 -42.34 98.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.851 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LYS . 2.6 tp60 -84.68 -31.71 23.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.818 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.77 -90.71 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.65 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 157' ' ' GLN . 7.6 tttt -74.82 139.99 43.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.65 125.78 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.04 125.18 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HB2' HD13 ' A' ' 163' ' ' ILE . 6.4 mmp_? 66.11 -72.47 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.611 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -105.22 139.99 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.15 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.881 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -158.93 -57.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.868 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.9 mmm -132.12 148.39 52.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 31.6 m -138.8 151.93 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' B' ' 172' ' ' PRO . 1.5 t80 -117.61 88.23 2.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.88 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 -67.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.412 ' HG3' ' CE2' ' B' ' 169' ' ' PHE . 73.1 Cg_exo -48.86 145.14 13.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.469 2.113 . . . . 0.0 112.406 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.588 HG22 HG22 ' A' ' 106' ' ' THR . 12.4 p -124.62 139.97 53.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.995 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.56 83.22 41.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.813 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.92 178.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.587 2.191 . . . . 0.0 112.277 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' LEU . . . . . 0.508 ' N ' HD12 ' B' ' 176' ' ' LEU . 4.9 mp -90.89 108.07 19.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.922 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.82 0.343 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -147.98 -44.63 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -59.88 -47.0 87.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -47.51 67.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.818 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -35.83 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -31.77 72.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.773 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -71.86 -35.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.71 -46.17 84.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.441 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.25 -23.76 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.8 -47.6 79.84 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.393 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.1 p -63.53 -32.27 73.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -79.43 -75.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -96.25 142.44 28.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.48 125.55 31.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -82.16 138.34 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.659 0.742 . . . . 0.0 111.818 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.78 73.8 0.16 Allowed Glycine 0 C--N 1.315 -0.629 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.474 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' HG3' HD11 ' A' ' 32' ' ' ILE . 1.6 pp20? -88.95 -36.66 15.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.749 0.309 . . . . 0.0 110.969 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 179.05 38.92 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -77.18 135.24 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 113.75 -1.568 . . . . 0.0 112.3 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.983 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.46 -60.23 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.998 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' HD22 ' A' ' 48' ' ' LEU . 11.5 p -146.53 162.11 39.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.434 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -131.68 128.47 39.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.281 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.695 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.7 t -97.8 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.925 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.842 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -120.9 115.5 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -82.21 99.81 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 110.343 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -80.25 -19.89 45.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.739 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.657 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.8 p -80.04 -2.59 44.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.574 0.226 . . . . 0.0 111.378 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.79 75.48 0.57 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.964 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -147.84 -41.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.068 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 78' ' ' LEU . 2.0 mt -127.43 141.29 40.45 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.8 Cg_endo -72.52 145.38 42.18 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.012 1.808 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.842 HG12 HG23 ' A' ' 37' ' ' ILE . 41.7 mt -54.36 142.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.225 0.536 . . . . 0.0 111.908 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 33.8 mtt-85 -140.84 164.28 30.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.79 120.43 26.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.802 HD23 ' CD2' ' A' ' 66' ' ' TRP . 9.3 mp -86.38 137.08 32.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.188 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.983 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.61 156.01 45.03 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.427 1.108 . . . . 0.0 113.664 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -135.11 141.86 46.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.65 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.66 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -78.08 137.58 38.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.042 0.449 . . . . 0.0 111.4 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.656 HD13 ' SG ' ' A' ' 154' ' ' CYS . 81.4 mt -64.21 -41.64 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.224 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.4 m -56.32 -40.26 74.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.0 mt-30 -68.35 -36.85 79.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.207 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.913 HG22 ' HG2' ' A' ' 63' ' ' LYS . 50.3 t -61.58 -40.48 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.99 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.05 -39.43 72.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -58.96 -36.68 75.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.006 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -88.99 125.05 34.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.1 74.69 5.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.8 mtt-85 59.23 78.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 t -152.03 -65.25 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.431 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 3.6 tp -173.49 139.24 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.913 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -103.15 -71.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.767 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt -155.14 150.11 26.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.002 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.625 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.3 t -128.64 139.31 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.256 0.551 . . . . 0.0 111.959 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.802 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.6 m-90 -105.82 139.07 40.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.538 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.03 128.09 55.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.179 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -111.65 145.93 38.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.926 -178.08 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.08 -175.98 41.51 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -79.57 -2.52 42.79 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.85 134.63 41.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.644 0.259 . . . . 0.0 111.01 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.34 -7.09 19.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.658 2.238 . . . . 0.0 111.708 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.7 16.55 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.956 0.884 . . . . 0.0 108.932 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.08 137.69 4.17 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.477 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -56.43 -18.89 12.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.834 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.7 t80 -129.89 120.34 24.74 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.723 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.14 119.31 31.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 43' ' ' ILE . 7.3 mt -111.49 -176.06 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 111.09 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.78 136.67 20.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.375 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -61.58 89.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.389 . . . . 0.0 111.278 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.8 mm -112.15 125.0 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.759 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.09 -44.07 74.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH1' ' HA3' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -61.58 -24.19 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.452 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.537 HD22 ' CE1' ' A' ' 88' ' ' HIS . 57.5 mt -93.24 152.26 19.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.8 0.333 . . . . 0.0 111.181 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.43 167.11 11.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.794 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.736 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.86 -53.9 5.7 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -117.65 82.97 1.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.2 t60 -60.44 -47.4 86.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.483 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.62 159.85 42.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.62 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.625 ' HG2' HG12 ' A' ' 65' ' ' VAL . 29.1 tt0 -135.78 139.59 43.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.723 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 57.6 mt -114.72 131.38 67.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.096 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.504 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.53 147.87 42.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.096 0.474 . . . . 0.0 111.758 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.757 HD22 ' CG1' ' A' ' 33' ' ' VAL . 20.2 tp -124.99 122.62 37.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.912 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 62' ' ' ILE . . . 177.45 89.85 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.594 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -177.86 35.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.741 0.305 . . . . 0.0 110.975 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 t70 60.49 22.78 12.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.378 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.34 -54.78 0.56 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.094 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -55.83 149.56 14.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 111.208 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -111.78 160.0 17.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.791 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.4 mp -132.46 143.46 49.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.415 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.537 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.81 126.04 55.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.4 t30 -119.02 115.54 24.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 111.564 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.817 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -78.27 141.21 38.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.665 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 67' ' ' THR . 13.8 pt -149.08 37.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.65 153.69 18.05 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.9 m -68.87 -31.7 70.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.005 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.4 -20.02 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.36 157.53 10.56 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.738 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.8 m -117.53 137.83 52.31 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.111 0.564 . . . . 0.0 109.573 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.67 148.49 38.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.473 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.04 113.41 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.392 177.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 90.8 m-20 44.3 42.86 5.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.08 76.02 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.51 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.64 118.68 37.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.9 tptp -73.27 121.71 20.8 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.203 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.817 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.3 m -93.69 165.52 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.267 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 26.1 mt-10 -69.8 126.33 29.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.6 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.9 tttm -54.55 162.76 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.655 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.26 34.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.015 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.04 40.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.136 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.66 ' HB3' HD23 ' A' ' 100' ' ' LEU . 68.6 m-20 -91.69 130.75 37.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.889 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.2 mm-40 -129.26 150.07 50.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.651 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.67 115.41 11.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.561 HD21 HG12 ' A' ' 147' ' ' ILE . 66.1 tp -52.74 157.18 1.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.413 0.625 . . . . 0.0 111.571 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.39 153.0 42.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.524 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.419 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -71.8 124.26 24.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.93 20.57 53.66 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.136 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.1 t0 -55.06 172.83 0.11 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.0 111.07 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.5 tt0 -145.04 135.4 24.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.204 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.472 ' CG2' HG22 ' A' ' 109' ' ' THR . 17.1 mt -114.76 127.95 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.42 139.27 39.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.991 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.489 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.25 158.27 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.01 27.69 33.34 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.106 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.544 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.5 t -67.33 140.24 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.582 0.706 . . . . 0.0 112.332 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.409 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 151.61 -41.75 0.73 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.283 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 138' ' ' SER . 45.0 t -126.39 133.28 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.61 -35.82 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.796 0.331 . . . . 0.0 111.485 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.1 m -93.59 6.3 48.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -119.89 21.88 11.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.4 mt -104.88 139.59 25.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.155 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 142' ' ' SER . 7.0 tt -121.81 134.36 54.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.606 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.662 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -111.5 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.111 0.482 . . . . 0.0 111.801 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.53 HD22 HG12 ' A' ' 36' ' ' VAL . 20.5 mt -124.12 138.41 54.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.504 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.4 t -110.71 136.61 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.401 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 124' ' ' LEU . 8.2 mt -106.28 130.56 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.58 118.15 31.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.705 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.561 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.93 134.11 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.684 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.96 117.55 23.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.721 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.28 -29.89 65.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -60.29 -46.01 91.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -58.68 -44.16 90.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.151 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -61.06 -33.84 73.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.834 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -47.05 86.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.656 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.8 t -64.55 -45.93 85.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.963 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.879 HD21 HG11 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -62.85 -39.62 94.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.933 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.34 -40.71 87.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -85.24 -36.66 20.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.966 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.68 31.72 0.32 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.476 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 152.68 44.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 160' ' ' VAL . 13.3 p -103.06 122.84 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.162 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -108.94 -31.73 7.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -129.41 176.35 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.61 122.23 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.876 0.369 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -75.88 157.03 33.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.07 -70.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 6.6 m -108.13 118.37 36.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -93.6 122.96 36.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -131.26 -46.27 1.0 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.042 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.57 102.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.505 2.136 . . . . 0.0 112.195 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 2.3 m -97.6 139.23 33.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.51 86.67 15.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.86 157.15 6.05 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.587 2.191 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.94 176.21 8.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.957 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.823 0.344 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -94.09 52.92 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -46.94 87.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -61.1 -36.15 78.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.34 -39.88 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.3 tp -58.9 -31.96 69.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.01 -35.52 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.5 -38.44 74.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.25 -23.86 65.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.71 -47.31 80.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.51 -31.15 37.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.721 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 159.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -62.98 135.96 57.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -73.15 112.09 8.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.943 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.94 138.39 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.63 0.729 . . . . 0.0 111.82 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.87 49.63 0.75 Allowed Glycine 0 C--N 1.315 -0.626 0 CA-C-N 114.491 -1.231 . . . . 0.0 112.478 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -87.67 -44.93 10.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.685 0.279 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 177.59 38.89 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -74.42 136.62 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.697 -1.592 . . . . 0.0 112.398 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -93.7 -60.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.191 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.581 ' SG ' HD22 ' A' ' 99' ' ' LEU . 1.2 m -147.01 156.42 43.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.754 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 138.15 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.095 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.725 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.8 m -108.27 122.62 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.795 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.837 HG23 HG12 ' A' ' 45' ' ' ILE . 18.8 mt -128.27 122.63 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.542 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD23 ' A' ' 143' ' ' LEU . 54.1 t -80.27 109.98 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 0.0 110.248 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.464 HG23 HG21 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -75.71 -26.26 57.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.924 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 142' ' ' SER . 47.3 p -79.82 -2.23 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.54 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 77.65 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.863 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -147.09 -43.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.915 0.388 . . . . 0.0 110.865 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.8 mt -115.16 141.43 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.783 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.9 Cg_endo -71.12 145.96 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.138 1.892 . . . . 0.0 112.248 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.837 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -56.94 141.57 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.38 164.07 28.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.991 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.63 119.91 26.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.423 . . . . 0.0 111.973 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.0 mp -89.64 129.35 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.347 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -134.34 157.04 47.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.998 0.904 . . . . 0.0 113.341 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.53 150.36 43.61 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.291 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.856 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.0 m-20 -96.2 102.25 14.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.37 -45.24 96.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.092 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -59.63 -40.25 86.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.282 0.563 . . . . 0.0 110.643 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 38.6 mm-40 -68.57 -37.86 80.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.622 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 51' ' ' ASP . 45.6 t -73.08 -40.29 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.971 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -30.74 67.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.733 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -73.9 -40.5 63.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.756 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -98.0 114.8 27.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -70.56 113.93 8.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.028 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.96 -177.68 6.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 m -98.93 -44.75 6.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.8 tp -109.24 146.72 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.751 ' HG2' HG11 ' A' ' 55' ' ' VAL . 18.8 mttm -96.12 -71.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.984 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 49' ' ' SER . 33.6 ttpt -147.29 139.73 24.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.611 HG12 ' HG2' ' A' ' 90' ' ' GLN . 3.6 t -121.14 138.84 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 111.664 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.766 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.0 m-90 -102.96 139.3 38.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.244 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.684 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.75 127.21 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -111.32 145.63 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.397 -178.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.84 -174.59 40.02 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -78.59 -2.22 37.9 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.86 135.05 40.47 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.9 Cg_exo -69.05 -7.86 22.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.779 2.32 . . . . 0.0 111.827 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.79 -43.77 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.949 0.88 . . . . 0.0 108.669 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.0 137.96 2.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -18.94 12.1 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.119 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.587 ' CE2' HG21 ' A' ' 43' ' ' ILE . 60.0 t80 -129.9 128.15 41.6 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.52 120.91 41.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.423 HD11 ' C ' ' A' ' 69' ' ' GLY . 1.1 pp -120.81 -178.27 3.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.087 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.91 146.99 41.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.525 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -78.9 76.87 5.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 111.195 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 84' ' ' LEU . 36.0 mt -94.7 124.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.827 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 p -54.86 -35.18 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -63.89 -45.94 87.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.054 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 81' ' ' ILE . 49.1 mt -72.8 152.09 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.125 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p -95.17 168.27 10.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -44.63 -53.6 7.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.373 0.606 . . . . 0.0 109.636 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HB2' HD12 ' A' ' 104' ' ' ILE . 33.8 mttm -119.43 83.1 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -60.49 -46.24 90.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.691 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.8 p90 -146.21 161.2 40.76 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.814 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.684 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -135.78 142.34 44.9 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 65' ' ' VAL . 27.1 mt -115.87 132.37 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.185 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.957 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.09 145.21 34.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.024 0.44 . . . . 0.0 111.807 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.624 ' HG ' HG11 ' A' ' 33' ' ' VAL . 2.6 tm? -125.33 122.64 37.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.409 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 139.83 -112.14 0.8 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.737 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 70.0 -65.76 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -165.37 -50.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.801 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.8 38.66 0.21 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.35 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -159.27 -174.23 4.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.604 ' HB3' HD13 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -109.84 153.58 24.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.722 HD13 ' OD1' ' A' ' 121' ' ' ASN . 11.3 mt -132.97 146.95 52.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.59 HD23 HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -117.57 124.48 48.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.9 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.957 ' HB2' HD11 ' A' ' 92' ' ' LEU . 47.9 t30 -114.38 115.5 27.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 111.531 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.782 ' OD2' HG23 ' A' ' 116' ' ' VAL . 17.6 p30 -79.47 138.63 37.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.2 pt -147.15 39.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -97.4 159.33 14.98 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.039 0.447 . . . . 0.0 111.497 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.673 HG21 HG21 ' B' ' 171' ' ' TPO . 85.4 m -68.88 -35.56 77.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.299 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -19.86 17.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 164.22 12.64 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.442 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.3 m -117.48 137.7 52.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.882 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.12 148.28 35.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.41 18.28 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.298 177.466 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.7 m120 44.11 42.93 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.41 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.6 -11.46 68.32 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.583 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -103.98 118.35 36.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.045 0.422 . . . . 0.0 110.777 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.882 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -74.0 127.89 34.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.782 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.3 m -98.11 165.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.19 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 mm-40 -69.83 126.57 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.707 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.9 tttt -53.65 162.66 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.61 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.063 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.13 40.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.377 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.722 ' OD1' HD13 ' A' ' 100' ' ' LEU . 8.9 m-80 -91.64 125.92 36.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.601 ' O ' HD23 ' A' ' 100' ' ' LEU . 43.1 mm-40 -127.44 147.54 50.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.429 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.8 tp -72.63 117.11 13.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.17 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.756 ' CD2' HG21 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -55.73 166.98 0.61 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.782 0.801 . . . . 0.0 111.952 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.37 153.28 43.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.398 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.558 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.26 118.18 13.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.67 24.01 69.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.8 t70 -55.83 175.21 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.8 tt0 -145.06 135.54 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 145' ' ' ILE . 17.9 mt -115.34 126.66 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.55 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.659 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.51 138.34 41.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.524 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 27.4 m -140.39 158.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.42 28.98 28.61 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.159 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.5 t -68.56 140.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.535 0.684 . . . . 0.0 112.409 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.08 -43.45 0.6 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.261 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 138' ' ' SER . 45.8 t -126.43 136.36 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -50.7 -37.7 42.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.469 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.64 6.39 48.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.93 21.15 13.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.659 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -106.58 139.17 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.239 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 142' ' ' SER . 7.6 tt -124.38 134.37 53.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.229 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.527 ' H ' HG21 ' A' ' 40' ' ' THR . 47.2 t -109.83 150.23 28.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.7 0.762 . . . . 0.0 112.589 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' CYS . 72.8 mt -135.88 151.15 49.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.725 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 HG23 ' A' ' 39' ' ' THR . 36.7 t -122.03 135.88 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 130' ' ' ILE . 46.2 mt -106.12 125.66 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.77 114.73 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.1 mt -84.92 130.12 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.33 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -83.63 119.05 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -27.54 69.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.04 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -42.53 81.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 110.613 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 34.5 t80 -59.16 -43.74 92.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -34.08 70.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.827 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -41.51 95.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.5 t -67.08 -46.08 75.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.428 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -67.01 -35.95 81.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.948 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -62.19 -37.0 83.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.974 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -92.06 -33.45 14.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.3 p30 42.58 73.73 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 123.66 20.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.7 m -85.33 136.7 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.47 38.57 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.77 -38.39 6.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.03 126.93 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.971 179.937 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 9.2 pttp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.779 0.323 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.98 168.73 9.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -159.12 34.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 3.3 p -66.05 162.6 19.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -58.9 -178.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -99.22 -64.26 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' TPO . . . . . 0.673 HG21 HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.87 142.3 51.55 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.351 2.034 . . . . 0.0 112.191 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 53.8 p -138.52 -179.06 5.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.021 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.13 102.82 10.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.25 153.82 73.61 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.384 2.056 . . . . 0.0 112.251 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.08 91.48 8.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.924 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.792 0.329 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.0 m -113.01 -72.28 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -37.45 83.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -71.01 -42.84 69.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -36.89 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.43 -31.93 70.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.86 -35.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.4 -41.11 79.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.502 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -67.19 -23.87 65.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.64 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.67 -47.41 79.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.224 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 p -81.07 -32.34 34.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.31 -75.99 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -85.68 156.42 20.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -82.39 122.48 28.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.812 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.415 HG13 ' CD1' ' A' ' 23' ' ' PHE . 20.2 mm -81.98 138.35 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.652 0.739 . . . . 0.0 111.828 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.39 66.61 0.5 Allowed Glycine 0 C--N 1.315 -0.637 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.453 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -80.8 -38.41 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.739 0.304 . . . . 0.0 110.969 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 176.33 39.09 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.09 135.27 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.653 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.8 -60.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.735 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.4 p -147.82 153.62 39.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.095 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.77 138.13 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.541 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 36' ' ' VAL . 11.7 p -103.04 122.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.591 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -130.41 119.24 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.729 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.625 ' HA ' HD23 ' A' ' 143' ' ' LEU . 44.4 t -79.86 118.31 21.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.233 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.76 -25.12 28.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.979 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.526 HG21 ' H ' ' A' ' 142' ' ' SER . 52.5 p -79.82 -2.11 41.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.02 76.55 0.28 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.718 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -146.51 -44.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.08 141.45 27.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.792 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.6 Cg_endo -73.2 141.49 32.49 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 0.0 112.265 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 37' ' ' ILE . 38.3 mt -56.98 143.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.14 164.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.38 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 119.85 35.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.189 0.518 . . . . 0.0 111.69 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.694 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.6 mt -98.64 134.54 41.42 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.96 158.95 43.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -178.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.74 142.17 25.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.883 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.594 ' O ' HG23 ' A' ' 55' ' ' VAL . 6.1 m-20 -74.94 132.62 41.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.144 0.497 . . . . 0.0 111.454 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.747 HD13 ' SG ' ' A' ' 154' ' ' CYS . 88.2 mt -64.4 -44.28 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.24 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -56.52 -37.52 70.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.251 0.548 . . . . 0.0 110.688 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.447 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 6.4 mm-40 -68.63 -36.84 79.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.264 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 51' ' ' ASP . 46.1 t -73.1 -42.57 58.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.113 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.05 -28.2 66.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.98 -49.83 64.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.966 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.63 136.94 39.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.52 -32.03 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.42 -169.44 2.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m 61.35 178.22 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.468 HD11 ' N ' ' A' ' 93' ' ' LEU . 10.4 tp -93.32 157.04 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -101.48 -81.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.259 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt -121.51 134.16 55.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.878 0.371 . . . . 0.0 111.216 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.8 t -125.49 137.58 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.694 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.9 m-90 -101.98 139.27 37.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.184 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.679 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.38 130.51 56.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -119.18 145.3 46.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.274 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.28 -170.74 36.38 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG3' HD11 ' A' ' 78' ' ' LEU . 17.1 mtp180 -78.86 3.72 16.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.617 HD21 ' HB3' ' A' ' 73' ' ' ALA . 30.5 t30 -84.66 132.03 47.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.574 0.226 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.3 Cg_exo -66.69 -13.74 41.1 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.476 2.117 . . . . 0.0 111.761 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 71' ' ' ASN . . . -82.68 -42.72 17.76 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.949 0.88 . . . . 0.0 108.937 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.5 139.51 1.09 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.015 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 m-20 -56.49 -18.75 12.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.015 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 16.7 t80 -129.55 123.01 30.35 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.117 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -99.87 107.96 20.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.558 HD11 ' HG3' ' A' ' 70' ' ' ARG . 2.3 pp -111.29 173.89 6.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.841 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.26 135.68 43.92 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.766 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.29 84.2 1.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.945 0.402 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.863 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.0 mt -111.25 135.49 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.921 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.2 p -56.49 -37.47 70.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.567 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.57 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.66 -22.1 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.19 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.863 HD23 ' HB ' ' A' ' 81' ' ' ILE . 2.1 mm? -107.54 152.64 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.905 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -96.93 163.77 12.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.45 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.622 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.84 -52.9 4.88 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.497 0.665 . . . . 0.0 109.663 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.1 mttm -120.84 82.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -61.4 -45.93 92.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.672 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.6 p90 -143.86 159.06 43.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.795 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.679 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.09 140.56 43.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.316 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.564 ' O ' HG13 ' A' ' 65' ' ' VAL . 58.1 mt -114.0 132.28 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.791 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.0 pt? -120.59 133.59 55.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.03 0.443 . . . . 0.0 111.967 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.676 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.6 tm? -125.2 122.69 37.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.064 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 135.91 94.98 0.44 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.467 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.64 -42.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.594 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.0 -173.11 4.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.711 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.11 60.5 3.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.524 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.4 p30 177.67 -178.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 110.982 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.676 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -108.61 160.14 16.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.76 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.573 ' H ' HD23 ' A' ' 99' ' ' LEU . 3.2 mp -125.85 143.29 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.484 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 101' ' ' LEU . 2.4 mm? -112.8 122.82 48.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.897 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.627 ' HB2' HD22 ' A' ' 92' ' ' LEU . 49.9 t30 -115.28 115.47 26.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.654 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.83 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -78.17 138.43 38.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.9 pt -145.12 40.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.611 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.69 156.45 16.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 111.362 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.79 -36.52 78.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.361 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.75 -19.7 17.32 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.14 159.18 10.44 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.005 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -117.55 137.93 52.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.991 -0.604 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.891 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.74 148.72 34.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.45 18.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.455 177.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 42.8 44.0 3.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.75 62.41 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -103.34 118.52 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.614 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.891 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.4 tptp -72.92 128.16 34.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.425 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.83 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.9 m -98.79 163.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.193 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 tp10 -69.92 126.89 31.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.536 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -53.16 160.74 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.81 35.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.311 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.13 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.136 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.502 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.1 m120 -85.13 127.92 34.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.93 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.29 146.93 51.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.532 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tp -72.77 134.2 44.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.287 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.883 HD11 HG21 ' A' ' 145' ' ' ILE . 65.2 tp -69.33 155.88 39.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.458 0.647 . . . . 0.0 111.485 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.452 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.58 153.02 42.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.256 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 121.3 18.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.886 0.374 . . . . 0.0 110.287 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.44 58.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.131 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.0 t70 -54.43 173.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.739 0.304 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.2 mt-10 -145.07 135.72 24.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.318 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.46 ' CG2' HG22 ' A' ' 109' ' ' THR . 12.9 mt -114.41 127.16 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.61 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.566 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.42 140.06 38.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.884 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.74 HG23 HD11 ' A' ' 84' ' ' LEU . 35.5 m -140.4 158.33 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 0.0 112.346 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.91 36.03 16.85 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.079 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.577 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.8 t -75.14 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.641 0.734 . . . . 0.0 112.505 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.21 -42.89 0.57 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.62 129.11 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 -31.18 14.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.795 0.331 . . . . 0.0 111.183 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.598 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 m -93.53 6.42 48.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -125.69 23.2 7.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.9 mt -105.35 139.33 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.011 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -124.23 134.43 53.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.577 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.526 ' H ' HG21 ' A' ' 40' ' ' THR . 48.3 t -109.4 150.57 27.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 112.25 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.0 mt -135.53 156.0 49.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.5 t -124.57 136.84 59.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.032 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.883 HG21 HD11 ' A' ' 124' ' ' LEU . 2.3 mm -106.33 126.37 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.923 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 37' ' ' ILE . 1.5 m-85 -112.53 116.33 30.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.738 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.749 HG12 HD21 ' A' ' 124' ' ' LEU . 3.7 mt -84.8 134.26 27.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.542 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -75.97 118.48 18.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.588 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -37.49 78.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -60.6 -45.73 92.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 33' ' ' VAL . 19.5 t80 -63.45 -43.8 96.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.187 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -60.06 -50.06 75.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.388 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 154' ' ' CYS . 3.9 pt20 -60.24 -36.9 78.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.078 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.747 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.8 t -68.08 -45.87 72.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.978 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -69.0 -42.51 76.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.956 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.58 -45.21 92.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.029 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.74 -36.84 28.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.68 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.422 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -60.0 133.05 55.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.05 125.85 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -106.08 120.7 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 60.01 70.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.6 tt -86.04 139.92 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.105 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 1.6 tttp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.792 0.329 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -140.49 143.72 35.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -137.56 -173.88 3.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 78.4 p -79.59 97.15 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' B' ' 172' ' ' PRO . 29.1 t80 -91.36 51.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.683 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -73.74 114.9 12.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.162 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' TPO . . . . . 0.462 ' HA ' ' HD2' ' B' ' 172' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' B' ' 171' ' ' TPO . 9.4 Cg_endo -52.57 163.39 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.679 2.253 . . . . 0.0 112.293 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 82.7 p -135.87 128.46 30.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.85 104.81 14.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.74 100.69 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.427 2.084 . . . . 0.0 112.389 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.49 151.55 39.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.974 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.834 0.349 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.3 p -148.26 -47.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.96 -47.12 72.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -46.06 88.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -57.04 -36.14 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -31.86 71.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.46 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.15 -35.53 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.86 -37.91 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.352 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.2 -23.64 65.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.996 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.69 -47.48 79.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.13 -30.01 58.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.968 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.23 -179.93 7.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.65 159.02 26.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.93 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -90.53 104.41 17.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.06 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.38 138.53 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.534 0.683 . . . . 0.0 111.823 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -69.02 64.02 0.51 Allowed Glycine 0 C--N 1.314 -0.645 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.239 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -40.18 84.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.647 0.261 . . . . 0.0 111.275 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-20 178.8 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.568 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.6 mm -71.49 142.64 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.361 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.757 HG22 HD13 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -105.78 -51.35 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.05 -178.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.454 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -155.17 165.37 36.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.635 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 138.0 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 16.4 t -106.23 122.84 60.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.211 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 mt -127.28 115.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.342 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.547 ' HA ' HD13 ' A' ' 143' ' ' LEU . 53.3 t -80.81 123.39 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -88.3 -26.88 22.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.639 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 142' ' ' SER . 53.2 p -79.95 -2.3 43.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.632 0.253 . . . . 0.0 111.559 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.59 76.29 0.29 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.007 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -147.18 -44.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.961 HD12 HD11 ' A' ' 143' ' ' LEU . 1.5 mt -108.78 140.46 21.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.36 146.03 34.93 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.203 1.936 . . . . 0.0 112.257 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.5 mt -59.98 130.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.629 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 164.21 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.194 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.89 119.47 34.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.972 0.415 . . . . 0.0 111.779 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.3 mp -86.09 133.54 33.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.581 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -139.9 156.49 46.66 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.38 1.086 . . . . 0.0 113.694 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.44 141.75 27.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.805 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.738 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.7 m-20 -79.2 122.06 25.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.157 0.503 . . . . 0.0 110.891 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.2 mt -64.47 -39.7 86.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.784 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -56.97 -42.46 80.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.102 0.477 . . . . 0.0 111.14 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.531 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.4 mt-30 -68.98 -38.18 79.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.903 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 63' ' ' LYS . 39.4 t -62.75 -45.06 99.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.273 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 tt -71.03 -36.23 72.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -42.06 45.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.056 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -87.4 112.56 22.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.1 31.2 5.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.766 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -174.83 3.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.695 ' O ' HG22 ' A' ' 62' ' ' ILE . 1.2 m -59.48 113.14 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.946 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 61' ' ' SER . 6.7 tp 52.0 161.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.963 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.744 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -107.99 -75.58 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.439 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -127.98 138.17 52.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.637 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.572 HG22 ' CB ' ' A' ' 92' ' ' LEU . 16.9 t -132.75 139.19 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.289 0.566 . . . . 0.0 111.858 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.581 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.9 m-90 -100.9 140.29 35.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.374 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.816 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -109.15 124.74 51.3 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.721 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.9 m-85 -112.46 145.68 39.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.045 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.76 -169.61 38.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.933 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.7 mtp180 -84.87 10.18 12.32 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.845 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 53.2 t30 -93.86 134.82 25.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.547 0.213 . . . . 0.0 111.135 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.3 Cg_exo -67.21 -11.01 30.62 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.516 2.144 . . . . 0.0 111.651 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.845 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . . . -83.04 -42.7 17.17 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.874 0.845 . . . . 0.0 109.004 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.6 137.8 2.06 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.831 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.46 -18.59 11.86 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.927 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CE2' HG21 ' A' ' 43' ' ' ILE . 7.7 t80 -129.35 120.38 25.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.964 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -96.95 107.88 20.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.662 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.1 pp -113.37 174.97 5.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.152 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.16 146.56 23.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.735 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -81.77 96.99 7.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.7 mm -110.56 126.63 67.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -31.77 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.542 ' H ' HG22 ' A' ' 81' ' ' ILE . 15.6 mtt-85 -73.98 -21.49 59.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 HD21 HG23 ' A' ' 132' ' ' VAL . 21.1 mt -99.13 152.33 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 111.007 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.67 165.27 12.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.668 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.91 -53.26 4.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 109.839 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.672 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.43 82.5 1.86 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.309 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.8 t60 -61.81 -45.0 95.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.919 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 22.1 p90 -146.74 164.15 33.69 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.298 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.816 ' CG ' HG23 ' A' ' 67' ' ' THR . 7.6 mt-30 -135.7 140.78 44.7 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.39 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 65' ' ' VAL . 2.7 mp -116.37 132.47 65.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.356 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.7 147.44 42.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 111.696 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.757 HD13 HG22 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -124.71 123.49 40.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.437 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.0 -130.53 1.37 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.398 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' OE2' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER 59.7 -177.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.866 0.365 . . . . 0.0 110.874 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -61.96 -31.36 71.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.62 52.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.22 172.79 14.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 93' ' ' LEU . 4.2 mm? -108.01 155.26 20.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.886 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -133.25 143.14 48.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.213 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.875 HD11 HD12 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -112.81 129.1 56.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.491 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB2' HD22 ' A' ' 92' ' ' LEU . 47.1 t30 -119.76 115.54 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.766 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -79.68 141.71 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.2 pt -148.3 39.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.655 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.68 151.06 21.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.058 0.456 . . . . 0.0 111.869 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.7 m -68.78 -31.7 70.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.901 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.42 -19.69 17.56 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.1 155.66 9.87 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.632 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.48 137.73 52.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.2 148.47 39.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.43 18.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.056 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m120 44.94 43.3 7.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -7.86 77.74 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.48 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -105.63 118.48 36.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.143 0.472 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.766 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.4 m -95.94 165.47 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.405 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 3.7 tt0 -69.93 129.55 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.9 tttt -54.33 163.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.193 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.6 m-80 33.92 36.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.827 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.72 145.22 39.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.843 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.725 ' HB3' HD22 ' A' ' 100' ' ' LEU . 29.9 m120 -93.0 127.75 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.813 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.886 ' O ' HD23 ' A' ' 100' ' ' LEU . 65.3 mm-40 -128.98 151.24 49.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.43 117.38 14.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.955 0.407 . . . . 0.0 110.553 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 101' ' ' LEU . 64.5 tp -57.89 157.8 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.408 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -124.37 153.2 42.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.438 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -71.58 124.42 24.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.49 20.16 55.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.954 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.37 173.25 0.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.04 135.58 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.822 ' CD1' HD21 ' A' ' 101' ' ' LEU . 7.2 mt -113.36 128.66 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.496 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 86.7 m -103.92 138.87 39.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.106 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.589 HG23 HD21 ' A' ' 84' ' ' LEU . 33.2 m -140.16 158.15 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.71 40.59 14.55 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.814 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -79.87 140.39 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.654 0.74 . . . . 0.0 112.537 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.13 0.56 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.289 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 43.5 t -126.42 134.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.67 -39.55 51.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.745 0.307 . . . . 0.0 111.702 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.428 ' H ' HG12 ' A' ' 136' ' ' VAL . 14.3 m -93.5 6.43 48.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.444 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.4 t0 -118.06 23.05 11.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.2 mt -106.12 139.49 27.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.302 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 43' ' ' ILE . 3.1 tp -120.51 134.34 55.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.232 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.555 ' C ' HD22 ' A' ' 143' ' ' LEU . 43.8 t -113.46 150.32 32.99 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 112.672 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 43' ' ' ILE . 2.5 mm? -136.23 146.05 46.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.572 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 39' ' ' THR . 23.9 t -116.72 132.82 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 111.097 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.875 HD12 HD11 ' A' ' 101' ' ' LEU . 6.3 mt -106.25 128.33 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.84 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.97 120.63 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.0 mt -84.82 134.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.278 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.16 127.75 32.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -74.06 -32.3 63.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -45.3 91.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -58.25 -44.04 88.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -34.11 76.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -60.35 -45.01 94.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.36 -43.68 76.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.064 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -50.19 50.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.322 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -33.71 70.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.98 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -77.74 -30.32 51.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.753 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -123.66 75.96 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.935 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.0 149.99 30.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.85 131.6 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.175 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -178.61 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -144.28 157.2 44.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 23.9 mm -92.13 116.12 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.865 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.916 0.389 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? 66.85 -74.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 5.5 ttp -65.44 152.37 44.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 -47.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -111.69 136.23 51.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -103.72 -56.52 2.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.41 122.49 7.79 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.602 2.201 . . . . 0.0 112.431 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 59.6 p -72.06 -59.26 2.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.027 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -165.89 92.31 0.84 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.08 118.92 5.98 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.522 2.148 . . . . 0.0 112.26 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.52 147.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 m -101.46 -58.77 1.82 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -65.32 -41.0 94.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -64.02 -39.52 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.63 -35.09 78.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.22 -39.99 84.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.6 mm -71.25 -35.14 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.27 -34.17 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.401 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -67.34 -23.81 65.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.78 -47.6 79.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.2 m -68.99 -26.88 65.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.024 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 62.66 162.89 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.934 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.65 125.36 24.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -110.97 118.82 37.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.07 138.26 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.608 0.718 . . . . 0.0 111.779 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.46 52.5 0.48 Allowed Glycine 0 C--N 1.314 -0.671 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.515 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.95 -43.81 10.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 177.69 38.8 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.696 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -75.07 134.62 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.76 -1.563 . . . . 0.0 112.583 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.0 -60.51 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 m -143.47 162.43 35.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.355 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 123.59 32.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.142 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.71 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -91.16 122.77 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -126.89 123.13 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.628 ' SG ' HD21 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -92.14 100.11 12.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.592 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.749 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.5 p -79.92 -2.63 44.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 111.341 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.81 73.28 0.66 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.065 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -144.9 -38.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.9 mt -127.54 141.32 40.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.846 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.76 137.97 28.14 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.112 1.874 . . . . 0.0 112.15 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -55.26 144.03 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.785 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.37 164.32 30.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.263 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.85 119.84 34.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 112.008 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.5 mt -94.67 137.43 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.25 158.09 43.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.82 141.98 31.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.424 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.879 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -78.33 134.9 37.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 111.424 -179.345 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.486 HG22 HD23 ' A' ' 56' ' ' LEU . 96.6 mt -64.46 -45.0 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.819 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.444 ' HA ' HD21 ' A' ' 56' ' ' LEU . 14.5 m -60.11 -39.11 85.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.305 0.574 . . . . 0.0 110.601 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.8 mm100 -68.49 -36.79 79.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.481 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 51' ' ' ASP . 61.1 t -68.4 -49.92 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.019 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD23 HG22 ' A' ' 52' ' ' ILE . 4.3 pp -68.83 -30.75 69.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -74.01 -35.32 64.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -80.45 115.66 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -99.08 31.78 2.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.61 -178.46 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 t -80.41 -30.76 37.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.89 HD11 HG22 ' A' ' 65' ' ' VAL . 8.8 tp -112.73 147.19 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' CD ' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -115.96 -65.21 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.862 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt -150.22 126.5 10.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.89 HG22 HD11 ' A' ' 62' ' ' ILE . 4.4 t -120.44 138.52 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.199 0.523 . . . . 0.0 112.031 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -100.74 139.69 36.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.403 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.722 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.4 129.7 55.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.711 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -120.43 145.66 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.628 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.64 -169.56 36.39 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.73 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.7 mtm105 -82.54 5.17 21.68 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.3 t-20 -84.9 132.62 45.43 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.523 0.201 . . . . 0.0 110.773 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.39 -13.97 42.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.446 2.097 . . . . 0.0 111.685 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -44.1 16.01 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.842 0.829 . . . . 0.0 108.835 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.25 137.84 3.33 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.871 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.49 -18.6 12.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.726 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -129.54 124.29 33.51 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.17 108.05 20.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.771 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.724 HD23 HD13 ' A' ' 84' ' ' LEU . 8.2 mp -72.63 -172.96 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.153 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.99 38.96 3.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.82 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.89 64.38 0.99 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 111.886 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 84' ' ' LEU . 39.2 mt -94.08 133.73 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.741 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -54.81 -44.9 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.455 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -45.55 89.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.724 HD13 HD23 ' A' ' 78' ' ' LEU . 28.6 mt -72.79 152.27 41.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.695 0.283 . . . . 0.0 111.318 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -97.18 163.5 12.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.017 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.76 -51.62 5.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.442 0.639 . . . . 0.0 109.846 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB2' HD11 ' A' ' 104' ' ' ILE . 16.3 ptmt -120.32 82.24 1.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -64.78 -45.39 86.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.455 -176.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.495 ' HA ' HG12 ' A' ' 104' ' ' ILE . 47.5 p90 -150.21 163.38 38.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.234 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.722 ' CD ' HG23 ' A' ' 67' ' ' THR . 10.3 mt-30 -135.71 158.41 44.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.468 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.711 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 68.2 mt -125.8 131.15 72.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.138 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.678 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -114.12 145.57 41.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.1 0.476 . . . . 0.0 111.711 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 33' ' ' VAL . 25.2 tp -125.18 126.96 46.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.192 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.8 -179.4 17.81 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.674 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.78 -166.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 110.975 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.442 ' C ' HD12 ' A' ' 155' ' ' LEU . 0.8 OUTLIER 70.15 -64.29 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.968 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.35 -17.25 1.69 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.782 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.406 ' O ' HD22 ' A' ' 99' ' ' LEU . 21.1 p-10 -69.43 173.75 5.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.858 0.361 . . . . 0.0 110.865 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.439 ' CD1' HD13 ' A' ' 93' ' ' LEU . 3.1 mm? -124.73 155.35 39.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.605 ' HB3' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -133.15 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.233 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.17 128.8 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.678 ' HB2' HD11 ' A' ' 92' ' ' LEU . 42.0 t30 -115.42 115.48 26.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.458 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.0 p30 -79.53 143.05 35.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.602 HD13 ' CG ' ' A' ' 90' ' ' GLN . 15.2 pt -150.93 37.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.32 158.31 15.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.003 0.43 . . . . 0.0 111.613 -178.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -68.87 -34.93 76.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.436 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.88 17.29 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.09 161.7 11.62 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.647 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.7 m -117.52 137.87 52.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.65 148.32 36.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.08 113.3 18.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.174 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.0 m120 44.17 43.39 5.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.285 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 -5.82 84.46 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.454 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.14 118.51 36.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.094 0.474 . . . . 0.0 110.828 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.2 tptp -74.89 120.59 20.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.363 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -95.17 163.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.4 tp10 -69.84 127.3 32.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.0 tttm -52.18 161.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.753 0.311 . . . . 0.0 110.577 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 35.48 34.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.215 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.09 40.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.901 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.41 ' HB3' ' CD2' ' A' ' 100' ' ' LEU . 1.9 m-80 -88.48 128.42 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.032 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.1 mm-40 -129.69 149.13 51.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.605 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.7 126.08 29.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.394 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.549 HD21 HG12 ' A' ' 147' ' ' ILE . 65.9 tp -64.69 158.43 24.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.301 0.572 . . . . 0.0 111.424 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.425 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -124.14 153.32 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.242 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.501 ' HA ' HD12 ' A' ' 147' ' ' ILE . 2.9 mm-40 -71.13 122.71 20.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 0.0 110.478 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.18 20.76 55.17 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.162 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.6 t70 -56.2 174.12 0.14 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.7 tt0 -145.12 135.59 24.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.104 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.829 HD11 HD11 ' A' ' 145' ' ' ILE . 12.7 mt -109.05 127.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.371 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.0 m -104.47 137.84 41.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.32 158.42 25.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.88 24.57 44.74 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.266 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.1 t -64.78 140.43 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.58 0.705 . . . . 0.0 112.237 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.36 -42.31 0.85 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.369 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.39 131.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.52 -33.08 20.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.557 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.56 6.25 48.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.7 20.2 11.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 134' ' ' VAL . 13.9 mt -102.95 139.52 23.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.07 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 142' ' ' SER . 6.4 tt -124.32 134.41 53.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.749 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -113.3 127.8 56.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.105 0.478 . . . . 0.0 111.742 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.487 HD11 HD12 ' A' ' 43' ' ' ILE . 19.2 mt -121.2 139.82 52.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.8 139.68 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.147 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.829 HD11 HD11 ' A' ' 130' ' ' ILE . 41.4 mt -106.04 130.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.65 114.0 25.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.36 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.549 HG12 HD21 ' A' ' 124' ' ' LEU . 6.6 mt -84.92 132.98 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.544 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -76.97 110.9 11.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.733 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -60.81 -39.35 88.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.995 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -46.05 92.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.2 -44.19 97.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -64.92 -33.88 77.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.061 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -58.89 -45.97 88.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.042 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.409 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -67.95 -45.94 72.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.978 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.442 HD12 ' C ' ' A' ' 96' ' ' ASP . 0.5 OUTLIER -67.31 -38.14 84.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.966 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.99 -43.49 95.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -85.58 -35.36 21.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.4 p30 42.47 84.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.456 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.22 150.93 20.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 160' ' ' VAL . 11.1 p -82.57 117.07 27.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.165 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -125.03 32.0 5.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.95 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.72 -169.48 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.2 mt -93.35 116.15 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.217 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.324 -0.845 . . . . 0.0 110.925 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.827 0.346 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.24 149.9 17.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.787 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 60.37 110.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 8.7 t -127.32 138.16 52.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' B' ' 172' ' ' PRO . 1.0 OUTLIER -58.23 179.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -134.32 126.96 30.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.426 ' HG3' ' CE1' ' B' ' 169' ' ' PHE . 33.5 Cg_exo -59.85 97.38 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.755 2.303 . . . . 0.0 112.222 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 70.9 p -65.66 175.13 1.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -110.43 86.6 5.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.21 132.85 23.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.58 2.187 . . . . 0.0 112.361 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' LEU . . . . . 0.524 ' H ' HD23 ' B' ' 176' ' ' LEU . 0.4 OUTLIER -66.86 177.42 1.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 t -154.99 -51.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -72.03 -46.97 55.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.88 -45.29 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -59.63 -32.39 70.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.2 -35.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -36.04 71.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -67.15 -31.11 71.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.311 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.8 m-85 -56.91 -48.2 78.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.455 0.645 . . . . 0.0 111.112 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.66 -27.34 37.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.062 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 64.38 121.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.9 158.2 33.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.45 135.45 37.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.814 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.68 136.62 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 C-N-CA 123.037 0.535 . . . . 0.0 110.623 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.55 67.1 0.52 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.427 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.5 -38.37 26.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.979 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 175.93 39.08 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -71.88 135.63 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.357 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.967 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -93.99 -60.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.168 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -145.09 164.53 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.485 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.678 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -126.17 126.86 44.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.769 HG21 ' HE2' ' A' ' 68' ' ' PHE . 36.5 t -93.96 122.83 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.79 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -126.8 122.56 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.512 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.27 106.64 18.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 110.372 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -77.31 -20.37 55.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.064 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' H ' ' A' ' 142' ' ' SER . 81.1 p -79.9 -2.46 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 74.25 0.48 Allowed Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.808 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -147.3 -44.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 0.0 110.805 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.783 HD13 HD22 ' A' ' 78' ' ' LEU . 4.2 mt -112.3 140.39 23.6 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.38 132.83 16.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.262 1.974 . . . . 0.0 112.036 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -53.22 135.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.57 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -130.72 164.24 25.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.524 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 6.5 m-20 -114.26 119.89 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 0.0 111.425 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.885 HD22 ' CD1' ' A' ' 66' ' ' TRP . 15.0 mt -93.85 137.08 33.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.812 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.967 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.86 157.63 44.09 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.503 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -130.86 150.63 51.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.023 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.851 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -93.66 96.89 10.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.955 0.407 . . . . 0.0 110.439 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.35 -45.16 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 m -61.37 -41.53 97.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.234 0.54 . . . . 0.0 110.743 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 3.3 mm-40 -68.41 -41.21 80.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 51' ' ' ASP . 59.9 t -70.98 -37.85 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -33.29 71.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.734 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -68.32 -51.28 46.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.51 137.05 54.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -73.56 -7.29 51.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.468 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.56 166.95 0.11 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.829 0.347 . . . . 0.0 111.083 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.71 41.21 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.16 138.27 7.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HG3' HG21 ' A' ' 55' ' ' VAL . 2.5 mptt -84.86 -81.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.6 ttmt -155.37 156.53 35.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.9 t -130.61 138.97 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.434 0.635 . . . . 0.0 112.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.885 ' CD1' HD22 ' A' ' 48' ' ' LEU . 13.0 m-90 -105.09 140.02 38.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.17 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.91 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.29 126.08 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.769 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -117.51 145.44 44.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.811 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.287 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -78.03 -1.28 31.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 28.8 t-20 -84.89 131.88 47.7 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.621 0.248 . . . . 0.0 111.093 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.1 Cg_exo -68.02 -10.57 29.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.469 2.112 . . . . 0.0 111.626 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.87 16.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.897 0.856 . . . . 0.0 108.988 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -38.93 141.14 0.31 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.74 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.17 -19.07 11.98 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.908 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.4 t80 -129.92 130.43 45.12 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.993 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -103.12 107.85 18.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.783 HD22 HD13 ' A' ' 43' ' ' ILE . 26.4 mt -74.24 -70.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.31 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.34 -109.1 0.29 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.656 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 80' ' ' ASN . 1.5 p-10 -153.77 63.14 0.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.774 0.321 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 84' ' ' LEU . 31.1 mt -112.01 115.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.947 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' HG22 ' B' ' 171' ' ' TPO . 0.0 OUTLIER -54.81 -35.1 63.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -61.19 -18.66 59.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 81' ' ' ILE . 13.7 mt -104.81 147.35 27.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.66 160.58 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.546 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.62 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -40.87 -51.32 3.18 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.606 0.717 . . . . 0.0 109.741 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 67' ' ' THR . 18.0 mttt -120.82 82.6 1.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.664 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 61.6 t-80 -63.16 -46.06 88.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.968 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.8 p90 -146.25 161.87 39.32 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.282 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.91 ' CG ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.35 137.26 42.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.38 -178.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 65' ' ' VAL . 45.2 mt -115.22 132.09 65.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -121.39 145.86 47.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.139 0.495 . . . . 0.0 111.876 -179.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.561 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.9 tm? -125.07 138.2 54.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.194 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 93' ' ' LEU . . . -140.25 -147.55 5.02 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.631 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.88 177.69 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.862 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 60.66 157.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.93 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.8 59.84 4.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -142.3 171.47 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.972 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.807 ' CB ' HD13 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -128.28 158.33 38.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.771 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.9 OUTLIER -128.37 138.37 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.594 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.1 pp -113.04 120.72 42.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.077 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.0 t30 -114.57 116.03 28.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.668 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.8 p30 -77.45 140.51 39.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.063 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.1 pt -143.89 28.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.448 0.166 . . . . 0.0 111.407 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 9.3 t -89.56 159.67 17.07 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.519 0.676 . . . . 0.0 112.677 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -69.72 -50.42 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.417 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.25 2.92 54.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.266 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.33 159.36 28.11 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.898 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.543 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.0 m -117.74 138.05 52.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.347 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.855 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.12 148.82 31.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.86 113.3 18.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.228 177.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.423 ' N ' HD12 ' A' ' 111' ' ' LEU . 59.1 m-20 44.77 42.9 6.4 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.57 -14.21 60.39 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.548 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.2 118.38 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.075 0.438 . . . . 0.0 110.482 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.855 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.92 123.9 23.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.407 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.7 m -95.39 165.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.029 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 mp0 -69.85 126.81 30.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.685 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 62.9 tttt -54.84 162.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.991 0.424 . . . . 0.0 110.579 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.59 33.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.147 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.54 144.55 41.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.89 179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.4 ' HB3' HD23 ' A' ' 100' ' ' LEU . 24.2 m-80 -93.22 133.32 36.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.946 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 53.8 mm-40 -129.24 151.25 50.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.61 113.56 9.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.2 tt -49.29 156.55 0.57 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.629 . . . . 0.0 111.739 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.48 153.48 41.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.641 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 4.8 mm-40 -71.2 121.93 19.27 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.57 19.68 65.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.734 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -49.26 165.35 0.06 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.857 0.361 . . . . 0.0 111.172 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.5 tt0 -143.2 135.48 27.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.973 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.555 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -115.12 127.77 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.646 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.6 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.5 m -104.64 139.13 39.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.664 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.9 m -140.57 158.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.08 23.48 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.148 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.5 t -71.75 140.34 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 121.536 0.684 . . . . 0.0 112.391 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.405 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 152.88 -42.18 0.67 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.314 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.34 131.76 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 -34.8 25.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 111.414 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.9 m -93.53 6.37 48.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 59.2 m-20 -121.16 21.82 11.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.6 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -103.93 139.28 25.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.99 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 141' ' ' LEU . 7.9 tt -124.36 134.53 53.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.505 ' H ' HG21 ' A' ' 40' ' ' THR . 46.6 t -110.59 150.21 29.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.716 0.769 . . . . 0.0 112.368 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.78 HD21 HD12 ' A' ' 43' ' ' ILE . 70.1 mt -135.68 145.74 47.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.831 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.51 139.97 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.349 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.555 HD11 HD11 ' A' ' 130' ' ' ILE . 39.6 mt -106.14 126.22 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.18 118.9 36.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.601 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.507 HD11 HD21 ' A' ' 124' ' ' LEU . 6.3 mt -84.64 133.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -84.3 115.42 22.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.809 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -58.87 -29.05 66.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.019 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -59.24 -44.04 92.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -33.86 73.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -67.31 -37.01 82.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -62.66 -46.02 90.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.97 -37.77 78.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.861 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -59.52 -39.78 84.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.974 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -35.93 14.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.956 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 44.63 -171.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.554 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -59.32 156.28 12.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.859 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 t -66.92 136.44 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.101 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -156.69 165.36 36.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.96 168.0 9.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.5 pt -82.58 132.63 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.048 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.821 179.993 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.956 0.407 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -168.88 -68.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -42.21 5.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.46 139.82 47.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' B' ' 172' ' ' PRO . 1.2 t80 -169.45 171.77 7.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.61 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' TPO . . . . . 0.458 HG22 ' O ' ' A' ' 82' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.421 ' HA ' ' CZ ' ' B' ' 169' ' ' PHE . 57.6 Cg_exo -51.84 126.48 20.03 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.561 2.174 . . . . 0.0 112.333 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 23.5 p -89.0 153.99 20.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -109.09 81.91 1.74 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.05 155.81 60.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.582 2.188 . . . . 0.0 112.239 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.44 106.41 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.979 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.215 -0.897 . . . . 0.0 110.813 -179.933 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.813 0.34 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.1 m -144.72 -55.63 0.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.72 -46.97 56.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -63.34 -36.16 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -40.43 93.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.01 -44.82 95.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.6 mm -67.7 -35.16 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -57.18 -35.8 70.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.358 . . . . 0.0 110.43 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -23.86 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.807 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.53 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.54 -47.54 79.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.067 0.461 . . . . 0.0 111.363 -179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.5 -32.82 48.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.886 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.37 14.51 9.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.15 132.34 46.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.775 0.321 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.48 101.94 13.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.27 138.41 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.664 0.745 . . . . 0.0 111.775 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.79 51.97 0.27 Allowed Glycine 0 C--N 1.313 -0.704 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.431 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.34 -45.89 75.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 0.0 111.067 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -169.64 32.9 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.33 134.19 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.48 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.71 -61.01 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.035 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.7 p -147.16 151.4 36.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.394 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.45 138.14 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.711 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.7 t -105.55 122.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.761 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -125.81 117.06 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.407 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.8 t -79.75 124.67 28.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 110.579 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.429 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -94.52 -24.56 17.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.387 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.486 HG23 ' HB3' ' A' ' 142' ' ' SER . 67.6 p -79.86 -2.36 43.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.397 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 73.84 0.54 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.894 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.77 -43.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.7 mt -115.15 140.53 25.78 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.24 138.47 25.09 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.2 1.933 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.761 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -56.11 129.48 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.629 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -126.23 164.14 21.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 119.71 35.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.994 0.426 . . . . 0.0 111.797 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 66' ' ' TRP . 2.0 mt -92.42 137.27 32.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.55 158.8 43.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.89 142.68 30.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.75 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.887 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.7 m-20 -74.92 121.81 22.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.039 0.447 . . . . 0.0 111.109 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.556 HD13 ' SG ' ' A' ' 154' ' ' CYS . 76.3 mt -64.32 -44.84 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.038 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -60.38 -40.85 92.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.235 0.54 . . . . 0.0 110.658 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.494 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 5.7 mm100 -68.6 -36.77 79.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.826 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 51' ' ' ASP . 60.3 t -69.26 -43.24 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.972 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -27.31 63.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.039 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -39.39 65.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.051 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.39 125.24 48.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.034 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.17 98.95 9.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -148.6 -167.2 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.2 t -76.27 -56.87 4.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.009 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 65' ' ' VAL . 26.3 mm -125.97 153.57 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.784 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.27 -72.42 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.734 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.5 ttpt -126.36 125.5 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 62' ' ' ILE . 3.7 t -111.87 139.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.264 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.601 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.2 m-90 -100.42 139.29 36.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.899 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.39 133.69 53.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.711 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -116.01 145.57 42.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.313 -178.578 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.797 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 170.57 -175.46 44.4 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.455 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -82.19 -4.39 56.92 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.4 p30 -87.71 139.34 31.31 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.861 0.362 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.7 Cg_exo -69.49 -4.27 13.5 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.889 2.393 . . . . 0.0 111.88 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -46.8 12.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.869 0.842 . . . . 0.0 109.081 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 139.01 3.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.724 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -19.09 12.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.552 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.9 t80 -129.75 120.76 25.6 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.848 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.41 107.92 19.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.681 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 69' ' ' GLY . 8.7 mp -75.14 -83.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.306 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.95 -96.8 0.1 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -175.37 60.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.298 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.756 HD11 HD12 ' A' ' 141' ' ' LEU . 41.0 mt -103.13 122.12 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.783 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -58.62 -33.89 70.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.484 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 5.1 tpt180 -60.71 -47.69 85.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.661 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.2 mp -72.63 153.61 41.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' ASN . 46.3 p -94.61 166.55 11.97 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.933 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.797 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m120 -40.54 -74.69 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.586 ' HB3' HG22 ' A' ' 67' ' ' THR . 15.0 mttt -97.95 85.59 3.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -63.32 -44.86 93.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.957 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' HA ' HG12 ' A' ' 104' ' ' ILE . 31.7 p90 -153.49 162.4 41.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG23 ' A' ' 67' ' ' THR . 10.6 mt-30 -135.92 160.0 39.94 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.732 HG23 HD23 ' A' ' 101' ' ' LEU . 58.3 mt -123.78 131.96 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.081 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.66 139.58 39.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.071 0.463 . . . . 0.0 111.685 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.6 HD13 ' C ' ' A' ' 93' ' ' LEU . 1.8 tm? -125.41 122.93 38.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.491 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 170.13 -139.38 5.5 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.622 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.03 -178.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.348 . . . . 0.0 110.855 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.08 -60.73 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -157.76 68.91 0.27 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -168.18 173.11 8.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.955 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.787 HD11 HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -120.0 156.23 31.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.743 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.8 mt -133.42 147.25 51.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.732 HD23 HG23 ' A' ' 91' ' ' ILE . 14.2 mt -112.66 130.33 56.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.617 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.6 t30 -115.05 115.63 27.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.642 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.762 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.6 p-10 -81.18 141.27 34.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.137 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.56 HG21 ' OE1' ' A' ' 90' ' ' GLN . 13.6 pt -149.82 37.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.606 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -97.39 156.42 16.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.11 0.481 . . . . 0.0 111.84 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.2 m -68.55 -32.79 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.103 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -98.63 -19.9 17.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.112 -179.59 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.606 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.91 164.3 13.45 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.215 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.9 m -117.4 137.68 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -115.74 148.42 39.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.601 ' CD1' HG11 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -124.41 113.36 18.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.544 177.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 45.76 37.4 3.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.013 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.58 -1.86 76.39 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.556 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -107.97 118.65 37.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.02 0.438 . . . . 0.0 110.919 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -75.63 129.72 37.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.348 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.762 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.4 m -106.49 165.11 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.358 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.85 131.77 44.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.209 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 6.1 tttt -55.45 168.78 0.35 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER 31.85 37.19 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.302 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.0 p -111.96 145.08 40.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.342 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.58 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.8 m-80 -93.58 122.44 36.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.626 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -128.59 146.73 50.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.23 115.48 12.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.148 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 99' ' ' LEU . 1.7 pt? -62.03 169.66 2.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.804 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.4 153.72 41.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.116 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.479 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.07 120.55 16.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.035 0.445 . . . . 0.0 110.136 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.58 20.84 64.2 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.139 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD2' HD23 ' A' ' 111' ' ' LEU . 5.0 t70 -61.63 179.6 0.24 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.852 0.358 . . . . 0.0 110.796 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.902 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.1 mt-10 -145.17 135.66 24.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.307 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 145' ' ' ILE . 11.8 mt -108.35 128.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.286 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.27 137.91 41.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 13.9 m -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.88 30.12 29.94 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.171 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.532 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.3 t -69.0 140.24 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.661 0.743 . . . . 0.0 112.332 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.8 -43.49 0.67 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.266 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 138' ' ' SER . 42.4 t -126.48 135.21 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.48 -37.15 37.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.666 0.269 . . . . 0.0 111.679 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.448 ' H ' HG12 ' A' ' 136' ' ' VAL . 95.0 p -93.58 6.33 48.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.31 19.88 14.56 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.678 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -106.04 138.96 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.238 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.756 HD12 HD11 ' A' ' 81' ' ' ILE . 3.3 tt -124.57 134.49 52.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.681 ' N ' HD23 ' A' ' 141' ' ' LEU . 38.8 t -111.56 150.32 30.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.8 . . . . 0.0 112.732 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -135.81 149.54 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.159 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.2 t -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.178 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 130' ' ' ILE . 10.8 mt -106.4 120.88 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 107.69 17.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.274 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.77 128.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.71 119.46 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.91 -32.0 72.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.83 -44.06 90.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -64.98 -42.04 94.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -59.47 -39.65 84.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.929 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.7 t -64.59 -46.09 84.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.98 -39.32 79.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.11 -35.68 75.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.16 -36.99 13.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.1 -170.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.573 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 119.03 6.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.966 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 p -101.3 131.49 48.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -85.75 -176.89 6.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -108.04 147.84 30.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.91 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.9 tp -86.83 140.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.051 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.904 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.783 0.325 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 -171.47 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtt -125.42 116.74 22.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 3.3 t 43.35 74.58 0.11 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.467 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' B' ' 172' ' ' PRO . 0.2 OUTLIER -132.13 89.49 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -73.63 68.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' TPO . . . . . 0.627 HG22 ' O3P' ' B' ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.435 ' HB3' ' CE2' ' B' ' 169' ' ' PHE . 44.2 Cg_endo -68.16 88.62 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.468 2.112 . . . . 0.0 112.347 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t -64.89 -37.9 89.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.36 139.83 0.51 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.798 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.67 114.52 4.04 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.446 2.097 . . . . 0.0 112.268 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.52 166.99 22.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.786 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.0 p -112.33 -71.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -71.89 -42.56 66.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.99 -43.64 81.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.81 -31.92 72.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.13 -35.35 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -57.44 -43.6 84.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.476 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -67.21 -23.7 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.546 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.72 -47.46 79.95 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.229 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.9 -29.67 50.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.883 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 62.12 116.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.51 152.19 45.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.53 138.28 31.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.823 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.16 138.41 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.69 0.757 . . . . 0.0 111.707 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.89 64.32 0.39 Allowed Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.536 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -87.77 -36.47 17.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 110.985 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 t-20 175.42 39.71 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.694 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -71.73 136.22 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.551 -177.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.017 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -91.97 -59.59 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.938 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 157.78 43.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.468 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -123.56 124.85 43.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.679 HG21 ' HE2' ' A' ' 68' ' ' PHE . 46.4 t -92.43 122.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.992 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.856 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -129.03 125.44 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.431 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.4 t -89.91 107.87 19.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -79.99 -26.2 40.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.767 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 142' ' ' SER . 58.7 p -79.83 -2.59 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.525 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.57 80.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.067 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 141' ' ' LEU . 9.2 mt-30 -147.73 -39.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.015 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.079 HD13 HD22 ' A' ' 78' ' ' LEU . 6.8 mt -127.43 141.99 42.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.8 Cg_endo -71.92 141.62 37.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.11 1.873 . . . . 0.0 112.127 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.856 HG12 HG23 ' A' ' 37' ' ' ILE . 34.2 mt -55.86 149.11 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.847 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.29 162.85 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -121.21 122.67 40.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.08 0.467 . . . . 0.0 111.907 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -101.03 137.26 39.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.193 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.017 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.12 158.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.89 148.56 31.93 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.12 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.886 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -78.75 122.27 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.0 111.233 -179.52 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.9 mt -64.45 -42.47 95.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.142 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.1 t -59.68 -40.19 87.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.36 0.6 . . . . 0.0 110.61 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 6.1 mm100 -68.48 -36.83 79.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.517 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 51' ' ' ASP . 28.8 t -71.35 -37.96 67.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.107 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -41.36 74.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.74 -44.97 91.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -99.59 119.42 38.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.972 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.65 -27.18 12.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -88.93 154.9 19.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 m 61.32 -178.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.067 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 tp -92.5 152.79 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.745 ' HG3' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -84.51 -79.48 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' A' ' 49' ' ' SER . 28.1 ttpt -132.77 138.47 47.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 92' ' ' LEU . 9.3 t -124.79 138.66 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.223 0.535 . . . . 0.0 111.702 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.601 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.9 m-90 -100.75 139.86 35.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.145 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.818 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.84 130.58 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.365 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.726 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -120.09 145.1 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.034 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.58 -172.78 39.58 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.109 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 30.5 mtp180 -75.74 1.64 14.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.481 HD22 ' HB3' ' A' ' 73' ' ' ALA . 1.9 t30 -84.67 141.93 39.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.339 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.76 -14.37 24.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.6 2.2 . . . . 0.0 111.271 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -43.28 17.21 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.881 0.848 . . . . 0.0 108.735 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 140.83 1.2 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.898 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.26 -18.58 10.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.094 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.6 ' CD2' HD21 ' A' ' 78' ' ' LEU . 3.0 t80 -129.18 122.68 30.29 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.723 0.296 . . . . 0.0 110.842 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -97.0 110.99 23.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.151 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.079 HD22 HD13 ' A' ' 43' ' ' ILE . 12.8 mt -92.59 170.75 9.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.658 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.43 -86.41 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.413 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.61 77.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.917 0.389 . . . . 0.0 110.665 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.745 HD11 HD12 ' A' ' 141' ' ' LEU . 28.8 mt -109.94 116.65 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -35.68 64.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.019 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -29.42 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.593 HD11 HD12 ' A' ' 81' ' ' ILE . 46.8 mt -90.15 152.35 21.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.55 166.11 12.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.51 -53.64 5.39 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.475 0.655 . . . . 0.0 109.507 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.729 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.74 84.42 2.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.15 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -62.04 -44.93 95.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.982 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -146.31 162.85 37.23 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.399 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.818 ' CG ' HG23 ' A' ' 67' ' ' THR . 11.2 mt-30 -135.57 148.01 48.93 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.726 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 64.5 mt -125.07 132.4 71.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.677 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.725 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -126.04 135.22 51.51 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.034 0.445 . . . . 0.0 112.146 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.68 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.8 tm? -125.41 131.38 52.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.161 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.68 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 154.05 -137.46 5.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.552 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 67.11 -74.26 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.824 0.345 . . . . 0.0 110.835 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -150.57 -60.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.26 172.2 30.83 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.468 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m120 60.99 175.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.987 HD21 HG12 ' A' ' 33' ' ' VAL . 5.6 mp -112.61 160.25 18.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.848 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.7 mp -129.79 142.93 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.08 125.14 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.132 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.567 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.2 t30 -116.57 116.33 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.792 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -76.63 139.49 40.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.831 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.2 pt -145.32 38.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.31 152.65 19.69 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.076 0.465 . . . . 0.0 111.829 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.0 m -68.9 -31.41 70.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.994 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -97.99 -19.92 17.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.01 157.37 10.8 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.841 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.46 137.81 52.28 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.48 148.35 37.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.2 113.47 18.35 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.329 177.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.408 ' N ' HD12 ' A' ' 111' ' ' LEU . 91.4 m-20 44.17 43.5 5.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.87 68.25 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.517 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -104.06 118.46 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.08 0.44 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 18.4 tptt -74.08 123.15 23.85 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.247 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.792 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -94.35 165.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.5 tp10 -69.94 127.24 32.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 69.2 tttt -55.07 162.53 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 110.354 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.411 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER 36.83 32.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.115 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 144.99 41.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.818 179.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.725 ' OD1' HD21 ' A' ' 92' ' ' LEU . 14.8 m-80 -94.8 133.44 38.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.042 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.5 mm-40 -129.22 152.28 48.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.376 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.34 125.81 28.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.948 0.404 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 145' ' ' ILE . 30.7 tp -56.36 154.68 7.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 0.0 111.814 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.467 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.88 152.93 43.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.601 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -72.11 124.25 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.779 0.323 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.04 22.56 42.95 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.15 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.5 t70 -52.81 171.81 0.06 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.96 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.927 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.5 mt-10 -143.91 135.5 26.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.094 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.854 HD11 HD11 ' A' ' 145' ' ' ILE . 15.5 mt -114.94 126.01 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.436 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.69 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.29 138.44 40.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 84' ' ' LEU . 35.7 m -140.24 158.26 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 84.97 27.09 35.16 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.105 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.0 t -66.28 140.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.618 0.723 . . . . 0.0 112.496 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.51 -41.58 0.62 Allowed Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.289 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.1 t -126.46 136.49 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -39.88 52.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.7 0.286 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.446 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.45 6.33 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 23.1 t0 -116.62 23.28 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.69 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.317 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 HD11 ' A' ' 81' ' ' ILE . 6.8 tt -119.25 134.39 55.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.591 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.5 m -109.01 141.98 40.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 111.654 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.809 HD21 HD12 ' A' ' 43' ' ' ILE . 73.8 mt -135.13 141.97 46.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.787 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.927 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.3 t -114.08 140.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.798 0.332 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.854 HD11 HD11 ' A' ' 130' ' ' ILE . 50.3 mt -106.16 129.64 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.83 115.29 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.446 HG12 HD21 ' A' ' 124' ' ' LEU . 1.8 mt -84.77 134.03 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -83.46 103.96 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -29.47 64.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -45.02 91.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -59.24 -44.3 92.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -40.47 94.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -59.12 -43.1 91.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.3 t -60.04 -45.98 91.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -36.02 81.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -64.79 -37.34 87.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -87.28 -36.43 17.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.783 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.56 35.78 0.71 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.488 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.68 139.68 52.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -65.02 116.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.8 105.81 16.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.4 ttp-105 -68.44 107.49 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.8 pt -91.09 130.29 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.189 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.4 ttp85 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.913 179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.799 0.333 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -74.15 -63.18 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -90.98 99.84 12.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 1.7 m -154.01 152.36 30.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.4 ' O ' ' CD1' ' B' ' 169' ' ' PHE . 36.4 p90 -98.79 118.76 36.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.09 80.75 3.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' TPO . . . . . 0.647 HG22 ' O1P' ' B' ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.7 150.09 17.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.585 2.19 . . . . 0.0 112.314 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 73.4 p -107.05 -67.04 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -155.53 72.73 5.46 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.2 -171.84 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.564 2.176 . . . . 0.0 112.244 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' LEU . . . . . 0.442 ' N ' HD12 ' B' ' 176' ' ' LEU . 2.5 mp -130.56 154.71 47.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.967 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.805 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.727 0.299 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 77.87 -56.55 0.49 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -39.34 84.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -61.26 -36.8 81.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.825 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -65.71 -38.27 88.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.24 -43.18 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.8 mm -68.23 -35.12 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.21 -34.73 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.378 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -67.23 -23.9 65.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.814 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.64 -47.63 79.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.87 -26.37 62.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.958 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 63.02 145.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.82 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.49 124.19 28.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.956 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -95.14 136.94 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.756 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.03 138.36 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.667 0.746 . . . . 0.0 111.785 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.47 30.96 0.47 Allowed Glycine 0 C--N 1.314 -0.678 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.56 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -41.62 85.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.722 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 49' ' ' SER . 3.0 m-20 179.78 38.09 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -71.39 143.77 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.477 -176.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.86 HG22 HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -109.94 -49.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.785 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.621 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -152.72 158.7 42.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.422 179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -130.83 136.88 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.749 0.309 . . . . 0.0 111.476 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 68' ' ' PHE . 58.3 t -108.54 122.62 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.964 0.411 . . . . 0.0 110.647 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -126.76 115.21 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.463 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.563 ' HA ' HD23 ' A' ' 143' ' ' LEU . 17.6 t -81.4 101.87 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 110.409 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -24.09 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.755 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.639 HG21 ' H ' ' A' ' 142' ' ' SER . 13.7 p -79.82 -2.42 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.417 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.6 78.81 0.26 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.133 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -147.64 -40.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.007 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.0 mt -124.64 141.85 39.05 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -71.57 137.64 30.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.252 1.968 . . . . 0.0 111.925 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -54.62 137.54 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.914 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 163.33 27.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.976 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.5 m-20 -118.65 119.75 35.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.892 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 34' ' ' CYS . 3.4 mt -92.24 137.37 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.5 158.59 44.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.228 1.013 . . . . 0.0 113.665 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -139.09 141.72 38.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.344 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.2 m-20 -75.34 133.31 41.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.362 0.601 . . . . 0.0 111.424 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.635 HD13 ' SG ' ' A' ' 154' ' ' CYS . 44.6 mt -64.82 -39.82 86.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.072 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -60.33 -42.69 96.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.598 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.473 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 3.5 pt20 -68.3 -38.6 81.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.451 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.829 HG11 HD21 ' A' ' 155' ' ' LEU . 63.6 t -66.37 -49.97 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.899 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 158' ' ' ASN . 4.2 mm? -67.12 -27.23 67.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -81.23 -32.91 33.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.056 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.91 118.96 17.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.77 99.2 9.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.63 -164.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.786 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 t 65.04 -168.16 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 0.0 110.841 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.4 tp -89.27 154.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -104.27 -67.9 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.204 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.8 ttpt -141.37 140.65 33.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.328 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.543 HG22 ' CB ' ' A' ' 92' ' ' LEU . 15.2 t -129.98 138.91 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.003 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.599 ' CH2' HG11 ' A' ' 33' ' ' VAL . 15.6 m-90 -102.13 139.6 37.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.107 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.944 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.87 126.78 55.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.115 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -117.47 145.58 44.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.317 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.31 -173.12 40.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.892 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 5.7 mtp-105 -77.48 -1.29 29.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.474 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.81 133.58 43.38 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.691 0.281 . . . . 0.0 111.216 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.66 -9.5 26.31 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.797 2.331 . . . . 0.0 112.065 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.8 -43.02 17.18 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.842 0.83 . . . . 0.0 108.921 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.28 139.56 0.72 Allowed 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.939 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.26 -18.77 11.5 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.977 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 55.6 t80 -129.55 123.68 32.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.832 0.349 . . . . 0.0 110.769 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -98.77 117.71 33.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.507 HD11 ' C ' ' A' ' 69' ' ' GLY . 1.3 pp -123.37 -177.08 3.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.774 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.34 163.18 7.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.596 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -97.28 68.22 2.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 0.0 110.934 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.7 mm -85.73 128.29 39.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -42.3 75.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.402 ' HB3' ' HA2' ' A' ' 133' ' ' GLY . 1.0 OUTLIER -60.91 -26.52 67.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.16 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.708 HD21 HG23 ' A' ' 132' ' ' VAL . 39.7 mt -90.96 152.33 20.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -99.88 167.44 10.52 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.687 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.96 -53.83 5.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.308 0.575 . . . . 0.0 109.808 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' HG22 ' A' ' 67' ' ' THR . 9.7 mttt -117.19 82.3 1.79 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.653 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 60.5 t-80 -58.65 -45.34 89.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.772 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -147.23 160.88 41.96 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.979 -0.688 . . . . 0.0 112.399 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.944 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.33 130.39 34.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 65' ' ' VAL . 51.3 mt -110.78 130.82 63.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.924 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.728 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -124.21 141.45 52.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.956 0.408 . . . . 0.0 111.607 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 33' ' ' VAL . 8.3 tt -125.25 126.37 45.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.01 120.92 2.45 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.554 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -176.56 -46.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.407 ' OD1' ' ND2' ' A' ' 98' ' ' ASN . 15.0 p-10 -158.07 -45.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.19 38.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.554 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.407 ' ND2' ' OD1' ' A' ' 96' ' ' ASP . 4.1 p30 -162.21 -174.72 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 93' ' ' LEU . 3.2 mp -112.68 160.17 18.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 99' ' ' LEU . 10.0 mp -132.17 141.45 49.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.944 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.645 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.74 124.16 51.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.518 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.581 ' HB2' HD21 ' A' ' 92' ' ' LEU . 65.9 t30 -117.29 132.66 56.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.105 0.478 . . . . 0.0 112.057 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.765 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.8 p30 -93.26 134.46 35.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.613 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.52 HD13 ' HG3' ' A' ' 90' ' ' GLN . 4.2 pt -136.1 26.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.531 0.205 . . . . 0.0 111.504 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.553 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 11.2 t -91.38 156.47 17.73 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.538 0.685 . . . . 0.0 112.539 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -69.68 -52.21 27.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.873 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -81.49 -1.02 44.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.389 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.77 158.97 30.58 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.417 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.545 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.0 m -117.54 137.72 52.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.88 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -111.95 148.54 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.608 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.05 113.32 18.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.4 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 72.1 m-20 43.9 43.64 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.37 66.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.35 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.97 118.58 37.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.467 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.88 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.7 tptm -73.93 121.17 20.55 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.551 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.8 m -92.37 163.7 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -69.91 128.44 36.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.4 tttt -53.91 161.59 1.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.314 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.7 p-10 36.83 32.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.42 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 144.73 41.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.818 179.063 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.728 ' OD1' HD11 ' A' ' 92' ' ' LEU . 15.7 m-80 -93.9 130.54 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -129.98 152.15 49.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.34 111.68 10.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.706 HD21 ' CB ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.18 168.43 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.806 -178.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 t -124.35 153.48 41.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.236 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.28 115.64 10.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.025 0.441 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.85 18.55 78.98 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.188 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.608 ' OD2' HD13 ' A' ' 111' ' ' LEU . 10.3 t70 -59.14 179.45 0.1 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.669 0.271 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.872 ' CG ' HG22 ' A' ' 144' ' ' VAL . 11.0 mt-10 -145.23 135.7 24.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.66 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 101' ' ' LEU . 6.2 mt -112.0 128.26 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 140.51 37.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.595 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.708 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.45 158.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 83.23 31.33 28.52 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.179 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.3 t -70.21 140.37 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.688 0.756 . . . . 0.0 112.503 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.84 -43.44 0.61 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.138 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.551 HG12 ' H ' ' A' ' 138' ' ' SER . 43.7 t -126.43 131.38 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.47 -33.04 19.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.824 0.345 . . . . 0.0 111.275 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.551 ' H ' HG12 ' A' ' 136' ' ' VAL . 88.1 p -93.64 6.19 49.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.58 22.63 9.84 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.7 mt -104.6 139.6 25.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.058 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 142' ' ' SER . 4.8 tt -119.64 134.55 55.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.454 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.639 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -110.19 136.7 49.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.678 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 38' ' ' CYS . 57.9 mt -131.0 144.52 51.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.593 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.872 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.7 t -110.95 135.12 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.402 . . . . 0.0 111.381 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.795 ' N ' HD12 ' A' ' 145' ' ' ILE . 2.0 mp -106.06 123.14 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.316 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.25 106.75 15.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.504 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.645 HG12 HD22 ' A' ' 124' ' ' LEU . 6.3 mt -84.79 133.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -75.96 118.72 19.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.003 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -74.01 -30.67 62.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.41 91.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.627 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.423 ' HZ ' HG21 ' A' ' 55' ' ' VAL . 36.1 t80 -58.15 -43.96 87.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -59.59 -41.09 89.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.43 -45.16 94.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.6 t -68.1 -42.15 80.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.829 HD21 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -66.66 -37.27 84.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.96 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.77 -39.65 93.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -86.28 -32.46 21.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.588 ' HB2' HD11 ' A' ' 56' ' ' LEU . 2.7 p30 42.47 85.49 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.441 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -104.25 116.51 32.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 p -84.06 136.89 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.079 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.15 31.55 2.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.99 143.86 29.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.3 pp -105.01 123.4 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.897 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.755 0.312 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -110.99 -31.84 7.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.963 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 167' ' ' MET . . . . . 0.433 ' HB3' ' CE2' ' B' ' 169' ' ' PHE . 0.0 OUTLIER -175.65 -39.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 4.8 p 58.44 107.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' B' ' 167' ' ' MET . 0.7 OUTLIER -163.41 -178.01 5.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.03 -70.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.956 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.19 151.23 68.61 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.477 2.118 . . . . 0.0 112.299 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 9.7 p -113.67 -25.84 8.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.189 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.73 68.59 0.75 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.762 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.43 109.39 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.639 2.226 . . . . 0.0 112.384 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.88 119.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.962 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' HB1' ' CG ' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.792 0.329 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 16' ' ' GLN . 5.7 t -151.21 -48.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.427 ' N ' HG23 ' A' ' 15' ' ' THR . 0.4 OUTLIER -60.7 -36.26 78.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -71.1 -38.05 72.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.897 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -41.22 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -31.95 70.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.27 -35.24 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.47 -41.1 79.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.52 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -23.99 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.648 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.75 -47.51 79.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.02 -38.34 27.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.921 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -81.49 105.47 12.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 120.95 32.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.705 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -107.1 108.68 20.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.024 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.0 138.43 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.606 0.717 . . . . 0.0 111.641 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 91.41 47.66 3.46 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.435 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -83.72 -31.08 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.702 0.287 . . . . 0.0 111.143 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.88 35.89 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.5 mm -77.85 135.09 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.457 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.043 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.78 -60.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.617 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.38 165.02 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.986 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 124.15 33.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 111.343 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.745 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.8 t -93.22 122.8 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.085 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.803 HG23 HG12 ' A' ' 45' ' ' ILE . 22.3 mt -127.34 118.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.205 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.434 ' HA ' HD23 ' A' ' 143' ' ' LEU . 12.2 t -80.04 109.81 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.428 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -80.46 -27.25 37.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.61 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.66 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.2 p -79.94 -2.61 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.669 0.271 . . . . 0.0 111.351 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.46 79.97 0.19 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.926 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.427 ' CB ' HD11 ' A' ' 141' ' ' LEU . 17.0 mt-30 -148.04 -39.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.886 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.749 HD13 ' HB3' ' A' ' 78' ' ' LEU . 7.5 mt -123.44 141.72 36.99 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.79 138.89 29.7 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.132 1.888 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.803 HG12 HG23 ' A' ' 37' ' ' ILE . 37.7 mt -54.9 132.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.956 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 1.5 ttt180 -126.13 164.21 21.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.051 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -117.63 119.71 35.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 111.976 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.759 HD23 ' CD2' ' A' ' 66' ' ' TRP . 5.8 mp -91.49 125.81 36.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.043 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.46 156.52 46.9 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.91 141.76 29.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.299 -1.773 . . . . 0.0 110.531 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -79.44 135.61 36.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.136 0.493 . . . . 0.0 111.039 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mm -64.3 -42.41 95.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.221 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.96 -40.21 76.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.129 0.49 . . . . 0.0 110.948 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.495 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 9.3 mt-30 -68.43 -40.11 81.31 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.74 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.5 t -69.19 -37.93 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.04 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -40.61 78.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.149 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -76.9 -38.67 53.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.07 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.93 120.84 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.97 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.19 -18.9 18.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -53.62 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.858 0.361 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.6 p -81.28 -32.07 33.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' CD1' ' A' ' 92' ' ' LEU . 23.5 mm -119.23 157.22 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.54 ' HG3' HG13 ' A' ' 55' ' ' VAL . 5.0 mmtp -119.42 -62.88 1.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.8 ttpt -139.78 130.24 25.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.941 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.718 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.8 t -125.86 139.31 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.248 0.546 . . . . 0.0 112.111 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.759 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.4 m-90 -102.32 139.14 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.054 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.679 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.53 126.78 55.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.745 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -110.47 145.66 37.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.646 -178.336 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -176.25 39.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.708 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 12.0 mtp180 -77.64 -0.93 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.7 t-20 -84.84 134.04 42.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.259 . . . . 0.0 111.029 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.6 Cg_exo -68.64 -8.09 22.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.749 2.299 . . . . 0.0 111.763 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.56 16.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.009 0.909 . . . . 0.0 108.796 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 137.32 2.99 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.507 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.53 -18.68 12.46 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.904 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.47 125.36 36.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -101.63 123.65 45.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.747 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.749 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -123.98 173.5 8.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.997 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.12 154.3 10.61 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.687 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 83.0 4.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.436 ' HB ' HD12 ' A' ' 84' ' ' LEU . 24.5 mm -104.16 119.55 53.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.96 -40.7 70.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.012 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -60.94 -15.88 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.227 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 132' ' ' VAL . 26.9 mt -105.97 149.59 26.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.2 p -93.97 165.21 12.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.863 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.707 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -41.66 -52.51 3.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.375 0.607 . . . . 0.0 109.818 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.06 82.16 1.88 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.0 t60 -60.62 -45.85 92.48 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.023 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 19.0 p90 -146.34 159.09 43.82 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.719 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.718 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.4 tt0 -135.53 141.66 45.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.285 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.782 HG12 HD23 ' A' ' 101' ' ' LEU . 46.7 mt -117.54 127.12 75.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.073 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.569 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -110.05 148.52 31.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.025 0.44 . . . . 0.0 111.748 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 33' ' ' VAL . 33.5 tp -125.18 122.87 38.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.446 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.38 -129.77 1.61 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.663 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.26 -71.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.857 0.361 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -176.34 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -147.86 58.25 0.48 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.442 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -173.38 177.95 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.643 HD21 ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -116.45 160.14 21.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 122' ' ' GLN . 7.3 mt -132.03 144.01 50.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.346 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.782 HD23 HG12 ' A' ' 91' ' ' ILE . 13.5 mt -112.69 124.18 51.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.6 t30 -118.11 115.79 25.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 111.729 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.5 p30 -77.5 139.2 39.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.83 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 67' ' ' THR . 16.7 pt -146.83 39.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.72 158.51 15.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.039 0.447 . . . . 0.0 111.571 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -68.91 -38.19 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.581 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.71 -19.73 17.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.169 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.99 158.64 10.09 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.929 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.58 138.01 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.943 -0.628 . . . . 0.0 109.517 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.851 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.26 148.57 35.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.03 113.46 18.43 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.366 177.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.87 43.64 5.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.415 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.75 -10.2 70.98 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.421 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -105.08 118.6 36.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.158 0.504 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.851 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 5.4 tptt -72.25 119.19 16.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.25 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.1 m -89.95 163.87 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.0 mm-40 -69.86 125.88 28.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.0 tttp -53.35 161.34 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.832 0.348 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.8 p-10 35.12 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.1 40.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.976 179.378 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.757 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.6 m-80 -89.51 131.81 35.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.888 ' O ' HD23 ' A' ' 100' ' ' LEU . 49.9 mm-40 -129.25 148.95 51.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.517 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -72.77 135.91 45.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.52 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.883 HD21 HG12 ' A' ' 147' ' ' ILE . 35.5 tp -59.87 152.85 22.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.55 0.69 . . . . 0.0 111.515 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.41 152.83 44.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.552 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.403 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.3 120.56 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.266 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.98 23.9 57.52 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.27 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.2 t70 -52.23 167.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.006 0.432 . . . . 0.0 111.314 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 16.5 tt0 -145.22 135.62 24.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.151 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 101' ' ' LEU . 11.0 mt -113.55 128.14 70.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.562 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.63 138.98 40.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.993 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.612 HG23 HD21 ' A' ' 84' ' ' LEU . 35.3 m -140.45 158.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.13 26.85 29.9 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.318 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.1 t -66.86 140.26 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.533 0.682 . . . . 0.0 112.204 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.51 -41.54 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 138' ' ' SER . 43.8 t -126.33 134.84 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.65 -34.69 27.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.712 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.5 -6.74 46.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.1 m-20 -102.42 19.7 18.37 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.562 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.8 mt -105.73 139.33 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.353 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 142' ' ' SER . 7.4 tt -124.22 134.45 53.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.342 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.66 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -110.58 128.93 55.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.151 0.5 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.597 HD21 HD12 ' A' ' 43' ' ' ILE . 20.2 mt -122.37 134.2 54.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.847 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.92 137.57 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.443 ' CD1' HD21 ' A' ' 101' ' ' LEU . 33.6 mt -106.14 137.61 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.518 ' CD1' HD12 ' A' ' 37' ' ' ILE . 9.3 m-85 -118.78 121.96 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.503 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.883 HG12 HD21 ' A' ' 124' ' ' LEU . 4.5 mt -85.47 134.12 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -86.11 113.16 21.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.3 -29.15 70.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -57.4 -42.88 83.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.98 0.419 . . . . 0.0 110.574 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -59.11 -44.0 91.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.923 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -60.94 -33.89 73.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.989 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.54 -45.7 92.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.75 -43.41 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.03 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -64.47 -35.93 82.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.59 -48.06 83.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -82.55 -36.0 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.916 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 42.78 43.83 3.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.468 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.66 158.72 20.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.46 129.0 49.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.142 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.18 87.27 6.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 ttt85 -113.88 152.31 30.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pt -76.99 124.28 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.985 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.792 0.329 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -74.51 134.51 42.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.857 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 70.6 mmm -96.55 100.61 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.15 119.29 26.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' B' ' 172' ' ' PRO . 0.1 OUTLIER -126.26 -49.99 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.03 -78.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' B' ' 169' ' ' PHE . 69.5 Cg_exo -51.42 112.69 0.87 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.522 2.148 . . . . 0.0 112.323 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -37.37 79.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.734 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 t70 60.01 81.73 0.24 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.83 140.8 43.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.542 2.161 . . . . 0.0 112.34 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 4.0 mt -123.72 130.95 53.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.836 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.93 -179.934 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.82 0.343 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 p -88.15 66.6 8.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -68.18 -41.88 80.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.813 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -35.94 82.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.69 -40.2 91.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.28 -41.09 92.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.6 mm -69.34 -35.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.28 -35.36 69.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.421 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -67.32 -23.78 65.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.868 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.63 -47.66 79.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -80.25 -31.12 38.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.794 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.58 71.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.969 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.68 121.06 31.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.738 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.14 103.12 14.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.3 mm -81.88 138.14 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 121.595 0.712 . . . . 0.0 111.779 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -173.13 102.28 0.17 Allowed Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.572 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -80.47 -33.72 36.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.827 0.346 . . . . 0.0 110.813 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 177.47 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -76.28 135.06 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.538 -177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.62 -60.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.758 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' HD22 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -150.08 165.23 33.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.25 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -129.18 138.1 51.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.88 0.372 . . . . 0.0 111.404 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.66 HG21 ' CE2' ' A' ' 68' ' ' PHE . 40.5 t -105.16 122.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.773 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -121.83 124.57 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.321 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.627 ' HA ' HD13 ' A' ' 143' ' ' LEU . 7.0 t -87.08 102.72 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.577 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -76.09 -21.18 56.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.666 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.493 HG21 ' H ' ' A' ' 142' ' ' SER . 82.3 p -79.94 -2.34 43.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.821 0.343 . . . . 0.0 111.599 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.91 74.76 0.39 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.818 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -147.49 -41.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.081 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -120.32 141.67 32.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.6 Cg_endo -72.05 140.03 33.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.135 1.89 . . . . 0.0 112.187 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.773 HG12 HG23 ' A' ' 37' ' ' ILE . 45.9 mt -56.41 144.89 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 111.797 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 164.08 30.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.916 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -122.73 119.81 31.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.443 . . . . 0.0 112.029 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 4.2 mp -85.1 129.56 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.98 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.03 155.85 49.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.231 1.015 . . . . 0.0 113.324 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.04 142.86 29.0 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.651 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.625 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -74.91 137.07 41.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.222 0.534 . . . . 0.0 111.058 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.722 HD13 ' SG ' ' A' ' 154' ' ' CYS . 84.1 mt -64.14 -41.44 92.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.896 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 m -56.87 -40.72 76.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.94 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 0.4 OUTLIER -68.45 -36.86 79.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.734 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 51' ' ' ASP . 42.5 t -70.83 -38.37 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.09 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.07 -33.52 70.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -50.42 15.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.79 119.39 24.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -135.65 25.47 3.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.989 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -137.87 -52.76 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -88.37 -166.22 1.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.609 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.436 HG12 ' CG2' ' A' ' 65' ' ' VAL . 7.6 tp -89.66 132.05 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.158 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -65.72 0.7 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.284 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.8 ttpt -153.23 141.22 20.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.464 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.691 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.7 t -133.59 139.28 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.22 0.533 . . . . 0.0 111.905 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.4 m-90 -103.21 139.21 38.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.524 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -109.95 130.79 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.822 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -120.01 145.44 46.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.02 -168.44 37.81 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 6.7 mtp-105 -81.76 1.84 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.4 t-20 -84.82 134.42 41.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.676 0.274 . . . . 0.0 111.553 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.4 Cg_exo -66.65 -13.53 40.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.747 2.298 . . . . 0.0 111.756 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -43.85 16.38 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.952 0.882 . . . . 0.0 109.05 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.56 140.17 1.34 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.593 . . . . 0.0 111.176 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 m-20 -56.35 -18.52 11.15 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.076 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.515 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.6 t80 -129.36 115.29 17.33 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 120.761 0.315 . . . . 0.0 110.697 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.474 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 -85.95 115.29 23.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.548 HD22 ' HA2' ' A' ' 69' ' ' GLY . 8.0 mp -91.75 166.05 12.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.66 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.65 -87.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.472 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 178.44 72.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.764 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.788 HD12 HD11 ' A' ' 84' ' ' LEU . 26.1 mt -106.94 116.65 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.403 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -38.19 67.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.86 -23.43 65.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 81' ' ' ILE . 30.3 mt -98.01 151.97 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.127 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 m -95.72 165.02 12.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.598 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.632 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.85 -52.78 4.95 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 109.782 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.468 ' HB2' HG22 ' A' ' 67' ' ' THR . 15.0 ptmt -119.33 81.77 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -60.21 -46.9 88.15 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.656 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.9 p90 -144.42 160.77 40.51 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.894 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.691 ' HG2' HG12 ' A' ' 65' ' ' VAL . 26.8 tt0 -136.07 142.58 44.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.24 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.784 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 63.6 mt -116.27 127.72 73.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.87 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -113.2 148.57 35.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.139 0.495 . . . . 0.0 111.645 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 33' ' ' VAL . 16.2 tp -125.1 123.46 39.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.66 -140.98 3.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.515 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 63.41 -79.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.845 0.355 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -159.46 -76.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -132.61 22.15 4.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.516 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.48 ' O ' HD12 ' A' ' 93' ' ' LEU . 68.8 m-20 -115.91 175.25 5.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.773 0.321 . . . . 0.0 110.777 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.636 HD22 ' SG ' ' A' ' 34' ' ' CYS . 4.0 mp -120.92 158.16 28.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.025 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.899 HD23 ' O ' ' A' ' 122' ' ' GLN . 3.2 mt -133.09 146.89 52.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.998 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.722 HD11 HD12 ' A' ' 145' ' ' ILE . 0.8 OUTLIER -112.69 124.97 53.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.481 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.4 t30 -115.06 115.56 27.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.781 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.9 p30 -79.53 136.78 36.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.072 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -145.98 39.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.634 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.6 152.85 19.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.474 ' CG2' HG22 ' B' ' 173' ' ' THR . 53.1 m -68.92 -31.7 70.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.886 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.4 -19.87 17.47 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.634 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.37 157.35 10.3 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.812 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.98 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.48 148.68 40.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.868 HD12 HG11 ' A' ' 116' ' ' VAL . 1.1 mt -124.22 113.64 18.56 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.983 177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 46.95 35.82 3.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.212 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.42 -8.84 74.8 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.502 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -106.45 118.53 36.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.111 0.456 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.35 137.49 48.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.212 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.868 HG11 HD12 ' A' ' 111' ' ' LEU . 6.7 m -111.24 168.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.7 tt0 -70.18 125.91 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.615 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 41.8 tttt -53.31 162.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.998 0.428 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.88 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.14 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.41 145.12 40.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.916 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.879 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.0 m-80 -86.68 133.86 33.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.994 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.899 ' O ' HD23 ' A' ' 100' ' ' LEU . 38.2 mm-40 -129.26 148.25 51.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 tp -72.66 119.78 17.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.77 HD11 HG21 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -57.49 153.67 12.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.537 0.685 . . . . 0.0 111.474 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.459 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.2 t -124.31 153.53 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.59 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 3.4 tp-100 -71.54 124.16 24.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.414 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.48 21.54 49.28 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.086 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.516 ' OD2' HD23 ' A' ' 111' ' ' LEU . 11.7 t70 -56.64 172.21 0.26 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.177 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.652 ' HG3' HG22 ' A' ' 144' ' ' VAL . 17.4 tt0 -145.25 135.58 24.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.377 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.949 HD11 HD11 ' A' ' 145' ' ' ILE . 1.3 mp -110.85 128.39 67.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.341 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.727 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.0 m -104.16 137.89 41.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.968 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.7 m -140.15 158.33 25.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.71 29.88 31.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.909 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -68.52 140.3 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.753 0.787 . . . . 0.0 112.487 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.54 -44.13 0.5 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.454 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 32.3 t -126.27 140.75 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.86 -42.03 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 6.27 48.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.467 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 4.4 m-20 -112.69 21.37 15.64 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.727 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.27 139.43 29.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 142' ' ' SER . 5.4 tt -123.41 134.35 53.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.206 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.695 ' N ' HD23 ' A' ' 141' ' ' LEU . 37.4 t -112.69 150.64 31.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.607 0.718 . . . . 0.0 112.932 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.627 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.2 mm? -135.46 139.14 43.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.321 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.652 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.1 t -110.66 140.4 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.216 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.949 HD11 HD11 ' A' ' 130' ' ' ILE . 38.8 mt -105.91 127.06 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.071 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 117.65 32.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.708 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.623 HG12 HD21 ' A' ' 124' ' ' LEU . 5.8 mt -84.89 134.18 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.11 108.36 17.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.53 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.03 -30.5 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -59.66 -45.89 90.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.666 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.54 -44.11 89.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -64.74 -33.97 77.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.023 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -59.26 -46.07 89.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.722 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.9 t -61.74 -46.02 91.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.04 -35.99 74.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.068 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -33.96 76.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.002 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -91.6 -35.24 14.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.026 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.58 90.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.463 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -99.46 114.9 28.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.97 128.16 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.91 113.58 27.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.26 -62.7 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.41 HD12 ' H ' ' A' ' 163' ' ' ILE . 3.6 mp -86.41 129.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.811 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.791 0.329 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -86.4 114.6 23.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.913 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 6.0 mtt -142.04 151.37 42.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 4.3 t -172.68 131.17 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 2.6 t80 61.47 82.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -30.9 14.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.01 135.63 60.31 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.6 2.2 . . . . 0.0 112.167 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.474 HG22 ' CG2' ' A' ' 106' ' ' THR . 61.5 p -105.43 133.15 50.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -107.01 77.1 0.49 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.05 139.64 39.7 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.512 2.141 . . . . 0.0 112.332 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.62 155.13 28.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.906 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.748 0.308 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.1 p -120.95 77.39 1.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.959 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -63.21 -47.0 84.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -64.46 -45.35 87.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -60.77 -35.06 75.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.34 -44.1 92.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -67.24 -35.02 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.23 -40.04 76.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -24.37 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.9 -47.45 80.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.956 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -77.4 -24.57 50.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.87 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -81.01 58.54 3.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -99.11 147.03 25.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.633 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.77 101.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.707 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 mm -82.91 138.05 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.642 0.734 . . . . 0.0 111.655 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 70.22 112.48 0.03 OUTLIER Glycine 0 C--N 1.313 -0.741 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.368 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -87.67 -23.87 24.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.6 0.238 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 174.69 40.38 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.706 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -71.92 134.55 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.627 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.072 HG12 HD21 ' A' ' 99' ' ' LEU . 3.0 t -92.08 -60.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.832 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.4 148.92 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.123 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.98 131.38 56.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.511 -179.213 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.595 HG13 HD11 ' A' ' 48' ' ' LEU . 3.6 m -97.94 122.69 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.844 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.796 HG23 HG12 ' A' ' 45' ' ' ILE . 22.3 mt -125.29 129.02 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.509 ' SG ' HD21 ' A' ' 141' ' ' LEU . 5.9 t -95.54 101.05 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.732 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -78.11 -19.08 54.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.617 HG21 ' OG ' ' A' ' 142' ' ' SER . 29.1 p -79.93 -2.88 45.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.777 0.322 . . . . 0.0 111.429 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.21 69.82 1.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.237 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB2' HD21 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -144.54 -35.11 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.413 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.592 HD12 HD21 ' A' ' 143' ' ' LEU . 3.6 mt -127.52 141.0 39.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.732 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.2 Cg_endo -72.49 137.49 28.03 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.166 1.911 . . . . 0.0 112.286 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.796 HG12 HG23 ' A' ' 37' ' ' ILE . 34.5 mt -55.83 141.11 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.755 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.06 164.18 27.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 m-20 -118.12 119.89 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD11 HG13 ' A' ' 36' ' ' VAL . 2.8 mt -95.39 135.74 36.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.014 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.0 158.52 43.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.56 141.79 30.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.511 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.515 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 2.7 m-20 -79.64 129.92 34.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.11 0.481 . . . . 0.0 111.099 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.688 HD13 ' SG ' ' A' ' 154' ' ' CYS . 49.9 mt -64.13 -38.67 83.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.858 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -41.02 76.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.938 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.37 -44.22 75.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.642 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.8 t -62.42 -45.88 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.01 -28.23 64.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.072 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.31 -46.88 13.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.14 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.26 114.39 9.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.958 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.83 30.45 4.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 169.38 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.678 ' O ' HG22 ' A' ' 62' ' ' ILE . 18.6 p -60.64 147.38 42.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 61' ' ' SER . 9.5 tp 51.69 158.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.973 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.14 -61.71 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.059 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.9 ttpt -144.37 133.62 23.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.087 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.707 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.0 t -126.48 139.15 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.273 0.559 . . . . 0.0 112.091 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.575 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.2 m-90 -101.09 139.38 36.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.7 130.16 55.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.806 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -119.31 145.28 46.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.72 -166.49 35.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.264 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.58 2.35 29.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.754 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.2 t-20 -84.81 132.04 47.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.54 0.21 . . . . 0.0 111.279 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.2 Cg_exo -65.46 -15.37 49.39 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.497 2.132 . . . . 0.0 111.44 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.57 -42.65 18.04 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.946 0.879 . . . . 0.0 108.833 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 139.3 1.96 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.836 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 m-20 -56.17 -18.8 11.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.922 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.552 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.66 124.95 34.9 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.67 107.94 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.65 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.565 HD13 ' CD1' ' A' ' 84' ' ' LEU . 19.5 mt -71.14 -71.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.313 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.26 -78.53 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.44 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -176.35 48.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 111.254 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.94 111.96 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.941 0.4 . . . . 0.0 110.791 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -39.24 68.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.517 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -21.47 63.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.357 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' CD1' HD13 ' A' ' 78' ' ' LEU . 32.8 mt -103.09 152.07 21.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 111.07 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 166.96 11.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.745 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.572 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -44.19 -53.48 6.5 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.416 0.626 . . . . 0.0 109.634 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HB2' HD12 ' A' ' 104' ' ' ILE . 1.9 mttt -118.97 82.61 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.87 -46.41 89.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.634 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.8 p90 -145.75 161.41 39.97 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.091 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.85 143.43 45.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.806 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 77.8 mt -117.62 124.2 72.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.237 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.41 147.99 26.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.533 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.949 HD22 HG11 ' A' ' 33' ' ' VAL . 27.9 tp -125.12 122.99 38.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.604 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.55 -156.24 18.13 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.62 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.52 173.4 11.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.343 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.685 ' HA ' HD12 ' A' ' 155' ' ' LEU . 4.3 t0 58.99 177.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.23 58.59 4.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -141.42 147.3 37.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.394 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.072 HD21 HG12 ' A' ' 33' ' ' VAL . 6.2 mp -124.29 160.1 28.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.813 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.531 HD21 HD12 ' A' ' 145' ' ' ILE . 8.7 mp -112.81 121.51 44.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.008 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.7 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.7 t30 -116.61 115.52 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.772 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.818 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.0 p30 -78.6 139.66 38.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.001 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.6 pt -147.82 38.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.614 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.51 152.6 19.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.102 0.477 . . . . 0.0 111.834 -178.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.96 -31.52 70.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.925 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.15 -19.84 17.66 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.55 156.59 10.23 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.771 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.75 148.62 39.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.36 18.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.358 177.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 44.4 43.19 5.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -11.15 68.42 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.486 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.13 118.64 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.082 0.441 . . . . 0.0 110.667 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -72.76 129.74 38.9 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.818 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -101.47 166.73 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.453 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.93 126.48 29.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.667 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.5 tttt -53.57 163.91 0.59 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.619 0.247 . . . . 0.0 110.365 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.2 m-80 33.35 37.19 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.887 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -111.71 144.97 40.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.728 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.7 m-80 -91.38 129.4 37.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.737 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.859 ' O ' HD23 ' A' ' 100' ' ' LEU . 61.5 mm-40 -128.47 149.9 50.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.437 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 124' ' ' LEU . 4.0 tt -72.65 136.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.534 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.847 HD21 HG12 ' A' ' 147' ' ' ILE . 42.6 tp -61.66 153.27 28.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.456 0.646 . . . . 0.0 111.621 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.416 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -125.32 152.66 44.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.561 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 121.73 19.58 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.54 25.6 55.54 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.02 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -51.09 168.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 111.427 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.861 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.16 135.29 23.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.865 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.7 mt -117.37 127.9 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.1 m -104.31 139.36 39.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.122 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.49 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.46 33.45 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.093 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.2 140.33 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.604 0.716 . . . . 0.0 112.266 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.04 -40.17 0.85 Allowed Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.246 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 138' ' ' SER . 49.1 t -126.5 131.13 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.62 -35.57 31.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.328 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.54 ' H ' HG12 ' A' ' 136' ' ' VAL . 12.3 p -93.59 6.38 48.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.3 t0 -120.87 22.28 11.14 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.639 ' CG2' HG22 ' A' ' 131' ' ' THR . 8.9 mt -103.69 139.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.926 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.686 HD22 ' CD2' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -121.79 134.42 54.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.64 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.11 132.0 55.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.065 0.459 . . . . 0.0 111.616 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.686 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.6 mm? -125.39 136.81 53.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.543 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.861 HG22 ' CG ' ' A' ' 129' ' ' GLU . 19.6 t -110.93 139.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.343 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.531 HD12 HD21 ' A' ' 101' ' ' LEU . 49.6 mt -106.18 132.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.166 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 117.9 31.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.345 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.847 HG12 HD21 ' A' ' 124' ' ' LEU . 5.3 mt -84.77 134.11 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -83.72 109.45 17.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.52 -31.03 67.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -60.49 -46.0 91.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.766 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -59.95 -44.17 94.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.03 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -33.93 77.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.117 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -58.93 -47.14 86.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.18 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.688 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.1 t -64.35 -46.11 84.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.019 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -63.83 -35.91 82.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.793 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -59.72 -39.01 83.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' LYS . 33.1 mt-30 -90.0 -29.37 18.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.03 -90.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.607 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 157' ' ' GLN . 1.6 tmtm? -85.16 123.69 30.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.96 0.41 . . . . 0.0 110.777 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.32 134.9 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.055 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.64 -69.48 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -113.51 147.32 38.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.4 tp -82.25 134.4 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.063 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.856 0.36 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.73 121.4 28.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -151.34 33.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 21.8 p -95.9 74.32 3.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -109.76 -29.96 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.67 33.45 15.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.943 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.38 115.94 2.21 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.516 2.144 . . . . 0.0 112.383 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 p -69.19 -13.66 62.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.263 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 t0 66.95 70.09 0.49 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.765 0.316 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.95 -174.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.506 2.137 . . . . 0.0 112.356 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 6.8 mt -74.8 172.44 12.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.768 0.318 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 p -146.07 -59.45 0.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -46.76 75.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -60.24 -39.06 85.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.8 -41.72 87.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.45 -31.86 69.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.39 -35.41 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.822 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.8 82.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.71 65.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.78 -47.48 80.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.0 m -80.78 -31.63 35.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.857 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -45.66 90.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.25 128.97 36.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 109.0 20.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.95 138.35 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.66 0.743 . . . . 0.0 111.715 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.58 96.27 1.4 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.447 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -77.52 -42.1 36.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.776 0.322 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.4 m-20 179.92 37.61 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.693 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.43 136.0 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.665 -1.607 . . . . 0.0 112.647 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.996 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -93.83 -61.48 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.02 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -145.19 161.74 38.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.261 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.41 138.13 54.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.776 0.322 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.743 HG21 ' HE2' ' A' ' 68' ' ' PHE . 39.4 t -106.22 122.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.867 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.764 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -126.19 120.89 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.615 ' SG ' HD21 ' A' ' 141' ' ' LEU . 49.8 t -85.91 106.81 17.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.428 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.9 -22.83 58.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.89 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.525 HG21 ' H ' ' A' ' 142' ' ' SER . 61.9 p -79.9 -2.36 43.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.614 0.245 . . . . 0.0 111.544 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.38 72.99 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.975 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' CB ' HD11 ' A' ' 141' ' ' LEU . 6.1 mt-30 -143.39 -44.74 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.807 HD12 HD21 ' A' ' 143' ' ' LEU . 2.8 mt -111.78 140.93 23.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.7 Cg_endo -73.59 132.02 16.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.117 1.878 . . . . 0.0 112.051 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.764 HG12 HG23 ' A' ' 37' ' ' ILE . 35.4 mt -54.08 130.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.579 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 164.13 20.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.42 119.78 38.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.567 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 36' ' ' VAL . 8.1 mt -91.5 136.29 33.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.355 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.996 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.26 158.37 43.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.79 143.54 29.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.716 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.846 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.0 m-20 -74.98 130.75 39.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.152 0.501 . . . . 0.0 111.236 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.534 HD13 ' SG ' ' A' ' 154' ' ' CYS . 92.0 mt -64.39 -44.92 97.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.054 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -57.67 -40.35 79.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.29 0.567 . . . . 0.0 110.686 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 5.0 mm100 -68.44 -36.93 79.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.782 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 51' ' ' ASP . 40.6 t -72.6 -40.87 63.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.974 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.726 HD11 ' HB2' ' A' ' 158' ' ' ASN . 0.2 OUTLIER -71.03 -35.13 71.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -71.24 -47.87 54.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.789 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.43 100.06 12.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -30.57 18.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -90.28 159.11 16.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.958 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.84 -168.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 65' ' ' VAL . 10.1 tp -89.39 154.43 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HG3' HG13 ' A' ' 55' ' ' VAL . 10.4 mmtm -87.14 -67.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.943 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt -149.18 134.08 17.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.0 t -125.57 139.12 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.149 0.5 . . . . 0.0 112.252 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.617 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.6 m-90 -100.72 139.26 36.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.969 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.685 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.11 128.91 56.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.743 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -120.25 145.4 47.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.137 -178.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.83 -169.95 36.61 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.556 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.51 1.02 15.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.57 126.27 69.32 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.365 0.126 . . . . 0.0 111.005 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 23.6 Cg_exo -64.19 -14.01 41.28 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.395 2.063 . . . . 0.0 111.417 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.87 17.63 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.73 140.98 0.62 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.422 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.12 -18.78 10.82 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.736 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -129.45 131.64 46.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.543 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -102.79 109.08 20.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 78' ' ' LEU . 5.9 mp -94.23 166.92 11.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.09 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.34 159.84 40.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.34 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.52 73.33 0.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.359 . . . . 0.0 111.117 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.641 HD12 HD11 ' A' ' 84' ' ' LEU . 19.3 mt -107.86 114.29 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.505 ' O ' HG22 ' B' ' 171' ' ' TPO . 0.1 OUTLIER -55.83 -34.8 65.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -61.88 -25.99 67.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.641 HD11 HD12 ' A' ' 81' ' ' ILE . 25.9 mt -96.03 150.4 20.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 m -93.81 166.2 12.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.399 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.555 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.9 m-20 -43.54 -54.82 4.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.422 0.629 . . . . 0.0 109.675 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HB2' HG22 ' A' ' 67' ' ' THR . 16.1 ptpt -119.22 82.6 1.89 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.7 t60 -58.96 -46.02 89.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.877 -176.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.0 p90 -145.19 160.32 41.63 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.358 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.7 tt0 -135.65 144.06 45.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.954 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.591 ' C ' HG13 ' A' ' 65' ' ' VAL . 50.1 mt -118.76 125.44 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.104 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -101.58 149.39 24.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.985 0.421 . . . . 0.0 111.499 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.79 HD22 HG11 ' A' ' 33' ' ' VAL . 48.7 tp -125.13 122.89 38.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.46 -141.06 3.59 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.632 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 60.44 -179.38 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -83.42 58.66 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.706 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . 94.25 38.54 5.05 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -136.55 170.52 15.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 0.0 110.985 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.762 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -123.12 159.77 27.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 99' ' ' LEU . 8.5 mp -133.1 143.18 49.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.756 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.699 HD21 HD11 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -112.83 121.37 44.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.864 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.685 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.2 t30 -116.51 115.55 26.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.844 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.0 p30 -78.18 139.91 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.776 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -146.23 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.62 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.85 152.13 20.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.984 0.421 . . . . 0.0 111.822 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.85 -31.51 70.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -97.67 -19.82 18.02 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.64 157.12 10.58 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.748 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.2 m -117.45 137.79 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.881 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.86 148.56 36.47 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.38 18.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.369 177.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.422 ' N ' HD12 ' A' ' 111' ' ' LEU . 21.9 m-20 43.75 43.75 5.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.528 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.91 -13.58 62.61 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.532 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -103.97 118.48 36.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.964 0.411 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.881 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.2 tptm -72.25 127.4 32.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.844 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.1 m -96.76 164.59 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' SER . 27.1 tt0 -69.89 124.55 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.584 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.4 tttt -52.82 162.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 34.51 34.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.155 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.13 40.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.138 179.45 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.732 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.2 m-80 -88.29 129.84 35.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.8 mm-40 -129.51 148.26 51.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.9 125.57 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.149 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 145' ' ' ILE . 65.0 tp -58.08 156.41 9.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.371 0.605 . . . . 0.0 111.683 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.573 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.66 153.47 42.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.691 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.656 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.8 tp60 -71.24 122.63 20.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.31 21.67 54.31 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.764 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 31.8 t70 -49.7 168.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.993 0.425 . . . . 0.0 111.24 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 tt0 -145.03 135.45 24.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.839 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 145' ' ' ILE . 2.8 mt -115.49 127.21 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.661 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.635 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.69 138.2 41.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.876 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.7 m -140.12 158.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.8 25.77 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.954 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -70.95 140.38 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.64 0.733 . . . . 0.0 112.314 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.88 -40.08 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.312 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 47.5 t -126.4 136.18 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -50.61 -41.62 55.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.406 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.3 m -93.42 6.29 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.814 . . . . 0.0 113.196 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 9.0 t0 -117.5 24.76 10.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.635 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -105.93 139.57 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.91 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.615 HD21 ' SG ' ' A' ' 38' ' ' CYS . 5.2 tt -122.03 134.41 54.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.705 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 141' ' ' LEU . 40.0 t -110.61 150.38 29.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.695 0.76 . . . . 0.0 112.548 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.807 HD21 HD12 ' A' ' 43' ' ' ILE . 76.0 mt -135.9 146.76 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.681 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.42 140.31 43.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.742 0.306 . . . . 0.0 111.065 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 130' ' ' ILE . 47.2 mt -105.98 126.1 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.347 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.55 109.75 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.318 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.4 mp -84.89 134.14 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.021 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.45 106.78 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.35 -26.42 63.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.353 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -60.18 -46.04 91.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -60.13 -44.28 95.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.152 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -65.16 -33.92 77.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.162 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -40.03 90.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.187 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.534 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.7 t -66.96 -43.71 82.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.706 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -59.62 -36.0 75.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.101 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -43.96 97.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.156 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.22 -36.32 24.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.056 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.726 ' HB2' HD11 ' A' ' 56' ' ' LEU . 3.0 p-10 45.16 -173.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.574 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -99.35 125.01 44.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.972 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.4 m -91.85 135.74 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.05 121.55 44.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.94 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.69 120.62 32.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.25 138.13 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.872 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.852 0.358 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 -51.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 5.3 mmt -104.5 -64.19 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.31 156.59 16.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.795 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' B' ' 170' ' ' GLN . 31.9 p90 -177.08 -38.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.032 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 170' ' ' GLN . . . . . 0.448 ' N ' ' CD1' ' B' ' 169' ' ' PHE . 1.3 mt-30 70.18 -63.75 0.39 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.995 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' TPO . . . . . 0.505 HG22 ' O ' ' A' ' 82' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' B' ' 169' ' ' PHE . 75.5 Cg_exo -49.55 174.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.563 2.175 . . . . 0.0 112.385 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 2.4 m -152.08 27.52 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.68 88.07 0.13 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.981 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.78 -174.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.55 2.167 . . . . 0.0 112.346 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.18 101.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.841 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -101.45 37.03 1.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.801 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -43.87 94.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -71.19 -35.82 71.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.488 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.41 ' HB2' ' HB ' ' A' ' 15' ' ' THR . 5.3 m-85 -56.88 -43.17 81.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.18 -31.85 69.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.205 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.58 HG23 ' HE2' ' A' ' 23' ' ' PHE . 13.7 mt -68.74 -47.99 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.58 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -33.61 73.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.441 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -57.47 -47.11 82.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.952 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.58 ' HE2' HG23 ' A' ' 20' ' ' ILE . 5.1 p90 -71.97 -47.22 53.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.561 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 83.9 p -56.38 -39.47 73.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.074 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.69 84.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -100.61 121.32 41.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -68.53 141.65 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.935 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.43 138.1 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.633 0.73 . . . . 0.0 111.897 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.85 31.3 0.11 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.592 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.16 -23.75 22.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.3 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -145.6 -2.29 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.855 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.62 100.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 121.842 0.829 . . . . 0.0 110.807 -179.289 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.738 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.3 t -50.55 -67.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.937 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.9 p -146.79 165.32 30.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.397 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.43 124.2 37.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG13 HD11 ' A' ' 48' ' ' LEU . 3.7 m -88.94 122.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 111.192 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.858 HG23 HG12 ' A' ' 45' ' ' ILE . 19.8 mt -129.6 119.56 48.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 t -80.82 113.5 19.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.399 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 p -86.55 -23.03 25.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.798 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.654 HG21 ' OG ' ' A' ' 142' ' ' SER . 81.7 p -79.91 -2.65 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.714 0.292 . . . . 0.0 111.487 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.84 75.42 0.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.551 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' CB ' HD11 ' A' ' 141' ' ' LEU . 9.6 mt-30 -145.29 -40.49 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 111.09 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.04 HD13 HD22 ' A' ' 78' ' ' LEU . 4.4 mt -125.1 142.74 42.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 43' ' ' ILE . 39.1 Cg_endo -69.19 145.27 59.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.203 1.935 . . . . 0.0 112.266 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.858 HG12 HG23 ' A' ' 37' ' ' ILE . 33.3 mt -58.9 150.88 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.738 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -142.27 164.35 30.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.301 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -122.8 119.76 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 0.0 111.756 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.773 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -100.02 133.17 44.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.139 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.855 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.71 156.82 43.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -142.78 146.71 34.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.575 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.6 m-20 -74.86 132.82 41.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.943 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.596 HD13 ' SG ' ' A' ' 154' ' ' CYS . 31.8 mt -63.94 -38.71 83.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.668 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.3 t -56.65 -41.35 77.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.883 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.4 OUTLIER -68.49 -38.15 80.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.553 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG13 ' HD3' ' A' ' 63' ' ' LYS . 37.6 t -70.29 -46.86 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.158 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -28.36 65.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -85.4 -57.03 3.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.25 129.36 39.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.4 29.8 0.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.29 -60.35 0.67 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 m -94.51 -173.2 2.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.876 HD13 ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -76.78 134.64 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.05 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.876 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -81.21 -65.37 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.083 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 10.2 ttpt -148.82 117.35 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 91' ' ' ILE . 9.7 p -110.61 139.34 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.94 139.51 36.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.437 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.683 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.71 129.48 56.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -118.11 145.27 45.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.881 0.372 . . . . 0.0 111.669 -178.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.54 -172.28 40.25 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.774 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -78.96 0.15 28.65 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.7 135.32 40.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 111.478 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.7 Cg_exo -66.37 -12.95 37.78 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.789 2.326 . . . . 0.0 111.84 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.5 -44.92 15.36 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.874 0.845 . . . . 0.0 108.965 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.15 141.87 1.12 Allowed 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.818 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.0 m-20 -56.22 -18.77 11.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.149 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.545 ' CD2' HD21 ' A' ' 78' ' ' LEU . 4.8 t80 -129.36 127.03 40.22 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-O 120.762 0.315 . . . . 0.0 110.693 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -97.92 108.75 21.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.278 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.04 HD22 HD13 ' A' ' 43' ' ' ILE . 17.1 mt -88.13 170.27 11.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.646 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.19 -86.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.391 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 175.64 69.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.942 0.401 . . . . 0.0 110.594 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 84' ' ' LEU . 25.0 mt -97.48 116.23 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.304 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -54.76 -35.8 64.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.466 ' O ' HG22 ' B' ' 171' ' ' TPO . 4.0 mtp180 -63.6 -42.11 98.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.072 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 81' ' ' ILE . 53.3 mt -72.91 152.13 41.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -94.39 167.33 11.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.718 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -42.95 -54.82 4.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.413 0.625 . . . . 0.0 109.769 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.683 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -119.02 82.95 1.95 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 177.214 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -58.52 -46.53 86.56 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.411 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -142.41 160.26 40.62 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.794 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.662 ' HG2' HG22 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.95 142.7 44.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.919 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 65' ' ' VAL . 62.1 mt -118.83 129.36 75.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.601 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.9 pt? -118.65 140.61 49.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.842 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.493 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.7 tp -116.53 122.9 46.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.972 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.464 ' HA2' ' HD2' ' A' ' 63' ' ' LYS . . . -176.07 -141.41 3.83 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.542 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 69.83 -65.76 0.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.746 0.308 . . . . 0.0 110.969 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -167.58 -44.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.29 -38.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.669 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -61.38 171.04 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.714 ' HB3' HD13 ' A' ' 124' ' ' LEU . 2.1 mt -107.45 156.28 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.803 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.6 mp -129.43 142.62 50.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.138 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.5 HD11 HG12 ' A' ' 130' ' ' ILE . 1.4 tt -112.63 122.39 47.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.629 ' HB2' HD22 ' A' ' 92' ' ' LEU . 50.2 t30 -113.23 115.49 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.39 . . . . 0.0 111.402 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.761 ' OD2' HG23 ' A' ' 116' ' ' VAL . 18.0 p30 -79.96 134.37 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.875 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.1 pt -142.34 40.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.581 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 158.08 15.99 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.082 0.468 . . . . 0.0 111.435 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.83 -35.71 77.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.443 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.6 -19.8 17.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.581 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.62 161.31 11.41 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.41 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.52 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.24 148.36 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.05 113.39 18.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.086 177.287 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 54.1 m-20 44.99 43.02 6.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -7.05 81.28 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.569 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.61 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.704 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 22.1 tptt -75.1 125.44 28.94 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.18 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.761 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.2 m -99.65 165.95 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 120' ' ' SER . 21.9 tt0 -69.88 128.75 37.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.372 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -54.03 163.75 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.93 37.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.5 p -111.64 145.06 39.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' HB3' HD23 ' A' ' 100' ' ' LEU . 6.9 m-80 -91.43 124.35 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -129.25 147.13 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.867 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp -72.97 113.47 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -55.35 167.39 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.643 0.735 . . . . 0.0 111.823 -179.145 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.27 153.22 43.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.476 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.59 121.48 18.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.09 22.4 62.71 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.073 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 144' ' ' VAL . 6.8 t70 -60.5 177.16 0.3 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.838 0.352 . . . . 0.0 110.919 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.0 tt0 -145.16 135.66 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.501 ' CG2' HG22 ' A' ' 109' ' ' THR . 1.5 mt -108.72 127.04 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.105 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.34 136.44 43.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.109 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.524 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.2 m -140.28 158.51 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.46 29.35 30.33 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.072 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.8 t -68.12 140.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.605 0.717 . . . . 0.0 112.406 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.42 -41.46 0.75 Allowed Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 138' ' ' SER . 47.8 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -50.55 -35.1 28.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.868 0.366 . . . . 0.0 111.331 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.54 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.5 t -93.57 6.33 48.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.466 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.4 t0 -120.2 21.9 11.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.678 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.6 mt -105.09 139.71 25.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.95 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.68 HD12 HD11 ' A' ' 81' ' ' ILE . 4.3 tt -122.34 134.4 54.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.654 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.73 133.58 53.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.086 0.47 . . . . 0.0 111.571 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 34.6 mt -126.1 133.23 51.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 128' ' ' ASP . 21.5 t -110.78 140.03 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 111.485 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 91' ' ' ILE . 9.2 mt -106.31 139.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.932 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.24 103.91 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 126' ' ' GLN . 8.7 mt -88.31 118.4 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.094 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -75.88 127.66 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.02 -21.71 64.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -44.15 85.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.016 0.436 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -58.55 -44.02 89.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.732 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -65.2 -40.28 93.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.935 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -59.03 -38.07 78.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.596 ' SG ' HD13 ' A' ' 52' ' ' ILE . 7.4 t -68.17 -40.1 82.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -50.03 51.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.45 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 153' ' ' GLN . 0.8 OUTLIER -61.11 -33.84 74.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.604 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -37.04 14.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.104 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.48 56.65 3.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.452 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.72 151.19 39.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.617 HG22 ' OD2' ' A' ' 161' ' ' ASP . 12.6 p -99.88 131.06 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.089 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.617 ' OD2' HG22 ' A' ' 160' ' ' VAL . 31.2 m-20 61.11 173.49 0.11 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.849 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.3 43.12 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.94 133.3 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.863 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.787 0.327 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.77 88.5 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 1.5 mtp -170.04 -44.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.88 87.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -65.82 83.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.7 -31.41 13.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' TPO . . . . . 0.466 HG22 ' O ' ' A' ' 83' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.87 110.49 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.414 2.076 . . . . 0.0 112.248 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 34.4 p -73.34 165.75 24.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -135.38 63.57 55.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.7 93.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.596 2.197 . . . . 0.0 112.311 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' B' ' 176' ' ' LEU . 6.5 mt -86.47 154.1 21.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.923 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.85 0.357 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.9 p -141.86 -50.2 0.4 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -35.71 77.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -40.5 85.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -38.4 90.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -40.78 96.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.627 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.0 mm -67.62 -48.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -33.65 72.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.35 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -47.14 85.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.017 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.627 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.6 p90 -71.76 -47.43 53.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.146 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.551 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 20.5 p -63.18 -30.52 71.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 60.91 71.77 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -69.8 127.06 31.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.98 125.06 23.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.85 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.99 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.606 0.717 . . . . 0.0 111.699 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.47 74.56 0.06 OUTLIER Glycine 0 C--N 1.313 -0.738 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.54 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.77 -40.2 94.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 175.81 39.36 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.697 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm -72.02 135.2 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.594 -1.639 . . . . 0.0 112.601 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.007 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.65 -59.67 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.35 147.41 29.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.328 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.97 136.59 52.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.609 HG21 ' HE2' ' A' ' 68' ' ' PHE . 10.7 t -103.23 122.52 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.804 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.832 HG23 HG12 ' A' ' 45' ' ' ILE . 15.2 mt -126.59 127.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.358 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' HD21 ' A' ' 141' ' ' LEU . 8.0 t -93.31 115.67 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.596 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.4 t -88.88 -22.64 23.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.428 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.674 HG23 ' HB2' ' A' ' 142' ' ' SER . 67.4 p -79.82 -2.69 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.3 . . . . 0.0 111.48 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.54 71.82 0.83 Allowed Glycine 0 N--CA 1.454 -0.106 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.947 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.682 ' HB2' HD21 ' A' ' 141' ' ' LEU . 4.5 mt-30 -142.9 -40.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.901 HD13 HD22 ' A' ' 78' ' ' LEU . 11.7 mt -122.88 140.77 33.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.66 141.79 28.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.165 1.91 . . . . 0.0 112.076 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.832 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -53.53 149.85 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.696 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -143.32 164.18 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.316 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -122.13 119.85 32.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.068 0.461 . . . . 0.0 111.962 -179.476 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.2 mt -98.51 136.69 38.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.007 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.2 158.79 44.07 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.8 141.84 29.49 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.712 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.514 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -75.04 133.26 41.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 110.966 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.706 HD13 ' SG ' ' A' ' 154' ' ' CYS . 65.8 mt -64.08 -39.79 86.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.717 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 p -56.45 -38.99 72.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.754 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -68.52 -44.9 73.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG13 ' HD3' ' A' ' 63' ' ' LYS . 46.2 t -61.77 -46.27 96.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.136 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.0 -28.58 65.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.992 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -83.62 -35.01 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.076 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -79.27 136.79 37.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.07 30.77 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.826 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -91.11 -67.3 0.86 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -172.92 -41.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.106 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.597 HD11 HG22 ' A' ' 65' ' ' VAL . 9.8 tp -127.3 152.93 35.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.176 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.709 ' HD3' HG13 ' A' ' 55' ' ' VAL . 4.9 mttm -122.46 -64.87 1.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt -141.49 132.05 25.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.258 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.613 HG12 ' HG2' ' A' ' 90' ' ' GLN . 7.3 t -127.89 138.19 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.175 0.512 . . . . 0.0 111.739 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.523 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.1 m-90 -100.85 139.12 36.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.207 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.673 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.12 125.94 54.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -112.96 145.68 40.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.475 -178.602 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.67 -169.1 38.54 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.711 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.9 mtp-105 -82.56 0.73 41.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 30.5 t-20 -84.96 132.63 45.21 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.057 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.6 Cg_exo -67.67 -10.26 28.16 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 111.656 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.54 16.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.898 0.856 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.46 139.09 1.15 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.342 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.15 -18.79 11.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.794 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.491 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.8 131.99 46.36 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.127 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.95 110.13 22.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.572 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.901 HD22 HD13 ' A' ' 43' ' ' ILE . 9.2 mt -85.31 -71.27 0.54 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.466 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.72 -109.61 0.25 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.587 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -163.14 61.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 111.273 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.443 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 28.6 mm -98.65 124.07 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 m -54.87 -43.43 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.482 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.402 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.5 mmp_? -60.78 -18.19 53.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.411 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD12 ' HB ' ' A' ' 81' ' ' ILE . 17.6 mt -103.48 147.08 27.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.882 0.372 . . . . 0.0 110.722 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m -93.56 164.74 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.765 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.82 -52.47 5.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.578 ' HB3' HG22 ' A' ' 67' ' ' THR . 8.4 mttp -120.45 82.4 1.9 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -60.46 -45.91 91.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.714 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.1 p90 -145.07 158.95 43.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.648 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.673 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.64 140.94 44.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.0 mt -117.31 132.04 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.098 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -109.98 147.11 34.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.073 0.463 . . . . 0.0 111.652 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.699 HD22 HG11 ' A' ' 33' ' ' VAL . 26.9 tp -125.13 122.96 38.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' HA2' ' CE ' ' A' ' 63' ' ' LYS . . . 162.58 -178.96 38.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.545 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.34 90.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.784 0.326 . . . . 0.0 110.983 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.23 -174.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.819 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -79.19 60.1 4.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.451 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -139.82 177.61 7.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.641 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -135.09 156.72 48.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.641 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.5 mp -132.98 141.96 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.522 ' CD2' HD11 ' A' ' 130' ' ' ILE . 4.5 mp -112.56 127.35 56.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.155 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.5 t30 -115.89 115.58 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 111.702 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.0 p30 -77.37 135.33 38.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.676 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.0 pt -143.94 41.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.87 161.13 13.8 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.096 0.474 . . . . 0.0 111.503 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.91 -38.8 79.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.698 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.63 -19.7 17.4 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.99 161.81 11.24 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.088 -1.053 . . . . 0.0 114.01 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 17.4 m -117.6 137.87 52.32 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.224 0.61 . . . . 0.0 109.565 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.11 148.43 37.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.3 OUTLIER -124.65 113.52 18.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.606 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 47.05 42.26 12.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.0 -10.15 71.76 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.863 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.777 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -105.52 118.7 37.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.245 0.523 . . . . 0.0 110.765 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -73.13 134.43 44.46 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.349 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.825 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -107.01 166.58 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.334 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 mm-40 -69.88 123.96 22.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.553 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 75.7 tttt -52.95 163.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.513 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 36.09 33.19 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.032 -179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.35 145.08 40.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.105 179.381 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -91.78 131.94 36.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.955 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 62.0 mm-40 -129.37 151.79 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.644 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.7 tt -72.83 133.33 44.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.238 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.648 HD11 HG21 ' A' ' 145' ' ' ILE . 66.9 tp -65.15 154.85 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.512 0.672 . . . . 0.0 111.668 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.409 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.92 153.09 43.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -72.0 123.69 23.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.358 . . . . 0.0 110.106 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.43 47.4 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.173 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -51.11 172.21 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.834 0.35 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.844 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.8 mt-10 -144.87 135.56 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.028 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.522 HD11 ' CD2' ' A' ' 101' ' ' LEU . 5.5 mt -118.51 124.84 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.32 140.47 37.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.896 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.29 158.26 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.61 30.23 24.77 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.873 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.588 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.7 t -71.17 140.44 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.645 0.736 . . . . 0.0 112.385 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.4 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 154.06 -38.52 0.69 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.341 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 138' ' ' SER . 50.4 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.59 -37.03 37.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.793 0.33 . . . . 0.0 111.479 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.6 m -93.53 6.52 47.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -124.34 26.51 7.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.5 mt -105.93 139.68 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.634 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 42' ' ' GLN . 1.2 tt -120.93 134.16 55.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.069 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.674 ' HB2' HG23 ' A' ' 40' ' ' THR . 3.0 m -108.56 143.71 37.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.0 mm? -135.48 144.18 46.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.534 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.844 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.3 t -114.13 136.53 50.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.037 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.648 HG21 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -106.57 126.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.436 ' CD1' HD12 ' A' ' 37' ' ' ILE . 5.4 m-85 -112.95 121.78 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.665 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.532 HG12 HD21 ' A' ' 124' ' ' LEU . 3.5 mt -85.05 134.14 27.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.395 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.85 109.0 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -62.15 -42.44 99.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -46.02 90.8 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -59.3 -44.09 92.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -33.87 77.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.85 -41.91 88.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.706 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.0 t -67.79 -44.53 77.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.014 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.819 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.3 -42.24 75.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.09 -48.07 59.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.471 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -37.15 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.186 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 42.43 31.4 0.27 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.486 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -125.12 162.05 25.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.011 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.63 132.99 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.03 127.99 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.004 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.07 148.2 34.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.16 110.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.882 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.787 0.327 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -107.52 105.26 15.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.03 124.18 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.851 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 169' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' B' ' 170' ' ' GLN . 11.6 p90 -112.09 -35.89 5.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.965 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 170' ' ' GLN . . . . . 0.423 ' N ' ' CD1' ' B' ' 169' ' ' PHE . 0.2 OUTLIER 67.92 -70.64 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' B' ' 169' ' ' PHE . 63.2 Cg_exo -51.62 139.33 48.02 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.653 2.235 . . . . 0.0 112.274 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.78 20.98 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.176 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.78 101.09 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.947 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.18 101.92 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.409 2.072 . . . . 0.0 112.273 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 mt -124.02 -171.43 2.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.807 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 120.936 0.398 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.99 79.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.702 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.8 -47.13 69.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.983 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -62.84 -35.99 81.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.5 -38.65 91.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 tp -63.05 -45.05 94.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.1 mm -66.98 -34.99 73.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -40.22 76.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.987 0.422 . . . . 0.0 110.445 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -67.26 -23.84 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.53 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.75 -47.36 80.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.198 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -60.24 -32.79 71.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -123.44 45.0 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -73.91 129.35 37.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.99 101.98 11.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.813 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.2 mm -84.7 138.27 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.661 0.744 . . . . 0.0 111.747 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.9 28.38 26.23 Favored Glycine 0 C--N 1.313 -0.703 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.483 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -75.78 -46.34 31.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.944 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -170.2 34.95 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -77.79 133.2 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 113.787 -1.552 . . . . 0.0 112.561 -177.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.015 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -89.92 -61.02 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.28 148.42 28.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.308 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -115.92 127.7 55.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 68' ' ' PHE . 43.5 t -97.27 122.75 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 111.02 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.908 HG23 HG12 ' A' ' 45' ' ' ILE . 12.3 mt -120.62 128.45 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.73 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.3 t -81.87 121.51 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.475 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.5 t -88.15 -27.12 22.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.634 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 142' ' ' SER . 35.4 p -79.94 -2.17 42.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.545 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 77.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.84 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -146.86 -44.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.574 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -113.54 141.51 26.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.91 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.574 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.6 Cg_endo -71.14 145.81 50.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.017 1.811 . . . . 0.0 112.037 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.908 HG12 HG23 ' A' ' 37' ' ' ILE . 39.0 mt -56.69 143.91 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.916 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.03 163.3 33.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.813 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.67 120.53 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 112.178 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.746 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.8 mp -84.7 128.3 34.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.015 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -133.48 155.92 48.69 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -155.37 141.94 18.77 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.304 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -82.06 143.26 31.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.145 0.498 . . . . 0.0 111.33 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 52' ' ' ILE . 2.3 mp -64.27 -41.47 92.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.542 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -56.98 -38.66 73.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.43 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.5 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 2.5 mm-40 -68.48 -37.04 79.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.475 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.4 t -73.12 -42.53 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.158 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.812 HD21 ' HD2' ' A' ' 159' ' ' LYS . 2.2 tp -66.14 -33.89 76.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.887 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -53.82 16.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.94 110.62 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.96 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.08 -29.13 15.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.37 166.54 14.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.19 -178.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.452 HG12 HG22 ' A' ' 65' ' ' VAL . 10.1 tp -85.01 153.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.012 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 7.1 mptt -87.02 -74.3 0.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.023 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.2 ttpt -133.17 134.86 44.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 90' ' ' GLN . 9.6 t -131.1 139.21 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.746 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.2 m-90 -103.38 139.51 38.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.057 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.697 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.93 127.19 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.154 0.502 . . . . 0.0 110.223 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.583 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -113.6 146.26 40.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.75 ' CA ' HD23 ' A' ' 78' ' ' LEU . . . 169.61 -174.87 43.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.487 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -87.06 45.65 1.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.495 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -141.11 139.07 18.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.27 -6.48 17.49 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.875 2.383 . . . . 0.0 111.904 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.33 11.14 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.88 0.848 . . . . 0.0 109.279 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.95 141.81 1.05 Allowed 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.96 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.41 -19.27 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.966 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 44.8 t80 -129.89 122.68 29.11 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.797 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -88.92 107.83 19.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.793 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD23 ' CA ' ' A' ' 69' ' ' GLY . 1.7 mm? -68.63 -82.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.038 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.85 -96.3 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.535 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -167.05 60.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 111.199 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 mm -112.18 115.68 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.023 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.5 p -55.21 -34.65 64.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.86 -23.26 65.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.206 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 132' ' ' VAL . 14.5 mt -97.49 147.73 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 111.084 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.17 164.75 12.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.998 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.639 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.44 -52.05 4.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.447 0.641 . . . . 0.0 109.847 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -120.51 79.92 1.55 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.5 t60 -60.87 -47.23 87.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.538 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 17.5 p90 -146.48 159.07 43.89 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.552 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.84 141.2 44.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.656 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 65' ' ' VAL . 37.2 mt -115.48 130.51 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.075 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.954 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -122.39 139.21 54.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.047 0.451 . . . . 0.0 111.839 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.809 HD22 ' CG1' ' A' ' 33' ' ' VAL . 4.4 tp -125.35 129.47 50.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.967 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.44 -30.27 0.86 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.714 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -53.76 -29.05 38.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.744 0.307 . . . . 0.0 111.26 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -171.26 -175.57 1.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.25 -21.39 39.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -94.32 -176.39 3.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.699 0.285 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.851 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -106.92 159.6 16.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.777 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.659 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -123.18 139.38 54.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -112.8 120.06 40.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.981 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.954 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.7 t30 -116.82 119.97 37.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.402 . . . . 0.0 112.057 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.829 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.3 p30 -79.87 141.0 36.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.982 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -147.06 36.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.428 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.651 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.53 149.81 21.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.128 0.489 . . . . 0.0 112.043 -178.688 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.0 m -68.62 -31.55 70.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.682 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -97.18 -19.75 18.41 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.652 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.651 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.12 156.15 10.42 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.604 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.9 m -117.45 137.81 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.876 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.31 148.62 37.24 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.35 18.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.452 177.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.8 m120 43.43 43.74 4.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.499 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.3 -13.71 62.9 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.418 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -103.38 118.54 36.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.027 0.442 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.876 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.6 tptm -72.66 127.6 33.05 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.829 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.0 m -97.89 162.95 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.6 tt0 -69.99 126.9 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.489 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.655 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttm -52.09 160.79 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.7 p-10 35.75 33.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.41 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 118.04 34.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.106 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.769 ' OD1' HD11 ' A' ' 92' ' ' LEU . 18.9 m-80 -66.01 135.16 54.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 33.1 mm-40 -129.48 151.14 50.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.8 tm? -72.77 132.71 43.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' A' ' 99' ' ' LEU . 44.0 tp -58.1 152.56 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.713 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.42 152.63 44.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.645 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -72.51 123.35 22.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.253 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.31 23.42 41.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.085 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.7 t70 -49.12 167.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.015 0.436 . . . . 0.0 111.429 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.909 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.4 mt-10 -144.8 135.44 24.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.007 HD11 HD11 ' A' ' 145' ' ' ILE . 1.1 mp -117.35 127.81 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.748 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.624 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.67 138.12 41.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.933 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 84' ' ' LEU . 34.8 m -140.31 158.06 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 30.93 25.2 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.811 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -70.83 140.41 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 112.452 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.48 -41.0 0.47 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 138' ' ' SER . 49.2 t -126.47 134.74 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 115.1 -0.55 . . . . 0.0 109.519 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -38.67 48.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.781 0.325 . . . . 0.0 111.467 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.496 ' H ' HG12 ' A' ' 136' ' ' VAL . 57.9 m -93.42 6.32 48.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.9 t0 -121.36 26.95 8.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.1 139.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.948 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 134.43 55.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.611 ' C ' HD22 ' A' ' 143' ' ' LEU . 47.3 t -112.11 150.78 30.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.518 0.675 . . . . 0.0 112.282 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -135.62 155.53 50.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.909 HG22 ' CG ' ' A' ' 129' ' ' GLU . 19.2 t -125.6 140.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.825 0.345 . . . . 0.0 111.431 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.007 HD11 HD11 ' A' ' 130' ' ' ILE . 34.0 mt -106.46 123.08 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.165 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.524 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -109.98 116.83 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.763 HG12 HD21 ' A' ' 124' ' ' LEU . 4.4 mt -86.27 134.21 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.608 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.78 122.91 27.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.649 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.28 -36.82 77.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -59.12 -45.37 91.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 110.719 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -57.81 -44.11 86.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -60.99 -34.01 74.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.218 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -60.38 -47.26 86.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.348 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.5 t -68.24 -42.44 79.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.45 -35.87 82.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.74 -45.26 93.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.929 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 159' ' ' LYS . 42.1 mm-40 -84.58 -31.02 24.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.966 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.05 -90.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.618 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.812 ' HD2' HD21 ' A' ' 56' ' ' LEU . 3.8 mttm -125.0 148.68 48.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.812 0.339 . . . . 0.0 110.816 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.3 p -86.47 126.25 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.4 t70 60.49 97.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.75 131.93 12.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.806 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.3 mm -101.8 133.18 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.187 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.831 0.348 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -154.13 143.81 21.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.766 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 7.8 tpp -158.63 84.5 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 3.4 t -77.11 -38.55 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.817 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -101.78 152.1 21.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.85 38.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' TPO . . . . . 0.631 HG22 ' O3P' ' B' ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.5 140.65 44.03 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.621 2.214 . . . . 0.0 112.37 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 3.9 t -134.11 43.66 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 60.98 74.6 0.51 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.31 172.69 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.59 2.194 . . . . 0.0 112.31 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 17.0 mt -137.94 159.75 41.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.958 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.884 0.374 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -35.68 74.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.81 -42.38 79.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -32.46 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.16 -35.39 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.808 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -57.26 -39.18 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 110.434 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -67.09 -24.05 65.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.233 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.771 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.427 -1.601 0 CA-C-O 121.866 0.841 . . . . 0.0 111.077 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -58.02 -66.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.193 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.749 ' SG ' HG23 ' A' ' 147' ' ' ILE . 91.1 m -152.23 165.13 35.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.836 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -125.86 138.03 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.072 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.751 HG23 HD11 ' A' ' 48' ' ' LEU . 21.7 t -102.57 123.81 56.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.768 HG23 HG12 ' A' ' 45' ' ' ILE . 11.4 mt -123.14 124.94 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.483 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.1 t -81.71 123.04 28.39 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 t -86.72 -28.92 22.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 142' ' ' SER . 36.8 p -79.91 -2.13 42.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.688 0.28 . . . . 0.0 111.552 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.75 77.0 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.422 ' NE2' HD12 ' A' ' 141' ' ' LEU . 8.0 mt-30 -145.36 -43.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.885 HD12 HD21 ' A' ' 143' ' ' LEU . 3.0 mt -111.35 140.85 23.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.3 Cg_endo -72.52 131.43 17.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.127 1.884 . . . . 0.0 111.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.768 HG12 HG23 ' A' ' 37' ' ' ILE . 32.6 mt -51.84 131.56 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.659 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.87 164.21 19.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.251 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -117.84 120.1 36.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 111.536 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.751 HD11 HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -97.64 134.87 40.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.426 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.864 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.79 157.25 43.63 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.74 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.6 ttpt . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 120.73 0.3 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.659 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.5 t -124.87 139.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 111.983 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.574 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.7 m-90 -100.9 139.23 36.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.435 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.92 128.45 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.25 145.52 43.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.624 -177.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.76 -169.61 40.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.722 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 3.4 mtp-105 -83.25 -1.62 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.76 136.22 39.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 111.602 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.1 Cg_exo -67.44 -10.57 29.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.843 2.362 . . . . 0.0 111.979 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.55 -44.47 15.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.84 0.829 . . . . 0.0 109.02 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.78 139.31 2.33 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.42 -18.21 10.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.955 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -129.18 118.67 22.77 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.897 0.379 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.7 m -54.79 -34.94 63.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.067 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -26.63 67.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 81' ' ' ILE . 33.1 mt -91.63 152.18 20.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -93.64 167.25 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -42.95 -54.12 4.39 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.374 0.607 . . . . 0.0 109.77 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.65 82.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.2 -46.25 88.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.836 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.5 p90 -143.57 159.84 41.71 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.13 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.7 tt0 -135.77 143.05 45.05 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.385 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.586 ' C ' HG13 ' A' ' 65' ' ' VAL . 49.6 mt -118.69 127.86 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.973 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.641 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -114.11 141.81 47.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 111.956 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 33' ' ' VAL . 7.5 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.229 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.632 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.9 0.381 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.0 mm? -130.31 145.41 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.316 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.77 121.37 44.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.888 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.641 ' HB2' HD23 ' A' ' 92' ' ' LEU . 49.6 t30 -116.81 115.66 25.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.789 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.849 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.7 p30 -78.96 136.62 37.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.751 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.8 pt -144.26 39.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.65 152.63 19.85 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.157 0.504 . . . . 0.0 111.956 -179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.0 m -68.79 -31.57 70.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.809 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.07 -19.97 17.64 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.628 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.53 157.04 10.58 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.695 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.38 137.71 52.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.04 148.56 40.06 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.556 177.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.39 43.64 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.96 -13.16 61.93 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.435 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.26 118.53 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.467 . . . . 0.0 110.465 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.66 129.26 38.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.52 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.849 HG23 ' OD2' ' A' ' 103' ' ' ASP . 17.4 m -97.84 163.45 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.91 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.71 125.34 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.487 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.1 tttt -52.25 161.27 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.755 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.19 34.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.21 145.03 40.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.145 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.602 HD22 HD21 ' A' ' 92' ' ' LEU . 18.3 m120 -85.69 129.13 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.758 ' O ' HD13 ' A' ' 100' ' ' LEU . 31.2 mm-40 -129.09 146.23 51.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.548 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.6 tm? -72.75 111.97 8.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.246 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.712 HD11 HG21 ' A' ' 145' ' ' ILE . 66.0 tp -50.66 157.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.397 0.618 . . . . 0.0 111.646 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.4 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -124.45 153.13 42.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.6 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.668 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.73 124.75 25.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.83 20.91 50.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t70 -55.79 174.96 0.1 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.934 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.6 mt-10 -145.04 135.7 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.316 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 145' ' ' ILE . 5.6 mt -111.59 126.99 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.624 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.65 137.23 42.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.944 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.637 HG23 HD21 ' A' ' 84' ' ' LEU . 34.8 m -140.47 158.32 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.29 22.81 42.87 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.324 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.4 t -62.62 140.33 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.663 0.744 . . . . 0.0 112.388 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -43.98 0.57 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.211 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.47 138.32 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -38.42 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.71 0.291 . . . . 0.0 111.584 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.449 ' H ' HG12 ' A' ' 136' ' ' VAL . 7.9 t -93.55 6.2 49.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 133' ' ' GLY . 3.2 m-20 -116.31 22.52 12.8 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.06 139.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.22 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 142' ' ' SER . 9.2 tt -124.48 134.27 53.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.243 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.507 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.9 t -111.28 150.54 29.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.716 0.769 . . . . 0.0 112.211 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.885 HD21 HD12 ' A' ' 43' ' ' ILE . 66.8 mt -135.38 156.57 48.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.67 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.934 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.9 t -125.68 137.54 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 130' ' ' ILE . 36.5 mt -106.48 120.96 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.01 122.39 46.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.749 HG23 ' SG ' ' A' ' 34' ' ' CYS . 3.4 mp -112.91 134.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.482 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.405 ' ND2' HG22 ' A' ' 32' ' ' ILE . 28.7 p30 -93.52 135.46 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -74.02 -21.34 60.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -58.22 -44.23 88.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.1 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.753 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.824 0.345 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -42.58 99.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -38.62 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.555 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 19' ' ' LEU . 13.8 tp -58.1 -31.94 67.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.49 -35.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.726 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.67 -36.18 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.309 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.217 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm . . . . . 0 N--CA 1.426 -1.635 0 CA-C-O 121.763 0.792 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.685 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.43 -50.48 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.974 -178.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -163.11 146.17 10.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.204 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -113.88 131.45 56.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.286 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 ' HE2' ' A' ' 68' ' ' PHE . 28.7 t -97.8 122.79 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 25.3 mt -123.34 119.56 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.269 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.643 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.5 t -80.48 121.05 25.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.451 ' CG2' HG21 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -91.23 -27.72 18.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.422 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 142' ' ' SER . 69.2 p -80.31 -2.96 47.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.686 0.279 . . . . 0.0 111.556 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.86 80.74 0.2 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.375 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.777 ' OE1' HD13 ' A' ' 141' ' ' LEU . 15.2 mt-30 -149.62 -45.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.862 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.02 141.16 26.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.68 139.81 28.52 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.169 1.913 . . . . 0.0 112.125 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -55.23 135.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.725 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -134.37 164.02 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.209 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.2 119.72 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 36' ' ' VAL . 5.7 mt -90.6 137.49 32.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.618 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.44 157.37 45.24 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.685 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.937 0 CA-C-N 113.3 -1.773 . . . . 0.0 110.497 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.4 t -129.95 139.61 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.293 0.568 . . . . 0.0 111.809 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.559 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.3 m-90 -100.24 139.68 35.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.146 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.23 131.94 54.59 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 0.0 111.624 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.74 -174.43 41.44 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.554 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.6 mtm105 -81.52 -0.78 43.54 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.77 135.66 40.02 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.666 0.269 . . . . 0.0 111.273 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.52 -7.53 20.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.728 2.285 . . . . 0.0 111.876 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.42 15.63 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.977 0.894 . . . . 0.0 108.936 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.73 137.33 5.46 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.646 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.45 -18.81 12.52 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.853 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.3 t80 -129.86 117.25 19.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.887 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.496 179.624 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 84' ' ' LEU . 31.5 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.951 0.405 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -43.17 73.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.343 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -44.15 97.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.654 ' CD1' HD12 ' A' ' 81' ' ' ILE . 46.5 mt -72.77 152.18 41.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.188 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.5 p -95.49 165.5 12.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.741 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.39 -53.01 5.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.344 0.593 . . . . 0.0 109.627 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.6 ' HB3' HG22 ' A' ' 67' ' ' THR . 17.1 mttt -119.69 84.57 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -63.99 -45.27 89.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.095 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.6 p90 -150.99 162.39 40.92 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.155 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.691 ' CD ' HG23 ' A' ' 67' ' ' THR . 11.6 mt-30 -135.49 158.27 44.8 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.378 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.53 ' O ' HG13 ' A' ' 65' ' ' VAL . 64.2 mt -127.45 132.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.957 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.776 ' CD1' HD13 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -113.72 144.46 42.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.731 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.605 ' C ' HD13 ' A' ' 93' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.521 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.073 HD11 HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.95 0.405 . . . . 0.0 111.047 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.776 HD13 ' CD1' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.55 149.44 50.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.506 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.872 HD21 HD12 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -110.52 131.59 54.92 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' HD22 ' A' ' 92' ' ' LEU . 46.9 t30 -113.28 115.92 28.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.849 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.1 p30 -76.65 143.06 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 87' ' ' LYS . 10.0 pt -150.75 37.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.06 158.82 15.25 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.047 0.451 . . . . 0.0 111.807 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.9 m -68.92 -35.31 76.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.587 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -20.04 17.3 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.538 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.33 163.36 11.96 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.488 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 20.8 m -117.53 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.842 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -114.36 148.4 37.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.17 113.43 18.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.281 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 43.72 43.4 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.48 -12.43 66.84 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.482 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -104.96 118.53 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.067 0.461 . . . . 0.0 110.642 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.19 134.9 45.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.501 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.849 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -105.01 164.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.4 tp10 -69.95 125.07 25.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.6 tttt -51.82 160.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 35.89 33.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.54 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.57 145.09 40.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 179.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -86.81 129.79 34.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.789 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.6 mm-40 -127.53 147.74 50.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.409 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.58 120.95 18.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.539 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.073 HD22 HD11 ' A' ' 99' ' ' LEU . 5.9 tp -58.89 155.94 12.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.486 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.573 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.3 t -124.25 153.43 41.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.342 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 6.5 tp60 -71.41 123.99 23.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.28 22.17 42.99 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.276 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.7 t70 -58.14 174.56 0.27 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -145.2 135.46 24.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.146 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.437 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.0 mt -111.59 128.39 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.261 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.663 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.08 138.85 40.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.543 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 30.3 m -140.15 158.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.89 22.37 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.85 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.579 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.32 140.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 121.598 0.713 . . . . 0.0 112.442 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.37 -39.87 0.7 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 138' ' ' SER . 52.0 t -126.59 128.62 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.48 -34.68 25.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 136' ' ' VAL . 87.4 p -93.54 6.3 48.69 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 7.5 t0 -124.18 24.85 8.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.663 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.9 mt -104.78 139.61 25.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.823 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.777 HD13 ' OE1' ' A' ' 42' ' ' GLN . 25.3 tp -117.54 134.75 54.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.956 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.663 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.8 OUTLIER -111.54 135.47 52.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.547 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.643 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.9 mm? -131.04 138.48 49.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 39' ' ' THR . 21.4 t -110.84 138.7 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.339 . . . . 0.0 110.927 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 124' ' ' LEU . 6.6 mt -106.26 139.01 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -119.9 119.88 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.762 HG12 HD21 ' A' ' 124' ' ' LEU . 3.4 mt -85.62 134.17 27.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.553 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.55 107.48 13.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -58.21 -32.18 68.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -60.25 -45.92 91.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 . . . . . 0 N--CA 1.452 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.074 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.797 0.332 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -42.62 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.65 -38.08 74.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -31.81 70.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.19 -35.54 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.49 -39.96 77.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -67.1 -23.87 65.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.4 mm . . . . . 0 N--CA 1.429 -1.511 0 CA-C-O 121.566 0.698 . . . . 0.0 112.575 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.006 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -93.53 -59.46 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.643 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.68 ' SG ' HD13 ' A' ' 99' ' ' LEU . 4.7 m -152.81 150.48 29.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.383 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -115.18 131.71 56.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.777 0.322 . . . . 0.0 111.248 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.746 HG21 ' HE2' ' A' ' 68' ' ' PHE . 43.8 t -96.18 122.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.053 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.839 HG23 HG12 ' A' ' 45' ' ' ILE . 16.5 mt -124.01 121.38 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.5 t -82.04 121.65 26.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.459 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.58 -25.1 16.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.501 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.599 HG21 ' OG ' ' A' ' 142' ' ' SER . 5.9 p -80.04 -2.38 44.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.663 0.268 . . . . 0.0 111.386 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.09 78.98 0.21 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.851 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 15.5 mt-30 -149.38 -40.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 9.2 mt -124.2 141.68 37.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.97 146.13 41.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.193 1.928 . . . . 0.0 112.12 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.839 HG12 HG23 ' A' ' 37' ' ' ILE . 33.8 mt -60.3 146.32 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.647 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 1.5 ttt180 -140.31 163.23 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.07 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.29 119.8 36.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 111.843 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.619 HD11 HG23 ' A' ' 36' ' ' VAL . 4.6 mt -93.25 137.42 32.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.273 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.006 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.39 157.32 43.76 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.854 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 49' ' ' SER . 8.6 ttpt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.887 0.375 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.749 HG22 ' HG2' ' A' ' 90' ' ' GLN . 13.9 p -110.44 140.23 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.568 ' HH2' HG21 ' A' ' 33' ' ' VAL . 13.5 m-90 -100.22 139.22 36.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.852 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.85 128.74 56.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.746 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -116.61 145.63 43.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.353 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.37 -170.0 39.38 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.788 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.9 mtp-105 -81.22 1.17 33.38 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 140.32 37.92 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.661 0.267 . . . . 0.0 110.903 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.27 -11.69 22.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.511 2.141 . . . . 0.0 111.354 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.7 18.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.12 138.31 3.01 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.317 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.36 -18.53 11.21 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.874 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.498 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 3.7 t80 -129.54 127.97 41.82 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.713 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.751 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.858 HD12 HD11 ' A' ' 84' ' ' LEU . 41.1 mt . . . . . 0 N--CA 1.458 -0.027 0 CA-C-O 120.799 0.333 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.55 -35.63 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.279 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.48 HH11 HG23 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -61.03 -45.65 93.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.834 0.349 . . . . 0.0 110.699 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.858 HD11 HD12 ' A' ' 81' ' ' ILE . 16.1 mt -75.32 148.29 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -93.7 167.13 11.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.54 -53.62 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.393 0.616 . . . . 0.0 109.834 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.38 82.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.4 t60 -58.8 -46.26 88.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.772 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.7 p90 -144.7 162.19 37.32 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.099 -0.641 . . . . 0.0 112.121 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 65' ' ' VAL . 2.8 tt0 -135.59 146.79 48.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.09 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 65' ' ' VAL . 64.8 mt -123.14 130.42 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.506 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.483 HD11 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -124.99 141.03 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.222 0.534 . . . . 0.0 112.188 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.406 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.778 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.868 HD11 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.887 0.375 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.8 mp -121.4 142.46 49.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.31 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.561 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -112.71 124.13 51.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.478 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.2 t30 -116.05 115.51 26.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.493 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.5 p30 -79.16 137.7 37.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.0 pt -146.61 40.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.85 160.18 14.51 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.971 0.415 . . . . 0.0 111.681 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.3 m -68.94 -36.44 77.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.46 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.94 17.26 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.52 163.94 12.29 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.581 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.51 137.89 52.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.828 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.94 148.46 36.8 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.11 113.43 18.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.039 177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 45.09 42.39 6.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.265 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.78 -7.98 79.29 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.499 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.05 118.47 36.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.174 0.487 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.828 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.14 129.76 38.77 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.297 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -101.8 166.71 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.272 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.8 tp10 -70.02 126.17 28.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.3 tttt -52.78 162.65 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.227 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.91 36.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.066 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.0 p -111.84 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.547 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.503 ' HB3' HD23 ' A' ' 100' ' ' LEU . 23.1 m120 -91.93 129.51 37.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.888 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.02 149.84 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.5 tm? -72.91 123.46 23.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.456 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.641 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.6 tt -57.67 155.72 9.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 152.92 42.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.459 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.618 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.85 125.52 27.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.05 22.88 44.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.193 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -56.34 173.4 0.17 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.93 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -145.02 135.46 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.073 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 145' ' ' ILE . 4.0 mt -114.16 127.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-O 120.893 0.377 . . . . 0.0 110.377 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.703 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.45 136.53 43.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.825 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.554 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.4 m -140.3 158.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 24.57 41.65 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.28 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.2 t -63.25 140.4 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.72 0.771 . . . . 0.0 112.462 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.67 -44.17 0.54 Allowed Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.353 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.48 HG23 HH11 ' A' ' 83' ' ' ARG . 45.5 t -126.37 137.87 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -50.75 -38.13 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.59 6.31 48.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 74.0 m-20 -117.25 22.97 12.14 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.703 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.11 139.63 28.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.175 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.546 ' CD2' HD13 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -119.53 134.49 55.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.674 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.599 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.29 131.6 56.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.584 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.546 HD13 ' CD2' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -127.01 142.79 51.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.892 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.93 HG22 ' CG ' ' A' ' 129' ' ' GLU . 11.3 t -111.0 140.32 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 130' ' ' ILE . 38.5 mt -105.85 120.88 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.069 0.461 . . . . 0.0 111.001 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.98 122.68 45.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.682 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -98.51 121.28 48.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.982 0.42 . . . . 0.0 111.376 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.451 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 10.5 p30 -82.92 135.79 34.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.1 -20.2 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.183 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -57.47 -43.74 84.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.623 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.678 179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.792 0.329 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -60.0 -40.35 88.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -36.02 82.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -41.39 93.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -69.23 -35.08 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.26 -36.81 71.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.24 -23.78 65.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.738 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.71 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm . . . . . 0 N--CA 1.43 -1.475 0 CA-C-O 121.626 0.727 . . . . 0.0 112.336 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.981 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -92.3 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.667 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.8 p -145.12 157.4 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.904 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.869 0.366 . . . . 0.0 111.472 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.7 HG11 ' CE2' ' A' ' 68' ' ' PHE . 30.7 m -104.18 122.64 57.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.627 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.841 HG23 HG12 ' A' ' 45' ' ' ILE . 19.5 mt -129.49 118.34 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.548 ' SG ' HD21 ' A' ' 141' ' ' LEU . 24.6 t -81.81 119.57 24.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.281 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.41 -25.59 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.893 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' H ' ' A' ' 142' ' ' SER . 30.8 p -79.99 -2.21 43.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.559 0.218 . . . . 0.0 111.508 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.15 73.25 0.64 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.825 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' CB ' HD11 ' A' ' 141' ' ' LEU . 3.3 mt-30 -141.58 -47.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.76 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.72 HD13 HD21 ' A' ' 143' ' ' LEU . 3.1 mp -114.0 140.68 25.16 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.85 139.91 31.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.182 1.921 . . . . 0.0 112.24 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.841 HG12 HG23 ' A' ' 37' ' ' ILE . 37.2 mt -54.2 139.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.555 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -129.33 164.1 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.492 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -119.36 119.87 35.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.112 0.482 . . . . 0.0 111.372 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.8 mt -97.9 128.89 44.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.981 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.84 158.32 43.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.819 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.4 ttpt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.765 0.317 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.665 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -132.16 139.36 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.376 0.607 . . . . 0.0 112.255 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.8 m-90 -101.68 139.26 37.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.935 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.66 128.68 56.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.859 0.361 . . . . 0.0 110.027 177.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -120.49 145.23 47.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.61 -166.72 34.98 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.47 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 4.9 mtp85 -79.01 2.05 21.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.609 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.71 130.83 51.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 0.0 111.197 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.67 -15.91 51.26 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.515 2.144 . . . . 0.0 111.495 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.77 -41.61 18.96 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -42.76 139.11 1.73 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.537 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.25 -18.63 11.04 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.109 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.546 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -129.82 125.09 34.89 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 179.461 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.769 HD12 ' CD1' ' A' ' 84' ' ' LEU . 30.7 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.883 0.373 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -42.58 71.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HB3' ' HA2' ' A' ' 133' ' ' GLY . 3.8 mtp85 -60.85 -18.69 57.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.332 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.769 ' CD1' HD12 ' A' ' 81' ' ' ILE . 29.7 mt -103.3 151.19 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.62 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.1 p -97.8 163.99 12.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.728 0.299 . . . . 0.0 111.667 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.576 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -43.22 -52.93 5.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.401 0.62 . . . . 0.0 109.912 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.66 ' CB ' HD12 ' A' ' 104' ' ' ILE . 12.9 mttm -117.67 80.73 1.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.582 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.4 t60 -60.34 -45.53 93.13 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.652 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 35.0 p90 -147.11 159.5 43.53 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.237 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.7 tt0 -136.14 142.88 44.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.114 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.595 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.7 mt -117.64 129.25 74.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.662 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 92' ' ' LEU . 1.6 pt? -115.95 148.04 40.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.113 0.482 . . . . 0.0 111.855 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.73 HD22 HG11 ' A' ' 33' ' ' VAL . 26.2 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.058 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.542 HD11 ' CG1' ' A' ' 33' ' ' VAL . 4.2 mm? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.791 0.329 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.4 mp -128.26 143.29 51.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.313 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.434 HD12 HG12 ' A' ' 91' ' ' ILE . 2.0 tp -112.79 121.6 45.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.522 ' HB2' HD22 ' A' ' 92' ' ' LEU . 56.5 t30 -115.38 115.72 27.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.543 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -79.77 137.97 37.14 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.66 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.3 pt -139.42 29.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.563 0.22 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.578 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 12.9 t -90.32 160.2 16.25 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.253 0.549 . . . . 0.0 112.369 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.5 m -69.54 -52.47 26.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.598 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -19.23 27.69 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.93 157.76 9.38 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.606 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -116.94 137.73 52.02 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.372 0.669 . . . . 0.0 109.252 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.904 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -112.27 149.15 32.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.733 HD23 ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -124.24 113.5 18.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.319 176.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 44.54 43.39 6.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.649 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.29 -13.49 63.45 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.725 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.07 118.6 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.106 0.453 . . . . 0.0 110.639 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.904 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.9 tptm -73.28 125.1 27.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.307 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -98.67 163.4 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.032 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.3 tt0 -69.96 128.87 37.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.549 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 1.8 tttt -54.08 156.84 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.092 0.473 . . . . 0.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.613 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.5 p30 37.46 34.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.065 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.9 144.89 40.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.865 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.402 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.0 m120 -88.59 129.0 35.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -129.25 147.79 51.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.299 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.1 tp -72.77 119.02 16.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.361 . . . . 0.0 110.192 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.942 HD11 HG21 ' A' ' 145' ' ' ILE . 66.7 tp -53.6 157.24 2.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.346 0.593 . . . . 0.0 111.643 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.416 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.47 153.28 42.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.422 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.406 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 7.9 tp60 -71.57 122.71 20.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.192 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.95 19.29 56.25 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.152 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.3 t70 -52.15 171.79 0.05 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.767 0.318 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.853 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.1 mt-10 -145.24 135.51 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.063 HD11 HD11 ' A' ' 145' ' ' ILE . 1.5 mt -110.91 126.48 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.009 0.433 . . . . 0.0 110.476 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.625 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.28 140.78 37.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.58 158.36 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 81.84 35.57 21.5 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.164 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.9 t -74.33 140.24 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.612 0.72 . . . . 0.0 112.24 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -40.91 0.83 Allowed Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.247 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 46.9 t -126.52 127.91 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.282 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -50.49 -31.49 15.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.217 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 66.8 m -93.67 6.16 49.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -124.35 21.65 8.65 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.625 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.5 mt -103.63 139.0 25.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 142' ' ' SER . 5.0 tt -124.53 134.43 53.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 141' ' ' LEU . 46.9 t -109.57 150.18 28.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.664 0.745 . . . . 0.0 112.359 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 43' ' ' ILE . 77.7 mt -135.84 153.01 51.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.484 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.853 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -121.53 139.18 49.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.294 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.063 HD11 HD11 ' A' ' 130' ' ' ILE . 33.9 mt -106.47 128.53 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.977 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.7 114.11 25.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.621 HG12 HD21 ' A' ' 124' ' ' LEU . 4.1 mt -84.76 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.3 113.38 17.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -37.38 83.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -60.09 -46.02 90.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.966 0.412 . . . . 0.0 110.855 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.6 t80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.107 -179.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.726 0.298 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -47.51 67.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.818 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -35.83 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -31.77 72.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.773 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -71.86 -35.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.71 -46.17 84.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.441 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.25 -23.76 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.393 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.427 -1.591 0 CA-C-O 121.469 0.652 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.983 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.46 -60.23 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.998 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' HD22 ' A' ' 48' ' ' LEU . 11.5 p -146.53 162.11 39.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.434 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -131.68 128.47 39.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.281 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.695 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.7 t -97.8 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.925 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.842 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -120.9 115.5 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -82.21 99.81 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 110.343 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -80.25 -19.89 45.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.739 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.657 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.8 p -80.04 -2.59 44.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.574 0.226 . . . . 0.0 111.378 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.79 75.48 0.57 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.964 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -147.84 -41.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.068 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.0 mt -127.43 141.29 40.45 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.8 Cg_endo -72.52 145.38 42.18 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.012 1.808 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.842 HG12 HG23 ' A' ' 37' ' ' ILE . 41.7 mt -54.36 142.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.225 0.536 . . . . 0.0 111.908 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 33.8 mtt-85 -140.84 164.28 30.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.79 120.43 26.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.802 HD23 ' CD2' ' A' ' 66' ' ' TRP . 9.3 mp -86.38 137.08 32.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.188 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.983 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.61 156.01 45.03 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.427 1.108 . . . . 0.0 113.664 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.65 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.761 0.315 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.625 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.3 t -128.64 139.31 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.256 0.551 . . . . 0.0 111.959 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.802 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.6 m-90 -105.82 139.07 40.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.538 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.03 128.09 55.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -111.65 145.93 38.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.926 -178.08 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.08 -175.98 41.51 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -79.57 -2.52 42.79 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.85 134.63 41.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.644 0.259 . . . . 0.0 111.01 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.34 -7.09 19.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.658 2.238 . . . . 0.0 111.708 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.7 16.55 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.956 0.884 . . . . 0.0 108.932 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.08 137.69 4.17 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.477 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -56.43 -18.89 12.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.834 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.7 t80 -129.89 120.34 24.74 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.723 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.8 mm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.09 -44.07 74.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH1' ' HA3' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -61.58 -24.19 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.452 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.537 HD22 ' CE1' ' A' ' 88' ' ' HIS . 57.5 mt -93.24 152.26 19.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.8 0.333 . . . . 0.0 111.181 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.43 167.11 11.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.794 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.736 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.86 -53.9 5.7 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -117.65 82.97 1.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.2 t60 -60.44 -47.4 86.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.483 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.62 159.85 42.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.62 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.625 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.3 tt0 -135.78 139.59 43.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.723 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 57.6 mt -114.72 131.38 67.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.096 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.547 HD21 HD22 ' A' ' 121' ' ' ASN . 1.0 OUTLIER -117.53 147.87 42.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.096 0.474 . . . . 0.0 111.758 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.757 HD22 ' CG1' ' A' ' 33' ' ' VAL . 20.2 tp . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.912 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.739 0.304 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.4 mp -132.46 143.46 49.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.415 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.537 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.81 126.04 55.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.4 t30 -119.02 115.54 24.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 111.564 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.817 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -78.27 141.21 38.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.665 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 67' ' ' THR . 13.8 pt -149.08 37.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.65 153.69 18.05 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.9 m -68.87 -31.7 70.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.005 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.4 -20.02 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.36 157.53 10.56 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.738 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.8 m -117.53 137.83 52.31 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.111 0.564 . . . . 0.0 109.573 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.67 148.49 38.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.473 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.04 113.41 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.392 177.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 90.8 m-20 44.3 42.86 5.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.08 76.02 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.51 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.64 118.68 37.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.9 tptp -73.27 121.71 20.8 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.203 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.817 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.3 m -93.69 165.52 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.267 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 26.1 mt-10 -69.8 126.33 29.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.6 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.9 tttm -54.55 162.76 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.655 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.26 34.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.015 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.04 40.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.136 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.66 ' HB3' HD23 ' A' ' 100' ' ' LEU . 29.5 m120 -91.69 130.75 37.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.889 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.2 mm-40 -129.26 150.07 50.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.651 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.67 115.41 11.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.561 HD21 HG12 ' A' ' 147' ' ' ILE . 66.1 tp -52.74 157.18 1.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.413 0.625 . . . . 0.0 111.571 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.39 153.0 42.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.524 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.419 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.7 tp60 -71.8 124.26 24.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.93 20.57 53.66 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.136 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.1 t0 -55.06 172.83 0.11 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.0 111.07 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.5 tt0 -145.04 135.4 24.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.204 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.472 ' CG2' HG22 ' A' ' 109' ' ' THR . 17.1 mt -114.76 127.95 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.42 139.27 39.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.991 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.489 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.25 158.27 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.01 27.69 33.34 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.106 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.544 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.5 t -67.33 140.24 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.582 0.706 . . . . 0.0 112.332 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.409 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 151.61 -41.75 0.73 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.283 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 138' ' ' SER . 45.0 t -126.39 133.28 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.61 -35.82 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.796 0.331 . . . . 0.0 111.485 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.1 m -93.59 6.3 48.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -119.89 21.88 11.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.4 mt -104.88 139.59 25.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.155 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 142' ' ' SER . 7.0 tt -121.81 134.36 54.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.606 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.662 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -111.5 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.111 0.482 . . . . 0.0 111.801 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.53 HD22 HG12 ' A' ' 36' ' ' VAL . 20.5 mt -124.12 138.41 54.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.504 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.4 t -110.71 136.61 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.401 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 124' ' ' LEU . 8.2 mt -106.28 130.56 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.58 118.15 31.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.705 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.561 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.93 134.11 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.684 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.96 117.55 23.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.721 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.28 -29.89 65.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -60.29 -46.01 91.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.6 t80 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.151 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.767 0.318 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -61.1 -36.15 78.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.34 -39.88 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.3 tp -58.9 -31.96 69.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.01 -35.52 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.5 -38.44 74.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.25 -23.86 65.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.428 -1.534 0 CA-C-O 121.463 0.649 . . . . 0.0 112.398 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -93.7 -60.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.191 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.581 ' SG ' HD22 ' A' ' 99' ' ' LEU . 1.2 m -147.01 156.42 43.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.754 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 138.15 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.095 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.725 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.8 m -108.27 122.62 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.795 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.837 HG23 HG12 ' A' ' 45' ' ' ILE . 18.8 mt -128.27 122.63 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.542 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD23 ' A' ' 143' ' ' LEU . 54.1 t -80.27 109.98 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 0.0 110.248 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.464 HG23 HG21 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -75.71 -26.26 57.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.924 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 142' ' ' SER . 47.3 p -79.82 -2.23 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.54 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 77.65 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.863 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -147.09 -43.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.915 0.388 . . . . 0.0 110.865 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.8 mt -115.16 141.43 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.783 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.9 Cg_endo -71.12 145.96 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.138 1.892 . . . . 0.0 112.248 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.837 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -56.94 141.57 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.38 164.07 28.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.991 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.63 119.91 26.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.423 . . . . 0.0 111.973 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.0 mp -89.64 129.35 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.347 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -134.34 157.04 47.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.998 0.904 . . . . 0.0 113.341 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.024 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.291 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 49' ' ' SER . 33.6 ttpt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.713 0.292 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.611 HG12 ' HG2' ' A' ' 90' ' ' GLN . 3.6 t -121.14 138.84 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 111.664 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.766 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.0 m-90 -102.96 139.3 38.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.244 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.684 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.75 127.21 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -111.32 145.63 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.397 -178.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.84 -174.59 40.02 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -78.59 -2.22 37.9 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.86 135.05 40.47 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.9 Cg_exo -69.05 -7.86 22.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.779 2.32 . . . . 0.0 111.827 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.79 -43.77 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.949 0.88 . . . . 0.0 108.669 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.0 137.96 2.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -18.94 12.1 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.119 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.587 ' CE2' HG21 ' A' ' 43' ' ' ILE . 60.0 t80 -129.9 128.15 41.6 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 84' ' ' LEU . 36.0 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.694 0.283 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 p -54.86 -35.18 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -63.89 -45.94 87.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.054 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 81' ' ' ILE . 49.1 mt -72.8 152.09 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.125 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p -95.17 168.27 10.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -44.63 -53.6 7.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.373 0.606 . . . . 0.0 109.636 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HB2' HD12 ' A' ' 104' ' ' ILE . 33.8 mttm -119.43 83.1 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -60.49 -46.24 90.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.691 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.8 p90 -146.21 161.2 40.76 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.814 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.684 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -135.78 142.34 44.9 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 65' ' ' VAL . 27.1 mt -115.87 132.37 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.185 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.957 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.09 145.21 34.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.024 0.44 . . . . 0.0 111.807 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.624 ' HG ' HG11 ' A' ' 33' ' ' VAL . 2.6 tm? . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.409 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.604 ' HB3' HD13 ' A' ' 124' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.823 0.344 . . . . 0.0 110.956 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.722 HD13 ' OD1' ' A' ' 121' ' ' ASN . 11.3 mt -132.97 146.95 52.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.59 HD23 HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -117.57 124.48 48.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.9 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.957 ' HB2' HD11 ' A' ' 92' ' ' LEU . 47.9 t30 -114.38 115.5 27.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 111.531 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.782 ' OD2' HG23 ' A' ' 116' ' ' VAL . 17.6 p30 -79.47 138.63 37.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.2 pt -147.15 39.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -97.4 159.33 14.98 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.039 0.447 . . . . 0.0 111.497 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.88 -35.56 77.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.299 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -19.86 17.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 164.22 12.64 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.442 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.3 m -117.48 137.7 52.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.882 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.12 148.28 35.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.41 18.28 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.298 177.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.2 m-80 44.11 42.93 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.41 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.6 -11.46 68.32 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.583 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -103.98 118.35 36.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.045 0.422 . . . . 0.0 110.777 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.882 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -74.0 127.89 34.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.782 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.3 m -98.11 165.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.19 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 mm-40 -69.83 126.57 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.707 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.9 tttt -53.65 162.66 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.61 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.063 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.13 40.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.377 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.722 ' OD1' HD13 ' A' ' 100' ' ' LEU . 8.9 m-80 -91.64 125.92 36.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.601 ' O ' HD23 ' A' ' 100' ' ' LEU . 43.1 mm-40 -127.44 147.54 50.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.429 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.8 tp -72.63 117.11 13.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.17 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.756 ' CD2' HG21 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -55.73 166.98 0.61 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.782 0.801 . . . . 0.0 111.952 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.37 153.28 43.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.398 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.558 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.26 118.18 13.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.67 24.01 69.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.8 t70 -55.83 175.21 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.8 tt0 -145.06 135.54 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 145' ' ' ILE . 17.9 mt -115.34 126.66 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.55 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.659 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.51 138.34 41.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.524 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 27.4 m -140.39 158.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.42 28.98 28.61 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.159 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.5 t -68.56 140.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.535 0.684 . . . . 0.0 112.409 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.08 -43.45 0.6 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.261 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 138' ' ' SER . 45.8 t -126.43 136.36 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -50.7 -37.7 42.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.469 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.64 6.39 48.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.93 21.15 13.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.659 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -106.58 139.17 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.239 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 142' ' ' SER . 7.6 tt -124.38 134.37 53.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.229 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.527 ' H ' HG21 ' A' ' 40' ' ' THR . 47.2 t -109.83 150.23 28.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.7 0.762 . . . . 0.0 112.589 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' CYS . 72.8 mt -135.88 151.15 49.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.725 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 HG23 ' A' ' 39' ' ' THR . 36.7 t -122.03 135.88 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 130' ' ' ILE . 46.2 mt -106.12 125.66 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.77 114.73 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.1 mt -84.92 130.12 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.33 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -83.63 119.05 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -27.54 69.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.04 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -42.53 81.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 110.613 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.5 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -71.01 -42.84 69.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -36.89 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.43 -31.93 70.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.86 -35.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.4 -41.11 79.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.502 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -67.19 -23.87 65.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.64 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.224 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 121.532 0.682 . . . . 0.0 112.653 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.8 -60.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.735 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.4 p -147.82 153.62 39.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.095 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.77 138.13 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.541 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 36' ' ' VAL . 11.7 p -103.04 122.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.591 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -130.41 119.24 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.729 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.625 ' HA ' HD23 ' A' ' 143' ' ' LEU . 44.4 t -79.86 118.31 21.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.233 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.76 -25.12 28.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.979 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.526 HG21 ' H ' ' A' ' 142' ' ' SER . 52.5 p -79.82 -2.11 41.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.02 76.55 0.28 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.718 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -146.51 -44.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.08 141.45 27.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.792 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.6 Cg_endo -73.2 141.49 32.49 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 0.0 112.265 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 37' ' ' ILE . 38.3 mt -56.98 143.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.14 164.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.38 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 119.85 35.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.189 0.518 . . . . 0.0 111.69 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.694 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.6 mt -98.64 134.54 41.42 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.96 158.95 43.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -178.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.883 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.878 0.371 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.8 t -125.49 137.58 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.694 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.9 m-90 -101.98 139.27 37.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.184 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.679 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.38 130.51 56.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -119.18 145.3 46.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.274 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.28 -170.74 36.38 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -78.86 3.72 16.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 5.4 t-20 -84.66 132.03 47.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.574 0.226 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.3 Cg_exo -66.69 -13.74 41.1 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.476 2.117 . . . . 0.0 111.761 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.68 -42.72 17.76 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.949 0.88 . . . . 0.0 108.937 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.5 139.51 1.09 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.015 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 m-20 -56.49 -18.75 12.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.015 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 16.7 t80 -129.55 123.01 30.35 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.117 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 179.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.863 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.0 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.803 0.335 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.2 p -56.49 -37.47 70.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.567 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.57 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.66 -22.1 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.19 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.863 HD23 ' HB ' ' A' ' 81' ' ' ILE . 2.1 mm? -107.54 152.64 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.905 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -96.93 163.77 12.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.45 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.622 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.84 -52.9 4.88 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.497 0.665 . . . . 0.0 109.663 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.1 mttm -120.84 82.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -61.4 -45.93 92.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.672 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.6 p90 -143.86 159.06 43.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.795 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.679 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.09 140.56 43.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.316 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.564 ' O ' HG13 ' A' ' 65' ' ' VAL . 58.1 mt -114.0 132.28 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.791 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 92' ' ' LEU . 2.0 pt? -120.59 133.59 55.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.03 0.443 . . . . 0.0 111.967 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.676 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.6 tm? . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.064 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.676 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.679 0.276 . . . . 0.0 110.76 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.573 ' H ' HD23 ' A' ' 99' ' ' LEU . 3.2 mp -125.85 143.29 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.484 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 101' ' ' LEU . 2.4 mm? -112.8 122.82 48.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.897 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.627 ' HB2' HD22 ' A' ' 92' ' ' LEU . 49.9 t30 -115.28 115.47 26.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.654 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.83 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -78.17 138.43 38.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.9 pt -145.12 40.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.611 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.69 156.45 16.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 111.362 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.79 -36.52 78.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.361 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.75 -19.7 17.32 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.14 159.18 10.44 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.005 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -117.55 137.93 52.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.991 -0.604 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.891 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.74 148.72 34.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.45 18.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.455 177.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 42.8 44.0 3.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.75 62.41 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -103.34 118.52 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.614 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.891 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.4 tptp -72.92 128.16 34.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.425 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.83 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.9 m -98.79 163.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.193 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 tp10 -69.92 126.89 31.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.536 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -53.16 160.74 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.81 35.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.311 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.13 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.136 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.502 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.1 m120 -85.13 127.92 34.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.93 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.29 146.93 51.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.532 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tp -72.77 134.2 44.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.287 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.883 HD11 HG21 ' A' ' 145' ' ' ILE . 65.2 tp -69.33 155.88 39.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.458 0.647 . . . . 0.0 111.485 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.452 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.58 153.02 42.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.256 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 121.3 18.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.886 0.374 . . . . 0.0 110.287 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.44 58.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.131 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.0 t70 -54.43 173.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.739 0.304 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.2 mt-10 -145.07 135.72 24.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.318 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.46 ' CG2' HG22 ' A' ' 109' ' ' THR . 12.9 mt -114.41 127.16 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.61 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.566 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.42 140.06 38.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.884 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.74 HG23 HD11 ' A' ' 84' ' ' LEU . 35.5 m -140.4 158.33 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 0.0 112.346 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.91 36.03 16.85 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.079 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.577 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.8 t -75.14 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.641 0.734 . . . . 0.0 112.505 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.21 -42.89 0.57 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.62 129.11 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 -31.18 14.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.795 0.331 . . . . 0.0 111.183 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.598 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 m -93.53 6.42 48.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -125.69 23.2 7.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.9 mt -105.35 139.33 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.011 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -124.23 134.43 53.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.577 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.526 ' H ' HG21 ' A' ' 40' ' ' THR . 48.3 t -109.4 150.57 27.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 112.25 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.0 mt -135.53 156.0 49.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.5 t -124.57 136.84 59.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.032 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.883 HG21 HD11 ' A' ' 124' ' ' LEU . 2.3 mm -106.33 126.37 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.923 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 37' ' ' ILE . 1.5 m-85 -112.53 116.33 30.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.738 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.749 HG12 HD21 ' A' ' 124' ' ' LEU . 3.7 mt -84.8 134.26 27.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.542 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -75.97 118.48 18.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.588 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -37.49 78.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -60.6 -45.73 92.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 33' ' ' VAL . 19.5 t80 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.187 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -46.06 88.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -57.04 -36.14 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -31.86 71.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.46 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.15 -35.53 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.86 -37.91 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.352 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.2 -23.64 65.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.996 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.568 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.6 mm . . . . . 0 N--CA 1.425 -1.69 0 CA-C-O 121.782 0.801 . . . . 0.0 112.361 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.757 HG22 HD13 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -105.78 -51.35 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.05 -178.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.454 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -155.17 165.37 36.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.635 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 138.0 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 16.4 t -106.23 122.84 60.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.211 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 mt -127.28 115.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.342 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.547 ' HA ' HD13 ' A' ' 143' ' ' LEU . 53.3 t -80.81 123.39 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -88.3 -26.88 22.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.639 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 142' ' ' SER . 53.2 p -79.95 -2.3 43.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.632 0.253 . . . . 0.0 111.559 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.59 76.29 0.29 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.007 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -147.18 -44.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.961 HD12 HD11 ' A' ' 143' ' ' LEU . 1.5 mt -108.78 140.46 21.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.36 146.03 34.93 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.203 1.936 . . . . 0.0 112.257 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.5 mt -59.98 130.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.629 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 164.21 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.194 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.89 119.47 34.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.972 0.415 . . . . 0.0 111.779 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.3 mp -86.09 133.54 33.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.581 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -139.9 156.49 46.66 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.38 1.086 . . . . 0.0 113.694 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.051 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.805 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.801 0.334 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.572 HG22 ' CB ' ' A' ' 92' ' ' LEU . 16.9 t -132.75 139.19 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.289 0.566 . . . . 0.0 111.858 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.581 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.9 m-90 -100.9 140.29 35.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.374 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.816 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -109.15 124.74 51.3 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.721 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.9 m-85 -112.46 145.68 39.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.045 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.76 -169.61 38.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.933 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.7 mtp180 -84.87 10.18 12.32 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.695 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.0 t-20 -93.86 134.82 25.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.547 0.213 . . . . 0.0 111.135 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.3 Cg_exo -67.21 -11.01 30.62 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.516 2.144 . . . . 0.0 111.651 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.695 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.04 -42.7 17.17 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.874 0.845 . . . . 0.0 109.004 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.6 137.8 2.06 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.831 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.46 -18.59 11.86 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.927 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CE2' HG21 ' A' ' 43' ' ' ILE . 7.7 t80 -129.35 120.38 25.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.964 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.615 179.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.7 mm . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.848 0.356 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -31.77 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.542 ' H ' HG22 ' A' ' 81' ' ' ILE . 15.6 mtt-85 -73.98 -21.49 59.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 HD21 HG23 ' A' ' 132' ' ' VAL . 21.1 mt -99.13 152.33 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 111.007 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.67 165.27 12.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.668 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.91 -53.26 4.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 109.839 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.672 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.43 82.5 1.86 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.8 t60 -61.81 -45.0 95.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.919 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 22.1 p90 -146.74 164.15 33.69 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.298 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.816 ' CG ' HG23 ' A' ' 67' ' ' THR . 7.6 mt-30 -135.7 140.78 44.7 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.39 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 65' ' ' VAL . 2.7 mp -116.37 132.47 65.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.356 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.7 147.44 42.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 111.696 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.757 HD13 HG22 ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.437 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 93' ' ' LEU . 4.2 mm? . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.756 0.312 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.886 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -133.25 143.14 48.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.213 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.875 HD11 HD12 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -112.81 129.1 56.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.491 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB2' HD22 ' A' ' 92' ' ' LEU . 47.1 t30 -119.76 115.54 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.766 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -79.68 141.71 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.2 pt -148.3 39.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.655 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.68 151.06 21.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.058 0.456 . . . . 0.0 111.869 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.7 m -68.78 -31.7 70.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.901 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.42 -19.69 17.56 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.1 155.66 9.87 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.632 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.48 137.73 52.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.2 148.47 39.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.43 18.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.056 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.94 43.3 7.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -7.86 77.74 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.48 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -105.63 118.48 36.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.143 0.472 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.766 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.4 m -95.94 165.47 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.405 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 3.7 tt0 -69.93 129.55 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.9 tttt -54.33 163.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.193 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.6 m-80 33.92 36.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.827 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.72 145.22 39.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.843 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.725 ' HB3' HD22 ' A' ' 100' ' ' LEU . 29.9 m120 -93.0 127.75 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.813 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.886 ' O ' HD23 ' A' ' 100' ' ' LEU . 65.3 mm-40 -128.98 151.24 49.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.43 117.38 14.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.955 0.407 . . . . 0.0 110.553 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 101' ' ' LEU . 64.5 tp -57.89 157.8 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.408 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -124.37 153.2 42.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.438 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -71.58 124.42 24.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.49 20.16 55.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.954 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.37 173.25 0.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.04 135.58 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.822 ' CD1' HD21 ' A' ' 101' ' ' LEU . 7.2 mt -113.36 128.66 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.496 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 86.7 m -103.92 138.87 39.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.106 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.589 HG23 HD21 ' A' ' 84' ' ' LEU . 33.2 m -140.16 158.15 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.71 40.59 14.55 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.814 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -79.87 140.39 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.654 0.74 . . . . 0.0 112.537 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.13 0.56 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.289 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 43.5 t -126.42 134.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.67 -39.55 51.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.745 0.307 . . . . 0.0 111.702 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.428 ' H ' HG12 ' A' ' 136' ' ' VAL . 14.3 m -93.5 6.43 48.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.444 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.4 t0 -118.06 23.05 11.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.2 mt -106.12 139.49 27.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.302 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 43' ' ' ILE . 3.1 tp -120.51 134.34 55.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.232 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.555 ' C ' HD22 ' A' ' 143' ' ' LEU . 43.8 t -113.46 150.32 32.99 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 112.672 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 43' ' ' ILE . 2.5 mm? -136.23 146.05 46.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.572 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 39' ' ' THR . 23.9 t -116.72 132.82 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 111.097 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.875 HD12 HD11 ' A' ' 101' ' ' LEU . 6.3 mt -106.25 128.33 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.84 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.97 120.63 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.0 mt -84.82 134.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.278 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -79.16 127.75 32.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -74.06 -32.3 63.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -45.3 91.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.0 t80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.907 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -64.02 -39.52 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.63 -35.09 78.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.22 -39.99 84.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.6 mm -71.25 -35.14 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.27 -34.17 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.401 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -67.34 -23.81 65.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.696 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm . . . . . 0 N--CA 1.428 -1.534 0 CA-C-O 121.611 0.719 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.0 -60.51 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 m -143.47 162.43 35.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.355 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 123.59 32.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.142 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.71 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -91.16 122.77 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -126.89 123.13 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.628 ' SG ' HD21 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -92.14 100.11 12.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.592 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.749 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.5 p -79.92 -2.63 44.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 111.341 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.81 73.28 0.66 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.065 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -144.9 -38.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.9 mt -127.54 141.32 40.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.846 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.76 137.97 28.14 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.112 1.874 . . . . 0.0 112.15 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -55.26 144.03 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.785 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.37 164.32 30.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.263 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.85 119.84 34.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 112.008 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.5 mt -94.67 137.43 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.25 158.09 43.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.424 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.649 0.261 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.575 HG11 HD23 ' A' ' 92' ' ' LEU . 4.4 t -120.44 138.52 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.199 0.523 . . . . 0.0 112.031 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -100.74 139.69 36.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.403 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.722 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.4 129.7 55.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.711 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -120.43 145.66 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.628 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.64 -169.56 36.39 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.73 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.7 mtm105 -82.54 5.17 21.68 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.3 t-20 -84.9 132.62 45.43 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.523 0.201 . . . . 0.0 110.773 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.39 -13.97 42.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.446 2.097 . . . . 0.0 111.685 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -44.1 16.01 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.842 0.829 . . . . 0.0 108.835 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.25 137.84 3.33 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.871 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.49 -18.6 12.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.726 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -129.54 124.29 33.51 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.771 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 84' ' ' LEU . 39.2 mt . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.905 0.383 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -54.81 -44.9 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.455 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -45.55 89.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' CD1' HD12 ' A' ' 81' ' ' ILE . 28.6 mt -72.79 152.27 41.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.695 0.283 . . . . 0.0 111.318 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -97.18 163.5 12.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.017 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.76 -51.62 5.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.442 0.639 . . . . 0.0 109.846 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB2' HD11 ' A' ' 104' ' ' ILE . 16.3 ptmt -120.32 82.24 1.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -64.78 -45.39 86.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.455 -176.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.495 ' HA ' HG12 ' A' ' 104' ' ' ILE . 47.5 p90 -150.21 163.38 38.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.234 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.722 ' CD ' HG23 ' A' ' 67' ' ' THR . 10.3 mt-30 -135.71 158.41 44.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.468 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.711 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 68.2 mt -125.8 131.15 72.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.138 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.678 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -114.12 145.57 41.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.1 0.476 . . . . 0.0 111.711 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 33' ' ' VAL . 25.2 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.192 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.439 ' CD1' HD13 ' A' ' 93' ' ' LEU . 3.1 mm? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.898 0.38 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.605 ' HB3' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -133.15 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.233 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.17 128.8 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.678 ' HB2' HD11 ' A' ' 92' ' ' LEU . 42.0 t30 -115.42 115.48 26.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.458 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.0 p30 -79.53 143.05 35.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.602 HD13 ' CG ' ' A' ' 90' ' ' GLN . 15.2 pt -150.93 37.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.32 158.31 15.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.003 0.43 . . . . 0.0 111.613 -178.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -68.87 -34.93 76.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.436 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.88 17.29 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.09 161.7 11.62 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.647 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.7 m -117.52 137.87 52.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.65 148.32 36.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.08 113.3 18.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.174 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.6 m-80 44.17 43.39 5.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.285 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 -5.82 84.46 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.454 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.14 118.51 36.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.094 0.474 . . . . 0.0 110.828 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.2 tptp -74.89 120.59 20.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.363 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -95.17 163.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.4 tp10 -69.84 127.3 32.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.0 tttm -52.18 161.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.753 0.311 . . . . 0.0 110.577 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.48 34.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.215 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.09 40.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.901 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.611 HD22 HD13 ' A' ' 92' ' ' LEU . 2.6 m120 -88.48 128.42 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.032 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.1 mm-40 -129.69 149.13 51.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.605 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.7 126.08 29.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.394 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.549 HD21 HG12 ' A' ' 147' ' ' ILE . 65.9 tp -64.69 158.43 24.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.301 0.572 . . . . 0.0 111.424 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.425 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -124.14 153.32 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.242 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.501 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.13 122.71 20.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 0.0 110.478 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.18 20.76 55.17 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.162 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.6 t70 -56.2 174.12 0.14 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.7 tt0 -145.12 135.59 24.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.104 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.829 HD11 HD11 ' A' ' 145' ' ' ILE . 12.7 mt -109.05 127.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.371 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.0 m -104.47 137.84 41.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.32 158.42 25.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.88 24.57 44.74 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.266 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.1 t -64.78 140.43 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.58 0.705 . . . . 0.0 112.237 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.36 -42.31 0.85 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.369 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.39 131.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.52 -33.08 20.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.557 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.56 6.25 48.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.7 20.2 11.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 134' ' ' VAL . 13.9 mt -102.95 139.52 23.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.07 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 142' ' ' SER . 6.4 tt -124.32 134.41 53.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.749 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -113.3 127.8 56.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.105 0.478 . . . . 0.0 111.742 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.487 HD11 HD12 ' A' ' 43' ' ' ILE . 19.2 mt -121.2 139.82 52.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.8 139.68 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.147 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.829 HD11 HD11 ' A' ' 130' ' ' ILE . 41.4 mt -106.04 130.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.65 114.0 25.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.36 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.549 HG12 HD21 ' A' ' 124' ' ' LEU . 6.6 mt -84.92 132.98 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.544 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -76.97 110.9 11.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.733 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -60.81 -39.35 88.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.995 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -46.05 92.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.3 t80 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.961 -179.878 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.746 0.308 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.88 -45.29 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -59.63 -32.39 70.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.2 -35.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -36.04 71.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -67.15 -31.11 71.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.311 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.8 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.455 0.645 . . . . 0.0 111.112 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 121.384 0.611 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.967 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -93.99 -60.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.168 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -145.09 164.53 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.485 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.678 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -126.17 126.86 44.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.769 HG21 ' HE2' ' A' ' 68' ' ' PHE . 36.5 t -93.96 122.83 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.79 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -126.8 122.56 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.512 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.27 106.64 18.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 110.372 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -77.31 -20.37 55.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.064 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' H ' ' A' ' 142' ' ' SER . 81.1 p -79.9 -2.46 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 74.25 0.48 Allowed Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.808 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -147.3 -44.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 0.0 110.805 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.78 HD12 HD21 ' A' ' 143' ' ' LEU . 4.2 mt -112.3 140.39 23.6 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.38 132.83 16.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.262 1.974 . . . . 0.0 112.036 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -53.22 135.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.57 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -130.72 164.24 25.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.524 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 6.5 m-20 -114.26 119.89 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 0.0 111.425 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.885 HD22 ' CD1' ' A' ' 66' ' ' TRP . 15.0 mt -93.85 137.08 33.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.812 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.967 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.86 157.63 44.09 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.503 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.967 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.023 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.6 ttmt . . . . . 0 CA--C 1.519 -0.217 0 CA-C-O 120.818 0.342 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.9 t -130.61 138.97 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.434 0.635 . . . . 0.0 112.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.885 ' CD1' HD22 ' A' ' 48' ' ' LEU . 13.0 m-90 -105.09 140.02 38.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.17 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.91 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.29 126.08 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.769 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -117.51 145.44 44.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.811 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.287 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -78.03 -1.28 31.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 28.8 t-20 -84.89 131.88 47.7 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.621 0.248 . . . . 0.0 111.093 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.1 Cg_exo -68.02 -10.57 29.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.469 2.112 . . . . 0.0 111.626 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.87 16.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.897 0.856 . . . . 0.0 108.988 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -38.93 141.14 0.31 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.74 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.17 -19.07 11.98 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.908 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.4 t80 -129.92 130.43 45.12 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.993 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 84' ' ' LEU . 31.1 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.789 0.328 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -35.1 63.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -61.19 -18.66 59.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 81' ' ' ILE . 13.7 mt -104.81 147.35 27.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.66 160.58 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.546 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.62 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -40.87 -51.32 3.18 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.606 0.717 . . . . 0.0 109.741 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 67' ' ' THR . 18.0 mttt -120.82 82.6 1.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 17.1 t60 -63.16 -46.06 88.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.968 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.8 p90 -146.25 161.87 39.32 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.282 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.91 ' CG ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.35 137.26 42.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.38 -178.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 65' ' ' VAL . 45.2 mt -115.22 132.09 65.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.559 HD21 HD22 ' A' ' 121' ' ' ASN . 1.0 OUTLIER -121.39 145.86 47.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.139 0.495 . . . . 0.0 111.876 -179.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.561 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.9 tm? . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.194 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.807 ' CB ' HD13 ' A' ' 124' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.832 0.349 . . . . 0.0 110.771 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.9 OUTLIER -128.37 138.37 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.594 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.1 pp -113.04 120.72 42.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.077 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.0 t30 -114.57 116.03 28.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.668 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.8 p30 -77.45 140.51 39.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.063 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.1 pt -143.89 28.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.448 0.166 . . . . 0.0 111.407 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 9.3 t -89.56 159.67 17.07 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.519 0.676 . . . . 0.0 112.677 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -69.72 -50.42 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.417 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.25 2.92 54.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.266 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.33 159.36 28.11 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.898 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.543 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.0 m -117.74 138.05 52.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.347 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.855 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.12 148.82 31.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.86 113.3 18.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.228 177.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.423 ' N ' HD12 ' A' ' 111' ' ' LEU . 59.1 m-20 44.77 42.9 6.4 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.57 -14.21 60.39 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.548 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.2 118.38 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.075 0.438 . . . . 0.0 110.482 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.855 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.92 123.9 23.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.407 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.7 m -95.39 165.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.029 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 mp0 -69.85 126.81 30.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.685 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 62.9 tttt -54.84 162.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.991 0.424 . . . . 0.0 110.579 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.59 33.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.147 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.54 144.55 41.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.89 179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.559 HD22 HD21 ' A' ' 92' ' ' LEU . 16.7 m120 -93.22 133.32 36.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.946 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 53.8 mm-40 -129.24 151.25 50.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.61 113.56 9.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.2 tt -49.29 156.55 0.57 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.629 . . . . 0.0 111.739 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.48 153.48 41.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.641 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.2 121.93 19.27 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.57 19.68 65.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.734 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -49.26 165.35 0.06 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.857 0.361 . . . . 0.0 111.172 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.5 tt0 -143.2 135.48 27.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.973 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.555 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -115.12 127.77 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.646 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.6 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.5 m -104.64 139.13 39.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.55 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.9 m -140.57 158.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.08 23.48 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.148 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.5 t -71.75 140.34 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 121.536 0.684 . . . . 0.0 112.391 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.405 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 152.88 -42.18 0.67 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.314 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.34 131.76 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 -34.8 25.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 111.414 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.9 m -93.53 6.37 48.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 59.2 m-20 -121.16 21.82 11.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.6 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -103.93 139.28 25.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.99 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 141' ' ' LEU . 7.9 tt -124.36 134.53 53.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.505 ' H ' HG21 ' A' ' 40' ' ' THR . 46.6 t -110.59 150.21 29.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.716 0.769 . . . . 0.0 112.368 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.78 HD21 HD12 ' A' ' 43' ' ' ILE . 70.1 mt -135.68 145.74 47.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.831 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.51 139.97 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.349 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.555 HD11 HD11 ' A' ' 130' ' ' ILE . 39.6 mt -106.14 126.22 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.18 118.9 36.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.601 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.507 HD11 HD21 ' A' ' 124' ' ' LEU . 6.3 mt -84.64 133.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -84.3 115.42 22.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.809 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -58.87 -29.05 66.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.019 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.9 t80 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.898 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.798 0.332 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -63.34 -36.16 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -40.43 93.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.01 -44.82 95.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.6 mm -67.7 -35.16 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -57.18 -35.8 70.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.358 . . . . 0.0 110.43 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -23.86 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.807 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.53 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.179 0 CA-C-O 121.067 0.461 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.429 -1.503 0 CA-C-O 121.521 0.677 . . . . 0.0 112.48 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.71 -61.01 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.035 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.7 p -147.16 151.4 36.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.394 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.45 138.14 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.711 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.7 t -105.55 122.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.761 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -125.81 117.06 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.407 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.8 t -79.75 124.67 28.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 110.579 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.429 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -94.52 -24.56 17.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.387 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.486 HG23 ' HB3' ' A' ' 142' ' ' SER . 67.6 p -79.86 -2.36 43.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.397 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 73.84 0.54 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.894 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.77 -43.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.7 mt -115.15 140.53 25.78 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.24 138.47 25.09 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.2 1.933 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.761 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -56.11 129.48 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.629 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -126.23 164.14 21.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 119.71 35.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.994 0.426 . . . . 0.0 111.797 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 66' ' ' TRP . 2.0 mt -92.42 137.27 32.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.55 158.8 43.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.834 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.75 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.5 ttpt . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 120.84 0.352 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 91' ' ' ILE . 3.7 t -111.87 139.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.264 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.601 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.2 m-90 -100.42 139.29 36.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.899 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.39 133.69 53.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.711 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -116.01 145.57 42.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.313 -178.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.797 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 170.57 -175.46 44.4 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.455 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -82.19 -4.39 56.92 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.4 p30 -87.71 139.34 31.31 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.861 0.362 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.7 Cg_exo -69.49 -4.27 13.5 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.889 2.393 . . . . 0.0 111.88 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -46.8 12.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.869 0.842 . . . . 0.0 109.081 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 139.01 3.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.724 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -19.09 12.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.552 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.9 t80 -129.75 120.76 25.6 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.848 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.681 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.756 HD11 HD12 ' A' ' 141' ' ' LEU . 41.0 mt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.922 0.391 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -58.62 -33.89 70.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.484 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 5.1 tpt180 -60.71 -47.69 85.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.661 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.2 mp -72.63 153.61 41.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' ASN . 46.3 p -94.61 166.55 11.97 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.933 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.797 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m120 -40.54 -74.69 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.586 ' HB3' HG22 ' A' ' 67' ' ' THR . 15.0 mttt -97.95 85.59 3.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -63.32 -44.86 93.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.957 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' HA ' HG12 ' A' ' 104' ' ' ILE . 31.7 p90 -153.49 162.4 41.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG23 ' A' ' 67' ' ' THR . 10.6 mt-30 -135.92 160.0 39.94 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.732 HG23 HD23 ' A' ' 101' ' ' LEU . 58.3 mt -123.78 131.96 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.081 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.66 139.58 39.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.071 0.463 . . . . 0.0 111.685 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.6 ' C ' HD13 ' A' ' 93' ' ' LEU . 1.8 tm? . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.787 HD11 HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.46 0.067 0 CA-C-O 120.913 0.387 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.8 mt -133.42 147.25 51.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.732 HD23 HG23 ' A' ' 91' ' ' ILE . 14.2 mt -112.66 130.33 56.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.617 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.6 t30 -115.05 115.63 27.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.642 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.762 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.6 p-10 -81.18 141.27 34.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.137 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.56 HG21 ' OE1' ' A' ' 90' ' ' GLN . 13.6 pt -149.82 37.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.606 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -97.39 156.42 16.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.11 0.481 . . . . 0.0 111.84 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.2 m -68.55 -32.79 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.103 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -98.63 -19.9 17.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.112 -179.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.606 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.91 164.3 13.45 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.215 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.9 m -117.4 137.68 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -115.74 148.42 39.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.601 ' CD1' HG11 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -124.41 113.36 18.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.544 177.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 45.76 37.4 3.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.013 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.58 -1.86 76.39 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.556 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -107.97 118.65 37.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.02 0.438 . . . . 0.0 110.919 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -75.63 129.72 37.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.348 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.762 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.4 m -106.49 165.11 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.358 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.85 131.77 44.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.209 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 6.1 tttt -55.45 168.78 0.35 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.445 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 31.85 37.19 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.302 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.0 p -111.96 145.08 40.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.342 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.59 HD22 HD13 ' A' ' 92' ' ' LEU . 6.2 m120 -93.58 122.44 36.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.626 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -128.59 146.73 50.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.23 115.48 12.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.148 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 99' ' ' LEU . 1.7 pt? -62.03 169.66 2.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.804 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.4 153.72 41.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.116 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.479 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.07 120.55 16.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.035 0.445 . . . . 0.0 110.136 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.58 20.84 64.2 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.139 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD2' HD23 ' A' ' 111' ' ' LEU . 5.0 t70 -61.63 179.6 0.24 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.852 0.358 . . . . 0.0 110.796 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.902 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.1 mt-10 -145.17 135.66 24.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.307 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 145' ' ' ILE . 11.8 mt -108.35 128.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.286 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.27 137.91 41.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 13.9 m -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.88 30.12 29.94 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.171 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.532 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.3 t -69.0 140.24 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.661 0.743 . . . . 0.0 112.332 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.8 -43.49 0.67 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.266 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 138' ' ' SER . 42.4 t -126.48 135.21 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.48 -37.15 37.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.666 0.269 . . . . 0.0 111.679 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.448 ' H ' HG12 ' A' ' 136' ' ' VAL . 95.0 p -93.58 6.33 48.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.31 19.88 14.56 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.678 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -106.04 138.96 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.238 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.756 HD12 HD11 ' A' ' 81' ' ' ILE . 3.3 tt -124.57 134.49 52.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.681 ' N ' HD23 ' A' ' 141' ' ' LEU . 38.8 t -111.56 150.32 30.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.8 . . . . 0.0 112.732 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -135.81 149.54 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.159 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.2 t -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.178 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 130' ' ' ILE . 10.8 mt -106.4 120.88 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 107.69 17.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.274 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.77 128.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.71 119.46 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.91 -32.0 72.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.7 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.949 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 . . . . . 0 N--CA 1.458 -0.043 0 CA-C-O 120.87 0.367 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.99 -43.64 81.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.81 -31.92 72.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.13 -35.35 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -57.44 -43.6 84.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.476 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -67.21 -23.7 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.546 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.229 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.694 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 121.618 0.723 . . . . 0.0 112.551 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.017 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -91.97 -59.59 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.938 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 157.78 43.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.468 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -123.56 124.85 43.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.679 HG21 ' HE2' ' A' ' 68' ' ' PHE . 46.4 t -92.43 122.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.992 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.856 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -129.03 125.44 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.431 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.4 t -89.91 107.87 19.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -79.99 -26.2 40.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.767 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 142' ' ' SER . 58.7 p -79.83 -2.59 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.525 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.57 80.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.067 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 141' ' ' LEU . 9.2 mt-30 -147.73 -39.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.015 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.809 HD12 HD21 ' A' ' 143' ' ' LEU . 6.8 mt -127.43 141.99 42.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.8 Cg_endo -71.92 141.62 37.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.11 1.873 . . . . 0.0 112.127 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.856 HG12 HG23 ' A' ' 37' ' ' ILE . 34.2 mt -55.86 149.11 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.847 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.29 162.85 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -121.21 122.67 40.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.08 0.467 . . . . 0.0 111.907 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -101.03 137.26 39.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.193 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.017 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.12 158.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.12 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' A' ' 49' ' ' SER . 28.1 ttpt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 92' ' ' LEU . 9.3 t -124.79 138.66 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.223 0.535 . . . . 0.0 111.702 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.601 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.9 m-90 -100.75 139.86 35.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.145 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.818 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.84 130.58 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.726 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -120.09 145.1 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.034 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.58 -172.78 39.58 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.109 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 30.5 mtp180 -75.74 1.64 14.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.481 HD22 ' HB3' ' A' ' 73' ' ' ALA . 1.9 t30 -84.67 141.93 39.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.339 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 61.7 Cg_endo -73.76 -14.37 24.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.6 2.2 . . . . 0.0 111.271 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -43.28 17.21 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.881 0.848 . . . . 0.0 108.735 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 140.83 1.2 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.898 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.26 -18.58 10.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.094 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.59 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 3.0 t80 -129.18 122.68 30.29 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.723 0.296 . . . . 0.0 110.842 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.151 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.745 HD11 HD12 ' A' ' 141' ' ' LEU . 28.8 mt . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.861 0.363 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -35.68 64.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.019 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -29.42 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.593 HD11 HD12 ' A' ' 81' ' ' ILE . 46.8 mt -90.15 152.35 21.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.55 166.11 12.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.51 -53.64 5.39 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.475 0.655 . . . . 0.0 109.507 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.729 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.74 84.42 2.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -62.04 -44.93 95.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.982 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -146.31 162.85 37.23 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.399 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.818 ' CG ' HG23 ' A' ' 67' ' ' THR . 11.2 mt-30 -135.57 148.01 48.93 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.726 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 64.5 mt -125.07 132.4 71.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.677 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.725 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -126.04 135.22 51.51 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.034 0.445 . . . . 0.0 112.146 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 93' ' ' LEU . 1.8 tm? . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.161 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.987 HD21 HG12 ' A' ' 33' ' ' VAL . 5.6 mp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.73 0.3 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.7 mp -129.79 142.93 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.08 125.14 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.132 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.567 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.2 t30 -116.57 116.33 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.792 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -76.63 139.49 40.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.831 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.2 pt -145.32 38.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.31 152.65 19.69 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.076 0.465 . . . . 0.0 111.829 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.0 m -68.9 -31.41 70.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.994 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -97.99 -19.92 17.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.01 157.37 10.8 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.841 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.46 137.81 52.28 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.48 148.35 37.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.2 113.47 18.35 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.329 177.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.408 ' N ' HD12 ' A' ' 111' ' ' LEU . 91.4 m-20 44.17 43.5 5.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.87 68.25 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.517 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -104.06 118.46 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.08 0.44 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 18.4 tptt -74.08 123.15 23.85 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.247 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.792 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -94.35 165.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.5 tp10 -69.94 127.24 32.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 69.2 tttt -55.07 162.53 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 110.354 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.411 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER 36.83 32.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.115 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 144.99 41.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.818 179.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.725 ' OD1' HD21 ' A' ' 92' ' ' LEU . 14.8 m-80 -94.8 133.44 38.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.042 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.5 mm-40 -129.22 152.28 48.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.376 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.34 125.81 28.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.948 0.404 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 145' ' ' ILE . 30.7 tp -56.36 154.68 7.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 0.0 111.814 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.467 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.88 152.93 43.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.601 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -72.11 124.25 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.779 0.323 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.04 22.56 42.95 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.15 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.5 t70 -52.81 171.81 0.06 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.96 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.927 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.5 mt-10 -143.91 135.5 26.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.094 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.854 HD11 HD11 ' A' ' 145' ' ' ILE . 15.5 mt -114.94 126.01 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.436 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.69 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.29 138.44 40.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 84' ' ' LEU . 35.7 m -140.24 158.26 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 84.97 27.09 35.16 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.105 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.0 t -66.28 140.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.618 0.723 . . . . 0.0 112.496 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.51 -41.58 0.62 Allowed Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.289 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.1 t -126.46 136.49 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -39.88 52.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.7 0.286 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.446 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.45 6.33 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 23.1 t0 -116.62 23.28 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.69 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.317 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 HD11 ' A' ' 81' ' ' ILE . 6.8 tt -119.25 134.39 55.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.591 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.5 m -109.01 141.98 40.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 111.654 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.809 HD21 HD12 ' A' ' 43' ' ' ILE . 73.8 mt -135.13 141.97 46.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.787 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.927 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.3 t -114.08 140.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.798 0.332 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.854 HD11 HD11 ' A' ' 130' ' ' ILE . 50.3 mt -106.16 129.64 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.83 115.29 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.446 HG12 HD21 ' A' ' 124' ' ' LEU . 1.8 mt -84.77 134.03 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -83.46 103.96 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -29.47 64.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -45.02 91.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.0 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.882 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -61.26 -36.8 81.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.825 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -65.71 -38.27 88.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.24 -43.18 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.8 mm -68.23 -35.12 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.21 -34.73 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.378 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -67.23 -23.9 65.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.814 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm . . . . . 0 N--CA 1.427 -1.606 0 CA-C-O 121.79 0.805 . . . . 0.0 112.477 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.86 HG22 HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -109.94 -49.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.785 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.621 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -152.72 158.7 42.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.422 179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -130.83 136.88 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.749 0.309 . . . . 0.0 111.476 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 68' ' ' PHE . 58.3 t -108.54 122.62 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.964 0.411 . . . . 0.0 110.647 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -126.76 115.21 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.463 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.563 ' HA ' HD23 ' A' ' 143' ' ' LEU . 17.6 t -81.4 101.87 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 110.409 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -24.09 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.755 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.639 HG21 ' H ' ' A' ' 142' ' ' SER . 13.7 p -79.82 -2.42 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.417 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.6 78.81 0.26 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.133 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -147.64 -40.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.007 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.0 mt -124.64 141.85 39.05 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -71.57 137.64 30.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.252 1.968 . . . . 0.0 111.925 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -54.62 137.54 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.914 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 163.33 27.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.976 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.5 m-20 -118.65 119.75 35.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.892 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 34' ' ' CYS . 3.4 mt -92.24 137.37 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.5 158.59 44.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.228 1.013 . . . . 0.0 113.665 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.344 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.8 ttpt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.824 0.345 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.543 HG22 ' CB ' ' A' ' 92' ' ' LEU . 15.2 t -129.98 138.91 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.003 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.599 ' CH2' HG11 ' A' ' 33' ' ' VAL . 15.6 m-90 -102.13 139.6 37.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.107 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.944 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.87 126.78 55.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -117.47 145.58 44.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.317 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.31 -173.12 40.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.892 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 5.7 mtp-105 -77.48 -1.29 29.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.474 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.81 133.58 43.38 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.691 0.281 . . . . 0.0 111.216 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.66 -9.5 26.31 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.797 2.331 . . . . 0.0 112.065 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.8 -43.02 17.18 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.842 0.83 . . . . 0.0 108.921 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.28 139.56 0.72 Allowed 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.939 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.26 -18.77 11.5 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.977 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 55.6 t80 -129.55 123.68 32.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.832 0.349 . . . . 0.0 110.769 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.407 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.7 mm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.77 0.319 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -42.3 75.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.402 ' HB3' ' HA2' ' A' ' 133' ' ' GLY . 1.0 OUTLIER -60.91 -26.52 67.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.16 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.708 HD21 HG23 ' A' ' 132' ' ' VAL . 39.7 mt -90.96 152.33 20.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -99.88 167.44 10.52 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.687 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.96 -53.83 5.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.308 0.575 . . . . 0.0 109.808 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' HG22 ' A' ' 67' ' ' THR . 9.7 mttt -117.19 82.3 1.79 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.591 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 14.0 t60 -58.65 -45.34 89.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.772 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -147.23 160.88 41.96 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.979 -0.688 . . . . 0.0 112.399 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.944 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.33 130.39 34.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 65' ' ' VAL . 51.3 mt -110.78 130.82 63.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.924 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.728 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -124.21 141.45 52.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.956 0.408 . . . . 0.0 111.607 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 33' ' ' VAL . 8.3 tt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 93' ' ' LEU . 3.2 mp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.724 0.297 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 99' ' ' LEU . 10.0 mp -132.17 141.45 49.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.944 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.645 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.74 124.16 51.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.518 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.581 ' HB2' HD21 ' A' ' 92' ' ' LEU . 65.9 t30 -117.29 132.66 56.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.105 0.478 . . . . 0.0 112.057 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.765 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.8 p30 -93.26 134.46 35.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.613 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.52 HD13 ' HG3' ' A' ' 90' ' ' GLN . 4.2 pt -136.1 26.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.531 0.205 . . . . 0.0 111.504 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.59 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.2 t -91.38 156.47 17.73 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.538 0.685 . . . . 0.0 112.539 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -69.68 -52.21 27.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.873 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -81.49 -1.02 44.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.389 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.77 158.97 30.58 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.417 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.545 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.0 m -117.54 137.72 52.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.88 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -111.95 148.54 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.608 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.05 113.32 18.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.4 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 72.1 m-20 43.9 43.64 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.37 66.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.35 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.97 118.58 37.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.467 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.88 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.7 tptm -73.93 121.17 20.55 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.551 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.8 m -92.37 163.7 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -69.91 128.44 36.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.4 tttt -53.91 161.59 1.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.314 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.3 p30 36.83 32.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.42 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 144.73 41.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.818 179.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.728 ' OD1' HD11 ' A' ' 92' ' ' LEU . 15.7 m-80 -93.9 130.54 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -129.98 152.15 49.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.34 111.68 10.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.706 HD21 ' CB ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.18 168.43 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.806 -178.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 t -124.35 153.48 41.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.236 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.28 115.64 10.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.025 0.441 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.85 18.55 78.98 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.188 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.608 ' OD2' HD13 ' A' ' 111' ' ' LEU . 10.3 t70 -59.14 179.45 0.1 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.669 0.271 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.872 ' CG ' HG22 ' A' ' 144' ' ' VAL . 11.0 mt-10 -145.23 135.7 24.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.66 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 101' ' ' LEU . 6.2 mt -112.0 128.26 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 140.51 37.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.595 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.708 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.45 158.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 83.23 31.33 28.52 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.179 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.3 t -70.21 140.37 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.688 0.756 . . . . 0.0 112.503 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.84 -43.44 0.61 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.138 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.551 HG12 ' H ' ' A' ' 138' ' ' SER . 43.7 t -126.43 131.38 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.47 -33.04 19.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.824 0.345 . . . . 0.0 111.275 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.551 ' H ' HG12 ' A' ' 136' ' ' VAL . 88.1 p -93.64 6.19 49.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.58 22.63 9.84 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.7 mt -104.6 139.6 25.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.058 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 142' ' ' SER . 4.8 tt -119.64 134.55 55.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.454 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.639 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -110.19 136.7 49.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.678 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 38' ' ' CYS . 57.9 mt -131.0 144.52 51.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.593 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.872 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.7 t -110.95 135.12 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.402 . . . . 0.0 111.381 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.795 ' N ' HD12 ' A' ' 145' ' ' ILE . 2.0 mp -106.06 123.14 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.316 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.25 106.75 15.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.504 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.645 HG12 HD22 ' A' ' 124' ' ' LEU . 6.3 mt -84.79 133.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -75.96 118.72 19.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.003 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -74.01 -30.67 62.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.41 91.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.627 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.1 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.854 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.732 0.301 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -71.1 -38.05 72.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.897 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -41.22 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -31.95 70.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.27 -35.24 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.47 -41.1 79.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.52 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -23.99 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.648 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.5 mm . . . . . 0 N--CA 1.427 -1.577 0 CA-C-O 121.566 0.698 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.043 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.78 -60.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.617 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.38 165.02 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.986 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 124.15 33.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 111.343 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.745 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.8 t -93.22 122.8 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.085 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.803 HG23 HG12 ' A' ' 45' ' ' ILE . 22.3 mt -127.34 118.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.205 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.434 ' HA ' HD23 ' A' ' 143' ' ' LEU . 12.2 t -80.04 109.81 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.428 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -80.46 -27.25 37.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.61 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.66 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.2 p -79.94 -2.61 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.669 0.271 . . . . 0.0 111.351 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.46 79.97 0.19 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.926 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.427 ' CB ' HD11 ' A' ' 141' ' ' LEU . 17.0 mt-30 -148.04 -39.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.886 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.597 HD12 HD21 ' A' ' 143' ' ' LEU . 7.5 mt -123.44 141.72 36.99 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.79 138.89 29.7 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.132 1.888 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.803 HG12 HG23 ' A' ' 37' ' ' ILE . 37.7 mt -54.9 132.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.956 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 1.5 ttt180 -126.13 164.21 21.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.051 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -117.63 119.71 35.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 111.976 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.759 HD23 ' CD2' ' A' ' 66' ' ' TRP . 5.8 mp -91.49 125.81 36.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.043 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.46 156.52 46.9 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 113.299 -1.773 . . . . 0.0 110.531 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.8 ttpt . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.711 0.291 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.718 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.8 t -125.86 139.31 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.248 0.546 . . . . 0.0 112.111 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.759 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.4 m-90 -102.32 139.14 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.054 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.679 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.53 126.78 55.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.745 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -110.47 145.66 37.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.646 -178.336 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -176.25 39.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.708 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 12.0 mtp180 -77.64 -0.93 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.7 t-20 -84.84 134.04 42.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.259 . . . . 0.0 111.029 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.6 Cg_exo -68.64 -8.09 22.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.749 2.299 . . . . 0.0 111.763 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.56 16.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.009 0.909 . . . . 0.0 108.796 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 137.32 2.99 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.507 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.53 -18.68 12.46 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.904 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.47 125.36 36.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.747 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.436 ' HB ' HD12 ' A' ' 84' ' ' LEU . 24.5 mm . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.795 0.331 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.96 -40.7 70.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.012 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -60.94 -15.88 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.227 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 132' ' ' VAL . 26.9 mt -105.97 149.59 26.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.2 p -93.97 165.21 12.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.863 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.707 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -41.66 -52.51 3.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.375 0.607 . . . . 0.0 109.818 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.06 82.16 1.88 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.0 t60 -60.62 -45.85 92.48 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.023 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 19.0 p90 -146.34 159.09 43.82 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.719 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.718 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.4 tt0 -135.53 141.66 45.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.285 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.782 HG12 HD23 ' A' ' 101' ' ' LEU . 46.7 mt -117.54 127.12 75.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.073 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.569 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -110.05 148.52 31.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.025 0.44 . . . . 0.0 111.748 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 33' ' ' VAL . 33.5 tp . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.446 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.643 HD21 ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.774 0.321 . . . . 0.0 110.868 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 122' ' ' GLN . 7.3 mt -132.03 144.01 50.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.346 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.782 HD23 HG12 ' A' ' 91' ' ' ILE . 13.5 mt -112.69 124.18 51.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.6 t30 -118.11 115.79 25.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 111.729 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.5 p30 -77.5 139.2 39.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.83 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 67' ' ' THR . 16.7 pt -146.83 39.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.72 158.51 15.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.039 0.447 . . . . 0.0 111.571 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -68.91 -38.19 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.581 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.71 -19.73 17.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.99 158.64 10.09 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.929 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.58 138.01 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.943 -0.628 . . . . 0.0 109.517 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.851 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.26 148.57 35.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.03 113.46 18.43 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.366 177.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.87 43.64 5.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.415 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.75 -10.2 70.98 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.421 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -105.08 118.6 36.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.158 0.504 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.851 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 5.4 tptt -72.25 119.19 16.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.25 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.1 m -89.95 163.87 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.0 mm-40 -69.86 125.88 28.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.0 tttp -53.35 161.34 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.832 0.348 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.9 p30 35.12 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.1 40.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.976 179.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.757 ' HB3' HD22 ' A' ' 100' ' ' LEU . 7.0 m120 -89.51 131.81 35.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.888 ' O ' HD23 ' A' ' 100' ' ' LEU . 49.9 mm-40 -129.25 148.95 51.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.517 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -72.77 135.91 45.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.52 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.883 HD21 HG12 ' A' ' 147' ' ' ILE . 35.5 tp -59.87 152.85 22.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.55 0.69 . . . . 0.0 111.515 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.41 152.83 44.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.552 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.403 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.3 120.56 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.266 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.98 23.9 57.52 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.27 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.446 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.2 t70 -52.23 167.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.006 0.432 . . . . 0.0 111.314 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 16.5 tt0 -145.22 135.62 24.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.151 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 101' ' ' LEU . 11.0 mt -113.55 128.14 70.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.562 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.63 138.98 40.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.993 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.612 HG23 HD21 ' A' ' 84' ' ' LEU . 35.3 m -140.45 158.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.13 26.85 29.9 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.318 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.1 t -66.86 140.26 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.533 0.682 . . . . 0.0 112.204 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.51 -41.54 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 138' ' ' SER . 43.8 t -126.33 134.84 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.65 -34.69 27.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.712 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.5 -6.74 46.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.1 m-20 -102.42 19.7 18.37 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.562 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.8 mt -105.73 139.33 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.353 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 142' ' ' SER . 7.4 tt -124.22 134.45 53.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.342 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.66 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -110.58 128.93 55.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.151 0.5 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.597 HD21 HD12 ' A' ' 43' ' ' ILE . 20.2 mt -122.37 134.2 54.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.847 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.92 137.57 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.443 ' CD1' HD21 ' A' ' 101' ' ' LEU . 33.6 mt -106.14 137.61 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.518 ' CD1' HD12 ' A' ' 37' ' ' ILE . 9.3 m-85 -118.78 121.96 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.503 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.883 HG12 HD21 ' A' ' 124' ' ' LEU . 4.5 mt -85.47 134.12 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -86.11 113.16 21.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.3 -29.15 70.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -57.4 -42.88 83.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.98 0.419 . . . . 0.0 110.574 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.923 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.851 0.357 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -35.94 82.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.69 -40.2 91.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.28 -41.09 92.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.6 mm -69.34 -35.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.28 -35.36 69.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.421 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -67.32 -23.78 65.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.868 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm . . . . . 0 N--CA 1.428 -1.533 0 CA-C-O 121.52 0.676 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.62 -60.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.758 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' HD22 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -150.08 165.23 33.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.25 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -129.18 138.1 51.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.88 0.372 . . . . 0.0 111.404 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.66 HG21 ' CE2' ' A' ' 68' ' ' PHE . 40.5 t -105.16 122.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.773 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -121.83 124.57 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.321 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.627 ' HA ' HD13 ' A' ' 143' ' ' LEU . 7.0 t -87.08 102.72 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.577 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -76.09 -21.18 56.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.666 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.493 HG21 ' H ' ' A' ' 142' ' ' SER . 82.3 p -79.94 -2.34 43.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.821 0.343 . . . . 0.0 111.599 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.91 74.76 0.39 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.818 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -147.49 -41.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.081 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -120.32 141.67 32.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.6 Cg_endo -72.05 140.03 33.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.135 1.89 . . . . 0.0 112.187 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.773 HG12 HG23 ' A' ' 37' ' ' ILE . 45.9 mt -56.41 144.89 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 111.797 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 164.08 30.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.916 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -122.73 119.81 31.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.443 . . . . 0.0 112.029 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 4.2 mp -85.1 129.56 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.98 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.03 155.85 49.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.231 1.015 . . . . 0.0 113.324 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.892 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.651 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.8 ttpt . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 120.808 0.337 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.691 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.7 t -133.59 139.28 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.22 0.533 . . . . 0.0 111.905 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.4 m-90 -103.21 139.21 38.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.524 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -109.95 130.79 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.822 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -120.01 145.44 46.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.02 -168.44 37.81 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 6.7 mtp-105 -81.76 1.84 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.4 t-20 -84.82 134.42 41.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.676 0.274 . . . . 0.0 111.553 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.4 Cg_exo -66.65 -13.53 40.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.747 2.298 . . . . 0.0 111.756 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -43.85 16.38 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.952 0.882 . . . . 0.0 109.05 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.56 140.17 1.34 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.593 . . . . 0.0 111.176 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 m-20 -56.35 -18.52 11.15 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.076 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.515 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.6 t80 -129.36 115.29 17.33 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 120.761 0.315 . . . . 0.0 110.697 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.474 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.788 HD12 HD11 ' A' ' 84' ' ' LEU . 26.1 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.854 0.359 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -38.19 67.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.86 -23.43 65.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 81' ' ' ILE . 30.3 mt -98.01 151.97 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.127 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 m -95.72 165.02 12.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.598 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.632 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.85 -52.78 4.95 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 109.782 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.468 ' HB2' HG22 ' A' ' 67' ' ' THR . 15.0 ptmt -119.33 81.77 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -60.21 -46.9 88.15 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.656 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.9 p90 -144.42 160.77 40.51 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.894 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.691 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.3 tt0 -136.07 142.58 44.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.24 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.784 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 63.6 mt -116.27 127.72 73.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.87 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -113.2 148.57 35.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.139 0.495 . . . . 0.0 111.645 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 33' ' ' VAL . 16.2 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.636 HD22 ' SG ' ' A' ' 34' ' ' CYS . 4.0 mp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.811 0.339 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.899 HD23 ' O ' ' A' ' 122' ' ' GLN . 3.2 mt -133.09 146.89 52.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.998 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.722 HD11 HD12 ' A' ' 145' ' ' ILE . 0.8 OUTLIER -112.69 124.97 53.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.481 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.4 t30 -115.06 115.56 27.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.781 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.9 p30 -79.53 136.78 36.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.072 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -145.98 39.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.634 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.6 152.85 19.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -68.92 -31.7 70.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.886 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.4 -19.87 17.47 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.634 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.37 157.35 10.3 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.812 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.98 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.48 148.68 40.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.868 HD12 HG11 ' A' ' 116' ' ' VAL . 1.1 mt -124.22 113.64 18.56 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.983 177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 46.95 35.82 3.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.212 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.42 -8.84 74.8 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.502 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -106.45 118.53 36.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.111 0.456 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.35 137.49 48.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.212 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.868 HG11 HD12 ' A' ' 111' ' ' LEU . 6.7 m -111.24 168.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.7 tt0 -70.18 125.91 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.615 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 41.8 tttt -53.31 162.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.998 0.428 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.88 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.14 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.41 145.12 40.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.916 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.879 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.2 m120 -86.68 133.86 33.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.994 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.899 ' O ' HD23 ' A' ' 100' ' ' LEU . 38.2 mm-40 -129.26 148.25 51.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 tp -72.66 119.78 17.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.77 HD11 HG21 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -57.49 153.67 12.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.537 0.685 . . . . 0.0 111.474 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.459 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.2 t -124.31 153.53 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.59 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 12.7 tp60 -71.54 124.16 24.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.414 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.48 21.54 49.28 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.086 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.516 ' OD2' HD23 ' A' ' 111' ' ' LEU . 11.7 t70 -56.64 172.21 0.26 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.177 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.652 ' HG3' HG22 ' A' ' 144' ' ' VAL . 17.4 tt0 -145.25 135.58 24.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.377 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.949 HD11 HD11 ' A' ' 145' ' ' ILE . 1.3 mp -110.85 128.39 67.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.341 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.727 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.0 m -104.16 137.89 41.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.968 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.7 m -140.15 158.33 25.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.71 29.88 31.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.909 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -68.52 140.3 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.753 0.787 . . . . 0.0 112.487 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.54 -44.13 0.5 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.454 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 32.3 t -126.27 140.75 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.86 -42.03 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 6.27 48.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.467 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 4.4 m-20 -112.69 21.37 15.64 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.727 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.27 139.43 29.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 142' ' ' SER . 5.4 tt -123.41 134.35 53.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.206 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.695 ' N ' HD23 ' A' ' 141' ' ' LEU . 37.4 t -112.69 150.64 31.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.607 0.718 . . . . 0.0 112.932 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.627 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.2 mm? -135.46 139.14 43.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.321 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.652 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.1 t -110.66 140.4 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.216 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.949 HD11 HD11 ' A' ' 130' ' ' ILE . 38.8 mt -105.91 127.06 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.071 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 117.65 32.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.708 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.623 HG12 HD21 ' A' ' 124' ' ' LEU . 5.8 mt -84.89 134.18 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.11 108.36 17.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.53 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.03 -30.5 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -59.66 -45.89 90.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.666 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.2 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.811 0.339 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -64.46 -45.35 87.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -60.77 -35.06 75.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.34 -44.1 92.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -67.24 -35.02 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.23 -40.04 76.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -24.37 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.956 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.706 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm . . . . . 0 N--CA 1.429 -1.514 0 CA-C-O 121.579 0.704 . . . . 0.0 112.627 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.072 HG12 HD21 ' A' ' 99' ' ' LEU . 3.0 t -92.08 -60.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.832 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.4 148.92 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.123 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.98 131.38 56.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.511 -179.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.595 HG13 HD11 ' A' ' 48' ' ' LEU . 3.6 m -97.94 122.69 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.844 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.796 HG23 HG12 ' A' ' 45' ' ' ILE . 22.3 mt -125.29 129.02 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.509 ' SG ' HD21 ' A' ' 141' ' ' LEU . 5.9 t -95.54 101.05 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.732 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -78.11 -19.08 54.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.617 HG21 ' OG ' ' A' ' 142' ' ' SER . 29.1 p -79.93 -2.88 45.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.777 0.322 . . . . 0.0 111.429 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.21 69.82 1.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.237 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB2' HD21 ' A' ' 141' ' ' LEU . 7.5 mt-30 -144.54 -35.11 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.413 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.592 HD12 HD21 ' A' ' 143' ' ' LEU . 3.6 mt -127.52 141.0 39.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.732 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.2 Cg_endo -72.49 137.49 28.03 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.166 1.911 . . . . 0.0 112.286 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.796 HG12 HG23 ' A' ' 37' ' ' ILE . 34.5 mt -55.83 141.11 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.755 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.06 164.18 27.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 m-20 -118.12 119.89 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD11 HG13 ' A' ' 36' ' ' VAL . 2.8 mt -95.39 135.74 36.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.014 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.0 158.52 43.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.511 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.9 ttpt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.687 0.279 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.707 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.0 t -126.48 139.15 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.273 0.559 . . . . 0.0 112.091 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.575 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.2 m-90 -101.09 139.38 36.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.7 130.16 55.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.806 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -119.31 145.28 46.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.72 -166.49 35.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.264 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.58 2.35 29.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.754 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.2 t-20 -84.81 132.04 47.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.54 0.21 . . . . 0.0 111.279 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.2 Cg_exo -65.46 -15.37 49.39 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.497 2.132 . . . . 0.0 111.44 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.57 -42.65 18.04 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.946 0.879 . . . . 0.0 108.833 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 139.3 1.96 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.836 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 m-20 -56.17 -18.8 11.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.922 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.552 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.66 124.95 34.9 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.65 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.941 0.4 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -39.24 68.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.517 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -21.47 63.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.357 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD22 ' CE1' ' A' ' 88' ' ' HIS . 32.8 mt -103.09 152.07 21.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 111.07 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 166.96 11.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.745 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.572 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.19 -53.48 6.5 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.416 0.626 . . . . 0.0 109.634 179.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HB2' HD12 ' A' ' 104' ' ' ILE . 1.9 mttt -118.97 82.61 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.87 -46.41 89.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.634 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.8 p90 -145.75 161.41 39.97 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.091 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.85 143.43 45.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.806 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 77.8 mt -117.62 124.2 72.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.237 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.41 147.99 26.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.533 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.949 HD22 HG11 ' A' ' 33' ' ' VAL . 27.9 tp . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.604 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.072 HD21 HG12 ' A' ' 33' ' ' VAL . 6.2 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.822 0.344 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.531 HD21 HD12 ' A' ' 145' ' ' ILE . 8.7 mp -112.81 121.51 44.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.008 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.7 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.7 t30 -116.61 115.52 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.772 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.818 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.0 p30 -78.6 139.66 38.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.001 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.6 pt -147.82 38.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.614 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.51 152.6 19.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.102 0.477 . . . . 0.0 111.834 -178.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.96 -31.52 70.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.925 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.15 -19.84 17.66 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.55 156.59 10.23 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.771 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.75 148.62 39.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.36 18.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.358 177.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 44.4 43.19 5.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -11.15 68.42 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.486 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.13 118.64 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.082 0.441 . . . . 0.0 110.667 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -72.76 129.74 38.9 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.818 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -101.47 166.73 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.453 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.93 126.48 29.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.667 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.5 tttt -53.57 163.91 0.59 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.619 0.247 . . . . 0.0 110.365 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.2 m-80 33.35 37.19 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.887 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -111.71 144.97 40.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.728 ' HB3' HD22 ' A' ' 100' ' ' LEU . 4.9 m120 -91.38 129.4 37.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.737 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.859 ' O ' HD23 ' A' ' 100' ' ' LEU . 61.5 mm-40 -128.47 149.9 50.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.437 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 124' ' ' LEU . 4.0 tt -72.65 136.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.534 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.847 HD21 HG12 ' A' ' 147' ' ' ILE . 42.6 tp -61.66 153.27 28.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.456 0.646 . . . . 0.0 111.621 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.416 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -125.32 152.66 44.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.561 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 121.73 19.58 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.54 25.6 55.54 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.02 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -51.09 168.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 111.427 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.861 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.16 135.29 23.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.865 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.7 mt -117.37 127.9 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.1 m -104.31 139.36 39.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.122 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.49 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.46 33.45 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.093 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.2 140.33 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.604 0.716 . . . . 0.0 112.266 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.04 -40.17 0.85 Allowed Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.246 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 138' ' ' SER . 49.1 t -126.5 131.13 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.62 -35.57 31.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.328 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.54 ' H ' HG12 ' A' ' 136' ' ' VAL . 12.3 p -93.59 6.38 48.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.3 t0 -120.87 22.28 11.14 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.639 ' CG2' HG22 ' A' ' 131' ' ' THR . 8.9 mt -103.69 139.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.926 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.686 HD22 ' CD2' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -121.79 134.42 54.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.64 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.11 132.0 55.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.065 0.459 . . . . 0.0 111.616 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.686 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.6 mm? -125.39 136.81 53.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.543 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.861 HG22 ' CG ' ' A' ' 129' ' ' GLU . 19.6 t -110.93 139.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.343 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.531 HD12 HD21 ' A' ' 101' ' ' LEU . 49.6 mt -106.18 132.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.166 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 117.9 31.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.345 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.847 HG12 HD21 ' A' ' 124' ' ' LEU . 5.3 mt -84.77 134.11 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -83.72 109.45 17.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.52 -31.03 67.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -60.49 -46.0 91.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.766 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.03 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.753 0.311 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -60.24 -39.06 85.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.8 -41.72 87.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.45 -31.86 69.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.39 -35.41 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.822 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.8 82.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.71 65.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.693 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm . . . . . 0 N--CA 1.429 -1.5 0 CA-C-O 121.435 0.636 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.996 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -93.83 -61.48 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.02 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.647 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -145.19 161.74 38.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.261 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.41 138.13 54.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.776 0.322 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.743 HG21 ' HE2' ' A' ' 68' ' ' PHE . 39.4 t -106.22 122.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.867 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.764 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -126.19 120.89 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.615 ' SG ' HD21 ' A' ' 141' ' ' LEU . 49.8 t -85.91 106.81 17.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.428 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.9 -22.83 58.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.89 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.525 HG21 ' H ' ' A' ' 142' ' ' SER . 61.9 p -79.9 -2.36 43.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.614 0.245 . . . . 0.0 111.544 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.38 72.99 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.975 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' CB ' HD11 ' A' ' 141' ' ' LEU . 6.1 mt-30 -143.39 -44.74 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.807 HD12 HD21 ' A' ' 143' ' ' LEU . 2.8 mt -111.78 140.93 23.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.7 Cg_endo -73.59 132.02 16.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.117 1.878 . . . . 0.0 112.051 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.764 HG12 HG23 ' A' ' 37' ' ' ILE . 35.4 mt -54.08 130.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.579 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 164.13 20.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.42 119.78 38.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.567 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 36' ' ' VAL . 8.1 mt -91.5 136.29 33.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.355 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.996 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.26 158.37 43.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.716 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.599 0.238 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.0 t -125.57 139.12 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.149 0.5 . . . . 0.0 112.252 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.617 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.6 m-90 -100.72 139.26 36.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.969 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.685 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.11 128.91 56.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.743 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -120.25 145.4 47.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.137 -178.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.83 -169.95 36.61 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.556 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.51 1.02 15.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.57 126.27 69.32 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.365 0.126 . . . . 0.0 111.005 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 23.6 Cg_exo -64.19 -14.01 41.28 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.395 2.063 . . . . 0.0 111.417 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.87 17.63 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.73 140.98 0.62 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.422 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.12 -18.78 10.82 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.736 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -129.45 131.64 46.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.543 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.641 HD12 HD11 ' A' ' 84' ' ' LEU . 19.3 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.857 0.361 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -34.8 65.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -61.88 -25.99 67.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.641 HD11 HD12 ' A' ' 81' ' ' ILE . 25.9 mt -96.03 150.4 20.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 m -93.81 166.2 12.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.399 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.555 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.54 -54.82 4.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.422 0.629 . . . . 0.0 109.675 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HB2' HG22 ' A' ' 67' ' ' THR . 16.1 ptpt -119.22 82.6 1.89 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.7 t60 -58.96 -46.02 89.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.877 -176.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.0 p90 -145.19 160.32 41.63 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.358 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.7 tt0 -135.65 144.06 45.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.954 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.591 ' C ' HG13 ' A' ' 65' ' ' VAL . 50.1 mt -118.76 125.44 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.104 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -101.58 149.39 24.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.985 0.421 . . . . 0.0 111.499 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.79 HD22 HG11 ' A' ' 33' ' ' VAL . 48.7 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.762 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.86 0.362 . . . . 0.0 110.848 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 99' ' ' LEU . 8.5 mp -133.1 143.18 49.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.756 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.699 HD21 HD11 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -112.83 121.37 44.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.864 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.685 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.2 t30 -116.51 115.55 26.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.844 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.0 p30 -78.18 139.91 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.776 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -146.23 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.62 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.85 152.13 20.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.984 0.421 . . . . 0.0 111.822 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.85 -31.51 70.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -97.67 -19.82 18.02 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.64 157.12 10.58 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.748 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.2 m -117.45 137.79 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.881 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.86 148.56 36.47 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.38 18.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.369 177.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.422 ' N ' HD12 ' A' ' 111' ' ' LEU . 21.9 m-20 43.75 43.75 5.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.528 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.91 -13.58 62.61 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.532 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -103.97 118.48 36.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.964 0.411 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.881 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.2 tptm -72.25 127.4 32.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.844 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.1 m -96.76 164.59 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' SER . 27.1 tt0 -69.89 124.55 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.584 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.4 tttt -52.82 162.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 34.51 34.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.155 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.13 40.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.138 179.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.732 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.2 m120 -88.29 129.84 35.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.8 mm-40 -129.51 148.26 51.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.9 125.57 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.149 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 145' ' ' ILE . 65.0 tp -58.08 156.41 9.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.371 0.605 . . . . 0.0 111.683 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.573 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.66 153.47 42.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.691 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.656 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.8 tp60 -71.24 122.63 20.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.31 21.67 54.31 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.764 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 31.8 t70 -49.7 168.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.993 0.425 . . . . 0.0 111.24 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 tt0 -145.03 135.45 24.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.839 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 145' ' ' ILE . 2.8 mt -115.49 127.21 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.661 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.635 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.69 138.2 41.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.876 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.7 m -140.12 158.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.8 25.77 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.954 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -70.95 140.38 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.64 0.733 . . . . 0.0 112.314 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.88 -40.08 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.312 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 47.5 t -126.4 136.18 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -50.61 -41.62 55.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.406 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.3 m -93.42 6.29 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.814 . . . . 0.0 113.196 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 9.0 t0 -117.5 24.76 10.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.635 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -105.93 139.57 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.91 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.615 HD21 ' SG ' ' A' ' 38' ' ' CYS . 5.2 tt -122.03 134.41 54.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.705 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 141' ' ' LEU . 40.0 t -110.61 150.38 29.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.695 0.76 . . . . 0.0 112.548 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.807 HD21 HD12 ' A' ' 43' ' ' ILE . 76.0 mt -135.9 146.76 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.681 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.42 140.31 43.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.742 0.306 . . . . 0.0 111.065 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 130' ' ' ILE . 47.2 mt -105.98 126.1 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.347 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.55 109.75 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.318 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.4 mp -84.89 134.14 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.021 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.45 106.78 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.35 -26.42 63.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.353 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -60.18 -46.04 91.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.152 -179.818 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.767 0.318 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -71.19 -35.82 71.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.488 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -56.88 -43.17 81.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.18 -31.85 69.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.205 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.58 HG23 ' HE2' ' A' ' 23' ' ' PHE . 13.7 mt -68.74 -47.99 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.58 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -33.61 73.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.441 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -57.47 -47.11 82.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.952 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.58 ' HE2' HG23 ' A' ' 20' ' ' ILE . 5.1 p90 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.855 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.426 -1.665 0 CA-C-O 121.842 0.829 . . . . 0.0 110.807 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.738 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.3 t -50.55 -67.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.937 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.9 p -146.79 165.32 30.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.397 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.43 124.2 37.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG13 HD11 ' A' ' 48' ' ' LEU . 3.7 m -88.94 122.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 111.192 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.858 HG23 HG12 ' A' ' 45' ' ' ILE . 19.8 mt -129.6 119.56 48.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 t -80.82 113.5 19.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.399 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 p -86.55 -23.03 25.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.798 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.654 HG21 ' OG ' ' A' ' 142' ' ' SER . 81.7 p -79.91 -2.65 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.714 0.292 . . . . 0.0 111.487 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.84 75.42 0.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.551 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' CB ' HD11 ' A' ' 141' ' ' LEU . 9.6 mt-30 -145.29 -40.49 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 111.09 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.4 mt -125.1 142.74 42.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 43' ' ' ILE . 39.1 Cg_endo -69.19 145.27 59.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.203 1.935 . . . . 0.0 112.266 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.858 HG12 HG23 ' A' ' 37' ' ' ILE . 33.3 mt -58.9 150.88 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.738 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -142.27 164.35 30.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.301 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -122.8 119.76 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 0.0 111.756 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.773 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -100.02 133.17 44.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.139 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.855 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.71 156.82 43.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' HG23 ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.828 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.575 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 10.2 ttpt . . . . . 0 N--CA 1.463 0.21 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 91' ' ' ILE . 9.7 p -110.61 139.34 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.94 139.51 36.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.437 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.683 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.71 129.48 56.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -118.11 145.27 45.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.881 0.372 . . . . 0.0 111.669 -178.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.54 -172.28 40.25 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.774 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -78.96 0.15 28.65 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.7 135.32 40.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 111.478 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.7 Cg_exo -66.37 -12.95 37.78 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.789 2.326 . . . . 0.0 111.84 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.5 -44.92 15.36 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.874 0.845 . . . . 0.0 108.965 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.15 141.87 1.12 Allowed 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.818 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.0 m-20 -56.22 -18.77 11.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.149 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.52 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 4.8 t80 -129.36 127.03 40.22 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-O 120.762 0.315 . . . . 0.0 110.693 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.278 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 84' ' ' LEU . 25.0 mt . . . . . 0 N--CA 1.46 0.052 0 CA-C-O 120.92 0.39 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -54.76 -35.8 64.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -63.6 -42.11 98.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 81' ' ' ILE . 53.3 mt -72.91 152.13 41.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -94.39 167.33 11.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.718 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -42.95 -54.82 4.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.413 0.625 . . . . 0.0 109.769 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.683 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -119.02 82.95 1.95 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 177.214 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -58.52 -46.53 86.56 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.411 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -142.41 160.26 40.62 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.794 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.662 ' HG2' HG22 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.95 142.7 44.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.919 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 65' ' ' VAL . 62.1 mt -118.83 129.36 75.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.601 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 92' ' ' LEU . 1.9 pt? -118.65 140.61 49.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.842 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.493 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.7 tp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.972 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.714 ' HB3' HD13 ' A' ' 124' ' ' LEU . 2.1 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.76 0.314 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.6 mp -129.43 142.62 50.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.138 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.5 HD11 HG12 ' A' ' 130' ' ' ILE . 1.4 tt -112.63 122.39 47.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.629 ' HB2' HD22 ' A' ' 92' ' ' LEU . 50.2 t30 -113.23 115.49 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.39 . . . . 0.0 111.402 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.761 ' OD2' HG23 ' A' ' 116' ' ' VAL . 18.0 p30 -79.96 134.37 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.875 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.1 pt -142.34 40.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.581 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 158.08 15.99 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.082 0.468 . . . . 0.0 111.435 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.83 -35.71 77.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.443 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.6 -19.8 17.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.581 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.62 161.31 11.41 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.41 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.52 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.24 148.36 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.05 113.39 18.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.086 177.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 54.1 m-20 44.99 43.02 6.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -7.05 81.28 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.569 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.61 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.704 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 22.1 tptt -75.1 125.44 28.94 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.18 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.761 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.2 m -99.65 165.95 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 120' ' ' SER . 21.9 tt0 -69.88 128.75 37.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.372 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -54.03 163.75 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.93 37.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.5 p -111.64 145.06 39.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.553 HD22 HD11 ' A' ' 92' ' ' LEU . 5.6 m120 -91.43 124.35 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -129.25 147.13 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.867 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp -72.97 113.47 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -55.35 167.39 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.643 0.735 . . . . 0.0 111.823 -179.145 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.27 153.22 43.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.476 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.59 121.48 18.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.09 22.4 62.71 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.073 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 144' ' ' VAL . 6.8 t70 -60.5 177.16 0.3 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.838 0.352 . . . . 0.0 110.919 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.0 tt0 -145.16 135.66 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.501 ' CG2' HG22 ' A' ' 109' ' ' THR . 1.5 mt -108.72 127.04 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.105 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.34 136.44 43.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.109 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.524 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.2 m -140.28 158.51 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.46 29.35 30.33 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.072 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.8 t -68.12 140.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.605 0.717 . . . . 0.0 112.406 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.42 -41.46 0.75 Allowed Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 138' ' ' SER . 47.8 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -50.55 -35.1 28.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.868 0.366 . . . . 0.0 111.331 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.54 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.5 t -93.57 6.33 48.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.466 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.4 t0 -120.2 21.9 11.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.678 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.6 mt -105.09 139.71 25.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.95 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.68 HD12 HD11 ' A' ' 81' ' ' ILE . 4.3 tt -122.34 134.4 54.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.654 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.73 133.58 53.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.086 0.47 . . . . 0.0 111.571 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 34.6 mt -126.1 133.23 51.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 128' ' ' ASP . 21.5 t -110.78 140.03 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 111.485 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 91' ' ' ILE . 9.2 mt -106.31 139.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.932 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.24 103.91 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 126' ' ' GLN . 8.7 mt -88.31 118.4 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.094 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -75.88 127.66 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.02 -21.71 64.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -44.15 85.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.016 0.436 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.0 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.732 179.832 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.762 0.315 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -40.5 85.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -38.4 90.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -40.78 96.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.627 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.0 mm -67.62 -48.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -33.65 72.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.35 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -47.14 85.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.017 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.627 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.6 p90 . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.146 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.697 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm . . . . . 0 N--CA 1.429 -1.495 0 CA-C-O 121.493 0.663 . . . . 0.0 112.601 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.007 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.65 -59.67 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.35 147.41 29.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.328 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.97 136.59 52.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.609 HG21 ' HE2' ' A' ' 68' ' ' PHE . 10.7 t -103.23 122.52 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.804 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.832 HG23 HG12 ' A' ' 45' ' ' ILE . 15.2 mt -126.59 127.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.358 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' HD21 ' A' ' 141' ' ' LEU . 8.0 t -93.31 115.67 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.596 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.4 t -88.88 -22.64 23.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.428 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.674 HG23 ' HB2' ' A' ' 142' ' ' SER . 67.4 p -79.82 -2.69 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.3 . . . . 0.0 111.48 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.54 71.82 0.83 Allowed Glycine 0 N--CA 1.454 -0.106 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.947 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.682 ' HB2' HD21 ' A' ' 141' ' ' LEU . 4.5 mt-30 -142.9 -40.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.545 HD12 HD21 ' A' ' 143' ' ' LEU . 11.7 mt -122.88 140.77 33.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.66 141.79 28.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.165 1.91 . . . . 0.0 112.076 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.832 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -53.53 149.85 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.696 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -143.32 164.18 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.316 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -122.13 119.85 32.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.068 0.461 . . . . 0.0 111.962 -179.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.2 mt -98.51 136.69 38.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.007 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.2 158.79 44.07 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.796 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.712 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.79 0.328 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.613 HG12 ' HG2' ' A' ' 90' ' ' GLN . 7.3 t -127.89 138.19 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.175 0.512 . . . . 0.0 111.739 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.523 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.1 m-90 -100.85 139.12 36.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.207 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.673 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.12 125.94 54.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -112.96 145.68 40.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.475 -178.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.67 -169.1 38.54 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.711 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.9 mtp-105 -82.56 0.73 41.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 30.5 t-20 -84.96 132.63 45.21 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.057 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.6 Cg_exo -67.67 -10.26 28.16 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 111.656 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.54 16.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.898 0.856 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.46 139.09 1.15 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.342 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.15 -18.79 11.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.794 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.491 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.8 131.99 46.36 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.127 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.572 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.443 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 28.6 mm . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.871 0.367 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 m -54.87 -43.43 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.482 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.402 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.5 mmp_? -60.78 -18.19 53.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.411 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD12 ' HB ' ' A' ' 81' ' ' ILE . 17.6 mt -103.48 147.08 27.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.882 0.372 . . . . 0.0 110.722 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m -93.56 164.74 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.765 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.82 -52.47 5.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.578 ' HB3' HG22 ' A' ' 67' ' ' THR . 8.4 mttp -120.45 82.4 1.9 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -60.46 -45.91 91.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.714 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.1 p90 -145.07 158.95 43.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.648 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.673 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.64 140.94 44.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.0 mt -117.31 132.04 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.098 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -109.98 147.11 34.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.073 0.463 . . . . 0.0 111.652 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.699 HD22 HG11 ' A' ' 33' ' ' VAL . 26.9 tp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.641 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.759 0.314 . . . . 0.0 110.962 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.641 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.5 mp -132.98 141.96 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.522 ' CD2' HD11 ' A' ' 130' ' ' ILE . 4.5 mp -112.56 127.35 56.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.155 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.5 t30 -115.89 115.58 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 111.702 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.0 p30 -77.37 135.33 38.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.676 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.0 pt -143.94 41.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.87 161.13 13.8 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.096 0.474 . . . . 0.0 111.503 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.91 -38.8 79.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.698 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.63 -19.7 17.4 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.99 161.81 11.24 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.088 -1.053 . . . . 0.0 114.01 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 17.4 m -117.6 137.87 52.32 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.224 0.61 . . . . 0.0 109.565 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.11 148.43 37.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.3 OUTLIER -124.65 113.52 18.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 47.05 42.26 12.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.0 -10.15 71.76 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.863 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.777 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -105.52 118.7 37.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.245 0.523 . . . . 0.0 110.765 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -73.13 134.43 44.46 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.349 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.825 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -107.01 166.58 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.334 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 mm-40 -69.88 123.96 22.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.553 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 75.7 tttt -52.95 163.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.513 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 36.09 33.19 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.032 -179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.35 145.08 40.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.105 179.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.78 131.94 36.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.955 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 62.0 mm-40 -129.37 151.79 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.644 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.7 tt -72.83 133.33 44.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.238 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.648 HD11 HG21 ' A' ' 145' ' ' ILE . 66.9 tp -65.15 154.85 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.512 0.672 . . . . 0.0 111.668 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.409 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.92 153.09 43.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 123.69 23.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.358 . . . . 0.0 110.106 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.43 47.4 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.173 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -51.11 172.21 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.834 0.35 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.844 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.8 mt-10 -144.87 135.56 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.028 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.522 HD11 ' CD2' ' A' ' 101' ' ' LEU . 5.5 mt -118.51 124.84 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.32 140.47 37.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.896 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.29 158.26 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.61 30.23 24.77 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.873 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.588 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.7 t -71.17 140.44 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.645 0.736 . . . . 0.0 112.385 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.4 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 154.06 -38.52 0.69 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.341 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 138' ' ' SER . 50.4 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.59 -37.03 37.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.793 0.33 . . . . 0.0 111.479 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.6 m -93.53 6.52 47.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -124.34 26.51 7.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.5 mt -105.93 139.68 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.634 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 42' ' ' GLN . 1.2 tt -120.93 134.16 55.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.069 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.674 ' HB2' HG23 ' A' ' 40' ' ' THR . 3.0 m -108.56 143.71 37.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.0 mm? -135.48 144.18 46.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.534 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.844 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.3 t -114.13 136.53 50.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.037 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.648 HG21 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -106.57 126.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.436 ' CD1' HD12 ' A' ' 37' ' ' ILE . 5.4 m-85 -112.95 121.78 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.665 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.532 HG12 HD21 ' A' ' 124' ' ' LEU . 3.5 mt -85.05 134.14 27.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.395 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.85 109.0 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -62.15 -42.44 99.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -46.02 90.8 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.3 t80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.835 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.77 0.319 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -62.84 -35.99 81.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.5 -38.65 91.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 tp -63.05 -45.05 94.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.1 mm -66.98 -34.99 73.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -40.22 76.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.987 0.422 . . . . 0.0 110.445 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -67.26 -23.84 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.53 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.198 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm . . . . . 0 N--CA 1.428 -1.561 0 CA-C-O 121.527 0.679 . . . . 0.0 112.561 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.015 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -89.92 -61.02 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.28 148.42 28.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.308 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -115.92 127.7 55.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 68' ' ' PHE . 43.5 t -97.27 122.75 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 111.02 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.908 HG23 HG12 ' A' ' 45' ' ' ILE . 12.3 mt -120.62 128.45 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.73 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.3 t -81.87 121.51 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.475 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.5 t -88.15 -27.12 22.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.634 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 142' ' ' SER . 35.4 p -79.94 -2.17 42.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.545 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 77.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.84 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -146.86 -44.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.574 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -113.54 141.51 26.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.91 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.574 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.6 Cg_endo -71.14 145.81 50.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.017 1.811 . . . . 0.0 112.037 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.908 HG12 HG23 ' A' ' 37' ' ' ILE . 39.0 mt -56.69 143.91 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.916 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.03 163.3 33.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.813 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.67 120.53 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 112.178 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.746 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.8 mp -84.7 128.3 34.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.015 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -133.48 155.92 48.69 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . . . . . . 0 C--N 1.315 -0.904 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.304 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.2 ttpt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.72 0.295 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 90' ' ' GLN . 9.6 t -131.1 139.21 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.746 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.2 m-90 -103.38 139.51 38.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.057 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.697 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.93 127.19 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.154 0.502 . . . . 0.0 110.223 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.583 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -113.6 146.26 40.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 169.61 -174.87 43.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.487 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -87.06 45.65 1.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.495 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -141.11 139.07 18.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.27 -6.48 17.49 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.875 2.383 . . . . 0.0 111.904 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.33 11.14 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.88 0.848 . . . . 0.0 109.279 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.95 141.81 1.05 Allowed 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.96 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.41 -19.27 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.966 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 44.8 t80 -129.89 122.68 29.11 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.797 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.793 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.827 0.346 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.5 p -55.21 -34.65 64.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.86 -23.26 65.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.206 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 132' ' ' VAL . 14.5 mt -97.49 147.73 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 111.084 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.17 164.75 12.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.998 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.639 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.44 -52.05 4.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.447 0.641 . . . . 0.0 109.847 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -120.51 79.92 1.55 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.5 t60 -60.87 -47.23 87.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.538 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 17.5 p90 -146.48 159.07 43.89 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.552 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.84 141.2 44.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.656 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 65' ' ' VAL . 37.2 mt -115.48 130.51 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.075 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.954 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -122.39 139.21 54.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.047 0.451 . . . . 0.0 111.839 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.809 HD22 ' CG1' ' A' ' 33' ' ' VAL . 4.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.967 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.851 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.876 0.37 . . . . 0.0 110.777 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.659 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -123.18 139.38 54.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -112.8 120.06 40.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.981 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.954 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.7 t30 -116.82 119.97 37.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.402 . . . . 0.0 112.057 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.829 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.3 p30 -79.87 141.0 36.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.982 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -147.06 36.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.428 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.651 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.53 149.81 21.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.128 0.489 . . . . 0.0 112.043 -178.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.0 m -68.62 -31.55 70.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.682 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -97.18 -19.75 18.41 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.652 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.651 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.12 156.15 10.42 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.604 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.9 m -117.45 137.81 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.876 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.31 148.62 37.24 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.35 18.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.452 177.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 5.5 m-80 43.43 43.74 4.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.499 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.3 -13.71 62.9 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.418 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -103.38 118.54 36.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.027 0.442 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.876 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.6 tptm -72.66 127.6 33.05 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.829 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.0 m -97.89 162.95 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.6 tt0 -69.99 126.9 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.489 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.655 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttm -52.09 160.79 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 35.75 33.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.41 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 118.04 34.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.106 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.912 ' ND2' HD11 ' A' ' 92' ' ' LEU . 14.3 m120 -66.01 135.16 54.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 33.1 mm-40 -129.48 151.14 50.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.8 tm? -72.77 132.71 43.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' A' ' 99' ' ' LEU . 44.0 tp -58.1 152.56 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.713 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.42 152.63 44.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.645 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -72.51 123.35 22.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.253 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.31 23.42 41.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.085 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.7 t70 -49.12 167.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.015 0.436 . . . . 0.0 111.429 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.909 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.4 mt-10 -144.8 135.44 24.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.007 HD11 HD11 ' A' ' 145' ' ' ILE . 1.1 mp -117.35 127.81 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.748 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.624 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.67 138.12 41.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.933 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 84' ' ' LEU . 34.8 m -140.31 158.06 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 30.93 25.2 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.811 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -70.83 140.41 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 112.452 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.48 -41.0 0.47 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 138' ' ' SER . 49.2 t -126.47 134.74 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 115.1 -0.55 . . . . 0.0 109.519 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -38.67 48.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.781 0.325 . . . . 0.0 111.467 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.496 ' H ' HG12 ' A' ' 136' ' ' VAL . 57.9 m -93.42 6.32 48.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.9 t0 -121.36 26.95 8.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.1 139.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.948 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 134.43 55.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.611 ' C ' HD22 ' A' ' 143' ' ' LEU . 47.3 t -112.11 150.78 30.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.518 0.675 . . . . 0.0 112.282 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -135.62 155.53 50.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.909 HG22 ' CG ' ' A' ' 129' ' ' GLU . 19.2 t -125.6 140.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.825 0.345 . . . . 0.0 111.431 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.007 HD11 HD11 ' A' ' 130' ' ' ILE . 34.0 mt -106.46 123.08 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.165 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.524 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -109.98 116.83 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.763 HG12 HD21 ' A' ' 124' ' ' LEU . 4.4 mt -86.27 134.21 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.608 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.78 122.91 27.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.649 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.28 -36.82 77.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -59.12 -45.37 91.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 110.719 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.9 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.904 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.8 0.333 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.4 36.92 1.89 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.811 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.95 -43.89 94.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.617 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -35.68 74.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.81 -42.38 79.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -32.46 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.687 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.16 -35.39 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.808 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -57.26 -39.18 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 110.434 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -67.09 -24.05 65.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.721 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.66 -47.47 79.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.233 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.4 p -66.9 -28.07 68.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 64.48 -174.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.83 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.93 127.78 32.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.51 120.12 25.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.816 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mm -83.12 138.34 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.679 0.752 . . . . 0.0 111.873 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . 115.63 25.35 3.73 Favored Glycine 0 C--N 1.314 -0.657 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.556 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.12 -23.64 22.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.69 0.281 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.87 -23.8 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.298 0.571 . . . . 0.0 110.977 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.771 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -70.05 101.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.601 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.077 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.4 t -58.02 -66.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.193 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.749 ' SG ' HG23 ' A' ' 147' ' ' ILE . 91.1 m -152.23 165.13 35.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.836 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -125.86 138.03 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.072 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.751 HG23 HD11 ' A' ' 48' ' ' LEU . 21.7 t -102.57 123.81 56.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.827 0.346 . . . . 0.0 111.34 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.768 HG23 HG12 ' A' ' 45' ' ' ILE . 11.4 mt -123.14 124.94 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.483 ' HA ' HD23 ' A' ' 143' ' ' LEU . 42.1 t -81.71 123.04 28.39 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.1 t -86.72 -28.92 22.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 142' ' ' SER . 36.8 p -79.91 -2.13 42.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.688 0.28 . . . . 0.0 111.552 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.75 77.0 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.422 ' NE2' HD12 ' A' ' 141' ' ' LEU . 8.0 mt-30 -145.36 -43.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.885 HD12 HD21 ' A' ' 143' ' ' LEU . 3.0 mt -111.35 140.85 23.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.3 Cg_endo -72.52 131.43 17.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.127 1.884 . . . . 0.0 111.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.768 HG12 HG23 ' A' ' 37' ' ' ILE . 32.6 mt -51.84 131.56 13.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.659 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.87 164.21 19.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.251 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -117.84 120.1 36.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 111.536 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.751 HD11 HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -97.64 134.87 40.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.426 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.864 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.79 157.25 43.63 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -143.03 142.11 31.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.74 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -74.98 133.3 41.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.154 0.502 . . . . 0.0 111.265 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.725 HD13 ' SG ' ' A' ' 154' ' ' CYS . 88.6 mt -64.58 -44.8 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.072 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.3 m -56.88 -39.39 74.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.35 0.595 . . . . 0.0 110.724 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.444 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 6.5 mm100 -68.55 -36.78 79.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.616 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.7 t -69.79 -43.77 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.066 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 tp -70.88 -32.11 68.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -30.95 65.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.996 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.17 116.85 27.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -114.95 31.71 6.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.712 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 60' ' ' ARG . 5.1 mtm105 -168.0 148.35 4.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.734 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.27 -165.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.766 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.535 HG21 HG22 ' A' ' 65' ' ' VAL . 40.5 mm -91.21 156.29 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.15 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' HG2' HG13 ' A' ' 55' ' ' VAL . 6.5 mptt -90.41 -63.85 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.6 ttpt -145.33 132.92 20.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.659 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.5 t -124.87 139.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 111.983 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.574 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 17.7 m-90 -100.9 139.23 36.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.435 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.92 128.45 56.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.25 145.52 43.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.624 -177.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.76 -169.61 40.82 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.722 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 3.4 mtp-105 -83.25 -1.62 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.76 136.22 39.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 111.602 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.1 Cg_exo -67.44 -10.57 29.15 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.843 2.362 . . . . 0.0 111.979 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.414 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.55 -44.47 15.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.84 0.829 . . . . 0.0 109.02 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.78 139.31 2.33 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.754 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.42 -18.21 10.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.955 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 6.0 t80 -129.18 118.67 22.77 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.551 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 -88.79 118.84 28.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.148 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.586 HD13 ' CA ' ' A' ' 69' ' ' GLY . 8.5 mp -89.99 -177.17 5.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.578 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.03 -82.55 0.38 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.275 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.4 p30 176.32 68.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 110.702 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp -107.49 112.9 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.413 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.7 m -54.79 -34.94 63.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.067 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -26.63 67.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 81' ' ' ILE . 33.1 mt -91.63 152.18 20.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.038 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -93.64 167.25 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -42.95 -54.12 4.39 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.374 0.607 . . . . 0.0 109.77 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -119.65 82.98 1.97 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.2 -46.25 88.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.836 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.5 p90 -143.57 159.84 41.71 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.13 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.687 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.7 tt0 -135.77 143.05 45.05 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.385 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.586 ' C ' HG13 ' A' ' 65' ' ' VAL . 49.6 mt -118.69 127.86 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.973 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.641 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -114.11 141.81 47.01 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.989 0.423 . . . . 0.0 111.956 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 33' ' ' VAL . 7.5 tp -125.22 122.88 38.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.229 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.93 -129.42 1.79 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.59 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 62.7 -79.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.702 0.286 . . . . 0.0 110.852 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.26 -41.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.91 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 179.41 -33.85 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -63.73 -174.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.632 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -115.65 156.96 24.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.002 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.0 mm? -130.31 145.41 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.316 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.77 121.37 44.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.888 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.641 ' HB2' HD23 ' A' ' 92' ' ' LEU . 49.6 t30 -116.81 115.66 25.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.105 0.479 . . . . 0.0 111.789 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.849 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.7 p30 -78.96 136.62 37.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.751 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.8 pt -144.26 39.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.628 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.65 152.63 19.85 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.157 0.504 . . . . 0.0 111.956 -179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.0 m -68.79 -31.57 70.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.809 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.07 -19.97 17.64 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.628 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.53 157.04 10.58 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.695 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.38 137.71 52.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -116.04 148.56 40.06 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.57 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.556 177.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.39 43.64 6.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.96 -13.16 61.93 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.435 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.26 118.53 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.082 0.467 . . . . 0.0 110.465 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.66 129.26 38.26 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.52 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.849 HG23 ' OD2' ' A' ' 103' ' ' ASP . 17.4 m -97.84 163.45 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.91 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 120' ' ' SER . 0.9 OUTLIER -69.71 125.34 26.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.487 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.1 tttt -52.25 161.27 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.755 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.19 34.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.21 145.03 40.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.145 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.602 HD22 HD21 ' A' ' 92' ' ' LEU . 18.3 m120 -85.69 129.13 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.758 ' O ' HD13 ' A' ' 100' ' ' LEU . 31.2 mm-40 -129.09 146.23 51.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.548 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.6 tm? -72.75 111.97 8.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.246 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.712 HD11 HG21 ' A' ' 145' ' ' ILE . 66.0 tp -50.66 157.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.397 0.618 . . . . 0.0 111.646 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.4 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.8 OUTLIER -124.45 153.13 42.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.6 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.668 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.73 124.75 25.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.219 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.83 20.91 50.02 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.3 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.4 t70 -55.79 174.96 0.1 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 110.849 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.934 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.6 mt-10 -145.04 135.7 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.316 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 145' ' ' ILE . 5.6 mt -111.59 126.99 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.624 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.65 137.23 42.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.944 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.637 HG23 HD21 ' A' ' 84' ' ' LEU . 34.8 m -140.47 158.32 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.29 22.81 42.87 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.324 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 140' ' ' ILE . 73.4 t -62.62 140.33 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.663 0.744 . . . . 0.0 112.388 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.64 -43.98 0.57 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.211 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.47 138.32 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -38.42 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.71 0.291 . . . . 0.0 111.584 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.449 ' H ' HG12 ' A' ' 136' ' ' VAL . 7.9 t -93.55 6.2 49.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' A' ' 133' ' ' GLY . 3.2 m-20 -116.31 22.52 12.8 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.06 139.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.22 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 142' ' ' SER . 9.2 tt -124.48 134.27 53.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.243 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.507 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.9 t -111.28 150.54 29.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.716 0.769 . . . . 0.0 112.211 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.885 HD21 HD12 ' A' ' 43' ' ' ILE . 66.8 mt -135.38 156.57 48.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.67 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.934 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.9 t -125.68 137.54 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.847 0.356 . . . . 0.0 111.08 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 130' ' ' ILE . 36.5 mt -106.48 120.96 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.01 122.39 46.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.749 HG23 ' SG ' ' A' ' 34' ' ' CYS . 3.4 mp -112.91 134.14 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.482 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.434 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 28.7 p30 -93.52 135.46 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -74.02 -21.34 60.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -58.22 -44.23 88.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -58.37 -44.02 88.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.753 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -33.95 76.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -60.5 -47.0 88.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.725 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.4 t -59.79 -45.96 90.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.972 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -60.19 -46.01 91.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.755 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -67.74 -43.76 79.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.824 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -22.15 66.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.091 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -125.09 98.43 5.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.895 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -85.67 150.41 24.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 160' ' ' VAL . 10.2 m -73.19 132.74 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.156 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.03 159.38 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.72 77.9 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 pp -81.61 136.65 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.972 179.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 14.3 mttt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.872 0.368 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.99 113.01 3.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.82 176.6 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 1.3 m -92.57 148.55 21.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -65.71 163.17 17.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -101.95 -60.65 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.69 90.47 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.43 2.087 . . . . 0.0 112.286 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 38.5 m -81.06 123.15 28.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.11 126.92 85.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.47 106.99 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.303 2.002 . . . . 0.0 112.264 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 3.5 pp -173.42 -179.37 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.955 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.87 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.886 0.374 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.7 p -103.92 -53.16 2.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -67.79 -43.48 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -42.58 99.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -38.62 74.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.555 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 19' ' ' LEU . 13.8 tp -58.1 -31.94 67.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.49 -35.54 51.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.726 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.67 -36.18 71.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.309 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.888 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.56 -47.45 79.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.217 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -30.78 71.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -74.02 154.75 39.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -101.02 158.04 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -82.84 137.96 34.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.65 138.57 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.547 0.689 . . . . 0.0 111.836 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -68.82 64.37 0.47 Allowed Glycine 0 C--N 1.315 -0.584 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.34 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -42.38 99.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.591 0.234 . . . . 0.0 111.401 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.6 m-20 179.68 39.75 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -71.47 142.42 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.284 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.685 ' CG2' ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.43 -50.48 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.974 -178.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -163.11 146.17 10.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.204 179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -113.88 131.45 56.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 111.286 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 ' HE2' ' A' ' 68' ' ' PHE . 28.7 t -97.8 122.79 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.941 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 25.3 mt -123.34 119.56 57.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.269 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.643 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.5 t -80.48 121.05 25.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.451 ' CG2' HG21 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -91.23 -27.72 18.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.422 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.663 HG23 ' HB2' ' A' ' 142' ' ' SER . 69.2 p -80.31 -2.96 47.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.686 0.279 . . . . 0.0 111.556 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.86 80.74 0.2 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.375 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.777 ' OE1' HD13 ' A' ' 141' ' ' LEU . 15.2 mt-30 -149.62 -45.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.938 0.399 . . . . 0.0 110.862 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.882 HD13 HD22 ' A' ' 78' ' ' LEU . 3.8 mt -115.02 141.16 26.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.958 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.68 139.81 28.52 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.169 1.913 . . . . 0.0 112.125 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -55.23 135.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.725 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -134.37 164.02 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.209 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.2 119.72 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 36' ' ' VAL . 5.7 mt -90.6 137.49 32.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.618 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.44 157.37 45.24 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.685 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -149.98 141.91 23.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.3 -1.773 . . . . 0.0 110.497 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.823 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -81.09 133.17 35.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.264 0.554 . . . . 0.0 111.197 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.759 HD13 ' SG ' ' A' ' 154' ' ' CYS . 44.1 mt -64.86 -43.13 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.542 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.6 m -58.44 -42.73 87.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.623 -177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 3.7 pt20 -68.43 -36.87 79.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.563 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.7 t -68.05 -47.48 78.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.29 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -29.56 69.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.156 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -44.39 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.007 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.96 131.56 49.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.7 53.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.36 -174.86 2.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.853 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -59.64 -32.68 70.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.571 HD13 HD12 ' A' ' 92' ' ' LEU . 8.5 tp -152.55 159.69 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.161 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.758 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -102.1 -72.9 0.67 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -130.27 132.2 45.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.413 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.4 t -129.95 139.61 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.293 0.568 . . . . 0.0 111.809 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.559 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.3 m-90 -100.24 139.68 35.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.146 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -109.23 131.94 54.59 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -118.81 145.59 45.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.002 0.429 . . . . 0.0 111.624 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.74 -174.43 41.44 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.554 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 5.6 mtm105 -81.52 -0.78 43.54 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.77 135.66 40.02 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.666 0.269 . . . . 0.0 111.273 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.52 -7.53 20.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.728 2.285 . . . . 0.0 111.876 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.74 -44.42 15.63 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.977 0.894 . . . . 0.0 108.936 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.73 137.33 5.46 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.646 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.45 -18.81 12.52 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.853 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.3 t80 -129.86 117.25 19.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.887 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -90.66 107.73 19.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.496 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.882 HD22 HD13 ' A' ' 43' ' ' ILE . 51.7 mt -78.93 -71.63 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.164 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.38 -100.9 0.14 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.1 p30 -175.32 47.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.33 . . . . 0.0 111.225 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 84' ' ' LEU . 31.5 mt -80.77 126.14 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.916 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.94 -43.17 73.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.343 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -44.15 97.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.284 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.654 ' CD1' HD12 ' A' ' 81' ' ' ILE . 46.5 mt -72.77 152.18 41.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.188 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 60.5 p -95.49 165.5 12.32 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.741 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.39 -53.01 5.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.344 0.593 . . . . 0.0 109.627 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.6 ' HB3' HG22 ' A' ' 67' ' ' THR . 17.1 mttt -119.69 84.57 2.23 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -63.99 -45.27 89.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.095 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' HA ' HG12 ' A' ' 104' ' ' ILE . 37.6 p90 -150.99 162.39 40.92 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.155 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.691 ' CD ' HG23 ' A' ' 67' ' ' THR . 11.6 mt-30 -135.49 158.27 44.8 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.378 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.53 ' O ' HG13 ' A' ' 65' ' ' VAL . 64.2 mt -127.45 132.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.957 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.776 ' CD1' HD13 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -113.72 144.46 42.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.073 0.463 . . . . 0.0 111.731 -179.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.605 ' C ' HD13 ' A' ' 93' ' ' LEU . 3.2 tm? -119.71 123.14 43.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.521 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.55 -120.95 0.77 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.379 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 56.27 -176.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 111.078 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -47.95 58.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.861 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.483 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -156.56 55.95 0.39 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.509 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -177.24 -176.44 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.727 0.299 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.073 HD11 HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -128.47 160.44 32.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.047 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.776 HD13 ' CD1' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.55 149.44 50.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.506 -179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.872 HD21 HD12 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -110.52 131.59 54.92 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' HD22 ' A' ' 92' ' ' LEU . 46.9 t30 -113.28 115.92 28.93 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.849 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.1 p30 -76.65 143.06 40.37 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 87' ' ' LYS . 10.0 pt -150.75 37.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.06 158.82 15.25 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.047 0.451 . . . . 0.0 111.807 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.9 m -68.92 -35.31 76.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.587 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.51 -20.04 17.3 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.538 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.33 163.36 11.96 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.488 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 20.8 m -117.53 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.842 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -114.36 148.4 37.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.17 113.43 18.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.281 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 43.72 43.4 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.48 -12.43 66.84 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.482 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -104.96 118.53 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.067 0.461 . . . . 0.0 110.642 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -72.19 134.9 45.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.501 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.849 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -105.01 164.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 6.4 tp10 -69.95 125.07 25.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.6 tttt -51.82 160.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.964 0.411 . . . . 0.0 110.836 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 35.89 33.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.54 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.57 145.09 40.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 179.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -86.81 129.79 34.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.931 0.396 . . . . 0.0 110.789 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.6 mm-40 -127.53 147.74 50.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.409 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.58 120.95 18.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.905 0.383 . . . . 0.0 110.539 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.073 HD22 HD11 ' A' ' 99' ' ' LEU . 5.9 tp -58.89 155.94 12.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.435 0.636 . . . . 0.0 111.486 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.573 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.3 t -124.25 153.43 41.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.342 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 6.5 tp60 -71.41 123.99 23.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 0.0 110.577 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.28 22.17 42.99 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.276 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.7 t70 -58.14 174.56 0.27 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -145.2 135.46 24.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.146 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.437 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.0 mt -111.59 128.39 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.261 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.663 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.08 138.85 40.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.543 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 30.3 m -140.15 158.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.89 22.37 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.85 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.579 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -73.32 140.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-O 121.598 0.713 . . . . 0.0 112.442 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.37 -39.87 0.7 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 138' ' ' SER . 52.0 t -126.59 128.62 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.48 -34.68 25.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 136' ' ' VAL . 87.4 p -93.54 6.3 48.69 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 7.5 t0 -124.18 24.85 8.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.663 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.9 mt -104.78 139.61 25.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.823 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.777 HD13 ' OE1' ' A' ' 42' ' ' GLN . 25.3 tp -117.54 134.75 54.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.956 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.663 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.8 OUTLIER -111.54 135.47 52.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.547 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.643 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.9 mm? -131.04 138.48 49.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.706 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 39' ' ' THR . 21.4 t -110.84 138.7 37.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.339 . . . . 0.0 110.927 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.671 HG21 HD11 ' A' ' 124' ' ' LEU . 6.6 mt -106.26 139.01 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -119.9 119.88 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.442 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.762 HG12 HD21 ' A' ' 124' ' ' LEU . 3.4 mt -85.62 134.17 27.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.553 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.55 107.48 13.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -58.21 -32.18 68.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -60.25 -45.92 91.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.43 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -59.64 -44.09 93.63 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.074 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -35.13 79.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.023 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -40.73 92.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.125 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.759 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.2 t -66.62 -45.09 80.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.951 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.483 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -65.75 -35.99 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.02 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.28 -39.37 93.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.018 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -86.72 -36.39 18.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.67 39.87 1.8 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.508 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.43 147.78 38.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.824 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.5 m -71.8 136.97 24.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -172.4 134.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.7 103.16 15.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.57 131.57 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.125 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 2.8 mttp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.787 0.327 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 13.3 mttm 62.11 150.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 5.1 mmt -147.29 -47.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . 0.414 ' O ' ' N ' ' B' ' 170' ' ' GLN . 2.6 m 62.06 116.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 66.53 -68.93 0.13 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.916 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' B' ' 168' ' ' THR . 2.8 tt0 64.43 48.85 2.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.982 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.75 125.6 14.66 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.583 2.189 . . . . 0.0 112.472 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 21.2 p -89.04 -55.13 3.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.992 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.8 108.36 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.57 154.24 71.99 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.424 2.083 . . . . 0.0 112.231 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mt 59.77 179.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.823 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.906 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.622 ' HB1' ' HB2' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.812 0.339 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.1 p -69.32 -50.07 49.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.45 -40.43 91.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.622 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -68.61 -42.62 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.924 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.65 -38.08 74.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.69 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -31.81 70.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.8 mt -73.19 -35.54 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.876 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.49 -39.96 77.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 0.0 110.475 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -67.1 -23.87 65.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.775 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -56.7 -47.49 79.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.268 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 p -67.04 -37.29 83.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.79 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.47 81.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.989 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -99.94 125.33 45.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.67 101.85 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.1 mm -87.69 138.27 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-O 121.728 0.775 . . . . 0.0 111.737 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 126.33 99.24 1.12 Allowed Glycine 0 C--N 1.315 -0.615 0 CA-C-N 114.458 -1.247 . . . . 0.0 112.526 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.16 -39.57 13.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.74 0.305 . . . . 0.0 110.995 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -171.4 34.03 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.4 mm -72.58 135.76 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.575 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.006 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -93.53 -59.46 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.643 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.68 ' SG ' HD13 ' A' ' 99' ' ' LEU . 4.7 m -152.81 150.48 29.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.383 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -115.18 131.71 56.84 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.777 0.322 . . . . 0.0 111.248 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.746 HG21 ' HE2' ' A' ' 68' ' ' PHE . 43.8 t -96.18 122.9 48.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.053 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.839 HG23 HG12 ' A' ' 45' ' ' ILE . 16.5 mt -124.01 121.38 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.661 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.5 t -82.04 121.65 26.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.459 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.58 -25.1 16.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.501 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.599 HG21 ' OG ' ' A' ' 142' ' ' SER . 5.9 p -80.04 -2.38 44.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.663 0.268 . . . . 0.0 111.386 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 66.09 78.98 0.21 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.851 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 15.5 mt-30 -149.38 -40.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.992 HD13 HD22 ' A' ' 78' ' ' LEU . 9.2 mt -124.2 141.68 37.95 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.8 Cg_endo -72.97 146.13 41.24 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.193 1.928 . . . . 0.0 112.12 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.839 HG12 HG23 ' A' ' 37' ' ' ILE . 33.8 mt -60.3 146.32 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.647 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 1.5 ttt180 -140.31 163.23 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.07 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.29 119.8 36.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.022 0.439 . . . . 0.0 111.843 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.619 HD11 HG23 ' A' ' 36' ' ' VAL . 4.6 mt -93.25 137.42 32.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.273 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.006 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.39 157.32 43.76 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.29 141.89 27.76 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.854 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.893 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.1 m-20 -77.78 129.82 35.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.101 0.476 . . . . 0.0 111.023 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 52' ' ' ILE . 3.8 mp -64.39 -45.02 97.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.531 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -57.0 -42.1 79.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.398 0.618 . . . . 0.0 110.914 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 5.5 mt-30 -68.51 -37.07 79.74 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.977 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.7 t -68.79 -49.17 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.017 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -29.17 68.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -74.36 -39.37 62.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.91 135.84 40.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.0 31.25 6.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.5 mtt-85 -101.84 -176.98 3.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.84 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -79.54 -24.01 42.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.412 ' CG1' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -131.71 137.35 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.756 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -109.23 -61.77 1.58 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 49' ' ' SER . 8.6 ttpt -136.0 116.47 13.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.227 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.749 HG22 ' HG2' ' A' ' 90' ' ' GLN . 13.9 p -110.44 140.23 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.568 ' HH2' HG21 ' A' ' 33' ' ' VAL . 13.5 m-90 -100.22 139.22 36.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.852 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.85 128.74 56.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.746 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -116.61 145.63 43.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.353 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.37 -170.0 39.38 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.788 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.9 mtp-105 -81.22 1.17 33.38 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 140.32 37.92 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.661 0.267 . . . . 0.0 110.903 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.27 -11.69 22.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.511 2.141 . . . . 0.0 111.354 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -42.7 18.25 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.12 138.31 3.01 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.317 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.36 -18.53 11.21 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.874 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.498 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 3.7 t80 -129.54 127.97 41.82 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.713 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.55 107.98 19.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.751 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.992 HD22 HD13 ' A' ' 43' ' ' ILE . 27.4 mt -77.49 -72.64 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.362 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.02 -96.31 0.1 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.363 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -173.62 51.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.801 0.334 . . . . 0.0 111.345 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.858 HD12 HD11 ' A' ' 84' ' ' LEU . 41.1 mt -90.33 121.16 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.612 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -54.55 -35.63 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.279 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.48 HH11 HG23 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -61.03 -45.65 93.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.834 0.349 . . . . 0.0 110.699 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.858 HD11 HD12 ' A' ' 81' ' ' ILE . 16.1 mt -75.32 148.29 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -93.7 167.13 11.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.54 -53.62 4.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.393 0.616 . . . . 0.0 109.834 179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.38 82.71 1.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.4 t60 -58.8 -46.26 88.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.772 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.7 p90 -144.7 162.19 37.32 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.099 -0.641 . . . . 0.0 112.121 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 65' ' ' VAL . 2.8 tt0 -135.59 146.79 48.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.09 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 65' ' ' VAL . 64.8 mt -123.14 130.42 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.506 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.483 HD11 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -124.99 141.03 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.222 0.534 . . . . 0.0 112.188 -179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.406 HD13 ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.13 123.12 39.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.778 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -136.63 -140.28 4.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.074 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.47 -168.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 111.264 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t70 73.53 -62.29 0.47 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.002 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 132.8 -32.38 2.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.349 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.08 -176.51 5.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.762 0.315 . . . . 0.0 110.754 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.868 HD11 HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -107.19 154.74 20.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.8 mp -121.4 142.46 49.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.31 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.561 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -112.71 124.13 51.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.478 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' HB2' HD21 ' A' ' 92' ' ' LEU . 51.2 t30 -116.05 115.51 26.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.493 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.5 p30 -79.16 137.7 37.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.0 pt -146.61 40.67 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.85 160.18 14.51 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 120.971 0.415 . . . . 0.0 111.681 -178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.452 HG22 ' HB ' ' B' ' 173' ' ' THR . 88.3 m -68.94 -36.44 77.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.46 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.94 17.26 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.52 163.94 12.29 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.581 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.2 m -117.51 137.89 52.25 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.828 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -113.94 148.46 36.8 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.11 113.43 18.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.039 177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 45.09 42.39 6.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.265 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.78 -7.98 79.29 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.499 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.05 118.47 36.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.174 0.487 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.828 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -73.14 129.76 38.77 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.297 -179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -101.8 166.71 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.272 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 120' ' ' SER . 2.8 tp10 -70.02 126.17 28.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 56.3 tttt -52.78 162.65 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.227 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.91 36.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.066 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.0 p -111.84 145.0 40.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.547 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.503 ' HB3' HD23 ' A' ' 100' ' ' LEU . 23.1 m120 -91.93 129.51 37.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.888 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 61.0 mm-40 -129.02 149.84 50.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.5 tm? -72.91 123.46 23.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.456 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.641 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.6 tt -57.67 155.72 9.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.415 0.626 . . . . 0.0 111.446 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.59 152.92 42.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.459 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.618 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.85 125.52 27.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.05 22.88 44.29 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.193 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -56.34 173.4 0.17 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.042 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.93 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -145.02 135.46 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.073 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 145' ' ' ILE . 4.0 mt -114.16 127.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-O 120.893 0.377 . . . . 0.0 110.377 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.703 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.45 136.53 43.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.825 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.554 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 31.4 m -140.3 158.39 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 24.57 41.65 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.28 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.2 t -63.25 140.4 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.72 0.771 . . . . 0.0 112.462 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.67 -44.17 0.54 Allowed Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.353 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.48 HG23 HH11 ' A' ' 83' ' ' ARG . 45.5 t -126.37 137.87 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -50.75 -38.13 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.59 6.31 48.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 74.0 m-20 -117.25 22.97 12.14 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.703 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.2 mt -107.11 139.63 28.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.175 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.546 ' CD2' HD13 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -119.53 134.49 55.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.674 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.599 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -114.29 131.6 56.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.584 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.546 HD13 ' CD2' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -127.01 142.79 51.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.892 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.93 HG22 ' CG ' ' A' ' 129' ' ' GLU . 11.3 t -111.0 140.32 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.088 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 130' ' ' ILE . 38.5 mt -105.85 120.88 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-O 121.069 0.461 . . . . 0.0 111.001 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.98 122.68 45.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.682 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 126' ' ' GLN . 3.1 mp -98.51 121.28 48.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.982 0.42 . . . . 0.0 111.376 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.451 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 10.5 p30 -82.92 135.79 34.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.1 -20.2 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.183 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -57.47 -43.74 84.29 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.996 0.427 . . . . 0.0 110.623 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -59.26 -43.97 92.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.678 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -65.13 -33.96 77.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.5 -45.09 95.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -67.22 -43.6 81.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.909 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -35.81 78.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -60.61 -43.4 97.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.755 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' LYS . 42.8 mt-30 -84.83 -30.04 24.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.52 -90.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.626 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 157' ' ' GLN . 6.9 tptt -100.43 134.99 42.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.4 p -96.8 132.06 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.082 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 60.61 93.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -155.86 73.27 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.802 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pt -105.05 114.25 44.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.171 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.837 0.351 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 62.16 149.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 9.6 mtm -68.22 173.69 4.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.964 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 9.4 t -152.51 159.43 43.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -110.2 118.32 36.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.14 -29.98 31.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . 0.404 ' HA ' ' HD2' ' B' ' 172' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' B' ' 171' ' ' TPO . 33.3 Cg_endo -64.5 144.22 84.39 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.441 2.094 . . . . 0.0 112.197 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.452 ' HB ' HG22 ' A' ' 106' ' ' THR . 3.6 t -117.49 42.13 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.946 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . 0.609 ' O ' HD12 ' B' ' 176' ' ' LEU . 4.4 t0 59.49 90.27 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.86 117.48 5.05 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.558 2.172 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . 0.609 HD12 ' O ' ' B' ' 174' ' ' ASP . 1.1 mp -143.73 158.05 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.815 0.34 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 t -167.87 -43.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.952 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -60.39 -36.51 78.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -60.0 -40.35 88.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -36.02 82.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -41.39 93.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -69.23 -35.08 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.26 -36.81 71.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.909 0.385 . . . . 0.0 110.455 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.24 -23.78 65.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.738 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.81 -47.52 80.05 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.149 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.84 -27.3 36.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.049 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 64.66 162.84 0.13 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.88 128.28 42.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -70.63 131.74 44.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.0 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.613 0.721 . . . . 0.0 111.698 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.28 102.87 0.92 Allowed Glycine 0 C--N 1.313 -0.709 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.439 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.02 -31.29 56.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 0.0 110.957 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 176.9 38.73 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.71 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.58 135.78 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-N 113.631 -1.622 . . . . 0.0 112.336 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.981 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -92.3 -60.76 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.667 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 48' ' ' LEU . 1.8 p -145.12 157.4 44.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.904 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.869 0.366 . . . . 0.0 111.472 -179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.7 HG11 ' CE2' ' A' ' 68' ' ' PHE . 30.7 m -104.18 122.64 57.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.627 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.841 HG23 HG12 ' A' ' 45' ' ' ILE . 19.5 mt -129.49 118.34 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.641 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.548 ' SG ' HD21 ' A' ' 141' ' ' LEU . 24.6 t -81.81 119.57 24.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.281 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.41 -25.59 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.893 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' H ' ' A' ' 142' ' ' SER . 30.8 p -79.99 -2.21 43.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.559 0.218 . . . . 0.0 111.508 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.15 73.25 0.64 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.825 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' CB ' HD11 ' A' ' 141' ' ' LEU . 3.3 mt-30 -141.58 -47.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.949 0.404 . . . . 0.0 110.76 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.72 HD13 HD21 ' A' ' 143' ' ' LEU . 3.1 mp -114.0 140.68 25.16 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.7 Cg_endo -72.85 139.91 31.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.182 1.921 . . . . 0.0 112.24 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.841 HG12 HG23 ' A' ' 37' ' ' ILE . 37.2 mt -54.2 139.21 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.555 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -129.33 164.1 24.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.492 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -119.36 119.87 35.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.112 0.482 . . . . 0.0 111.372 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.8 mt -97.9 128.89 44.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.981 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.84 158.32 43.93 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.06 141.93 29.29 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.848 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -77.17 137.23 38.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 111.462 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.627 HD13 ' SG ' ' A' ' 154' ' ' CYS . 61.9 mt -65.31 -45.23 94.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.337 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -58.51 -42.92 88.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.764 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.6 -36.77 79.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 0.0 110.46 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.1 t -70.33 -43.06 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -32.74 69.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.28 -44.01 59.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -89.99 109.59 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.877 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -97.26 -31.08 12.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.26 167.25 11.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.35 -173.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -88.73 149.69 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.011 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.596 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -83.43 -75.89 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.944 -179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.4 ttpt -144.49 137.69 27.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.165 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.665 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.3 t -132.16 139.36 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.376 0.607 . . . . 0.0 112.255 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.8 m-90 -101.68 139.26 37.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.935 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.66 128.68 56.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.859 0.361 . . . . 0.0 110.027 177.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.7 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -120.49 145.23 47.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -178.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.61 -166.72 34.98 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.47 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 4.9 mtp85 -79.01 2.05 21.8 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.609 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.71 130.83 51.55 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.644 0.259 . . . . 0.0 111.197 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.67 -15.91 51.26 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.515 2.144 . . . . 0.0 111.495 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.77 -41.61 18.96 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -42.76 139.11 1.73 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.537 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.25 -18.63 11.04 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.109 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.546 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -129.82 125.09 34.89 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -105.3 107.98 19.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.562 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HA ' HG12 ' A' ' 43' ' ' ILE . 7.1 mt -75.4 -69.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.199 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.79 -88.47 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.584 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -170.79 57.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.764 0.316 . . . . 0.0 111.32 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.769 HD12 ' CD1' ' A' ' 84' ' ' LEU . 30.7 mt -95.52 115.8 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.942 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -42.58 71.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.279 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HB3' ' HA2' ' A' ' 133' ' ' GLY . 3.8 mtp85 -60.85 -18.69 57.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.332 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.769 ' CD1' HD12 ' A' ' 81' ' ' ILE . 29.7 mt -103.3 151.19 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.62 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.1 p -97.8 163.99 12.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.728 0.299 . . . . 0.0 111.667 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.576 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -43.22 -52.93 5.39 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.401 0.62 . . . . 0.0 109.912 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.66 ' CB ' HD12 ' A' ' 104' ' ' ILE . 12.9 mttm -117.67 80.73 1.55 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.582 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.4 t60 -60.34 -45.53 93.13 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.652 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.502 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 35.0 p90 -147.11 159.5 43.53 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.026 -0.67 . . . . 0.0 112.237 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.7 tt0 -136.14 142.88 44.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.114 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.595 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.7 mt -117.64 129.25 74.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.662 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 92' ' ' LEU . 1.6 pt? -115.95 148.04 40.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.113 0.482 . . . . 0.0 111.855 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.73 HD22 HG11 ' A' ' 33' ' ' VAL . 26.2 tp -125.02 134.75 52.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.058 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.39 -166.77 38.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.537 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 59.14 -176.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.699 0.285 . . . . 0.0 110.704 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.45 80.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.73 -158.84 49.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.433 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 61.38 163.21 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.985 0.422 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.542 HD11 ' CG1' ' A' ' 33' ' ' VAL . 4.2 mm? -120.77 160.04 24.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.689 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' HD21 ' A' ' 92' ' ' LEU . 1.4 mp -128.26 143.29 51.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.313 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.434 HD12 HG12 ' A' ' 91' ' ' ILE . 2.0 tp -112.79 121.6 45.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.159 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.522 ' HB2' HD22 ' A' ' 92' ' ' LEU . 56.5 t30 -115.38 115.72 27.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.543 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.785 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.5 p30 -79.77 137.97 37.14 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.66 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.3 pt -139.42 29.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.563 0.22 . . . . 0.0 111.268 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.578 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 12.9 t -90.32 160.2 16.25 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.253 0.549 . . . . 0.0 112.369 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.588 HG22 HG22 ' B' ' 173' ' ' THR . 24.5 m -69.54 -52.47 26.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.598 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.86 -19.23 27.69 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.93 157.76 9.38 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.606 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -116.94 137.73 52.02 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.372 0.669 . . . . 0.0 109.252 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.904 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -112.27 149.15 32.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.733 HD23 ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -124.24 113.5 18.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.319 176.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 44.54 43.39 6.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.649 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.29 -13.49 63.45 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.725 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.07 118.6 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.106 0.453 . . . . 0.0 110.639 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.904 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.9 tptm -73.28 125.1 27.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.307 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.785 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.0 m -98.67 163.4 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.032 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.3 tt0 -69.96 128.87 37.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.549 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 1.8 tttt -54.08 156.84 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.092 0.473 . . . . 0.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.613 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.5 p30 37.46 34.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.065 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -111.9 144.89 40.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.865 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.402 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.0 m120 -88.59 129.0 35.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 111.126 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -129.25 147.79 51.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.299 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.1 tp -72.77 119.02 16.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.857 0.361 . . . . 0.0 110.192 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.942 HD11 HG21 ' A' ' 145' ' ' ILE . 66.7 tp -53.6 157.24 2.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.346 0.593 . . . . 0.0 111.643 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.416 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.47 153.28 42.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.422 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.406 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 7.9 tp60 -71.57 122.71 20.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.192 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.95 19.29 56.25 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.152 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.3 t70 -52.15 171.79 0.05 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.767 0.318 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.853 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.1 mt-10 -145.24 135.51 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.286 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.063 HD11 HD11 ' A' ' 145' ' ' ILE . 1.5 mt -110.91 126.48 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.009 0.433 . . . . 0.0 110.476 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.625 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.2 m -104.28 140.78 37.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.601 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 28.4 m -140.58 158.36 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 81.84 35.57 21.5 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.164 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.9 t -74.33 140.24 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.612 0.72 . . . . 0.0 112.24 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -40.91 0.83 Allowed Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.247 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 46.9 t -126.52 127.91 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 114.894 -0.653 . . . . 0.0 109.282 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -50.49 -31.49 15.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.853 0.359 . . . . 0.0 111.217 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 66.8 m -93.67 6.16 49.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -124.35 21.65 8.65 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.625 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.5 mt -103.63 139.0 25.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 142' ' ' SER . 5.0 tt -124.53 134.43 53.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 141' ' ' LEU . 46.9 t -109.57 150.18 28.57 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.664 0.745 . . . . 0.0 112.359 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 43' ' ' ILE . 77.7 mt -135.84 153.01 51.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.484 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.853 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -121.53 139.18 49.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.803 0.335 . . . . 0.0 111.294 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.063 HD11 HD11 ' A' ' 130' ' ' ILE . 33.9 mt -106.47 128.53 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.977 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -114.7 114.11 25.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.712 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.621 HG12 HD21 ' A' ' 124' ' ' LEU . 4.1 mt -84.76 134.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.695 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.3 113.38 17.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -37.38 83.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -60.09 -46.02 90.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.966 0.412 . . . . 0.0 110.855 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -59.23 -44.13 92.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.107 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.593 ' HE3' HG21 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -60.83 -40.06 91.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -59.09 -40.7 86.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.103 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.627 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.4 t -67.38 -46.06 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.999 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -66.62 -35.92 81.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.838 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.86 -42.34 98.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.851 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LYS . 2.6 tp60 -84.68 -31.71 23.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.818 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.77 -90.71 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.65 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 157' ' ' GLN . 7.6 tttt -74.82 139.99 43.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.65 125.78 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.04 125.18 2.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HB2' HD13 ' A' ' 163' ' ' ILE . 6.4 mmp_? 66.11 -72.47 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.611 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -105.22 139.99 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.15 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.881 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -158.93 -57.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.868 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.9 mmm -132.12 148.39 52.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.821 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 31.6 m -138.8 151.93 47.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' B' ' 172' ' ' PRO . 1.5 t80 -117.61 88.23 2.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.88 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.11 -67.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.412 ' HG3' ' CE2' ' B' ' 169' ' ' PHE . 73.1 Cg_exo -48.86 145.14 13.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.469 2.113 . . . . 0.0 112.406 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.588 HG22 HG22 ' A' ' 106' ' ' THR . 12.4 p -124.62 139.97 53.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.995 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.56 83.22 41.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.813 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.92 178.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.587 2.191 . . . . 0.0 112.277 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . 0.508 HD12 ' N ' ' B' ' 176' ' ' LEU . 4.9 mp -90.89 108.07 19.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.922 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.82 0.343 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -147.98 -44.63 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -59.88 -47.0 87.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -47.51 67.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.818 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -35.83 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.675 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -31.77 72.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.773 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -71.86 -35.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.71 -46.17 84.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.441 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -67.25 -23.76 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.54 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.8 -47.6 79.84 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.393 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.1 p -63.53 -32.27 73.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -79.43 -75.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.834 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -96.25 142.44 28.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -82.48 125.55 31.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -82.16 138.34 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.659 0.742 . . . . 0.0 111.818 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.78 73.8 0.16 Allowed Glycine 0 C--N 1.315 -0.629 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.474 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' HG3' HD11 ' A' ' 32' ' ' ILE . 1.6 pp20? -88.95 -36.66 15.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.749 0.309 . . . . 0.0 110.969 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 179.05 38.92 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -77.18 135.24 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 113.75 -1.568 . . . . 0.0 112.3 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.983 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.46 -60.23 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.998 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' HD22 ' A' ' 48' ' ' LEU . 11.5 p -146.53 162.11 39.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.434 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -131.68 128.47 39.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.281 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.695 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.7 t -97.8 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.925 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.842 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -120.9 115.5 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 141' ' ' LEU . 0.5 OUTLIER -82.21 99.81 9.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 110.343 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -80.25 -19.89 45.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.739 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.657 HG21 ' OG ' ' A' ' 142' ' ' SER . 12.8 p -80.04 -2.59 44.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.574 0.226 . . . . 0.0 111.378 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.79 75.48 0.57 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.964 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -147.84 -41.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.068 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.842 HD13 HD22 ' A' ' 78' ' ' LEU . 2.0 mt -127.43 141.29 40.45 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.8 Cg_endo -72.52 145.38 42.18 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.012 1.808 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.842 HG12 HG23 ' A' ' 37' ' ' ILE . 41.7 mt -54.36 142.96 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.225 0.536 . . . . 0.0 111.908 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 33.8 mtt-85 -140.84 164.28 30.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.79 120.43 26.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.802 HD23 ' CD2' ' A' ' 66' ' ' TRP . 9.3 mp -86.38 137.08 32.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.188 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.983 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -142.61 156.01 45.03 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.427 1.108 . . . . 0.0 113.664 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -135.11 141.86 46.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.65 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.66 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -78.08 137.58 38.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.042 0.449 . . . . 0.0 111.4 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.656 HD13 ' SG ' ' A' ' 154' ' ' CYS . 81.4 mt -64.21 -41.64 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.224 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.4 m -56.32 -40.26 74.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.0 mt-30 -68.35 -36.85 79.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.207 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.913 HG22 ' HG2' ' A' ' 63' ' ' LYS . 50.3 t -61.58 -40.48 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.99 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.05 -39.43 72.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -58.96 -36.68 75.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.006 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -88.99 125.05 34.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.1 74.69 5.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.8 mtt-85 59.23 78.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 t -152.03 -65.25 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.431 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 3.6 tp -173.49 139.24 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.913 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -103.15 -71.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.767 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' CE ' ' O ' ' A' ' 49' ' ' SER . 31.1 ttpt -155.14 150.11 26.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.002 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.625 HG12 ' HG2' ' A' ' 90' ' ' GLN . 16.3 t -128.64 139.31 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.256 0.551 . . . . 0.0 111.959 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.802 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.6 m-90 -105.82 139.07 40.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.538 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.03 128.09 55.75 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -111.65 145.93 38.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.926 -178.08 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 166.08 -175.98 41.51 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -79.57 -2.52 42.79 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.85 134.63 41.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.644 0.259 . . . . 0.0 111.01 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -68.34 -7.09 19.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.658 2.238 . . . . 0.0 111.708 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.7 16.55 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.956 0.884 . . . . 0.0 108.932 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.08 137.69 4.17 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.477 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -56.43 -18.89 12.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.834 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.7 t80 -129.89 120.34 24.74 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.723 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.14 119.31 31.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.842 HD22 HD13 ' A' ' 43' ' ' ILE . 7.3 mt -111.49 -176.06 2.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 111.09 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.78 136.67 20.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.375 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -61.58 89.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.389 . . . . 0.0 111.278 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.8 mm -112.15 125.0 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.759 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -55.09 -44.07 74.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.409 ' NH1' ' HA3' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -61.58 -24.19 66.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.452 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.537 HD22 ' CE1' ' A' ' 88' ' ' HIS . 57.5 mt -93.24 152.26 19.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.8 0.333 . . . . 0.0 111.181 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.43 167.11 11.2 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.794 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.736 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.86 -53.9 5.7 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -117.65 82.97 1.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 14.2 t60 -60.44 -47.4 86.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.483 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.0 p90 -146.62 159.85 42.93 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.62 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.625 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.3 tt0 -135.78 139.59 43.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.27 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.723 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 57.6 mt -114.72 131.38 67.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.096 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.547 HD21 HD22 ' A' ' 121' ' ' ASN . 1.0 OUTLIER -117.53 147.87 42.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.096 0.474 . . . . 0.0 111.758 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.757 HD22 ' CG1' ' A' ' 33' ' ' VAL . 20.2 tp -124.99 122.62 37.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.912 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 62' ' ' ILE . . . 177.45 89.85 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.594 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -177.86 35.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.741 0.305 . . . . 0.0 110.975 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 t70 60.49 22.78 12.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.378 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.34 -54.78 0.56 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.432 -0.89 . . . . 0.0 113.094 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -55.83 149.56 14.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 111.208 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -111.78 160.0 17.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.791 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.674 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.4 mp -132.46 143.46 49.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.415 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.537 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -112.81 126.04 55.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.4 t30 -119.02 115.54 24.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 111.564 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.817 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.9 p30 -78.27 141.21 38.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.665 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 67' ' ' THR . 13.8 pt -149.08 37.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.65 153.69 18.05 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.029 0.442 . . . . 0.0 111.713 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.9 m -68.87 -31.7 70.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.005 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.4 -20.02 17.38 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.36 157.53 10.56 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.738 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.8 m -117.53 137.83 52.31 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.111 0.564 . . . . 0.0 109.573 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.67 148.49 38.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.473 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.04 113.41 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.392 177.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 90.8 m-20 44.3 42.86 5.55 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.02 -9.08 76.02 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.51 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -105.64 118.68 37.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.033 0.444 . . . . 0.0 110.746 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.9 tptp -73.27 121.71 20.8 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.203 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.817 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.3 m -93.69 165.52 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.267 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 26.1 mt-10 -69.8 126.33 29.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.6 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.9 tttm -54.55 162.76 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.342 . . . . 0.0 110.655 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.26 34.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.015 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.04 40.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.136 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.66 ' HB3' HD23 ' A' ' 100' ' ' LEU . 29.5 m120 -91.69 130.75 37.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.889 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.2 mm-40 -129.26 150.07 50.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.651 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.67 115.41 11.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.561 HD21 HG12 ' A' ' 147' ' ' ILE . 66.1 tp -52.74 157.18 1.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.413 0.625 . . . . 0.0 111.571 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.39 153.0 42.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.524 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.419 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.7 tp60 -71.8 124.26 24.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.094 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.93 20.57 53.66 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.136 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.1 t0 -55.06 172.83 0.11 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.0 111.07 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG3' HG22 ' A' ' 144' ' ' VAL . 25.5 tt0 -145.04 135.4 24.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.204 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.472 ' CG2' HG22 ' A' ' 109' ' ' THR . 17.1 mt -114.76 127.95 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.4 m -104.42 139.27 39.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.991 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.489 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.7 m -140.25 158.27 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.01 27.69 33.34 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.106 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.544 ' HA ' HG12 ' A' ' 140' ' ' ILE . 67.5 t -67.33 140.24 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.582 0.706 . . . . 0.0 112.332 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.409 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 151.61 -41.75 0.73 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.283 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 138' ' ' SER . 45.0 t -126.39 133.28 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.61 -35.82 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.796 0.331 . . . . 0.0 111.485 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.1 m -93.59 6.3 48.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -119.89 21.88 11.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.4 mt -104.88 139.59 25.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.155 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 142' ' ' SER . 7.0 tt -121.81 134.36 54.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.606 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.662 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -111.5 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.111 0.482 . . . . 0.0 111.801 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.53 HD22 HG12 ' A' ' 36' ' ' VAL . 20.5 mt -124.12 138.41 54.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.504 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.4 t -110.71 136.61 46.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.736 0.303 . . . . 0.0 111.401 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 124' ' ' LEU . 8.2 mt -106.28 130.56 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.58 118.15 31.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.705 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.561 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.93 134.11 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.684 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.96 117.55 23.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.721 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.28 -29.89 65.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -60.29 -46.01 91.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.785 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -58.68 -44.16 90.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.151 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -61.06 -33.84 73.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.834 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -47.05 86.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.656 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.8 t -64.55 -45.93 85.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.963 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.879 HD21 HG11 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -62.85 -39.62 94.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.933 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.34 -40.71 87.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -85.24 -36.66 20.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.966 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.68 31.72 0.32 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.476 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 152.68 44.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 160' ' ' VAL . 13.3 p -103.06 122.84 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.162 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -108.94 -31.73 7.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -129.41 176.35 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.61 122.23 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.876 0.369 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -75.88 157.03 33.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.07 -70.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 6.6 m -108.13 118.37 36.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -93.6 122.96 36.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -131.26 -46.27 1.0 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.042 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.57 102.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.505 2.136 . . . . 0.0 112.195 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 2.3 m -97.6 139.23 33.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.51 86.67 15.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.86 157.15 6.05 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.587 2.191 . . . . 0.0 112.406 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.94 176.21 8.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.957 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.823 0.344 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -94.09 52.92 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -46.94 87.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -61.1 -36.15 78.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.34 -39.88 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.3 tp -58.9 -31.96 69.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.773 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.01 -35.52 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.5 -38.44 74.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.25 -23.86 65.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.71 -47.31 80.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.51 -31.15 37.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.721 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.58 159.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -62.98 135.96 57.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -73.15 112.09 8.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.943 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -81.94 138.39 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-O 121.63 0.729 . . . . 0.0 111.82 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.87 49.63 0.75 Allowed Glycine 0 C--N 1.315 -0.626 0 CA-C-N 114.491 -1.231 . . . . 0.0 112.478 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -87.67 -44.93 10.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.685 0.279 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 177.59 38.89 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.665 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -74.42 136.62 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.697 -1.592 . . . . 0.0 112.398 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -93.7 -60.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.191 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.581 ' SG ' HD22 ' A' ' 99' ' ' LEU . 1.2 m -147.01 156.42 43.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.754 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 138.15 51.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.095 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.725 HG11 ' CE2' ' A' ' 68' ' ' PHE . 2.8 m -108.27 122.62 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.795 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.837 HG23 HG12 ' A' ' 45' ' ' ILE . 18.8 mt -128.27 122.63 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.542 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD23 ' A' ' 143' ' ' LEU . 54.1 t -80.27 109.98 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 0.0 110.248 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.464 HG23 HG21 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -75.71 -26.26 57.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.924 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 142' ' ' SER . 47.3 p -79.82 -2.23 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 0.0 111.54 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.75 77.65 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.863 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -147.09 -43.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.915 0.388 . . . . 0.0 110.865 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 76' ' ' TYR . 1.8 mt -115.16 141.43 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.783 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 47.9 Cg_endo -71.12 145.96 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.138 1.892 . . . . 0.0 112.248 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.837 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -56.94 141.57 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.38 164.07 28.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.991 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.63 119.91 26.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.989 0.423 . . . . 0.0 111.973 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.0 mp -89.64 129.35 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.347 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -134.34 157.04 47.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.998 0.904 . . . . 0.0 113.341 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.53 150.36 43.61 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.291 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.856 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.0 m-20 -96.2 102.25 14.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.37 -45.24 96.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.092 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -59.63 -40.25 86.99 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.282 0.563 . . . . 0.0 110.643 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 38.6 mm-40 -68.57 -37.86 80.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.622 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 51' ' ' ASP . 45.6 t -73.08 -40.29 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.971 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.55 -30.74 67.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.733 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -73.9 -40.5 63.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.756 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -98.0 114.8 27.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -70.56 113.93 8.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.028 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.96 -177.68 6.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.8 m -98.93 -44.75 6.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.8 tp -109.24 146.72 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.751 ' HG2' HG11 ' A' ' 55' ' ' VAL . 18.8 mttm -96.12 -71.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.984 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 49' ' ' SER . 33.6 ttpt -147.29 139.73 24.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.611 HG12 ' HG2' ' A' ' 90' ' ' GLN . 3.6 t -121.14 138.84 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.007 0.432 . . . . 0.0 111.664 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.766 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.0 m-90 -102.96 139.3 38.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.244 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.684 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.75 127.21 56.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -111.32 145.63 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.397 -178.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.84 -174.59 40.02 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -78.59 -2.22 37.9 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.86 135.05 40.47 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.301 . . . . 0.0 111.114 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.9 Cg_exo -69.05 -7.86 22.0 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.779 2.32 . . . . 0.0 111.827 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.79 -43.77 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.949 0.88 . . . . 0.0 108.669 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.0 137.96 2.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.29 -18.94 12.1 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.119 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.587 ' CE2' HG21 ' A' ' 43' ' ' ILE . 60.0 t80 -129.9 128.15 41.6 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.71 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.52 120.91 41.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.423 HD11 ' C ' ' A' ' 69' ' ' GLY . 1.1 pp -120.81 -178.27 3.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.087 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.91 146.99 41.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.525 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -78.9 76.87 5.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 111.195 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 84' ' ' LEU . 36.0 mt -94.7 124.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.827 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.8 p -54.86 -35.18 63.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.7 OUTLIER -63.89 -45.94 87.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.054 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.653 HD11 HD12 ' A' ' 81' ' ' ILE . 49.1 mt -72.8 152.09 41.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.125 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 p -95.17 168.27 10.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.677 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -44.63 -53.6 7.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.373 0.606 . . . . 0.0 109.636 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' HB2' HD12 ' A' ' 104' ' ' ILE . 33.8 mttm -119.43 83.1 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.5 t60 -60.49 -46.24 90.83 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.691 -176.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.8 p90 -146.21 161.2 40.76 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.814 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.684 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -135.78 142.34 44.9 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.074 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 65' ' ' VAL . 27.1 mt -115.87 132.37 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.185 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.957 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -108.09 145.21 34.39 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.024 0.44 . . . . 0.0 111.807 -179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.624 ' HG ' HG11 ' A' ' 33' ' ' VAL . 2.6 tm? -125.33 122.64 37.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.409 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 139.83 -112.14 0.8 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.737 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 70.0 -65.76 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -165.37 -50.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.801 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.8 38.66 0.21 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.35 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -159.27 -174.23 4.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.604 ' HB3' HD13 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -109.84 153.58 24.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.956 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.722 HD13 ' OD1' ' A' ' 121' ' ' ASN . 11.3 mt -132.97 146.95 52.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.59 HD23 HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -117.57 124.48 48.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.9 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.957 ' HB2' HD11 ' A' ' 92' ' ' LEU . 47.9 t30 -114.38 115.5 27.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 111.531 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.782 ' OD2' HG23 ' A' ' 116' ' ' VAL . 17.6 p30 -79.47 138.63 37.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.2 pt -147.15 39.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.587 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -97.4 159.33 14.98 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.039 0.447 . . . . 0.0 111.497 -179.088 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.673 HG21 HG21 ' B' ' 171' ' ' TPO . 85.4 m -68.88 -35.56 77.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.299 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -19.86 17.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.32 164.22 12.64 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.442 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.3 m -117.48 137.7 52.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.882 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.12 148.28 35.63 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.19 113.41 18.28 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.298 177.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.2 m-80 44.11 42.93 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.41 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.6 -11.46 68.32 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.583 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -103.98 118.35 36.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.045 0.422 . . . . 0.0 110.777 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.882 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.8 tptm -74.0 127.89 34.07 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.375 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.782 HG23 ' OD2' ' A' ' 103' ' ' ASP . 9.3 m -98.11 165.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.19 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.4 mm-40 -69.83 126.57 30.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.707 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.9 tttt -53.65 162.66 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.61 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.063 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.43 145.13 40.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.377 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.722 ' OD1' HD13 ' A' ' 100' ' ' LEU . 8.9 m-80 -91.64 125.92 36.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.766 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.601 ' O ' HD23 ' A' ' 100' ' ' LEU . 43.1 mm-40 -127.44 147.54 50.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.429 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.8 tp -72.63 117.11 13.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.17 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.756 ' CD2' HG21 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -55.73 166.98 0.61 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.782 0.801 . . . . 0.0 111.952 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -125.37 153.28 43.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.398 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.558 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.26 118.18 13.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.67 24.01 69.34 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.8 t70 -55.83 175.21 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 10.8 tt0 -145.06 135.54 24.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 145' ' ' ILE . 17.9 mt -115.34 126.66 72.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.55 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.659 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.51 138.34 41.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.045 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.524 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 27.4 m -140.39 158.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.42 28.98 28.61 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.159 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 140' ' ' ILE . 62.5 t -68.56 140.27 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.535 0.684 . . . . 0.0 112.409 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.08 -43.45 0.6 Allowed Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.261 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 138' ' ' SER . 45.8 t -126.43 136.36 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -50.7 -37.7 42.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.469 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.64 6.39 48.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.93 21.15 13.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.659 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -106.58 139.17 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.239 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 142' ' ' SER . 7.6 tt -124.38 134.37 53.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.229 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.527 ' H ' HG21 ' A' ' 40' ' ' THR . 47.2 t -109.83 150.23 28.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.7 0.762 . . . . 0.0 112.589 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' CYS . 72.8 mt -135.88 151.15 49.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.725 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 HG23 ' A' ' 39' ' ' THR . 36.7 t -122.03 135.88 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.825 0.345 . . . . 0.0 111.051 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 130' ' ' ILE . 46.2 mt -106.12 125.66 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.137 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.77 114.73 27.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.1 mt -84.92 130.12 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 0.0 111.33 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -83.63 119.05 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.04 -27.54 69.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.04 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.28 -42.53 81.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.973 0.416 . . . . 0.0 110.613 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 155' ' ' LEU . 34.5 t80 -59.16 -43.74 92.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.787 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -34.08 70.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.827 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -41.51 95.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.5 t -67.08 -46.08 75.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.428 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -67.01 -35.95 81.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.948 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -62.19 -37.0 83.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.974 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -92.06 -33.45 14.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.3 p30 42.58 73.73 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.478 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 123.66 20.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.7 m -85.33 136.7 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.08 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.47 38.57 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.77 -38.39 6.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.03 126.93 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.971 179.937 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 9.2 pttp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.779 0.323 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.98 168.73 9.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -159.12 34.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 3.3 p -66.05 162.6 19.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -58.9 -178.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -99.22 -64.26 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . 0.673 HG21 HG21 ' A' ' 106' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.87 142.3 51.55 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.351 2.034 . . . . 0.0 112.191 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 53.8 p -138.52 -179.06 5.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.021 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.13 102.82 10.22 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.25 153.82 73.61 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.384 2.056 . . . . 0.0 112.251 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.08 91.48 8.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.924 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.792 0.329 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.0 m -113.01 -72.28 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -37.45 83.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -71.01 -42.84 69.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.34 -36.89 71.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.666 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.43 -31.93 70.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -72.86 -35.57 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.4 -41.11 79.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.502 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -67.19 -23.87 65.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.64 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.67 -47.41 79.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.224 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 p -81.07 -32.34 34.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.31 -75.99 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -85.68 156.42 20.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -82.39 122.48 28.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.812 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.415 HG13 ' CD1' ' A' ' 23' ' ' PHE . 20.2 mm -81.98 138.35 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-O 121.652 0.739 . . . . 0.0 111.828 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.39 66.61 0.5 Allowed Glycine 0 C--N 1.315 -0.637 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.453 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -80.8 -38.41 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.739 0.304 . . . . 0.0 110.969 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 176.33 39.09 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.7 mm -72.09 135.27 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.653 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.993 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -91.8 -60.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.735 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.4 p -147.82 153.62 39.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.095 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.77 138.13 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.541 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 36' ' ' VAL . 11.7 p -103.04 122.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.591 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.795 HG23 HG12 ' A' ' 45' ' ' ILE . 18.9 mt -130.41 119.24 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.729 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.625 ' HA ' HD23 ' A' ' 143' ' ' LEU . 44.4 t -79.86 118.31 21.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.233 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 t -84.76 -25.12 28.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.979 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.526 HG21 ' H ' ' A' ' 142' ' ' SER . 52.5 p -79.82 -2.11 41.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.02 76.55 0.28 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.718 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -146.51 -44.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.744 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mt -115.08 141.45 27.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.792 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.6 Cg_endo -73.2 141.49 32.49 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.119 1.879 . . . . 0.0 112.265 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.795 HG12 HG23 ' A' ' 37' ' ' ILE . 38.3 mt -56.98 143.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.424 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.14 164.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.38 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 119.85 35.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.189 0.518 . . . . 0.0 111.69 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.694 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.6 mt -98.64 134.54 41.42 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.993 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.96 158.95 43.86 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -178.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.74 142.17 25.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.67 -1.605 . . . . 0.0 110.883 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.594 ' O ' HG23 ' A' ' 55' ' ' VAL . 6.1 m-20 -74.94 132.62 41.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.144 0.497 . . . . 0.0 111.454 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.747 HD13 ' SG ' ' A' ' 154' ' ' CYS . 88.2 mt -64.4 -44.28 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.24 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.1 m -56.52 -37.52 70.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.251 0.548 . . . . 0.0 110.688 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.447 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 6.4 mm-40 -68.63 -36.84 79.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.264 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 51' ' ' ASP . 46.1 t -73.1 -42.57 58.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.113 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.05 -28.2 66.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.98 -49.83 64.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.966 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.63 136.94 39.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.52 -32.03 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.42 -169.44 2.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m 61.35 178.22 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.468 HD11 ' N ' ' A' ' 93' ' ' LEU . 10.4 tp -93.32 157.04 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -101.48 -81.42 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.259 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.1 ttpt -121.51 134.16 55.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.878 0.371 . . . . 0.0 111.216 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.8 t -125.49 137.58 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.576 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.694 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.9 m-90 -101.98 139.27 37.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.184 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.679 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.38 130.51 56.7 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -119.18 145.3 46.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.274 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.28 -170.74 36.38 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HG3' HD11 ' A' ' 78' ' ' LEU . 17.1 mtp180 -78.86 3.72 16.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 5.4 t-20 -84.66 132.03 47.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.574 0.226 . . . . 0.0 111.102 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.3 Cg_exo -66.69 -13.74 41.1 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.476 2.117 . . . . 0.0 111.761 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.68 -42.72 17.76 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.949 0.88 . . . . 0.0 108.937 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.5 139.51 1.09 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.015 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 m-20 -56.49 -18.75 12.49 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.015 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 16.7 t80 -129.55 123.01 30.35 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-O 120.69 0.281 . . . . 0.0 111.117 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -99.87 107.96 20.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.558 HD11 ' HG3' ' A' ' 70' ' ' ARG . 2.3 pp -111.29 173.89 6.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.841 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.26 135.68 43.92 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.766 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.29 84.2 1.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.945 0.402 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.863 ' HB ' HD23 ' A' ' 84' ' ' LEU . 9.0 mt -111.25 135.49 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.921 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.2 p -56.49 -37.47 70.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.567 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.57 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.66 -22.1 63.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.19 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.863 HD23 ' HB ' ' A' ' 81' ' ' ILE . 2.1 mm? -107.54 152.64 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.905 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -96.93 163.77 12.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.45 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.622 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.84 -52.9 4.88 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.497 0.665 . . . . 0.0 109.663 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HB3' HG22 ' A' ' 67' ' ' THR . 5.1 mttm -120.84 82.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -61.4 -45.93 92.25 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.672 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.6 p90 -143.86 159.06 43.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.795 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.679 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.2 tt0 -136.09 140.56 43.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.316 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.564 ' O ' HG13 ' A' ' 65' ' ' VAL . 58.1 mt -114.0 132.28 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.791 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.697 ' H ' HD23 ' A' ' 92' ' ' LEU . 2.0 pt? -120.59 133.59 55.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.03 0.443 . . . . 0.0 111.967 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.676 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.6 tm? -125.2 122.69 37.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.064 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 135.91 94.98 0.44 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.467 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.64 -42.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.594 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.0 -173.11 4.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.711 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.11 60.5 3.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.524 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.4 p30 177.67 -178.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 110.982 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.676 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -108.61 160.14 16.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.76 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.573 ' H ' HD23 ' A' ' 99' ' ' LEU . 3.2 mp -125.85 143.29 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.84 0.352 . . . . 0.0 110.484 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 101' ' ' LEU . 2.4 mm? -112.8 122.82 48.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.897 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.627 ' HB2' HD22 ' A' ' 92' ' ' LEU . 49.9 t30 -115.28 115.47 26.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.654 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.83 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -78.17 138.43 38.68 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.9 pt -145.12 40.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.611 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.69 156.45 16.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.005 0.431 . . . . 0.0 111.362 -179.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.3 m -68.79 -36.52 78.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.361 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.75 -19.7 17.32 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.14 159.18 10.44 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.137 -1.03 . . . . 0.0 114.005 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.5 m -117.55 137.93 52.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.991 -0.604 . . . . 0.0 109.593 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.891 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -112.74 148.72 34.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.1 113.45 18.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.455 177.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 42.8 44.0 3.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.75 62.41 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.457 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -103.34 118.52 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.614 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.891 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.4 tptp -72.92 128.16 34.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.425 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.83 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.9 m -98.79 163.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.193 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 tp10 -69.92 126.89 31.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.536 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.674 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -53.16 160.74 0.99 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.81 35.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.311 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.24 145.13 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.136 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.502 ' HB3' HD23 ' A' ' 100' ' ' LEU . 14.1 m120 -85.13 127.92 34.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.93 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.29 146.93 51.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.532 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 tp -72.77 134.2 44.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.287 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.883 HD11 HG21 ' A' ' 145' ' ' ILE . 65.2 tp -69.33 155.88 39.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.458 0.647 . . . . 0.0 111.485 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.452 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.58 153.02 42.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.256 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 121.3 18.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.886 0.374 . . . . 0.0 110.287 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.44 58.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.131 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.0 t70 -54.43 173.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.739 0.304 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.901 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.2 mt-10 -145.07 135.72 24.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.318 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.46 ' CG2' HG22 ' A' ' 109' ' ' THR . 12.9 mt -114.41 127.16 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.61 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.566 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.42 140.06 38.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.884 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.74 HG23 HD11 ' A' ' 84' ' ' LEU . 35.5 m -140.4 158.33 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 0.0 112.346 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.91 36.03 16.85 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.079 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.577 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.8 t -75.14 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.641 0.734 . . . . 0.0 112.505 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.21 -42.89 0.57 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.62 129.11 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -50.46 -31.18 14.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.795 0.331 . . . . 0.0 111.183 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.598 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 m -93.53 6.42 48.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -125.69 23.2 7.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.9 mt -105.35 139.33 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.011 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.8 tt -124.23 134.43 53.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.577 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.526 ' H ' HG21 ' A' ' 40' ' ' THR . 48.3 t -109.4 150.57 27.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 112.25 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 38' ' ' CYS . 74.0 mt -135.53 156.0 49.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.901 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.5 t -124.57 136.84 59.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.032 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.883 HG21 HD11 ' A' ' 124' ' ' LEU . 2.3 mm -106.33 126.37 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.923 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 37' ' ' ILE . 1.5 m-85 -112.53 116.33 30.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.738 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.749 HG12 HD21 ' A' ' 124' ' ' LEU . 3.7 mt -84.8 134.26 27.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.542 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -75.97 118.48 18.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.588 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -37.49 78.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.068 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -60.6 -45.73 92.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 33' ' ' VAL . 19.5 t80 -63.45 -43.8 96.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.187 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -60.06 -50.06 75.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.388 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 154' ' ' CYS . 3.9 pt20 -60.24 -36.9 78.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.078 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.747 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.8 t -68.08 -45.87 72.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.978 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -69.0 -42.51 76.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.956 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.58 -45.21 92.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.029 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.74 -36.84 28.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.919 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.68 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.422 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -60.0 133.05 55.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.05 125.85 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -106.08 120.7 42.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 60.01 70.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.6 tt -86.04 139.92 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.105 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 1.6 tttp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.792 0.329 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -140.49 143.72 35.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -137.56 -173.88 3.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 78.4 p -79.59 97.15 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' B' ' 172' ' ' PRO . 29.1 t80 -91.36 51.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.683 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -73.74 114.9 12.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.162 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . 0.462 ' HA ' ' HD2' ' B' ' 172' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' B' ' 171' ' ' TPO . 9.4 Cg_endo -52.57 163.39 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.679 2.253 . . . . 0.0 112.293 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 82.7 p -135.87 128.46 30.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.85 104.81 14.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.74 100.69 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.427 2.084 . . . . 0.0 112.389 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.49 151.55 39.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.974 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.834 0.349 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.3 p -148.26 -47.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.96 -47.12 72.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -46.06 88.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -57.04 -36.14 70.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.589 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -31.86 71.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.46 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.15 -35.53 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.722 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -57.86 -37.91 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.053 0.454 . . . . 0.0 110.352 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -67.2 -23.64 65.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.996 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.69 -47.48 79.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.098 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.13 -30.01 58.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.968 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.23 -179.93 7.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.65 159.02 26.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.93 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -90.53 104.41 17.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.06 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.38 138.53 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.534 0.683 . . . . 0.0 111.823 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -69.02 64.02 0.51 Allowed Glycine 0 C--N 1.314 -0.645 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.239 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -40.18 84.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.647 0.261 . . . . 0.0 111.275 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-20 178.8 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.568 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.6 mm -71.49 142.64 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 113.707 -1.588 . . . . 0.0 112.361 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.757 HG22 HD13 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -105.78 -51.35 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.05 -178.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.454 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -155.17 165.37 36.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.635 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.47 138.0 53.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 16.4 t -106.23 122.84 60.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.211 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.8 mt -127.28 115.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.342 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.547 ' HA ' HD13 ' A' ' 143' ' ' LEU . 53.3 t -80.81 123.39 28.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -88.3 -26.88 22.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.639 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 142' ' ' SER . 53.2 p -79.95 -2.3 43.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.632 0.253 . . . . 0.0 111.559 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.59 76.29 0.29 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.007 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -147.18 -44.48 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.961 HD12 HD11 ' A' ' 143' ' ' LEU . 1.5 mt -108.78 140.46 21.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.36 146.03 34.93 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.203 1.936 . . . . 0.0 112.257 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.5 mt -59.98 130.87 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.629 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 164.21 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.194 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.89 119.47 34.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.972 0.415 . . . . 0.0 111.779 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.3 mp -86.09 133.54 33.88 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.581 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -139.9 156.49 46.66 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.38 1.086 . . . . 0.0 113.694 -179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.44 141.75 27.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.805 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.738 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.7 m-20 -79.2 122.06 25.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.157 0.503 . . . . 0.0 110.891 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.2 mt -64.47 -39.7 86.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.784 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -56.97 -42.46 80.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.102 0.477 . . . . 0.0 111.14 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.531 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.4 mt-30 -68.98 -38.18 79.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.903 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.744 HG13 ' HG2' ' A' ' 63' ' ' LYS . 39.4 t -62.75 -45.06 99.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.273 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 tt -71.03 -36.23 72.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -42.06 45.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.056 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -87.4 112.56 22.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.1 31.2 5.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.766 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -174.83 3.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.695 ' O ' HG22 ' A' ' 62' ' ' ILE . 1.2 m -59.48 113.14 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.946 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 61' ' ' SER . 6.7 tp 52.0 161.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.963 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.744 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -107.99 -75.58 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.439 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -127.98 138.17 52.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.637 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.572 HG22 ' CB ' ' A' ' 92' ' ' LEU . 16.9 t -132.75 139.19 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.289 0.566 . . . . 0.0 111.858 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.581 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.9 m-90 -100.9 140.29 35.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.374 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.816 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -109.15 124.74 51.3 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.721 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.9 m-85 -112.46 145.68 39.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.045 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.76 -169.61 38.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.933 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 16.7 mtp180 -84.87 10.18 12.32 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.695 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.0 t-20 -93.86 134.82 25.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.547 0.213 . . . . 0.0 111.135 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.3 Cg_exo -67.21 -11.01 30.62 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.516 2.144 . . . . 0.0 111.651 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.695 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.04 -42.7 17.17 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-O 121.874 0.845 . . . . 0.0 109.004 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -42.6 137.8 2.06 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.831 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.46 -18.59 11.86 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.927 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.618 ' CE2' HG21 ' A' ' 43' ' ' ILE . 7.7 t80 -129.35 120.38 25.5 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.964 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -96.95 107.88 20.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.662 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.1 pp -113.37 174.97 5.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.152 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.16 146.56 23.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.735 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -81.77 96.99 7.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.7 mm -110.56 126.63 67.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -31.77 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.542 ' H ' HG22 ' A' ' 81' ' ' ILE . 15.6 mtt-85 -73.98 -21.49 59.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 HD21 HG23 ' A' ' 132' ' ' VAL . 21.1 mt -99.13 152.33 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.782 0.325 . . . . 0.0 111.007 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.67 165.27 12.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.668 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.91 -53.26 4.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 109.839 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.672 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.43 82.5 1.86 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.8 t60 -61.81 -45.0 95.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.919 -176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 22.1 p90 -146.74 164.15 33.69 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.298 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.816 ' CG ' HG23 ' A' ' 67' ' ' THR . 7.6 mt-30 -135.7 140.78 44.7 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.39 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.531 ' O ' HG13 ' A' ' 65' ' ' VAL . 2.7 mp -116.37 132.47 65.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.356 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.7 147.44 42.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 111.696 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.757 HD13 HG22 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -124.71 123.49 40.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.437 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.0 -130.53 1.37 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.398 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' OE2' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER 59.7 -177.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.866 0.365 . . . . 0.0 110.874 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -61.96 -31.36 71.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.62 52.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.22 172.79 14.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 93' ' ' LEU . 4.2 mm? -108.01 155.26 20.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.886 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -133.25 143.14 48.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.213 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.875 HD11 HD12 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -112.81 129.1 56.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.491 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HB2' HD22 ' A' ' 92' ' ' LEU . 47.1 t30 -119.76 115.54 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.81 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.766 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -79.68 141.71 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.2 pt -148.3 39.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.655 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.68 151.06 21.14 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.058 0.456 . . . . 0.0 111.869 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.7 m -68.78 -31.7 70.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.901 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.42 -19.69 17.56 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.1 155.66 9.87 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.632 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -117.48 137.73 52.34 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.2 148.47 39.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.2 113.43 18.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.056 177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 44.94 43.3 7.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.66 -7.86 77.74 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.48 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -105.63 118.48 36.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.143 0.472 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.8 tptm -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.766 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.4 m -95.94 165.47 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.405 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 3.7 tt0 -69.93 129.55 39.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.405 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.9 tttt -54.33 163.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 0.0 110.193 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.6 m-80 33.92 36.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.827 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.6 p -111.72 145.22 39.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.843 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.725 ' HB3' HD22 ' A' ' 100' ' ' LEU . 29.9 m120 -93.0 127.75 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.813 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.886 ' O ' HD23 ' A' ' 100' ' ' LEU . 65.3 mm-40 -128.98 151.24 49.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.494 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.43 117.38 14.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.955 0.407 . . . . 0.0 110.553 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 101' ' ' LEU . 64.5 tp -57.89 157.8 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.398 0.618 . . . . 0.0 111.413 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.408 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -124.37 153.2 42.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.438 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -71.58 124.42 24.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.49 20.16 55.14 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.954 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.37 173.25 0.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.04 135.58 24.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.822 ' CD1' HD21 ' A' ' 101' ' ' LEU . 7.2 mt -113.36 128.66 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.496 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 86.7 m -103.92 138.87 39.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.106 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.589 HG23 HD21 ' A' ' 84' ' ' LEU . 33.2 m -140.16 158.15 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.71 40.59 14.55 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.814 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.8 t -79.87 140.39 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.654 0.74 . . . . 0.0 112.537 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.13 0.56 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.289 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 43.5 t -126.42 134.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.67 -39.55 51.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.745 0.307 . . . . 0.0 111.702 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.428 ' H ' HG12 ' A' ' 136' ' ' VAL . 14.3 m -93.5 6.43 48.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.444 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.4 t0 -118.06 23.05 11.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 134' ' ' VAL . 5.2 mt -106.12 139.49 27.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.302 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 43' ' ' ILE . 3.1 tp -120.51 134.34 55.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.232 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.555 ' C ' HD22 ' A' ' 143' ' ' LEU . 43.8 t -113.46 150.32 32.99 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.637 0.732 . . . . 0.0 112.672 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 43' ' ' ILE . 2.5 mm? -136.23 146.05 46.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.572 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.632 HG21 HG23 ' A' ' 39' ' ' THR . 23.9 t -116.72 132.82 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 111.097 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.875 HD12 HD11 ' A' ' 101' ' ' LEU . 6.3 mt -106.25 128.33 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.84 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.97 120.63 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.0 mt -84.82 134.01 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.278 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -79.16 127.75 32.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -74.06 -32.3 63.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -45.3 91.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.023 0.439 . . . . 0.0 110.66 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -58.25 -44.04 88.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.847 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -34.11 76.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -60.35 -45.01 94.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.36 -43.68 76.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.064 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -50.19 50.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.322 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -33.71 70.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.98 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -77.74 -30.32 51.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.753 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -123.66 75.96 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.935 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.0 149.99 30.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.85 131.6 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.175 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -178.61 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -144.28 157.2 44.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 23.9 mm -92.13 116.12 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.865 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.916 0.389 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? 66.85 -74.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.894 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 5.5 ttp -65.44 152.37 44.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 -47.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -111.69 136.23 51.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -103.72 -56.52 2.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.41 122.49 7.79 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.602 2.201 . . . . 0.0 112.431 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 59.6 p -72.06 -59.26 2.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.027 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -165.89 92.31 0.84 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.08 118.92 5.98 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.522 2.148 . . . . 0.0 112.26 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.52 147.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.858 0.361 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.5 m -101.46 -58.77 1.82 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -65.32 -41.0 94.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.8 ttt-85 -64.02 -39.52 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.63 -35.09 78.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.22 -39.99 84.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.852 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.6 mm -71.25 -35.14 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.233 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.27 -34.17 68.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.401 . . . . 0.0 110.482 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -67.34 -23.81 65.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.78 -47.6 79.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.2 m -68.99 -26.88 65.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.024 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 62.66 162.89 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.934 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.65 125.36 24.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -110.97 118.82 37.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.07 138.26 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.608 0.718 . . . . 0.0 111.779 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.46 52.5 0.48 Allowed Glycine 0 C--N 1.314 -0.671 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.515 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.95 -43.81 10.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.9 OUTLIER 177.69 38.8 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.696 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -75.07 134.62 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 113.76 -1.563 . . . . 0.0 112.583 -177.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.0 -60.51 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 m -143.47 162.43 35.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.355 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.23 123.59 32.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.0 111.142 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.71 HG21 ' HE2' ' A' ' 68' ' ' PHE . 38.5 t -91.16 122.77 42.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.041 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -126.89 123.13 61.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.38 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.628 ' SG ' HD21 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -92.14 100.11 12.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.592 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.749 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.5 p -79.92 -2.63 44.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 111.341 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.81 73.28 0.66 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.065 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -144.9 -38.72 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.9 mt -127.54 141.32 40.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.846 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.76 137.97 28.14 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.112 1.874 . . . . 0.0 112.15 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -55.26 144.03 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.785 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.37 164.32 30.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.263 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.85 119.84 34.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 112.008 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.538 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.5 mt -94.67 137.43 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.25 158.09 43.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.82 141.98 31.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.424 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.879 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -78.33 134.9 37.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 111.424 -179.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.486 HG22 HD23 ' A' ' 56' ' ' LEU . 96.6 mt -64.46 -45.0 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.819 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.444 ' HA ' HD21 ' A' ' 56' ' ' LEU . 14.5 m -60.11 -39.11 85.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.305 0.574 . . . . 0.0 110.601 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 3.8 mm100 -68.49 -36.79 79.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.481 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 51' ' ' ASP . 61.1 t -68.4 -49.92 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.019 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD23 HG22 ' A' ' 52' ' ' ILE . 4.3 pp -68.83 -30.75 69.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -74.01 -35.32 64.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -80.45 115.66 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -99.08 31.78 2.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.61 -178.46 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 t -80.41 -30.76 37.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.954 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.89 HD11 HG22 ' A' ' 65' ' ' VAL . 8.8 tp -112.73 147.19 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' CD ' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -115.96 -65.21 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.862 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.0 ttpt -150.22 126.5 10.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.89 HG22 HD11 ' A' ' 62' ' ' ILE . 4.4 t -120.44 138.52 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.199 0.523 . . . . 0.0 112.031 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -100.74 139.69 36.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.403 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.722 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.4 129.7 55.25 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.711 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -120.43 145.66 46.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.628 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.64 -169.56 36.39 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.73 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 9.7 mtm105 -82.54 5.17 21.68 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.3 t-20 -84.9 132.62 45.43 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.523 0.201 . . . . 0.0 110.773 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.3 Cg_exo -65.39 -13.97 42.54 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.446 2.097 . . . . 0.0 111.685 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.74 -44.1 16.01 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.842 0.829 . . . . 0.0 108.835 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.25 137.84 3.33 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.871 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.49 -18.6 12.0 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.726 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -129.54 124.29 33.51 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.17 108.05 20.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.771 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.724 HD23 HD13 ' A' ' 84' ' ' LEU . 8.2 mp -72.63 -172.96 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.153 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.99 38.96 3.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.82 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.89 64.38 0.99 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 111.886 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 84' ' ' LEU . 39.2 mt -94.08 133.73 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.741 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 p -54.81 -44.9 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.455 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -45.55 89.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.56 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.724 HD13 HD23 ' A' ' 78' ' ' LEU . 28.6 mt -72.79 152.27 41.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.695 0.283 . . . . 0.0 111.318 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -97.18 163.5 12.89 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.017 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.1 m-20 -42.76 -51.62 5.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.442 0.639 . . . . 0.0 109.846 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HB2' HD11 ' A' ' 104' ' ' ILE . 16.3 ptmt -120.32 82.24 1.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -64.78 -45.39 86.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.455 -176.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.495 ' HA ' HG12 ' A' ' 104' ' ' ILE . 47.5 p90 -150.21 163.38 38.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.234 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.722 ' CD ' HG23 ' A' ' 67' ' ' THR . 10.3 mt-30 -135.71 158.41 44.46 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.468 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.711 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 68.2 mt -125.8 131.15 72.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.138 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.678 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -114.12 145.57 41.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.1 0.476 . . . . 0.0 111.711 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 33' ' ' VAL . 25.2 tp -125.18 126.96 46.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.192 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.8 -179.4 17.81 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.674 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.78 -166.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 110.975 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.442 ' C ' HD12 ' A' ' 155' ' ' LEU . 0.8 OUTLIER 70.15 -64.29 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.968 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.35 -17.25 1.69 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.782 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.406 ' O ' HD22 ' A' ' 99' ' ' LEU . 21.1 p-10 -69.43 173.75 5.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.858 0.361 . . . . 0.0 110.865 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.439 ' CD1' HD13 ' A' ' 93' ' ' LEU . 3.1 mm? -124.73 155.35 39.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.605 ' HB3' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -133.15 141.34 48.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.233 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.17 128.8 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.678 ' HB2' HD11 ' A' ' 92' ' ' LEU . 42.0 t30 -115.42 115.48 26.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.458 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 15.0 p30 -79.53 143.05 35.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.602 HD13 ' CG ' ' A' ' 90' ' ' GLN . 15.2 pt -150.93 37.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.32 158.31 15.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.003 0.43 . . . . 0.0 111.613 -178.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -68.87 -34.93 76.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.436 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.65 -19.88 17.29 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.09 161.7 11.62 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.647 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.7 m -117.52 137.87 52.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.843 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -113.65 148.32 36.51 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.08 113.3 18.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.174 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.6 m-80 44.17 43.39 5.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.285 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 -5.82 84.46 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.454 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.14 118.51 36.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.094 0.474 . . . . 0.0 110.828 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.843 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 13.2 tptp -74.89 120.59 20.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.363 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -95.17 163.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.267 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 15.4 tp10 -69.84 127.3 32.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.611 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 16.0 tttm -52.18 161.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.753 0.311 . . . . 0.0 110.577 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.48 34.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.215 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.21 145.09 40.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.901 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.611 HD22 HD13 ' A' ' 92' ' ' LEU . 2.6 m120 -88.48 128.42 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.032 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.1 mm-40 -129.69 149.13 51.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.605 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.7 126.08 29.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.394 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.549 HD21 HG12 ' A' ' 147' ' ' ILE . 65.9 tp -64.69 158.43 24.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.301 0.572 . . . . 0.0 111.424 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.425 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -124.14 153.32 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.242 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.501 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.13 122.71 20.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 0.0 110.478 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.18 20.76 55.17 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.162 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 12.6 t70 -56.2 174.12 0.14 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.7 tt0 -145.12 135.59 24.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.104 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.829 HD11 HD11 ' A' ' 145' ' ' ILE . 12.7 mt -109.05 127.96 65.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.371 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.486 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.0 m -104.47 137.84 41.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.523 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.32 158.42 25.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.88 24.57 44.74 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.266 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.1 t -64.78 140.43 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.58 0.705 . . . . 0.0 112.237 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.36 -42.31 0.85 Allowed Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.369 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.39 131.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.52 -33.08 20.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.557 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.56 6.25 48.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.7 20.2 11.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 134' ' ' VAL . 13.9 mt -102.95 139.52 23.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.07 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 142' ' ' SER . 6.4 tt -124.32 134.41 53.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.267 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.749 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.4 OUTLIER -113.3 127.8 56.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.105 0.478 . . . . 0.0 111.742 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.487 HD11 HD12 ' A' ' 43' ' ' ILE . 19.2 mt -121.2 139.82 52.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.482 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.5 t -110.8 139.68 33.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 111.147 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.829 HD11 HD11 ' A' ' 130' ' ' ILE . 41.4 mt -106.04 130.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.253 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.65 114.0 25.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.36 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.549 HG12 HD21 ' A' ' 124' ' ' LEU . 6.6 mt -84.92 132.98 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.544 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -76.97 110.9 11.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.733 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -60.81 -39.35 88.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.995 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -46.05 92.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.2 -44.19 97.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.961 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -64.92 -33.88 77.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.061 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -58.89 -45.97 88.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.042 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.409 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -67.95 -45.94 72.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.978 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.442 HD12 ' C ' ' A' ' 96' ' ' ASP . 0.5 OUTLIER -67.31 -38.14 84.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.966 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.99 -43.49 95.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -85.58 -35.36 21.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.4 p30 42.47 84.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.456 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.22 150.93 20.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 160' ' ' VAL . 11.1 p -82.57 117.07 27.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.165 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -125.03 32.0 5.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.95 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.72 -169.48 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.2 mt -93.35 116.15 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.217 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.324 -0.845 . . . . 0.0 110.925 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.827 0.346 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.24 149.9 17.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.787 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 60.37 110.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 8.7 t -127.32 138.16 52.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' B' ' 172' ' ' PRO . 1.0 OUTLIER -58.23 179.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -134.32 126.96 30.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.426 ' HG3' ' CE1' ' B' ' 169' ' ' PHE . 33.5 Cg_exo -59.85 97.38 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.755 2.303 . . . . 0.0 112.222 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 70.9 p -65.66 175.13 1.97 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -110.43 86.6 5.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.21 132.85 23.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.58 2.187 . . . . 0.0 112.361 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . 0.524 ' H ' HD23 ' B' ' 176' ' ' LEU . 0.4 OUTLIER -66.86 177.42 1.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 t -154.99 -51.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -72.03 -46.97 55.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -36.03 79.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.88 -45.29 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -59.63 -32.39 70.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.736 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.2 -35.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -36.04 71.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -67.15 -31.11 71.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.311 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 1.8 m-85 -56.91 -48.2 78.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.455 0.645 . . . . 0.0 111.112 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.66 -27.34 37.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.062 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 64.38 121.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.9 158.2 33.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -78.45 135.45 37.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.814 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.68 136.62 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 C-N-CA 123.037 0.535 . . . . 0.0 110.623 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -124.55 67.1 0.52 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.427 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.5 -38.37 26.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.979 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 175.93 39.08 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -71.88 135.63 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.357 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.967 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -93.99 -60.25 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.168 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' HD12 ' A' ' 48' ' ' LEU . 4.0 p -145.09 164.53 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.485 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.678 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -126.17 126.86 44.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.769 HG21 ' HE2' ' A' ' 68' ' ' PHE . 36.5 t -93.96 122.83 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.79 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -126.8 122.56 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.512 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.27 106.64 18.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 110.372 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 t -77.31 -20.37 55.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.064 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' H ' ' A' ' 142' ' ' SER . 81.1 p -79.9 -2.46 43.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.39 74.25 0.48 Allowed Glycine 0 N--CA 1.454 -0.155 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.808 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -147.3 -44.95 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 0.0 110.805 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.783 HD13 HD22 ' A' ' 78' ' ' LEU . 4.2 mt -112.3 140.39 23.6 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' HG22 ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.38 132.83 16.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.262 1.974 . . . . 0.0 112.036 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.79 HG12 HG23 ' A' ' 37' ' ' ILE . 36.2 mt -53.22 135.95 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.57 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -130.72 164.24 25.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.524 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 6.5 m-20 -114.26 119.89 38.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.99 0.424 . . . . 0.0 111.425 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.885 HD22 ' CD1' ' A' ' 66' ' ' TRP . 15.0 mt -93.85 137.08 33.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.812 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.967 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.86 157.63 44.09 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.156 0.979 . . . . 0.0 113.4 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.503 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -130.86 150.63 51.93 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.023 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.851 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -93.66 96.89 10.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.955 0.407 . . . . 0.0 110.439 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.35 -45.16 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 m -61.37 -41.53 97.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.234 0.54 . . . . 0.0 110.743 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.477 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 3.3 mm-40 -68.41 -41.21 80.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 51' ' ' ASP . 59.9 t -70.98 -37.85 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.5 -33.29 71.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.734 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -68.32 -51.28 46.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.51 137.05 54.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -73.56 -7.29 51.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.468 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.56 166.95 0.11 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.829 0.347 . . . . 0.0 111.083 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.71 41.21 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.16 138.27 7.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HG3' HG21 ' A' ' 55' ' ' VAL . 2.5 mptt -84.86 -81.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 49' ' ' SER . 2.6 ttmt -155.37 156.53 35.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 91' ' ' ILE . 12.9 t -130.61 138.97 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.434 0.635 . . . . 0.0 112.402 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.885 ' CD1' HD22 ' A' ' 48' ' ' LEU . 13.0 m-90 -105.09 140.02 38.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.17 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.91 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -115.29 126.08 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.769 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -117.51 145.44 44.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.811 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.31 -170.6 40.32 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.287 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -78.03 -1.28 31.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 28.8 t-20 -84.89 131.88 47.7 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.621 0.248 . . . . 0.0 111.093 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.1 Cg_exo -68.02 -10.57 29.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.469 2.112 . . . . 0.0 111.626 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.68 -43.87 16.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-O 121.897 0.856 . . . . 0.0 108.988 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -38.93 141.14 0.31 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.74 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.17 -19.07 11.98 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.908 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.4 t80 -129.92 130.43 45.12 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.993 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -103.12 107.85 18.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.484 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.783 HD22 HD13 ' A' ' 43' ' ' ILE . 26.4 mt -74.24 -70.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.31 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.34 -109.1 0.29 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.656 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -153.77 63.14 0.72 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.774 0.321 . . . . 0.0 111.166 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 84' ' ' LEU . 31.1 mt -112.01 115.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.947 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.458 ' O ' HG22 ' B' ' 171' ' ' TPO . 0.0 OUTLIER -54.81 -35.1 63.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG3' ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -61.19 -18.66 59.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 81' ' ' ILE . 13.7 mt -104.81 147.35 27.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.652 0.263 . . . . 0.0 110.675 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.66 160.58 14.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.546 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.62 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -40.87 -51.32 3.18 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.606 0.717 . . . . 0.0 109.741 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 67' ' ' THR . 18.0 mttt -120.82 82.6 1.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.575 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 17.1 t60 -63.16 -46.06 88.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.968 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 21.8 p90 -146.25 161.87 39.32 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.121 -0.632 . . . . 0.0 112.282 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.91 ' CG ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.35 137.26 42.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.38 -178.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 65' ' ' VAL . 45.2 mt -115.22 132.09 65.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.559 HD21 HD22 ' A' ' 121' ' ' ASN . 1.0 OUTLIER -121.39 145.86 47.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.139 0.495 . . . . 0.0 111.876 -179.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.561 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.9 tm? -125.07 138.2 54.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.194 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 93' ' ' LEU . . . -140.25 -147.55 5.02 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.631 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.88 177.69 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.862 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 60.66 157.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.93 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.8 59.84 4.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -142.3 171.47 14.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.972 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.807 ' CB ' HD13 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -128.28 158.33 38.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.771 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.9 OUTLIER -128.37 138.37 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.387 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.594 ' O ' HD12 ' A' ' 101' ' ' LEU . 3.1 pp -113.04 120.72 42.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.077 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 56.0 t30 -114.57 116.03 28.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.668 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.797 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.8 p30 -77.45 140.51 39.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.063 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 89' ' ' PHE . 12.1 pt -143.89 28.42 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.448 0.166 . . . . 0.0 111.407 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 9.3 t -89.56 159.67 17.07 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.519 0.676 . . . . 0.0 112.677 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -69.72 -50.42 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.417 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.25 2.92 54.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.266 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.33 159.36 28.11 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.898 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.543 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.0 m -117.74 138.05 52.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.347 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.855 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -110.12 148.82 31.02 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.86 113.3 18.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.228 177.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.423 ' N ' HD12 ' A' ' 111' ' ' LEU . 59.1 m-20 44.77 42.9 6.4 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.57 -14.21 60.39 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.548 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.2 118.38 36.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.075 0.438 . . . . 0.0 110.482 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.855 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -70.92 123.9 23.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.407 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.7 m -95.39 165.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.029 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 mp0 -69.85 126.81 30.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.685 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 62.9 tttt -54.84 162.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.991 0.424 . . . . 0.0 110.579 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.59 33.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.147 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.54 144.55 41.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.89 179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.559 HD22 HD21 ' A' ' 92' ' ' LEU . 16.7 m120 -93.22 133.32 36.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.946 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 53.8 mm-40 -129.24 151.25 50.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -72.61 113.56 9.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' A' ' 99' ' ' LEU . 7.2 tt -49.29 156.55 0.57 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.629 . . . . 0.0 111.739 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.48 153.48 41.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.641 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.2 121.93 19.27 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.57 19.68 65.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.734 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -49.26 165.35 0.06 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.857 0.361 . . . . 0.0 111.172 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.5 tt0 -143.2 135.48 27.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.973 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.555 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -115.12 127.77 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.646 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.6 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.5 m -104.64 139.13 39.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.55 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.9 m -140.57 158.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.36 32.08 23.48 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.148 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.5 t -71.75 140.34 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-O 121.536 0.684 . . . . 0.0 112.391 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.405 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 152.88 -42.18 0.67 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.314 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 138' ' ' SER . 44.7 t -126.34 131.76 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 -34.8 25.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 111.414 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.521 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.9 m -93.53 6.37 48.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 83' ' ' ARG . 59.2 m-20 -121.16 21.82 11.1 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.6 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.1 mt -103.93 139.28 25.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.99 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 141' ' ' LEU . 7.9 tt -124.36 134.53 53.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.505 ' H ' HG21 ' A' ' 40' ' ' THR . 46.6 t -110.59 150.21 29.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.716 0.769 . . . . 0.0 112.368 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.78 HD21 HD12 ' A' ' 43' ' ' ILE . 70.1 mt -135.68 145.74 47.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.831 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.51 139.97 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.349 . . . . 0.0 111.073 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.555 HD11 HD11 ' A' ' 130' ' ' ILE . 39.6 mt -106.14 126.22 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.18 118.9 36.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.601 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.507 HD11 HD21 ' A' ' 124' ' ' LEU . 6.3 mt -84.64 133.79 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -84.3 115.42 22.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.809 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -58.87 -29.05 66.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.019 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -59.24 -44.04 92.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -33.86 73.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.94 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -67.31 -37.01 82.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -62.66 -46.02 90.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.97 -37.77 78.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.861 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -59.52 -39.78 84.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.974 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -35.93 14.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.956 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.7 p30 44.63 -171.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.554 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -59.32 156.28 12.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.859 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 t -66.92 136.44 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.101 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -156.69 165.36 36.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.96 168.0 9.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.5 pt -82.58 132.63 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.048 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.821 179.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.956 0.407 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -168.88 -68.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -42.21 5.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.46 139.82 47.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' B' ' 172' ' ' PRO . 1.2 t80 -169.45 171.77 7.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.61 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . 0.458 HG22 ' O ' ' A' ' 82' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.421 ' HA ' ' CZ ' ' B' ' 169' ' ' PHE . 57.6 Cg_exo -51.84 126.48 20.03 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.561 2.174 . . . . 0.0 112.333 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 23.5 p -89.0 153.99 20.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -109.09 81.91 1.74 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.05 155.81 60.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.582 2.188 . . . . 0.0 112.239 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.44 106.41 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.979 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.215 -0.897 . . . . 0.0 110.813 -179.933 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.813 0.34 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.1 m -144.72 -55.63 0.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -71.72 -46.97 56.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mtt180 -63.34 -36.16 82.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.2 -40.43 93.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.01 -44.82 95.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 10.6 mm -67.7 -35.16 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.187 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -57.18 -35.8 70.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.358 . . . . 0.0 110.43 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 -23.86 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.807 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.53 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.54 -47.54 79.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.067 0.461 . . . . 0.0 111.363 -179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.5 -32.82 48.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.886 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.37 14.51 9.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.15 132.34 46.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.775 0.321 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.48 101.94 13.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.27 138.41 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.664 0.745 . . . . 0.0 111.775 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.79 51.97 0.27 Allowed Glycine 0 C--N 1.313 -0.704 0 CA-C-N 114.502 -1.226 . . . . 0.0 112.431 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.34 -45.89 75.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 0.0 111.067 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -169.64 32.9 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.33 134.19 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.48 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.71 -61.01 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.035 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.7 p -147.16 151.4 36.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.394 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.45 138.14 50.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.711 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.7 t -105.55 122.76 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.761 HG23 HG12 ' A' ' 45' ' ' ILE . 17.0 mt -125.81 117.06 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.407 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HA ' HD13 ' A' ' 143' ' ' LEU . 13.8 t -79.75 124.67 28.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 110.579 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.429 HG23 HG21 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -94.52 -24.56 17.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.387 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.486 HG23 ' HB3' ' A' ' 142' ' ' SER . 67.6 p -79.86 -2.36 43.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.397 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.8 73.84 0.54 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.894 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.77 -43.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.151 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.7 mt -115.15 140.53 25.78 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.9 Cg_endo -74.24 138.47 25.09 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.2 1.933 . . . . 0.0 112.149 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.761 HG12 HG23 ' A' ' 37' ' ' ILE . 35.3 mt -56.11 129.48 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.629 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -126.23 164.14 21.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.31 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 119.71 35.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.994 0.426 . . . . 0.0 111.797 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 66' ' ' TRP . 2.0 mt -92.42 137.27 32.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.012 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.55 158.8 43.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.89 142.68 30.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.75 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.887 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.7 m-20 -74.92 121.81 22.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.039 0.447 . . . . 0.0 111.109 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.556 HD13 ' SG ' ' A' ' 154' ' ' CYS . 76.3 mt -64.32 -44.84 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.038 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -60.38 -40.85 92.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.235 0.54 . . . . 0.0 110.658 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.494 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 5.7 mm100 -68.6 -36.77 79.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.826 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 51' ' ' ASP . 60.3 t -69.26 -43.24 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.972 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -27.31 63.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.039 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -39.39 65.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.051 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.39 125.24 48.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.034 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.17 98.95 9.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -148.6 -167.2 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.2 t -76.27 -56.87 4.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.009 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 65' ' ' VAL . 26.3 mm -125.97 153.57 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.784 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.27 -72.42 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.734 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.5 ttpt -126.36 125.5 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 62' ' ' ILE . 3.7 t -111.87 139.14 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.264 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.601 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.2 m-90 -100.42 139.29 36.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.899 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.39 133.69 53.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.711 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -116.01 145.57 42.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.313 -178.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.797 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 170.57 -175.46 44.4 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.455 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -82.19 -4.39 56.92 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.4 p30 -87.71 139.34 31.31 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.861 0.362 . . . . 0.0 111.18 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 8.7 Cg_exo -69.49 -4.27 13.5 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.889 2.393 . . . . 0.0 111.88 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -46.8 12.8 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.869 0.842 . . . . 0.0 109.081 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -44.78 139.01 3.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.724 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.29 -19.09 12.7 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.552 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 5.9 t80 -129.75 120.76 25.6 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.848 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -89.41 107.92 19.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.681 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 69' ' ' GLY . 8.7 mp -75.14 -83.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.306 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.95 -96.8 0.1 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.531 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -175.37 60.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.298 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.756 HD11 HD12 ' A' ' 141' ' ' LEU . 41.0 mt -103.13 122.12 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.783 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -58.62 -33.89 70.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.484 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 5.1 tpt180 -60.71 -47.69 85.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.661 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 84' ' ' LEU . 4.2 mp -72.63 153.61 41.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' ASN . 46.3 p -94.61 166.55 11.97 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.933 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.797 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m120 -40.54 -74.69 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.586 ' HB3' HG22 ' A' ' 67' ' ' THR . 15.0 mttt -97.95 85.59 3.55 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -63.32 -44.86 93.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.957 -176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' HA ' HG12 ' A' ' 104' ' ' ILE . 31.7 p90 -153.49 162.4 41.3 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG23 ' A' ' 67' ' ' THR . 10.6 mt-30 -135.92 160.0 39.94 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.732 HG23 HD23 ' A' ' 101' ' ' LEU . 58.3 mt -123.78 131.96 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.081 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -104.66 139.58 39.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.071 0.463 . . . . 0.0 111.685 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.6 ' C ' HD13 ' A' ' 93' ' ' LEU . 1.8 tm? -125.41 122.93 38.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.491 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 170.13 -139.38 5.5 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.622 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 63.03 -178.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.348 . . . . 0.0 110.855 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.08 -60.73 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -157.76 68.91 0.27 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -168.18 173.11 8.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.955 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.787 HD11 HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -120.0 156.23 31.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.743 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.8 mt -133.42 147.25 51.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.595 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.732 HD23 HG23 ' A' ' 91' ' ' ILE . 14.2 mt -112.66 130.33 56.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.617 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.6 t30 -115.05 115.63 27.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.642 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.762 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.6 p-10 -81.18 141.27 34.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.137 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.56 HG21 ' OE1' ' A' ' 90' ' ' GLN . 13.6 pt -149.82 37.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.606 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -97.39 156.42 16.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.11 0.481 . . . . 0.0 111.84 -178.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.2 m -68.55 -32.79 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.103 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -98.63 -19.9 17.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.112 -179.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.606 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.91 164.3 13.45 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.443 -0.884 . . . . 0.0 113.215 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 14.9 m -117.4 137.68 52.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.825 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -115.74 148.42 39.82 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.601 ' CD1' HG11 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -124.41 113.36 18.06 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.544 177.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 45.76 37.4 3.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.013 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.58 -1.86 76.39 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.556 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -107.97 118.65 37.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.02 0.438 . . . . 0.0 110.919 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.825 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -75.63 129.72 37.62 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.348 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.762 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.4 m -106.49 165.11 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.358 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -69.85 131.77 44.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.209 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 6.1 tttt -55.45 168.78 0.35 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.445 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 31.85 37.19 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.302 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.0 p -111.96 145.08 40.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.342 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.59 HD22 HD13 ' A' ' 92' ' ' LEU . 6.2 m120 -93.58 122.44 36.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.626 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -128.59 146.73 50.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.23 115.48 12.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.148 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 99' ' ' LEU . 1.7 pt? -62.03 169.66 2.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.804 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.4 153.72 41.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.116 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.479 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.07 120.55 16.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.035 0.445 . . . . 0.0 110.136 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.58 20.84 64.2 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.139 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.545 ' OD2' HD23 ' A' ' 111' ' ' LEU . 5.0 t70 -61.63 179.6 0.24 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.852 0.358 . . . . 0.0 110.796 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.902 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.1 mt-10 -145.17 135.66 24.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.307 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 145' ' ' ILE . 11.8 mt -108.35 128.08 64.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.286 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.27 137.91 41.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 13.9 m -140.46 158.48 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.88 30.12 29.94 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.171 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.532 ' HA ' HG12 ' A' ' 140' ' ' ILE . 64.3 t -69.0 140.24 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 121.661 0.743 . . . . 0.0 112.332 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.8 -43.49 0.67 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.266 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 138' ' ' SER . 42.4 t -126.48 135.21 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.48 -37.15 37.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.666 0.269 . . . . 0.0 111.679 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.448 ' H ' HG12 ' A' ' 136' ' ' VAL . 95.0 p -93.58 6.33 48.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.31 19.88 14.56 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.678 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -106.04 138.96 28.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.238 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.756 HD12 HD11 ' A' ' 81' ' ' ILE . 3.3 tt -124.57 134.49 52.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.681 ' N ' HD23 ' A' ' 141' ' ' LEU . 38.8 t -111.56 150.32 30.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.8 . . . . 0.0 112.732 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.9 mm? -135.81 149.54 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.159 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.2 t -114.18 139.14 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 111.178 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 130' ' ' ILE . 10.8 mt -106.4 120.88 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.997 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 107.69 17.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.274 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.6 mt -84.77 128.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.598 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.71 119.46 20.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.91 -32.0 72.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -45.54 91.64 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.679 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.83 -44.06 90.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -64.98 -42.04 94.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -59.47 -39.65 84.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.929 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.7 t -64.59 -46.09 84.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.89 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.98 -39.32 79.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.11 -35.68 75.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.16 -36.99 13.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 p30 44.1 -170.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.573 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 119.03 6.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.966 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 p -101.3 131.49 48.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -85.75 -176.89 6.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -108.04 147.84 30.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.91 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 6.9 tp -86.83 140.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.051 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.904 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.783 0.325 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 -171.47 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtt -125.42 116.74 22.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 3.3 t 43.35 74.58 0.11 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.467 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' B' ' 172' ' ' PRO . 0.2 OUTLIER -132.13 89.49 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -73.63 68.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . 0.627 ' O3P' HG22 ' B' ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.435 ' HB3' ' CE2' ' B' ' 169' ' ' PHE . 44.2 Cg_endo -68.16 88.62 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.468 2.112 . . . . 0.0 112.347 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t -64.89 -37.9 89.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.36 139.83 0.51 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.798 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.67 114.52 4.04 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.446 2.097 . . . . 0.0 112.268 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.52 166.99 22.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.786 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.0 p -112.33 -71.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -71.89 -42.56 66.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.888 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.99 -43.64 81.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.81 -31.92 72.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -73.13 -35.35 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -57.44 -43.6 84.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.476 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -67.21 -23.7 65.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.546 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.72 -47.46 79.95 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.229 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.9 -29.67 50.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.883 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 62.12 116.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.51 152.19 45.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.53 138.28 31.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.823 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.16 138.41 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.69 0.757 . . . . 0.0 111.707 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.89 64.32 0.39 Allowed Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.536 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -87.77 -36.47 17.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.672 0.272 . . . . 0.0 110.985 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 t-20 175.42 39.71 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.694 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -71.73 136.22 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-N 113.588 -1.642 . . . . 0.0 112.551 -177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.017 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -91.97 -59.59 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.938 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 157.78 43.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.468 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -123.56 124.85 43.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.679 HG21 ' HE2' ' A' ' 68' ' ' PHE . 46.4 t -92.43 122.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.992 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.856 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -129.03 125.44 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.431 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.4 t -89.91 107.87 19.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.316 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 t -79.99 -26.2 40.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.767 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 142' ' ' SER . 58.7 p -79.83 -2.59 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 0.0 111.525 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . 67.57 80.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.067 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 141' ' ' LEU . 9.2 mt-30 -147.73 -39.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.787 0.327 . . . . 0.0 111.015 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.079 HD13 HD22 ' A' ' 78' ' ' LEU . 6.8 mt -127.43 141.99 42.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.8 Cg_endo -71.92 141.62 37.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.11 1.873 . . . . 0.0 112.127 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.856 HG12 HG23 ' A' ' 37' ' ' ILE . 34.2 mt -55.86 149.11 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.847 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.29 162.85 35.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.289 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -121.21 122.67 40.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.08 0.467 . . . . 0.0 111.907 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -101.03 137.26 39.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.193 178.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.017 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.12 158.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.89 148.56 31.93 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.12 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.886 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -78.75 122.27 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.161 0.505 . . . . 0.0 111.233 -179.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.9 mt -64.45 -42.47 95.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.142 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.1 t -59.68 -40.19 87.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.36 0.6 . . . . 0.0 110.61 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 6.1 mm100 -68.48 -36.83 79.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.517 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 51' ' ' ASP . 28.8 t -71.35 -37.96 67.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.107 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.97 -41.36 74.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.74 -44.97 91.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -99.59 119.42 38.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.972 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.65 -27.18 12.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -88.93 154.9 19.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 m 61.32 -178.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.067 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 tp -92.5 152.79 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.022 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.745 ' HG3' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -84.51 -79.48 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.045 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' A' ' 49' ' ' SER . 28.1 ttpt -132.77 138.47 47.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 92' ' ' LEU . 9.3 t -124.79 138.66 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.223 0.535 . . . . 0.0 111.702 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.601 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 18.9 m-90 -100.75 139.86 35.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.145 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.818 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.84 130.58 55.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.726 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -120.09 145.1 47.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.034 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.58 -172.78 39.58 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.109 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 30.5 mtp180 -75.74 1.64 14.23 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.481 HD22 ' HB3' ' A' ' 73' ' ' ALA . 1.9 t30 -84.67 141.93 39.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.339 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 61.7 Cg_endo -73.76 -14.37 24.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.6 2.2 . . . . 0.0 111.271 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -43.28 17.21 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.881 0.848 . . . . 0.0 108.735 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.74 140.83 1.2 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.791 -1.55 . . . . 0.0 110.898 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -56.26 -18.58 10.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.094 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.6 ' CD2' HD21 ' A' ' 78' ' ' LEU . 3.0 t80 -129.18 122.68 30.29 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.723 0.296 . . . . 0.0 110.842 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 -97.0 110.99 23.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.151 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.079 HD22 HD13 ' A' ' 43' ' ' ILE . 12.8 mt -92.59 170.75 9.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.658 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.43 -86.41 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.413 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 176.61 77.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.917 0.389 . . . . 0.0 110.665 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.745 HD11 HD12 ' A' ' 141' ' ' LEU . 28.8 mt -109.94 116.65 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -35.68 64.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.019 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -29.42 69.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.948 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.593 HD11 HD12 ' A' ' 81' ' ' ILE . 46.8 mt -90.15 152.35 21.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.55 166.11 12.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.535 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.51 -53.64 5.39 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.475 0.655 . . . . 0.0 109.507 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.729 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.74 84.42 2.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -62.04 -44.93 95.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.982 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 25.8 p90 -146.31 162.85 37.23 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.399 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.818 ' CG ' HG23 ' A' ' 67' ' ' THR . 11.2 mt-30 -135.57 148.01 48.93 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.726 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 64.5 mt -125.07 132.4 71.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 121.164 -0.215 . . . . 0.0 110.677 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.725 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -126.04 135.22 51.51 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.034 0.445 . . . . 0.0 112.146 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.68 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.8 tm? -125.41 131.38 52.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.161 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.68 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 154.05 -137.46 5.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.552 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 67.11 -74.26 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.824 0.345 . . . . 0.0 110.835 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -150.57 -60.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.26 172.2 30.83 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.468 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m120 60.99 175.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.987 HD21 HG12 ' A' ' 33' ' ' VAL . 5.6 mp -112.61 160.25 18.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.848 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.7 mp -129.79 142.93 50.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.736 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.08 125.14 52.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.132 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.567 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.2 t30 -116.57 116.33 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.792 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -76.63 139.49 40.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.831 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.2 pt -145.32 38.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.31 152.65 19.69 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.076 0.465 . . . . 0.0 111.829 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 54.0 m -68.9 -31.41 70.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.994 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -97.99 -19.92 17.73 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.01 157.37 10.8 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.841 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.46 137.81 52.28 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -114.48 148.35 37.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.2 113.47 18.35 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.329 177.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.408 ' N ' HD12 ' A' ' 111' ' ' LEU . 91.4 m-20 44.17 43.5 5.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.7 -10.87 68.25 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.517 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -104.06 118.46 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.08 0.44 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 18.4 tptt -74.08 123.15 23.85 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.247 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.792 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.5 m -94.35 165.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.014 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 12.5 tp10 -69.94 127.24 32.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 69.2 tttt -55.07 162.53 1.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.952 0.406 . . . . 0.0 110.354 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.411 ' CG ' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER 36.83 32.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.115 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 144.99 41.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.818 179.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.725 ' OD1' HD21 ' A' ' 92' ' ' LEU . 14.8 m-80 -94.8 133.44 38.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.042 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.5 mm-40 -129.22 152.28 48.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.376 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.34 125.81 28.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.948 0.404 . . . . 0.0 110.476 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 145' ' ' ILE . 30.7 tp -56.36 154.68 7.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.496 0.665 . . . . 0.0 111.814 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.467 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.88 152.93 43.39 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.601 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -72.11 124.25 24.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.779 0.323 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.04 22.56 42.95 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.15 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.5 t70 -52.81 171.81 0.06 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 110.96 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.927 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.5 mt-10 -143.91 135.5 26.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.094 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.854 HD11 HD11 ' A' ' 145' ' ' ILE . 15.5 mt -114.94 126.01 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.436 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.69 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.29 138.44 40.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 84' ' ' LEU . 35.7 m -140.24 158.26 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 84.97 27.09 35.16 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.105 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.0 t -66.28 140.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.618 0.723 . . . . 0.0 112.496 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.51 -41.58 0.62 Allowed Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.289 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.1 t -126.46 136.49 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -39.88 52.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.7 0.286 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.446 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.45 6.33 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 23.1 t0 -116.62 23.28 12.13 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.69 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.0 mt -107.03 139.56 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.317 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 HD11 ' A' ' 81' ' ' ILE . 6.8 tt -119.25 134.39 55.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.591 ' HB2' HG23 ' A' ' 40' ' ' THR . 1.5 m -109.01 141.98 40.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 111.654 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.809 HD21 HD12 ' A' ' 43' ' ' ILE . 73.8 mt -135.13 141.97 46.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.787 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.927 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.3 t -114.08 140.07 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.798 0.332 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.854 HD11 HD11 ' A' ' 130' ' ' ILE . 50.3 mt -106.16 129.64 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.211 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -113.83 115.29 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.446 HG12 HD21 ' A' ' 124' ' ' LEU . 1.8 mt -84.77 134.03 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -83.46 103.96 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -29.47 64.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -45.02 91.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.977 0.418 . . . . 0.0 110.667 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -59.24 -44.3 92.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -40.47 94.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -59.12 -43.1 91.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.3 t -60.04 -45.98 91.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -36.02 81.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -64.79 -37.34 87.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -87.28 -36.43 17.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.783 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.56 35.78 0.71 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.488 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.68 139.68 52.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -65.02 116.99 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.8 105.81 16.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.4 ttp-105 -68.44 107.49 2.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.8 pt -91.09 130.29 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.189 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.4 ttp85 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.913 179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.799 0.333 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -74.15 -63.18 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -90.98 99.84 12.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 1.7 m -154.01 152.36 30.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.4 ' O ' ' CD1' ' B' ' 169' ' ' PHE . 36.4 p90 -98.79 118.76 36.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.09 80.75 3.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . 0.647 HG22 ' O1P' ' B' ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.7 150.09 17.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.585 2.19 . . . . 0.0 112.314 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 73.4 p -107.05 -67.04 0.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -155.53 72.73 5.46 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.2 -171.84 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.564 2.176 . . . . 0.0 112.244 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . 0.442 HD12 ' N ' ' B' ' 176' ' ' LEU . 2.5 mp -130.56 154.71 47.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.967 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.805 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.727 0.299 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 77.87 -56.55 0.49 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.189 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -39.34 84.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -61.26 -36.8 81.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.825 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -65.71 -38.27 88.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.24 -43.18 96.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.875 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.8 mm -68.23 -35.12 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.21 -34.73 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.378 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -67.23 -23.9 65.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.814 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.64 -47.63 79.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.87 -26.37 62.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.958 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 63.02 145.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.82 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.49 124.19 28.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.956 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -95.14 136.94 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.756 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.03 138.36 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.667 0.746 . . . . 0.0 111.785 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.47 30.96 0.47 Allowed Glycine 0 C--N 1.314 -0.678 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.56 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -41.62 85.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.722 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 49' ' ' SER . 3.0 m-20 179.78 38.09 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -71.39 143.77 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.477 -176.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.86 HG22 HD13 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -109.94 -49.51 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.785 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.621 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -152.72 158.7 42.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.422 179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -130.83 136.88 49.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.749 0.309 . . . . 0.0 111.476 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 68' ' ' PHE . 58.3 t -108.54 122.62 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.964 0.411 . . . . 0.0 110.647 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.846 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -126.76 115.21 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.463 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.563 ' HA ' HD23 ' A' ' 143' ' ' LEU . 17.6 t -81.4 101.87 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 110.409 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -24.09 56.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.755 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.639 HG21 ' H ' ' A' ' 142' ' ' SER . 13.7 p -79.82 -2.42 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.417 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.6 78.81 0.26 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.133 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -147.64 -40.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.007 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.0 mt -124.64 141.85 39.05 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 54.2 Cg_endo -71.57 137.64 30.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.252 1.968 . . . . 0.0 111.925 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.846 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -54.62 137.54 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.914 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 163.33 27.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.976 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.5 m-20 -118.65 119.75 35.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.0 111.892 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 34' ' ' CYS . 3.4 mt -92.24 137.37 32.42 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.5 158.59 44.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.228 1.013 . . . . 0.0 113.665 -178.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -139.09 141.72 38.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.344 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.2 m-20 -75.34 133.31 41.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.362 0.601 . . . . 0.0 111.424 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.635 HD13 ' SG ' ' A' ' 154' ' ' CYS . 44.6 mt -64.82 -39.82 86.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.072 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 p -60.33 -42.69 96.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.598 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.473 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 3.5 pt20 -68.3 -38.6 81.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.451 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.829 HG11 HD21 ' A' ' 155' ' ' LEU . 63.6 t -66.37 -49.97 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.899 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 158' ' ' ASN . 4.2 mm? -67.12 -27.23 67.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -81.23 -32.91 33.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.056 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.91 118.96 17.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.77 99.2 9.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.63 -164.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.786 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.0 t 65.04 -168.16 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 0.0 110.841 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.4 tp -89.27 154.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -104.27 -67.9 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.204 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.8 ttpt -141.37 140.65 33.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.328 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.543 HG22 ' CB ' ' A' ' 92' ' ' LEU . 15.2 t -129.98 138.91 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 121.336 0.589 . . . . 0.0 112.003 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.599 ' CH2' HG11 ' A' ' 33' ' ' VAL . 15.6 m-90 -102.13 139.6 37.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.107 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.944 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.87 126.78 55.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' CE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -117.47 145.58 44.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.317 -178.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.31 -173.12 40.26 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.892 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 5.7 mtp-105 -77.48 -1.29 29.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.474 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.1 t30 -84.81 133.58 43.38 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.691 0.281 . . . . 0.0 111.216 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.3 Cg_exo -68.66 -9.5 26.31 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.797 2.331 . . . . 0.0 112.065 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.8 -43.02 17.18 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.842 0.83 . . . . 0.0 108.921 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.28 139.56 0.72 Allowed 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.939 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.26 -18.77 11.5 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.977 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 55.6 t80 -129.55 123.68 32.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.832 0.349 . . . . 0.0 110.769 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.407 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 -98.77 117.71 33.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.507 HD11 ' C ' ' A' ' 69' ' ' GLY . 1.3 pp -123.37 -177.08 3.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.774 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.34 163.18 7.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.596 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -97.28 68.22 2.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 0.0 110.934 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.43 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 37.7 mm -85.73 128.29 39.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -42.3 75.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.402 ' HB3' ' HA2' ' A' ' 133' ' ' GLY . 1.0 OUTLIER -60.91 -26.52 67.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.16 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.708 HD21 HG23 ' A' ' 132' ' ' VAL . 39.7 mt -90.96 152.33 20.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.6 p -99.88 167.44 10.52 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.687 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -43.96 -53.83 5.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.308 0.575 . . . . 0.0 109.808 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' HG22 ' A' ' 67' ' ' THR . 9.7 mttt -117.19 82.3 1.79 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.591 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 14.0 t60 -58.65 -45.34 89.54 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.772 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.516 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -147.23 160.88 41.96 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.979 -0.688 . . . . 0.0 112.399 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.944 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.33 130.39 34.95 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 65' ' ' VAL . 51.3 mt -110.78 130.82 63.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.924 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.728 HD11 ' OD1' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -124.21 141.45 52.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.956 0.408 . . . . 0.0 111.607 -179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 33' ' ' VAL . 8.3 tt -125.25 126.37 45.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.01 120.92 2.45 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.554 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -176.56 -46.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -158.07 -45.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.19 38.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.554 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -162.21 -174.72 4.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 93' ' ' LEU . 3.2 mp -112.68 160.17 18.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 99' ' ' LEU . 10.0 mp -132.17 141.45 49.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.944 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.645 HD11 HD11 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -112.74 124.16 51.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.518 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.581 ' HB2' HD21 ' A' ' 92' ' ' LEU . 65.9 t30 -117.29 132.66 56.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.105 0.478 . . . . 0.0 112.057 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.765 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.8 p30 -93.26 134.46 35.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.613 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.52 HD13 ' HG3' ' A' ' 90' ' ' GLN . 4.2 pt -136.1 26.5 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.531 0.205 . . . . 0.0 111.504 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.59 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 11.2 t -91.38 156.47 17.73 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.538 0.685 . . . . 0.0 112.539 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.6 m -69.68 -52.21 27.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.873 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -81.49 -1.02 44.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.389 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.77 158.97 30.58 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.417 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.545 HG22 ' CG2' ' A' ' 130' ' ' ILE . 6.0 m -117.54 137.72 52.39 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.88 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -111.95 148.54 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.608 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.05 113.32 18.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.4 177.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 72.1 m-20 43.9 43.64 5.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.37 66.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.35 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.97 118.58 37.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.08 0.467 . . . . 0.0 110.554 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.88 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.7 tptm -73.93 121.17 20.55 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.551 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG23 ' OD2' ' A' ' 103' ' ' ASP . 5.8 m -92.37 163.7 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tp10 -69.91 128.44 36.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.45 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.4 tttt -53.91 161.59 1.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.813 0.339 . . . . 0.0 110.314 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.3 p30 36.83 32.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.42 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.55 144.73 41.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.818 179.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.728 ' OD1' HD11 ' A' ' 92' ' ' LEU . 15.7 m-80 -93.9 130.54 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -129.98 152.15 49.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.194 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 tp -75.34 111.68 10.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.706 HD21 ' CB ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -63.18 168.43 4.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.23 0.538 . . . . 0.0 111.806 -178.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 t -124.35 153.48 41.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.236 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.28 115.64 10.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.025 0.441 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.85 18.55 78.98 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.188 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.608 ' OD2' HD13 ' A' ' 111' ' ' LEU . 10.3 t70 -59.14 179.45 0.1 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.669 0.271 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.872 ' CG ' HG22 ' A' ' 144' ' ' VAL . 11.0 mt-10 -145.23 135.7 24.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.66 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 101' ' ' LEU . 6.2 mt -112.0 128.26 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.642 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 140.51 37.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.595 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.708 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.45 158.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 83' ' ' ARG . . . 83.23 31.33 28.52 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.179 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.3 t -70.21 140.37 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.688 0.756 . . . . 0.0 112.503 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.84 -43.44 0.61 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.138 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.551 HG12 ' H ' ' A' ' 138' ' ' SER . 43.7 t -126.43 131.38 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.47 -33.04 19.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.824 0.345 . . . . 0.0 111.275 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.551 ' H ' HG12 ' A' ' 136' ' ' VAL . 88.1 p -93.64 6.19 49.11 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.58 22.63 9.84 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.642 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.7 mt -104.6 139.6 25.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.058 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 142' ' ' SER . 4.8 tt -119.64 134.55 55.18 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.454 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.639 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -110.19 136.7 49.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.063 0.459 . . . . 0.0 111.678 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 38' ' ' CYS . 57.9 mt -131.0 144.52 51.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.593 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.872 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.7 t -110.95 135.12 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.402 . . . . 0.0 111.381 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.795 ' N ' HD12 ' A' ' 145' ' ' ILE . 2.0 mp -106.06 123.14 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.316 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.25 106.75 15.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.504 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.645 HG12 HD22 ' A' ' 124' ' ' LEU . 6.3 mt -84.79 133.78 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.2 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -75.96 118.72 19.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.003 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -74.01 -30.67 62.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.41 91.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.627 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.423 ' HZ ' HG21 ' A' ' 55' ' ' VAL . 36.1 t80 -58.15 -43.96 87.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.854 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -59.59 -41.09 89.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.43 -45.16 94.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.6 t -68.1 -42.15 80.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.829 HD21 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -66.66 -37.27 84.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.96 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.77 -39.65 93.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -86.28 -32.46 21.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.588 ' HB2' HD11 ' A' ' 56' ' ' LEU . 2.7 p30 42.47 85.49 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.441 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -104.25 116.51 32.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 p -84.06 136.89 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.079 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.15 31.55 2.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.99 143.86 29.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.3 pp -105.01 123.4 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.897 179.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.755 0.312 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -110.99 -31.84 7.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.963 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . 0.433 ' HB3' ' CE2' ' B' ' 169' ' ' PHE . 0.0 OUTLIER -175.65 -39.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 4.8 p 58.44 107.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' B' ' 167' ' ' MET . 0.7 OUTLIER -163.41 -178.01 5.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.03 -70.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.956 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.19 151.23 68.61 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.477 2.118 . . . . 0.0 112.299 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 9.7 p -113.67 -25.84 8.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.189 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.73 68.59 0.75 Allowed Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.762 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.43 109.39 0.36 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.639 2.226 . . . . 0.0 112.384 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.88 119.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.962 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' HB1' ' CG ' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.792 0.329 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 16' ' ' GLN . 5.7 t -151.21 -48.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.955 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.427 ' N ' HG23 ' A' ' 15' ' ' THR . 0.4 OUTLIER -60.7 -36.26 78.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -71.1 -38.05 72.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.897 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -41.22 84.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -31.95 70.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.9 mt -73.27 -35.24 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.47 -41.1 79.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.52 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -23.99 65.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.648 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.75 -47.51 79.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.02 -38.34 27.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.921 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -81.49 105.47 12.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 120.95 32.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.705 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -107.1 108.68 20.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.024 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.0 138.43 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.606 0.717 . . . . 0.0 111.641 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 91.41 47.66 3.46 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.435 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -83.72 -31.08 26.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.702 0.287 . . . . 0.0 111.143 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.88 35.89 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.731 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.5 mm -77.85 135.09 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.457 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.043 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -89.78 -60.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.617 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.38 165.02 29.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.986 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 124.15 33.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 111.343 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.745 HG21 ' HE2' ' A' ' 68' ' ' PHE . 24.8 t -93.22 122.8 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.085 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.803 HG23 HG12 ' A' ' 45' ' ' ILE . 22.3 mt -127.34 118.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.205 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.434 ' HA ' HD23 ' A' ' 143' ' ' LEU . 12.2 t -80.04 109.81 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.428 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -80.46 -27.25 37.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.61 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.66 HG21 ' OG ' ' A' ' 142' ' ' SER . 6.2 p -79.94 -2.61 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.669 0.271 . . . . 0.0 111.351 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.46 79.97 0.19 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.926 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.427 ' CB ' HD11 ' A' ' 141' ' ' LEU . 17.0 mt-30 -148.04 -39.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.391 . . . . 0.0 110.886 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.749 HD13 ' HB3' ' A' ' 78' ' ' LEU . 7.5 mt -123.44 141.72 36.99 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.9 Cg_endo -72.79 138.89 29.7 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.132 1.888 . . . . 0.0 111.941 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.803 HG12 HG23 ' A' ' 37' ' ' ILE . 37.7 mt -54.9 132.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.956 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 1.5 ttt180 -126.13 164.21 21.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.051 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -117.63 119.71 35.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.991 0.424 . . . . 0.0 111.976 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.759 HD23 ' CD2' ' A' ' 66' ' ' TRP . 5.8 mp -91.49 125.81 36.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.043 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.46 156.52 46.9 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.91 141.76 29.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.299 -1.773 . . . . 0.0 110.531 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -79.44 135.61 36.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.136 0.493 . . . . 0.0 111.039 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mm -64.3 -42.41 95.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.221 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.96 -40.21 76.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.129 0.49 . . . . 0.0 110.948 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.495 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 9.3 mt-30 -68.43 -40.11 81.31 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.74 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.5 t -69.19 -37.93 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.04 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -40.61 78.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.149 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -76.9 -38.67 53.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.07 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.93 120.84 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.97 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.19 -18.9 18.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -53.62 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.858 0.361 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.6 p -81.28 -32.07 33.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' CD1' ' A' ' 92' ' ' LEU . 23.5 mm -119.23 157.22 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.54 ' HG3' HG13 ' A' ' 55' ' ' VAL . 5.0 mmtp -119.42 -62.88 1.45 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.8 ttpt -139.78 130.24 25.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.941 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.718 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.8 t -125.86 139.31 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 121.248 0.546 . . . . 0.0 112.111 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.759 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.4 m-90 -102.32 139.14 38.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.054 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.679 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.53 126.78 55.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.745 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -110.47 145.66 37.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.646 -178.336 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.99 -176.25 39.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.708 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 12.0 mtp180 -77.64 -0.93 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.7 t-20 -84.84 134.04 42.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.643 0.259 . . . . 0.0 111.029 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.6 Cg_exo -68.64 -8.09 22.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.749 2.299 . . . . 0.0 111.763 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.7 -43.56 16.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 122.009 0.909 . . . . 0.0 108.796 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 137.32 2.99 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.507 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.53 -18.68 12.46 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.904 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 3.6 t80 -129.47 125.36 36.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.691 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.63 123.65 45.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.747 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.749 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -123.98 173.5 8.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.997 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.12 154.3 10.61 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.687 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 83.0 4.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.436 ' HB ' HD12 ' A' ' 84' ' ' LEU . 24.5 mm -104.16 119.55 53.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.96 -40.7 70.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.012 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -60.94 -15.88 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.227 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 132' ' ' VAL . 26.9 mt -105.97 149.59 26.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 110.885 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.2 p -93.97 165.21 12.77 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.863 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.707 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -41.66 -52.51 3.82 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.375 0.607 . . . . 0.0 109.818 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.06 82.16 1.88 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.0 t60 -60.62 -45.85 92.48 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.023 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 19.0 p90 -146.34 159.09 43.82 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.719 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.718 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.4 tt0 -135.53 141.66 45.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.285 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.782 HG12 HD23 ' A' ' 101' ' ' LEU . 46.7 mt -117.54 127.12 75.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.073 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.569 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -110.05 148.52 31.55 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.025 0.44 . . . . 0.0 111.748 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.781 HD22 HG11 ' A' ' 33' ' ' VAL . 33.5 tp -125.18 122.87 38.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.446 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.38 -129.77 1.61 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.663 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.26 -71.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.857 0.361 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -176.34 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -147.86 58.25 0.48 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.442 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -173.38 177.95 2.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.643 HD21 ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -116.45 160.14 21.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 122' ' ' GLN . 7.3 mt -132.03 144.01 50.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.346 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.782 HD23 HG12 ' A' ' 91' ' ' ILE . 13.5 mt -112.69 124.18 51.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.299 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 53.6 t30 -118.11 115.79 25.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 111.729 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.5 p30 -77.5 139.2 39.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.83 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 67' ' ' THR . 16.7 pt -146.83 39.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.574 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.72 158.51 15.42 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.039 0.447 . . . . 0.0 111.571 -179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -68.91 -38.19 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.581 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.71 -19.73 17.33 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 124.99 158.64 10.09 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.929 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.58 138.01 52.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.943 -0.628 . . . . 0.0 109.517 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.851 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.26 148.57 35.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.03 113.46 18.43 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.366 177.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.87 43.64 5.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.415 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.75 -10.2 70.98 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.421 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -105.08 118.6 36.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.158 0.504 . . . . 0.0 110.597 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.851 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 5.4 tptt -72.25 119.19 16.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.25 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.1 m -89.95 163.87 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.0 mm-40 -69.86 125.88 28.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.47 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 12.0 tttp -53.35 161.34 0.96 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.832 0.348 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.435 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.9 p30 35.12 34.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.281 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.22 145.1 40.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.976 179.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.757 ' HB3' HD22 ' A' ' 100' ' ' LEU . 7.0 m120 -89.51 131.81 35.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.888 ' O ' HD23 ' A' ' 100' ' ' LEU . 49.9 mm-40 -129.25 148.95 51.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.517 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -72.77 135.91 45.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.52 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.883 HD21 HG12 ' A' ' 147' ' ' ILE . 35.5 tp -59.87 152.85 22.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.55 0.69 . . . . 0.0 111.515 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.41 152.83 44.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.552 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.403 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.3 120.56 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.266 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.98 23.9 57.52 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.27 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.2 t70 -52.23 167.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.006 0.432 . . . . 0.0 111.314 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 16.5 tt0 -145.22 135.62 24.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.151 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.597 HD11 HD22 ' A' ' 101' ' ' LEU . 11.0 mt -113.55 128.14 70.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.562 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.63 138.98 40.15 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.993 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.612 HG23 HD21 ' A' ' 84' ' ' LEU . 35.3 m -140.45 158.43 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 87.13 26.85 29.9 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.318 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 140' ' ' ILE . 79.1 t -66.86 140.26 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.533 0.682 . . . . 0.0 112.204 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.51 -41.54 0.88 Allowed Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 138' ' ' SER . 43.8 t -126.33 134.84 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.65 -34.69 27.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.709 0.29 . . . . 0.0 111.712 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.504 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.6 m -93.5 -6.74 46.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.1 m-20 -102.42 19.7 18.37 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.562 ' CG2' HG22 ' A' ' 131' ' ' THR . 7.8 mt -105.73 139.33 27.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.353 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 142' ' ' SER . 7.4 tt -124.22 134.45 53.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.342 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.66 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.6 OUTLIER -110.58 128.93 55.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.151 0.5 . . . . 0.0 111.551 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.597 HD21 HD12 ' A' ' 43' ' ' ILE . 20.2 mt -122.37 134.2 54.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.847 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 t -110.92 137.57 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 110.964 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.443 ' CD1' HD21 ' A' ' 101' ' ' LEU . 33.6 mt -106.14 137.61 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.518 ' CD1' HD12 ' A' ' 37' ' ' ILE . 9.3 m-85 -118.78 121.96 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.503 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.883 HG12 HD21 ' A' ' 124' ' ' LEU . 4.5 mt -85.47 134.12 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -86.11 113.16 21.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -62.3 -29.15 70.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.996 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -57.4 -42.88 83.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.98 0.419 . . . . 0.0 110.574 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -59.11 -44.0 91.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.923 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -60.94 -33.89 73.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.989 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.54 -45.7 92.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.75 -43.41 79.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.03 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -64.47 -35.93 82.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -60.59 -48.06 83.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.958 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -82.55 -36.0 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.916 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.4 p30 42.78 43.83 3.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.468 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.66 158.72 20.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.918 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.46 129.0 49.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.142 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.18 87.27 6.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 ttt85 -113.88 152.31 30.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.2 pt -76.99 124.28 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.985 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.792 0.329 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -74.51 134.51 42.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.857 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 70.6 mmm -96.55 100.61 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.15 119.29 26.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.428 ' CD2' ' HG3' ' B' ' 172' ' ' PRO . 0.1 OUTLIER -126.26 -49.99 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.03 -78.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.428 ' HG3' ' CD2' ' B' ' 169' ' ' PHE . 69.5 Cg_exo -51.42 112.69 0.87 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.522 2.148 . . . . 0.0 112.323 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -37.37 79.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.734 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 t70 60.01 81.73 0.24 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.83 140.8 43.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.542 2.161 . . . . 0.0 112.34 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 4.0 mt -123.72 130.95 53.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.836 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.93 -179.934 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.82 0.343 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 p -88.15 66.6 8.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -68.18 -41.88 80.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.813 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -35.94 82.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -60.69 -40.2 91.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.28 -41.09 92.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 9.6 mm -69.34 -35.2 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -57.28 -35.36 69.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.421 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -67.32 -23.78 65.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.868 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.63 -47.66 79.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.185 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -80.25 -31.12 38.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.794 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.58 71.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.969 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.68 121.06 31.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.738 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.14 103.12 14.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.3 mm -81.88 138.14 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 121.595 0.712 . . . . 0.0 111.779 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -173.13 102.28 0.17 Allowed Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.572 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -80.47 -33.72 36.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.827 0.346 . . . . 0.0 110.813 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m-20 177.47 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.662 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -76.28 135.06 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.538 -177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.98 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -91.62 -60.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.758 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' SG ' HD22 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -150.08 165.23 33.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.25 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -129.18 138.1 51.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.88 0.372 . . . . 0.0 111.404 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.66 HG21 ' CE2' ' A' ' 68' ' ' PHE . 40.5 t -105.16 122.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.773 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -121.83 124.57 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.321 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.627 ' HA ' HD13 ' A' ' 143' ' ' LEU . 7.0 t -87.08 102.72 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.577 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -76.09 -21.18 56.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.666 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.493 HG21 ' H ' ' A' ' 142' ' ' SER . 82.3 p -79.94 -2.34 43.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.821 0.343 . . . . 0.0 111.599 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.91 74.76 0.39 Allowed Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.818 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -147.49 -41.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.081 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -120.32 141.67 32.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.6 Cg_endo -72.05 140.03 33.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.135 1.89 . . . . 0.0 112.187 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.773 HG12 HG23 ' A' ' 37' ' ' ILE . 45.9 mt -56.41 144.89 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 111.797 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.34 164.08 30.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.916 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -122.73 119.81 31.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.031 0.443 . . . . 0.0 112.029 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 4.2 mp -85.1 129.56 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.98 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.03 155.85 49.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.231 1.015 . . . . 0.0 113.324 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.04 142.86 29.0 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.651 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.625 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -74.91 137.07 41.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.222 0.534 . . . . 0.0 111.058 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.722 HD13 ' SG ' ' A' ' 154' ' ' CYS . 84.1 mt -64.14 -41.44 92.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.896 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.5 m -56.87 -40.72 76.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.94 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 0.4 OUTLIER -68.45 -36.86 79.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.734 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 51' ' ' ASP . 42.5 t -70.83 -38.37 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.09 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.07 -33.52 70.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -50.42 15.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.79 119.39 24.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -135.65 25.47 3.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.989 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -137.87 -52.76 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.672 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -88.37 -166.22 1.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.609 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.436 HG12 ' CG2' ' A' ' 65' ' ' VAL . 7.6 tp -89.66 132.05 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.158 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -65.72 0.7 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.284 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.8 ttpt -153.23 141.22 20.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.464 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.691 HG12 ' HG2' ' A' ' 90' ' ' GLN . 17.7 t -133.59 139.28 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.22 0.533 . . . . 0.0 111.905 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.558 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 19.4 m-90 -103.21 139.21 38.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.524 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -109.95 130.79 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.822 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -120.01 145.44 46.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.622 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.02 -168.44 37.81 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HD2' ' HB2' ' A' ' 84' ' ' LEU . 6.7 mtp-105 -81.76 1.84 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 4.4 t-20 -84.82 134.42 41.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.676 0.274 . . . . 0.0 111.553 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 16.4 Cg_exo -66.65 -13.53 40.3 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.747 2.298 . . . . 0.0 111.756 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -43.85 16.38 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.952 0.882 . . . . 0.0 109.05 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.56 140.17 1.34 Allowed 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.593 . . . . 0.0 111.176 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.7 m-20 -56.35 -18.52 11.15 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.076 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.515 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.6 t80 -129.36 115.29 17.33 Favored 'General case' 0 N--CA 1.457 -0.08 0 CA-C-O 120.761 0.315 . . . . 0.0 110.697 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.474 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 -85.95 115.29 23.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.548 HD22 ' HA2' ' A' ' 69' ' ' GLY . 8.0 mp -91.75 166.05 12.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.66 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.65 -87.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.472 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 178.44 72.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.764 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.788 HD12 HD11 ' A' ' 84' ' ' LEU . 26.1 mt -106.94 116.65 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.403 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -38.19 67.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.86 -23.43 65.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 81' ' ' ILE . 30.3 mt -98.01 151.97 19.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.127 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 m -95.72 165.02 12.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.598 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.632 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -42.85 -52.78 4.95 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 109.782 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.468 ' HB2' HG22 ' A' ' 67' ' ' THR . 15.0 ptmt -119.33 81.77 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -60.21 -46.9 88.15 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.656 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.475 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.9 p90 -144.42 160.77 40.51 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.894 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.691 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.3 tt0 -136.07 142.58 44.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.24 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.784 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 63.6 mt -116.27 127.72 73.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.87 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -113.2 148.57 35.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.139 0.495 . . . . 0.0 111.645 -179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 33' ' ' VAL . 16.2 tp -125.1 123.46 39.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.338 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.66 -140.98 3.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.515 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 63.41 -79.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.845 0.355 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -159.46 -76.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.855 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -132.61 22.15 4.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.516 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.48 ' O ' HD12 ' A' ' 93' ' ' LEU . 68.8 m-20 -115.91 175.25 5.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.773 0.321 . . . . 0.0 110.777 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.636 HD22 ' SG ' ' A' ' 34' ' ' CYS . 4.0 mp -120.92 158.16 28.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.025 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.899 HD23 ' O ' ' A' ' 122' ' ' GLN . 3.2 mt -133.09 146.89 52.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.998 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.722 HD11 HD12 ' A' ' 145' ' ' ILE . 0.8 OUTLIER -112.69 124.97 53.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.481 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 45.4 t30 -115.06 115.56 27.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.882 0.372 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.781 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.9 p30 -79.53 136.78 36.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.072 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.6 pt -145.98 39.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.634 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -100.6 152.85 19.93 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.474 ' CG2' HG22 ' B' ' 173' ' ' THR . 53.1 m -68.92 -31.7 70.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.886 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.4 -19.87 17.47 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.634 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.37 157.35 10.3 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.812 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.98 52.21 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.48 148.68 40.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.868 HD12 HG11 ' A' ' 116' ' ' VAL . 1.1 mt -124.22 113.64 18.56 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.983 177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 46.95 35.82 3.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.212 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.42 -8.84 74.8 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.502 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -106.45 118.53 36.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.111 0.456 . . . . 0.0 110.761 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.35 137.49 48.48 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.212 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.868 HG11 HD12 ' A' ' 111' ' ' LEU . 6.7 m -111.24 168.28 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.7 tt0 -70.18 125.91 28.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.615 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 41.8 tttt -53.31 162.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.998 0.428 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.88 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.14 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.41 145.12 40.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.916 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.879 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.2 m120 -86.68 133.86 33.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.994 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.899 ' O ' HD23 ' A' ' 100' ' ' LEU . 38.2 mm-40 -129.26 148.25 51.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.316 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 tp -72.66 119.78 17.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.418 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.77 HD11 HG21 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -57.49 153.67 12.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.537 0.685 . . . . 0.0 111.474 -179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.459 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 1.2 t -124.31 153.53 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.59 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.464 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 12.7 tp60 -71.54 124.16 24.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.414 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.48 21.54 49.28 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.086 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.516 ' OD2' HD23 ' A' ' 111' ' ' LEU . 11.7 t70 -56.64 172.21 0.26 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.177 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.652 ' HG3' HG22 ' A' ' 144' ' ' VAL . 17.4 tt0 -145.25 135.58 24.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.377 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.949 HD11 HD11 ' A' ' 145' ' ' ILE . 1.3 mp -110.85 128.39 67.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.341 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.727 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.0 m -104.16 137.89 41.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.968 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.535 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.7 m -140.15 158.33 25.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.71 29.88 31.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.909 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -68.52 140.3 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.753 0.787 . . . . 0.0 112.487 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.54 -44.13 0.5 Allowed Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.454 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 32.3 t -126.27 140.75 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -50.86 -42.03 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 6.27 48.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.467 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 4.4 m-20 -112.69 21.37 15.64 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.727 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.27 139.43 29.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.512 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.695 HD23 ' N ' ' A' ' 142' ' ' SER . 5.4 tt -123.41 134.35 53.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.206 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.695 ' N ' HD23 ' A' ' 141' ' ' LEU . 37.4 t -112.69 150.64 31.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.607 0.718 . . . . 0.0 112.932 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.627 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.2 mm? -135.46 139.14 43.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.321 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.652 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.1 t -110.66 140.4 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 111.216 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.949 HD11 HD11 ' A' ' 130' ' ' ILE . 38.8 mt -105.91 127.06 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.071 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.43 117.65 32.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.708 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.623 HG12 HD21 ' A' ' 124' ' ' LEU . 5.8 mt -84.89 134.18 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.11 108.36 17.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.53 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.03 -30.5 66.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -59.66 -45.89 90.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.666 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.54 -44.11 89.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -64.74 -33.97 77.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.023 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -59.26 -46.07 89.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.722 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.9 t -61.74 -46.02 91.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.04 -35.99 74.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.068 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -33.96 76.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.002 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -91.6 -35.24 14.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.026 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.58 90.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.463 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -99.46 114.9 28.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.97 128.16 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.91 113.58 27.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.26 -62.7 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.41 HD12 ' H ' ' A' ' 163' ' ' ILE . 3.6 mp -86.41 129.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.108 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.811 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.791 0.329 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -86.4 114.6 23.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.913 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 6.0 mtt -142.04 151.37 42.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 4.3 t -172.68 131.17 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 2.6 t80 61.47 82.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -30.9 14.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.01 135.63 60.31 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.6 2.2 . . . . 0.0 112.167 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.474 HG22 ' CG2' ' A' ' 106' ' ' THR . 61.5 p -105.43 133.15 50.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -107.01 77.1 0.49 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.05 139.64 39.7 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.512 2.141 . . . . 0.0 112.332 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.62 155.13 28.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.874 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.906 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.748 0.308 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.1 p -120.95 77.39 1.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.959 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -63.21 -47.0 84.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -64.46 -45.35 87.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -60.77 -35.06 75.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.34 -44.1 92.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.731 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 7.5 mm -67.24 -35.02 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.941 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.23 -40.04 76.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.266 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -24.37 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.445 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.9 -47.45 80.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.956 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -77.4 -24.57 50.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.87 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -81.01 58.54 3.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -99.11 147.03 25.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.633 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.77 101.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.707 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 mm -82.91 138.05 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 121.642 0.734 . . . . 0.0 111.655 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 70.22 112.48 0.03 OUTLIER Glycine 0 C--N 1.313 -0.741 0 CA-C-N 114.526 -1.215 . . . . 0.0 112.368 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -87.67 -23.87 24.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.6 0.238 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER 174.69 40.38 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.706 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.4 mm -71.92 134.55 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.627 -177.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.072 HG12 HD21 ' A' ' 99' ' ' LEU . 3.0 t -92.08 -60.57 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.832 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.4 148.92 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.123 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.98 131.38 56.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 111.511 -179.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.595 HG13 HD11 ' A' ' 48' ' ' LEU . 3.6 m -97.94 122.69 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.844 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.796 HG23 HG12 ' A' ' 45' ' ' ILE . 22.3 mt -125.29 129.02 73.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.509 ' SG ' HD21 ' A' ' 141' ' ' LEU . 5.9 t -95.54 101.05 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.732 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -78.11 -19.08 54.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.617 HG21 ' OG ' ' A' ' 142' ' ' SER . 29.1 p -79.93 -2.88 45.74 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.777 0.322 . . . . 0.0 111.429 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.21 69.82 1.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.237 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HB2' HD21 ' A' ' 141' ' ' LEU . 7.5 mt-30 -144.54 -35.11 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.585 0.231 . . . . 0.0 111.413 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.592 HD12 HD21 ' A' ' 143' ' ' LEU . 3.6 mt -127.52 141.0 39.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.732 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.2 Cg_endo -72.49 137.49 28.03 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.166 1.911 . . . . 0.0 112.286 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.796 HG12 HG23 ' A' ' 37' ' ' ILE . 34.5 mt -55.83 141.11 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.755 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -134.06 164.18 27.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.3 m-20 -118.12 119.89 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD11 HG13 ' A' ' 36' ' ' VAL . 2.8 mt -95.39 135.74 36.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.014 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.0 158.52 43.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.56 141.79 30.82 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.511 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.515 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 2.7 m-20 -79.64 129.92 34.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.11 0.481 . . . . 0.0 111.099 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.688 HD13 ' SG ' ' A' ' 154' ' ' CYS . 49.9 mt -64.13 -38.67 83.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.858 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -41.02 76.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.938 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.37 -44.22 75.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.642 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.8 t -62.42 -45.88 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.3 mt -71.01 -28.23 64.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.072 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.31 -46.88 13.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.14 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.26 114.39 9.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.958 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.83 30.45 4.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 169.38 9.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.678 ' O ' HG22 ' A' ' 62' ' ' ILE . 18.6 p -60.64 147.38 42.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 61' ' ' SER . 9.5 tp 51.69 158.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.973 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.14 -61.71 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.059 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.9 ttpt -144.37 133.62 23.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.087 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.707 HG12 ' HG2' ' A' ' 90' ' ' GLN . 12.0 t -126.48 139.15 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.273 0.559 . . . . 0.0 112.091 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.575 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.2 m-90 -101.09 139.38 36.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.7 130.16 55.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.806 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -119.31 145.28 46.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.72 -166.49 35.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.264 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.58 2.35 29.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.754 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.2 t-20 -84.81 132.04 47.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.54 0.21 . . . . 0.0 111.279 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 18.2 Cg_exo -65.46 -15.37 49.39 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.497 2.132 . . . . 0.0 111.44 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.754 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.57 -42.65 18.04 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.946 0.879 . . . . 0.0 108.833 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.26 139.3 1.96 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.836 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' THR . 17.8 m-20 -56.17 -18.8 11.13 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.922 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.552 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.66 124.95 34.9 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.801 0.334 . . . . 0.0 111.197 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.67 107.94 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.65 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.565 HD13 ' CD1' ' A' ' 84' ' ' LEU . 19.5 mt -71.14 -71.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.313 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.26 -78.53 0.11 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.44 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -176.35 48.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 111.254 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.94 111.96 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.941 0.4 . . . . 0.0 110.791 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -39.24 68.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.517 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -21.47 63.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.357 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' CD1' HD13 ' A' ' 78' ' ' LEU . 32.8 mt -103.09 152.07 21.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.822 0.344 . . . . 0.0 111.07 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.9 m -94.56 166.96 11.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.745 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.572 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -44.19 -53.48 6.5 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.416 0.626 . . . . 0.0 109.634 179.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HB2' HD12 ' A' ' 104' ' ' ILE . 1.9 mttt -118.97 82.61 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.4 t60 -59.87 -46.41 89.39 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.634 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.8 p90 -145.75 161.41 39.97 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.163 -0.615 . . . . 0.0 112.091 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.707 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.85 143.43 45.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.995 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.806 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 77.8 mt -117.62 124.2 72.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.237 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.41 147.99 26.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.533 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.949 HD22 HG11 ' A' ' 33' ' ' VAL . 27.9 tp -125.12 122.99 38.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.604 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.55 -156.24 18.13 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.62 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.52 173.4 11.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.819 0.343 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.685 ' HA ' HD12 ' A' ' 155' ' ' LEU . 4.3 t0 58.99 177.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.23 58.59 4.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -141.42 147.3 37.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.394 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.072 HD21 HG12 ' A' ' 33' ' ' VAL . 6.2 mp -124.29 160.1 28.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.813 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.531 HD21 HD12 ' A' ' 145' ' ' ILE . 8.7 mp -112.81 121.51 44.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.008 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.7 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.7 t30 -116.61 115.52 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.772 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.818 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.0 p30 -78.6 139.66 38.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.001 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.6 pt -147.82 38.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.614 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.51 152.6 19.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.102 0.477 . . . . 0.0 111.834 -178.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.96 -31.52 70.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.925 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.15 -19.84 17.66 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.55 156.59 10.23 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.771 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.38 137.89 52.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.75 148.62 39.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.36 18.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.358 177.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 44.4 43.19 5.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.2 -11.15 68.42 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.486 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.13 118.64 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.082 0.441 . . . . 0.0 110.667 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.9 tptm -72.76 129.74 38.9 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.818 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -101.47 166.73 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.453 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.93 126.48 29.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.667 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 17.5 tttt -53.57 163.91 0.59 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.619 0.247 . . . . 0.0 110.365 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.2 m-80 33.35 37.19 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.887 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.1 p -111.71 144.97 40.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.728 ' HB3' HD22 ' A' ' 100' ' ' LEU . 4.9 m120 -91.38 129.4 37.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.737 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.859 ' O ' HD23 ' A' ' 100' ' ' LEU . 61.5 mm-40 -128.47 149.9 50.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.437 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 124' ' ' LEU . 4.0 tt -72.65 136.01 45.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.534 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.847 HD21 HG12 ' A' ' 147' ' ' ILE . 42.6 tp -61.66 153.27 28.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.456 0.646 . . . . 0.0 111.621 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.416 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -125.32 152.66 44.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.561 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 121.73 19.58 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.54 25.6 55.54 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.02 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -51.09 168.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 111.427 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.861 ' CG ' HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -145.16 135.29 23.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.865 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 109' ' ' THR . 15.7 mt -117.37 127.9 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.1 m -104.31 139.36 39.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.122 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.49 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.5 m -140.27 158.25 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.46 33.45 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.093 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.6 t -68.2 140.33 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.604 0.716 . . . . 0.0 112.266 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.04 -40.17 0.85 Allowed Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.246 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 138' ' ' SER . 49.1 t -126.5 131.13 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.62 -35.57 31.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.328 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.54 ' H ' HG12 ' A' ' 136' ' ' VAL . 12.3 p -93.59 6.38 48.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.3 t0 -120.87 22.28 11.14 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.639 ' CG2' HG22 ' A' ' 131' ' ' THR . 8.9 mt -103.69 139.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.926 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.686 HD22 ' CD2' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -121.79 134.42 54.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.64 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.617 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.11 132.0 55.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.065 0.459 . . . . 0.0 111.616 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.686 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.6 mm? -125.39 136.81 53.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.543 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.861 HG22 ' CG ' ' A' ' 129' ' ' GLU . 19.6 t -110.93 139.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.973 0.416 . . . . 0.0 111.343 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.531 HD12 HD21 ' A' ' 101' ' ' LEU . 49.6 mt -106.18 132.93 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.166 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 117.9 31.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.345 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.847 HG12 HD21 ' A' ' 124' ' ' LEU . 5.3 mt -84.77 134.11 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -83.72 109.45 17.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.624 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.52 -31.03 67.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -60.49 -46.0 91.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.907 0.384 . . . . 0.0 110.766 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -59.95 -44.17 94.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.03 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -33.93 77.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.117 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -58.93 -47.14 86.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.18 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.688 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.1 t -64.35 -46.11 84.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.019 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -63.83 -35.91 82.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.793 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -59.72 -39.01 83.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' LYS . 33.1 mt-30 -90.0 -29.37 18.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.03 -90.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.607 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 157' ' ' GLN . 1.6 tmtm? -85.16 123.69 30.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.96 0.41 . . . . 0.0 110.777 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.32 134.9 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.055 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.64 -69.48 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -113.51 147.32 38.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.4 tp -82.25 134.4 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.063 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.856 0.36 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.73 121.4 28.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -151.34 33.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 21.8 p -95.9 74.32 3.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -109.76 -29.96 8.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.67 33.45 15.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.943 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.38 115.94 2.21 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.516 2.144 . . . . 0.0 112.383 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 8.6 p -69.19 -13.66 62.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.263 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 t0 66.95 70.09 0.49 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.765 0.316 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.95 -174.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.506 2.137 . . . . 0.0 112.356 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 6.8 mt -74.8 172.44 12.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.768 0.318 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 p -146.07 -59.45 0.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.48 -46.76 75.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -60.24 -39.06 85.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.8 -41.72 87.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.45 -31.86 69.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.39 -35.41 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.822 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.8 82.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.71 65.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.57 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.78 -47.48 80.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.0 m -80.78 -31.63 35.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.857 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -45.66 90.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.25 128.97 36.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 109.0 20.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -81.95 138.35 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.66 0.743 . . . . 0.0 111.715 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.58 96.27 1.4 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.447 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -77.52 -42.1 36.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.776 0.322 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 179.92 37.61 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.693 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.0 mm -75.43 136.0 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 113.665 -1.607 . . . . 0.0 112.647 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.996 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -93.83 -61.48 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.02 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -145.19 161.74 38.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.261 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.41 138.13 54.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.776 0.322 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.743 HG21 ' HE2' ' A' ' 68' ' ' PHE . 39.4 t -106.22 122.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.867 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.764 HG23 HG12 ' A' ' 45' ' ' ILE . 21.0 mt -126.19 120.89 57.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.507 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.615 ' SG ' HD21 ' A' ' 141' ' ' LEU . 49.8 t -85.91 106.81 17.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.428 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.9 -22.83 58.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.89 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.525 HG21 ' H ' ' A' ' 142' ' ' SER . 61.9 p -79.9 -2.36 43.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.614 0.245 . . . . 0.0 111.544 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.38 72.99 0.59 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.975 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' CB ' HD11 ' A' ' 141' ' ' LEU . 6.1 mt-30 -143.39 -44.74 0.28 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 110.869 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.807 HD12 HD21 ' A' ' 143' ' ' LEU . 2.8 mt -111.78 140.93 23.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.786 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.7 Cg_endo -73.59 132.02 16.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.117 1.878 . . . . 0.0 112.051 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.764 HG12 HG23 ' A' ' 37' ' ' ILE . 35.4 mt -54.08 130.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.579 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 164.13 20.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.42 119.78 38.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 111.567 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 36' ' ' VAL . 8.1 mt -91.5 136.29 33.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.355 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.996 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -146.26 158.37 43.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.79 143.54 29.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.716 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.846 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.0 m-20 -74.98 130.75 39.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.152 0.501 . . . . 0.0 111.236 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.534 HD13 ' SG ' ' A' ' 154' ' ' CYS . 92.0 mt -64.39 -44.92 97.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.054 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -57.67 -40.35 79.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.29 0.567 . . . . 0.0 110.686 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 5.0 mm100 -68.44 -36.93 79.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.782 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 51' ' ' ASP . 40.6 t -72.6 -40.87 63.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.974 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.726 HD11 ' HB2' ' A' ' 158' ' ' ASN . 0.2 OUTLIER -71.03 -35.13 71.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -71.24 -47.87 54.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.789 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.43 100.06 12.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 -30.57 18.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 mtp85 -90.28 159.11 16.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.958 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.84 -168.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.416 HG12 ' CG2' ' A' ' 65' ' ' VAL . 10.1 tp -89.39 154.43 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HG3' HG13 ' A' ' 55' ' ' VAL . 10.4 mmtm -87.14 -67.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.943 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.5 ttpt -149.18 134.08 17.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.921 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.0 t -125.57 139.12 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.149 0.5 . . . . 0.0 112.252 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.617 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.6 m-90 -100.72 139.26 36.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.969 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.685 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.11 128.91 56.62 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.743 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -120.25 145.4 47.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.137 -178.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.83 -169.95 36.61 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.556 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER -75.51 1.02 15.26 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.57 126.27 69.32 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 120.365 0.126 . . . . 0.0 111.005 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 23.6 Cg_exo -64.19 -14.01 41.28 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.395 2.063 . . . . 0.0 111.417 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.87 17.63 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.73 140.98 0.62 Allowed 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.422 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.12 -18.78 10.82 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.736 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -129.45 131.64 46.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.543 179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -102.79 109.08 20.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 78' ' ' LEU . 5.9 mp -94.23 166.92 11.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.09 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.34 159.84 40.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.34 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.52 73.33 0.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.359 . . . . 0.0 111.117 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.641 HD12 HD11 ' A' ' 84' ' ' LEU . 19.3 mt -107.86 114.29 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.505 ' O ' HG22 ' B' ' 171' ' ' TPO . 0.1 OUTLIER -55.83 -34.8 65.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -61.88 -25.99 67.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.214 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.641 HD11 HD12 ' A' ' 81' ' ' ILE . 25.9 mt -96.03 150.4 20.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 m -93.81 166.2 12.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.399 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.555 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.54 -54.82 4.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.422 0.629 . . . . 0.0 109.675 179.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HB2' HG22 ' A' ' 67' ' ' THR . 16.1 ptpt -119.22 82.6 1.89 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.7 t60 -58.96 -46.02 89.08 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.877 -176.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.0 p90 -145.19 160.32 41.63 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.004 -0.678 . . . . 0.0 112.358 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.7 tt0 -135.65 144.06 45.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.954 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.591 ' C ' HG13 ' A' ' 65' ' ' VAL . 50.1 mt -118.76 125.44 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.104 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -101.58 149.39 24.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.985 0.421 . . . . 0.0 111.499 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.79 HD22 HG11 ' A' ' 33' ' ' VAL . 48.7 tp -125.13 122.89 38.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.433 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.46 -141.06 3.59 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.632 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 60.44 -179.38 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -83.42 58.66 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.706 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . 94.25 38.54 5.05 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -136.55 170.52 15.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 0.0 110.985 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.762 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -123.12 159.77 27.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 99' ' ' LEU . 8.5 mp -133.1 143.18 49.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.756 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.699 HD21 HD11 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -112.83 121.37 44.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.864 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.685 ' HB2' HD11 ' A' ' 92' ' ' LEU . 49.2 t30 -116.51 115.55 26.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.96 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.844 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.0 p30 -78.18 139.91 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.776 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 13.8 pt -146.23 38.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.62 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.85 152.13 20.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 120.984 0.421 . . . . 0.0 111.822 -179.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.6 m -68.85 -31.51 70.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.959 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -97.67 -19.82 18.02 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.64 157.12 10.58 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.748 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.2 m -117.45 137.79 52.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.881 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.86 148.56 36.47 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.38 18.35 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.369 177.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.422 ' N ' HD12 ' A' ' 111' ' ' LEU . 21.9 m-20 43.75 43.75 5.15 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.528 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.91 -13.58 62.61 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.532 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -103.97 118.48 36.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.964 0.411 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.881 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.2 tptm -72.25 127.4 32.44 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.844 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.1 m -96.76 164.59 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' SER . 27.1 tt0 -69.89 124.55 24.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.584 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 21.4 tttt -52.82 162.49 0.6 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.1 m-80 34.51 34.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.155 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.22 145.13 40.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.138 179.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.732 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.2 m120 -88.29 129.84 35.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.816 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.8 mm-40 -129.51 148.26 51.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.805 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.9 125.57 27.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.149 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 145' ' ' ILE . 65.0 tp -58.08 156.41 9.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.371 0.605 . . . . 0.0 111.683 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.573 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.66 153.47 42.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.691 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.656 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.8 tp60 -71.24 122.63 20.57 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.31 21.67 54.31 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.764 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 31.8 t70 -49.7 168.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.993 0.425 . . . . 0.0 111.24 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.2 tt0 -145.03 135.45 24.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.839 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 145' ' ' ILE . 2.8 mt -115.49 127.21 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.661 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.635 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.69 138.2 41.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.876 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.7 m -140.12 158.29 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.8 25.77 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.954 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -70.95 140.38 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.64 0.733 . . . . 0.0 112.314 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.88 -40.08 0.59 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.312 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 47.5 t -126.4 136.18 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -50.61 -41.62 55.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.406 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.3 m -93.42 6.29 48.66 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.196 0.814 . . . . 0.0 113.196 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 9.0 t0 -117.5 24.76 10.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.635 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -105.93 139.57 26.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.91 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.615 HD21 ' SG ' ' A' ' 38' ' ' CYS . 5.2 tt -122.03 134.41 54.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.705 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 141' ' ' LEU . 40.0 t -110.61 150.38 29.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.695 0.76 . . . . 0.0 112.548 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.807 HD21 HD12 ' A' ' 43' ' ' ILE . 76.0 mt -135.9 146.76 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.453 -1.248 . . . . 0.0 110.681 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.42 140.31 43.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.742 0.306 . . . . 0.0 111.065 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.026 HD11 HD11 ' A' ' 130' ' ' ILE . 47.2 mt -105.98 126.1 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.347 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -110.55 109.75 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.318 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.4 mp -84.89 134.14 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.021 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.45 106.78 18.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.437 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -58.35 -26.42 63.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.353 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -60.18 -46.04 91.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.994 0.426 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -60.13 -44.28 95.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.152 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -65.16 -33.92 77.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.162 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -40.03 90.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.187 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.534 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.7 t -66.96 -43.71 82.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.706 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -59.62 -36.0 75.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.101 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -43.96 97.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.156 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.22 -36.32 24.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.056 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.726 ' HB2' HD11 ' A' ' 56' ' ' LEU . 3.5 p30 45.16 -173.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.574 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -99.35 125.01 44.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.972 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.4 m -91.85 135.74 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.05 121.55 44.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.94 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.69 120.62 32.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.25 138.13 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.872 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.852 0.358 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 -51.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 5.3 mmt -104.5 -64.19 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.31 156.59 16.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.795 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' B' ' 170' ' ' GLN . 31.9 p90 -177.08 -38.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.032 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . 0.448 ' N ' ' CD1' ' B' ' 169' ' ' PHE . 1.3 mt-30 70.18 -63.75 0.39 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.995 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . 0.505 HG22 ' O ' ' A' ' 82' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' B' ' 169' ' ' PHE . 75.5 Cg_exo -49.55 174.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.563 2.175 . . . . 0.0 112.385 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 2.4 m -152.08 27.52 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.68 88.07 0.13 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.981 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.78 -174.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.55 2.167 . . . . 0.0 112.346 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 61.18 101.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.841 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -101.45 37.03 1.88 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.801 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -43.87 94.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -71.19 -35.82 71.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.488 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.41 ' HB2' ' HB ' ' A' ' 15' ' ' THR . 5.3 m-85 -56.88 -43.17 81.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.569 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.18 -31.85 69.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.205 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.58 HG23 ' HE2' ' A' ' 23' ' ' PHE . 13.7 mt -68.74 -47.99 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.58 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -33.61 73.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.441 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -57.47 -47.11 82.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.952 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.58 ' HE2' HG23 ' A' ' 20' ' ' ILE . 5.1 p90 -71.97 -47.22 53.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.561 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 83.9 p -56.38 -39.47 73.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.074 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.69 84.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -100.61 121.32 41.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -68.53 141.65 55.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.935 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.43 138.1 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.633 0.73 . . . . 0.0 111.897 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.85 31.3 0.11 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.592 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.16 -23.75 22.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.729 0.3 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -145.6 -2.29 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.855 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.62 100.43 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 121.842 0.829 . . . . 0.0 110.807 -179.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.738 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.3 t -50.55 -67.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.937 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.9 p -146.79 165.32 30.04 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.397 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.43 124.2 37.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG13 HD11 ' A' ' 48' ' ' LEU . 3.7 m -88.94 122.79 40.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 111.192 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.858 HG23 HG12 ' A' ' 45' ' ' ILE . 19.8 mt -129.6 119.56 48.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.2 t -80.82 113.5 19.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.399 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 p -86.55 -23.03 25.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.798 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.654 HG21 ' OG ' ' A' ' 142' ' ' SER . 81.7 p -79.91 -2.65 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.714 0.292 . . . . 0.0 111.487 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.84 75.42 0.39 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.551 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' CB ' HD11 ' A' ' 141' ' ' LEU . 9.6 mt-30 -145.29 -40.49 0.24 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 111.09 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.04 HD13 HD22 ' A' ' 78' ' ' LEU . 4.4 mt -125.1 142.74 42.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 43' ' ' ILE . 39.1 Cg_endo -69.19 145.27 59.86 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.203 1.935 . . . . 0.0 112.266 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.858 HG12 HG23 ' A' ' 37' ' ' ILE . 33.3 mt -58.9 150.88 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.738 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -142.27 164.35 30.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.301 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -122.8 119.76 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 0.0 111.756 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.773 HD12 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -100.02 133.17 44.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.139 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.855 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.71 156.82 43.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -142.78 146.71 34.51 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.575 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.6 m-20 -74.86 132.82 41.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.943 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.596 HD13 ' SG ' ' A' ' 154' ' ' CYS . 31.8 mt -63.94 -38.71 83.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.668 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.3 t -56.65 -41.35 77.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.883 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.4 OUTLIER -68.49 -38.15 80.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.553 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG13 ' HD3' ' A' ' 63' ' ' LYS . 37.6 t -70.29 -46.86 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.158 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -28.36 65.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -85.4 -57.03 3.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.25 129.36 39.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.957 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.4 29.8 0.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.29 -60.35 0.67 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 m -94.51 -173.2 2.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.876 HD13 ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -76.78 134.64 28.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.05 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.876 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -81.21 -65.37 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.083 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' CE ' ' O ' ' A' ' 49' ' ' SER . 10.2 ttpt -148.82 117.35 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 91' ' ' ILE . 9.7 p -110.61 139.34 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.94 139.51 36.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.437 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.683 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.71 129.48 56.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 1.0 OUTLIER -118.11 145.27 45.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.881 0.372 . . . . 0.0 111.669 -178.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.54 -172.28 40.25 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.774 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -78.96 0.15 28.65 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.7 135.32 40.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 111.478 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.7 Cg_exo -66.37 -12.95 37.78 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.789 2.326 . . . . 0.0 111.84 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.5 -44.92 15.36 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.874 0.845 . . . . 0.0 108.965 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.15 141.87 1.12 Allowed 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.818 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.0 m-20 -56.22 -18.77 11.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.149 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.545 ' CD2' HD21 ' A' ' 78' ' ' LEU . 4.8 t80 -129.36 127.03 40.22 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-O 120.762 0.315 . . . . 0.0 110.693 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -97.92 108.75 21.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.278 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.04 HD22 HD13 ' A' ' 43' ' ' ILE . 17.1 mt -88.13 170.27 11.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.646 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.19 -86.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.391 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 175.64 69.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.942 0.401 . . . . 0.0 110.594 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 84' ' ' LEU . 25.0 mt -97.48 116.23 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.304 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -54.76 -35.8 64.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.466 ' O ' HG22 ' B' ' 171' ' ' TPO . 4.0 mtp180 -63.6 -42.11 98.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.072 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 81' ' ' ILE . 53.3 mt -72.91 152.13 41.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.876 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -94.39 167.33 11.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.718 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -42.95 -54.82 4.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.413 0.625 . . . . 0.0 109.769 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.683 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.2 OUTLIER -119.02 82.95 1.95 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 177.214 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.0 t60 -58.52 -46.53 86.56 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.411 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.2 p90 -142.41 160.26 40.62 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.794 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.662 ' HG2' HG22 ' A' ' 65' ' ' VAL . 4.3 tt0 -135.95 142.7 44.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.919 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 65' ' ' VAL . 62.1 mt -118.83 129.36 75.15 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.601 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 92' ' ' LEU . 1.9 pt? -118.65 140.61 49.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.842 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.493 HD13 ' CG1' ' A' ' 33' ' ' VAL . 6.7 tp -116.53 122.9 46.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.972 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.464 ' HA2' ' HD2' ' A' ' 63' ' ' LYS . . . -176.07 -141.41 3.83 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.542 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 69.83 -65.76 0.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.746 0.308 . . . . 0.0 110.969 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -167.58 -44.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.29 -38.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.669 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -61.38 171.04 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.912 0.387 . . . . 0.0 110.919 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.714 ' HB3' HD13 ' A' ' 124' ' ' LEU . 2.1 mt -107.45 156.28 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.803 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 121' ' ' ASN . 1.6 mp -129.43 142.62 50.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.138 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.5 HD11 HG12 ' A' ' 130' ' ' ILE . 1.4 tt -112.63 122.39 47.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.33 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.629 ' HB2' HD22 ' A' ' 92' ' ' LEU . 50.2 t30 -113.23 115.49 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.918 0.39 . . . . 0.0 111.402 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.761 ' OD2' HG23 ' A' ' 116' ' ' VAL . 18.0 p30 -79.96 134.37 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.875 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 87' ' ' LYS . 12.1 pt -142.34 40.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.581 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 158.08 15.99 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.082 0.468 . . . . 0.0 111.435 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 85.4 m -68.83 -35.71 77.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.443 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.6 -19.8 17.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.581 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.62 161.31 11.41 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.41 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.52 137.98 52.2 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.856 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.24 148.36 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.05 113.39 18.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.086 177.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 54.1 m-20 44.99 43.02 6.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.71 -7.05 81.28 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.569 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.61 118.55 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.064 0.459 . . . . 0.0 110.704 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.856 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 22.1 tptt -75.1 125.44 28.94 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.18 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.761 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.2 m -99.65 165.95 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.311 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 120' ' ' SER . 21.9 tt0 -69.88 128.75 37.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.372 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.691 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.3 tttt -54.03 163.75 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.3 m-80 33.93 37.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.656 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 5.5 p -111.64 145.06 39.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.977 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.553 HD22 HD11 ' A' ' 92' ' ' LEU . 5.6 m120 -91.43 124.35 35.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -129.25 147.13 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.867 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 tp -72.97 113.47 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.714 HD13 ' HB3' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -55.35 167.39 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.643 0.735 . . . . 0.0 111.823 -179.145 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.27 153.22 43.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.476 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.573 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.59 121.48 18.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.09 22.4 62.71 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.073 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 144' ' ' VAL . 6.8 t70 -60.5 177.16 0.3 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.838 0.352 . . . . 0.0 110.919 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.0 tt0 -145.16 135.66 24.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.501 ' CG2' HG22 ' A' ' 109' ' ' THR . 1.5 mt -108.72 127.04 65.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.105 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.34 136.44 43.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.109 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.524 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.2 m -140.28 158.51 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.46 29.35 30.33 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.072 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 140' ' ' ILE . 65.8 t -68.12 140.37 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.605 0.717 . . . . 0.0 112.406 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.42 -41.46 0.75 Allowed Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 138' ' ' SER . 47.8 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -50.55 -35.1 28.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.868 0.366 . . . . 0.0 111.331 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.54 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.5 t -93.57 6.33 48.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.466 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.4 t0 -120.2 21.9 11.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.678 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.6 mt -105.09 139.71 25.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.95 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.68 HD12 HD11 ' A' ' 81' ' ' ILE . 4.3 tt -122.34 134.4 54.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.929 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.654 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -110.73 133.58 53.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.086 0.47 . . . . 0.0 111.571 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 34.6 mt -126.1 133.23 51.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 128' ' ' ASP . 21.5 t -110.78 140.03 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 111.485 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 91' ' ' ILE . 9.2 mt -106.31 139.15 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.932 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.24 103.91 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 126' ' ' GLN . 8.7 mt -88.31 118.4 33.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.094 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -75.88 127.66 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.016 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.02 -21.71 64.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -44.15 85.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.016 0.436 . . . . 0.0 110.624 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -58.55 -44.02 89.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.732 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -65.2 -40.28 93.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.935 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.408 ' HA ' ' HG2' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -59.03 -38.07 78.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.596 ' SG ' HD13 ' A' ' 52' ' ' ILE . 7.4 t -68.17 -40.1 82.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -50.03 51.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.45 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 153' ' ' GLN . 0.8 OUTLIER -61.11 -33.84 74.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.604 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -37.04 14.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.104 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.48 56.65 3.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.452 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.72 151.19 39.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.617 HG22 ' OD2' ' A' ' 161' ' ' ASP . 12.6 p -99.88 131.06 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.089 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.617 ' OD2' HG22 ' A' ' 160' ' ' VAL . 31.2 m-20 61.11 173.49 0.11 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.849 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.3 43.12 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 7.2 pt -76.94 133.3 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.863 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.787 0.327 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.77 88.5 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.793 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 1.5 mtp -170.04 -44.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.88 87.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -65.82 83.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.7 -31.41 13.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . 0.466 HG22 ' O ' ' A' ' 83' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.87 110.49 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.414 2.076 . . . . 0.0 112.248 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 34.4 p -73.34 165.75 24.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -135.38 63.57 55.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.7 93.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.596 2.197 . . . . 0.0 112.311 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' B' ' 176' ' ' LEU . 6.5 mt -86.47 154.1 21.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.923 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.85 0.357 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.9 p -141.86 -50.2 0.4 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -35.71 77.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -40.5 85.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -38.4 90.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -40.78 96.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.627 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.0 mm -67.62 -48.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.26 -33.65 72.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.35 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.53 -47.14 85.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.017 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.627 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.6 p90 -71.76 -47.43 53.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.146 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.551 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 20.5 p -63.18 -30.52 71.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 60.91 71.77 0.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -69.8 127.06 31.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.98 125.06 23.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.85 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.99 138.29 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.606 0.717 . . . . 0.0 111.699 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.47 74.56 0.06 OUTLIER Glycine 0 C--N 1.313 -0.738 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.54 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.77 -40.2 94.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 175.81 39.36 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.697 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.2 mm -72.02 135.2 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.594 -1.639 . . . . 0.0 112.601 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.007 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -92.65 -59.67 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.35 147.41 29.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.328 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.97 136.59 52.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.354 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.609 HG21 ' HE2' ' A' ' 68' ' ' PHE . 10.7 t -103.23 122.52 55.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.804 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.832 HG23 HG12 ' A' ' 45' ' ' ILE . 15.2 mt -126.59 127.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.358 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' HD21 ' A' ' 141' ' ' LEU . 8.0 t -93.31 115.67 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 0.0 110.596 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.4 t -88.88 -22.64 23.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.428 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.674 HG23 ' HB2' ' A' ' 142' ' ' SER . 67.4 p -79.82 -2.69 44.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.729 0.3 . . . . 0.0 111.48 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.54 71.82 0.83 Allowed Glycine 0 N--CA 1.454 -0.106 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.947 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.682 ' HB2' HD21 ' A' ' 141' ' ' LEU . 4.5 mt-30 -142.9 -40.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.901 HD13 HD22 ' A' ' 78' ' ' LEU . 11.7 mt -122.88 140.77 33.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.66 141.79 28.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.165 1.91 . . . . 0.0 112.076 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.832 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -53.53 149.85 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.696 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' CB ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -143.32 164.18 30.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.316 179.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -122.13 119.85 32.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.068 0.461 . . . . 0.0 111.962 -179.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.2 mt -98.51 136.69 38.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.007 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.2 158.79 44.07 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.8 141.84 29.49 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.712 178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.514 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -75.04 133.26 41.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 110.966 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.706 HD13 ' SG ' ' A' ' 154' ' ' CYS . 65.8 mt -64.08 -39.79 86.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.717 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 p -56.45 -38.99 72.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.754 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -68.52 -44.9 73.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG13 ' HD3' ' A' ' 63' ' ' LYS . 46.2 t -61.77 -46.27 96.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.136 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.0 -28.58 65.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.992 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -83.62 -35.01 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.076 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -79.27 136.79 37.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.07 30.77 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.826 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -91.11 -67.3 0.86 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -172.92 -41.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.106 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.597 HD11 HG22 ' A' ' 65' ' ' VAL . 9.8 tp -127.3 152.93 35.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.176 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.709 ' HD3' HG13 ' A' ' 55' ' ' VAL . 4.9 mttm -122.46 -64.87 1.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.0 ttpt -141.49 132.05 25.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.258 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.613 HG12 ' HG2' ' A' ' 90' ' ' GLN . 7.3 t -127.89 138.19 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.175 0.512 . . . . 0.0 111.739 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.523 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.1 m-90 -100.85 139.12 36.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.207 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.673 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.12 125.94 54.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -112.96 145.68 40.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.475 -178.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.67 -169.1 38.54 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.711 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 8.9 mtp-105 -82.56 0.73 41.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 30.5 t-20 -84.96 132.63 45.21 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.057 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.6 Cg_exo -67.67 -10.26 28.16 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 111.656 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.54 16.9 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.898 0.856 . . . . 0.0 108.759 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.46 139.09 1.15 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.727 -1.579 . . . . 0.0 110.342 179.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.15 -18.79 11.02 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.794 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.491 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.8 131.99 46.36 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.127 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.95 110.13 22.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.572 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.901 HD22 HD13 ' A' ' 43' ' ' ILE . 9.2 mt -85.31 -71.27 0.54 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.466 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.72 -109.61 0.25 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.587 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -163.14 61.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 111.273 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.443 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 28.6 mm -98.65 124.07 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.4 m -54.87 -43.43 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.482 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.402 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 2.5 mmp_? -60.78 -18.19 53.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.411 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD12 ' HB ' ' A' ' 81' ' ' ILE . 17.6 mt -103.48 147.08 27.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.882 0.372 . . . . 0.0 110.722 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 m -93.56 164.74 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.765 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.665 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -42.82 -52.47 5.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.414 0.626 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.578 ' HB3' HG22 ' A' ' 67' ' ' THR . 8.4 mttp -120.45 82.4 1.9 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.7 t60 -60.46 -45.91 91.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.714 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 20.1 p90 -145.07 158.95 43.67 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.648 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.673 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.64 140.94 44.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.554 ' O ' HG13 ' A' ' 65' ' ' VAL . 62.0 mt -117.31 132.04 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.098 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -109.98 147.11 34.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.073 0.463 . . . . 0.0 111.652 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.699 HD22 HG11 ' A' ' 33' ' ' VAL . 26.9 tp -125.13 122.96 38.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' HA2' ' CE ' ' A' ' 63' ' ' LYS . . . 162.58 -178.96 38.16 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.545 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.34 90.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.784 0.326 . . . . 0.0 110.983 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.23 -174.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.819 ' HA2' HD22 ' A' ' 155' ' ' LEU . . . -79.19 60.1 4.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.451 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -139.82 177.61 7.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.641 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -135.09 156.72 48.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.641 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.5 mp -132.98 141.96 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.522 ' CD2' HD11 ' A' ' 130' ' ' ILE . 4.5 mp -112.56 127.35 56.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.155 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 43.5 t30 -115.89 115.58 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 111.702 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.825 ' OD2' HG23 ' A' ' 116' ' ' VAL . 19.0 p30 -77.37 135.33 38.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.676 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.552 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.0 pt -143.94 41.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.87 161.13 13.8 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.096 0.474 . . . . 0.0 111.503 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 86.6 m -68.91 -38.8 79.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.698 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.63 -19.7 17.4 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 123.99 161.81 11.24 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.088 -1.053 . . . . 0.0 114.01 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 17.4 m -117.6 137.87 52.32 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.224 0.61 . . . . 0.0 109.565 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.854 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.11 148.43 37.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 114' ' ' GLN . 0.3 OUTLIER -124.65 113.52 18.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 47.05 42.26 12.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.0 -10.15 71.76 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.863 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.777 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -105.52 118.7 37.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.245 0.523 . . . . 0.0 110.765 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.2 tptt -73.13 134.43 44.46 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.349 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.825 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -107.01 166.58 3.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.334 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 2.6 mm-40 -69.88 123.96 22.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.553 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 75.7 tttt -52.95 163.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.988 0.423 . . . . 0.0 110.513 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER 36.09 33.19 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.032 -179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.35 145.08 40.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.105 179.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.78 131.94 36.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.955 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 62.0 mm-40 -129.37 151.79 49.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.644 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.7 tt -72.83 133.33 44.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.758 0.313 . . . . 0.0 110.238 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.648 HD11 HG21 ' A' ' 145' ' ' ILE . 66.9 tp -65.15 154.85 36.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.512 0.672 . . . . 0.0 111.668 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.409 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -124.92 153.09 43.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.75 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 123.69 23.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.358 . . . . 0.0 110.106 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.27 21.43 47.4 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.173 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -51.11 172.21 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.834 0.35 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.844 ' CG ' HG22 ' A' ' 144' ' ' VAL . 7.8 mt-10 -144.87 135.56 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.028 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.522 HD11 ' CD2' ' A' ' 101' ' ' LEU . 5.5 mt -118.51 124.84 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.567 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.32 140.47 37.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.896 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 26.8 m -140.29 158.26 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.61 30.23 24.77 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.873 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.588 ' HA ' HG12 ' A' ' 140' ' ' ILE . 61.7 t -71.17 140.44 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.645 0.736 . . . . 0.0 112.385 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.4 ' HA3' ' NH1' ' A' ' 83' ' ' ARG . . . 154.06 -38.52 0.69 Allowed Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.341 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 138' ' ' SER . 50.4 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.59 -37.03 37.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.793 0.33 . . . . 0.0 111.479 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.503 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.6 m -93.53 6.52 47.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.1 t0 -124.34 26.51 7.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 134' ' ' VAL . 6.5 mt -105.93 139.68 26.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.634 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 42' ' ' GLN . 1.2 tt -120.93 134.16 55.29 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.069 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.674 ' HB2' HG23 ' A' ' 40' ' ' THR . 3.0 m -108.56 143.71 37.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.576 ' CD2' HD22 ' A' ' 141' ' ' LEU . 3.0 mm? -135.48 144.18 46.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.534 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.844 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.3 t -114.13 136.53 50.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.749 0.309 . . . . 0.0 111.037 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.648 HG21 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -106.57 126.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.111 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.436 ' CD1' HD12 ' A' ' 37' ' ' ILE . 5.4 m-85 -112.95 121.78 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.665 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.532 HG12 HD21 ' A' ' 124' ' ' LEU . 3.5 mt -85.05 134.14 27.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.395 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.85 109.0 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.756 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -62.15 -42.44 99.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -46.02 90.8 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -59.3 -44.09 92.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -33.87 77.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.85 -41.91 88.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.706 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.0 t -67.79 -44.53 77.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.014 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.819 HD22 ' HA2' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.3 -42.24 75.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.09 -48.07 59.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.471 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.7 -37.15 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.186 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p30 42.43 31.4 0.27 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.486 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -125.12 162.05 25.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.011 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.63 132.99 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.03 127.99 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.004 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.07 148.2 34.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.16 110.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.882 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.787 0.327 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 2.9 mtmt -107.52 105.26 15.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.89 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.03 124.18 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.851 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' B' ' 170' ' ' GLN . 11.6 p90 -112.09 -35.89 5.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.965 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . 0.423 ' N ' ' CD1' ' B' ' 169' ' ' PHE . 0.2 OUTLIER 67.92 -70.64 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' B' ' 169' ' ' PHE . 63.2 Cg_exo -51.62 139.33 48.02 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.653 2.235 . . . . 0.0 112.274 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.78 20.98 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.176 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.78 101.09 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.947 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.18 101.92 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.409 2.072 . . . . 0.0 112.273 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 mt -124.02 -171.43 2.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.807 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 120.936 0.398 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.99 79.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.702 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.8 -47.13 69.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.983 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -62.84 -35.99 81.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.5 -38.65 91.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 tp -63.05 -45.05 94.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.942 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 14.1 mm -66.98 -34.99 73.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -40.22 76.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.987 0.422 . . . . 0.0 110.445 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -67.26 -23.84 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.53 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.75 -47.36 80.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.198 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -60.24 -32.79 71.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -123.44 45.0 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -73.91 129.35 37.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.99 101.98 11.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.813 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.2 mm -84.7 138.27 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.661 0.744 . . . . 0.0 111.747 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.9 28.38 26.23 Favored Glycine 0 C--N 1.313 -0.703 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.483 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -75.78 -46.34 31.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.944 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -170.2 34.95 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -77.79 133.2 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 113.787 -1.552 . . . . 0.0 112.561 -177.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.015 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -89.92 -61.02 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.28 148.42 28.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.308 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -115.92 127.7 55.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 68' ' ' PHE . 43.5 t -97.27 122.75 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 111.02 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.908 HG23 HG12 ' A' ' 45' ' ' ILE . 12.3 mt -120.62 128.45 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.73 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.3 t -81.87 121.51 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.475 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.5 t -88.15 -27.12 22.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.634 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 142' ' ' SER . 35.4 p -79.94 -2.17 42.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.545 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 77.2 0.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.84 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -146.86 -44.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.574 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -113.54 141.51 26.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.91 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.574 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.6 Cg_endo -71.14 145.81 50.19 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.017 1.811 . . . . 0.0 112.037 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.908 HG12 HG23 ' A' ' 37' ' ' ILE . 39.0 mt -56.69 143.91 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.916 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.03 163.3 33.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.813 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.67 120.53 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 112.178 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.746 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.8 mp -84.7 128.3 34.53 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.015 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -133.48 155.92 48.69 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -155.37 141.94 18.77 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.268 -1.787 . . . . 0.0 110.304 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -82.06 143.26 31.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.145 0.498 . . . . 0.0 111.33 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 52' ' ' ILE . 2.3 mp -64.27 -41.47 92.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.542 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -56.98 -38.66 73.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.43 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.5 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 2.5 mm-40 -68.48 -37.04 79.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.475 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 51' ' ' ASP . 43.4 t -73.12 -42.53 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.158 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.812 HD21 ' HD2' ' A' ' 159' ' ' LYS . 2.2 tp -66.14 -33.89 76.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.887 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -53.82 16.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.94 110.62 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.96 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.08 -29.13 15.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.37 166.54 14.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.19 -178.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.452 HG12 HG22 ' A' ' 65' ' ' VAL . 10.1 tp -85.01 153.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.012 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 7.1 mptt -87.02 -74.3 0.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.023 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.2 ttpt -133.17 134.86 44.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.655 HG12 ' HG2' ' A' ' 90' ' ' GLN . 9.6 t -131.1 139.21 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.272 0.558 . . . . 0.0 112.423 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.746 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.2 m-90 -103.38 139.51 38.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.057 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.697 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.93 127.19 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.154 0.502 . . . . 0.0 110.223 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.583 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -113.6 146.26 40.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.757 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.75 ' CA ' HD23 ' A' ' 78' ' ' LEU . . . 169.61 -174.87 43.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.487 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -87.06 45.65 1.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.735 0.302 . . . . 0.0 111.495 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -141.11 139.07 18.59 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.5 Cg_exo -68.27 -6.48 17.49 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.875 2.383 . . . . 0.0 111.904 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.33 11.14 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.88 0.848 . . . . 0.0 109.279 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.95 141.81 1.05 Allowed 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.96 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -56.41 -19.27 14.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.966 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.583 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 44.8 t80 -129.89 122.68 29.11 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.797 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -88.92 107.83 19.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.793 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD23 ' CA ' ' A' ' 69' ' ' GLY . 1.7 mm? -68.63 -82.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.038 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.85 -96.3 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.535 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -167.05 60.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 111.199 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 23.6 mm -112.18 115.68 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.023 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.5 p -55.21 -34.65 64.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.27 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.86 -23.26 65.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.206 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 132' ' ' VAL . 14.5 mt -97.49 147.73 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 111.084 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.17 164.75 12.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.998 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.639 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -42.44 -52.05 4.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.447 0.641 . . . . 0.0 109.847 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -120.51 79.92 1.55 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.5 t60 -60.87 -47.23 87.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.538 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 17.5 p90 -146.48 159.07 43.89 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.552 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.697 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -135.84 141.2 44.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.656 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 65' ' ' VAL . 37.2 mt -115.48 130.51 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.075 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.954 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -122.39 139.21 54.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.047 0.451 . . . . 0.0 111.839 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.809 HD22 ' CG1' ' A' ' 33' ' ' VAL . 4.4 tp -125.35 129.47 50.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.967 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.44 -30.27 0.86 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.714 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -53.76 -29.05 38.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.744 0.307 . . . . 0.0 111.26 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -171.26 -175.57 1.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.25 -21.39 39.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -94.32 -176.39 3.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.699 0.285 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.851 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -106.92 159.6 16.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.777 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.659 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -123.18 139.38 54.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.568 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -112.8 120.06 40.18 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.981 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.954 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.7 t30 -116.82 119.97 37.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.402 . . . . 0.0 112.057 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.829 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.3 p30 -79.87 141.0 36.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.982 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -147.06 36.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.428 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.651 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.53 149.81 21.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.128 0.489 . . . . 0.0 112.043 -178.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.0 m -68.62 -31.55 70.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.682 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -97.18 -19.75 18.41 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.652 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.651 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.12 156.15 10.42 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.604 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.9 m -117.45 137.81 52.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.876 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -114.31 148.62 37.24 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.35 18.23 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.452 177.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' N ' HD12 ' A' ' 111' ' ' LEU . 5.5 m-80 43.43 43.74 4.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.499 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.3 -13.71 62.9 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.418 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -103.38 118.54 36.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.027 0.442 . . . . 0.0 110.628 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.876 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 4.6 tptm -72.66 127.6 33.05 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.829 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.0 m -97.89 162.95 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.17 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.6 tt0 -69.99 126.9 31.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.489 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.655 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttm -52.09 160.79 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.479 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 35.75 33.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.41 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.51 118.04 34.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.106 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.912 ' ND2' HD11 ' A' ' 92' ' ' LEU . 14.3 m120 -66.01 135.16 54.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 33.1 mm-40 -129.48 151.14 50.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.525 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.8 tm? -72.77 132.71 43.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.851 HD22 ' HB2' ' A' ' 99' ' ' LEU . 44.0 tp -58.1 152.56 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.713 . . . . 0.0 111.694 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.42 152.63 44.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.645 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -72.51 123.35 22.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.253 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.31 23.42 41.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.085 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.7 t70 -49.12 167.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.015 0.436 . . . . 0.0 111.429 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.909 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.4 mt-10 -144.8 135.44 24.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.872 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.007 HD11 HD11 ' A' ' 145' ' ' ILE . 1.1 mp -117.35 127.81 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.915 0.388 . . . . 0.0 110.748 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.624 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.67 138.12 41.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.933 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 84' ' ' LEU . 34.8 m -140.31 158.06 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 112.217 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 30.93 25.2 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.811 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -70.83 140.41 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.644 0.735 . . . . 0.0 112.452 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.48 -41.0 0.47 Allowed Glycine 0 N--CA 1.434 -1.467 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.374 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 138' ' ' SER . 49.2 t -126.47 134.74 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 115.1 -0.55 . . . . 0.0 109.519 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -38.67 48.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.781 0.325 . . . . 0.0 111.467 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.496 ' H ' HG12 ' A' ' 136' ' ' VAL . 57.9 m -93.42 6.32 48.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.448 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 6.9 t0 -121.36 26.95 8.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.7 mt -107.1 139.65 27.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.948 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 134.43 55.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.786 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.611 ' C ' HD22 ' A' ' 143' ' ' LEU . 47.3 t -112.11 150.78 30.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.518 0.675 . . . . 0.0 112.282 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.2 mm? -135.62 155.53 50.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.909 HG22 ' CG ' ' A' ' 129' ' ' GLU . 19.2 t -125.6 140.21 49.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.825 0.345 . . . . 0.0 111.431 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.007 HD11 HD11 ' A' ' 130' ' ' ILE . 34.0 mt -106.46 123.08 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.165 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.524 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -109.98 116.83 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.46 179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.763 HG12 HD21 ' A' ' 124' ' ' LEU . 4.4 mt -86.27 134.21 27.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.608 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.78 122.91 27.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.649 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.28 -36.82 77.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -59.12 -45.37 91.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.054 0.454 . . . . 0.0 110.719 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -57.81 -44.11 86.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -60.99 -34.01 74.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.218 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -60.38 -47.26 86.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.348 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.5 t -68.24 -42.44 79.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.045 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.45 -35.87 82.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.74 -45.26 93.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.929 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 159' ' ' LYS . 42.1 mm-40 -84.58 -31.02 24.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.966 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.05 -90.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.618 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.812 ' HD2' HD21 ' A' ' 56' ' ' LEU . 3.8 mttm -125.0 148.68 48.34 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.812 0.339 . . . . 0.0 110.816 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.3 p -86.47 126.25 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 14.4 t70 60.49 97.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.75 131.93 12.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.806 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.3 mm -101.8 133.18 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.187 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.831 0.348 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -154.13 143.81 21.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.766 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 7.8 tpp -158.63 84.5 0.83 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 3.4 t -77.11 -38.55 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.817 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -101.78 152.1 21.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.85 38.4 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' TPO . . . . . 0.631 ' O3P' HG22 ' B' ' 171' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.5 140.65 44.03 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.621 2.214 . . . . 0.0 112.37 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 3.9 t -134.11 43.66 2.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 60.98 74.6 0.51 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.31 172.69 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.59 2.194 . . . . 0.0 112.31 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' LEU . . . . . . . . . . . . . 17.0 mt -137.94 159.75 41.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.958 179.969 . . . . . . . . 0 0 . 1 stop_ save_